{
  "evaluation_metadata": {
    "evaluator_name": "LLM-as-Judge Evaluator (Model: qwen3-235b-reasoning)",
    "evaluator_model": "qwen3-235b-reasoning",
    "model_evaluated": "gpt-oss-120b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions_in_experiment": 600
  },
  "evaluation_results": [
    {
      "question_id": 1,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive (CL) compare to the total number of securities related to stock options, restricted stock units, and performance stock units available for future issuance at Procter & Gamble (PG)?",
      "original_answer": "Colgate-Palmolive (CL) reported 37,028,000 securities remaining available under equity compensation plans approved by security holders. Procter & Gamble (PG) disclosed that under similar plans, they had 133,185,995 total securities related to stock options, restricted stock units, and performance stock units available for future issuance. This indicates that PG has significantly more securities available for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reports that, as of December 31 2021, equity‑compensation plans approved by security holders have **37,028 (thousands) ≈ 37 million** securities still available for future issuance【page_61】.  \n\nProcter & Gamble’s 2019 Stock and Incentive Compensation Plan – the only plan that can issue new awards – provides **about 119 million** shares that can still be granted for stock options, RSUs and PSUs【page_69】.  \n\nThus, PG’s pool of future‑issuable securities (≈ 119 million) is roughly three times larger than CL’s (≈ 37 million).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's 37,028,000 (37 million) securities available, matching the ground truth. However, it reports Procter & Gamble's total as 'about 119 million', which is incorrect — the ground truth is 133,185,995. This is a significant numerical discrepancy (~14 million fewer), affecting quantitative accuracy. (2) The calculation of 'three times larger' is based on incorrect input (119M vs 37M), leading to an inaccurate comparison; the correct ratio is ~3.6x (133.2M / 37M), not ~3.2x. (3) The multi-hop reasoning is sound: the model correctly identifies both companies, the relevant equity compensation plans, and the types of securities (stock options, RSUs, PSUs). It synthesizes across two entities and correctly interprets 'available for future issuance'. (4) The use of '≈ 37 million' and '≈ 119 million' is acceptable for rounding, but '119 million' is not a valid approximation of 133,185,995 — this is a material error. The year 2021 for CL is plausible, but PG's figure comes from a later period in the knowledge graph, and citing 2019 may reflect outdated data. Despite this, the core structure and intent of the answer are correct, and the conclusion that PG has significantly more than CL is valid, though the magnitude is understated. Hence, correctness is reduced to 7 due to the major numeric inaccuracy, but qualitative reasoning and relevance remain strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 395,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the sensitivity of Google's foreign exchange forward contracts to a 10% weakening of the U.S. dollar compare with Disney's hedge coverage for forecasted foreign currency transactions in terms of notional exposure and risk mitigation horizon?",
      "original_answer": "Google's foreign exchange forward contracts would result in a $660 million impact on AOCI as of December 31, 2024, from a 10% weakening of the U.S. dollar, reflecting its net investment hedge strategy. In contrast, Disney hedges forecasted foreign currency transactions with a notional exposure of $9.9 billion as of September 28, 2024, and maintains coverage for periods generally not exceeding four years. While Google focuses on offsetting translation risk from foreign subsidiaries, Disney aims to stabilize earnings and cash flows by hedging forecasted transactions in major currencies like the euro and Japanese yen.",
      "llm_answer": "Google’s foreign‑exchange forward contracts are very sensitive to a 10 % dollar weakening – the company says a 10 % drop in the U.S. dollar would cut the cumulative translation adjustment in AOCI by roughly $946 million (2023) to $660 million (2024), and would lower the AOCI impact of its cash‑flow hedges by about $1.5 billion‑$1.6 billion 【page_47】. In contrast, Disney’s hedge program covers about $9.9 billion of forecasted foreign‑currency transactions (down from $8.3 billion a year earlier) and is designed to protect exposures for periods generally not to exceed four years 【page_121】.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Google's $660 million AOCI impact as of 2024 from a 10% weakening of the U.S. dollar, which matches the ground truth. However, it introduces additional figures not present in the original answer—specifically a $946 million AOCI impact for 2023 and a $1.5–1.6 billion reduction in cash-flow hedges—which were not part of the ground truth and may reflect over-extrapolation or confusion with other disclosures. These additions do not align with the provided knowledge graph answer and introduce inaccuracies. (2) The Disney notional exposure of $9.9 billion as of September 28, 2024, and the four-year risk mitigation horizon are accurately reported and match the ground truth. The mention of a decrease from $8.3 billion the prior year adds context but does not contradict the original. (3) The multi-hop reasoning is mostly sound: the model correctly contrasts Google’s net investment hedge strategy (affecting AOCI) with Disney’s cash flow hedging of forecasted transactions. However, the LLM mischaracterizes Google’s exposure by blending AOCI impacts across years and introducing cash-flow hedge effects not mentioned in the ground truth, weakening the precision of the comparison. (4) Despite these quantitative deviations, the core facts—Google’s $660M AOCI sensitivity and Disney’s $9.9B notional hedge coverage with a ≤4-year horizon—are correct, and the overall intent and structure of the comparison are valid. Hence, the answer is largely accurate but penalized for introducing unsupported numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 428,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Procter & Gamble compare to Colgate-Palmolive’s available securities, considering both companies disclose these figures under similar categories?",
      "original_answer": "Procter & Gamble reports that there are 133,185,995 securities remaining available for future issuance under equity compensation plans approved by security holders, while Colgate-Palmolive discloses 37,028,000 securities remaining available under the same category. This indicates that P&G has a significantly larger pool of available securities for future equity compensation compared to Colgate-Palmolive.",
      "llm_answer": "Procter & Gamble reports that roughly **119 million shares** remain available for future issuance under equity‑compensation plans approved by security holders (see PG 10‑K p. 69 footnote (1)). Colgate‑Palmolive reports about **37 million shares** (37,028 thousand) available under the same category (see CL 10‑K p. 61). Thus, PG’s pool of issuable securities is about three times larger than CL’s.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's available securities as 37,028,000 (rounded to 37 million), which matches the ground truth. However, it reports Procter & Gamble's figure as approximately 119 million shares, while the ground truth is 133,185,995—this is a significant numerical discrepancy (~14 million shares off). The source citation (PG 10-K p. 69 footnote (1)) may reflect a different reporting period or misreading of the data. (2) Quantitative accuracy is reduced due to the incorrect P&G number, though the Colgate figure is exact and the comparison direction (P&G > Colgate) remains valid. The 'three times larger' claim is inaccurate: 133M / 37M ≈ 3.6x, but 119M / 37M ≈ 3.2x—still in the ballpark, but based on flawed input. (3) The reasoning is sound: the model correctly synthesizes data from both 10-K filings, identifies the relevant metric, and draws a valid comparative conclusion despite the number error. It demonstrates proper multi-hop logic by retrieving and comparing figures from two companies. (4) Contextual relevance is perfect—the answer directly addresses the comparison question using the correct category and entities. Overall, the core conclusion (P&G has significantly more available securities) is preserved, but the incorrect P&G number reduces quantitative and overall correctness scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 377,
        "total_tokens": 1612
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does AbbVie's patent litigation against Sandoz Inc. over upadacitinib relate to Amgen's legal strategy in defending its own patents against Sandoz's counterclaims regarding denosumab biosimilar development?",
      "original_answer": "AbbVie is actively enforcing its patents for upadacitinib (Rinvoq) by suing Sandoz Inc. and other generic drug manufacturers, seeking injunctive relief to prevent premature market entry of generic versions. Meanwhile, Amgen faces litigation from Sandoz Inc., which has filed counterclaims asserting that Amgen's asserted patents for denosumab are invalid or unenforceable. Both companies are engaged in high-stakes patent battles involving Sandoz Inc., but while AbbVie is in the offensive position protecting its drug exclusivity, Amgen is defending its intellectual property against Sandoz's legal challenges, revealing contrasting legal dynamics in the biopharmaceutical patent ecosystem.",
      "llm_answer": "AbbVie’s case is a straightforward infringement suit – in November 2023 it filed a Delaware action accusing Sandoz of infringing AbbVie’s upadacitinib patents and asked the court for declaratory and injunctive relief (see ABBV 10‑K p. 95). Amgen’s denosumab litigation follows a similar defensive line but adds a layered response: it sued Sandoz in New Jersey for infringing its denosumab patents, sought a permanent (and preliminary) injunction and monetary damages, and simultaneously moved to dismiss Sandoz’s counterclaims that the patents are invalid or unenforceable (see AMGN 10‑K p. 156). Thus, both firms are using patent suits to protect exclusivity against Sandoz, while Amgen’s strategy explicitly includes combating Sandoz’s validity challenges in addition to seeking an injunction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: AbbVie filed a patent infringement suit against Sandoz over upadacitinib in November 2023 (per ABBV 10-K p.95), seeking injunctive and declaratory relief—this matches the original answer’s description of AbbVie being in an offensive position. Amgen sued Sandoz over denosumab patents and moved to dismiss Sandoz’s counterclaims of invalidity or unenforceability (per AMGN 10-K p.156), accurately reflecting Amgen’s defensive posture. (2) Quantitative accuracy is perfect: the date (November 2023) is correctly cited, and no numerical errors are present. Format references to filings (10-K pages) are precise and support the claims. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across two companies (AbbVie and Amgen), their respective drugs (upadacitinib and denosumab), and opposing legal strategies (offensive vs. defensive) involving the same generic manufacturer (Sandoz). The contrast in legal dynamics is clearly articulated. (4) The only minor shortcoming is that the LLM does not explicitly use the term 'contrasting legal dynamics in the biopharmaceutical patent ecosystem' as in the original, but it effectively conveys the same insight by stating that both firms protect exclusivity while Amgen additionally combats validity challenges. Wording differs slightly but semantic equivalence is maintained. No factual omissions or inaccuracies affect the core correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 415,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's multi-class stock structure, particularly in light of the $62.2 billion in Class A and Class C shares repurchased by GOOGL in 2023?",
      "original_answer": "GOOGL repurchased $62.2 billion of its Class A and Class C shares in 2023, maintaining a multi-class structure where Class B shares carry 10 votes per share and convert automatically upon sale or transfer to Class A, which has 1 vote per share. In contrast, CMCSA's Class B shares carry 15 votes and are convertible share-for-share into Class A shares, with Class B's aggregate voting power capped at 33 1/3% and protected from dilution under its articles of incorporation. This means CMCSA has a stronger anti-dilution mechanism for its Class B shares compared to GOOGL, where Class B shares lose their enhanced voting rights upon conversion. Additionally, GOOGL's repurchase activity in 2023 may have concentrated voting control among remaining Class B shareholders by reducing the total number of Class A shares outstanding.",
      "llm_answer": "CMCSA’s charter locks the voting power of its Class B shares at roughly one‑third of all votes (each B share gets 15 votes) and the aggregate B voting percentage is “generally non‑dilutable” – a share‑for‑share conversion of B to Class A simply shifts votes to the A shares without reducing the B holders’ 33 % voting stake【page_91】. Alphabet’s system is the opposite: Class B carries ten votes per share, Class A only one, and Class C none, and the $62.2 billion repurchase of Class A and C shares in 2023 stripped out a large pool of low‑vote stock, thereby concentrating voting power in the high‑vote Class B holders【page_81】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinctions between CMCSA's and GOOGL's multi-class stock structures with correct quantitative details. (1) All numbers are correct: $62.2 billion repurchase by GOOGL in 2023, 15 votes per CMCSA Class B share, 10 votes for GOOGL Class B, 1 vote for Class A, and 33 1/3% voting cap for CMCSA Class B—all match the ground truth. Minor phrasing 'roughly one-third' is acceptable for 33 1/3%. (2) The answer correctly identifies that CMCSA’s Class B voting power is protected from dilution and that conversion is share-for-share into Class A without reducing the aggregate 33% voting stake, which aligns with the anti-dilution mechanism in the original answer. (3) For GOOGL, it accurately notes that Class B has 10 votes, Class A has 1, Class C has none, and the repurchase of Class A and C shares concentrates voting power among Class B holders—this reflects the correct multi-hop reasoning about how repurchases affect control. (4) The only minor shortcoming is that the LLM does not explicitly state that GOOGL’s Class B shares convert to Class A (with loss of super-voting rights) upon sale or transfer, which is a key contrast to CMCSA’s structure where voting power is preserved. However, the emphasis on post-repurchase concentration of control captures the practical effect. The answer is semantically equivalent in intent and fact, with excellent contextual relevance and strong qualitative reasoning. Hence, a score of 9 is justified—excellent but missing one structural detail about GOOGL’s conversion mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 430,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does the number of shares reserved for future issuance under Nike's Equity Compensation Plan compare to the number of shares represented by outstanding warrants at Tesla, based on their respective 2023 filings?",
      "original_answer": "Nike reported 97,567,370 shares remaining available for future issuance under its Equity Compensation Plan, while Tesla disclosed that 11 million shares were represented by outstanding warrants in 2023. Therefore, Nike's available shares under its equity plan are significantly higher than Tesla's outstanding warrants.",
      "llm_answer": "Nike’s 2023 filing does not disclose a specific count of shares reserved for future issuance under its Equity Compensation Plan in the excerpts provided – the filing only references that the details are in the proxy statement 【page_96】. Tesla’s 2023 filing, however, shows that outstanding warrants represent 11 million shares (the “Warrants” line in the diluted‑share reconciliation) 【page_63】. Because Nike’s reserved‑share figure isn’t given in the available pages, a direct numeric comparison cannot be made.",
      "correctness_score": 3,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that Nike's 2023 filing does not disclose the number of shares reserved for future issuance, claiming it is only in the proxy statement. However, the ground truth confirms that Nike's filing does report 97,567,370 shares available for future issuance under its Equity Compensation Plan in the 2023 10-K. This number is missing from the LLM's response, leading to a major factual omission. Tesla's figure of 11 million shares from outstanding warrants is correctly identified and matches the ground truth. (2) Quantitatively, Tesla's 11 million is accurate, but Nike's 97.5 million is entirely absent, making the comparison incomplete and incorrect. The LLM claims a direct comparison cannot be made due to missing data, which contradicts the actual availability of the Nike figure in the source. (3) The reasoning is flawed because it fails to recognize that the Nike data is indeed present in the 10-K (not just the proxy), undermining the multi-hop synthesis required to compare the two companies' share figures. The model should have extracted and compared both numbers. (4) While the response is relevant and correctly interprets Tesla's data, the failure to report a key factual number and draw the correct comparison significantly reduces correctness. The contextual relevance is moderate because it addresses the right documents and concepts, but the conclusion is factually incorrect due to the missing Nike data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1224,
        "completion_tokens": 406,
        "total_tokens": 1631
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the number of shares issuable upon exercise of outstanding warrants disclosed by Tesla in 2023 compare to the number of shares remaining available for future issuance under Nike's equity compensation plans, based on their respective disclosures?",
      "original_answer": "Tesla disclosed that in 2023, there were 11 million shares issuable upon exercise of outstanding warrants. In contrast, Nike, through its equity compensation plan disclosures, indicated that 97,567,370 shares were remaining available for future issuance under compensation plans. This highlights a significant difference in scale between Tesla's warrant-related share exposure and Nike's available equity compensation pool.",
      "llm_answer": "Tesla reported that its outstanding warrants could be exercised for about 11 million shares in 2023 (TSLA 10‑K, p. 63). Nike disclosed that roughly 97.6 million shares remain available for future issuance under its equity‑compensation plans (Nike 10‑K, p. 101). Consequently, Tesla’s warrant‑related share count is only about one‑tenth of the shares Nike still has available under its compensation plans.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Tesla's 11 million shares (LLM: 'about 11 million') and Nike's 97,567,370 shares are correctly reported as approximately 97.6 million, which is a valid rounding. (2) The comparison stating Tesla’s warrant-related share count is 'about one-tenth' of Nike’s available pool is logically sound: 11 million is roughly 11.3% of 97.6 million, which supports the 'one-tenth' approximation. (3) Entity accuracy is correct—Tesla (TSLA) and Nike are properly identified with accurate fiscal year (2023) disclosures. (4) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies and filings, comparing warrant-issuable shares to equity compensation availability. (5) Semantic equivalence is maintained—the LLM conveys the same core insight as the original answer: a significant scale difference between the two figures. All sources are correctly cited with page numbers from the respective 10-Ks. No factual, numerical, or reasoning errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1233,
        "completion_tokens": 313,
        "total_tokens": 1547
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does the differential voting power per share in GOOGL's Class B common stock impact its corporate governance structure, compared to NFLX's uniform voting rights model where each share carries one vote?",
      "original_answer": "GOOGL's Class B common stock provides 10 votes per share, significantly enhancing the voting influence of its holders compared to the 1 vote per share for Class A and no voting rights for Class C stock. This structure allows key stakeholders holding Class B shares to maintain disproportionate control over corporate decisions. In contrast, NFLX provides uniform voting rights, where each share of common stock entitles the holder to exactly one vote, promoting a more egalitarian governance model. The difference in voting rights structures reflects contrasting philosophies in corporate governance between the two companies.",
      "llm_answer": "Alphabet’s dual‑class structure gives each Class B share ten votes, so holders of Class B stock (largely founders and insiders) can out‑vote the much larger number of Class A and non‑voting Class C shares and retain decisive control over board elections and other corporate actions【page_82】. Netflix, on the other hand, grants every common share one vote, meaning voting power is directly proportional to economic ownership and no single class can dominate governance【page_60】. This makes Alphabet’s governance more concentrated in the hands of its super‑voting shareholders, whereas Netflix’s model is more egalitarian and democratic.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that GOOGL's Class B shares carry 10 votes per share, contrasting with Class A (1 vote) and Class C (no vote), and accurately describes the concentration of control among insiders. It correctly identifies NFLX's uniform one-vote-per-share structure. (2) All quantitative elements are correct: '10 votes' and '1 vote' match the ground truth; no calculations are required, but the comparison is numerically sound. (3) The multi-hop reasoning is strong—LLM synthesizes governance models across two companies (GOOGL and NFLX), correctly contrasting concentrated vs. egalitarian control based on share structure. (4) The answer is fully relevant, directly addressing the impact of differential voting rights on corporate governance as asked. Minor wording differences (e.g., 'egalitarian and democratic' vs. 'egalitarian governance model') do not affect factual equivalence. All entities (Alphabet/GOOGL, Netflix/NFLX, Class A/B/C shares) are correctly identified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 304,
        "total_tokens": 1634
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "What percentage of Chevron's average daily net crude oil production in 2021 came from the QG3 project through its stake in Qatargas Operating Company Limited?",
      "original_answer": "Chevron's average daily net crude oil production from the QG3 project through its stake in Qatargas Operating Company Limited was 13 MBD in 2021. Since Chevron holds a 30% interest in Qatargas, this production volume reflects Chevron's proportional share of the crude oil output from the QG3 project.",
      "llm_answer": "Chevron’s interest in the QG3 project was 30.0 percent, meaning that roughly 30 percent of its average daily net crude‑oil production in 2021 came from QG3 through its stake in Qatargas Operating Company Limited【page_11】.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer incorrectly states that 30% of Chevron's total average daily net crude oil production in 2021 came from the QG3 project. However, the ground truth clarifies that Chevron's net production from QG3 was 13 MBD (thousand barrels per day) due to its 30% stake in Qatargas, not that 30% of Chevron’s total crude production came from this project. This is a critical factual misrepresentation. (2) The percentage figure of 30% is correctly cited as Chevron’s interest in Qatargas, but it is misapplied — the 30% refers to ownership stake, not the proportion of total Chevron production attributable to QG3. The actual percentage of Chevron’s total crude production from QG3 cannot be determined without knowing Chevron’s total global net crude production in 2021, which is not provided in either answer. Thus, the LLM fabricates a quantitative claim not supported by the data. (3) The multi-hop reasoning fails: while the model identifies the correct ownership stake, it incorrectly infers that this stake translates to 30% of Chevron’s total crude production, conflating ownership percentage with production contribution share. (4) Scores reflect major factual inaccuracy in quantitative and qualitative reasoning, though the context (Chevron, QG3, Qatargas, 30% stake, 2021) is partially relevant, warranting moderate contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1133,
        "completion_tokens": 379,
        "total_tokens": 1513
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the adoption of ASU 2022-04 impact the transparency of supplier finance obligations for both 3M and Honeywell, particularly in terms of the new roll-forward disclosure requirements effective in 2024?",
      "original_answer": "The adoption of ASU 2022-04 enhances transparency for both 3M and Honeywell by mandating detailed annual disclosures about supplier finance program obligations, including a roll-forward of confirmed invoice amounts. For 3M, this includes reporting $1.5 billion of invoices confirmed and $1.5 billion of invoices paid or adjusted in 2024, which is now disclosed as part of the roll-forward requirement. Honeywell adopted the roll-forward provisions starting in 2024, aligning with the ASU’s phased implementation. Both companies now provide clearer visibility into their supplier finance activities, improving comparability and risk assessment for stakeholders.",
      "llm_answer": "Both 3M and Honeywell have adopted ASU 2022‑04, which now obliges them to provide a roll‑forward of supplier‑finance program balances. Starting January 1 2024 each company must reconcile the opening balance, invoices confirmed, payments made and the ending balance for the period—3M’s Note 16 shows a $0.3 billion year‑end balance and $1.5 billion of invoices confirmed and paid in 2024, while Honeywell must disclose the same roll‑forward and interim amounts (though it notes the change is not material). This new schedule gives investors a clearer view of the size and movement of supplier‑finance obligations.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both 3M and Honeywell adopted ASU 2022-04 with new roll-forward disclosures effective in 2024, and correctly notes the requirement to disclose opening balance, invoices confirmed, payments, and ending balance. However, there is a significant quantitative discrepancy: the LLM states that 3M confirmed and paid $1.5 billion in invoices in 2024 (which matches the ground truth), but incorrectly implies that the $0.3 billion year-end balance is part of the roll-forward for 2024 without clarifying the full reconciliation. The ground truth specifies that $1.5 billion was confirmed and $1.5 billion was paid or adjusted—suggesting a full turnover—but the LLM does not mention the $1.5 billion paid amount separately, instead combining it with confirmed, potentially misrepresenting the flow. Additionally, the $0.3 billion ending balance is not mentioned in the original answer, raising concerns about its accuracy or relevance. (2) The date (2024) and entity names (3M, Honeywell) are correct. The reference to Note 16 for 3M may be accurate but is not verifiable from the ground truth. The claim that Honeywell’s change is 'not material' is not present in the original and may downplay the significance of adoption. (3) The multi-hop reasoning is generally sound—linking ASU 2022-04 to roll-forward requirements and applying it to both companies—but misses the precise synthesis of the roll-forward components (opening, confirmed, paid, ending) with accurate figures. (4) Despite the numerical inconsistency and unverified detail (the $0.3B balance), the core message about enhanced transparency and alignment with ASU 2022-04 is preserved, warranting a score of 7 for correctness. The qualitative and contextual scores are higher due to strong conceptual understanding and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 498,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does LMT's revenue recognition approach for U.S. Government contracts regulated by FAR compare to RTX's financial exposure to U.S. Government contract risks, particularly in relation to fixed-price contract structures?",
      "original_answer": "LMT recognizes revenue for U.S. Government contracts regulated by the FAR using a cost-plus-fixed-fee model, where the standalone selling price is typically equal to the contract price due to FAR-mandated cost-plus structures. RTX, on the other hand, faces financial exposure from its reliance on fixed-price contracts, especially firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns. Both companies are subject to U.S. Government contract risks, but LMT's FAR-regulated contracts provide more predictable revenue due to cost reimbursement with a reasonable profit margin, whereas RTX's FFP contracts carry higher risk of negative profit adjustments, particularly in development programs.",
      "llm_answer": "LMT treats its FAR‑regulated U.S. Government contracts as cost‑plus arrangements, usually as a single performance obligation, and recognizes revenue over time as work‑in‑process is transferred to the government—reflecting the FAR requirement that the customer pays allowable costs plus a reasonable profit (LMT 10‑K p. 77). In contrast, RTX notes that many of its government contracts are fixed‑price (firm‑fixed‑price or fixed‑price‑incentive); under these structures RTX bears the full burden of any cost overruns on FFP contracts and only shares overruns up to a ceiling on FPI contracts, exposing its earnings to profit risk if actual costs exceed the fixed price (RTX 10‑K p. 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies LMT's revenue recognition approach for U.S. Government contracts regulated by FAR as cost-plus, with revenue recognized over time based on work-in-process transfer, consistent with FAR requirements for allowable costs plus a reasonable profit. It also accurately characterizes RTX's exposure under fixed-price contracts—specifically firm fixed-price (FFP) and fixed-price-incentive (FPI)—where RTX bears full cost overrun risk in FFP and shared risk up to a ceiling in FPI. These descriptions match the original answer's core claims. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised; all financial terms are used correctly. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LMT and RTX), two contract types (cost-plus vs. fixed-price), and their respective financial implications, directly addressing the comparative aspect of the question. (4) The only minor shortcoming is that the LLM answer does not explicitly contrast the predictability of LMT's revenue versus RTX's profit risk, though this is implied through the description of cost reimbursement versus cost overrun exposure. This slight omission prevents a perfect 10 but does not detract significantly from the overall correctness. Wording differs but semantic equivalence is maintained. Contextual relevance is excellent—every part of the response addresses the question directly with appropriate sourcing cues (e.g., 10-K page references).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 453,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the expiration timeline of BMY's Eliquis patent rights in Europe compare to MRK's Januvia family patent expiration in the U.S., and what impact does this have on their respective market exclusivity strategies?",
      "original_answer": "BMY is actively litigating to extend the market exclusivity of Eliquis in Europe, having secured final positive decisions in Norway, Sweden, and Switzerland, while facing negative outcomes in the UK and ongoing appeals in several other countries. Despite these efforts, generic competition has already entered in some markets like Finland and Portugal. In contrast, MRK's Januvia family lost its key U.S. patent in January 2023, but due to court rulings and settlements, exclusivity is maintained until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This difference in timelines and enforcement success highlights how BMY's fragmented European patent strategy faces more immediate generic erosion, while MRK has extended exclusivity in the U.S. through secondary patents, delaying generic entry and preserving revenue longer.",
      "llm_answer": "BMS’s Eliquis composition‑of‑matter patent and its associated SPCs are still in force in Europe but are being aggressively challenged – generic versions have already launched in several EU countries and further launches may occur before the patents finally expire (see BMS 10‑K pages 121 & 28). By contrast, Merck’s key U.S. sitagliptin patent expired in Jan 2023, but a later salt‑form patent keeps U.S. exclusivity for Januvia/Janumet until May 2026 and for Janumet XR until July 2026 (see Merck 10‑K page 58). Thus BMS must rely on litigation and settlement to preserve European market exclusivity for Eliquis, while Merck is preparing for a known 2026 exclusivity cliff in the U.S. and will need to offset the impending generic competition through pricing, new formulations or pipeline products.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Merck's Januvia/Janumet exclusivity until May 2026 and Janumet XR until July 2026 aligns perfectly with the original answer; BMS's ongoing litigation and generic entry in several European markets are also correctly represented. (2) Quantitative accuracy is excellent: dates (Jan 2023 expiration, May 2026 and July 2026 extensions) are exact and match the ground truth. (3) Multi-hop reasoning is sound—correctly contrasts BMS's fragmented, litigation-dependent European strategy with Merck's use of secondary patents (salt-form) to extend U.S. exclusivity. (4) Minor omission: the original answer specifies positive outcomes in Norway, Sweden, Switzerland and negative in UK, which the LLM omits, slightly reducing completeness. However, this does not undermine the overall correctness. The LLM correctly identifies the strategic implications: BMS relies on litigation while Merck faces a defined 2026 cliff. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect—directly addresses patent timelines and strategic impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 335,
        "total_tokens": 1763
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "What is the total amount of appeal bonds posted by PM USA related to adverse verdicts on appeal, and how does this compare to the total payments made by PM USA for judgments and settlements in tobacco-related litigation since October 2004?",
      "original_answer": "PM USA has posted appeal bonds totaling $35 million related to adverse verdicts currently on appeal. Since October 2004, PM USA has paid approximately $1 billion in judgments and settlements (including related costs and fees) and approximately $241 million in interest related to tobacco litigation. This indicates that the current appeal bonds represent a small fraction of the total historical litigation-related payments made by PM USA.",
      "llm_answer": "PM USA has posted appeal bonds of roughly **$35 million** to secure stays of adverse verdicts that are on appeal (see Note 19, page 49). Since October 2004, the company has paid **about $1 billion** in judgments and settlements (plus $241 million in related interest) for tobacco‑related litigation (see Note 19, page 92). Thus, the appeal‑bond amount is only a few percent of the total judgments and settlement payments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key numbers are correct: $35 million in appeal bonds, $1 billion in judgments and settlements, and $241 million in interest since October 2004. These match the original answer exactly, with acceptable formatting variations (e.g., 'about $1 billion' = 'approximately $1 billion'). (2) The quantitative accuracy is perfect—no calculation errors, and the comparison correctly frames the $35 million as a small fraction of the $1 billion, even noting it is 'only a few percent,' which is a reasonable approximation (3.5%). (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different timeframes and contexts—current appeal bonds vs. historical payments—and draws a logical comparison. (4) The only minor shortcoming is that the original answer explicitly states that the $1 billion includes 'related costs and fees,' which the LLM omits, though it mentions 'plus $241 million in related interest,' implying awareness of additional costs. This is a slight omission but does not undermine the core accuracy. Overall, the answer is factually correct, contextually appropriate, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1238,
        "completion_tokens": 344,
        "total_tokens": 1582
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How does the revenue contribution from Taiwan differ between Apple's Greater China segment in 2022 and NVIDIA's direct revenue reported from Taiwan in the same year?",
      "original_answer": "Apple's Greater China segment generated $74,200 million in net sales in 2022, which includes Taiwan along with China mainland and Hong Kong. In contrast, NVIDIA directly reported $8,544 million in revenue from Taiwan in 2022. Since Apple's figure for Taiwan is embedded within the broader Greater China segment, the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely but is a subset of the $74,200 million. NVIDIA’s $8,544 million provides a direct and isolated measure of its Taiwan revenue.",
      "llm_answer": "Apple’s Greater China segment – which comprises mainland China, Hong Kong and Taiwan – recorded net sales of **$74.2 billion in 2022**【page_25†L13-L20】. In contrast, NVIDIA disclosed **$8.544 billion of revenue from Taiwan** in its 2022 fiscal year【page_100†L13-L20】. Thus Apple’s Taiwan‑related contribution (as part of Greater China) is about **$65.7 billion higher**, roughly nine times the amount NVIDIA earned directly from Taiwan.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM correctly reports Apple's Greater China net sales as $74.2 billion (equivalent to $74,200 million) and NVIDIA's Taiwan revenue as $8.544 billion ($8,544 million), which matches the ground truth in absolute values. However, it makes a critical error in reasoning by calculating a $65.7 billion difference and claiming Apple’s Taiwan-related contribution is 'about $65.7 billion higher' and 'roughly nine times' NVIDIA’s. This is factually incorrect because Apple does not report Taiwan’s revenue separately — it is embedded within the Greater China segment. The LLM falsely implies that Apple’s Taiwan revenue can be directly compared or derived as a standalone figure, which contradicts the ground truth that states 'the exact revenue contribution from Taiwan alone for Apple cannot be determined precisely.' (2) While the input numbers are accurate (allowing for format variation: $74.2B = $74,200M), the subtraction ($74.2B - $8.544B = ~$65.7B) is irrelevant and misleading because it compares a regional subtotal (Greater China, including Taiwan) to a country-specific revenue (Taiwan for NVIDIA). This calculation assumes Apple’s Taiwan revenue is nearly the entire Greater China figure, which is unsupported. (3) The multi-hop reasoning fails: the model should have recognized that Apple’s data does not allow isolation of Taiwan’s revenue, making any direct quantitative comparison invalid. Instead, it performs an erroneous arithmetic comparison. (4) Contextual relevance is high because the answer addresses the right companies, years, and metrics. However, qualitative and correctness scores are low due to the fundamental misrepresentation of Apple’s revenue granularity and invalid comparison logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 466,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 233,
      "question": "How has the growth in NVDA's revenue from Taiwan between fiscal years 2020 and 2022 compared to the growth in AAPL's revenue from the Greater China region, which includes Taiwan?",
      "original_answer": "NVDA's revenue from Taiwan grew from $3,025 million in 2020 to $8,544 million in 2022, representing a 182.5% increase over two years. AAPL's revenue from Greater China, which includes Taiwan, grew from $40,308 million in 2020 to $74,200 million in 2022, representing an 84.1% increase over the same period. Therefore, NVDA experienced significantly higher growth in revenue from Taiwan (as part of its broader regional exposure) compared to AAPL's growth in the broader Greater China region.",
      "llm_answer": "NVDA’s revenue from Taiwan rose from $3,025 million in FY 2020 to $8,544 million in FY 2022 – a $5.5 billion increase, or roughly 182 % growth【page_100】. Apple’s Greater China net sales (which includes Taiwan) grew from $40,308 million in FY 2020 to $74,200 million in FY 2022 – a $33.9 billion rise, or about 84 % growth【page_52】. Thus, NVDA’s Taiwan revenue grew at a far higher percentage rate than Apple’s Greater China revenue, even though Apple’s absolute increase was larger.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: All numbers are correct — NVDA's revenue from Taiwan is accurately reported as $3,025 million in 2020 and $8,544 million in 2022, with a calculated growth of approximately 182%, which matches the ground truth 182.5% (rounding to whole percentage is acceptable). AAPL's Greater China revenue is correctly stated as $40,308 million in 2020 and $74,200 million in 2022, with ~84% growth, consistent with the 84.1% in the original (again, rounding is reasonable). The absolute increases ($5.5 billion and $33.9 billion) are also accurate. (2) Completeness: The answer addresses both companies, the correct fiscal years (2020–2022), and the relevant geographies (Taiwan for NVDA, Greater China including Taiwan for AAPL). It compares both percentage and absolute growth, adding contextual insight without distorting facts. (3) Entity accuracy: Companies (NVDA, AAPL), regions (Taiwan, Greater China), and time frame (FY 2020 to FY 2022) are correctly identified. (4) Reasoning: The multi-hop synthesis — comparing percentage growth of NVDA’s Taiwan-specific revenue to AAPL’s broader regional growth — is sound and logically presented. The conclusion that NVDA had higher percentage growth despite lower absolute increase is valid and well-supported. (5) Semantic equivalence: The LLM conveys the same core message as the original answer, with slightly different phrasing but identical factual and inferential content. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1251,
        "completion_tokens": 427,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 235,
      "question": "How does Microsoft's projected tax liability under the OECD's Pillar Two Model Rules compare to Broadcom's exposure from the global minimum tax, given their differing international tax structures?",
      "original_answer": "Microsoft projects no material impact from the OECD's Pillar Two Model Rules, which establish a 15% global minimum tax, as it begins applying to the company in fiscal year 2025. In contrast, Broadcom notes that global minimum tax provisions, such as Singapore's adoption effective for fiscal year 2026, may materially increase its effective tax rate and cash tax costs. This divergence reflects Microsoft's current lack of material operations in jurisdictions with tax rates below the 15% threshold, versus Broadcom's existing reliance on tax incentives in various jurisdictions that could be adversely affected by the global minimum tax.",
      "llm_answer": "Microsoft says that, although the OECD Pillar Two rules (a 15 % global minimum tax) will apply to it from FY 2025, it does not currently expect a material impact on its consolidated tax expense because much of its foreign earnings are already taxed at rates near the floor (its effective rate is low thanks to an Irish regional centre)【page_47】. In contrast, Broadcom warns that the same global minimum‑tax regime “may materially increase our effective tax rate and cash tax costs,” indicating a much larger exposure to the new tax ​【page_31】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: Microsoft’s application of Pillar Two from FY 2025, the 15% global minimum tax rate, and Broadcom’s exposure starting FY 2026 (implied by 'may materially increase' in context of Singapore’s 2026 adoption). The LLM correctly states Microsoft expects no material impact and Broadcom warns of material increases in tax rate and cash costs. (2) The numbers and dates match the original answer—no calculations are required, but the fiscal years and percentages are accurately reported. (3) The multi-hop reasoning is sound: the model contrasts Microsoft’s limited exposure (due to existing tax structure, e.g., Irish operations already near 15%) with Broadcom’s higher exposure from reliance on lower-tax jurisdictions. While the LLM adds detail about Ireland not explicitly in the ground truth, this is consistent with public knowledge and does not contradict the original. (4) The only minor gap is that the original answer explicitly references Singapore’s adoption of the rules and Broadcom’s use of tax incentives, which the LLM omits—this contextual nuance slightly reduces completeness, but the core contrast in exposure and reasoning is preserved. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 374,
        "total_tokens": 1681
      },
      "error": null
    },
    {
      "question_id": 245,
      "question": "How does the difference in voting rights structure between NFLX common stock and GOOGL Class B common stock impact shareholder influence, given that GOOGL Class B shares carry 10 votes per share while NFLX shares carry only one vote per share?",
      "original_answer": "NFLX common stock provides one vote per share to all shareholders, granting equal influence per share. In contrast, GOOGL has a multi-tiered voting rights structure where Class B common stockholders receive 10 votes per share, significantly amplifying their voting power compared to Class A shareholders who receive one vote per share. This structural difference means that GOOGL's Class B shareholders have disproportionately greater influence over corporate decisions than any single group of shareholders at NFLX, where voting power is uniformly distributed across all shares.",
      "llm_answer": "NFLX’s 10‑K states that each share of its common stock is entitled to one vote per share (see NFLX 10‑K p. 61). Alphabet’s 10‑K notes that each Class B share carries ten votes per share (see GOOGL 10‑K p. 81). Thus, a GOOGL Class B shareholder wields roughly ten‑times the voting power of a NFLX shareholder on a per‑share basis, giving Class B owners far greater influence over corporate decisions such as board elections and other shareholder votes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) Quantitative accuracy: The numbers are correct—NFLX has 1 vote per share, GOOGL Class B has 10 votes per share. The statement that GOOGL Class B shareholders have roughly ten times the voting power per share is accurate and consistent with the original answer. (2) Completeness: The LLM addresses the core of the question—comparing voting rights and their impact on shareholder influence. It correctly identifies the per-share voting power and draws the logical conclusion about disproportionate influence. However, it does not explicitly mention that NFLX has a uniform voting structure across all shares (i.e., no multi-class structure), which is a minor omission but does not detract significantly from the overall correctness. (3) Entity accuracy: Correctly identifies NFLX and GOOGL (Alphabet) and references the appropriate stock classes and their voting rights. (4) Reasoning: The multi-hop reasoning is sound—synthesizing information from two different 10-Ks to compare shareholder influence. The conclusion that Class B GOOGL shareholders have greater influence is logically supported. (5) Semantic equivalence: The LLM conveys the same essential information as the original answer, though with slightly less detail on the structural contrast (uniform vs. tiered). Wording differences are acceptable and do not affect meaning. Overall, this is a highly accurate, well-reasoned response with only minor room for added context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1281,
        "completion_tokens": 414,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does AMD's revenue from Taiwan in 2021 compare to Apple's 2022 revenue from the broader Greater China region, which includes Taiwan?",
      "original_answer": "AMD reported $1,187 million in revenue from Taiwan in 2021, while Apple reported $74,200 million in revenue from the Greater China region in 2022. Since Greater China includes Taiwan along with China mainland and Hong Kong, Apple's revenue from the broader region was significantly higher than AMD's revenue specifically from Taiwan.",
      "llm_answer": "AMD reported Taiwan sales of $2,091 million for the year ended December 25 2021 (AMD 10‑K p. 78). Apple’s Greater China segment – which includes mainland China, Hong Kong and Taiwan – generated $74,200 million of net sales in fiscal 2022 (Apple 10‑K p. 52). Thus Apple’s Greater China revenue was about $72 billion higher, roughly 35 times the size of AMD’s Taiwan revenue.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual error in the AMD revenue figure. The ground truth states AMD reported $1,187 million in revenue from Taiwan in 2021, but the LLM claims $2,091 million, which is nearly double the correct amount. This error significantly undermines the quantitative accuracy. Apple's revenue figure of $74,200 million from Greater China in 2022 is correct and matches the ground truth. (2) The calculation comparing Apple's revenue to AMD's is based on incorrect input: the LLM states Apple's revenue was 'about $72 billion higher' and 'roughly 35 times' AMD's. With correct numbers, Apple's revenue ($74,200M) is about 62.5 times AMD's actual Taiwan revenue ($1,187M), not 35 times. The '35 times' multiplier would only be valid if AMD's revenue were ~$2,120M, close to the incorrect value cited. (3) The multi-hop reasoning structure is sound—correctly identifying that Apple's Greater China includes Taiwan and comparing regional vs. country-specific revenues—but the faulty AMD number invalidates the conclusion. The model correctly cites fiscal years (2021 for AMD, 2022 for Apple) and matches the entities (AMD, Apple, Taiwan, Greater China). (4) Contextual relevance is high as the answer addresses the comparison directly and includes proper sourcing. However, due to the critical error in AMD's revenue figure, the correctness score is limited to 4—partially correct but with significant factual inaccuracy affecting the core comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1174,
        "completion_tokens": 409,
        "total_tokens": 1583
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the availability of shares under Tesla's 2019 Equity Incentive Plan compare with Starbucks' remaining equity grant capacity, particularly in relation to their respective use of incentive stock options as a component of compensation strategy?",
      "original_answer": "Tesla's 2019 Equity Incentive Plan had 49.0 million shares reserved and available for issuance as of December 31, 2021, while Starbucks had 99.7 million shares available for future equity-based compensation awards as of October 2, 2022. Both companies utilize incentive stock options as part of their broader equity compensation structures, with Tesla's 2019 Plan explicitly including the provision for granting incentive stock options to employees, and Starbucks maintaining several equity incentive plans that include incentive stock options among other forms of equity compensation.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan had about 49 million shares reserved for issuance (as of 12/31/2021) 【page_83】. Starbucks reports roughly 99.7 million shares still available for future equity‑based awards 【page_80】. Both firms include incentive stock options among the awards they can grant, but Starbucks’ remaining grant capacity is roughly twice the size of Tesla’s pool.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Tesla's 49.0 million shares reserved under its 2019 Equity Incentive Plan as of December 31, 2021, and Starbucks' 99.7 million shares available for future equity-based awards as of October 2, 2022. These figures match the ground truth exactly, with acceptable rounding (49 million vs. 49.0 million). (2) All numeric values, dates, and comparisons are accurate. The statement that Starbucks’ remaining grant capacity is 'roughly twice' the size of Tesla’s is a reasonable qualitative comparison (99.7M / 49M ≈ 2.03), so the calculation and interpretation are sound. (3) The multi-hop reasoning is correct: the model synthesizes data from two different companies, plans, and reporting dates, and accurately compares their equity availability. It correctly identifies that both companies include incentive stock options as part of their equity compensation strategies, though it provides less detail than the original answer about the structural aspects (e.g., Tesla’s plan 'explicitly' allowing ISOs, Starbucks’ 'several' plans). (4) The answer is semantically equivalent to the ground truth in terms of key facts and intent, with only minor reduction in descriptive depth. No factual errors; excellent contextual relevance and quantitative precision. Slight deduction in qualitative accuracy due to less explicit elaboration on the structural use of ISOs, but core reasoning remains sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1266,
        "completion_tokens": 398,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the use of valuation models incorporating broker/dealer quotes impact the fair value determination of Level 2 assets for GD compared to BA's approach for available-for-sale debt investments?",
      "original_answer": "GD determines the fair value of its Level 2 fixed-income securities using valuation models that incorporate observable inputs such as quoted prices for similar assets and broker/dealer quotes. Similarly, BA values its available-for-sale debt investments using broker/dealer quotes for identical or comparable instruments. Both companies rely on these observable inputs through third-party pricing services and industry-standard models, indicating a parallel approach in determining fair value for Level 2 assets, despite being in different industries.",
      "llm_answer": "GD determines the fair value of its Level 2 plan assets (primarily fixed‑income securities) with a market‑approach model that uses observable inputs such as interest‑rate curves, bond yields and quoted prices for comparable securities, rather than direct dealer quotations【page_93】. In contrast, Boeing values its available‑for‑sale debt investments at Level 2 by applying a market approach that relies on actual quoted market prices or broker‑dealer quotes of identical or comparable instruments, and for non‑traded debt it uses indicative borrowing costs derived from dealer quotes【page_113】【page_115】. Thus, GD’s fair‑value estimates are model‑driven using broader market inputs, whereas BA’s Level 2 valuations are more directly tied to specific broker/dealer price information.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of both GD's and BA's valuation approaches, with no numeric errors (quantitative accuracy is perfect, though no specific numbers like dollar amounts or percentages are involved). The answer correctly identifies that GD uses valuation models with observable inputs such as interest-rate curves and quoted prices for comparable securities, while BA relies more directly on broker/dealer quotes and actual market prices for identical or comparable instruments. However, the LLM introduces a subtle but important distinction by suggesting GD does *not* use broker/dealer quotes, stating it relies on 'broader market inputs' instead—this contrasts with the ground truth, which explicitly states GD *does* use broker/dealer quotes as part of its valuation models. The original answer emphasizes a 'parallel approach' between GD and BA, while the LLM frames them as meaningfully different. This misrepresents the degree of similarity in their methodologies, particularly in reliance on third-party broker/dealer inputs. While the LLM cites specific pages and adds detail (e.g., 'indicative borrowing costs'), the qualitative inaccuracy in downplaying GD's use of broker/dealer quotes affects the synthesis. The reasoning is logical and contextually relevant, but the conclusion overstates the divergence between the two companies' approaches, missing the core point of methodological alignment emphasized in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 404,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the current zero percent setting of the Countercyclical Capital Buffer (CCyB) impact the total capital buffer requirements for both Morgan Stanley and American Express under Basel III, considering Morgan Stanley's inclusion of the Stress Capital Buffer (SCB) in its Advanced Approach calculation and American Express's explicit subjectivity to the SCB?",
      "original_answer": "Under the current zero percent Countercyclical Capital Buffer (CCyB), Morgan Stanley's total capital buffer requirement under the Advanced Approach includes the 2.5% Capital Conservation Buffer (CCB), the G-SIB capital surcharge, and the Stress Capital Buffer (SCB). American Express is also subject to the SCB under Basel III, which contributes to its minimum capital requirements. Since the CCyB is currently set at zero, neither firm is required to add additional capital under this buffer. Therefore, the SCB plays a key role in both firms’ capital planning and distribution constraints, despite differing regulatory calculation approaches.",
      "llm_answer": "The Federal Reserve’s zero‑percent CCyB contributes nothing to either firm’s buffer, so the total requirement is simply the sum of the other buffers. For Morgan Stanley the overall buffer is therefore 5.5 % under the Advanced Approach (2.5 % capital‑conservation buffer + 3.0 % G‑SIB surcharge + 0 % CCyB) and 8.4 % under the Standardized Approach (5.4 % SCB + 3.0 % G‑SIB surcharge + 0 % CCyB)【page_134】. For American Express, the effective minimum capital requirement already includes the stress capital buffer (and the bank’s capital‑conservation buffer), and with CCyB set at 0 % the total buffer is just that SCB‑based amount, with no additional CCyB contribution【page_151】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies that undermine its correctness. While it correctly notes the CCyB is at 0% and thus contributes nothing to capital requirements for both Morgan Stanley and American Express, it introduces specific numerical values not present in the ground truth. For Morgan Stanley, the LLM claims a 5.5% Advanced Approach buffer (2.5% CCB + 3.0% G-SIB) and an 8.4% Standardized Approach buffer (5.4% SCB + 3.0% G-SIB), but the original answer does not provide these exact percentages or confirm the SCB value for Morgan Stanley. More critically, the ground truth emphasizes that Morgan Stanley includes the SCB in its Advanced Approach calculation, but the LLM incorrectly separates Advanced and Standardized approaches and assigns the SCB only to the latter, which contradicts the regulatory framework described. For American Express, the LLM vaguely states the total buffer is 'that SCB-based amount' without specifying numbers, which aligns partially with the original answer, but fails to clarify how the SCB integrates into the total buffer. The reasoning is partially sound in recognizing that a 0% CCyB means no additional requirement, but the multi-hop synthesis is flawed—especially in misrepresenting how the SCB applies across approaches and firms. The entities (Morgan Stanley, American Express, SCB, CCyB, G-SIB) are correctly identified, and the context of Basel III is appropriately addressed, earning moderate scores for qualitative accuracy and good contextual relevance. However, the unsupported numerical precision and incorrect structural assumptions about regulatory calculations severely reduce quantitative and overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 461,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 1,
      "question": "How does the $4.0 billion increased commitment under AMT's 2021 Credit Facility relate to its financing strategy for acquisitions, and how does this contrast with SPG's approach to financing through joint ventures as of December 31, 2021?",
      "original_answer": "AMT increased the commitment under its 2021 Credit Facility to $4.0 billion, which was used to finance acquisitions such as the CoreSite Acquisition, reflecting a strategy of leveraging large-scale credit facilities for major transactions. This contrasts with SPG's approach, where it provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, indicating a focus on internal financing and partnership structures to support real estate development and diversify risk.",
      "llm_answer": "American Tower’s $4 billion increase in the 2021 Credit Facility gave it a much larger revolving‑loan pool that it tapped to fund its two marquee purchases – the Telxius and CoreSite acquisitions – and other corporate needs (the facility was expanded to $4 billion and “used to fund the Telxius Acquisition and the CoreSite Acquisition and for general corporate purposes”【page_111†L2-L5】【page_51†L1-L4】). By contrast, Simon Property Group does not rely on a big credit line for acquisitions; it finances new properties and development through joint‑venture structures, providing modest construction loans/advances (about $88 million) and earning management‑fee revenue from those JV assets rather than using a large revolving facility【page_116†L1-L5】【page_116†L6-L9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $4.0 billion credit facility increase and SPG's $88.4 million (rounded to $88 million, which is acceptable) in joint venture financing are accurately reported. The years (2021) and entities (AMT, SPG, CoreSite, Telxius) are correctly identified. (2) The answer correctly explains that AMT used its expanded credit facility to fund major acquisitions—specifically naming both Telxius and CoreSite—which matches the original answer’s emphasis on leveraging large-scale credit for acquisitions. (3) For SPG, the LLM correctly identifies the use of joint ventures and construction loans/advances as the primary financing mechanism, contrasting it with AMT’s revolving credit approach. It adds value by noting SPG earns management fees, which is consistent with the source but not in the original answer—this is a relevant and accurate enhancement. (4) The multi-hop reasoning is sound: it synthesizes financing strategies across two companies from different filings, correctly contrasting debt-based acquisition funding (AMT) vs. partnership-based development financing (SPG). The only minor shortcoming is that the original answer emphasizes SPG’s risk diversification, which the LLM omits, but the core contrast in strategy is clearly and correctly conveyed. Wording differs but semantic meaning is equivalent. No calculation errors. All citations support the claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 408,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering Taiwan's inclusion within Greater China's geographic reporting?",
      "original_answer": "Starbucks added 21 net new stores in Taiwan from fiscal year 2021 to 2022, reflecting a growth in its operational footprint. Meanwhile, Nike reported $7,547 million in total revenues from the Greater China region in FY2022, which includes Taiwan. This indicates that while Starbucks is expanding its physical presence in Taiwan, Nike's revenue from the broader Greater China region—which encompasses Taiwan—represents a significant portion of its global revenue, highlighting different modes of market engagement and performance metrics across the two companies.",
      "llm_answer": "Starbucks’ licensed‑store data shows Taiwan’s net store count rose by 21 stores in FY 2022 (from 523 to 544). Nike’s segment tables report that the Greater China region – which by definition includes Taiwan – generated about $6.7 billion of revenue in FY 2022. Thus, Starbucks’ Taiwan expansion is a modest increase of a few dozen stores, whereas Nike’s Greater China contribution is a multi‑billion‑dollar revenue stream.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Starbucks' net store growth in Taiwan as 21 stores in FY2022, matching the ground truth (from 523 to 544 stores). However, it incorrectly states Nike's Greater China revenue as $6.7 billion, while the ground truth reports $7,547 million ($7.547 billion), a significant discrepancy of over $800 million. This error undermines the quantitative accuracy. (2) The store count numbers for Starbucks are accurate and properly contextualized with a net increase. But the Nike revenue figure is factually wrong—despite being in the right general range, the exact value matters in financial reporting and comparisons. (3) The reasoning structure is sound: the model correctly recognizes that Taiwan is included in Nike’s Greater China reporting segment and contrasts physical expansion (Starbucks) with regional revenue (Nike). It synthesizes across entities and metrics appropriately, showing understanding of multi-hop requirements—comparing operational footprint growth to financial performance in a shared geography. (4) While the qualitative reasoning and contextual relevance are strong—correctly framing the comparison and identifying the inclusion of Taiwan in Greater China—the major numerical inaccuracy in Nike’s revenue reduces the correctness and quantitative accuracy scores. A score of 6 reflects partial correctness: core structure and entities are right, but a key financial figure is materially off.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 401,
        "total_tokens": 1661
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "What percentage of Boeing's (BA) OPB plan assets are indirectly invested in equities through the balanced index fund, and how does this compare to the total fair value of equities held by 3M's (MMM) pension plan as of December 31, 2023?",
      "original_answer": "Boeing's OPB plan assets are approximately 60% invested in equities via the balanced index fund. Meanwhile, 3M's pension plan reported a total fair value of $785 million in equities as of December 31, 2023.",
      "llm_answer": "Boeing’s other‑post‑retirement benefit (OPB) plan invests the bulk of its assets in a balanced index fund that is roughly **60 % equities and 40 % debt**【page_96】.  \n3M’s pension‑plan disclosures show that the **fair‑value of equities held by its plans was $785 million at December 31 2023**【page_73】.  \n\nSo, Boeing’s OPB assets are about 60 % indirectly in equities, whereas 3M’s pension plans hold $785 million of equities in total.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the percentage of Boeing's OPB plan assets indirectly invested in equities (60%) is accurately reported, and the total fair value of equities held by 3M's pension plan ($785 million as of December 31, 2023) is correctly stated. Number formats are consistent and acceptable. (2) The answer is complete, addressing both parts of the multi-part question: the percentage for Boeing and the dollar amount for 3M. (3) Entities are correctly identified—Boeing (BA) and 3M (MMM), with accurate plan types (OPB for Boeing, pension plan for 3M), and the correct date (December 31, 2023) is used. (4) The reasoning is sound: the LLM correctly interprets that Boeing’s exposure to equities is indirect via a balanced index fund and synthesizes this with 3M’s direct equity holdings. The comparison is logically presented, even if not numerically contrasted, as the question only asks for a comparison in context, which is fulfilled. Semantic equivalence is maintained throughout.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1182,
        "completion_tokens": 303,
        "total_tokens": 1485
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does AMT's utilization of the 2021 USD Delayed Draw Term Loans for financing compare to SPG's use of financing mechanisms for real estate joint ventures, particularly in terms of dollar amounts and financing structure?",
      "original_answer": "AMT utilized the 2021 USD Delayed Draw Term Loans as part of a $10.5 billion financing structure to support the CoreSite Acquisition, ensuring funding availability without drawing on bridge loans. In contrast, SPG provided $88.4 million in financing to joint ventures through interest-bearing construction loans and other advances as of December 31, 2021, primarily to support real estate development and investment activities. While AMT's financing was large-scale and acquisition-focused, SPG's approach was smaller in scale and oriented toward real estate joint ventures.",
      "llm_answer": "American Tower tapped its 2021 USD Delayed‑Draw Term Loans for a massive acquisition: it drew a $3 billion 364‑day loan and a $1.5 billion two‑year loan – about $4.5 billion in total – under unsecured term‑loan facilities that can be drawn and repaid without amortization (see AMT 10‑K p.51‑52).  Simon Property Group, on the other hand, finances its real‑estate joint ventures with much smaller, project‑level debt – primarily interest‑bearing construction loans and other advances that total roughly $88.4 million (see SPG 10‑K p.116).  Thus AMT’s financing is orders of magnitude larger and structured as corporate term loans, whereas SPG’s joint‑venture financing is modest and limited to construction‑type loans.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the correct contrast in scale and structure between AMT's and SPG's financing mechanisms and correctly identifies SPG's $88.4 million in joint venture financing (matching the ground truth). However, it significantly underreports AMT's total financing: the LLM states $4.5 billion ($3B + $1.5B), while the ground truth specifies a $10.5 billion financing structure related to the CoreSite Acquisition via the 2021 USD Delayed Draw Term Loans. This discrepancy suggests the LLM may have reported only a portion of the draw or misinterpreted the total facility size. The ground truth does not mention a 364-day loan or two-year loan breakdown, so those details, while possibly present in the 10-K, do not align with the synthesized knowledge graph answer focused on the total $10.5B structure. The qualitative reasoning is sound—correctly contrasting large-scale corporate acquisition financing (AMT) with smaller, project-level real estate financing (SPG)—and the entities (AMT, SPG), years (2021), and financing types are accurately identified. Contextually, the answer is highly relevant and addresses both dollar amounts and financing structure as required. However, the major quantitative inaccuracy in AMT's total financing amount limits the correctness score despite otherwise strong reasoning and structure comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 372,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 2,
      "question": "How does XOM's reliance on crude oil as a raw material intersect with CVX's 15% ownership in the Caspian Pipeline Consortium, considering the volume of crude oil transported through CPC from Chevron's operations in Kazakhstan?",
      "original_answer": "XOM depends on crude oil as a core raw material for its operations. Meanwhile, CVX holds a 15% interest in the Caspian Pipeline Consortium (CPC), which transports an average of 1.4 million barrels of crude oil per day, with 1.2 million barrels sourced from Kazakhstan—specifically from fields like Tengiz and Karachaganak in which Chevron operates or holds stakes. This means that a portion of the crude oil CVX produces or co-produces in Kazakhstan relies on CPC for export, linking upstream production to midstream logistics. Since crude oil is essential for XOM’s business, any disruption in supply chains like CPC could impact the availability or cost of crude oil for companies downstream, including XOM.",
      "llm_answer": "XOM’s upstream cost structure shows a heavy reliance on crude oil, with $9.9 billion of U.S.‑based and $11.3 billion of non‑U.S.‑based crude‑oil and product purchases in 2024 (total ≈ $21.2 billion)【page_112】. CVX owns 15 % of the Caspian Pipeline Consortium, which in 2024 moved an average 1.4 million barrels of crude per day—about 1.2 million barrels per day of that volume coming from Chevron’s TCO operations in Kazakhstan【page_16】. Thus, CVX’s pipeline stake ties it to a sizable flow of Kazakh crude that contributes to the global supply pool from which XOM sources its raw‑material crude, influencing XOM’s procurement volumes and pricing exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CVX holds a 15% stake in the CPC, which transports 1.4 million barrels per day, with 1.2 million barrels sourced from Kazakhstan operations (specifically TCO, a Chevron-operated project in Kazakhstan like Tengiz). The LLM correctly identifies that this crude contributes to the global supply pool. While the original answer references Karachaganak as another field, the LLM’s focus on TCO is still accurate as it is the primary source. (2) Quantitative accuracy is excellent: the $9.9B U.S. and $11.3B non-U.S. crude/product purchases (total $21.2B) are correctly reported, and the 1.4M bpd and 1.2M bpd figures match the ground truth. No calculation errors. (3) Multi-hop reasoning is sound: the LLM connects XOM’s crude oil procurement needs to the global supply chain, correctly noting that CVX’s stake in CPC affects the flow of Kazakh crude into the market, which indirectly influences XOM’s sourcing environment. The link between midstream infrastructure (CPC) and downstream procurement is logically drawn. (4) The only minor shortcoming is that the LLM does not explicitly mention that the CPC-transported crude includes production from fields in which Chevron holds stakes (though TCO is correctly cited), and the answer slightly reframes the relationship as influencing 'procurement volumes and pricing exposure' rather than potential supply chain disruptions. However, this is a valid and relevant interpretation. Overall, the answer is factually correct, contextually appropriate, and synthesizes across entities and documents effectively.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 451,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the decommissioning funding shortfall risk at NEE's nuclear facilities compare to Duke Energy's exposure to nuclear decommissioning trust fund volatility, given the shared environmental and financial risks associated with nuclear power plant operations?",
      "original_answer": "NEE faces potential decommissioning funding shortfalls due to the risk that decommissioning costs could exceed the amount available in its decommissioning funds, which are subject to market and operational uncertainties. Similarly, Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida maintain Nuclear Decommissioning Trust Funds (NDTFs) whose values are subject to market fluctuations. A decline in the market value of these NDTF assets could significantly increase Duke Energy's funding requirements for decommissioning. Both companies are exposed to the financial risks of nuclear power plant decommissioning, with NEE highlighting potential shortfalls and Duke Energy emphasizing the impact of capital market performance on its NDTF investments.",
      "llm_answer": "NEE warns that the actual cost to de‑commission its nuclear plants could exceed the amount it has set aside in its de‑commissioning fund, which would force the company to absorb higher depreciation, impairment charges or additional cash outlays (NEE 30‑31). By contrast, Duke Energy’s risk stems from the market‑value volatility of the nuclear‑decommissioning trust‑fund assets that back its obligations; a decline in those assets could raise the amount the company must fund to meet future de‑commissioning costs (Duke 35). Both firms therefore share the underlying environmental and financial exposure of nuclear operations, but NEE’s concern is a potential funding shortfall versus Duke’s exposure to trust‑fund value swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual information is correct: NEE's risk is framed as potential cost overruns leading to funding shortfalls, while Duke Energy's exposure is tied to market volatility in its Nuclear Decommissioning Trust Funds (NDTFs). The LLM correctly identifies that both companies face financial risks from nuclear decommissioning, with distinct but related risk drivers. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either answer, so quantitative accuracy is not compromised—both answers are qualitative and consistent. (3) Multi-hop reasoning is sound: the LLM synthesizes information across two companies (NEE and Duke Energy), correctly distinguishing their respective risk exposures while acknowledging shared environmental and financial contexts. The citation of page numbers (NEE 30–31, Duke 35) suggests grounding in source documents, though not required for correctness. (4) Semantic equivalence is strong: the LLM rephrases the core idea effectively—'funding shortfall' for NEE vs. 'trust-fund value swings' for Duke—mirroring the original's comparative structure. The only minor limitation is slightly less explicit mention of the three Duke subsidiaries (Duke Energy Carolinas, Progress, and Florida), but the reference to Duke Energy’s overall risk is sufficient given the question’s focus on company-level comparison. No factual errors, strong reasoning, and full contextual relevance justify a 9/10 correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 425,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does LOW's use of pricing models for Level 3 fair value measurements compare to GM's application of unobservable inputs in Level 3 valuations, particularly in light of the stated accounting policy that classifies valuations based on the observability of inputs?",
      "original_answer": "LOW applies pricing models to determine fair value for Level 2 assets and uses an income approach with significant unobservable inputs like volatility and expected term for its Level 3 contingent consideration related to the Canadian retail business sale. This aligns with the accounting policy that defines Level 3 valuations as those using significant unobservable inputs, often involving pricing models or discounted cash flow methodologies. GM similarly relies on unobservable inputs for Level 3 valuations, particularly in its GM Financial receivables, where static pool modeling and economic forecasts such as unemployment rates and GDP growth are used to estimate expected credit losses. Both companies follow the same accounting hierarchy but apply it differently depending on the nature of their assets and business operations.",
      "llm_answer": "Lowe’s Level 3 fair‑value measurement is derived from an option‑pricing model that relies on significant unobservable inputs—such as total equity value, volatility and expected term—for its contingent‑consideration liability (see LOW page 53). General Motors likewise classifies assets as Level 3 when the valuation depends on unobservable assumptions, using model‑based approaches (e.g., discounted‑cash‑flow or other pricing models) and management forecasts when market prices are not available (see GM page 63). Both companies’ practices reflect the accounting policy that an instrument is placed in Level 3 whenever the fair‑value estimate is driven by significant unobservable inputs (policy description on page 212).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that LOW uses an option-pricing model with significant unobservable inputs (volatility, expected term, total equity value) for its Level 3 contingent consideration, which matches the original answer's reference to an income approach for the Canadian retail business sale. (2) It accurately states that GM applies model-based approaches (e.g., discounted cash flow) and management forecasts (like economic assumptions) for Level 3 valuations in GM Financial receivables, consistent with the use of static pool modeling and macroeconomic inputs such as unemployment and GDP growth. (3) The multi-hop reasoning is sound: the answer synthesizes information across both companies, correctly linking their use of unobservable inputs to the accounting policy that classifies valuations based on input observability. (4) All entities (LOW, GM, Level 3, contingent consideration, GM Financial receivables), metrics, and methodologies are correctly identified. The only minor shortcoming is that the LLM does not explicitly mention 'static pool modeling' or 'expected credit losses'—specifics included in the ground truth—but it does capture the essence of GM’s use of forecasts and models. Wording differs slightly (e.g., 'option-pricing model' vs 'income approach'), but these are semantically equivalent in context. No numeric inaccuracies; no calculations required. Overall, the answer is factually correct, complete in substance, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 425,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 3,
      "question": "How does the $10.5 billion in committed financing under AMT's 2021 Multicurrency Credit Facility compare with SPG's financing activities in joint ventures, particularly in terms of capital deployment strategy and risk diversification?",
      "original_answer": "AMT secured $10.5 billion in committed financing through its 2021 Multicurrency Credit Facility and related facilities, which were used to fund acquisitions like CoreSite and Telxius, while SPG provided $88.4 million in financing to joint ventures primarily in the form of interest-bearing construction loans, aligning with its strategy to diversify risk and finance property development. This shows that AMT leveraged large-scale credit facilities for major acquisitions, whereas SPG used smaller, targeted financings to support joint venture operations and risk-sharing.",
      "llm_answer": "AMT’s $10.5 billion commitment under its 2021 Multicurrency Credit Facility is a huge, revolving pool that the company uses to fund large‑scale acquisitions (e.g., CoreSite and Telxius) and other corporate needs, giving it a centralized source of liquidity for strategic growth. By contrast, Simon Property Group’s joint‑venture financing is modest—about $88.4 million of construction loans and other advances to 84 JV properties—and is deployed on a project‑by‑project basis to finance and develop individual assets, thereby spreading risk across many partnerships. Thus, AMT’s approach is a massive, centrally‑managed capital source, while SPG’s is a smaller, decentralized tool that diversifies risk at the property level.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMT's $10.5 billion 2021 Multicurrency Credit Facility is accurately cited and linked to acquisitions like CoreSite and Telxius; SPG's $88.4 million in financing to joint ventures is correctly reported. Number formats are consistent and acceptable ($10.5 billion, $88.4 million). (2) The answer fully addresses both parts of the multi-hop question: it compares the scale and structure of AMT’s financing with SPG’s joint venture activities and interprets the strategic implications—centralized vs. decentralized capital deployment and risk diversification. (3) Entities are correct: AMT (American Tower), SPG (Simon Property Group), correct fiscal year (2021), and correct use of financial instruments (revolving credit facility vs. construction loans). (4) Reasoning is sound: the LLM correctly infers that AMT uses large-scale financing for strategic acquisitions, while SPG uses smaller, project-level financings to diversify risk across partnerships. The only minor shortcoming is that the LLM does not explicitly name 'interest-bearing construction loans' as in the original, instead generalizing to 'construction loans and other advances'—a slight loss in precision but not in semantic meaning. Overall, the answer demonstrates strong multi-hop synthesis and conveys the same strategic contrast as the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 393,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does AMD's revenue exposure to Taiwan in 2023 compare to QCOM's operational dependency on foundry partners in Taiwan, given the geopolitical risks associated with the region?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, indicating a notable but declining revenue exposure compared to previous years. Meanwhile, QCOM explicitly states that its business depends on consistent and reliable chipset supply from foundry partners, particularly in Taiwan. A significant or prolonged military or geopolitical conflict involving China and Taiwan could severely limit or prevent QCOM from receiving chipset supply, which would have a material adverse impact on its business. Given that both companies are exposed to Taiwan—AMD through revenue and QCOM through critical supply chain dependencies—geopolitical instability in the region poses a dual risk, impacting both revenue streams and manufacturing continuity.",
      "llm_answer": "AMD reported that sales to customers in Taiwan were $1.841 billion in fiscal 2023 – roughly 8 % of its total external‑customer revenue. Qualcomm does not give a dollar amount, but its 2023 filing says the company “depends on consistent and reliable chipset supply from our foundry partners, particularly in Taiwan,” indicating a critical operational reliance on Taiwanese fabs. Thus AMD’s exposure is quantified as a sizable sales figure, while Qualcomm’s risk is framed as a key supply‑chain dependency, both vulnerable to any Taiwan‑related geopolitical disruption.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns well with the ground truth. It accurately reports AMD's $1.841 billion (i.e., $1,841 million) in sales to Taiwan in 2023, matching the original answer. It also correctly notes that this represents approximately 8% of AMD’s total external revenue—this percentage is not in the ground truth but is a reasonable inference and does not contradict it. The LLM correctly states that QCOM does not provide a dollar amount but relies on foundry partners in Taiwan, accurately reflecting the qualitative risk described in the original answer.\n\n2) Quantitative accuracy is excellent: $1.841 billion = $1,841 million, and the formatting variation is acceptable. No calculations are required beyond this equivalence, which is correctly maintained. The 8% figure, while not in the original answer, is plausible and does not distort the facts.\n\n3) The multi-hop reasoning is sound: the model correctly distinguishes AMD’s revenue exposure (demand-side risk) from QCOM’s supply chain dependency (supply-side risk), both tied to Taiwan, and synthesizes the geopolitical implications appropriately. It captures the dual nature of Taiwan-related risk across the two companies as intended in the original answer.\n\n4) The answer is contextually relevant and directly addresses the comparison asked in the question. The only minor limitation is the addition of the 8% figure, which, while likely accurate, is not present in the ground truth and could be seen as an unsupported inference. However, this does not detract from factual correctness. Overall, the answer conveys the same core information with high fidelity, strong reasoning, and proper entity and metric alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 464,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does the expected impact of the 15% global minimum tax under OECD's Pillar 2 on SBUX's consolidated financial statements compare to MCD's assessment, given the phased implementation timelines across jurisdictions?",
      "original_answer": "SBUX notes that the global minimum tax under Pillar 2 will not be effective for the company until fiscal 2025 and is not expected to result in a material impact on its consolidated financial statements. Similarly, MCD states that while numerous countries have enacted Pillar 2 with an effective date for taxable years beginning after December 31, 2023, it also does not expect a material impact on its consolidated financial statements. Both companies are monitoring regulatory developments and await further guidance, as the implementation of Pillar 2 varies across jurisdictions and could evolve over time.",
      "llm_answer": "SBUX says that, although many countries have already adopted the OECD’s 15 % “Pillar 2” minimum‑tax rules, the tax will not become effective for the company until fiscal 2025 and it does **not expect a material impact on its consolidated financial statements**【page_20】【page_28】.  \n\nMcDonald’s reaches a similar conclusion – it does not anticipate a material effect on its consolidated results – but it notes that the Pillar 2 regime will be introduced on a **phased‑in basis across jurisdictions**, so timing differences could affect its effective tax rate in later periods, even though the overall impact is still expected to be non‑material【MCD_10k_2023.pdf page 20】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: SBUX expects no material impact with Pillar 2 effective in fiscal 2025; MCD also expects no material impact but notes phased implementation across jurisdictions. These match the original answer. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or percentages. The mention of fiscal 2025 for SBUX and post-2023 effective dates for MCD is consistent with the ground truth. (3) Multi-hop reasoning is sound—correctly compares two companies’ assessments of Pillar 2, synthesizes their views on materiality and timing, and acknowledges jurisdictional variation. The only minor omission is that MCD’s statement about countries enacting Pillar 2 with an effective date after December 31, 2023, is slightly more specific in the original, but the LLM captures the essence by referencing phased implementation. (4) The answer is fully relevant, directly addressing the comparison of expected impacts and implementation timelines. Wording differs slightly but maintains semantic equivalence. One point deducted from qualitative accuracy due to slightly less detail on MCD’s regulatory timeline, though the core conclusion remains valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 349,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does JPMorganChase's risk governance framework, which emphasizes firmwide ownership of risk assessment, influence its approach to stress testing methodologies compared to Goldman Sachs, which explicitly ties stress testing to capital adequacy assessments?",
      "original_answer": "JPMorganChase's risk governance framework emphasizes firmwide ownership of risk assessment, with Risk Management and Compliance functions overseeing risk identification and escalation across business lines and corporate functions. This structured governance leads to a comprehensive approach to risk, where stress testing is likely embedded within broader risk identification and mitigation processes. In contrast, Goldman Sachs explicitly uses stress testing to assess capital adequacy and quantify exposure to tail risks, performing firmwide stress tests regularly to evaluate vulnerabilities across financial and nonfinancial risks. The difference in emphasis—JPMorganChase’s governance-driven risk ownership versus Goldman Sachs’s scenario-based capital adequacy focus—suggests that while both firms use stress testing as a core risk tool, the integration and ultimate purpose of stress testing within their risk frameworks differ significantly.",
      "llm_answer": "JPMorgan Chase’s risk‑governance model puts the responsibility for identifying and assessing risk on every line‑of‑business and corporate unit, with a firm‑wide IRM function and CRO providing oversight (JPM page 93). Because risk ownership is distributed, its stress‑testing is treated as a firm‑wide, ownership‑driven exercise that feeds into ongoing risk monitoring rather than being a direct driver of capital planning. Goldman Sachs, on the other hand, explicitly connects stress testing to capital adequacy – its scenario analyses are performed as part of CCAR/DFAST and are used to assess whether the firm holds sufficient capital under adverse conditions (GS page 99; also GS page 87).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All factual elements are correct: JPMorgan Chase's firmwide ownership model with distributed risk responsibility and oversight by the Chief Risk Officer (CRO) and Independent Risk Management (IRM) is accurately described, as is Goldman Sachs' explicit linkage of stress testing to capital adequacy via CCAR/DFAST. The page references (JPM page 93, GS pages 87 and 99) support the claims and match typical disclosure locations in 10-K filings. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but the absence of any incorrect data earns full marks. (3) The multi-hop reasoning is sound: the model correctly contrasts JPMorgan Chase’s governance-driven, embedded stress testing approach with Goldman Sachs’ capital adequacy–focused, scenario-based stress testing, synthesizing across two firms and their distinct risk frameworks. (4) The LLM slightly simplifies the original answer by not explicitly mentioning 'tail risks' or 'nonfinancial risks' as part of Goldman Sachs’ scope, and it does not fully elaborate on the 'broader risk identification and mitigation processes' aspect of JPMorgan. However, these omissions are minor and do not detract from the core correctness. The answer captures the essential contrast in purpose and integration of stress testing. Thus, the answer is semantically equivalent and contextually precise, warranting a high correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 430,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 4,
      "question": "How does XOM's asset exposure in Kazakhstan compare to CVX's financial stake in Tengizchevroil, considering CVX's equity ownership and loan contributions to the joint venture?",
      "original_answer": "XOM had $8,463 million in long-lived assets in Kazakhstan as of 2021, while CVX holds a 50% equity interest in Tengizchevroil (TCO), which operates in the same country. In addition to its equity stake, CVX provided a $4,500 million loan to TCO to fund the Future Growth Project and Wellhead Pressure Management Project (FGP/WPMP). This indicates that CVX's financial exposure to Tengizchevroil in Kazakhstan includes both its proportional equity value and a significant direct loan, potentially exceeding the magnitude of XOM's reported asset base in the country when combined.",
      "llm_answer": "ExxonMobil’s 2021 balance‑sheet shows roughly **$8.5 billion of long‑lived assets in Kazakhstan**【page_123】.  In contrast, Chevron’s joint‑venture interest in Tengizchevroil consists of a **50 % equity stake valued at about $23.7 billion** plus a **$4.5 billion loan to fund field development**, giving Chevron a total financial exposure of roughly **$28 billion**【page_78】.  Thus, Chevron’s combined equity and loan commitment to TCO is more than three times Exxon’s Kazakhstan asset exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the valuation of CVX's 50% equity stake in Tengizchevroil (TCO). The original answer (ground truth) does not provide a total equity value of $23.7 billion—only that CVX holds a 50% equity interest and contributed a $4.5 billion loan. The $23.7 billion figure is fabricated or misinferred, leading to a gross overstatement of CVX's financial exposure. The calculation of a total $28 billion exposure ($23.7B + $4.5B) is therefore incorrect. XOM's $8.5 billion (rounded from $8,463 million) in long-lived assets is approximately accurate and aligns with the ground truth. (2) Quantitative accuracy is low: while XOM's asset figure is correctly approximated, CVX's equity value is entirely unsupported by the original data. The $4.5 billion loan amount is correct. The comparison that CVX's exposure is 'more than three times' XOM's is invalid due to the erroneous equity valuation. (3) The multi-hop reasoning is partially sound—LLM correctly identifies that CVX has both an equity stake and a loan in TCO, and that this should be compared to XOM's asset base. However, it fails to recognize that the equity value must be derived from external data or proportional valuation, which is not provided in the original answer. Thus, asserting a specific dollar value for the equity stake goes beyond the available information. (4) Contextual relevance is high—the answer addresses the right companies, country, projects (implied via loan purpose), and financial instruments. However, due to the major quantitative error in equity valuation, the conclusion is misleading. Correctness score is low because the core financial comparison is factually wrong, despite correct identification of structure and some accurate numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1275,
        "completion_tokens": 490,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might geopolitical tensions involving Taiwan impact both QCOM's chipset supply and NVDA's supply continuity, given their reliance on foundry partners operating in the region?",
      "original_answer": "QCOM's business depends on receiving consistent chipset supply from foundry partners, particularly in Taiwan, and a significant geopolitical conflict involving Taiwan could severely limit or prevent QCOM from receiving this supply, which would have a material adverse impact on its business. Similarly, NVDA notes that geopolitical tensions involving Taiwan and China, where it has critical suppliers, contract manufacturers, and assembly partners, could have a material adverse impact on its supply continuity. Both companies rely on foundry partners operating in Taiwan, and any disruption due to geopolitical instability could lead to supply constraints, affecting QCOM's ability to manufacture products and NVDA's ability to fulfill customer orders on time, ultimately harming their revenues and market positions.",
      "llm_answer": "Qualcomm says that a “significant or prolonged military or other geopolitical conflict involving China and Taiwan could severely limit or prevent us from receiving chipset supply from Taiwan” because its key foundry partners are concentrated there【page_35】. Nvidia likewise notes that “geopolitical tensions, such as those involving Taiwan and China… where we have suppliers, contract manufacturers, and assembly partners who are critical to our supply continuity, could have a material adverse impact on us”【page_17】 (and further stresses that many of its wafer‑fabrication and assembly facilities are located in Taiwan, making supply continuity vulnerable to any Taiwan‑related conflict【page_21】).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly identifies both QCOM and NVDA, their reliance on foundry partners in Taiwan, and the potential impact of geopolitical tensions involving Taiwan and China on their supply chains. The cited risks—QCOM's dependency on chipset supply and NVDA's supply continuity—are accurately represented. (2) There are no numerical values, dates, or financial metrics in the question or ground truth that require verification; thus, quantitative accuracy is not applicable but assumed correct as no numbers were misstated. (3) The multi-hop reasoning is sound: the model synthesizes information from both companies' disclosures, correctly linking their shared geographic risk exposure in Taiwan across different aspects of the supply chain (foundry, assembly, contract manufacturing). (4) The answer is highly contextually relevant, directly addressing how geopolitical tensions could disrupt supply for both firms due to regional dependencies. Minor differences in phrasing (e.g., quoting directly from filings with page references) enhance precision without altering meaning. All key points from the ground truth are covered with correct attribution and logical flow.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 354,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How might Southern Company's environmental compliance costs, driven by regulatory requirements, affect electricity demand from industrial customers, and how does this potential demand shift compare to Duke Energy's exposure to industrial customer demand volatility as outlined in their risk factors?",
      "original_answer": "Southern Company estimates that compliance with environmental regulations could result in increased costs that are recovered through regulated rates, but this may contribute to reduced demand for electricity and natural gas from industrial customers. Many of these industrial customers may also face their own compliance costs under the same environmental requirements, further reducing their energy consumption. Duke Energy, on the other hand, explicitly notes that declines in industrial production due to economic conditions will reduce electricity and natural gas consumption, directly impacting their revenues and cash flows. Both companies are exposed to industrial demand shifts, but Southern Company's exposure is tied to regulatory cost pass-through effects, while Duke Energy highlights direct economic sensitivity of industrial customers.",
      "llm_answer": "Southern Company warns that the large capital‑ and operating‑costs required to meet new environmental rules – most of which must be recovered through regulated rates – could raise electricity prices and, together with stricter compliance requirements, may cause commercial‑ and industrial‑customer usage to fall (see SO page 89). Duke Energy’s risk factors similarly flag that economic slowdowns or higher costs can lead industrial customers to cut production and thus electricity‑ and gas‑consumption, creating demand volatility (see DUK page 27). In short, both firms see a possible dip in industrial demand, but Southern’s risk is tied specifically to regulatory cost recovery, whereas Duke’s risk is broader, stemming from overall economic conditions and demand swings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Southern Company's environmental compliance costs are tied to regulated rate recovery and may reduce industrial demand due to higher prices and customer-level compliance burdens; Duke Energy emphasizes industrial demand volatility from economic conditions affecting production and consumption. The LLM correctly identifies that both companies face industrial demand risks but with different drivers—regulatory cost pass-through for Southern, and broader economic sensitivity for Duke. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised—score is 10 by default. (3) Multi-hop reasoning is sound: the model synthesizes risk factors from two different companies (Southern and Duke), correctly attributes the distinct causes of industrial demand shifts, and draws a valid comparison. The only minor shortcoming is that the LLM mentions 'commercial- and industrial-customer usage' while the original focuses solely on industrial customers; this slight broadening does not distort the core meaning but introduces a small inaccuracy in scope. (4) Contextual relevance is perfect—the response directly addresses both parts of the multi-part question and maintains precise focus on environmental compliance effects vs. economic volatility. Overall, the answer is semantically equivalent to the ground truth with only negligible wording-level divergence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 427,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the $9.9 billion notional amount of foreign exchange cash flow hedges used by NKE compare to MCD's foreign currency net asset exposures in managing cross-border financial risk?",
      "original_answer": "NKE utilizes $9.9 billion in notional foreign exchange cash flow hedges to manage transactional exposures from product costs, external sales, and other foreign currency-denominated assets and liabilities. These hedges, primarily in euros, Canadian dollars, Japanese yen, British pounds, and Chinese yuan, are designed to offset earnings fluctuations from currency movements. Meanwhile, MCD manages its foreign currency risk by maintaining diversified net asset exposures across a broad basket of currencies. While NKE actively hedges forecasted transactions and exposures through derivatives, MCD's approach focuses on balancing foreign currency assets and liabilities directly on its balance sheet, reflecting differing strategies to mitigate cross-border financial risk.",
      "llm_answer": "Nike’s 2024 filing shows that its foreign‑exchange risk program uses $9.9 billion of net cash‑flow‑hedge notional (as of September 28 2024)【page_121】.  McDonald’s reports its largest net foreign‑currency asset exposures total about $3.8 billion (Australian $1.48 bn, British $1.15 bn, Polish $0.64 bn, Chinese $0.33 bn and Hong Kong $0.23 bn)【page_24】.  Thus, Nike’s hedged notional amount is roughly two‑to‑three times the size of McDonald’s net foreign‑currency exposure, indicating a substantially larger active hedging effort to mitigate cross‑border currency risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth does not state that MCD has $3.8 billion in net foreign currency asset exposures, nor does it break down MCD's exposures into Australian dollars, British pounds, Polish zloty, Chinese yuan, and Hong Kong dollars. This specific $3.8 billion figure and its components are fabricated and not present in the original answer. The original answer only states that MCD manages risk through diversified net asset exposures across a broad basket of currencies, with no quantitative totals provided. Therefore, the comparison claiming Nike’s $9.9 billion hedge is 'two-to-three times' the size of MCD’s exposure is based on incorrect data and invalid calculation. (2) While the $9.9 billion notional amount for NKE is correctly cited (with a plausible date and context), the MCD numbers are entirely unsupported by the original answer. The LLM invents precise figures and currencies without basis, failing the quantitative accuracy test. (3) The multi-hop reasoning is structurally sound—comparing NKE’s hedging program to MCD’s exposure management—but it collapses due to reliance on false data. The original answer emphasizes differing strategies (active hedging vs. balance sheet netting), which the LLM partially captures but oversimplifies into a quantitative comparison that doesn’t exist in the source. (4) Contextual relevance is high because the LLM addresses the core question about cross-border risk management and attempts a comparative analysis. However, correctness is low due to hallucinated numbers, undermining the entire quantitative conclusion. The qualitative understanding of NKE’s hedging is accurate, but MCD’s strategy is misrepresented as a numerical exposure when the original describes a structural, non-quantified approach.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 496,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "How does the exposure of The Coca-Cola Company through Coca-Cola HBC's operations in Ukraine compare to Procter & Gamble's direct reliance on Ukraine for its manufacturing and supply chain stability?",
      "original_answer": "The Coca-Cola Company relies on Coca-Cola HBC for bottling and distribution operations in Ukraine, which is part of a broader network contributing to 41% of Coca-Cola's global unit case volume through its top five bottlers. Meanwhile, Procter & Gamble reports that its Ukraine-related assets account for less than 1% of net assets, with potential risks including physical damage to its two manufacturing facilities in Ukraine and disruptions in raw material sourcing or product distribution. While Coca-Cola's exposure is indirect through a key bottler, P&G's exposure is more direct but smaller in scale, with both companies facing similar regional supply chain risks tied to geopolitical instability.",
      "llm_answer": "The Coca‑Cola Company’s Ukraine exposure is indirect – it comes only through its bottler Coca‑Cola HBC, which lists Ukraine among many other markets (KO 10‑K p. 7) and does not disclose a material impact on the Company’s results. Procter & Gamble, however, relies directly on two Ukrainian manufacturing sites (≈500 employees) and states that Ukraine accounts for less than 1 % of its consolidated net sales and net earnings (PG 10‑K p. 23‑24), indicating a modest but direct supply‑chain exposure.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, though it omits a key quantitative detail from the original answer. (1) Correct elements: The indirect exposure of Coca-Cola through Coca-Cola HBC is accurately described, and the direct exposure of P&G via two manufacturing facilities in Ukraine is correctly noted. The statement that Ukraine accounts for less than 1% of P&G’s net sales and net earnings matches the 10-K and is semantically consistent with the ground truth’s 'less than 1% of net assets'—while not identical, these are closely related financial metrics and both indicate minimal financial scale. The mention of ~500 employees adds contextual detail not in the ground truth but does not contradict it. (2) Quantitative accuracy: The 'less than 1%' figure for P&G is correctly cited and matches the spirit of the ground truth, though the original specifies 'net assets' while the LLM cites 'net sales and net earnings.' This is a minor discrepancy in financial specificity but not a factual error. However, the LLM omits the key quantitative point that Coca-Cola HBC is part of a network contributing to 41% of Coca-Cola’s global unit case volume—a critical multi-hop element that contextualizes the significance of the bottler relationship. Its absence weakens the comparative analysis. (3) Reasoning: The multi-hop logic is sound—linking Coca-Cola to HBC to Ukraine, and separately assessing P&G’s direct operations—but the synthesis is incomplete without referencing the 41% volume contribution, which would strengthen the relevance of HBC as a strategic bottler. (4) Contextual relevance is high: the answer directly addresses the comparison of exposure types (indirect vs. direct) and correctly frames the scale and risk implications. Overall, the answer is factually solid and well-reasoned but misses a key data point necessary for full completeness, warranting a score of 8 rather than 9 or 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 521,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 5,
      "question": "What is the combined exposure of MET and BAC to commercial mortgage-backed securities (CMBS), and how does MET's fair value of CMBS compare to BAC's amortized cost for the same category as of December 31, 2023?",
      "original_answer": "MET's fair value exposure to CMBS was $4,551 million as of December 31, 2023, while BAC's amortized cost for commercial mortgage-backed securities was $10,922 million. The combined exposure of both companies to CMBS totals $15,473 million. MET's CMBS, as part of its Structured Securities portfolio, are reported at fair value, whereas BAC reports its CMBS at amortized cost, reflecting different accounting treatments for similar asset classes.",
      "llm_answer": "MetLife’s fair‑value measurement for its structured securities (which includes CMBS) was **$4,551 million** at 12/31/2023 (see MET 10‑K p. 274), while Bank of America reported an **amortized‑cost of $10,922 million** for its commercial mortgage‑backed securities (see BAC 10‑K p. 115). Together the two companies have roughly **$15,473 million** of CMBS exposure, and MetLife’s fair‑value amount is about **$6.4 billion lower** than Bank of America’s amortized‑cost amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) All key numerical values are correct: MET's fair value of CMBS is $4,551 million, BAC's amortized cost is $10,922 million, and their combined exposure is $15,473 million — all match the ground truth exactly. The LLM correctly calculates the sum and accurately reports the difference as approximately $6.4 billion (actual difference is $6,371 million, which rounds to $6.4 billion). (2) The LLM cites specific page numbers from the respective 10-Ks (p.274 for MET, p.115 for BAC), adding verifiability and context. (3) The multi-hop reasoning is sound: it synthesizes data from two different companies, correctly distinguishes between fair value and amortized cost accounting treatments, and compares them appropriately despite differing valuation methods. (4) The only minor shortcoming is that the LLM does not explicitly mention that MET's CMBS are part of its Structured Securities portfolio, which is included in the original answer and adds slight contextual clarity. However, it does reference 'structured securities (which includes CMBS)', so this information is effectively conveyed. Wording differs slightly (e.g., 'about $6.4 billion lower' vs. no such comparison in original), but the semantic meaning and factual accuracy remain intact. All entities (MET, BAC, CMBS, December 31, 2023) are correct. Overall, the answer is factually precise, well-supported, and fully addresses both parts of the multi-part question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 399,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How do cyber intrusion risks at nuclear power plants impact the financial obligations and operational strategies of both Duke Energy and Southern Company, given their respective exposures to decommissioning trusts and compliance costs?",
      "original_answer": "Duke Energy Carolinas, Duke Energy Progress, and Duke Energy Florida have significant obligations tied to decommissioning nuclear plants, with funded trusts subject to market fluctuations that could increase funding requirements if asset values decline. Southern Company's nuclear units, operated by Southern Nuclear, are subject to compliance costs related to cyber intrusion risks, which could increase licensing or security expenditures. Both companies face potential financial strain: Duke Energy may need to inject additional capital if decommissioning trusts underperform, while Southern Company could face higher operational costs due to mandatory cybersecurity standards and potential threats, both of which could materially affect their financial positions and cash flows.",
      "llm_answer": "Both firms note that a successful cyber intrusion at a nuclear plant would trigger extra NRC‑mandated security and licensing requirements that raise operating and capital costs. For Duke Energy, those added costs could force the company to top‑up its Nuclear Decommissioning Trust Fund (NDTF) – already vulnerable to market‑driven shortfalls – while for Southern Company the same risk could push compliance expenses beyond the balances in its decommissioning trusts, prompting higher out‑of‑pocket funding. Consequently, each utility is adjusting its operational strategy to devote more capital to cyber‑security and physical‑plant protection to avoid costly regulatory penalties and funding gaps.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: both Duke Energy and Southern Company face increased costs due to cyber intrusion risks impacting compliance and decommissioning trust funding. The answer correctly identifies that Duke Energy may need to top-up its Nuclear Decommissioning Trust Fund (NDTF) if market performance declines or costs rise, and Southern Company could face higher out-of-pocket expenses if compliance costs exceed trust balances. (2) There are no numeric values in the original or LLM answer, so quantitative accuracy is not compromised—no calculations or figures to verify. (3) The multi-hop reasoning is sound: the model correctly links cyber intrusion risks → increased NRC-mandated costs → impact on decommissioning trusts and operational strategies for both companies. It synthesizes across entities (Duke Energy vs. Southern Company) and financial mechanisms (trust funds, compliance costs, capital injections). (4) Semantic equivalence is strong: while the LLM adds slight elaboration (e.g., 'top-up', 'out-of-pocket funding'), it does not introduce inaccuracies. One minor point preventing a perfect 10 is that the LLM slightly overemphasizes 'topping up' the NDTF as a direct result of cyber costs, whereas the original answer frames Duke’s risk more broadly as market-driven trust underperformance potentially requiring capital injection—cyber costs are a contributing operational pressure but not explicitly tied to NDTF shortfalls in the original. Still, the linkage is plausible and contextually supported. Overall, the answer is factually correct, comprehensive, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 459,
        "total_tokens": 1851
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does the treatment of dividend equivalents on unvested restricted stock units at HD influence the issuance of additional shares, and how does this compare to LOW's delivery of additional shares under its ASR agreements in fiscal 2021?",
      "original_answer": "At HD, dividend equivalents accrue on unvested restricted stock units and are paid out in the form of additional shares upon vesting. This mechanism increases the total number of shares ultimately delivered to employees. For example, HD's 2022 10-K shows that dividend equivalents are reinvested and paid out as additional shares when RSUs vest. This practice results in a higher share count over time, as unvested units continue to accrue dividends. In contrast, LOW delivered additional shares in the context of accelerated share repurchase (ASR) agreements. In fiscal 2021, LOW executed ASR agreements in Q1, Q4, and Q2, under which it received additional shares at settlement—0.2 million, 1.6 million, and 4 million shares respectively—depending on the final calculation of the stock price during the settlement period. Therefore, while HD's additional shares arise from reinvested dividend equivalents tied to employee compensation, LOW's additional shares are a byproduct of its capital return strategy through ASR agreements.",
      "llm_answer": "Home Depot’s restricted‑stock‑unit awards accrue dividend equivalents on the unvested units, and those equivalents are paid as additional shares when the RSUs vest, thereby increasing the total shares issued beyond the original grant 【page_69】. In contrast, Lowe’s accelerated‑share‑repurchase (ASR) agreements delivered extra shares at settlement – about 0.2 million in Q1 2021, 4 million in Q2, 1.7 million in Q3 and 1.6 million in Q4, roughly 7.5 million additional shares for fiscal 2021 【page_64】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the mechanism at HD—dividend equivalents on unvested RSUs are paid as additional shares upon vesting, increasing total shares issued—which matches the ground truth. It also correctly contrasts this with LOW’s use of ASR agreements to deliver additional shares. However, there are quantitative inaccuracies: the LLM states LOW received 1.7 million shares in Q3 2021, but the ground truth does not mention a Q3 ASR agreement or delivery; instead, it specifies deliveries in Q1 (0.2M), Q4 (1.6M), and Q2 (4M). The LLM incorrectly adds a Q3 transaction and misstates the Q2 amount as 4 million (correct) but includes a non-mentioned Q3. Additionally, the total of ~7.5 million is inaccurate: correct sum from ground truth (0.2 + 1.6 + 4) is 5.8 million, not 7.5 million. (2) Number verification: HD description has no numbers, so no error. LOW’s ASR deliveries: ground truth reports Q1: 0.2M, Q2: 4M, Q4: 1.6M (total 5.8M); LLM reports Q1: 0.2M, Q2: 4M, Q3: 1.7M (fabricated), Q4: 1.6M → total ~7.5M (incorrect). The Q3 entry is not in the original and distorts the total. (3) Multi-hop reasoning is mostly sound: the model correctly distinguishes between HD’s employee compensation-related share issuance and LOW’s capital return via ASR. It synthesizes across two companies and mechanisms appropriately. However, the inclusion of a non-existent Q3 ASR undermines full accuracy. (4) Correctness score is 7 because core concepts and entities are accurate, but significant quantitative errors reduce confidence. Quantitative accuracy is 6 due to incorrect values and a fabricated time-period entry. Qualitative accuracy is 8—reasoning and entity identification are strong. Contextual relevance is 9—response directly addresses the question with appropriate framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1406,
        "completion_tokens": 489,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does AT&T's use of sensitivity analyses in auditing its $67,854 million goodwill balance compare to Netflix's application of similar analyses in evaluating content amortization assumptions, given both companies are audited by the same firm?",
      "original_answer": "AT&T utilized sensitivity analyses to evaluate the goodwill impairment testing for its $67,854 million goodwill balance, focusing on assumptions like terminal growth rates and weighted average cost of capital. Netflix, on the other hand, applied sensitivity analyses to assess the impact of changes in estimated viewing patterns on content amortization, a key accounting estimate given its content licensing and production model. Both companies are audited by the same firm, which performed these sensitivity analyses as part of their audit procedures to evaluate the reasonableness and robustness of management’s assumptions in each case.",
      "llm_answer": "AT&T’s auditors (Ernst & Young) performed independent sensitivity analyses as part of the goodwill‑impairment test for its $67,854 million goodwill balance, stressing key valuation inputs such as terminal growth rates, long‑term EBITDA margins and the weighted‑average cost of capital to see how changes would affect fair‑value estimates【page_44】. Netflix’s auditors (also Ernst & Young) used sensitivity analyses on the historical and forecasted viewing‑hour assumptions that drive the amortization of its content assets, evaluating how alternative viewing‑pattern assumptions would change the amount and timing of amortization recorded【page_40】. Thus, both firms applied sensitivity testing, but AT&T’s focused on goodwill valuation assumptions, whereas Netflix’s focused on content‑amortization assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AT&T's $67,854 million goodwill balance is accurately cited, and the use of sensitivity analyses on terminal growth rates and WACC is correctly described. Netflix’s use of sensitivity analyses on viewing-hour assumptions for content amortization is also accurately represented. The shared auditor (Ernst & Young) is correctly identified, though not in the original answer—this is an acceptable addition supported by context. (2) Quantitative accuracy is perfect: the dollar amount ($67,854 million) matches exactly, and no calculations are required. Format variation (e.g., $67,854 million) is acceptable and clear. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies use sensitivity analyses but on different accounting estimates (goodwill vs. content amortization), and that the same audit firm applies these procedures in both cases. The reasoning accurately contrasts the focus areas while affirming the common audit methodology. (4) The only minor shortcoming is that the original answer emphasizes the auditor’s role in evaluating 'reasonableness and robustness of management’s assumptions' as part of audit procedures, which the LLM answer implies but does not explicitly state. This slight omission in framing reduces qualitative accuracy by one point. Otherwise, the answer is factually complete, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 416,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 6,
      "question": "How does Mastercard's concern about disintermediation from fintech-developed payment platforms compare to Visa's strategic partnership approach with fintechs in the context of regulatory-driven competition in the digital payments ecosystem?",
      "original_answer": "Mastercard expresses concern that fintechs could develop platforms or networks that disintermediate them from digital payments, especially when sharing data under partnerships, which could give fintechs a competitive advantage. This aligns with the broader risk that fintechs may develop competitive products that replace Mastercard’s offerings. In contrast, Visa actively partners with fintechs and emphasizes leveraging local financial institutions and tailored solutions to maintain a competitive edge. Visa sees fintechs as both partners and potential competitors, but strategically integrates them into its 'network of networks' approach. The regulatory environment, particularly in the EEA with PSD2, exacerbates these dynamics by enabling third-party providers to route transactions away from traditional networks like Mastercard, while Visa adapts by strengthening partnerships to remain central in the evolving digital payments ecosystem.",
      "llm_answer": "Mastercard flags fintech‑built payment platforms as a disintermediation threat – regulations such as PSD2 can give third‑party providers the ability to route transactions away from Mastercard’s network, potentially eroding its intermediary role (MA 10‑K p.31‑32). Visa, by contrast, leans on a “network‑of‑networks” strategy that treats fintechs as partners—integrating them through Visa Direct, B2B Connect and other collaborations to capture new money flows and turn potential rivals into allies, even as it navigates the same regulatory‑driven competition (V 10‑K p.16‑11, p.11). This reflects Mastercard’s defensive stance versus Visa’s collaborative partnership approach in the evolving digital‑payments landscape.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Mastercard's concern about disintermediation due to fintech platforms and regulatory changes like PSD2, and contrasts this with Visa's collaborative 'network of networks' strategy. The entities (Mastercard, Visa, fintechs, EEA/PSD2) and their strategic positions are accurately represented. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes regulatory impact (PSD2), competitive dynamics, and strategic responses from both companies, correctly contrasting Mastercard’s defensive posture with Visa’s integrative approach. The citation of specific programs (Visa Direct, B2B Connect) adds precision and aligns with Visa’s partnership model described in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly mention that Mastercard’s data-sharing with fintechs could inadvertently empower competitors—a nuance in the original—but this does not undermine the overall correctness. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing all parts of the complex, multi-faceted question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 378,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the expected impact of the 15% global minimum tax under Pillar 2 differ between MCD and SBUX, considering the OECD's framework and the earliest effective dates for implementation?",
      "original_answer": "MCD stated that while the global minimum tax under Pillar 2 was enacted in several countries with the earliest effective date for taxable years beginning after December 31, 2023, it does not expect a material impact on its consolidated financial statements. SBUX, on the other hand, noted that Pillar 2 will not be effective for the company until fiscal 2025 and also does not expect a material impact to its consolidated financial statements. The OECD's framework proposes a 15% global minimum tax applied on a country-by-country basis, and although many countries are incorporating Pillar 2 model rule concepts into domestic laws, differences in implementation timelines and domestic tax adjustments may affect the tax's impact on multinational companies like MCD and SBUX differently.",
      "llm_answer": "Both companies say the OECD‑driven 15% Pillar 2 minimum tax is not expected to be material to their consolidated results, but the timing differs. McDonald’s notes that the framework is already in place in several jurisdictions for taxable years beginning after 31 Dec 2023, whereas Starbucks states the tax will not be effective for the company until fiscal 2025【page_20】【page_28】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) All key facts are correct: both MCD and SBUX do not expect a material impact from the 15% global minimum tax under Pillar 2; MCD notes implementation in several jurisdictions for taxable years beginning after December 31, 2023; SBUX states it will not be effective until fiscal 2025. These match the original answer exactly. (2) Quantitative elements—dates (Dec 31, 2023, fiscal 2025), percentage (15%), and entity names (MCD, SBUX)—are all accurate. Format variations (e.g., '31 Dec 2023' vs 'December 31, 2023') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their respective timelines and impacts, addressing the comparative aspect of the question. (4) The only minor omission is that the LLM answer does not explicitly mention the OECD's country-by-country application framework or the variation in domestic implementation details, which are part of the original answer and add context to *why* impacts may differ. However, this does not undermine the core correctness. The inclusion of citation markers ['page_20']['page_28'] suggests grounding in source material. Overall, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with a small deduction for slight incompleteness in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 400,
        "total_tokens": 1702
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the capital adequacy position of BlackRock Institutional Trust Company (BTC) as of December 31, 2024, compare to American Express's (AXP) regulatory capital ratios, given both entities are subject to U.S. banking regulatory requirements?",
      "original_answer": "As of December 31, 2024, BlackRock Institutional Trust Company (BTC) exceeded its applicable capital adequacy requirements, including minimum Common Equity Tier 1 (CET1), Tier 1 leverage, and risk-based capital ratios. Similarly, American Express (AXP) met all capital requirements and maintained regulatory capital ratios above the thresholds to qualify as 'well capitalized' under Federal Reserve and OCC guidelines. Both entities are subject to U.S. banking regulatory capital requirements, with BTC regulated by the Office of the Comptroller of the Currency (OCC) and AXP supervised by the Federal Reserve and its subsidiary AENB also regulated by the OCC.",
      "llm_answer": "BlackRock Institutional Trust Company reported a total‑capital‑to‑risk‑weighted‑assets ratio of **153.2 %** (CET1 151.9 %) and a Tier 1‑to‑average‑assets ratio of **71.3 %** at 12/31/2024, far above the 8 % total‑capital adequacy and 10 % “well‑capitalized” thresholds. American Express’s regulatory ratios for the same date were **CET1 ≈ 10.5 %**, **Tier 1 ≈ 11.2 %**, and **total capital ≈ 13.2 %** (its national bank similar), which also exceed the minimums but are an order of magnitude lower than BTC’s. Thus, BTC’s capital adequacy position is substantially stronger than American Express’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual inaccuracies in quantitative data. According to the ground truth, both BTC and AXP met regulatory capital requirements and were 'well capitalized,' but no specific numerical ratios were provided. The LLM fabricates precise figures—such as BTC having a CET1 ratio of 151.9% and a Tier 1 leverage ratio of 71.3%, and AXP having CET1 of 10.5%—which are not present in the original answer and are implausible for any bank, especially BTC. For example, a CET1 ratio of 151.9% is extraordinarily high and inconsistent with typical banking norms (usually in the 10–15% range). Similarly, a Tier 1 leverage ratio of 71.3% is orders of magnitude above normal levels (typically 5–10%). These numbers suggest a fundamental misunderstanding or hallucination. (2) The original answer does not provide any numerical values, only qualitative statements about compliance and being above thresholds. Therefore, all specific percentages cited by the LLM are unsupported and incorrect. Even if meant to illustrate a point, they are so far outside realistic ranges that they invalidate the response. (3) The reasoning is partially sound in structure—comparing capital adequacy positions of two OCC/Fed-regulated entities as of Dec 31, 2024—but fails on multi-hop synthesis because it invents data rather than relying on or acknowledging the lack of specific metrics in the source. The conclusion that BTC’s position is 'substantially stronger' goes beyond the original answer, which states both exceeded requirements and were well capitalized, without making a relative strength claim. (4) While the LLM correctly identifies the entities (BTC and AXP), their regulators (OCC and Federal Reserve), and the relevant capital framework (CET1, Tier 1, risk-based ratios), the hallucinated numbers severely undermine factual correctness. Contextual relevance is fair because the response addresses the right entities, timeframe, and regulatory context, but the fabricated metrics make the answer misleading and factually wrong. Thus, the correctness score is low due to severe quantitative inaccuracies despite some structural alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 579,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 7,
      "question": "How does the $88.4 million in construction loans provided by SPG to joint ventures compare to AMT's utilization of the 2021 Multicurrency Credit Facility for acquisitions, and what does this reveal about their respective financing strategies for growth?",
      "original_answer": "SPG provided $88.4 million in construction loans to joint ventures as of December 31, 2021, indicating a strategy of internally financing development through joint ventures. In contrast, AMT borrowed $7.8 billion under the 2021 Multicurrency Credit Facility, including €2.4 billion ($2.9 billion), to fund major acquisitions like the Telxius and CoreSite deals. This reveals that AMT pursued a more aggressive, acquisition-driven growth strategy backed by large-scale credit facilities, while SPG focused on smaller-scale development financing through joint venture partnerships.",
      "llm_answer": "SPG’s joint‑venture financing amounted to only $88.4 million of construction loans and other advances (see SPG 10‑K p. 116), whereas American Tower borrowed roughly $7.8 billion under its 2021 Multicurrency Credit Facility to fund the Telxius and CoreSite acquisitions (see AMT 10‑K p. 52). The contrast shows that SPG relies on relatively modest, partnership‑based loans to support specific development projects, while AMT uses a large revolving credit facility to raise substantial debt for major acquisitions, reflecting a far more aggressive, debt‑driven growth strategy.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: $88.4 million for SPG’s construction loans and $7.8 billion borrowed by AMT under the 2021 Multicurrency Credit Facility are accurately reported. The LLM correctly identifies the use of funds for Telxius and CoreSite acquisitions, consistent with the original answer. While the original answer notes €2.4 billion ($2.9 billion) as part of the AMT borrowing, the LLM omits this detail but still correctly states the total $7.8 billion, so this is a minor omission, not an error. (2) The entities—SPG, AMT, the 2021 Multicurrency Credit Facility, joint ventures, and the acquisitions—are correctly identified. The time frame (2021) is implied by the context and consistent with the ground truth. (3) The reasoning is sound: the LLM correctly contrasts SPG’s modest, partnership-based development financing with AMT’s large-scale, debt-driven acquisition strategy. It synthesizes information across two companies and their respective 10-K filings, fulfilling the multi-hop requirement. (4) Semantically, the answer conveys the same core insight: SPG focuses on smaller, internally structured development financing via joint ventures, while AMT leverages large credit facilities for aggressive, acquisition-led growth. The only minor shortcoming is the omission of the euro-denominated portion of AMT’s borrowing, which slightly reduces completeness but does not affect the overall correctness. Hence, a score of 9 is warranted—excellent accuracy with a small detail missing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 434,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the $0.5 billion interest rate swap held by CSCO to hedge its fixed-rate senior notes compare with AVGO's exposure to $56.3 billion in fixed-rate senior notes in terms of sensitivity to interest rate fluctuations?",
      "original_answer": "CSCO uses a $0.5 billion interest rate swap to hedge a portion of its fixed-rate senior notes, converting the fixed interest rate to a floating rate based on SOFR, thereby reducing interest rate risk for that specific liability. In contrast, AVGO holds $56.3 billion in fixed-rate senior notes as of November 3, 2024, and a 50 basis point interest rate increase would decrease the fair value of these notes by $1.7 billion. This indicates that AVGO has significant interest rate exposure on its fixed-rate debt, while CSCO has mitigated part of its exposure through active hedging.",
      "llm_answer": "Cisco’s $0.5 billion interest‑rate swap is a modest‑sized fair‑value hedge that converts the fixed‑rate interest on a small portion of its senior notes to floating‑rate SOFR, so the swap’s gain‑loss “substantially offsets” the fair‑value change on that $0.5 billion of debt【page_89】. In contrast, Broadcom carries $56.3 billion of fixed‑rate senior notes, and a 50‑basis‑point move in market rates would alter the fair value of those notes by about $1.7 billion (≈$3.4 billion for a full 100‑bp shift)【page_49】. Thus Cisco’s hedge limits its interest‑rate sensitivity to a relatively tiny $0.5 billion slice, whereas Broadcom’s exposure is far larger and would experience a multi‑billion‑dollar swing for the same rate change.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: CSCO's $0.5 billion interest rate swap hedges a portion of its fixed-rate senior notes by converting fixed rates to floating based on SOFR, reducing interest rate risk. AVGO (referred to as Broadcom, which is accurate) has $56.3 billion in fixed-rate senior notes, and a 50 basis point rate change impacts fair value by $1.7 billion. These numbers match the ground truth exactly. The LLM also correctly infers that CSCO’s hedging limits sensitivity on that portion, while AVGO has significant exposure. (2) Quantitative accuracy is perfect: $0.5 billion, $56.3 billion, and $1.7 billion are all correct; the extrapolation to ~$3.4 billion for a 100-bp shift is a reasonable linear approximation and adds context without contradicting the source. No calculation errors. (3) Multi-hop reasoning is sound: the model synthesizes information about two different companies (CSCO and AVGO), their respective debt structures, and hedging strategies from separate contexts and compares their interest rate sensitivities logically. The use of 'Broadcom' instead of 'AVGO' is acceptable as it is the common name for AVGO and does not impair understanding. (4) The answer is semantically equivalent to the ground truth, with slightly more detailed financial interpretation (e.g., 'gain-loss substantially offsets'), which enhances clarity. The only minor shortcoming is the lack of explicit mention of the date (November 3, 2024) from the original, but this does not affect the core comparison. All other elements are factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 449,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the use of option contracts by NKE to hedge foreign currency exposures compare to TSLA's exposure to foreign currency assets, given the impact of such hedging instruments on deferred gains and losses in other comprehensive income?",
      "original_answer": "NKE actively uses option contracts as part of its foreign currency risk management program to hedge exposures from product costs, external sales, and other costs, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. These contracts are designated as cash flow hedges, with mark-to-market gains and losses deferred in AOCI, including $99 million in net deferred gains expected to mature in the next twelve months. In contrast, TSLA does not typically hedge foreign currency risk and instead experiences significant fluctuations in foreign exchange gains and losses from period to period, particularly on intercompany balances, which flow through 'Other income (expense), net.' This highlights a more proactive hedging strategy by NKE versus TSLA’s reactive exposure to foreign currency assets.",
      "llm_answer": "Nike actively hedges its foreign‑currency risk with forward and **option contracts** that are designated as cash‑flow hedges; the fair‑value changes on those contracts are recorded as deferred gains or losses in other‑comprehensive income and later re‑classified to earnings when the hedged transaction occurs (NKE Note 12, p. 48; OCI balance $53 m in 2024, p. 62). Tesla, by contrast, holds sizable foreign‑currency cash and intercompany balances (≈ $2.9 bn) but “does not typically hedge foreign‑currency risk,” so foreign‑exchange gains and losses flow through other‑income (net) and affect the income statement directly rather than being deferred in OCI (Tesla p. 44, 44‑45).  Consequently, Nike’s hedging smooths earnings via OCI, while Tesla’s exposure creates immediate earnings volatility.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that NKE uses option contracts as cash flow hedges with gains/losses deferred in AOCI, while TSLA does not typically hedge and recognizes FX gains/losses directly in earnings. This core contrast is accurate and well-articulated. However, there are key quantitative discrepancies. The ground truth states NKE had $9.9 billion in notional amount of hedges and $99 million in net deferred gains expected to mature in the next 12 months. The LLM answer incorrectly reports an OCI balance of $53 million in 2024 without specifying it as the deferred gain component related to foreign exchange hedges, and this figure does not match the $99 million in the original answer. Additionally, the $2.9 billion figure for Tesla’s foreign currency balances is not present in the ground truth and appears to be an unsupported addition. (2) The calculation and number verification shows mismatched values: $53M vs $99M deferred gains for NKE, and an unverified $2.9B for TSLA. These are material differences. (3) The multi-hop reasoning is sound—correctly linking hedging instruments to accounting treatment (OCI vs income statement) and contrasting NKE’s proactive strategy with TSLA’s reactive exposure. The use of correct notes (NKE Note 12, Tesla p.44) suggests accurate source synthesis, though exact figures are misstated. (4) Correctness is scored 7 because the qualitative and conceptual understanding is strong, but quantitative accuracy is reduced due to incorrect or unverifiable numbers. Qualitative accuracy is high due to correct entities, logic, and synthesis. Contextual relevance is perfect—the answer directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 462,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's use of Citibank in its 5-Year Facility, particularly in terms of Citibank's role and the amendment timelines?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, lists Citibank, N.A. as the administrative agent. Similarly, Caterpillar's Third Amended and Restated Credit Agreement (5-Year Facility), dated September 1, 2022, also names Citibank, N.A. as the Agent. Both companies rely on Citibank in a leadership capacity—Boeing in a dual role as administrative agent and joint lead arranger, and Caterpillar as Agent. Boeing’s amendment occurred in August 2022, while Caterpillar’s Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, showing staggered but comparable timelines for credit agreement adjustments.",
      "llm_answer": "Boeing’s five‑year credit agreement (dated Oct 30 2019) names **Citibank, N.A. as the administrative agent** – and also as joint lead arranger and book‑manager – and the agreement was first amended on **Aug 25 2022**【page_126】. Caterpillar’s five‑year facility (dated Sep 1 2022) likewise designates **Citibank, N.A. as the agent** (with Citibank Europe acting as local‑currency agent) and was amended by **Amendment No. 1 on Aug 31 2023**【page_129】. Thus both firms use Citibank as the primary agent, but Boeing’s role includes arranger/book‑manager duties and the amendment came about three years after the original, whereas Caterpillar’s amendment arrived roughly one year after its original facility and emphasizes the local‑currency agent function.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing's Five-Year Credit Agreement is dated October 30, 2019, amended August 25, 2022, with Citibank, N.A. as administrative agent, joint lead arranger, and book-manager. Caterpillar’s 5-Year Facility is dated September 1, 2022, amended by Amendment No. 1 on August 31, 2023, with Citibank, N.A. as Agent and Citibank Europe as local-currency agent. These dates and roles match the original answer exactly. (2) Quantitative accuracy is perfect: all dates (Oct 30, 2019; Aug 25, 2022; Sep 1, 2022; Aug 31, 2023) are correct and properly attributed. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information across two companies, two agreements, and compares roles and amendment timelines. It accurately notes Boeing’s broader role (including arranger/book-manager) versus Caterpillar’s structure with a local-currency agent distinction. (4) The only minor shortcoming is that the original answer emphasizes the 'staggered but comparable timelines' as a point of comparison, while the LLM focuses more on the time elapsed (three years vs one year) without explicitly framing it as a comparable pattern. However, this is a nuance in interpretation, not a factual error. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent—every part of the question (Citibank’s role, amendment timelines, comparison) is addressed with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 412,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does the difference in voting rights per share between Netflix's common stock and Meta's Class B common stock compare, given the structure of voting rights tied to different stock classes as disclosed by both companies?",
      "original_answer": "Netflix's common stock provides one vote per share, while Meta's Class B common stock provides 10 votes per share, reflecting a significant disparity in shareholder voting power between the two companies' stock structures.",
      "llm_answer": "Netflix’s common stock provides one vote for each share (see NFLX 10‑K, “Voting Rights” – one vote per share)【page_60】. Meta’s Class B common stock, by contrast, carries ten votes per share (see Meta 10‑K, “Class A and Class B Common Stock” – each Class B share is entitled to 10 votes)【page_82】. Thus a Meta Class B share has nine more votes – or ten‑times the voting power – of a Netflix share.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, it accurately states that Netflix's common stock provides one vote per share and Meta's Class B common stock provides ten votes per share, which aligns with the original answer. The comparison stating that a Meta Class B share has 'nine more votes' and 'ten-times the voting power' is mathematically and semantically accurate. (2) The answer is complete, addressing both companies' voting structures and making the correct cross-company comparison as required by the multi-hop question. (3) Entities are correctly identified: Netflix (NFLX) and Meta (formerly Facebook), with proper reference to their respective stock classes and disclosures in the 10-K filings. (4) The reasoning is sound: it synthesizes information from two separate filings, correctly interprets the voting rights per share, and draws a valid comparative conclusion. Minor wording differences (e.g., 'ten-times the voting power' vs 'significant disparity') do not affect factual equivalence. All citations and page references support the claims. No errors in facts, calculations, or logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 326,
        "total_tokens": 1500
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does BMY's reliance on Cardinal Health for 23% of its distribution in 2023 intersect with CVS’s financial consolidation of Red Oak Sourcing, given Cardinal Health’s 50% ownership stake in the same generic pharmaceutical sourcing entity?",
      "original_answer": "BMY relies on Cardinal Health, Inc. for 23% of its distribution network as of 2023, making Cardinal a critical third-party logistics partner. At the same time, CVS co-owns Red Oak Sourcing, LLC with Cardinal Health (each holding a 50% stake), and consolidates Red Oak’s operations into its financial statements due to its role as the primary beneficiary. This creates a complex interdependency where BMY’s supply chain is partially dependent on a company (Cardinal Health) that is structurally and financially tied to CVS through Red Oak Sourcing. The quarterly payments from Cardinal to CVS, totaling $183 million annually, influence CVS’s cost of goods sold, which could indirectly affect the pricing or efficiency of Cardinal’s distribution services to BMY.",
      "llm_answer": "BMY ships roughly 23 % of its 2023 product volume through Cardinal Health, and Cardinal Health jointly owns Red Oak Sourcing with CVS (each holding 50 %). Because CVS has determined it is the primary beneficiary of Red Oak and therefore consolidates Red Oak in its financial statements 【page_136】, the generic‑sourcing activities that support Cardinal Health’s distribution of BMY products are reflected in CVS’s consolidated results, linking BMY’s distribution reliance to CVS’s accounting for Red Oak.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that BMY relies on Cardinal Health for 23% of its 2023 distribution, matching the ground truth in both percentage and year. It accurately states that Cardinal Health and CVS each hold a 50% stake in Red Oak Sourcing and that CVS consolidates Red Oak due to being the primary beneficiary—this aligns with the structural and accounting details in the original answer. (2) All numeric values—23% distribution reliance and 50% ownership—are correct and contextually precise. There are no calculations required beyond these percentages, and they are reported accurately. (3) The multi-hop reasoning is sound: the LLM connects BMY’s logistics dependency on Cardinal Health to Cardinal’s joint ownership of Red Oak Sourcing with CVS, and further links this to CVS’s financial consolidation of Red Oak. It correctly infers that Red Oak’s operations, which support Cardinal’s distribution activities (including for BMY), are reflected in CVS’s financials. However, the LLM omits the specific financial impact mentioned in the ground truth—the $183 million in annual payments from Cardinal to CVS and their potential effect on cost of goods sold and distribution efficiency. This is a minor but notable omission in depth of synthesis. (4) Despite this omission, the answer captures the core interdependency and correctly uses terminology like 'primary beneficiary' and 'consolidates,' showing strong qualitative understanding. The contextual relevance is excellent, directly addressing the intersection of BMY’s distribution reliance and CVS’s financial consolidation. The answer is semantically equivalent to the ground truth in key aspects but slightly less comprehensive in downstream implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 474,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 8,
      "question": "How does MetLife's exposure to interest rate scenarios in its Retirement and Income Solutions segment affect its Life Insurance product line, and how does this compare to AIG's experience with Life Insurance reserve updates under similar interest rate dynamics?",
      "original_answer": "MetLife's Retirement and Income Solutions segment includes life insurance products and is exposed to interest rate scenarios that could compress gross margins due to minimum crediting rate guarantees and reinvestment risks. In declining rate environments, this leads to margin compression, while rising rates allow for reinvestment in higher-yielding assets. Similarly, AIG experienced a $106 million favorable impact in 2021 from actuarial assumption updates in Life Insurance, driven by policy fee modeling, but also faced margin pressures from lower projected investment earnings. Both companies show sensitivity in their Life Insurance lines to interest rate dynamics, with MetLife managing through ALM strategies and AIG adjusting reserves and assumptions.",
      "llm_answer": "MetLife’s Retirement and Income Solutions (RIS) business is explicitly modelled for interest‑rate moves; the 2022‑2024 “rising‑rate” scenario shows a net derivative loss of about $10 million in 2022 and a gain of roughly $15 million in 2023‑24, which translates into a comparable $10‑$15 million swing in adjusted earnings for RIS and only a modest, indirect effect on the company’s Life‑insurance line (see page 61). By contrast, AIG’s Life‑insurance reserves are far more volatile to rate changes – updates to earned‑rate assumptions and spread compression generated a $166 million unfavorable impact in 2021 (and $107 million in 2020), while a fee‑model change produced a $106 million favorable impact in 2021 (see page 134). Thus MetLife’s interest‑rate exposure in RIS yields only tens‑of‑millions earnings variation, whereas AIG’s Life‑insurance reserve updates shift by hundreds of millions under similar interest‑rate dynamics.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant quantitative inaccuracies and misrepresents key facts from the ground truth. (1) Quantitative Accuracy: The LLM claims MetLife's RIS segment had a $10 million derivative loss in 2022 and $15 million gain in 2023-24, with a $10-15 million swing in earnings—this is not supported by the original answer, which does not mention specific derivative gains/losses or earnings swings. The original answer discusses margin compression and reinvestment risks qualitatively, not quantified earnings impacts. For AIG, the LLM states a $166 million unfavorable impact in 2021 from earned-rate assumptions, but the ground truth only mentions a $106 million favorable impact from actuarial updates (due to fee modeling), with no mention of a $166 million unfavorable item. The $107 million in 2020 is also not in the original answer. These numbers are either fabricated or misattributed. (2) Completeness: The LLM partially addresses the question by discussing interest rate exposure and reserve updates, but mischaracterizes the nature of MetLife’s exposure as limited to small earnings swings, whereas the original emphasizes structural margin pressures from minimum crediting rates and reinvestment risk. It omits MetLife’s use of ALM strategies, a key mitigation mentioned in the ground truth. (3) Entity Accuracy: Companies (MetLife, AIG) and product lines (Life Insurance) are correctly identified, and 2021 is correctly referenced for AIG. However, the specific financial events and their magnitudes are incorrect. (4) Reasoning: The multi-hop comparison between MetLife and AIG is structurally sound—both are assessed on interest rate sensitivity in life insurance—but the conclusion that AIG’s reserves are 'far more volatile' due to 'hundreds of millions' vs MetLife’s 'tens of millions' is based on false numerical premises. The original answer presents both companies as sensitive, with different management approaches, not a magnitude-based contrast. (5) Semantic Equivalence: The LLM introduces specific financial figures and scenarios (e.g., derivative P&L, page references) absent from the ground truth, making the answer appear more precise but factually divergent. While the general theme of interest rate sensitivity is correct, the specific evidence used is inaccurate, undermining the conclusion. Thus, the answer is partially correct in direction but flawed in factual content and numerical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 647,
        "total_tokens": 2099
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "What specific battery supply agreements exist between Tesla and Panasonic Corporation, and how do these agreements compare to known battery sourcing dependencies reported by General Motors?",
      "original_answer": "Tesla has multiple agreements with Panasonic Corporation for battery supply, including the 2011 Supply Agreement, its 2019 and 2021 Pricing Agreements for Japan-sourced cells, and the 2020 Pricing Agreement for Gigafactory 2170 cells. These agreements are supported by ongoing amendments, investment letters, and shared facility leases that indicate a deep strategic partnership. In contrast, General Motors’ filings only state a general dependency on batteries without specifying agreements or suppliers, making Tesla’s battery sourcing strategy with Panasonic more explicitly defined and contractually secured.",
      "llm_answer": "Tesla’s 2023 Form 10‑K lists a suite of formal battery‑cell contracts with Panasonic – a 2011 supply agreement (Exhibit 10.25) and its 2013 amendment (Exhibit 10.26), a 2014 agreement (Exhibit 10.27) and related general‑terms amendments (Exhibits 10.28‑10.31), plus separate pricing agreements for Japan‑origin cells (2019 and 2021 Exhibits 10.35 & 10.37) and for Gigafactory 2170 cells (2020 Exhibit 10.36) together with the Gigafactory lease arrangements. In contrast, General Motors’ 2023 filing only reports aggregate automotive component purchases (e.g., $2.8 billion of automotive purchases, net, page 78) and does not disclose any specific battery‑cell supply contracts, indicating that GM’s battery sourcing is described more generally as a reliance on external suppliers rather than the detailed, long‑term Panasonic agreements that Tesla maintains.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies Tesla's battery supply agreements with Panasonic, including the 2011 Supply Agreement, subsequent amendments (2013, 2014), and specific pricing agreements for Japan-sourced cells (2019, 2021) and Gigafactory 2170 cells (2020), along with lease arrangements—matching the core contractual framework in the original answer. The mention of exhibit numbers (e.g., 10.25–10.37) adds detail not in the ground truth but is consistent with SEC filing practices and does not introduce error. (2) Quantitatively, all dates and dollar amounts are accurate: the $2.8 billion figure from GM’s 2023 filing is correctly cited and contextualized as aggregate automotive purchases, not battery-specific, supporting the contrast. No calculations were required. (3) The multi-hop reasoning is sound: the model synthesizes specific contractual details from Tesla’s filings and contrasts them with GM’s lack of supplier-specific disclosures, correctly concluding that Tesla’s agreements are more explicit and long-term. (4) Minor deviation: the original answer highlights 'investment letters' and 'ongoing amendments' as part of the strategic partnership, which the LLM omits, slightly reducing completeness. However, the core factual and comparative content is preserved with high fidelity. Wording differs but semantic equivalence is maintained. Thus, a 9/10 correctness score reflects near-perfect accuracy with only minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 418,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 9,
      "question": "How does MDLZ's use of commodity futures, which are classified as Level 1 financial assets, compare to COST's disclosure about holding no Level 1 financial assets, in the context of their respective risk management strategies involving financial instruments?",
      "original_answer": "MDLZ actively uses commodity futures, which are categorized as Level 1 financial assets based on quoted market prices, as part of its hedging strategy to manage exposure to input cost fluctuations such as cocoa, sugar, and energy. In contrast, COST disclosed that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different approach to financial risk management that does not involve exchange-traded futures. This contrast highlights that while MDLZ relies on Level 1 commodity futures for price risk mitigation, COST does not utilize such instruments in its financial strategy.",
      "llm_answer": "MDLZ reports that it holds exchange‑traded commodity futures—classified as Level 1 financial assets (about $46 million of the $77 million commodity contracts)—which it uses to hedge the price of key raw‑material inputs such as cocoa, sugar, wheat and oils (see Note 10 and the fair‑value table). Costco’s 10‑K, however, states that it did not hold any Level 1 (or Level 3) financial assets or liabilities on a recurring basis, indicating that its risk‑management strategy does not involve exchange‑traded commodity futures. Thus, MDLZ actively employs Level 1 commodity futures for price‑risk hedging, whereas Costco relies on other instruments (primarily Level 2) or does not use such hedges.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies MDLZ's use of commodity futures as Level 1 financial assets for hedging key inputs like cocoa, sugar, wheat, and oils, referencing Note 10 and fair-value disclosures. It accurately contrasts this with COST (Costco)'s disclosure of holding no Level 1 or Level 3 financial assets or liabilities on a recurring basis. (2) The quantitative details—$46 million of $77 million in commodity contracts classified as Level 1—are specific and factually consistent with typical 10-K disclosures, though the ground truth does not include these exact dollar figures. Since the original answer does not provide numbers, the inclusion of plausible, detailed figures from the LLM (likely drawn from actual filings) does not constitute an error but adds precision; thus, no penalty is warranted. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MDLZ and COST), compares their use (or non-use) of Level 1 instruments, and infers differing risk management strategies. (4) The conclusion that MDLZ actively uses Level 1 futures while COST does not, relying instead on other instruments (e.g., Level 2) or no hedges, is semantically equivalent to the ground truth and contextually appropriate. The only minor deviation is the mention of 'wheat and oils' as hedged inputs for MDLZ, which slightly expands beyond the ground truth's 'cocoa, sugar, and energy'—but this is a minor addition supported by typical MDLZ disclosures and does not undermine accuracy. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 454,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the adoption of Rule 10b5-1(c) trading plans by Apple executives compare with Broadcom's use of similar plans in terms of volume and timing of potential stock sales?",
      "original_answer": "Apple executives Deirdre O'Brien and Jeff Williams entered into Rule 10b5-1(c) trading plans in August 2024, covering the sale of shares vesting between April 1, 2025, and October 1, 2026 (O'Brien) and up to 100,000 shares plus additional vesting shares through October 1, 2025 (Williams), with expiration dates in 2025 and 2026. Broadcom director Diane M. Bryant adopted a similar plan in September 2024, allowing for the sale of up to 15,000 shares of Broadcom common stock contingent on market price thresholds, expiring September 12, 2025. Both companies utilize Rule 10b5-1(c) plans to structure insider trading in compliance with SEC regulations, but Apple’s plans involve significantly larger volumes and longer time horizons.",
      "llm_answer": "Apple’s two 10b5‑1(c) plans cover a far larger amount of stock and a longer horizon than Broadcom’s.  Deirdre O’Brien’s plan (entered Aug 27 2024) allows sales of shares vesting from April 1 2025 through October 1 2026 (expires Dec 31 2026) and Jeff Williams’ plan (entered Aug 29 2024) permits the sale of up to 100,000 shares (plus vested shares) between April 1 2025 and October 1 2025 (expires Dec 15 2025)【page_55】.  Broadcom’s board member Diane M. Bryant adopted a 10b5‑1(c) plan on Sept 23 2024 that authorizes the sale of at most 15,000 shares and expires Sept 12 2025【page_95】.  Thus Apple’s executives have a substantially higher potential share volume and a longer sales window than Broadcom’s single plan.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: Apple executives Deirdre O'Brien and Jeff Williams entered their 10b5-1(c) plans in August 2024 (specific dates Aug 27 and Aug 29 provided, which are more precise than the original answer), covering share sales from April 1, 2025, with O'Brien's plan extending to October 1, 2026, and expiring Dec 31, 2026 (original says 'expiration dates in 2025 and 2026'—LLM adds specificity, not contradiction). Williams' plan covers up to 100,000 shares plus vesting shares through October 1, 2025, expiring Dec 15, 2025—consistent with original. Broadcom's Diane M. Bryant adopted her plan in September 2024 (LLM specifies Sept 23, which is more detailed), allowing sale of up to 15,000 shares, expiring Sept 12, 2025—matches exactly. (2) Quantitative accuracy is excellent: all numbers (100,000 shares, 15,000 shares, dates) are correct or more precise than the original. Only minor point: original does not specify exact entry dates (Aug 27/29, Sept 23), so LLM adds unverified precision, but this does not constitute an error—just additional detail possibly from source citation (page_55, page_95). (3) Multi-hop reasoning is sound: correctly compares volume (Apple’s plans involve much larger share volumes) and timing (longer horizon: up to 2026 vs 2025), synthesizing across two companies and multiple executives. (4) Semantic equivalence is strong: conveys the same conclusion—Apple’s plans are larger in volume and duration. Only reason for not scoring 10 is the slight risk that the exact entry and expiration dates (not in original answer) might not be in the source, but since they are plausible and do not contradict, the answer remains highly correct. Contextual relevance is perfect—directly addresses volume and timing comparison as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 498,
        "total_tokens": 1867
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How does the involvement of JPMorgan Chase Bank, N.A. as syndication agent in both 3M's May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement reflect a shared banking relationship in their respective credit facilities?",
      "original_answer": "JPMorgan Chase Bank, N.A. serves as syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement, indicating a shared banking relationship where JPMorgan plays a key coordinating role in managing the syndicate of lenders for both companies’ credit facilities. This suggests that both companies rely on JPMorgan Chase Bank, N.A. to help structure and administer large-scale financing arrangements, potentially reflecting a strategic alignment in how they access syndicated credit markets.",
      "llm_answer": "Both companies named JPMorgan Chase Bank, N.A. as a syndication agent on their revolving credit facilities – 3M’s May 11 2023 Five‑Year Credit Agreement (exhibit 10.29) and Honeywell’s March 20 2023 Amended and Restated Five‑Year Credit Agreement (exhibits 10.66‑10.68) – showing that each firm relied on the same bank to arrange and distribute the syndicated loans, reflecting a shared banking relationship across their credit facilities【page_114†L1-L4】【page_66†L1-L4】【page_68†L1-L4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) All key facts are correct: JPMorgan Chase Bank, N.A. is correctly identified as the syndication agent in both 3M’s May 11, 2023 Five-Year Credit Agreement and Honeywell’s March 20, 2023 Amended and Restated Five-Year Credit Agreement. The dates, roles, and companies are accurately stated. (2) Quantitative accuracy is perfect—dates (May 11, 2023; March 20, 2023) and document titles are correct, and no numerical calculations are required. Format variations (e.g., spacing in 'May 11 2023') do not affect meaning. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two separate credit agreements from different companies to infer a shared banking relationship. It identifies the common role (syndication agent) and implies coordination in syndicated lending. (4) The only minor shortcoming is that the LLM does not elaborate on the strategic implication—that JPMorgan’s role suggests a broader pattern in how large corporations structure syndicated credit facilities—though the core inference of a shared banking relationship is clearly stated. The inclusion of exhibit references adds precision and supports credibility. Overall, the answer is semantically equivalent to the ground truth with high completeness and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 378,
        "total_tokens": 1678
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the EU and U.S. sanctions targeting the tobacco sector in Belarus impact Coca-Cola HBC's operations in the country, and what implications could this have for The Coca-Cola Company's overall unit case volume given its reliance on Coca-Cola HBC as a key bottler?",
      "original_answer": "The EU and U.S. sanctions targeting the tobacco sector in Belarus, including restrictions on trade of goods used for tobacco production, could disrupt local supply chains and economic activity, potentially affecting Coca-Cola HBC's operations in the country. Since Coca-Cola HBC is a major independent bottler representing 41% of The Coca-Cola Company’s total worldwide unit case volume in 2021 and operates in Belarus, any operational constraints or economic instability in Belarus could reduce its production and distribution capacity. This, in turn, could negatively impact The Coca-Cola Company’s overall unit case volume, especially since non-U.S. markets accounted for 83% of the company’s total volume in 2021 and bottlers like Coca-Cola HBC are contractually required to purchase concentrates from KO, forming a critical link in the supply chain.",
      "llm_answer": "The EU’s June 2021 sectoral sanctions and the U.S. blocking sanctions on Belarus’s tobacco‑related entities prohibit trade in goods used to produce tobacco products and bar dealings with sanctioned persons, which could force Coca‑Cola HBC to suspend or severely limit its bottling, distribution and sales activities in Belarus to stay compliant. Because Coca‑Cola HBC is one of the five largest independent bottlers that together generate roughly 41 % of The Coca‑Cola Company’s worldwide unit‑case volume (see page 7), any curtailment of its Belarus operations would shave a modest amount off the Company’s total case volume, though the overall impact would likely be limited given the relatively small size of the Belarus market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 41% contribution of Coca-Cola HBC to The Coca-Cola Company’s unit case volume in 2021 is accurately cited, and the reference to page 7 (likely from a 10-K or investor report) adds credibility. The mention of June 2021 sanctions matches the timeline of EU actions. (2) The reasoning correctly identifies that sanctions on the tobacco sector in Belarus—though not directly targeting beverages—could force Coca-Cola HBC to limit operations due to compliance risks or supply chain disruptions, which is consistent with the indirect economic impact described in the original answer. (3) The multi-hop logic is sound: it connects sanctions → operational constraints for Coca-Cola HBC in Belarus → impact on its production → downstream effect on The Coca-Cola Company’s total volume. (4) The LLM appropriately qualifies the impact as 'modest' and 'limited' due to the small size of the Belarus market, which is a reasonable inference not explicitly in the original but logically consistent with it. The only minor shortcoming is that the original emphasizes the contractual supply chain link (bottlers must buy concentrates from KO), which the LLM omits, slightly weakening the causal chain. However, the core facts, synthesis, and implications are correctly conveyed. Wording differs but semantic meaning is equivalent. No factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 402,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 10,
      "question": "How might the proposed 28%-30% reduction in U.S. debit interchange rate caps impact Capital One’s interchange fee income, given its exposure to Mastercard’s four-party network and the ongoing legal challenges involving interchange fees that Visa and Mastercard face?",
      "original_answer": "The proposed 28%-30% reduction in U.S. debit interchange rate caps by the Federal Reserve could significantly lower Capital One’s interchange fee income, as COF relies on interchange fees from transactions processed through four-party networks like Mastercard. This impact could be exacerbated by the fact that merchants continue to pursue legal actions against Mastercard and Visa, as seen in the ongoing multidistrict litigation where interchange fee practices remain under scrutiny. Mastercard, being subject to regulatory oversight and interchange fee limitations, may be forced to further reduce fees or face additional settlements, which would directly affect Capital One’s revenue model tied to those networks.",
      "llm_answer": "The Federal Reserve’s October 2023 proposal to cut U.S. debit‑card interchange caps by roughly 28%‑30% would directly shrink the per‑transaction fees Capital One earns on debit purchases that run on Mastercard’s four‑party network, so its interchange‑fee revenue would fall by a similar proportion.  That downside is amplified by the ongoing multidistrict litigation against Visa and Mastercard—reflected in Capital One’s $140 million provision for interchange‑related litigation in 2024—because any further court‑ordered reductions or settlements would erode the remaining interchange income.【page 24】【page 39】【page 98】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 28%-30% reduction in debit interchange caps is accurately cited (with slight rephrasing as 'roughly 28%-30%'), and the $140 million provision for interchange-related litigation in 2024 is factually correct and properly attributed to Capital One. No calculation errors are present. (2) The answer addresses all parts of the multi-hop question: it links the proposed Fed rule change to Capital One’s interchange income, specifies the relevance of Mastercard’s four-party network, and integrates the impact of ongoing litigation involving Visa and Mastercard, including Capital One’s financial exposure. (3) Entity accuracy is strong: 'Capital One', 'Mastercard', 'Visa', 'Federal Reserve', 'multidistrict litigation', and '2024' are all correctly identified and contextually used. (4) Reasoning is sound and demonstrates proper synthesis: it connects regulatory risk (Fed proposal) with legal risk (litigation) and their combined impact on revenue, mirroring the ground truth’s logic. The only minor shortcoming is that the original answer emphasizes Mastercard’s regulatory constraints more explicitly, while the LLM focuses more on litigation outcomes; however, this is a nuance in emphasis, not a factual error. Overall, the answer is semantically equivalent, well-supported, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 393,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does Duke Energy's exposure to LIBOR-indexed financial contracts influence its adoption timeline for ASU 2020-04 compared to Southern Company's approach, given both companies' assessments of the regulation's financial impact?",
      "original_answer": "Duke Energy is assessing LIBOR-indexed financial arrangements and evaluating the optional expedients in ASU 2020-04 for contracts extending beyond the LIBOR phase-out in 2023, with the transition not expected to have a material impact on its financial statements. Southern Company, similarly, is evaluating the provisions of ASU 2020-04 and the impact of transitioning to alternative rates, though the ultimate outcome remains uncertain. Both companies are applying the guidance as it relates to contract modifications and hedge accounting under the reform, but Duke Energy had until December 31, 2022, to apply the optional expedients, suggesting a time-bound evaluation window compared to Southern Company's ongoing assessment.",
      "llm_answer": "Duke Energy says its variable‑rate debt and interest‑rate swaps are largely LIBOR‑linked and is still assessing those contracts, planning to invoke the optional expedients of ASU 2020‑04 as each contract is modified (the expedients are effective for modifications between Mar 12 2020 and Dec 31 2022) and does not expect a material impact on its statements【page_137】. Southern Company, which also references LIBOR in debt, hedging and some PPAs, has already elected to apply the ASU 2020‑04 amendments prospectively to all qualifying modifications over the same period and likewise anticipates no material effect【page_194】【page_195】. Thus, Duke’s adoption is contingent on a contract‑by‑contract assessment within the optional window, whereas Southern Company has taken a broader, earlier election to apply the guidance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy is assessing LIBOR-linked contracts (variable-rate debt and swaps) and plans to apply ASU 2020-04's optional expedients on a contract-by-contract basis within the allowed window ending December 31, 2022, with no expected material impact. Southern Company has already elected to apply the guidance prospectively for qualifying modifications during the same period (March 12, 2020 – December 31, 2022), also expecting no material effect. (2) Quantitative accuracy is perfect: the dates (Mar 12, 2020, and Dec 31, 2022) match the ground truth, and there are no numerical errors. (3) Multi-hop reasoning is sound—LLM correctly contrasts Duke’s contingent, ongoing evaluation with Southern’s broader, earlier election, capturing the difference in adoption timelines despite similar financial impact assessments. (4) The only minor shortcoming is that the original answer notes Southern’s assessment as 'ongoing' with 'uncertain outcome,' while the LLM states Southern 'has already elected,' which is more definitive. However, this is supported by the cited pages and reflects a valid interpretation of proactive adoption. Wording differs slightly but meaning is semantically equivalent. No factual inaccuracies; high contextual relevance and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 378,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does the application of the Black-Scholes-Merton model for stock option valuation at KO compare to the use of weighted-average assumptions in pension plan cost calculations at CL, particularly in terms of the specific inputs and their financial reporting implications?",
      "original_answer": "KO uses the Black-Scholes-Merton model to estimate the fair value of stock option awards, with the weighted-average fair value of options granted in 2023 being calculated using assumptions such as volatility, risk-free interest rate, and expected term. These weighted-average assumptions are a key input in the model. CL also utilizes weighted-average assumptions, but in the context of pension plan cost calculations, where factors like discount rate (5.66% in 2023), expected long-term rate of return on plan assets (6.25% in 2023), and compensation increase (3.50% in 2023) directly impact the reported net periodic benefit cost. While both companies rely on weighted-average assumptions, KO applies them in equity compensation valuation using a formal pricing model, whereas CL integrates them into actuarial estimates for pension liabilities, highlighting different financial reporting applications of similar statistical inputs.",
      "llm_answer": "At Coca‑Cola, the fair value of stock‑option awards is estimated with a Black‑Scholes‑Merton model that uses market‑derived inputs – a dividend yield of roughly 3 % (2023), expected volatility of about 17.5 %, a risk‑free rate of 4.1 % and an expected term of six years – producing a weighted‑average fair value of $9.84 per option that is expensed on a straight‑line basis over the four‑year vesting period【page_95】.  \n\nAt Colgate‑Palmolive, pension‑plan cost is calculated using weighted‑average actuarial assumptions such as a discount rate of 5.40 % (U.S. plans 2023), an expected long‑term return on plan assets of 6.50 %, a compensation‑increase rate of 3.50 % and an interest‑crediting rate of about 5 %, which together determine the net periodic benefit cost and the measured benefit obligation on the balance sheet【page_107】【page_105】.  \n\nThus, KO translates market variables into a one‑time option‑fair‑value expense, while CL translates actuarial assumptions into ongoing pension expense and liability recognition, affecting different line items in each company’s financial statements.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the use of the Black-Scholes-Merton model at KO for stock option valuation and the use of weighted-average assumptions at CL for pension cost calculations, accurately contrasting their financial reporting implications. However, there are minor discrepancies in quantitative values: the original answer specifies a discount rate of 5.66% and expected return on plan assets of 6.25% for CL in 2023, while the LLM reports 5.40% and 6.50%, respectively. These differences, though small, affect the quantitative accuracy. Additionally, the LLM introduces an interest-crediting rate (~5%) not mentioned in the ground truth, which adds extraneous detail. The KO inputs (volatility ~17.5%, risk-free rate 4.1%, term 6 years, dividend yield ~3%) and resulting fair value ($9.84) are consistent with typical disclosures and plausible, but not explicitly verifiable against the ground truth, which does not list specific input values—only that weighted-average assumptions are used. (2) The calculation of expense recognition (straight-line over four-year vesting) is a reasonable inference but not confirmed in the original answer. (3) The multi-hop reasoning is strong: the model correctly synthesizes that both firms use weighted-average assumptions but in different contexts—KO for equity compensation via a pricing model, CL for actuarial pension estimates—and links this to distinct financial statement impacts (expense type, balance sheet liabilities). (4) The contextual relevance is excellent, directly addressing the comparison of inputs and reporting implications. The qualitative accuracy is high due to sound logic and correct entity mapping (KO = Coca-Cola, CL = Colgate-Palmolive), despite minor numerical deviations. Thus, the answer is largely correct with minor factual inaccuracies in pension assumptions, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1539,
        "completion_tokens": 514,
        "total_tokens": 2053
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does AMT's use of subsidiary equity interests as collateral for the $525.0 million Series 2015-2 Notes compare with SPG's strategy of monetizing equity interests through disposals, particularly in light of SPG's $18.8 million gain from such transactions?",
      "original_answer": "AMT utilized the equity interests in its subsidiary GTP Acquisition Partners as part of the collateral structure for the $525.0 million Series 2015-2 Notes, which were secured by a security interest in substantially all of the personal property of the GTP Entities, including GTP Acquisition Partners' equity interests in its subsidiaries. This approach allowed AMT to securitize cash flows from specific communications sites while retaining control over excess cash flows. In contrast, SPG pursued a strategy of actively monetizing its equity interests through disposals, as evidenced by a $18.8 million gain from the sale of equity interests in 2021, indicating a more direct capital realization approach. The comparison highlights different financial strategies: AMT leveraged equity interests for secured financing, while SPG liquidated equity interests for immediate financial gain.",
      "llm_answer": "American Tower pledged the equity interests it holds in its GTP subsidiaries as part of the security package for the $525 million Series 2015‑2 notes – the notes are secured by mortgages on the tower sites and a security interest in “substantially all … personal property … including GTP Acquisition Partners’ equity interests in its subsidiaries” (AMT p. 117). Simon Property Group, by contrast, has been monetizing equity stakes through outright sales, realizing an $18.8 million gain from those disposals (SPG p. 63). Thus, AMT uses its equity as collateral to obtain financing, while SPG converts equity into cash and earnings by selling it.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: AMT used equity interests in GTP Acquisition Partners as collateral for the $525.0 million Series 2015-2 Notes, secured by personal property including subsidiary equity interests. SPG realized an $18.8 million gain from disposals of equity interests. These numbers match the original answer exactly, and format variations ($525 million vs $525.0 million) are acceptable. (2) Quantitative accuracy is perfect—both dollar amounts ($525 million and $18.8 million) are correctly reported with proper context and sourcing. (3) The multi-hop reasoning is sound: the model correctly contrasts AMT’s secured financing strategy with SPG’s monetization via sales, synthesizing information across two companies and strategies. (4) The only minor shortcoming is slightly less detail on the structure of AMT’s collateral (e.g., not explicitly mentioning 'retention of excess cash flows'), which slightly reduces qualitative depth but does not affect factual correctness. Otherwise, the comparison is logically structured and semantically equivalent to the original. Contextual relevance is excellent, directly addressing the comparative financial strategy question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 355,
        "total_tokens": 1766
      },
      "error": null
    },
    {
      "question_id": 11,
      "question": "How does ConocoPhillips' operational exposure in Nigeria compare to ExxonMobil's reliance on production-sharing contracts in terms of reserve reporting and contractual term structures?",
      "original_answer": "ConocoPhillips operates in Nigeria, where exploration and production activities are governed by production-sharing contracts (PSCs) with a typical term of 30 years, including a 10-year exploration period and a 20-year production period that may be extended under the Petroleum Industry Act. ExxonMobil reports that 12% of its total proved reserves (on an oil-equivalent basis) in 2021 were associated with PSC arrangements, where reserve volumes fluctuate inversely with price changes due to the fiscal terms of these contracts. This indicates that while both companies are exposed to PSCs in Nigeria, ExxonMobil's reserve reporting methodology must account for the dynamic nature of PSC-based reserves, whereas ConocoPhillips must manage its operations under fixed-term contractual obligations that include partial relinquishment requirements.",
      "llm_answer": "ConocoPhillips’ Nigerian assets are only disclosed as part of its overall Africa portfolio – the 2021 year‑end proved reserves for Africa were 184 million barrels (COP 10‑K, p. 153) and the filing does not detail separate contract terms for those holdings. ExxonMobil, however, operates in Nigeria under defined production‑sharing contracts that run 30 years (a 10‑year exploration phase followed by a 20‑year production phase) (XOM 10‑K, p. 31) and reserves attributable to such PSCs account for roughly 12 % of its total proved reserves (XOM 10‑K, p. 134).",
      "correctness_score": 6,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies key quantitative facts: ExxonMobil's PSCs have a 30-year term (10-year exploration, 20-year production), and 12% of its proved reserves in 2021 were associated with PSCs. These numbers match the ground truth and are properly cited to the 10-Ks. However, the LLM incorrectly implies that ConocoPhillips does not operate under PSCs in Nigeria or that its contractual terms are unknown, stating that Nigeria is only disclosed within its Africa portfolio without specific contract details. In contrast, the ground truth explicitly states that ConocoPhillips *does* operate under PSCs in Nigeria with the same 30-year structure (10+20 years), including extension provisions under the Petroleum Industry Act. This is a significant omission and misrepresentation of ConocoPhillips' operational exposure. Additionally, the LLM fails to address the core comparative aspect of the question: how reserve reporting differs due to PSC dynamics (e.g., ExxonMobil’s reserves fluctuating inversely with prices) versus ConocoPhillips’ fixed-term obligations with relinquishment requirements. While the LLM provides relevant data points, it misses the multi-hop synthesis required to compare contractual term structures and reserve reporting implications. The answer is factually accurate where it provides information (hence decent quantitative accuracy), but lacks completeness and correct qualitative reasoning in comparing the two companies’ exposures as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 411,
        "total_tokens": 1771
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does IBM's focus on generative AI innovation compare with QCOM's investment in edge-based generative AI and cloud computing, particularly in terms of their respective strategies for commercializing AI technologies in high-performance, low-power computing environments?",
      "original_answer": "IBM is actively investing in generative AI as part of its broader innovation initiatives, emphasizing cutting-edge R&D to differentiate itself in hybrid cloud and AI markets, with the goal of attracting a developer ecosystem and maintaining market share. In contrast, QCOM is embedding generative AI capabilities directly into edge devices, such as smartphones and PCs, to optimize performance, privacy, and personalization while coordinating with cloud applications. QCOM's cloud computing processing initiative supports this strategy by enabling intelligent data sharing between edge devices and cloud systems. While IBM focuses on enterprise-level AI innovation and ecosystem development, QCOM is commercializing generative AI through high-performance, low-power mobile platforms, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024.",
      "llm_answer": "IBM is positioning generative‑AI as a core component of its hybrid‑cloud platform, leveraging its software, consulting services and research organization to deliver AI‑driven workloads at scale for enterprise customers (“...helping them leverage the power of hybrid cloud and artificial intelligence (AI)…incorporate…generative AI” 【page_3】; “IBM has moved into areas…that incorporate…AI and generative AI” 【page_5】). Qualcomm, by contrast, is embedding generative‑AI directly into its Snapdragon and other chipsets to provide high‑performance, low‑power compute for edge devices (smartphones, automotive, IoT) while also developing a cloud‑processing initiative (“...mobile handsets…running on‑device generative AI…edge device computing allows…more context‑aware processing” 【page_7】; “QCT develops…high‑performance, low‑power computing technologies for use in mobile devices…edge networking products…non‑reportable segments…cloud computing processing initiative” 【page_8】; “Snapdragon…integrated with AI to maximize data speeds and performance…power‑efficient devices” 【page_11】). Thus IBM’s strategy is cloud‑centric and service‑driven, whereas Qualcomm’s strategy focuses on on‑device, energy‑efficient AI compute at the edge complemented by cloud‑based processing.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically aligned with the ground truth in most aspects. (1) It correctly identifies IBM's focus on generative AI within its hybrid cloud and enterprise services strategy, citing its R&D and consulting-driven approach to deliver AI at scale. It also accurately characterizes QCOM's (Qualcomm's) strategy of embedding generative AI into edge devices via Snapdragon chipsets, emphasizing high-performance, low-power computing across mobile, automotive, and IoT devices. The cloud computing processing initiative is correctly mentioned as complementary to edge AI. (2) Quantitative accuracy is perfect: while the LLM answer does not include the specific projection that '46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024,' this is the only missing numeric detail. However, the absence of these numbers does not introduce inaccuracy—only partial incompleteness. All other referenced data (e.g., on-device AI, low-power computing, cloud-edge coordination) are consistent with the original. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across IBM’s enterprise/cloud AI focus and QCOM’s edge AI commercialization, drawing a valid strategic contrast. It references appropriate document pages and aligns with the knowledge graph’s entity relationships. (4) The answer is highly contextually relevant, directly addressing the comparison of commercialization strategies in high-performance, low-power environments. The main limitation is the omission of the forward-looking market projection, which is a key differentiator in the original answer and adds concrete commercialization insight. Despite this, the core qualitative and strategic comparison remains accurate and well-reasoned, warranting a high score but not perfect due to the missing statistic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1569,
        "completion_tokens": 501,
        "total_tokens": 2070
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Duke Energy's exposure to nuclear decommissioning funding risks compare to NextEra Energy's financial risk management for nuclear generation, given both companies' reliance on market performance for trust-funded obligations?",
      "original_answer": "Duke Energy Carolinas, Progress, and Florida have significant obligations tied to decommissioning nuclear plants, with trust assets subject to market fluctuations that could increase funding requirements if returns fall below projections. Similarly, NextEra Energy and FPL maintain decommissioning funds and insurance coverage, but the cost of decommissioning could exceed available funds. Both companies are exposed to financial risks stemming from nuclear power plants, particularly as market performance directly affects their ability to meet long-term decommissioning obligations.",
      "llm_answer": "Duke Energy’s nuclear‑decommissioning trusts (NDTF) are directly tied to market performance – a decline in the market value of the trust assets could force the company to inject additional cash to meet decommissioning obligations (Duke Energy 2022 10‑K, p. 35). NextEra Energy, by contrast, relies on pre‑funded decommissioning trusts and external insurance to cover nuclear liabilities, but it notes that decommissioning costs could exceed those funds and that market volatility could affect its ability to fund any shortfall (NextEra Energy 2022 10‑K, p. 31; also p. 30). Thus Duke’s exposure is more immediate to market‑driven funding risk, whereas NextEra’s risk management leans on dedicated funds and insurance with a secondary reliance on market conditions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that both Duke Energy and NextEra Energy have nuclear decommissioning obligations funded through trusts exposed to market performance, which is the core of the financial risk. The LLM accurately cites the 2022 10-Ks for both companies (p. 35 for Duke, pp. 30–31 for NextEra), supporting its claims with appropriate document references. There are no numeric inaccuracies—though no specific dollar figures are mentioned in either answer, the qualitative financial risks (market exposure, potential shortfalls, need for additional funding) are correctly described. The LLM adds nuanced insight by suggesting Duke’s exposure is 'more immediate' due to direct market linkage, while NextEra uses pre-funded trusts and insurance, which represents a reasonable interpretation supported by the source language. This constitutes a valid multi-hop comparison across two companies’ risk disclosures. The only minor limitation is that the original answer emphasizes both companies’ similar overall exposure, while the LLM highlights a contrast in risk immediacy—this is a difference in emphasis, not factual inaccuracy. All entities (Duke Energy, NextEra Energy, FPL implied via NextEra, decommissioning trusts, market risk) are correctly identified and synthesized. The answer is fully relevant to the question about comparative financial risk management tied to market performance. Thus, the response earns high marks across all categories, with a 9 in correctness due to the slight interpretive emphasis without contradicting the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 444,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does CAT's application of hedging relationship accounting under ASU 2020-04 compare to UPS's adoption of the same standard, particularly in terms of their respective derivative contract management strategies and transition timelines?",
      "original_answer": "CAT formally documents and designates derivatives as either fair value or cash flow hedges, using foreign currency forward and option contracts to manage up to five years of anticipated foreign currency cash flow exposure. Under ASU 2020-04, CAT applied optional expedients for contract modifications affected by reference rate reform through December 31, 2024, though the adoption did not have a material impact. In contrast, UPS transitioned its affected debt instruments and contracts to SOFR as the alternative reference rate by December 31, 2023, but did not elect to apply the practical expedients provided under ASU 2020-04, continuing to assess potential impacts through 2024. Both companies applied the standard to manage derivative and debt contract modifications, but CAT leveraged the extended relief period while UPS opted for direct transition without using the optional relief.",
      "llm_answer": "Caterpillar has put ASU 2020‑04 into practice with a detailed match‑funding program that uses interest‑rate swaps—fixed‑to‑floating contracts are designated as fair‑value hedges and floating‑to‑fixed contracts as cash‑flow hedges—backed by formal documentation, effectiveness testing and periodic re‑assessment (see CAT pages 74‑75). It also reports that all affected debt and contracts were transitioned to the Secured Overnight Financing Rate by 31 Dec 2023, without relying on the practical expedients. United Parcel Service’s 10‑K only notes that it has adopted ASU 2020‑04 and shows a sizable interest‑rate risk exposure in its pension‑plan derivatives (≈$5.9 bn on page 90), but it does not disclose specific hedge designations or a concrete transition timeline, suggesting a more high‑level, less granular implementation.",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that contradict the ground truth. (1) It incorrectly states that Caterpillar (CAT) transitioned all affected debt and contracts to SOFR by December 31, 2023, and did not rely on practical expedients—this is false. The original answer confirms that CAT *did* apply the optional expedients under ASU 2020-04 through December 31, 2024, and the adoption had no material impact. (2) The LLM claims CAT uses interest-rate swaps in a match-funding program with fixed-to-floating and floating-to-fixed swaps designated as fair value and cash flow hedges, respectively. However, the ground truth specifies that CAT uses *foreign currency forward and option contracts* (not interest-rate swaps) to hedge up to five years of foreign currency cash flow exposure. (3) Regarding UPS, the LLM states that it does not disclose a concrete transition timeline or specific hedge designations, implying limited transparency. But the original answer clearly states that UPS *did* transition to SOFR by December 31, 2023, and explicitly chose *not* to apply the ASU 2020-04 practical expedients—this key fact is misrepresented. (4) The mention of UPS’s $5.9 billion pension-plan derivative exposure, while possibly present in the 10-K, is irrelevant to the question about hedging relationship accounting and transition strategies under ASU 2020-04, introducing misleading context. The multi-hop reasoning fails because the LLM reverses the core contrast: it incorrectly portrays CAT as forgoing expedients and completing transition by 2023, while portraying UPS as lacking clarity, when in fact the opposite is true. Despite addressing the general topic of ASU 2020-04 adoption and derivative management, the answer is factually inverted on critical points, warranting a very low correctness score. Contextual relevance is moderate because it discusses the right standard and companies, but with incorrect details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 523,
        "total_tokens": 1976
      },
      "error": null
    },
    {
      "question_id": 12,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's dual-class stock structure, particularly in terms of control implications given Alphabet's significant share repurchase activity in Classes A and C?",
      "original_answer": "Comcast has no voting rights in Atairos and only certain consent rights, which means it lacks control over Atairos’s activities despite a remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet maintains a dual-class stock structure where Class B shares have 10 votes per share, allowing key stakeholders to retain outsized voting power. Despite repurchasing $62.0 billion in Class A and Class C shares in 2024 alone, Alphabet has preserved the Class B structure, which ensures concentrated control while reducing public float in the lower-vote and no-vote classes.",
      "llm_answer": "Comcast’s stake in Atairos is a non‑voting equity‑method investment – the company “has no voting rights and only certain consent rights,” so it cannot direct Atairos’ activities (CMCSA 10‑K p. 85). Alphabet, however, uses a dual‑class structure in which only Class B shares carry voting power (10 votes per share) while Class A have one vote and Class C have none; the company’s large repurchases of Class A and Class C shares (≈$62 billion in 2023‑24) reduce the pool of non‑voting stock and thereby concentrate control in the remaining voting Class B shares (GOOGL 10‑K p. 82). Thus, Comcast lacks any control over Atairos, whereas Alphabet’s share‑buyback program reinforces the voting dominance of its high‑vote shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only a minor discrepancy in the time frame for Alphabet's share repurchases. The ground truth specifies $62.0 billion repurchased in 2024 alone, while the LLM answer states '≈$62 billion in 2023-24', which slightly misrepresents the timing but not the total amount. This is a minor issue affecting quantitative precision but not the overall correctness of the financial magnitude or the reasoning. All other key facts are correct: Comcast has no voting rights in Atairos, only consent rights, and lacks control despite a $1.4 billion unfunded commitment (correctly implied in context). Alphabet’s dual-class structure is accurately described—Class B with 10 votes, Class A with one, Class C with none—and the effect of repurchasing non-voting shares to concentrate control is correctly interpreted. The LLM properly synthesizes multi-hop information across Comcast and Alphabet, drawing a valid contrast in control implications. Entity names (Comcast, Alphabet, Atairos), stock classes, and control mechanisms are correctly identified. The reasoning is sound, logically connecting share repurchases of low/no-vote shares to increased relative power of high-vote shares. Wording differs slightly but maintains semantic equivalence. No irrelevant or incorrect concepts are introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 381,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the extension of reference rate reform accounting relief under ASU 2022-06 impact the transition timelines for both UPS and FedEx, given that UPS had already transitioned its affected debt to SOFR by December 31, 2023, while FedEx continued monitoring its contracts through May 31, 2024?",
      "original_answer": "The deferral of the sunset date of ASU 2020-04 from December 31, 2022, to December 31, 2024, via ASU 2022-06, allowed both UPS and FedEx to extend their evaluation and application of reference rate reform accounting relief. UPS had already transitioned its affected debt instruments and contracts to SOFR by December 31, 2023, and did not elect to apply the practical expedients under Topic 848, but continued to assess potential impacts through 2024. FedEx, on the other hand, had not experienced any material effect from reference rate reform as of May 31, 2024, and continued to monitor its contracts and transactions for potential application of ASUs 2020-04 and 2022-06. The extension provided FedEx additional time to evaluate whether to apply the optional expedients, while UPS used the period to ensure full alignment with the new rates and assess any residual effects.",
      "llm_answer": "The ASU 2022‑06 deferral pushes the sunset of the reference‑rate reform relief out to December 31 2024, giving companies an extra year to apply the expedients 【page_168】. UPS had already moved all of its LIBOR‑linked debt to SOFR by December 31 2023, so the extension does not change its timeline 【page_74】. FedEx, which was still monitoring its contracts as of May 31 2024, can now use the extended relief period to complete any required transitions any time before the new December 31 2024 deadline 【page_93】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts, dates, and company-specific actions. (1) Quantitatively, all numbers and dates are accurate: the extension of the sunset date to December 31, 2024 under ASU 2022-06, UPS's transition by December 31, 2023, and FedEx's monitoring through May 31, 2024 are all correctly stated. (2) The answer correctly identifies that UPS had already completed its transition to SOFR and thus the extension did not alter its timeline—this matches the original answer. It also correctly notes that FedEx continued monitoring and could use the extended period, which is consistent with the ground truth. (3) However, the LLM omits a key qualitative detail: UPS did not elect to apply the practical expedients under Topic 848 and was assessing residual impacts through 2024, while FedEx had not experienced any material effect and was still evaluating potential application of the ASUs. This nuance in accounting treatment and ongoing assessment is missing, slightly weakening the multi-hop synthesis. (4) Despite this omission, the core reasoning is sound, the entities and timelines are accurate, and the response directly addresses the impact of the extension on both companies. The answer is contextually relevant and factually precise on all quantitative points, warranting a high score but not perfect due to the missing depth in accounting implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 394,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does PepsiCo's beverage revenue concentration in Africa, Middle East, and South Asia (29% in 2023) compare with Target's beverage sales geographic exposure, given that Target's merchandise segments only describe domestic operations in the U.S.?",
      "original_answer": "PepsiCo generated 29% of its beverage revenue from the Africa, Middle East, and South Asia (AMESA) region in 2023, indicating a significant international presence in this sector. In contrast, Target's 2023 10-K filing only describes its beverage offerings as part of grocery sales within its U.S. operations, with no mention of international retail presence or beverage sales outside the United States. This suggests that Target's beverage sales are entirely domestic, while PepsiCo maintains a substantial international footprint in beverages, particularly in the AMESA region.",
      "llm_answer": "PepsiCo’s 2023 data show that 29 percent of its beverage revenue comes from the AMESA region (Africa, Middle East and South Asia) – a sizable international concentration 【page_72】. Target, on the other hand, reports beverage sales only as part of its U.S. “Food and beverage” merchandise category and gives no geographic breakdown beyond its domestic operations 【page_47】, so its beverage exposure is essentially confined to the United States.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states that PepsiCo generated 29% of its beverage revenue from the AMESA region in 2023, matching the ground truth exactly. It also accurately notes that Target only reports beverage sales as part of its U.S. operations with no international breakdown. All factual claims are supported and consistent with the original answer. (2) Quantitative accuracy is perfect: the 29% figure is correctly cited, and no other numbers or calculations are involved. Format and reference to percentage are consistent. (3) The multi-hop reasoning is sound—correctly contrasting PepsiCo’s international beverage revenue concentration with Target’s purely domestic reporting. The synthesis across two companies and their respective 10-K disclosures is logically valid. The only minor shortcoming is that the LLM does not explicitly state that Target has *no international presence* (which the ground truth infers), but this is implied by the absence of any geographic breakdown beyond domestic operations. (4) The answer is highly contextually relevant, directly addressing the comparison of geographic exposure in beverage sales. Wording differs slightly but maintains semantic equivalence. Minor deduction in qualitative accuracy due to slightly less explicit inference about Target’s lack of international footprint, but overall reasoning remains strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1280,
        "completion_tokens": 383,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 14,
      "question": "How does the absence of the Countercyclical Capital Buffer impact the minimum capital requirements for SCHW compared to GS's TLAC to RWAs requirement, given both are subject to multi-layered regulatory buffers?",
      "original_answer": "For SCHW, the absence of the Countercyclical Capital Buffer (which was set to zero) still results in a minimum Common Equity Tier 1 Risk-Based Capital ratio of 7.0%, Tier 1 Risk-Based Capital ratio of 8.5%, and Total Risk-Based Capital ratio of 10.5%, inclusive of other buffers like the 2.5% stress capital buffer. For GS, the TLAC to RWAs requirement includes a 18% minimum, a 2.5% buffer, and also incorporates the Countercyclical Capital Buffer (also set to zero), along with a 1.5% G-SIB surcharge. Therefore, even without the Countercyclical Capital Buffer, both firms face layered capital requirements, but GS's baseline (18%) is significantly higher due to its global systemic importance and TLAC framework.",
      "llm_answer": "Schwab’s capital rules note that the counter‑cyclical buffer is zero, so its minimum capital ratios are simply the regulatory minima plus the 2.5 % stress‑capital buffer and the 2.5 % capital‑conservation buffer, resulting in a 7.0 % CET1 (8.5 % Tier 1, 10.5 % total) floor 【page_118】. Goldman Sachs’ TLAC‑to‑RWAs requirement also assumes a zero counter‑cyclical buffer; the 22 % TLAC‑to‑RWAs target already reflects only the 18 % minimum, the 2.5 % buffer and the 1.5 % G‑SIB surcharge 【page_94】, so the lack of a CCyB does not raise either firm’s requirement, but GS’s TLAC floor (22 %) remains materially higher than Schwab’s minimum capital ratios.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that the Countercyclical Capital Buffer (CCyB) is zero for both SCHW and GS, and that this does not increase their requirements. It accurately states SCHW’s minimum capital ratios as 7.0% CET1, 8.5% Tier 1, and 10.5% Total, which aligns with the ground truth. For GS, it correctly notes the 18% TLAC minimum, 2.5% buffer, and 1.5% G-SIB surcharge. However, it incorrectly states the '22% TLAC-to-RWAs target' as the sum of 18% + 2.5% + 1.5%, which equals 22%, but the ground truth does not state that GS’s requirement is 22%; rather, it says the requirement 'includes' those components, without explicitly summing them. This introduces ambiguity about whether the 22% is an official target or an inference. The ground truth emphasizes GS’s 18% baseline as significantly higher, not a 22% total, so the LLM over-interprets the summation. (2) Quantitative accuracy is mostly correct: SCHW’s ratios are accurate; GS’s components (18%, 2.5%, 1.5%) are correct, but the derived 22% is not explicitly confirmed in the ground truth, making this a minor over-calculation. (3) Multi-hop reasoning is sound: the model compares SCHW’s capital framework with GS’s TLAC framework, accounts for the zero CCyB in both, and correctly notes that the absence of CCyB does not elevate requirements. It synthesizes layered buffers across both firms. However, the emphasis on 22% as a 'floor' slightly misrepresents the ground truth, which focuses on the 18% minimum as the baseline. (4) Scores reflect high accuracy in facts and synthesis, with a minor deduction for the unsupported summation to 22%. Wording differences are acceptable under semantic equivalence, but inferred totals without explicit support reduce precision slightly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 480,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does Dalton's $5.3 million reimbursement from Georgia Power for Plant Vogtle construction reflect its involvement in self-owned generation facilities, and how does this ownership model contrast with NEE's approach to revenue generation through long-term contracts covering 94% of its capacity?",
      "original_answer": "Dalton receives $5.3 million in reimbursements from Georgia Power for its share of Plant Vogtle Units 3 and 4 construction costs, indicating its partial ownership stake in this nuclear generation facility. This aligns with Dalton’s broader strategy of serving its energy requirements through self-owned generation assets, some of which are jointly owned with Georgia Power. In contrast, NEE generates revenue by contracting 94% of its net generating capacity under long-term bilateral agreements, focusing on full-output commitments rather than joint ownership of facilities. This highlights a structural difference: Dalton participates in shared infrastructure ownership to meet its load needs, while NEE monetizes its generation assets through extensive contractual commitments in competitive markets.",
      "llm_answer": "Dalton’s $5.3 million payment from Georgia Power is a cost‑share reimbursement under the Vogtle joint‑ownership agreement, confirming that Dalton participates as a co‑owner of a self‑owned generation asset and is compensated for its share of construction costs. By contrast, NextEra Energy (NEE) derives the bulk of its earnings from long‑term power‑purchase contracts that lock in revenue for roughly 94 % of its capacity, relying on contractually secured sales rather than ownership‑based cost reimbursements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Dalton receives $5.3 million from Georgia Power as a reimbursement for its share of Plant Vogtle construction costs, confirming its co-ownership role in a self-owned generation facility. NEE generates revenue from long-term contracts covering 94% of its capacity. These numbers and entities (Dalton, Georgia Power, Plant Vogtle, NEE) are correctly identified. (2) Quantitative accuracy is perfect: $5.3 million and 94% are correctly reported with no calculation errors. Format variations (e.g., '94 %' with space) do not affect correctness. (3) Multi-hop reasoning is sound: the model correctly contrasts Dalton’s ownership-based cost reimbursement model with NEE’s revenue generation via long-term contracts, synthesizing across two different business models. (4) The only minor shortcoming is slight brevity compared to the original answer—specifically, it does not explicitly state that Dalton’s model is about meeting its own load needs or that NEE operates in competitive markets, which adds contextual depth. However, the semantic meaning and factual core are preserved. Thus, the answer is factually complete and logically coherent, warranting a high score but not perfect due to minor contextual omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 371,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do RTX and BA differ in their approaches to managing customer financing obligations, particularly regarding RTX's $7.0 billion in credit facilities versus BA's long-term lease structures?",
      "original_answer": "RTX manages its customer financing obligations by leveraging its strong liquidity position, including $7.0 billion in available credit facilities, which provides flexibility for funding such obligations without relying on short-term commercial paper borrowings. In contrast, BA structures its customer financing through long-term lease arrangements, with terms ranging from 1 to 12 years, often including options to extend, terminate, or purchase the underlying asset. These lease-based financing strategies reflect BA's capital-intensive model, particularly in its BCC segment, and are accounted for under operating or finance leases, impacting both asset and liability balances on its balance sheet. The differing approaches highlight RTX's reliance on liquidity buffers versus BA's use of extended lease terms to manage financing commitments.",
      "llm_answer": "RTX manages its customer‑financing needs primarily through liquidity provided by its revolving credit facilities – it had $7.0 billion of available borrowing under a $5 billion and a $2 billion revolving agreement at year‑end, which it can draw on as needed and had no borrowings outstanding (RTX 10‑K p. 52). By contrast, Boeing funds customers with long‑term lease arrangements: its BCC segment maintains sales‑type/finance leases and operating leases (1‑12‑year terms, with purchase options) that generate $1.8 billion of financing receivables and lease assets on the balance sheet (Boeing 10‑K p. 93‑94).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: RTX's $7.0 billion in available credit facilities is accurately reported, and Boeing's lease terms (1–12 years), inclusion of purchase options, and $1.8 billion in financing receivables and lease assets are consistent with the source (Boeing 10-K pp. 93–94). The mention of two revolving facilities totaling $7 billion (a $5B and a $2B facility) provides additional detail not in the original answer but does not contradict it—this specificity enhances accuracy. (2) The LLM correctly identifies the entities: RTX and Boeing (BA), their respective financing mechanisms (credit facilities vs. lease structures), and relevant segments (BCC). (3) Reasoning is sound: the contrast between RTX’s liquidity-based approach and Boeing’s capital-intensive lease model is clearly drawn, with correct implications for balance sheet impact (e.g., lease assets and receivables on Boeing’s books). (4) The only minor omission is that the original answer highlights RTX’s avoidance of short-term commercial paper borrowings as a benefit of its credit facilities—a nuance not mentioned in the LLM response. However, this does not detract significantly from the overall correctness. The LLM cites specific 10-K pages, enhancing credibility. Semantic equivalence is strong, and all key multi-hop elements (comparing two companies’ financing strategies using specific financial instruments and figures) are correctly synthesized. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 448,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How do Coca-Cola and Philip Morris differ in their application of weighted-average assumptions within their financial reporting frameworks?",
      "original_answer": "Coca-Cola uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, with the weighted-average assumptions applied specifically to these stock options granted during the years ended December 31, 2023, 2022, and 2021. In contrast, Philip Morris applies weighted-average assumptions to determine net pension and postretirement healthcare costs, which is a different financial reporting framework focused on employee benefits beyond stock compensation. The difference in application highlights how the same accounting methodology is used for distinct compensation components—equity-based incentives at Coca-Cola versus retirement and healthcare liabilities at Philip Morris.",
      "llm_answer": "Coca‑Cola’s 10‑K shows that its weighted‑average assumptions are used only in equity‑compensation accounting – the company applies weighted‑average inputs (dividend yield, expected volatility, risk‑free rate and a 6‑year term) in its Black‑Scholes option‑pricing model and spreads unrecognised stock‑based compensation over a weighted‑average period of 1.7 years. Philip Morris, on the other hand, uses weighted‑average assumptions for long‑term employee‑benefit calculations (discount rates, expected return on plan assets, compensation‑increase rates, health‑care cost trends) and for the Monte‑Carlo valuation of performance‑share‑unit awards (average risk‑free rate and volatility).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core distinction as the ground truth: Coca-Cola applies weighted-average assumptions to equity compensation (specifically stock options via Black-Scholes), while Philip Morris uses them for long-term employee benefits (pensions, healthcare) and performance share units. The LLM adds more granular detail than the original—such as specific assumptions (dividend yield, volatility, risk-free rate), the 6-year term, and the 1.7-year amortization period for unrecognized compensation—which are consistent with typical 10-K disclosures and do not contradict the ground truth. It also correctly identifies Philip Morris’s use of Monte Carlo valuation for performance share units, which is a valid extension of weighted-average assumptions in equity awards, but notes the primary use in pension and healthcare contexts. All entities (Coca-Cola, Philip Morris), financial frameworks (equity compensation vs. postretirement benefits), and methodologies (Black-Scholes, Monte Carlo) are correctly identified. The only minor gap is that the original emphasizes the three-year period (2023–2021) for Coca-Cola’s assumptions, which the LLM omits, but this is a secondary detail. No calculation errors; semantic equivalence is strong. Quantitative accuracy is high—specific inputs and timeframes are plausible and contextually appropriate, even if not explicitly in the ground truth. Reasoning is sound and reflects proper multi-hop synthesis across two companies’ distinct applications of weighted averages in financial reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 429,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 15,
      "question": "How does the expiration timeline of regulatory exclusivity for Merck's Januvia family of products compare to Gilead's U.S. regulatory exclusivity expiration in 2032, and what impact might this have on their respective market positions given the role of exclusivity in delaying generic competition?",
      "original_answer": "Merck's Januvia family of products is expected to lose U.S. market exclusivity in May 2026 (Januvia and Janumet) and July 2026 (Janumet XR), while Gilead has a U.S. regulatory exclusivity that expires in 2032. According to the evidence, regulatory exclusivity provides a period during which generic competitors cannot rely on the innovator’s data for approval, thus delaying market entry of generics. Since Gilead benefits from a significantly longer exclusivity period, it may maintain a more protected market position through 2032, whereas Merck will face substantial sales declines starting in 2026 due to generic competition and pricing pressures, as seen in other markets post-expiry.",
      "llm_answer": "Merck expects its Januvia, Janumet and Janumet XR to retain U.S. market exclusivity until May 2026 (Januvia/Janumet) and July 2026 (Janumet XR) (MRK_10k_2024, page 58). Gilead’s relevant product retains U.S. regulatory exclusivity through 2032 (GILD_10k_2024, page 41). Because exclusivity blocks generic entry, Merck will confront generic competition about six years earlier, likely eroding its diabetes franchise, whereas Gilead’s later expiry gives it a longer protected period to preserve market share.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the U.S. market exclusivity expiration dates for Merck's Januvia family—May 2026 for Januvia and Janumet, and July 2026 for Janumet XR—and correctly states that Gilead's U.S. regulatory exclusivity extends to 2032. These dates match the ground truth exactly. (2) All numeric values (dates) are accurate and properly attributed to the respective products and companies. The comparison of a roughly six-year difference in exclusivity timelines is a reasonable approximation (2032 vs. 2026 = 6-year gap), which aligns with the factual timeline. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Merck and Gilead filings, compares their exclusivity timelines, and draws a logical conclusion about the impact on market position. It correctly notes that regulatory exclusivity delays generic entry and that earlier expiry will likely lead to erosion of Merck’s franchise, while Gilead benefits from prolonged protection. (4) The only minor shortcoming is that the LLM answer does not explicitly mention the mechanism of data exclusivity (i.e., generics cannot rely on innovator’s data), which is included in the ground truth and adds depth to the explanation of how exclusivity delays competition. However, the core reasoning about blocked generic entry is present. Wording differs slightly but maintains semantic equivalence. All entities (Merck, Gilead, Januvia family products) and years are correct. Thus, the answer is highly accurate, complete, and relevant, warranting a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 458,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does Intel's amortization expense for developed technology used in cybersecurity compare with Cisco's revenue recognition timing for its cloud security offerings?",
      "original_answer": "Intel reported $1,283 million in amortization expenses for developed technology in 2021, which includes technology used for cybersecurity solutions like cloud security. Cisco recognizes revenue for its cloud security offerings ratably over the contract term, aligning with the ongoing delivery of updates and upgrades critical to the software’s performance. This contrasts with Intel’s cost recognition pattern, where developed technology is amortized over a 9-year weighted average useful life, reflecting a more fixed cost structure compared to Cisco’s recurring revenue model.",
      "llm_answer": "Intel reports an amortization expense of about $1.283 billion for its “developed technology” (recorded in cost of sales) in the year ended Dec 25 2021 【page_95】. Cisco’s cloud‑security offerings, which fall under its End‑to‑End Security category, are accounted for as a single performance obligation with revenue recognized ratably over the contract term—that is, over time rather than upfront 【page_75】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the amortization expense of $1.283 billion (or $1,283 million) for Intel in 2021 is correctly reported, matching the original answer. The date (Dec 25, 2021) corresponds to Intel’s fiscal year-end for 2021, which is accurate. (2) The answer correctly identifies Cisco’s revenue recognition policy for cloud security offerings as ratable over the contract term, citing the appropriate context (End-to-End Security category and single performance obligation), which matches the ground truth. (3) The multi-hop reasoning is sound: it contrasts Intel’s cost amortization (a cost-side, fixed-period recognition) with Cisco’s revenue recognition (a revenue-side, recurring model), even if the explicit comparison sentence about 'fixed cost structure vs recurring revenue model' is slightly less elaborated than in the original. (4) All entities—Intel, Cisco, developed technology, cloud security, amortization, revenue recognition—are correctly identified and contextualized. The only minor shortcoming is the lack of mention of the 9-year weighted average useful life for Intel’s amortization, which is a detail present in the original and adds depth to the cost recognition pattern. However, this omission does not undermine the core correctness. Wording differences are acceptable and semantically equivalent. Overall, the answer is factually correct, well-supported, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 407,
        "total_tokens": 1658
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How has the adoption of ASU 2022-02 affected MET's loan modification disclosures compared to JPM's reporting under the legacy TDR guidance, particularly in terms of the types and financial impact of modifications made to borrowers experiencing financial difficulty?",
      "original_answer": "MET adopted ASU 2022-02 on January 1, 2023, which eliminated the TDR accounting framework and introduced the concept of Financial Difficulty Modifications (FDMs), requiring expanded disclosures. MET reported that the adoption did not have a material impact on its financial statements, but it now discloses FDMs instead of TDRs. JPM, under the legacy TDR guidance prior to 2023, reported $362 million in new TDRs for 2022, with modifications typically involving interest rate reductions, term extensions, and payment delays. In 2023, under FDM reporting, JPM noted $136 million in FDMs, predominantly term extensions and rate reductions, which extended the weighted-average life of loans by 20 years and reduced the weighted-average interest rate from 7.21% to 4.44%. This shift reflects a more principles-based approach under ASU 2022-02, focusing on financial difficulty rather than concession-based criteria, resulting in more consistent and transparent reporting of loan modifications across both institutions.",
      "llm_answer": "MetLife’s 2023 filing shows that, after adopting ASU 2022‑02 on 1 Jan 2023, every borrower‑difficulty modification is now reported as a “financial‑difficulty modification” (FDM) rather than a troubled‑debt restructuring (TDR). The firm says the concessions it offers – interest‑rate cuts, term extensions, principal forgiveness or other‑than‑insignificant payment delays – have not changed, and the new rule only expanded the narrative disclosures (Note 11) with no material effect on the consolidated statements (see MET p.167).  \n\nJPMorgan, which still reports pre‑2023 modifications under the legacy TDR guidance, provides far more quantitative detail: it lists the dollar amount of TDRs, the number of loans, the percentage of each concession type, before‑and‑after weighted‑average interest rates and terms, charge‑offs and re‑default balances (see JPM p.245).  \n\nThus, MetLife’s post‑ASU disclosure is primarily qualitative and classification‑focused, whereas JPMorgan’s legacy TDR reporting remains a detailed, numeric breakdown of the types and financial impact of the modifications.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures some correct qualitative aspects but fails significantly on quantitative accuracy, which is critical for this financial multi-hop question. (1) Correct elements: MET adopted ASU 2022-02 on January 1, 2023, and now reports FDMs instead of TDRs; the adoption had no material impact on financial statements; both institutions report similar types of modifications (rate reductions, term extensions, payment delays). The contrast in disclosure style—MET’s more qualitative vs. JPM’s more quantitative—is contextually relevant and partially accurate. (2) Quantitative inaccuracies: The LLM omits and misrepresents key numbers from the ground truth. It fails to report JPM’s $362 million in TDRs for 2022 under legacy guidance and $136 million in FDMs in 2023. Crucially, it omits the specific financial impact metrics: the weighted-average interest rate reduction from 7.21% to 4.44% and the 20-year extension in loan life—both central to the question about financial impact. These omissions severely undermine correctness. (3) Multi-hop reasoning: The model attempts to compare MET’s post-ASU disclosures with JPM’s legacy reporting, but it does not synthesize the actual data points across years and standards to show how the adoption of ASU 2022-02 changed reporting practices in a measurable way. Instead, it defaults to a generic contrast in disclosure format without grounding it in the provided numerical evidence. (4) While the LLM correctly identifies entities (MET, JPM, ASU 2022-02, TDR, FDM) and the general shift in disclosure philosophy, the absence of key financial figures and comparative impact data results in a partially correct but materially incomplete answer. The contextual relevance is high because it addresses the right concepts, but correctness is limited by missing core quantitative facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1556,
        "completion_tokens": 495,
        "total_tokens": 2051
      },
      "error": null
    },
    {
      "question_id": 16,
      "question": "How does CVX's upstream position in South American natural gas reserves compare with XOM's downstream footprint across the broader Americas region?",
      "original_answer": "CVX reported 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, reflecting its upstream exposure in the region. South America is geographically included within the broader 'Americas' reporting segment, which encompasses both North and South America. XOM maintains a large downstream presence across the Americas, with integrated refining, marketing, and logistics operations focused on delivering refined products like gasoline, diesel, and synthetic motor oils. While CVX's position centers on upstream resource extraction in South America, XOM's downstream operations span the entire Americas region, highlighting complementary but distinct strategic focuses within the energy value chain.",
      "llm_answer": "Chevron’s upstream portfolio includes only a modest amount of South‑American gas – the 2021 year‑end proved natural‑gas reserves for South America were about 108 billion cubic feet (≈0.1 TCF) (CVX 10‑K p. 108). In contrast, ExxonMobil’s downstream business is a large, fully integrated operation that spans the whole Americas, generating roughly $2.1 billion of downstream earnings in 2021, with $1.3 billion from the United States and $0.8 billion from non‑U.S. (including Canada and other Americas) and a “well‑established presence in the Americas” across refining, logistics, trading and marketing (XOM 10‑K p. 63 & p. 65).",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative data. The ground truth states CVX had 329 billion cubic feet of natural gas reserves in South America as of December 31, 2022, but the LLM incorrectly reports 108 billion cubic feet for 2021, citing a different year and lower volume. This discrepancy undermines the core comparison. Additionally, the LLM introduces downstream earnings figures for XOM ($2.1B total, $1.3B U.S., $0.8B non-U.S.) that are not present in the original answer and were not requested by the question, potentially confusing the comparison with extraneous data. (2) Number verification: CVX reserves — incorrect year (2021 vs 2022) and incorrect volume (108 vs 329 Bcf); XOM downstream earnings — not mentioned in ground truth, so their inclusion is unsupported. While the broader geographic scope of XOM’s downstream operations across the Americas is correctly characterized, the financial figures are irrelevant to the original comparison. (3) Multi-hop reasoning is partially sound: the model correctly identifies CVX’s upstream focus in South America and contrasts it with XOM’s downstream footprint across the Americas. However, it fails to align the timeframes (2022 vs 2021) and misrepresents CVX’s reserve size, weakening the synthesis. The strategic contrast is conceptually valid but based on flawed data. (4) Contextual relevance is high because the answer addresses the upstream vs downstream comparison across the two companies and regions as asked. However, due to major quantitative errors and introduction of unsupported financial metrics, the correctness and qualitative accuracy scores are significantly reduced. Minor formatting variations (e.g., Bcf vs TCF) are acceptable, but magnitude and year mismatches are not.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 489,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the $25 million commercial paper exposure of Duke Energy Ohio compare with Tesla's $470 million commercial paper holdings in terms of their short-term liquidity strategies?",
      "original_answer": "Duke Energy Ohio reports a $25 million commercial paper exposure as part of its short-term liabilities, reflecting its reliance on modest short-term borrowing for operational needs. In contrast, Tesla holds $470 million in commercial paper as part of its short-term investments, indicating a cash deployment strategy rather than a funding need. This comparison highlights two distinct uses of commercial paper: Duke Energy utilizes it as a financing tool, while Tesla treats it as an investment to optimize liquidity returns.",
      "llm_answer": "Tesla’s 10‑K shows $470 million of commercial paper listed under cash, cash equivalents and short‑term investments, meaning it is a core component of the company’s liquidity buffer 【page_72】. By contrast, Duke Energy’s footnote on short‑term obligations classifies only $25 million of commercial paper for its Ohio subsidiary as a modest short‑term borrowing 【page_165】. Thus Tesla relies heavily on commercial paper for liquidity, while Duke Energy Ohio’s exposure is relatively small and represents a limited, ancillary source of short‑term funding.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $25 million commercial paper exposure for Duke Energy Ohio and Tesla's $470 million commercial paper holdings, matching the ground truth in absolute values. These figures are accurately attributed to their respective financial contexts—Duke Energy’s as short-term borrowing and Tesla’s as part of cash and short-term investments. (2) Quantitative accuracy is perfect: both dollar amounts ($25M and $470M) are correct, with no calculation errors. Format variations (e.g., $470 million) are acceptable and do not affect correctness. (3) However, the reasoning contains a key misinterpretation: the LLM states that 'Tesla relies heavily on commercial paper for liquidity,' which inverts the correct interpretation. In reality, Tesla *holds* commercial paper as an investment of excess cash, not as a source of funding. The ground truth correctly frames Tesla’s position as a cash deployment strategy, whereas the LLM incorrectly implies Tesla uses commercial paper as a liquidity *source*, confusing investment with financing. This undermines the qualitative accuracy of the multi-hop synthesis. (4) Despite this, the answer is contextually relevant and addresses the comparison of short-term liquidity strategies with mostly accurate data. The error in interpreting the *direction* of commercial paper use (asset vs. liability) prevents a higher score, but core facts are present, warranting a 7 for correctness and qualitative accuracy. Quantitative accuracy is flawless, and relevance remains high due to proper entity alignment and comparative structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 439,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the voting power structure of META's Class A common stock compare to GOOGL's Class B common stock in terms of shareholder influence, given the dual-class stock structures described in their filings?",
      "original_answer": "META's Class A common stock has limited voting power compared to its Class B common stock, where a single shareholder (Mr. Zuckerberg) retains significant control, with Class B shares requiring majority approval for change-in-control transactions until they represent less than 35% of combined voting power. In contrast, GOOGL's Class B common stock provides 10 votes per share, significantly more than the 1 vote per share for Class A, though Class B shares automatically convert to Class A upon sale or transfer. CMCSA's example shows a similar dual-class structure where Class A holds 66 2/3% of voting power with 1 vote per share and Class B holds 33 1/3% with 15 votes per share, illustrating a pattern of concentrated voting control in dual-class structures like those of META and GOOGL.",
      "llm_answer": "META’s Class A common stock carries only one vote per share and is effectively out‑voted by the super‑voting Class B shares, which hold the majority of the combined voting power and let the controlling shareholder dominate decisions even with a minority of equity (see META 10‑K p. 50). In Alphabet, each Class B share is entitled to ten votes per share, giving Class B holders far greater voting influence than a typical one‑vote share (see GOOGL 10‑K p. 81). Thus, META’s Class A shareholders have far less voting power than GOOGL’s Class B shareholders.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core voting power differences in the dual-class structures of META and GOOGL. It accurately states that META's Class A has one vote per share and is outvoted by Class B shares, which carry superior voting rights and enable concentrated control—consistent with the ground truth noting Mr. Zuckerberg's control and the 35% threshold for change-in-control transactions. The answer correctly notes that GOOGL's Class B shares have 10 votes per share versus 1 for Class A, and that this gives Class B holders disproportionate influence. The citation of specific 10-K pages adds precision. However, the LLM omits key details present in the original answer: (1) the automatic conversion of GOOGL Class B to Class A upon sale/transfer, which is a critical structural feature; (2) the specific threshold (35% voting power) for META’s change-in-control provision; and (3) the comparative example of CMCSA, which provides broader context on dual-class patterns. While the LLM correctly compares META Class A to GOOGL Class B in terms of voting power, it does so in a way that could mislead—the question asks how META Class A compares to GOOGL Class B in terms of shareholder influence, and the answer correctly notes the disparity but could be interpreted as comparing the two classes directly in a way that overlooks that GOOGL Class B is the high-vote share, not Class A. The quantitative accuracy is high: '1 vote' and '10 votes' are correct. Reasoning is sound but incomplete in synthesis—while it draws the right conclusion about disproportionate influence, it misses multi-hop elements like structural safeguards and conversion rules. The answer remains contextually relevant and factually accurate on the main points, warranting a high but not perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 484,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 17,
      "question": "How does the dividend structure for non-voting share classes at Mastercard and Charles Schwab impact the alignment of shareholder returns between voting and non-voting equity holders, given Mastercard's explicit distinction in dividend rights for B Class Shares and Charles Schwab's statement that dividend rights are identical across voting and nonvoting stock classes?",
      "original_answer": "At Mastercard, both A Class (voting) and B Class (non-voting) shares have dividend rights, indicating equal treatment in shareholder returns through dividends despite differences in voting power. In contrast, Charles Schwab explicitly states that dividend and liquidation rights are identical between its voting and nonvoting stock classes, ensuring full alignment in shareholder returns across share types. This means that while both companies provide dividend rights to non-voting shares, Charles Schwab maintains a stronger structural alignment in returns between share classes, whereas Mastercard preserves dividend parity but separates voting control.",
      "llm_answer": "Mastercard’s B‑class shares are non‑voting but the charter expressly gives them “non‑voting dividend rights,” meaning they receive the same per‑share dividend as the voting A‑class shares while lacking voting power (see Mastercard Note 16, p. 92). Charles Schwab, by contrast, states that its voting and non‑voting common stock have “identical participation rights, including dividend and liquidation rights,” so both classes receive the same dividend (see Schwab Note 20, p. 66). Thus, cash‑return alignment is achieved in both companies, but Mastercard does it through a distinct non‑voting class with explicit dividend rights, whereas Schwab treats the rights as identical across classes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns closely with the ground truth. (1) It correctly identifies that Mastercard's B-class shares are non-voting but have dividend rights equivalent to A-class shares, and that Charles Schwab explicitly states identical dividend and liquidation rights across share classes. These points match the original answer's core claims. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—no errors in this dimension. (3) The multi-hop reasoning is sound: the model synthesizes information from two companies (Mastercard and Charles Schwab), compares their dividend structures for voting vs. non-voting shares, and draws a valid conclusion about cash-return alignment. The only minor shortcoming is that the LLM does not explicitly state that Charles Schwab's structural alignment is 'stronger' or make the normative comparison about 'preserving dividend parity but separating voting control' as in the original answer, slightly weakening the qualitative depth. (4) The answer is fully contextually relevant, directly addressing the impact of dividend structures on shareholder return alignment. Wording differs but semantic meaning is equivalent. One point deducted from correctness and qualitative accuracy for the slightly less nuanced conclusion, but overall the response is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 390,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How might the implementation of the OECD's Pillar Two global minimum tax differently affect Microsoft's and Oracle's effective tax rates, given Microsoft's expectation of no material impact and Oracle's concern about materially increased international tax costs?",
      "original_answer": "Microsoft expects no material impact from the OECD's Pillar Two global minimum tax due to its current operations not being concentrated in jurisdictions with tax rates below the 15% threshold. In contrast, Oracle explicitly notes that the adoption of Pillar Two in many jurisdictions could materially increase its international tax costs. While both companies are subject to the same global regulatory framework, their differing geographic footprints and tax planning strategies appear to lead to divergent expectations about the financial impact of the new rules.",
      "llm_answer": "Microsoft says that the OECD Pillar‑Two rules, which impose a 15 % global minimum tax, “are not expected to materially increase our global tax costs” and therefore its effective tax rate (about 18 % in FY 2024) should remain essentially unchanged【page_47】. In contrast, Oracle warns that the same Pillar‑Two framework “could materially increase the level of income tax on our international profits,” implying that its effective tax rate could rise as the new minimum‑tax rules are adopted in the jurisdictions where it does business【page_29】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: Microsoft's expected lack of material impact and its ~18% effective tax rate in FY2024 are accurately reported. Oracle's concern about materially increased international tax costs is correctly represented without specific numbers, consistent with the source. No calculations were required. (2) The entities—Microsoft and Oracle—are correctly identified, and the reference to OECD Pillar Two with a 15% minimum tax is factually accurate. Fiscal year 2024 is appropriately cited for Microsoft. (3) The multi-hop reasoning is sound: the model correctly contrasts Microsoft’s and Oracle’s differing expectations under the same regulatory framework, attributing the divergence to their respective international tax exposures, even if not explicitly stating the geographic footprint rationale. The synthesis across the two companies’ disclosures is logical and supported by the original answer. (4) Semantically, the LLM conveys the same core information: Microsoft sees no material impact, Oracle anticipates higher taxes. The only minor shortcoming is that the LLM does not explicitly mention the reason for the difference (i.e., Microsoft's operations not being concentrated in low-tax jurisdictions), which slightly reduces qualitative accuracy. However, the implication is present through the contrast in statements. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 414,
        "total_tokens": 1719
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How do GM's and LOW's applications of Level 3 valuation techniques differ in their financial reporting, particularly regarding the unobservable inputs and methodologies used for fair value measurements?",
      "original_answer": "GM utilizes Level 3 valuation techniques primarily for marketable debt securities and finance receivables, relying on pricing models, discounted cash flow models, and industry-standard pricing models with unobservable inputs such as economic forecasts, including unemployment rates, interest rate spreads, disposable personal income, and GDP growth rates. LOW, on the other hand, applies Level 3 valuation specifically to contingent consideration from the fiscal 2022 sale of its Canadian retail business, using an income approach with unobservable inputs like total equity value, volatility, and expected term. While both companies use Level 3 valuations, GM focuses on macroeconomic assumptions across a range of financial instruments, whereas LOW applies it to a specific long-term investment with performance-based metrics.",
      "llm_answer": "GM uses Level 3 fair‑value measurements chiefly for impairment of leased‑vehicle asset groups and, when market quotes are unavailable, for certain debt securities, applying discounted‑cash‑flow or residual‑value models that depend on management’s forecasts of cash flows and estimated residual values (GM 10‑K p.64‑63). Lowe’s Level 3 measurements, by contrast, are applied to its performance‑based contingent consideration and retained receivables, which are valued with an option‑pricing model and present‑value of cash‑flow techniques that incorporate unobservable inputs such as total equity value, volatility, expected term, credit‑loss assumptions and a risk‑adjusted discount rate (Lowe’s 10‑K p.53‑47).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of unobservable inputs and valuation methodologies used by GM and LOW (Lowe's), with correct references to their respective 10-K filings. It correctly identifies GM's use of discounted cash flow and residual-value models with management forecasts (aligned with economic assumptions like cash flows and residual values), and Lowe’s use of option-pricing and present-value techniques with unobservable inputs such as total equity value, volatility, expected term, and discount rates. These align semantically with the ground truth, which specifies GM’s reliance on macroeconomic forecasts (e.g., unemployment, GDP) and Lowe’s focus on contingent consideration with performance-based metrics. However, the LLM answer introduces 'impairment of leased-vehicle asset groups' and 'retained receivables' for Lowe’s, which are not mentioned in the original answer and slightly shift focus from the ground truth emphasis on the Canadian retail business sale and contingent consideration as the primary Level 3 application. While the core methodologies and inputs are correctly reported, the LLM does not fully emphasize the contrast in scope: GM’s broad use across financial instruments versus Lowe’s narrow, event-specific use. There are no numerical inaccuracies (quantitative accuracy is perfect), and the reasoning is mostly sound, but the synthesis slightly misses the precise context of LOW’s Level 3 application. Wording differences are acceptable under semantic equivalence, but the omission of the Canadian retail business context reduces completeness in multi-hop synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 443,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential conversion dynamics of Class A shares, especially in light of Alphabet's aggressive share repurchase strategy involving Class A and Class C shares?",
      "original_answer": "At CMCSA, Class B common stock holds 33 1/3% of the voting power, with each share entitled to 15 votes, and this voting power is non-dilutable under the company's articles of incorporation. This structure creates a concentrated voting control that could influence decisions regarding potential conversions of Class A shares, as Class B shares can be converted share-for-share into Class A under certain restrictions. Meanwhile, Alphabet (GOOGL) has been actively repurchasing Class A and Class C shares, spending $62.2 billion in 2023 alone and maintaining $36.3 billion in remaining authorization as of year-end. This aggressive repurchase strategy could reduce the number of outstanding shares in similar classes, potentially increasing the proportional influence of remaining shareholders, including those holding voting shares like CMCSA's Class B. The combination suggests that while CMCSA's Class A shareholders may see increased influence through potential Class B conversion, GOOGL's repurchase activity could further concentrate ownership and influence within its own capital structure.",
      "llm_answer": "CMCSA’s Class B shares lock in about one‑third of the total voting power (each B share carries 15 votes and the 33 % voting block is non‑dilutable) and are convertible share‑for‑share into Class A stock, so any conversion adds to the pool of Class A shares while preserving the fixed B‑share voting slice, thereby diluting the voting influence of existing Class A holders (CMCSA 10‑K p. 91). In contrast, Alphabet’s aggressive buy‑back of its voting Class A and non‑voting Class C shares reduces the number of outstanding Class A shares and concentrates voting power among the remaining Class A holders, without the constraint of a protected voting‑power class (Alphabet 10‑K p. 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: CMCSA's Class B holds 33 1/3% voting power with 15 votes per share, the non-dilutable nature is implied by 'fixed B-share voting slice', and the share-for-share convertibility is correctly stated. Alphabet's repurchase of Class A and C shares is accurately described, though specific dollar figures ($62.2B spent in 2023, $36.3B remaining) from the original answer are omitted—this is a minor completeness gap but does not affect factual correctness. (2) The reasoning is sound: the LLM correctly identifies that Class B conversion would increase Class A supply and dilute existing Class A voting power, while Alphabet’s buybacks concentrate voting power among remaining Class A holders. (3) Multi-hop synthesis across CMCSA and Alphabet is logically coherent, contrasting structural voting control with repurchase-driven concentration. (4) The answer is contextually precise, directly addressing how CMCSA’s voting structure interacts with conversion dynamics and how Alphabet’s strategy creates a parallel concentration effect. The only reason for not scoring 10 is the omission of specific repurchase amounts, which were present in the ground truth and relevant to 'aggressive' characterization. However, the qualitative and structural analysis remains excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 383,
        "total_tokens": 1853
      },
      "error": null
    },
    {
      "question_id": 18,
      "question": "What is the difference in remaining securities available for future issuance under equity compensation plans between MDLZ and CL, based on their 2022 10-K disclosures?",
      "original_answer": "MDLZ reported 48,932,017 securities remaining available for future issuance under equity compensation plans, while CL reported 37,028,000 securities (in thousands). The difference between the two companies' remaining issuance capacity is 11,904,017 securities.",
      "llm_answer": "Mondelez International disclosed that about 71 million shares remain available for future issuance under its equity‑compensation plans, whereas Colgate‑Palmolive reported roughly 37.0 million such shares (see Colgate‑Palmolive Item 12, Table – 37,028 thousand shares). The gap between the two companies is therefore about 34 million shares (≈33.97 million).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key numbers. It states MDLZ has 'about 71 million' shares available, but the ground truth is 48,932,017—over 22 million shares higher than actual. CL's figure is correctly cited as 37,028,000 (37.0 million), matching the ground truth. The calculated difference is ≈34 million, but the correct difference is 11,904,017—nearly half of what the model reports. These quantitative inaccuracies severely undermine the answer's correctness. (2) Number verification: MDLZ value is wrong (71M vs 48.9M); CL value is correct (37.0M); difference is wrong (34M vs 11.9M). Even allowing for rounding, 'about 71 million' is not a reasonable approximation of 48.9 million. (3) Multi-hop reasoning: The model correctly identifies that the question requires comparing remaining securities from two companies' 10-Ks and computing a difference—this shows sound reasoning structure. However, the execution fails due to incorrect data retrieval for MDLZ. (4) Contextual relevance is high—the answer addresses the right companies, metric, year, and calculation type. But due to major numerical inaccuracies, especially on MDLZ, the correctness score is low. Quantitative accuracy is very poor; qualitative accuracy is partially acceptable due to correct framework; relevance is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1159,
        "completion_tokens": 371,
        "total_tokens": 1531
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the impact of Illinois' Clean Energy Law on ComEd's transmission rate structure compare to Tesla's exposure to state-level regulatory challenges in markets with direct sales restrictions?",
      "original_answer": "Illinois' Clean Energy Law directly affects ComEd's transmission rate structure by requiring a new four-year multi-year plan to establish rates after the expiration of its performance-based distribution formula rate, and accelerating the amortization of ComEd's unprotected excess deferred income taxes over approximately 39.5 years. These regulatory changes introduce uncertainty around ComEd’s rate of return on equity, which is currently set at 11.50% with a 50-basis-point incentive adder as a RTO member. In contrast, Tesla faces state-level regulatory challenges related to its direct-to-consumer sales model, where certain U.S. states have laws interpreted to restrict its ability to sell vehicles through company-owned stores or obtain dealer licenses. While ComEd’s exposure centers on rate-setting mechanisms and compliance with decarbonization mandates, Tesla’s risk is tied to legal interpretations of motor vehicle industry laws and potential legislative pushback from dealer associations. Both face significant regulatory uncertainty, but the financial implications differ: ComEd’s are embedded in its cost recovery and capital structure, while Tesla’s affect its go-to-market strategy and expansion potential.",
      "llm_answer": "Illinois’ Clean Energy Law obligates ComEd to file a new rate case (or a four‑year multi‑year plan) that will reshape its transmission‑formula rates—altering amortization, efficiency‑goal recoveries and other charge components—and the company warns that legal challenges to the law’s implementation are possible. Tesla’s exposure, by contrast, stems from state‑level dealer‑law restrictions that could bar the company from selling directly in certain markets, creating regulatory risk that could limit its sales model and earnings. Both face uncertain regulatory outcomes, but ComEd’s risk is a restructuring of its transmission rates, while Tesla’s risk is the potential loss of direct‑sale access in specific states.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and captures the essential contrast between ComEd's regulatory exposure under Illinois' Clean Energy Law and Tesla's state-level sales restrictions. (1) There are no numeric inaccuracies—while the LLM does not repeat specific numbers like the 11.50% ROE or 50-basis-point adder, it does not introduce any incorrect figures, and the absence of these numbers does not constitute a factual error, only a slight omission. The 39.5-year amortization period for deferred taxes is also not mentioned, which is a minor completeness gap. (2) The LLM correctly identifies the key regulatory mechanisms: ComEd’s requirement to file a four-year multi-year rate plan and Tesla’s direct-sales restrictions. It accurately frames both companies as facing regulatory uncertainty, though it does not fully elaborate on the financial structure implications for ComEd (e.g., cost recovery, capital structure) or the legislative dynamics (e.g., dealer association pushback) mentioned in the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes that ComEd’s risk is tied to transmission rate restructuring while Tesla’s is to market access, which aligns with the comparative intent of the question. (4) The answer is contextually relevant and directly addresses the comparison asked. The LLM omits some granular details (ROE value, incentive adder, exact amortization timeline, RTO membership context), but the core qualitative and quantitative elements are correct. Thus, the answer earns a high score but not perfect due to these omissions affecting completeness and depth of financial implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1498,
        "completion_tokens": 453,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How will the IRA-driven Medicare Part D redesign, which imposes manufacturer discounts and price caps starting in 2025, affect the gross-to-net rebate accruals for both AMGN's ENBREL and BMY's Medicare Part D-dependent products, given AMGN's regulatory exposure and BMY's accounting for GTN adjustments based on payer channel mix and contract prices?",
      "original_answer": "The IRA-driven Medicare Part D redesign, which introduces manufacturer discounts and caps beneficiary out-of-pocket costs starting in 2025, will increase the gross-to-net (GTN) rebate accruals for both AMGN and BMY. For AMGN, the redesign compounds the impact of the set price for ENBREL starting in 2026, which is significantly lower than current pricing, and the potential inclusion of Otezla in the next round of Medicare price setting in 2027. This will likely reduce profitability and necessitate larger GTN adjustments. For BMY, which depends on Medicare Part D and accounts for GTN rebates using assumptions like payer channel mix and contract prices, the new obligations under the IRA will increase rebate liabilities, particularly in the catastrophic phase where manufacturers absorb more costs. The combined effect will be a material adverse impact on both companies' revenues and financial reporting accuracy, as they must adjust accruals to reflect the new regulatory environment and pricing pressures.",
      "llm_answer": "The IRA’s Part D redesign forces manufacturers to provide additional discounts and accept price caps beginning in 2025, so the liability for expected rebates will grow. Amgen notes that CMS has set a lower Medicare Part D price for ENBREL (effective 1 Jan 2026) and that its regulatory exposure to pricing‑data reporting could require extra rebates, meaning ENBREL’s gross‑to‑net rebate accruals will increase (see Amgen p. 36). Bristol‑Myers Squibb likewise must incorporate the new mandatory discounts into its GTN U.S. rebate accruals for Medicare Part D‑dependent products, and because its GTN calculations rely on payer‑channel mix and contract‑price assumptions, those accruals will rise to reflect the higher expected rebates (see BMS p. 125).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the IRA's Medicare Part D redesign starting in 2025, increased manufacturer discounts and price caps, and the resulting higher gross-to-net (GTN) rebate accruals for both AMGN and BMY are correctly stated. The effective date of the lower Medicare Part D price for ENBREL (January 1, 2026) matches the ground truth's 'starting in 2026' and is precise. (2) Quantitatively, all dates (2025, 2026) are accurate; no numerical values (e.g., dollar amounts, percentages) are missing or incorrect. Format and specificity are appropriate. (3) Multi-hop reasoning is sound: the answer correctly links AMGN’s regulatory exposure (pricing-data reporting) to higher GTN accruals for ENBREL and references a specific page (p. 36), indicating proper synthesis. For BMY, it correctly ties the IRA’s new discounts to increased GTN accruals and explains that their reliance on payer-channel mix and contract prices necessitates upward adjustments—mirroring the ground truth’s reasoning. (4) The only minor omission is the lack of mention of Otezla’s potential inclusion in 2027 price setting, which adds to AMGN’s exposure but is a secondary point. This does not undermine the core accuracy. Semantic equivalence is strong, and contextual relevance is complete. The answer is concise but fully responsive.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1492,
        "completion_tokens": 386,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How do AIG's and MET's differing accounting treatments for structured securities impact the valuation and reporting of ABS & CLO assets in their respective financial statements?",
      "original_answer": "AIG applies the effective yield method to structured securities, recalculating yields based on expected cash flows and adjusting amortized cost accordingly, with changes in expected cash flows either charged or credited to net investment income. MET, on the other hand, classifies ABS & CLO as available-for-sale (AFS) and measures them at estimated fair value, including those valued using Level 3 inputs, which are disclosed in recurring fair value measurements. These differing approaches—AIG's yield-based adjustments versus MET's fair value measurement—result in different financial statement presentations and sensitivity to market changes, affecting how investors assess the valuation and risk profile of each company's structured securities portfolio.",
      "llm_answer": "AIG elects the **fair‑value option** for its hybrid/structured securities, so the fair‑value changes on ABS and CLO are booked directly in earnings (net investment income) as gains or losses 【page 166】. MetLife, however, places ABS and CLO in **fixed‑maturity securities‑available‑for‑sale**; unrealized fair‑value gains and losses are recorded in other‑comprehensive‑income (net of tax) and only realized amounts affect net investment income 【page 92】【page 169】. Thus AIG’s ABS/CLO values swing reported earnings each period, while MetLife’s affect equity until the assets are sold or otherwise realized.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of MET's accounting treatment—classifying ABS and CLO as available-for-sale (AFS) securities with unrealized gains/losses going to other comprehensive income (OCI), which aligns with the ground truth. It also correctly notes that MetLife discloses Level 3 inputs in recurring fair value measurements, though this specific detail is omitted in the LLM response, it does not contradict it. However, the LLM incorrectly states that AIG applies the *fair-value option* and records changes in fair value directly in earnings. The ground truth specifies that AIG uses the *effective yield method*, adjusting amortized cost based on expected cash flows, with changes impacting net investment income—this is not the same as fair-value accounting. While both methods may affect net investment income, the underlying valuation model (amortized cost with yield adjustments vs. fair value through earnings) is fundamentally different. The LLM’s characterization of AIG’s method misrepresents the accounting model, leading to an incorrect synthesis of the key difference. There are no numerical values to verify, so quantitative accuracy is scored as 10. Contextual relevance is high because the response directly addresses the question’s focus on valuation and reporting impacts. Qualitative accuracy is low due to the critical error in AIG’s accounting treatment, undermining the multi-hop comparison. The conclusion about differential impacts on earnings vs. equity is partially valid but based on flawed premises regarding AIG.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 429,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 19,
      "question": "How does the percentage of Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) compare with ExxonMobil's (XOM) operational exposure in Nigeria, given Nigeria's reliance on PSCs for deepwater offshore exploration and production?",
      "original_answer": "Chevron's (CVX) reserves tied to production-sharing contracts (PSCs) accounted for 8% of its consolidated reserves in 2021. ExxonMobil (XOM) operates in Nigeria, where deepwater offshore exploration and production are governed by PSCs with terms typically lasting 30 years, including a 10-year exploration period and a 20-year production period. This indicates that both companies are exposed to PSC frameworks, but while CVX quantifies its PSC exposure directly in terms of reserves, XOM's exposure in Nigeria is structural and long-term, embedded in the regulatory framework of a key operational region.",
      "llm_answer": "Chevron’s 2022 filing shows that PSC‑related reserves account for only about 8 % of its consolidated proved reserves in 2021 (10 % in 2020 and 2019)【page_108】. ExxonMobil’s 2022 filing notes that its deep‑water offshore activities in Nigeria are conducted under production‑sharing contracts, but it does not disclose a numeric share of its total reserves—its Nigeria exposure is described qualitatively as being fully PSC‑based【page_31】. Thus, Chevron’s PSC‑linked reserves represent a modest single‑digit percentage of its portfolio, whereas ExxonMobil’s Nigeria operations are entirely PSC‑driven but not quantified as a percentage of its overall reserves.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, it correctly states that Chevron's PSC-related reserves accounted for 8% of its consolidated proved reserves in 2021, matching the original answer. It also accurately references the 2022 filing discussing 2021 data, which is consistent with SEC filing timelines. The mention of 10% in 2020 and 2019 adds context not in the ground truth but does not contradict it and reflects actual trends in Chevron's filings. (2) For ExxonMobil, the LLM correctly notes that while XOM operates in Nigeria under PSCs, it does not disclose a numerical percentage of reserves tied to PSCs—this matches the original answer’s point about structural, non-quantified exposure. (3) The multi-hop reasoning is sound: the model synthesizes Chevron's quantified PSC reserve exposure with ExxonMobil's operational reliance on PSCs in Nigeria without conflating the two, and correctly contrasts measured vs. structural exposure. (4) The wording differs slightly—'modest single-digit percentage' vs. '8%'—but this is semantically equivalent and appropriately cautious. The only minor shortcoming is that the original answer includes detail about the 30-year PSC structure (10-year exploration, 20-year production), which the LLM omits. This contextual regulatory detail is relevant but not central to the core comparison, so the omission reduces completeness slightly but does not impair correctness. All entities (CVX, XOM, Nigeria, PSCs), years (2021), and metrics (reserves, PSC exposure) are accurate. The answer is fully contextually relevant and addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1340,
        "completion_tokens": 450,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Tesla's fixed share reservation under the 2019 Plan compare with HD's approach to stock appreciation rights in terms of long-term equity compensation flexibility, given Tesla's 49.0 million reserved shares and HD's forfeiture-adjusted vesting methodology?",
      "original_answer": "Tesla's 2019 Plan establishes a fixed reservation of 49.0 million shares for equity incentives including stock appreciation rights (SARs), indicating a structured long-term approach to compensation with defined capacity. In contrast, HD's SAR program incorporates estimated forfeitures into its compensation expense calculation and recognizes value on a straight-line basis as restrictions lapse, allowing for dynamic adjustment based on actual retention of talent. While both companies utilize SARs, Tesla's approach suggests greater predictability and constraint in equity issuance, whereas HD's method provides flexibility in response to workforce attrition and vesting outcomes.",
      "llm_answer": "Tesla’s 2019 Equity Incentive Plan sets a fixed pool of 49.0 million shares that can be issued as stock‑based awards, establishing a hard ceiling on future equity grants【page_83】. In contrast, Home Depot’s stock appreciation rights are accounted for using a forfeiture‑adjusted vesting methodology that reduces the number of SARs expected to vest based on estimated forfeitures, allowing the company to preserve long‑term equity compensation capacity without a static share reserve【page_53】. This makes Home Depot’s approach more flexible over time than Tesla’s predetermined share reservation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 49.0 million share reservation for Tesla is correctly stated, and the description of HD's forfeiture-adjusted methodology is consistent with the original answer. No calculations are required, and all numeric references are correct. (2) The LLM correctly identifies both companies (Tesla and Home Depot), the relevant compensation instruments (SARs), and the key differentiator: fixed share pool vs. forfeiture-adjusted vesting. (3) The multi-hop reasoning is sound—comparing Tesla’s static share reservation with HD’s dynamic, attrition-sensitive approach demonstrates proper synthesis across the two companies’ compensation strategies. (4) The LLM conveys the same core conclusion: Tesla’s approach offers predictability with a hard cap, while HD’s method provides greater long-term flexibility by adjusting for actual forfeitures. The only minor limitation is that the LLM does not explicitly mention 'straight-line recognition' or 'compensation expense calculation' as in the original, slightly reducing qualitative completeness, but the essence of HD's flexible accounting treatment is preserved. Wording differs slightly but maintains semantic equivalence. Contextual relevance is excellent, directly addressing the comparison on long-term equity compensation flexibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 380,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 20,
      "question": "How does Chevron's financial exposure to Tengizchevroil in Kazakhstan, including its $4,500 million loan for the FGP/WPMP development, compare to ExxonMobil's reported long-lived asset value in Kazakhstan of $8,463 million as of 2021?",
      "original_answer": "Chevron holds a 50% equity stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan, and has extended a $4,500 million loan to TCO specifically for the FGP/WPMP development. In 2021, Chevron's upstream earnings from TCO contributed positively to its income from equity affiliates. Meanwhile, ExxonMobil reported a total long-lived asset value in Kazakhstan of $8,463 million as of 2021. This suggests that while Chevron's exposure is primarily through equity investment and project-specific financing, ExxonMobil's presence is reflected in substantial asset holdings, indicating differing capital deployment strategies in the same geographic region.",
      "llm_answer": "Chevron’s equity‑method investment in Tengizchevroil (TCO) was $23.7 billion at 31 Dec 2021, and that amount includes a $4.5 billion loan to fund the FGP/WPMP development 【page_78】.  By contrast, ExxonMobil reported long‑lived assets in Kazakhstan of $8.463 billion for 2021 【page_123】.  Thus Chevron’s total exposure to TCO is roughly $15 billion higher – about three times the size of ExxonMobil’s Kazakhstan asset base.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that Chevron has a 50% equity stake in Tengizchevroil and provided a $4.5 billion loan for the FGP/WPMP project, but does not state that Chevron's total equity-method investment was $23.7 billion as of 2021. This $23.7 billion figure is not present in the original answer and appears to be fabricated or misattributed. The only confirmed financial figure from the ground truth is the $4.5 billion loan. ExxonMobil's reported long-lived asset value of $8.463 billion is correctly cited. (2) The calculation comparing Chevron’s exposure as 'three times' that of ExxonMobil is invalid because it relies on the unsupported $23.7 billion figure. The original answer does not make any quantitative comparison of total exposure, only describing the nature of the investments. Thus, the claimed $15 billion difference and the 'three times' conclusion are incorrect. (3) The multi-hop reasoning is partially sound in that the model attempts to compare Chevron’s financial exposure with ExxonMobil’s assets in Kazakhstan, but it fails in synthesis because it introduces a number not present in the source. The original answer emphasizes differing investment strategies—Chevron via equity and project financing, ExxonMobil via asset holdings—without quantifying total exposure. The LLM overreaches by asserting a precise comparative magnitude. (4) While the context and entities (Chevron, ExxonMobil, Tengizchevroil, FGP/WPMP, Kazakhstan, 2021) are correctly identified and the response is relevant to the question, the introduction of an unverified large-scale financial figure severely undermines factual accuracy. The qualitative reasoning is reasonable but built on a false premise. Correctness score is low due to major quantitative inaccuracy despite relevant structure and some correct data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 511,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How do Duke Energy's PPA negotiations for renewable facilities compare to Southern Power's PPA structures in wind facilities, particularly in terms of cash flow implications given Southern Power's utilization of production tax credits through 2024?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, where these agreements significantly influence the economic performance of its renewable energy VIEs. Southern Power, on the other hand, acts as a lessor in PPAs related to wind facilities, which are accounted for as operating leases with terms up to 25 years. These PPAs directly affect Southern Power's cash flows through lease income, which is further enhanced by production tax credits (PTCs) tied to the first 10 years of energy production from these wind facilities. Southern Power had approximately $0.8 billion in unutilized PTCs at the end of 2021, expected to be fully utilized by 2024. This creates a distinct cash flow dynamic: while Duke's PPAs are central to the performance of its consolidated VIEs, Southern Power's PPAs are structured to align with tax credit monetization strategies, directly shaping its lease income and tax equity partnership returns.",
      "llm_answer": "Duke Energy’s filing notes that the economic performance of its renewable‑energy VIEs hinges on siting, PPA and EPC negotiations, but it does not describe a specific cash‑flow structure for those PPAs—only that the decisions drive the assets’ economics. Southern Power, by contrast, accounts for its wind PPAs as operating leases with variable, production‑based payments and relies on federal production‑tax‑credits that will be fully utilized through 2024, which directly augments cash inflows (reflected in lease‑income and undiscounted cash‑flow forecasts).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the key distinctions between Duke Energy's and Southern Power's PPA structures and their cash flow implications. (1) It correctly identifies that Duke Energy's PPA negotiations are central to the economic performance of its renewable VIEs without specifying a detailed cash flow structure, which aligns with the ground truth. It accurately contrasts this with Southern Power's use of operating leases for wind PPAs, noting variable, production-based payments and the role of production tax credits (PTCs) through 2024. (2) Quantitatively, the LLM omits the specific $0.8 billion figure for unutilized PTCs at the end of 2021 mentioned in the original answer. While it correctly states PTCs will be fully utilized by 2024, the absence of the dollar amount reduces quantitative completeness. However, no incorrect numbers are presented, and the time frame (through 2024) is accurate. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their differing PPA structures (VIE economics vs. operating leases), and the impact of PTCs on cash flows. It links PTCs to enhanced cash inflows via lease income and forecasts, which reflects the monetization strategy described in the ground truth. (4) The answer is contextually precise, directly addressing the comparison in PPA structures and cash flow implications. The only notable omission is the $0.8 billion PTC balance, which slightly weakens completeness but does not undermine the core accuracy. Wording differences (e.g., 'augments cash inflows' vs. 'directly shaping lease income and tax equity returns') are semantically acceptable. Overall, the answer is factually strong with minor gaps in specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 474,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 21,
      "question": "How does LOW's receipt of additional shares through ASR agreements compare to HD's issuance of additional shares via dividend equivalents in deferred share awards for non-employee directors?",
      "original_answer": "LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, where the final share delivery depends on the difference between the maximum notional amount paid and the final notional value of shares repurchased. In contrast, HD issues additional shares to non-employee directors through dividend equivalents that accrue on deferred shares and are paid out in stock upon termination of board service. While LOW's additional shares result from share repurchase efficiency, HD's additional shares are a structured compensation element tied to deferred share awards.",
      "llm_answer": "Lowe’s ASR agreements are structured so that after paying the maximum notional amount, the company “receives additional shares” (and a cash payment) from the third‑party financial institution when the transaction is finalized 【page_62】. In contrast, Home Depot’s deferred‑share awards to non‑employee directors carry dividend equivalents that are “paid out in the form of additional shares of stock” when the underlying shares vest, and the company granted 19,000 deferred shares in fiscal 2023 【page_68】. Thus, Lowe’s mechanism adds shares to its own holdings, whereas Home Depot’s mechanism creates new shares that are issued to directors.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, citing page 62, and explains that this occurs when the final notional value of repurchased shares is less than the maximum notional amount paid—this matches the ground truth's description of share receipt due to repurchase efficiency. (2) For HD, it accurately notes that dividend equivalents on deferred share awards are paid in additional shares upon vesting (not termination, as in the ground truth), citing page 68, and includes the specific figure of 19,000 deferred shares granted in fiscal 2023. This quantitative detail is correct and adds precision not in the original answer. (3) The reasoning correctly contrasts LOW’s mechanism—receiving existing shares post-repurchase—with HD’s issuance of new shares as compensation. The only minor discrepancy is the trigger event: the ground truth specifies payout occurs upon termination of board service, while the LLM says 'when the underlying shares vest.' While vesting and termination may coincide, they are not necessarily equivalent; this is a subtle but notable difference in timing mechanics, slightly weakening the qualitative accuracy. (4) Despite this nuance, the core multi-hop synthesis—comparing how two companies handle additional shares in different financial contexts (ASR vs. director compensation)—is sound, complete, and contextually relevant. Number formats and entity references (LOW, HD, ASR, deferred shares) are accurate. The inclusion of a specific number (19,000 shares) enhances completeness. Thus, the answer earns a 9/10 for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 487,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does Boeing's equity income from ULA in 2024 correlate with Lockheed Martin's commercial satellite launch revenue, given ULA's role in serving both government and commercial customers?",
      "original_answer": "Boeing reported equity income of $125 million from ULA in 2024, reflecting its stake in the joint venture. ULA, co-owned by Boeing and Lockheed Martin, provides expendable launch services to both the U.S. Government and commercial customers. Lockheed Martin’s Space segment includes revenue from commercial satellite launches facilitated through ULA. Additionally, Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes payments related to ULA’s commercial launch services. Therefore, Boeing’s equity income from ULA is directly tied to the revenue Lockheed Martin recognizes from commercial satellite launches via ULA’s dual customer base.",
      "llm_answer": "Boeing reported $125 million of equity income from its United Launch Alliance joint‑venture in 2024 (BA 10‑K p. 42). Lockheed Martin’s Space segment includes its 50 % ownership of ULA, so the commercial satellite‑launch revenue that Lockheed reports is generated by the same ULA launch services that produced Boeing’s $125 million equity share (Lockheed Martin 10‑K p. 71).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Boeing's $125 million equity income from ULA in 2024 is accurately reported, and the 50% ownership structure (implied by Lockheed Martin's 10-K reference) is consistent with ULA being a joint venture. (2) The answer correctly identifies the key entities: Boeing, Lockheed Martin, ULA, and the relevant financial metric (equity income). (3) The reasoning correctly synthesizes the multi-hop connection: Boeing’s equity income is tied to ULA’s overall performance, which in turn generates commercial satellite launch revenue that contributes to Lockheed Martin’s reported figures. The LLM correctly notes that both companies benefit from ULA’s commercial launch services. (4) The only minor omission is that the original answer includes additional context about Lockheed Martin’s $665 million in receivables from commercial customers as of December 31, 2024, which strengthens the link between ULA’s commercial operations and Lockheed’s financials. While this detail enhances completeness, its absence does not undermine the core factual or logical accuracy of the LLM response. The answer is semantically equivalent in conveying the correlation between Boeing’s equity income and Lockheed’s commercial satellite launch revenue via ULA. Wording differences are acceptable and do not affect meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 390,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 22,
      "question": "How does the loss of market exclusivity for LLY's pharmaceutical products, influenced by patent rights and regulatory data protection, compare to MRK's exposure to patent-related risks, particularly in light of the varying durations of exclusivity in major markets such as the U.S., Europe, and Japan?",
      "original_answer": "LLY faces a severe and rapid revenue decline when pharmaceutical products lose effective market exclusivity, which is often tied to patent expiration. However, LLY may retain exclusivity through later-expiring patents on formulations or methods of use, or through regulatory data protection, such as 12 years for biologics in the U.S., 10 years in Europe, and 8 years in Japan. This market exclusivity is determined by both patent rights and regulatory protections, as noted in the BMY evidence, which explains that patent coverage and data exclusivity (e.g., orphan drug exclusivity for 7 years or pediatric exclusivity for 6 months) are the two key determinants of exclusivity. MRK similarly depends on patent rights for market exclusivity and faces material adverse impacts if those rights are invalidated or circumvented. MRK frequently engages in patent litigation to defend its exclusivity, especially against generic manufacturers seeking to enter the market before patent expiration. Thus, both companies are highly exposed to patent-related risks, but LLY may have more nuanced opportunities to extend exclusivity through regulatory mechanisms, while MRK emphasizes legal defense of its patents as a core strategy.",
      "llm_answer": "Lilly notes that its market‑exclusivity is tied to both patent terms and statutory data‑package protection – typically five years in the United States, about ten years in Europe and eight years in Japan – and that once those periods expire the company expects a rapid, severe decline in product revenues. Merck’s filing similarly warns that loss of patent‑based exclusivity – illustrated by Januvia and Janumet losing U.S. exclusivity in January 2023, EU exclusivity in September 2022 and China exclusivity in July 2022 – would trigger a swift sales drop, underscoring its exposure to patent‑related risk across the same major markets.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It states that statutory data-package protection is 'typically five years in the United States,' which directly contradicts the ground truth that specifies 12 years for biologics in the U.S. This is a major error, as biologics data exclusivity is a critical component of pharmaceutical market exclusivity. The durations for Europe (10 years) and Japan (8 years) are correctly stated, aligning with the ground truth. However, the LLM incorrectly generalizes data exclusivity without distinguishing between small molecules and biologics, and fails to mention key regulatory mechanisms like orphan drug exclusivity (7 years) or pediatric exclusivity (+6 months), which are highlighted in the original answer as part of LLY's strategy.\n\n(2) The Merck example citing Januvia and Janumet losing exclusivity in specific months and years (e.g., U.S. in January 2023, EU in September 2022) introduces very specific dates not present in the ground truth. While these may be factually accurate in reality, they are not supported by the provided ground truth, which only states that MRK faces risks from patent expiration and engages in litigation, without referencing specific drugs or exact expiration dates. This introduces unverified specifics, reducing quantitative accuracy.\n\n(3) The reasoning partially captures the multi-hop comparison: both LLY and MRK face revenue declines upon loss of exclusivity, and both rely on patents and regulatory protections. However, the LLM fails to fully synthesize the nuanced distinction in strategies—LLY leveraging regulatory mechanisms to extend exclusivity versus MRK emphasizing patent litigation. This key differentiator is present in the ground truth but missing in the LLM answer, weakening qualitative accuracy.\n\n(4) Contextual relevance is high because the answer addresses the core issue—patent and regulatory exclusivity risks in major markets—and compares LLY and MRK appropriately. However, due to significant factual errors in U.S. data exclusivity duration and unsupported specifics about MRK’s drug timelines, the correctness score is limited to 5. The answer is partially correct but contains critical inaccuracies that affect decision-useful understanding of the companies’ risk profiles.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 621,
        "total_tokens": 2125
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How do the potential financial impacts of cyber intrusion-related compliance costs at Southern Company's nuclear facilities compare to Duke Energy's decommissioning trust fund funding risks given both companies' exposure to nuclear power plant operations?",
      "original_answer": "Southern Company highlights that cyber intrusions could result in increased nuclear licensing or compliance costs that are difficult to predict, particularly at its nuclear facilities where Alabama Power and Georgia Power hold ownership interests representing 26% and 28% of their total KWH generation in 2021, respectively. These compliance costs could rise unpredictably due to threats of cyber intrusions or physical attacks. Meanwhile, Duke Energy notes that a decline in the market value of assets in its Nuclear Decommissioning Trust Funds (NDTF) could increase funding requirements for decommissioning its nuclear plants. Both companies face distinct financial risks tied to nuclear power plant operations—Southern Company through potential cyber-related compliance costs and Duke Energy through market-dependent decommissioning funding obligations.",
      "llm_answer": "Southern Company warns that “actual or potential threats of cyber intrusions … could result in increased nuclear licensing or compliance costs that are difficult to predict” (SO 10‑K p. 29), and that the cost of implementing and maintaining enhanced cyber‑security measures could “materially increase” (SO 10‑K p. 30). By contrast, Duke Energy’s risk is that the market value of its nuclear decommissioning trust assets may fall short of projected returns, forcing the company to make “significant additional funding” to meet decommissioning obligations (DUK 10‑K p. 35). Thus, Southern’s exposure is an uncertain, potentially large compliance cost driven by cyber‑security threats, while Duke’s exposure is a more quantifiable funding shortfall tied to trust‑asset performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Southern Company's exposure to cyber intrusion-related compliance costs is accurately described, including the citation from its 10-K about unpredictable licensing costs and materially increased cybersecurity spending. Duke Energy's risk related to underperformance of its Nuclear Decommissioning Trust Funds (NDTF) and potential need for significant additional funding is also correctly presented with proper context from its 10-K. (2) Quantitative accuracy is perfect—no numerical data was misrepresented, and while the original answer included percentages of KWH generation (26% for Alabama Power, 28% for Georgia Power), the LLM answer omits these but does not misstate any numbers. The omission is minor and does not affect the core comparison. (3) Multi-hop reasoning is sound: the model correctly synthesizes risks from two different companies, identifies distinct financial exposures (cyber compliance vs. decommissioning funding), and contrasts their nature (uncertain vs. more quantifiable). (4) Semantic equivalence is strong—the LLM captures the essence and key distinctions in risk profiles as presented in the ground truth. The only minor shortcoming is the omission of the specific KWH generation percentages tied to Southern Company’s nuclear operations, which adds contextual depth but does not alter the fundamental correctness. Hence, a score of 9 is justified for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 437,
        "total_tokens": 1872
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of dividend equivalents on deferred stock units granted to non-employee directors in 2023 by Lowe's compare with Home Depot's policy on dividend equivalents related to deferred shares, particularly in terms of vesting schedules and payout structure?",
      "original_answer": "Lowe's provides dividend equivalents on deferred stock units granted to non-employee directors, which vest either on the first anniversary of the grant date or the day before the next Annual Meeting of Shareholders, with immediate vesting for awards granted prior to 2022. In contrast, Home Depot pays dividend equivalents on deferred shares granted to non-employee directors that accrue and are paid out in additional shares upon termination of service, with the fair value expensed immediately upon grant. This shows differences in both vesting timing and payout mechanisms between the two companies’ deferred compensation structures.",
      "llm_answer": "Lowe’s 2023 deferred‑stock‑unit awards to non‑employee directors “vest on the earlier of the first anniversary of the grant date and the day immediately preceding the next Annual Meeting of Shareholders, subject to acceleration” and the units “earn dividend equivalents” that are paid out as additional shares when the units vest 【page_64】. Home Depot’s deferred‑share awards, however, “entitle the non‑employee director to one share of common stock to be received following termination of Board service” and the “dividend equivalents … are paid out in the form of additional shares of stock upon payout of the underlying shares following termination of service” 【page_68】.  Thus, Lowe’s DSUs have a defined, time‑based vesting schedule with dividend equivalents paid at vesting, whereas Home Depot’s deferred shares vest only upon termination of service and dividend equivalents are paid when the underlying shares are delivered after that termination.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Lowe's DSUs vest on the earlier of the first anniversary or the day before the next Annual Meeting, with dividend equivalents paid in additional shares upon vesting. Home Depot’s dividend equivalents accrue and are paid in additional shares upon termination of service, not at a fixed time. These details match the original answer. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—only structural and timing descriptions, which are correctly reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes policies from two different companies (Lowe's and Home Depot), compares their vesting schedules (time-based vs. termination-based), and contrasts payout structures (at vesting vs. after termination). The only minor omission is that the original answer notes Lowe's awards granted prior to 2022 have immediate vesting, which the LLM answer does not mention—this slightly reduces completeness but does not invalidate the core correctness. (4) Despite this omission, the LLM captures the essential contrast in vesting timing and payout mechanisms, maintaining semantic equivalence on the main comparison. Wording differs but meaning is preserved. Contextual relevance is perfect as it directly addresses both parts of the question: vesting schedules and payout structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 407,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the potential loss of 12-year biologic data exclusivity in the U.S. impact AMGN's competitive position compared to MRK's strategy of leveraging compound patents and pediatric exclusivity extensions?",
      "original_answer": "The potential removal of the 12-year biologic data exclusivity in the U.S., as highlighted in AMGN's 10-K, could expose AMGN to earlier biosimilar competition, particularly for products like EPOGEN, which is sold almost exclusively to a concentrated customer base. In contrast, MRK's strategy, as outlined in its 10-K, relies on a layered approach to market exclusivity, including compound patents, pediatric exclusivity extensions (which can add six months), and regulatory data protection. This layered approach allows MRK to maintain commercial control even after initial patent expiration, giving it a more diversified defense against generic erosion compared to AMGN's reliance on regulatory exclusivity.",
      "llm_answer": "Amgen’s biologics depend heavily on the 12‑year data‑exclusivity granted under the BPCIA; if that period is shortened or “umbrella” exclusivity is denied, biosimilar competitors could enter the market earlier, eroding Amgen’s market share and cash flow (see AMGN p.46). Merck, by contrast, layers protection through compound patents (with up to five‑year term restoration) and six‑month pediatric‑exclusivity extensions, giving it additional, patent‑based barriers that can offset any loss of regulatory data exclusivity (see MRK p.8 and p.17). Thus, a loss of the 12‑year exclusivity would weaken Amgen’s competitive position more sharply than Merck’s, whose multi‑pronged patent and pediatric‑extension strategy provides broader, more resilient protection.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the 12-year biologic data exclusivity for AMGN, the risk of earlier biosimilar entry if exclusivity is lost, and MRK's use of compound patents and pediatric exclusivity (6-month extension) are all accurately represented. The mention of 'up to five-year term restoration' for patents slightly expands beyond the original answer, which does not specify patent term restoration length, but this is a plausible detail from 10-K filings and does not contradict the ground truth. (2) Quantitative elements—'12-year', 'six-month'—are correct and match the original. No calculations are required, but comparisons are sound. (3) Multi-hop reasoning is strong: the model correctly synthesizes AMGN's regulatory exclusivity reliance vs. MRK's layered patent and regulatory strategy, concluding that AMGN would be more negatively impacted by exclusivity loss. (4) The answer is contextually precise, directly addressing the comparative competitive impact. The only minor gap is that the original answer references EPOGEN and customer concentration as a vulnerability for AMGN, which the LLM omits—this is a small but relevant detail affecting completeness. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only minor omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 382,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does the treatment of the countercyclical capital buffer under TLAC requirements for GS compare with SCHW's application of the same buffer, particularly in light of GS's 18% minimum TLAC to RWAs threshold and SCHW's 2.5% stress capital buffer?",
      "original_answer": "Goldman Sachs (GS) includes the countercyclical capital buffer as part of its TLAC to RWAs requirement, which the Federal Reserve has set to zero percent, within the broader 18% minimum TLAC threshold (as stated in GS's 10-K filing). In contrast, Schwab (SCHW) is also subject to a countercyclical capital buffer above the minimum risk-based capital ratios, which was zero percent as of December 31, 2024 (as disclosed in SCHW's 10-K). However, SCHW specifically maintains a 2.5% stress capital buffer, indicating a differentiated approach to regulatory capital planning despite both institutions operating under a zero percent countercyclical buffer.",
      "llm_answer": "Goldman Sachs’ TLAC calculation treats the counter‑cyclical buffer as **zero** – the TLAC‑to‑RWAs ratio is built from the 18 % statutory minimum, a 2.5 % buffer and the 1.5 % G‑SIB surcharge, but the FRB has set the counter‑cyclical component to 0 % (see GS 10‑K p. 93). Charles Schwab likewise has a **zero** counter‑cyclical buffer, but it must also hold a separate **2.5 % stress‑capital buffer** on its holding‑company capital (see Schwab 10‑K p. 118). Thus, both firms have a zero counter‑cyclical buffer, but Goldman’s TLAC is anchored by an 18 % minimum plus the 2.5 % buffer, whereas Schwab’s 2.5 % buffer is a distinct stress‑capital requirement applied above its regulatory minimum.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: both Goldman Sachs (GS) and Schwab (SCHW) have a 0% countercyclical capital buffer, GS has an 18% minimum TLAC to RWAs threshold, and SCHW maintains a 2.5% stress capital buffer. The LLM correctly identifies that the Federal Reserve has set the countercyclical buffer to zero for GS and that SCHW also operates under a zero percent countercyclical buffer as of the relevant period. (2) Quantitatively, all percentages—18%, 2.5%, 1.5% G-SIB surcharge, and 0% countercyclical buffer—are accurately reported. While the original answer does not mention the 1.5% G-SIB surcharge, the LLM includes it as part of GS’s TLAC composition, which is factually correct and adds context without contradicting the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory treatment across two firms, distinguishes TLAC (GS) from stress capital buffer (SCHW), and highlights that both have zero countercyclical buffers but different buffer frameworks. (4) The only minor gap is that the original answer emphasizes that GS includes the countercyclical buffer within its broader 18% TLAC requirement, while the LLM frames the 18% as a statutory minimum that is supplemented by additional buffers—this is a subtle difference in framing but does not constitute a factual error. Overall, the LLM conveys semantically equivalent and factually correct information with excellent contextual relevance and precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 420,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 23,
      "question": "How does XOM's asset exposure in Kazakhstan compare with CVX's stake in TCO's operations in the region?",
      "original_answer": "XOM reported $7,728 million in long-lived assets in Kazakhstan in 2023, reflecting its operational exposure in the region. Meanwhile, CVX holds a significant stake in TCO, which operates major oil fields like Tengiz and Korolev under a concession agreement expiring in 2033. TCO achieved mechanical completion of the Future Growth Project (FGP) in 2023, with start-up expected in the first half of 2025, and is also advancing the Karachaganak Expansion Project, with Stage 1A expected to complete in 2024. CVX’s involvement through TCO demonstrates its strategic positioning in Kazakhstan’s upstream sector, despite not directly owning long-lived assets like XOM.",
      "llm_answer": "Exxon Mobil’s direct asset exposure in Kazakhstan is modest – the company reports roughly $7.7 billion of long‑lived assets there (2023 figure)【page_115】.  By contrast, Chevron’s involvement is a ownership‑based stake: it holds a 50 percent interest in the Tengizchevroil (TCO) joint‑venture that operates the country’s major oil fields【page_16】.  So XOM’s exposure is measured in a few‑billion‑dollar asset base, whereas CVX’s exposure is a half‑ownership of TCO’s operations.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies XOM's $7,728 million (rounded to $7.7 billion) in long-lived assets in Kazakhstan as of 2023, which matches the ground truth. It also accurately states CVX's 50% stake in Tengizchevroil (TCO), which operates major oil fields in Kazakhstan. These core quantitative and entity facts are correct.\n\n2) Quantitative accuracy is high: $7.7 billion is an acceptable rounding of $7,728 million. The 50% ownership stake in TCO is factually accurate. However, the LLM omits key project updates mentioned in the original answer—specifically, the mechanical completion of TCO’s Future Growth Project (FGP) in 2023, its expected start-up in H1 2025, and the Karachaganak Expansion Project (Stage 1A completion in 2024). These omissions reduce completeness but do not invalidate the core comparison.\n\n3) The reasoning is sound in contrasting XOM’s direct asset ownership with CVX’s indirect exposure via a joint venture. The multi-hop synthesis—linking CVX to TCO and explaining the nature of its operational involvement—is logically presented and entity-accurate. However, the lack of forward-looking project milestones weakens the full qualitative picture of CVX’s strategic positioning.\n\n4) Contextual relevance is excellent: the answer directly addresses the comparison between XOM’s asset exposure and CVX’s stake in TCO. Wording differs but meaning aligns semantically on the main point: XOM has direct assets, CVX has indirect operational exposure via ownership. The omission of project timelines and developments prevents a perfect score, but the core factual and conceptual content is accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 448,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does Southern Company's uncertainty around the financial impact of transitioning from LIBOR to alternative rates under ASU 2020-04 compare with NextEra Energy's disclosure that it is applying the same standard to its interest rate contracts, given that both companies rely on reference rate reform guidance to manage derivative exposures?",
      "original_answer": "Southern Company explicitly states that the 'ultimate outcome of the transition [from LIBOR] cannot be determined at this time,' indicating uncertainty in assessing the financial impact of ASU 2020-04. In contrast, NextEra Energy affirms that it is applying the guidance under ASU 2020-04 to manage its interest rate contracts affected by reference rate reform. Both companies are subject to the same regulatory framework and are actively navigating the transition from LIBOR to alternative rates, but NEE demonstrates a more definitive implementation stance compared to SO's ongoing evaluation.",
      "llm_answer": "Southern Company notes that, while it has elected to apply ASU 2020‑04 to its LIBOR‑linked debt and hedging arrangements, “the ultimate outcome of the transition cannot be determined at this time” (see SO 10‑K p. 195), reflecting considerable uncertainty about any financial effect. NextEra Energy, by contrast, says it is applying the same ASU 2020‑04 guidance to its interest‑rate contracts and, although it will keep evaluating the changes through 2022, “to date there has not been a material impact” (see NEE 10‑K p. 79), indicating a more certain, non‑material impact outlook. Both firms are relying on the reference‑rate‑reform guidance to manage their derivative exposures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly captures Southern Company's (SO) uncertainty, quoting the exact phrase 'the ultimate outcome of the transition cannot be determined at this time' and citing the correct page (p. 195) from its 10-K, which matches the original answer’s emphasis on uncertainty. It also accurately represents NextEra Energy's (NEE) position: applying ASU 2020-04 and stating no material impact to date, with a citation to p. 79 of its 10-K. (2) There are no numerical values, dates, or financial figures in dispute—both disclosures are qualitative, and the LLM correctly reports the absence of material impact for NEE and ongoing uncertainty for SO. Format and citations are precise. (3) The multi-hop reasoning is sound: the model correctly synthesizes disclosures from two companies, compares their stances on the same accounting standard (ASU 2020-04), and contextualizes their use of reference rate reform guidance for derivative exposures. The conclusion that NEE has a more certain, non-material impact outlook compared to SO’s uncertainty is logically derived and consistent with the ground truth. (4) The only minor difference from the original answer is that the LLM adds a detail not in the ground truth—'will keep evaluating the changes through 2022'—which may be accurate but isn't present in the provided truth. This doesn't introduce error but adds slight extraneous detail. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 429,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the dual-class stock structure and voting rights limitations in META's Class A Common Stock compare to GOOGL's governance framework under their respective Certificates of Incorporation, particularly in terms of protecting minority shareholder interests?",
      "original_answer": "GOOGL's Certificate of Incorporation ensures equal dividend and liquidation rights across all stock classes and mandates unanimous board approval before amendments affecting stockholder rights can be proposed, with affected classes requiring to approve such changes. This provides a structural safeguard for minority shareholders. In contrast, META's Class A Common Stock is subject to a controlled company structure where the board is not required to be majority independent, and key governance decisions require approval from Class B stockholders, who hold superior voting rights. META's Certificate of Incorporation also includes anti-takeover provisions that require a two-thirds majority vote for certain amendments once Class B voting power drops below 35%, further entrenching control and potentially limiting minority shareholder influence.",
      "llm_answer": "META’s charter creates a heavily‑weighted dual‑class system in which the founder’s Class B shares carry ten votes per share and the certificate contains anti‑takeover provisions that bar minority owners from calling special meetings, voting by written consent, or influencing board composition – effectively limiting the ability of Class A shareholders to affect corporate actions (META_10k_2023 p. 50). Alphabet’s (Google) charter also uses a dual‑class structure (Class A = 1 vote, Class B = 10 votes, Class C = no vote) but requires any amendment that would adversely affect a class’s rights to be approved by that class and by the board unanimously, giving minority shareholders a procedural safeguard that is stronger than META’s (GOOGL_10k_2023 p. 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between META's and GOOGL's governance frameworks with respect to dual-class structures and minority shareholder protections. (1) All factual elements are correct: META’s Class B shares have 10 votes per share, Class A shareholders are restricted from calling special meetings or voting by written consent, and GOOGL has a dual-class structure with Class A (1 vote), Class B (10 votes), and Class C (no vote) — all consistent with known filings. (2) Quantitative accuracy is perfect: no incorrect numbers, percentages, or misstatements of voting rights. The 10-to-1 voting ratio for both companies is correctly stated. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance provisions across two companies, comparing procedural safeguards (e.g., class-level approval for adverse amendments at GOOGL) against structural limitations at META. It correctly identifies that GOOGL requires both unanimous board approval and affected class approval for amendments harming shareholder rights — a key protective feature absent in META’s charter. (4) The only minor omission is that the LLM does not mention META’s two-thirds supermajority requirement for certain charter amendments when Class B voting power falls below 35%, which is a critical anti-takeover entrenchment mechanism highlighted in the ground truth. While the LLM notes anti-takeover provisions generally, this specific threshold and voting rule is missing, slightly reducing completeness. However, the core contrast — that GOOGL provides stronger procedural safeguards for minorities via class voting rights while META entrenches founder control — is clearly and correctly conveyed. Wording differs from the original answer but maintains semantic equivalence on all major points. Contextual relevance is excellent, directly addressing the comparative governance question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 516,
        "total_tokens": 1947
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How might the implementation of the OECD's global minimum tax framework impact the effective tax rates of both PepsiCo and Altria, given their differing U.S. tax burdens and exposure to international tax changes?",
      "original_answer": "The implementation of the OECD's global minimum tax framework could increase PepsiCo's effective tax rate due to its international operations and exposure to countries implementing the 15% minimum tax, as noted in PepsiCo's 10-K. Altria, which reported $2,346 million in federal tax payments in the U.S. and minimal foreign tax liabilities, may not face the same upward pressure on its effective tax rate, as its tax burden is more concentrated domestically. The U.S. tax legislation context suggests that multinational corporations with significant overseas earnings, like PepsiCo, are more likely to see tax increases under the new framework, while companies like Altria with limited international exposure may remain relatively unaffected.",
      "llm_answer": "The OECD Pillar‑Two rules, which set a 15 % floor on multinational profits, could lift PepsiCo’s overall tax burden because the company warns that “as the legislation becomes effective in countries in which we do business, our taxes could increase and negatively impact our provision for income taxes” (PEP 10‑K p. 25) and it has a large share of earnings generated outside the United States. Altria already carries a sizable U.S. tax load—including regular federal tax, state tax and a corporate AMT (MO 10‑K p. 77)—and reported a 2023 effective tax rate of roughly 27 % ($3.0 bn provision on $10.9 bn earnings) (MO 10‑K p. 78), so the 15 % global minimum tax on its relatively modest foreign earnings would likely raise its effective rate only modestly.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that PepsiCo is exposed to the OECD's global minimum tax due to its international operations, citing a direct quote from its 10-K (p. 25), which matches the original answer’s reasoning. (2) For Altria, the LLM accurately notes its high U.S. tax burden and minimal foreign exposure, correctly calculating its 2023 effective tax rate as ~27% based on $3.0 billion tax provision on $10.9 billion earnings (MO 10-K p. 78). While the original answer cites $2,346 million in federal taxes, the LLM’s $3.0 billion likely includes state and AMT, which is consistent with Altria’s total tax burden and supported by its 10-K—this is a reasonable aggregation and not an error. (3) The multi-hop reasoning is sound: the model synthesizes information across both companies’ 10-Ks, compares their international exposure, and correctly infers differential impacts of the 15% minimum tax. (4) Minor difference: the original answer emphasizes Altria’s 'minimal foreign tax liabilities' more explicitly, while the LLM implies it through 'modest foreign earnings'—semantically equivalent. No factual inaccuracies; only slight lack of explicit mention of Altria’s minimal foreign liabilities reduces completeness by a point. All entities, metrics, and sources are correct. Wording differs but meaning is preserved. Quantitative accuracy is high—calculations are correct, formats acceptable. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 412,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 24,
      "question": "How does the extension of market exclusivity through orphan drug designation in the U.S. impact AbbVie's risk of generic competition, given Eli Lilly's reliance on the same regulatory mechanism to protect its products beyond compound patent expiration?",
      "original_answer": "In the U.S., orphan drug designation grants seven years of market exclusivity, which runs in parallel with any applicable patents and can extend beyond the expiration of compound patents, as noted in Eli Lilly's 2023 10-K. This exclusivity period prevents the FDA from approving another application for the same drug product for the same orphan use, as described in the regulatory overview. For AbbVie, the loss or weakening of such exclusivity—whether through patent challenges, regulatory changes, or compulsory licensing—could accelerate generic competition and significantly reduce revenues, as stated in AbbVie's 2023 10-K. Therefore, the strength and duration of orphan drug exclusivity directly influence AbbVie’s exposure to market erosion, especially in the context of competitors like Eli Lilly leveraging the same protections to maintain market control beyond traditional patent life.",
      "llm_answer": "U.S. orphan‑drug designation adds a seven‑year market‑exclusivity period that runs in parallel with any patents, effectively extending a product’s protected life beyond the expiration of its compound patent (AbbVie 10‑K, p. 10). Consequently, if AbbVie secures orphan status for a product, its exposure to generic competition is reduced—mirroring Eli Lilly’s strategy of relying on orphan exclusivity (e.g., Onureg’s 2027 exclusivity based on seven years of orphan status) to protect its products beyond patent expiry (Eli Lilly 10‑K, footnote, p. 9).",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the seven-year orphan drug exclusivity period in the U.S. and its parallel run with patents, which aligns with the ground truth. It also accurately notes that this can extend protection beyond compound patent expiration, and links this mechanism to reduced generic competition for AbbVie, mirroring Eli Lilly's strategy. However, the LLM introduces a specific example—'Onureg’s 2027 exclusivity'—which is not present in the original answer or supported by the provided context. This adds unsupported detail and risks factual inaccuracy, as Onureg (azacitidine) is actually a Celgene/BMS product, not an Eli Lilly drug, undermining entity accuracy. (2) Quantitatively, the 'seven-year' exclusivity period is correct and consistently reported. The mention of '2027' as an exclusivity end date lacks sourcing and cannot be verified against the ground truth, which does not include any specific drug examples or dates. This is a minor quantitative overreach but not a calculation error. (3) The multi-hop reasoning is partially sound: the model connects orphan exclusivity to reduced generic risk for AbbVie and draws a valid comparison to Eli Lilly’s use of the same mechanism. However, the reasoning is weakened by the incorrect attribution of Onureg to Eli Lilly, which reflects a failure in entity synthesis. The original answer avoids specific drug examples, focusing instead on structural regulatory dynamics, making the LLM’s addition speculative. (4) The contextual relevance is high, as the response directly addresses the impact of orphan exclusivity on generic competition and AbbVie’s risk exposure. The core logic and regulatory framework are accurately conveyed, but the inclusion of an incorrect product example reduces overall correctness. Hence, a score of 7 is justified—core facts and reasoning are correct, but with notable factual overreach in entity attribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 521,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How did Coca-Cola FEMSA's operational footprint in Argentina in 2021 influence KO's equity investee sales exposure compared to PEP's direct exposure to Argentina's economic volatility during the same period?",
      "original_answer": "KO reported net sales to equity method investees, including Coca-Cola FEMSA, of $14,471 million in 2021, which were influenced by recovery from the pandemic. Coca-Cola FEMSA operated in Argentina's federal capital and surrounding areas in 2021, contributing to KO's indirect exposure in that market. Meanwhile, PEP directly operated in Argentina and faced economic volatility, including currency controls and inflationary pressures, which posed risks to their financial results. Therefore, while KO's exposure to Argentina was indirect through Coca-Cola FEMSA's operations and tied to equity investee sales, PEP faced direct exposure to Argentina's macroeconomic instability in 2021.",
      "llm_answer": "Coca‑Cola FEMSA’s 2021 bottling footprint included “Argentina (federal capital of Buenos Aires and surrounding areas)” 【page_7】, and The Coca‑Cola Company’s equity‑method investment in FEMSA generated part of its $14.5 billion of net sales to equity‑method investees in 2021 【page_89】—so KO’s exposure to Argentina is indirect, limited to its share of FEMSA’s Argentine sales. PepsiCo, however, explicitly notes that it is “exposed to… volatile economic… conditions… in Argentina” as part of its market‑risk discussion 【page_41】, indicating a direct exposure to the country’s economic volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $14.5 billion figure matches the original $14,471 million (rounded appropriately), and the 2021 timeframe is correctly used. No calculations were required, but the reference to equity-method investee sales is precise. (2) The LLM correctly identifies Coca-Cola FEMSA's operational footprint in Argentina (federal capital and surrounding areas), citing the correct geographic detail. (3) It accurately contrasts KO’s indirect exposure via equity investee sales with PEP’s direct exposure to Argentina’s economic volatility, drawing correct inferences from the risk disclosures. (4) The multi-hop reasoning—linking FEMSA’s operations to KO’s financials and contrasting with PEP’s direct operations and risk factors—is sound and well-supported. The only minor shortcoming is that the LLM does not explicitly mention specific macroeconomic factors like currency controls or inflationary pressures that PEP faced, which were included in the original answer and add contextual depth. However, the reference to PEP’s market-risk disclosure on page 41 adequately supports the conclusion of direct exposure. Wording differs slightly but maintains semantic equivalence. All entities (KO, PEP, Coca-Cola FEMSA), years (2021), and financial concepts (equity-method investees, net sales) are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 383,
        "total_tokens": 1718
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does AbbVie's reliance on patent rights for emraclidine through its acquisition of Cerevel Therapeutics influence its market exclusivity strategy compared to Merck's experience with Januvia's patent expiration and regulatory exclusivity timeline?",
      "original_answer": "AbbVie's acquisition of Cerevel Therapeutics included an exclusive global license under certain Pfizer patent rights, which were critical for developing and commercializing emraclidine. However, despite this licensing arrangement, AbbVie recorded a $4.5 billion intangible asset impairment charge related to emraclidine, suggesting that the expected market exclusivity or commercial viability did not materialize as anticipated. Patent rights are a key determinant of market exclusivity in the pharmaceutical industry, often supplemented by regulatory exclusivity periods that can extend beyond patent terms. In contrast, Merck was able to extend its market exclusivity for Januvia and Janumet in the U.S. until May 2026 and for Janumet XR until July 2026 due to favorable court rulings and settlement agreements around a later-expiring patent on the sitagliptin salt form, despite the core compound patent expiring in January 2023. This demonstrates that while AbbVie's strategy relied heavily on patent licensing to secure exclusivity, it faced significant financial consequences when that exclusivity or market uptake failed to deliver expected returns, unlike Merck, which successfully leveraged later-stage intellectual property strategies to delay generic competition.",
      "llm_answer": "AbbVie’s purchase of Cerevel gave it an exclusive global license to Pfizer‑patented compounds—including emraclidine—so AbbVie can lean on those patent rights to create a new period of market exclusivity for the candidate (the acquisition notes the exclusive license and a $4.5 bn impairment tied to emraclidine)【page_68】【page_69】. By contrast, Merck’s Januvia already lost its key U.S. patent in January 2023 and must rely on later‑expiring patents and regulatory exclusivity extensions (pushing U.S. exclusivity to May/July 2026 and subject to IRA pricing rules) to postpone generic competition, yet it still expects a steep sales decline once that exclusivity ends【page_58】.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies key facts: AbbVie's acquisition of Cerevel included an exclusive global license to Pfizer's patents covering emraclidine, and AbbVie recorded a $4.5 billion impairment charge related to emraclidine. It also accurately states that Merck's core Januvia patent expired in January 2023 and that U.S. market exclusivity for Januvia/Janumet was extended to May 2026 and Janumet XR to July 2026 due to later-expiring patents. These dates and dollar amounts match the ground truth exactly, supporting a high quantitative accuracy score. (2) Quantitative accuracy is strong: $4.5 billion impairment, January 2023 patent expiration, and May/July 2026 exclusivity end dates are all correct. The mention of IRA pricing rules adds context not in the original but does not contradict it. (3) The multi-hop reasoning is mostly sound—linking AbbVie’s strategy (patent licensing via acquisition) with Merck’s (extending exclusivity via salt-form patents and litigation outcomes). However, the LLM omits a key point from the original answer: that AbbVie’s impairment suggests its exclusivity or commercial expectations failed to materialize, which contrasts directly with Merck’s successful extension strategy. This missing nuance slightly weakens the qualitative accuracy. Also, the LLM implies AbbVie can 'create a new period of market exclusivity'—but the original suggests this strategy failed, given the impairment. This misrepresents the outcome. (4) Contextual relevance is perfect: the answer directly addresses the comparison of market exclusivity strategies based on patent reliance and regulatory timelines. Despite minor gaps in conveying the failure of AbbVie’s strategy, the core facts and synthesis are accurate, warranting a correctness score of 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1513,
        "completion_tokens": 488,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 25,
      "question": "How does Chevron's investment in the Caspian Pipeline Consortium (CPC) influence its crude oil export capacity, and how does this compare to ConocoPhillips' reliance on crude oil production for its upstream operations?",
      "original_answer": "Chevron's 15% interest in the Caspian Pipeline Consortium (CPC) enables it to export approximately 1.2 million barrels of crude oil per day from Kazakhstan, which is critical for transporting output from the Tengiz and Karachaganak fields. The CPC pipeline's debottlenecking project, completed in January 2023, increased throughput capacity, directly supporting Chevron's Future Growth Project (FGP) expected to ramp up in early 2025. In contrast, ConocoPhillips' upstream operations are fundamentally dependent on crude oil production, as evidenced by its 2023 filings, where crude oil remains a core component of its asset base and revenue generation. Therefore, Chevron's exposure to crude oil export capacity is mediated through its stake in CPC, while ConocoPhillips has a more direct operational dependency on crude oil production.",
      "llm_answer": "Chevron’s 15 % ownership of the Caspian Pipeline Consortium (CPC) gives it access to a pipeline that moved about 1.4 million barrels of crude oil per day in 2023 (1.2 million bbl/d from Kazakhstan and 0.2 million bbl/d from Russia) and whose recent debottlenecking project has increased its throughput capacity (CVX 10‑K, p. 16). In contrast, ConocoPhillips’ upstream business is heavily dependent on crude‑oil production, which generated the bulk of its $27.2 billion of consolidated sales in 2023 (e.g., $4.8 billion in Alaska, $14.1 billion in the Lower 48, $1.5 billion in Canada) (COP 10‑K, p. 150).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies Chevron's 15% stake in the CPC and ConocoPhillips' reliance on crude oil production, addressing the core comparison. However, there is a quantitative discrepancy: the ground truth states Chevron's access enables export of approximately 1.2 million barrels per day from Kazakhstan, while the LLM claims 1.4 million total (1.2M from Kazakhstan and 0.2M from Russia), which is not supported by the original answer and introduces unsourced geographic breakdowns. The debottlenecking completion in January 2023 and its relevance to Chevron’s Future Growth Project (FGP) in 2025 is omitted, weakening the multi-hop reasoning. 2) The ConocoPhillips revenue figures ($27.2B total, with $4.8B Alaska, $14.1B Lower 48, $1.5B Canada) are accurate per its 10-K, but the original answer does not include these specifics, so their inclusion is extra detail rather than error. However, the LLM implies these revenues are solely from crude oil, while the original emphasizes crude oil as a 'core component' without specifying exact revenue attribution—this overprecision risks misrepresentation. 3) The reasoning correctly contrasts Chevron’s indirect export capacity via infrastructure investment with ConocoPhillips’ direct production dependency, showing sound qualitative synthesis. However, it fails to link the CPC’s capacity increase to Chevron’s FGP ramp-up in 2025—a key causal connection in the original. 4) Contextually, the answer is highly relevant and well-structured, but the numerical inaccuracies and missing forward-looking project linkage reduce factual correctness. The use of 1.4 million bbl/d instead of the correct 1.2 million bbl/d from Kazakhstan undermines quantitative accuracy despite plausible sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 474,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Oracle's integration of generative AI in MySQL HeatWave compare with Qualcomm's strategic vision for on-device generative AI in edge computing, given both companies' investments in cloud computing infrastructure?",
      "original_answer": "Oracle integrates generative AI into its MySQL HeatWave cloud service, combining transactions, real-time analytics, machine learning, and generative AI in one managed service to enhance data processing and decision-making capabilities. Meanwhile, Qualcomm envisions generative AI becoming ubiquitous across industries, with a focus on running complex models on edge devices such as smartphones and PCs to improve immediacy, privacy, and personalization. Qualcomm expects that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024, and sees cloud computing as a complementary enabler of these edge AI capabilities. Both companies are investing in cloud computing—Oracle through its Oracle Cloud Infrastructure (OCI) and Autonomous Database offerings, while Qualcomm supports cloud-edge coordination through its cloud computing processing initiative within its QSI segment.",
      "llm_answer": "Oracle is adding generative‑AI directly into its MySQL HeatWave offering, positioning it as a **managed cloud database service** that blends transactions, real‑time analytics, machine‑learning and generative AI on Oracle Cloud Infrastructure (see Oracle 10‑K page 12). Qualcomm, by contrast, is **building a vision for on‑device generative AI** that runs on its Snapdragon processors in smartphones, PCs, IoT and automotive edge products, emphasizing low‑latency, privacy‑centric AI at the edge while using its cloud‑computing initiatives to train and distribute models (see Qualcomm 10‑K pages 7 and 6). Thus, Oracle’s AI is delivered as a cloud‑native service, whereas Qualcomm’s AI is meant to reside on the edge device itself, even though both companies are investing heavily in cloud infrastructure to support the broader AI ecosystem.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service on Oracle Cloud Infrastructure (OCI), combining transactions, analytics, ML, and AI—consistent with Oracle's 10-K. Qualcomm focuses on on-device generative AI via Snapdragon processors for edge devices (smartphones, PCs, etc.), emphasizing low latency and privacy, with cloud support for model training and distribution—aligned with Qualcomm’s 10-K. (2) Quantitative accuracy is perfect: although the LLM answer does not explicitly mention the 19% (2024) and 46% (2027) smartphone adoption figures, this omission does not detract significantly from the core comparison, and no incorrect numbers are presented. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Oracle and Qualcomm, contrasting cloud-native AI delivery (Oracle) vs. edge-centric AI (Qualcomm), while acknowledging both companies' cloud investments—Oracle in OCI and Autonomous Database, Qualcomm via cloud-edge coordination in its QSI segment. (4) Semantic equivalence is strong: the LLM captures the strategic distinction between Oracle’s integrated cloud database AI and Qualcomm’s edge-first AI vision, and correctly frames cloud infrastructure as complementary in both cases. The only minor shortcoming is the absence of the specific forecasted percentages for generative AI-capable smartphones, which were present in the original answer and would have strengthened quantitative completeness. However, the conceptual and qualitative alignment remains excellent, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 457,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Walmart's use of firm commitments for inventory and utility purchases compare to Colgate-Palmolive's use of option contracts in managing financial exposure, given the role of such instruments in mitigating cash flow risks?",
      "original_answer": "Walmart has $15.9 billion in firm commitments due within one year, primarily for inventory, utilities, and capital expenditures, which represent legally binding contracts that lock in future cash outflows. These obligations are managed through operational cash flows and are not typically hedged with financial derivatives. In contrast, Colgate-Palmolive actively uses option contracts as part of its foreign exchange risk management strategy to hedge forecasted transactions, protecting against currency fluctuations. Both companies aim to reduce cash flow volatility, but Walmart focuses on operational liquidity planning while Colgate employs financial instruments like options to manage exposure. This distinction reflects differing approaches to financial risk mitigation aligned with their respective business models.",
      "llm_answer": "Walmart’s “material cash requirements” note that a large portion of its $37.2 billion of purchase obligations are “legally‑binding contracts, such as firm commitments for inventory and utility purchases” that fix quantities, prices or timing and therefore give the retailer a predictable cash‑outflow schedule for those core operating costs【page_45】. By contrast, Colgate‑Palmolive’s risk‑management discussion says the company “enters into option contracts (and forwards) to protect the value of its existing foreign‑currency assets, liabilities, firm commitments and forecasted foreign‑currency transactions,” using those derivatives to offset currency‑related cash‑flow volatility【page_90】【page_121】. Thus, Walmart relies on non‑derivative firm‑commitment contracts to lock in supply‑costs, while Colgate‑Palmolive uses option‑type derivatives to hedge the cash‑flow risk of its commitments against exchange‑rate movements.",
      "correctness_score": 8,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly captures the core distinction between Walmart's use of firm commitments and Colgate-Palmolive's use of option contracts to manage financial exposure, aligning well with the ground truth in terms of reasoning and intent. It accurately describes Walmart’s use of legally binding contracts for inventory and utilities to secure predictable cash outflows and Colgate’s use of options to hedge foreign exchange risk on forecasted transactions. However, there is a significant quantitative discrepancy: the LLM states Walmart has $37.2 billion in purchase obligations, while the ground truth specifies $15.9 billion in firm commitments due within one year. This overstatement affects factual accuracy, though the qualitative interpretation of firm commitments remains valid. 2) The $37.2 billion figure does not match the ground truth’s $15.9 billion. While both figures relate to purchase obligations, the LLM’s number appears to include longer-term or broader obligations and may conflate total purchase obligations with short-term firm commitments. This is a material error, especially since the time horizon (within one year) is relevant to cash flow risk. 3) The multi-hop reasoning is strong: the model correctly synthesizes information across two companies and contrasting risk management strategies—Walmart’s operational approach using fixed contracts versus Colgate’s financial hedging with derivatives. It draws the correct conclusion about differing methods to reduce cash flow volatility, reflecting sound understanding of the underlying financial concepts. 4) Despite the numerical inaccuracy, the answer is contextually excellent and semantically close to the original, explaining the strategic difference clearly. The use of citations (page references) suggests accurate sourcing from documents. The error is limited to the dollar amount, not the conceptual framework. Thus, correctness is reduced to 8 due to the significant but isolated quantitative error; qualitative and contextual scores remain high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 546,
        "total_tokens": 2005
      },
      "error": null
    },
    {
      "question_id": 26,
      "question": "How does Morgan Stanley's use of credit default swaps (CDS) to hedge default risk relate to Capital One's reliance on default rate assumptions in valuing their net derivative assets, given the sensitivity of both institutions to credit event outcomes?",
      "original_answer": "Morgan Stanley actively uses credit default swaps (CDS) to hedge against the risk of default on debt obligations, entering into contracts where it receives or provides protection against credit events such as bankruptcy or failure to pay. The firm manages exposure through risk mitigation strategies and monitors aggregate market risk limits. Meanwhile, Capital One values its net derivative assets using discounted cash flow models that depend heavily on unobservable inputs, including a weighted average default rate assumption of 4% with a range of 53–163%. The connection between the two lies in the systemic sensitivity both institutions have to default outcomes: Morgan Stanley’s CDS contracts are triggered by defaults, directly affecting its derivative liabilities, while Capital One’s valuation models depend on projected default rates, meaning actual deviations from these assumptions would materially impact the fair value of its derivative assets. Thus, both firms are indirectly exposed to the same macroeconomic or sector-specific credit events that could simultaneously affect their derivative positions.",
      "llm_answer": "Morgan Stanley manages its exposure to credit events by buying and selling credit‑default swaps – contracts that pay out if a reference entity experiences a bankruptcy, failure‑to‑pay or restructuring – and it holds large CDS notional amounts (e.g., $409 bn of protection purchased in 2023) as part of its market‑making and hedging program【page_111】. Capital One does not use CDS for hedging; instead it values its net derivative assets with a discounted‑cash‑flow model that relies on a “default” input (range 53‑163 % with a weighted‑average of 4 %) and explicitly states that higher default rates lower the fair value of those assets【page_208】【page_207】. Thus, both firms are highly sensitive to credit‑event outcomes: Morgan Stanley’s CDS positions generate gains or losses when defaults occur, while Capital One’s derivative fair‑value is directly impacted by the default‑rate assumptions that drive its valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly states that Morgan Stanley uses CDS to hedge credit risk, with specific reference to bankruptcy, failure-to-pay, and restructuring as triggers, and cites a notional amount of $409 billion in protection purchased in 2023 (though this specific figure is not in the original answer, it is plausible and contextually consistent with Morgan Stanley's scale; its inclusion does not contradict the ground truth and may reflect additional data from the source document). (2) For Capital One, the LLM accurately notes the use of discounted cash flow models with a weighted average default rate assumption of 4% and a range of 53–163%, matching the original answer exactly in value and interpretation—though the range is presented as '53-163%' without the percent sign on the lower bound, this is a minor formatting issue and does not affect meaning. (3) The multi-hop reasoning is sound: the LLM correctly identifies that while Morgan Stanley’s exposure is direct (CDS payouts triggered by actual defaults), Capital One’s is indirect (valuation sensitivity to assumed default rates), and both are systemically sensitive to credit events. (4) The LLM adds value by clarifying that higher default rates reduce the fair value of Capital One’s derivative assets, which is implied but not explicitly stated in the original answer—this strengthens the explanation. The only minor discrepancy is the $409B figure not appearing in the ground truth, but since the original answer does not provide quantitative CDS exposure data, the LLM’s inclusion of such a number (with citation) likely reflects a valid extraction from the filing and does not introduce error. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1535,
        "completion_tokens": 491,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How do Duke Energy's natural gas distribution assets in Georgia compare to Southern Company Gas's investment in SNG in terms of capital scale and contribution to regional infrastructure reliability, given their respective exposures to Georgia's energy market?",
      "original_answer": "Duke Energy operates 28,000 miles of natural gas distribution and transmission pipelines in Georgia, directly contributing to local infrastructure reliability by delivering gas to end-users. Southern Company Gas holds a 50% interest in SNG, a 7,000-mile pipeline system that connects supply basins in the Gulf Coast to markets including Georgia, underpinning supply-side reliability. While Duke’s assets are focused on distribution with direct customer delivery, SNG serves as a backbone transmission system feeding regional utilities, including those in Georgia like Duke, creating an integrated infrastructure network. Southern Power’s 97% investment coverage ratio through 2028 indicates strong contracted revenue stability for SNG-related assets, while Duke’s localized pipeline miles reflect a high dependency on regional demand and regulatory frameworks governing distribution rates and returns.",
      "llm_answer": "Duke Energy’s Georgia‑based natural‑gas system includes roughly 28,800 miles of service lines (35,700 miles of combined distribution‑and‑transmission pipelines)【page_39】, far larger in physical scope than Southern Company Gas’s 50 % equity stake in the 7,000‑mile Southern Natural Gas (SNG) interstate pipeline【page_13】. Duke’s extensive local distribution network underpins reliability for end‑users in Georgia, while Southern Company Gas’s SNG investment provides critical transmission capacity that diversifies supply and bolsters regional reliability for Georgia and surrounding markets【page_170】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Duke Energy's extensive pipeline network in Georgia and Southern Company Gas's 50% stake in the 7,000-mile SNG pipeline, aligning with the ground truth on entity roles and infrastructure types. However, there are quantitative discrepancies: the ground truth states Duke operates 28,000 miles of pipelines, while the LLM claims '28,800 miles of service lines' and '35,700 miles of combined distribution-and-transmission pipelines,' which overstates the scale and introduces a category (service lines) not in the original. This inflates Duke's footprint and misrepresents the data. (2) The SNG pipeline length (7,000 miles) and Southern Company Gas's 50% interest are accurately reported. However, the LLM omits key financial context from the ground truth—Southern Power’s 97% investment coverage ratio through 2028—which is critical for assessing capital stability and revenue predictability. (3) The reasoning correctly distinguishes between Duke’s distribution-focused, end-user reliability role and SNG’s transmission-level, supply-diversification function, showing sound multi-hop synthesis of infrastructure roles. It appropriately frames the systems as complementary in regional reliability. (4) Despite missing the investment coverage metric and introducing inaccurate pipeline mileage figures, the LLM captures the core comparative structure: Duke’s local delivery scale vs. SNG’s regional transmission role. Wording differences are acceptable under semantic equivalence, but the numerical inaccuracies and omission of a key financial indicator reduce the correctness score. Contextual relevance is high as all parts of the question are addressed in spirit, though not fully in detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 474,
        "total_tokens": 1878
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How did the enactment of Louisiana's corporate tax rate reduction legislation in 2024 impact Union Pacific's deferred tax expense, and how does this compare to the impact from similar legislation in Arkansas during the same year?",
      "original_answer": "Louisiana's enactment of corporate tax rate reduction legislation in 2024 resulted in a $34 million reduction in Union Pacific's deferred tax expense. This mirrors a similar impact from Arkansas, which also enacted tax rate reductions, contributing to a comparable adjustment. Together, these state-level legislative changes reflect a broader regional shift in corporate tax policy affecting Union Pacific's financial position.",
      "llm_answer": "The 2024 reduction in Louisiana’s corporate income‑tax rate (together with a similar Arkansas change) lowered Union Pacific’s deferred tax expense by **$34 million** (see UNP 10‑K page 29). The filing does not separate the Arkansas effect, so the Arkansas legislation’s impact is included in that same $34 million total – there is no distinct amount disclosed for Arkansas alone.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $34 million reduction in deferred tax expense due to Louisiana's tax rate change is correctly stated, and the answer accurately notes that Arkansas's similar legislation is included in that same $34 million figure. The original answer states Louisiana's change caused a $34 million reduction and that Arkansas had a 'comparable adjustment,' but does not specify whether the $34 million is combined or separate. The LLM correctly infers from the source (UNP 10-K page 29) that the Arkansas impact is not broken out, which adds precision not explicitly in the original answer. (2) The date (2024) and entities (Louisiana, Arkansas, Union Pacific) are correct. (3) The reasoning is sound: the LLM correctly synthesizes that both states enacted changes and that their impacts are reported collectively, which constitutes accurate multi-hop interpretation given the source constraints. (4) The only minor gap is that the original answer suggests Arkansas had a 'comparable adjustment,' implying a similar magnitude, while the LLM clarifies it's not separately disclosed—this is a nuance rather than an error. Overall, the LLM provides a more precise and contextually grounded response, warranting a high correctness score despite slight interpretive difference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1222,
        "completion_tokens": 374,
        "total_tokens": 1597
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does the difference in voting rights between META's Class B Common Stock and GOOGL's Class A Common Stock influence their respective corporate governance structures, particularly in light of the specified voting limitations tied to Class B shares in merger scenarios?",
      "original_answer": "META's Class B Common Stock has no voting rights except in specified merger or consolidation scenarios, where they receive voting power proportional to their conversion rate. This limits shareholder influence outside of exceptional corporate actions. In contrast, GOOGL's Class A Common Stock provides one vote per share, offering more consistent voting influence to shareholders. This structural difference means that at META, decision-making control is more concentrated among holders of shares with superior voting rights (e.g., Class A), while at GOOGL, Class A shareholders have a steadier role in corporate governance. The specified voting limitations in META's charter for Class B shares in merger scenarios create a tailored influence mechanism that only activates under specific corporate events, unlike GOOGL's ongoing voting rights for Class A shares.",
      "llm_answer": "META’s charter gives each Class B share ten votes (vs. one vote for Class A), so holders of Class B stock can dominate board elections and approve major actions—including mergers—without any specific voting cap (Meta 10‑K p. 82). Alphabet’s public Class A shares also have one vote per share, but its insider‑held Class B shares, while ten‑voted, must convert to Class A on sale or transfer (including in merger transactions), which reduces their voting weight in a merger and forces broader shareholder consent (Alphabet 10‑K p. 82).",
      "correctness_score": 2,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that severely undermine its correctness. (1) It incorrectly states that META's Class B shares have 10 votes per share, when in fact, according to the ground truth and actual SEC filings, META's Class B Common Stock has *no voting rights* except in specified merger or consolidation scenarios. This is a critical misrepresentation of the corporate structure. (2) The claim that 'each Class B share' at META has ten votes is false; it is META's Class A shares that are typically held by insiders (like Mark Zuckerberg) with superior voting rights (10 votes per share), while Class B shares are non-voting. The LLM reverses the voting structure. (3) For GOOGL, the LLM correctly notes that Class A shares have one vote per share and Class B shares (held by insiders) have ten votes, but incorrectly implies that Class B shares convert to Class A in merger transactions, thereby reducing insider voting power. While Alphabet's Class B shares do convert upon transfer, the answer mischaracterizes the governance impact in mergers without clear support from the cited page. (4) The original question focuses on the *voting limitations tied to Class B shares in merger scenarios*—the ground truth emphasizes that META's Class B shares gain voting rights only in such cases, whereas the LLM claims the opposite: that Class B shares have dominant voting power generally, which is incorrect. (5) Multi-hop reasoning fails: the model does not correctly synthesize the contrast between META’s event-triggered voting for Class B shares versus GOOGL’s consistent voting rights for Class A. Instead, it fabricates a conversion mechanism in mergers for GOOGL without directly addressing the core structural difference. (6) Quantitative accuracy is poor: the 10-vote claim for META Class B is wrong; no correct numbers are presented for the actual voting rights. (7) Despite being off-factual, the answer attempts to address corporate governance implications and cites 10-K pages, maintaining moderate contextual relevance. However, due to severe factual and structural errors, the overall correctness is very low.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 573,
        "total_tokens": 1953
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How might U.S. payer restrictions on high-cost therapies like Repatha impact Pfizer's revenue recognition strategy for similar cardiovascular products, given both companies face challenges with formulary placement and patient affordability?",
      "original_answer": "U.S. commercial payer actions have significantly restricted access to high-cost therapies like Repatha through formulary exclusions, prior authorization requirements, and increased patient cost-sharing, which has directly limited sales despite price reductions. Pfizer faces similar risks, as it notes challenges in obtaining or maintaining favorable formulary placement and pricing for its products amid managed care and healthcare cost containment trends. Gilead's revenue recognition strategy accounts for these payer dynamics through complex gross-to-net deductions that factor in expected payer mix, rebate levels, and patient affordability trends. Therefore, if Pfizer markets similar high-cost cardiovascular therapies, it would likely face comparable pressures requiring careful estimation of rebates and chargebacks to align with payer realities and maintain revenue integrity.",
      "llm_answer": "U.S. payer restrictions on high‑cost drugs such as Repatha have pushed Pfizer to offer deeper discounts, rebates and step‑therapy/ prior‑authorization requirements, which the company now reflects by recognizing product revenue net of larger, more uncertain gross‑to‑net deductions. As a result, Pfizer’s revenue‑recognition approach for its cardiovascular portfolio is likely to become more conservative—estimating higher rebate/charge‑back allowances and potentially deferring or reducing the amount of revenue recorded until those payer‑related adjustments are settled 【page_41】 【page_48】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. It correctly identifies that U.S. payer restrictions on high-cost therapies like Repatha have led to increased rebates, discounts, and utilization management tactics (e.g., prior authorization), which in turn impact revenue recognition. The answer accurately reflects that Pfizer must account for these dynamics by recognizing revenue net of substantial gross-to-net deductions, including rebates and chargebacks, and notes the increased uncertainty and conservatism in estimating these allowances—consistent with Gilead's strategy mentioned in the original answer. While the LLM does not explicitly name Gilead or directly reference its revenue strategy, it correctly infers the implication for Pfizer’s approach based on shared market challenges, which constitutes sound multi-hop reasoning. All entities (Pfizer, U.S. payers, Repatha) are correct, and there are no numerical inaccuracies—no specific numbers were in the original, so scoring is based on conceptual precision. The answer is semantically equivalent to the ground truth, with only minor omission of Gilead as a comparative example, which slightly reduces qualitative completeness but does not undermine the core correctness. Contextual relevance is strong, directly addressing formulary placement, patient affordability, and revenue recognition strategy as required by the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 391,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 27,
      "question": "How does Chevron's 15% ownership stake in TCO's Kazakhstan crude oil operations influence its exposure to TCO's planned production ramp-up from the FGP project starting in 2025, especially when compared to COP's broader dependence on crude oil as a raw material?",
      "original_answer": "Chevron's 15% ownership in TCO provides it with partial exposure to TCO's planned production ramp-up from the FGP project in Kazakhstan, which is expected to start-up in the first half of 2025 and ramp up to full production within three months. This production increase will flow through the Caspian Pipeline Consortium (CPC), in which Chevron also holds a 15% interest, enabling increased throughput capacity. In contrast, COP has a direct and full dependency on crude oil as a raw material, indicating a more concentrated exposure to crude oil supply dynamics. Chevron’s partial ownership in TCO creates a more indirect exposure to crude oil production volumes and timelines in Kazakhstan, as opposed to COP’s direct reliance on crude oil for its operations.",
      "llm_answer": "Chevron’s exposure to the Tengizchevroil (TCO) Future‑Growth Project is confined to its 15 % working interest in the Caspian Pipeline Consortium that carries the Kazakh crude – so only about one‑fifteenth of the FGP’s incremental output (which is slated to start‑up in the first half of 2025 and reach full rate within three months) will flow to Chevron 【page_16】. By contrast, ConocoPhillips’ results are driven by crude‑oil production across its worldwide portfolio, with oil sales and related production costs representing the bulk of its $27 billion‑plus revenue and $5 billion‑plus production expense line‑items, indicating a far broader dependence on crude oil as a raw material 【page_150】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies that affect factual correctness. It incorrectly states that Chevron's exposure is 'confined to its 15% working interest in the Caspian Pipeline Consortium' — while Chevron does hold a 15% stake in the CPC, its 15% ownership in TCO (Tengizchevroil) is the primary source of exposure to production ramp-up, not the pipeline. The original answer correctly identifies both the 15% TCO ownership and 15% CPC interest as complementary exposures. The LLM conflates the two, implying Chevron’s only exposure is via the pipeline, which is factually incorrect. (2) The phrase 'only about one-fifteenth of the FGP’s incremental output...will flow to Chevron' is a significant error: 15% is approximately one-seventh, not one-fifteenth. This miscalculation undermines quantitative accuracy. The startup timeline (first half of 2025, ramp-up within three months) is correctly stated and matches the ground truth. However, the $27 billion revenue and $5 billion expense figures for COP are not in the original answer and may be factually correct but are not part of the ground truth comparison, introducing extraneous detail without clear sourcing from the context. (3) Multi-hop reasoning is partially sound — the model attempts to compare Chevron’s partial exposure with COP’s broader crude oil dependence — but the flawed understanding of Chevron’s ownership structure (TCO vs. CPC) weakens the synthesis. The contrast between indirect (Chevron) and direct (COP) exposure is conceptually aligned with the original answer, but the reasoning is based on an incorrect premise. (4) Contextual relevance is high — the answer addresses the core question about exposure to TCO’s FGP and compares it to COP’s crude oil dependence. However, due to key factual and quantitative errors in ownership interpretation and calculation, the correctness score is reduced to 6. Quantitative accuracy is scored lower (5) due to the 'one-fifteenth' error and unsupported financial figures. Qualitative accuracy is moderate (6) as the conceptual framework is partially correct but built on faulty premises.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 572,
        "total_tokens": 1965
      },
      "error": null
    },
    {
      "question_id": 28,
      "question": "How does Goldman Sachs' exposure to hotel-related commercial real estate loans compare to MetLife's investment in real estate funds focused on hotels, given the role of real estate funds in both companies' strategies?",
      "original_answer": "Goldman Sachs has significant credit exposure to commercial real estate loans secured by hotels, as detailed in their 2024 10-K filing, which highlights the importance of this asset class in their lending portfolio. These loans are often channeled through or connected to real estate funds, which are also a key vehicle for investment in hotel assets. MetLife, on the other hand, holds $13.3 billion in real estate investments as of December 31, 2024, including interests in real estate funds that invest in hotel properties. While both companies are exposed to hotel real estate, Goldman Sachs' involvement is primarily through lending, whereas MetLife participates through direct ownership stakes in funds. This distinction reflects different risk profiles and strategic approaches to the hotel sector within the broader commercial real estate market.",
      "llm_answer": "Goldman Sachs says it had $29.8 billion of commercial‑real‑estate loans at year‑end 2024, with 5 % (≈ $1.5 billion) classified as hospitality (hotel) loans and it also holds $3.46 billion of real‑estate fund interests. MetLife’s real‑estate holdings include $700 million of hotel properties within its $3.65 billion of real‑estate fund investments. Accordingly, Goldman’s hotel‑related loan exposure is roughly twice the size of MetLife’s direct hotel investment, even though both firms use real‑estate funds as a core part of their overall strategies.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that MetLife holds $13.3 billion in total real estate investments including hotel-focused real estate funds, but does not specify the exact amount invested in hotel properties or hotel-related funds. However, the LLM claims MetLife has $700 million in hotel properties within $3.65 billion of real estate fund investments — figures not present in the original answer and likely fabricated. Similarly, the LLM asserts Goldman Sachs had $29.8 billion in CRE loans with 5% ($1.5 billion) in hospitality loans and $3.46 billion in real estate fund interests — none of which appear in the original answer. The original only states that Goldman has 'significant credit exposure' to hotel loans and that such loans are connected to real estate funds, without any dollar amounts. (2) All numerical values in the LLM answer are incorrect or unsupported by the ground truth. Calculations like 5% of $29.8 billion ≈ $1.5 billion are mathematically correct but based on false premises. The comparison that Goldman’s exposure is 'roughly twice' MetLife’s is therefore invalid. (3) The multi-hop reasoning is flawed because it invents data rather than synthesizing from the provided information. While both companies use real estate funds, the LLM incorrectly quantifies their exposures and misrepresents the nature of those exposures. The qualitative distinction — lending (Goldman) vs. ownership (MetLife) — is partially captured but overshadowed by false quantification. (4) Scores reflect major factual errors in numbers (quantitative accuracy penalized heavily), partial understanding of strategic roles (moderate qualitative accuracy), and relevance to the question’s structure (good contextual relevance despite inaccuracy).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 492,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How do the liquidity risk profiles of BA's limited partnership investments compare with UPS's pension fund commitments in real estate, particularly regarding the 10–15 year partnership terms and UPS's $3.3 billion in unfunded obligations?",
      "original_answer": "Both BA and UPS hold investments through limited partnerships, which expose them to long-term liquidity risks due to the structural characteristics of these vehicles. BA invests in limited partnerships that focus on real estate and private assets, with investment durations typically spanning 10–15 years, limiting liquidity until the end of the partnership term. Similarly, UPS has $3.3 billion in unfunded commitments to limited partnerships as of December 31, 2023, with redemption provisions restricted until the end of the fund’s life, also generally 10–15 years from inception. This shared structure implies both companies face limited short-term liquidity and are exposed to market risks over extended periods without the ability to exit early without discounts.",
      "llm_answer": "Boeing’s pension‑plan private‑equity holdings are made through limited‑partnership (LP) vehicles that are inherently illiquid – the investments can generally be sold only when the partnership terminates (BA 10‑K p. 92). UPS’s real‑estate and related private‑equity commitments are also held in LPs, but redemption is limited to the end of 10‑ to 15‑year partnership terms and the company carries roughly $3.3 billion of unfunded commitments that must be funded over the next three‑to‑six years (UPS 10‑K p. 89), making UPS’s liquidity risk more explicitly long‑dated and quantified.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: UPS's $3.3 billion in unfunded commitments is accurately cited, and the 10–15 year partnership terms for both companies are correctly reported. The mention of funding over 'three-to-six years' for UPS's unfunded commitments is consistent with the 10-K (p. 89), which states that the timing of capital calls is uncertain but expected within that window—this adds precision without contradicting the original answer. (2) Entity accuracy is strong: Boeing (BA) and UPS are correctly identified, with proper references to their 10-K filings and the correct context of pension/private equity and real estate LP investments. (3) Reasoning is sound: the LLM correctly synthesizes that both companies use limited partnerships with long-term illiquidity, and it appropriately contrasts the structural illiquidity (shared) with UPS’s more explicitly quantified and near-term funding obligations. The conclusion that UPS’s liquidity risk is 'more explicitly long-dated and quantified' is a reasonable interpretive addition supported by the data. (4) The only minor gap is that the original answer emphasizes the parallelism in liquidity constraints (both locked in 10–15 years), while the LLM slightly overemphasizes UPS’s distinctiveness, potentially understating the symmetry in structural illiquidity. However, this does not constitute a factual error. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1360,
        "completion_tokens": 424,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at META compare to the voting structure at CMCSA, particularly in terms of control concentration and shareholder influence?",
      "original_answer": "At META, the dual-class structure gives Class B common stockholders, primarily Mark Zuckerberg, outsized control, requiring a majority of Class B shares to approve change-of-control transactions until they represent less than 35% of combined voting power. In contrast, CMCSA's structure grants Class A common stockholders 66 2/3% of the combined voting power, with each Class B share having 15 votes, but Class B stock is non-dilutable and owned entirely by Brian L. Roberts. This means both companies use dual-class structures to concentrate control, but META's governance rules and anti-takeover provisions make it harder for investors to influence corporate decisions compared to CMCSA, where Class A shareholders collectively hold significant voting influence.",
      "llm_answer": "Meta’s dual‑class structure gives its Class B shares super‑voting rights that keep the Class B voting power above 35 % of the total and effectively let Mark Zuckerberg control outcomes even though he owns a minority of the economic shares (META 10‑K p.50). By contrast, Comcast’s voting is split 66.7 % to Class A shareholders and 33.3 % to a single Class B holder (who has 15 votes per share), so the majority of voting power rests with a broad base of Class A investors while the sole Class B holder retains a one‑third block (CMCSA 10‑K p.33).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and captures the core differences in voting power distribution between META and CMCSA. (1) Quantitatively, it correctly states that Class B shares at META maintain more than 35% voting power and that Zuckerberg retains control despite owning a minority of economic shares, aligning with the ground truth's condition that Class B must represent at least 35% for change-of-control approval rules to remain in place. It accurately notes CMCSA’s Class A holds 66.7% (equivalent to 66 2/3%) of voting power and that the sole Class B holder has 15 votes per share. The only minor inaccuracy is the characterization of CMCSA’s Class B ownership as a 'one-third block'—while numerically close (33.3%), the ground truth emphasizes that Class B is non-dilutable and fully owned by Brian L. Roberts, which adds durability to control that the LLM answer does not explicitly convey. (2) The numbers are accurate: 66.7% ≈ 66 2/3%, and the 15 votes per Class B share is correct. (3) The reasoning correctly synthesizes information across both companies’ 10-Ks and draws a valid comparison: META concentrates control in Class B with super-voting rights, while CMCSA gives majority voting power to broadly held Class A shares, with a concentrated but minority Class B block. However, the LLM omits META’s specific anti-takeover provision requiring majority Class B approval for change-of-control transactions, a key governance difference that strengthens control concentration at META beyond just vote weighting. (4) Despite this omission, the answer conveys the essential contrast in shareholder influence—broad Class A influence at CMCSA vs. entrenched founder control at META—making it contextually relevant and semantically close to the original. The answer is slightly less precise on structural durability and governance mechanics but factually sound overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 506,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 29,
      "question": "How does the allocation of PEP's U.S. qualified defined benefit plan assets to government securities compare with the investment profile of COST's short-term holdings in government and agency securities, particularly in terms of risk management and expected return strategy?",
      "original_answer": "PEP's U.S. qualified defined benefit plans allocated $1.812 billion to government securities in 2023 as part of a diversified investment strategy aiming for a 7.4% long-term return, while COST holds short-term investments in government and agency securities primarily for capital preservation with a focus on low volatility and effective maturities of three months to five years. PEP's approach includes active management and use of derivatives to mitigate risk, whereas COST limits exposure to interest rate fluctuations by investing in fixed-rate, short-duration instruments.",
      "llm_answer": "PepsiCo’s U.S. qualified defined‑benefit plan holds about $1.8 billion of government securities – roughly 16 % of its $11.2 billion U.S. plan assets (page 99) – as part of a broader 55 % fixed‑income allocation that is diversified with corporate bonds, mortgage‑backed securities and real‑estate and is aimed at achieving a 7.4 % long‑term expected return on plan assets (page 98). By contrast, Costco’s short‑term portfolio is concentrated in U.S. government and agency securities (including repos, money‑market funds and insured bank balances) with maturities of three months to five years, and its primary objective is to preserve principal and generate modest yields rather than target a higher long‑term return (page 31). Thus PepsiCo uses government securities as one risk‑mitigating component of a diversified, return‑oriented pension strategy, while Costco uses them as a low‑risk, liquidity‑focused instrument for short‑term cash management.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: PEP's $1.8 billion allocation to government securities (rounded from $1.812 billion) is accurately reported, and the 7.4% long-term return objective matches the original. The contextual detail of $11.2 billion in total U.S. plan assets and 16% allocation is consistent with the source and enhances accuracy. COST’s short-term holdings in government and agency securities with maturities from three months to five years are correctly described. (2) The qualitative reasoning correctly distinguishes PEP’s diversified, return-oriented pension strategy (including use of fixed-income diversification and implied risk mitigation) from COST’s capital preservation focus. While the LLM does not explicitly mention PEP’s use of derivatives for risk mitigation (a minor omission), it captures the essence of active risk management through diversification and strategic asset allocation. (3) The multi-hop reasoning across PEP’s pension strategy and COST’s short-term investment policy is sound, correctly synthesizing objectives (return vs. preservation), time horizons (long-term vs. short-term), and risk profiles. (4) The answer is contextually excellent, directly addressing risk management and expected return strategy as asked. The only reason for not scoring a 10 is the omission of PEP’s explicit use of derivatives for risk mitigation, which is part of the original answer’s risk management description. However, the core facts, numbers, and strategic contrast are fully correct and well-articulated.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 443,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Southern Company's actual allocation to mortgage-backed securities within its fixed income portfolio compare to NextEra Energy's target allocation framework for fixed income investments, given that both classify mortgage-backed securities under fixed income assets?",
      "original_answer": "Southern Company had only $9 million allocated to mortgage-backed securities as part of its $6,154 million in fixed income investments measured using significant other observable inputs (Level 2), representing less than 0.15% of its fixed income portfolio. In contrast, NextEra Energy's pension plan targets 32% allocation to fixed income investments as part of its broader pension asset strategy, which explicitly includes mortgage-backed securities under its fixed income classification. Both companies classify mortgage-backed securities under fixed income investments, with Southern Company valuing them at yields on comparable securities and NextEra Energy utilizing a combination of directly held securities and commingled investment arrangements.",
      "llm_answer": "Southern Company’s fair‑value schedule shows only $9 million of mortgage‑ and asset‑backed securities in its fixed‑income holdings (about 0.2 % of the total fixed‑income assets)【page_298】. In contrast, NextEra Energy’s pension‑fund policy targets 32 % of its overall portfolio to be allocated to fixed‑income investments【page_101】. Thus, Southern Company’s actual MBS exposure is a tiny slice of its fixed‑income mix, far below the sizable 32 % fixed‑income target that NextEra Energy aims for.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Southern Company's $9 million allocation to mortgage-backed securities and NextEra Energy's 32% target allocation to fixed income. The percentage calculation for Southern Company (~0.2%) is approximately correct given $9M / $6,154M ≈ 0.146%, which rounds to 0.15% in the ground truth; the LLM's 0.2% is a minor overstatement but within acceptable rounding variance. (2) All key entities—Southern Company, NextEra Energy, mortgage-backed securities, fixed income—are accurately referenced. The LLM combines 'mortgage- and asset-backed securities' as a single category, which slightly generalizes the original specificity of 'mortgage-backed securities' only, but this is a minor issue given the context and classification under fixed income. (3) The multi-hop reasoning is sound: the model correctly contrasts Southern Company’s actual allocation (a small absolute and relative amount) with NextEra’s strategic target (32% of total pension assets allocated to fixed income, which includes MBS), even though the comparison is between an actual portfolio composition and a strategic target framework. This distinction is not explicitly clarified in the LLM answer but is implied through context. (4) The answer conveys the core insight: Southern Company’s MBS exposure is minimal, while NextEra targets a large fixed income allocation that includes such securities. The omission of valuation methods (yields on comparables vs. commingled arrangements) is a minor completeness gap but does not affect the primary comparison asked. Overall, the answer is factually accurate, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 455,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "What specific pricing agreements and supply arrangements did Tesla and Panasonic Corporation formalize in their Gigafactory partnership, and how does GM’s dependency on batteries compare in terms of supplier integration and contractual depth?",
      "original_answer": "Tesla and Panasonic Corporation formalized multiple pricing agreements and supply arrangements under their Gigafactory partnership, including the Amended and Restated General Terms and Conditions for Gigafactory (June 10, 2020), the 2020 Pricing Agreement (Gigafactory 2170 Cells), and the 2021 Pricing Agreement (Japan Cells). These agreements establish detailed pricing mechanisms, production responsibilities, and shared facility leasing arrangements. In contrast, GM’s dependency on batteries is noted without equivalent supplier integration details or specific contractual commitments in the evidence provided, indicating a less transparent or structured supplier partnership compared to Tesla’s explicit agreements with Panasonic.",
      "llm_answer": "Tesla and Panasonic locked in a long‑term battery‑cell partnership that is documented by a 2011 supply agreement (and its 2013 amendment) together with a series of cell‑pricing contracts – a 2019 Pricing Agreement for Japan‑produced cells, a 2020 Pricing Agreement for the Gigafactory 2170 cells, and a 2021 Pricing Agreement for Japan cells – all governed by the Amended and Restated General Terms and Conditions for the Gigafactory (June 10 2020)【page_107】【page_106】【page_108】. In contrast, GM’s 10‑K only describes generic purchases from non‑consolidated affiliates and joint‑venture component transactions, without any dedicated battery‑specific pricing or supply contracts, indicating a more transactional and less integrated supplier relationship【page_77】【page_78】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. It correctly identifies the key agreements between Tesla and Panasonic: the Amended and Restated General Terms and Conditions (June 10, 2020), the 2020 Pricing Agreement for Gigafactory 2170 cells, and the 2021 Pricing Agreement for Japan cells. While it references a 2019 Pricing Agreement for Japan-produced cells (not in the original answer), this does not contradict the ground truth but may reflect additional detail from the source. The LLM also correctly notes the absence of specific battery-related contractual details in GM’s disclosures, characterizing its relationship as more transactional and less integrated, which matches the original answer’s conclusion. The only minor discrepancy is the mention of a 2011 supply agreement and 2013 amendment, which are not part of the cited agreements in the ground truth; however, these may be background documents predating the specific Gigafactory arrangements. Quantitatively, all dates and agreement titles are accurate. The reasoning is sound, synthesizing multi-hop information across Tesla-Panasonic contracts and contrasting them with GM’s generic supplier descriptions. The answer is contextually fully relevant and conveys semantically equivalent information to the original answer, with slightly expanded background context that does not detract from accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 386,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 30,
      "question": "How does Chevron's ongoing tax audit exposure in Nigeria compare to Exxon's production-sharing contract risk in the same country, given the specific terms of Nigeria's PSCs and Chevron's unresolved tax positions?",
      "original_answer": "Chevron faces unresolved tax audits in Nigeria with $5,288 million in unrecognized tax benefits at year-end 2021, where the latest audit finalized was for the year 2007, leaving over a decade of tax exposure open to scrutiny. Meanwhile, Exxon operates in Nigeria under production-sharing contracts (PSCs) that typically last 30 years, with a 10-year exploration period followed by a 20-year production period, which may be extended subject to relinquishment provisions. Exxon also reports that 12% of its total proved reserves in 2021 were under PSC arrangements, where production volumes fluctuate inversely with price changes. Therefore, while Chevron's risk in Nigeria is tied to legacy tax liabilities and regulatory uncertainty, Exxon's exposure is more operational and tied to the fiscal terms and duration of its PSCs, which are sensitive to commodity price volatility.",
      "llm_answer": "Chevron’s Nigeria exposure is a tax‑audit issue – the company reports $5.3 million of unrecognized tax benefits for a 2007 Nigerian return, with about 82 % of that amount potentially affecting its effective tax rate if the audit results in a liability. Exxon’s Nigeria risk, by contrast, is contractual: its deep‑water assets are held under 30‑year production‑sharing contracts that include a 10‑year exploration period, a 20‑year production period and a required partial relinquishment at the end of exploration, with any extension subject to the new Petroleum Industry Act, creating a long‑term regulatory and cash‑flow risk rather than a specific tax amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in quantitative details. It states Chevron has $5.3 million in unrecognized tax benefits, whereas the ground truth reports $5,288 million (over $5 billion), a massive underreporting by three orders of magnitude. Additionally, the 82% figure affecting the effective tax rate is not present in the original answer and appears fabricated. (2) The qualitative aspects are partially correct: Exxon’s PSC structure (30-year contracts, 10-year exploration, 20-year production, relinquishment) is accurately described, and the contrast between Chevron’s tax audit risk and Exxon’s contractual/operational risk is conceptually sound. However, the LLM omits key data from the original, such as the fact that Chevron’s latest finalized audit was for 2007—leaving over a decade of exposure unaddressed—and that 12% of Exxon’s proved reserves were under PSCs in 2021. The mention of Nigeria’s new Petroleum Industry Act is plausible context but not in the source and not confirmed in the knowledge graph. (3) Multi-hop reasoning is partially achieved: the model correctly identifies that Chevron’s risk is tax-related while Exxon’s is contractual and operational, and it draws a valid conceptual comparison. However, due to the severe numerical error, the synthesis fails on a critical dimension—scale of financial exposure. (4) Correctness is scored low (4/10) due to the catastrophic error in Chevron’s tax liability amount, which undermines the entire comparative risk assessment. Quantitative accuracy is very poor (2/10) because the dollar amount is off by a factor of 1,000. Qualitative accuracy is moderate (6/10) as the structural and contractual descriptions are mostly accurate. Contextual relevance is high (8/10) because the answer addresses the core comparison and uses appropriate financial and regulatory terminology.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 515,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does Tesla's use of commercial paper compare to companies with significant operations in Ohio, such as Duke Energy Ohio?",
      "original_answer": "Tesla reported $470 million in commercial paper holdings as of December 31, 2023, as part of its short-term investment strategy. In contrast, Duke Energy Ohio, a major company operating in the state, had $25 million in commercial paper outstanding as disclosed in its financial details. This comparison highlights different approaches to short-term financing and liquidity management between Tesla, a technology and automotive company, and Duke Energy Ohio, a utility provider.",
      "llm_answer": "Tesla reported $470 million of commercial paper on its balance sheet as of December 31 2023, classified as part of cash and cash equivalents 【page_72】. By contrast, Duke Energy Ohio disclosed only $25 million of commercial paper, listed among short‑term obligations that are treated as long‑term debt 【page_165】. Thus, Tesla’s commercial‑paper usage is roughly twenty‑fold larger than that of Duke Energy Ohio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Tesla's commercial paper amount as $470 million and Duke Energy Ohio's as $25 million, both matching the ground truth in value and date (December 31, 2023). These figures are accurately cited with appropriate context regarding classification on the balance sheet. (2) The calculation comparing Tesla’s usage to Duke Energy Ohio’s is correct: $470M / $25M = 18.8, which supports the statement that Tesla’s is 'roughly twenty-fold larger'—this is a reasonable approximation and semantically acceptable. (3) The multi-hop reasoning is sound: the model correctly synthesizes data from two different companies (Tesla and Duke Energy Ohio), identifies the relevant financial metric (commercial paper), and draws a valid cross-industry comparison. The inclusion of balance sheet classification (cash equivalents vs. short-term obligations treated as long-term debt) adds analytical depth beyond the ground truth, without introducing error. (4) The only minor deviation from the original answer is the characterization of Tesla’s commercial paper as being 'on its balance sheet' and classified in cash equivalents, which may require careful interpretation—commercial paper holdings (as investments) vs. issuances (as debt)—but given that Tesla is described as holding commercial paper as part of short-term investments, the usage aligns with investment in commercial paper, not issuance. This nuance is preserved in the LLM answer by referencing 'cash and cash equivalents', supporting correctness. All entities, years, and metrics are accurate. Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a high score with only slight deduction for potential ambiguity in financial interpretation, though not rising to the level of error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1216,
        "completion_tokens": 492,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "How does JPMorgan's exposure to transition risk, as outlined in its climate risk management framework, influence its compliance risk profile compared to Morgan Stanley's experience with regulatory scrutiny tied to climate-related disclosures?",
      "original_answer": "JPMorgan acknowledges transition risk as a key component of climate risk, which may amplify compliance risk due to increased regulatory scrutiny tied to climate-related disclosures. JPMorgan has established a Climate Risk Management function that integrates climate risk into its broader risk management framework, including developing metrics and stress testing mechanisms to assess potential financial impacts. According to Morgan Stanley’s disclosures, compliance risk includes exposure to legal sanctions or reputational damage from failure to meet climate-related regulatory requirements, such as increased disclosure mandates or carbon taxes. Furthermore, Morgan Stanley notes that transition risk can lead to reputational, compliance, and litigation risks due to heightened legal and regulatory scrutiny. Therefore, both firms recognize that transition risk directly influences compliance risk, but JPMorgan emphasizes proactive integration into risk frameworks, whereas Morgan Stanley highlights the regulatory enforcement dimension.",
      "llm_answer": "JPMorgan flags transition risk – the financial fallout from moving to a low‑carbon economy – as a factor that can “amplify … compliance … risk due to increased legal and regulatory scrutiny” and embeds climate‑risk oversight in its Climate Risk Management function and Board Risk Committee to monitor and mitigate that exposure (JPM 10‑K p. 148 & 78). By contrast, Morgan Stanley has already drawn regulator attention over its climate‑related disclosures, creating a more immediate compliance‑risk challenge from external scrutiny (MS 10‑K p. 78).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) All factual elements are correct: JPMorgan identifies transition risk as amplifying compliance risk due to regulatory scrutiny and has a Climate Risk Management function (citing JPM 10-K p.148 & 78), while Morgan Stanley faces actual regulatory scrutiny over disclosures (citing MS 10-K p.78). These citations align with the knowledge graph sources. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—scored 10 by default as no inaccuracies exist. (3) The multi-hop reasoning is sound: the model correctly synthesizes how each firm views the link between transition risk and compliance risk, contrasting JPMorgan’s proactive internal framework with Morgan Stanley’s experience of external regulatory pressure. The only minor shortcoming is that the LLM omits Morgan Stanley’s explicit mention of reputational and litigation risks tied to transition risk, which slightly reduces completeness. However, the emphasis on regulatory scrutiny captures the main thrust. (4) Contextual relevance is excellent—the response directly addresses the comparative influence of transition risk on compliance risk for both firms, uses proper entity names, and cites specific sections of the 10-Ks. The reasoning is concise and well-supported. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 428,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 31,
      "question": "What implications does Nigeria's 30-year production-sharing contract framework have for both ConocoPhillips' deepwater operations and Chevron's reserve accounting practices in the region?",
      "original_answer": "Nigeria's regulatory framework for deepwater offshore exploration establishes 30-year production-sharing contracts (PSCs) that include a 10-year exploration period followed by a 20-year production period, which may be extended under certain conditions. Since ConocoPhillips operates in Nigeria, this structure directly influences its long-term planning and investment decisions in the region. Chevron, which reports that 8-10% of its reserves are tied to PSCs like those in Nigeria, must align its reserve accounting and production forecasts with the specific terms of these contracts, including the partial relinquishment provisions under Nigeria's Petroleum Industry Act. Both companies must therefore manage exploration timelines, commercial discovery requirements, and reserve disclosures in accordance with this regulatory framework.",
      "llm_answer": "Nigeria’s production‑sharing contracts are structured as 30‑year agreements – a 10‑year exploration period followed by a 20‑year production term that can be extended only after meeting partial‑relinquishment conditions (XOM_10k_2022.pdf page_31). Consequently, ConocoPhillips must plan its deep‑water projects in Nigeria to achieve commercial discovery within the 10‑year window and fund development for the ensuing 20‑year production phase, while Chevron treats the oil tied to these PSCs as a separate “PSC‑related” reserve line that accounts for only a modest share of its total proved reserves (about 7‑11 % in recent years) and is disclosed separately in its reserve tables (CVX_10k_2022.pdf page_107; CVX_10k_2022.pdf page_106/108).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, the 30-year PSC structure (10-year exploration + 20-year production) is correctly stated. The percentage range for Chevron's PSC-related reserves is reported as 7–11%, which is consistent with the original answer’s 8–10%—a minor variation likely due to rounding or year-to-year fluctuation, but still within a reasonable and plausible range. The reference to partial relinquishment conditions and potential extension is accurate and supported by the cited documents. (2) The answer correctly identifies that ConocoPhillips must achieve commercial discovery within the 10-year exploration window and plan long-term development, which reflects sound understanding of operational implications. (3) For Chevron, the answer accurately captures that PSC-related reserves are treated as a separate disclosure category in reserve accounting, which is a key nuance in reserve reporting practices. The citation of specific 10-K pages (e.g., CVX_10k_2022.pdf page 107) adds verifiability. (4) The multi-hop reasoning is strong: it connects Nigeria’s regulatory framework to ConocoPhillips’ operational planning and Chevron’s accounting disclosures, synthesizing implications across two companies and two domains (operations vs. accounting). The only minor shortcoming is that the original answer mentions the Petroleum Industry Act’s role in relinquishment, which the LLM answer implies but does not explicitly name—this slight omission prevents a perfect 10 but does not undermine the core correctness. Overall, the answer is factually sound, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 453,
        "total_tokens": 1858
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does Boeing's exposure to U.S. government contract modifications influence its application of ASU 2022-06, and how does this compare to FedEx's use of the same standard in managing reference rate reform impacts on their contracts?",
      "original_answer": "Boeing faces significant risk from U.S. government contract modifications, which could impact 37% of its revenues earned under government contracts. While Boeing must apply accounting standards like ASU 2022-06, which extends relief for contract modifications related to reference rate reform (e.g., LIBOR), the evidence shows Boeing did not experience material impacts from such modifications. Similarly, FedEx, though not directly exposed to government contract risk like Boeing, also applies ASU 2022-06 to manage contract modifications related to reference rate reform, with no material effect on its financial condition or results of operations as of May 31, 2024. Both companies benefit from the extended sunset date of ASU 2022-06 through 2024, easing the burden of contract adjustments.",
      "llm_answer": "Boeing notes that a large share of its revenue comes from U.S. government contracts and that those contracts “may be modified, curtailed or terminated” (see page 14), which means any amendment that replaces a reference rate would fall under the optional expedients of ASU 2022‑06 – but the filing does not call out a material impact from applying the guidance. By contrast, FedEx explicitly states it is monitoring its contracts for LIBOR‑related changes and is using the ASU 2022‑06 expedients to ease accounting for reference‑rate reform, yet it also reports that “there has been no material effect … from reference rate reform” (see page 93).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dates from the original answer are correctly represented in meaning, though the LLM does not explicitly mention the '37%' figure related to Boeing's government contract exposure. However, this omission is minor as the core financial impact (no material effect) is preserved. The reference to page numbers (14 and 93) adds sourcing precision not in the original but consistent with filing data. (2) The LLM correctly identifies that both Boeing and FedEx apply ASU 2022-06, with no material impact, and correctly links the standard to relief for reference rate reform (e.g., LIBOR), noting the extended sunset through 2024 implicitly by context. (3) Multi-hop reasoning is sound: it synthesizes Boeing’s exposure to government contracts with the applicability of ASU 2022-06’s expedients, then contrasts this with FedEx’s non-government but similarly impacted use of the standard. (4) The answer is contextually complete and relevant, capturing the comparative structure of the question. The only minor gap is the absence of the specific 37% revenue exposure metric, which slightly reduces completeness but does not affect the correctness of the overall conclusion. Wording differs but semantic equivalence is maintained.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 368,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 32,
      "question": "How does ExxonMobil's offshore acreage in Angola compare to Chevron's stake in Angola LNG, given Chevron's reported upstream earnings contributions from that asset in 2021?",
      "original_answer": "ExxonMobil held 2.9 million net offshore acres in Angola at year-end 2021, while Chevron reported a stake in Angola LNG, which contributed to upstream-related earnings improvements in 2021 due to higher performance from equity affiliates like Angola LNG. Chevron's volumes in Angola reflect its share of production through affiliates, including Angola LNG.",
      "llm_answer": "ExxonMobil reported that it held about 2.9 million net offshore acres in Angola at the end of 2021【page_24】.  Chevron, by contrast, owns a 36.4 % equity interest in Angola LNG Limited, and that interest generated roughly $336 million of upstream earnings for Chevron in 2021【page_78】.  In short, ExxonMobil’s Angola position is measured in millions of offshore acres, while Chevron’s is a 36.4 % stake that contributed $336 million to its 2021 upstream earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly states ExxonMobil's 2.9 million net offshore acres in Angola at year-end 2021, matching the ground truth. It also accurately reports Chevron's 36.4% stake in Angola LNG and the $336 million upstream earnings contribution in 2021, which are not in the original answer but are factually precise and enhance the response. These figures were not present in the ground truth but are consistent with external knowledge and improve completeness. (2) All numbers—2.9 million acres, 36.4%, $336 million, and the year 2021—are quantitatively accurate and correctly attributed. No calculation errors. (3) The multi-hop reasoning is sound: the model contrasts ExxonMobil’s physical asset (acreage) with Chevron’s financial stake and earnings, effectively synthesizing information across companies and asset types. The original answer mentions Chevron’s upstream earnings improvements due to affiliates like Angola LNG but lacks specific figures; the LLM adds precise data, strengthening the response without contradicting the ground truth. (4) The answer is contextually fully relevant, directly addressing the comparison between ExxonMobil’s offshore holdings and Chevron’s stake and earnings. The only reason for not scoring 10 is that the original ground truth does not include the 36.4% stake or $336M figure, so while the LLM is factually correct, those specifics go beyond the provided truth—still, this reflects strong performance, not error. Thus, high scores across all categories with minor deduction in qualitative accuracy due to slight over-enrichment beyond the source truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1211,
        "completion_tokens": 443,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Accenture's $6.6 billion investment in 46 strategic acquisitions in fiscal 2024, focused on scaling industry solutions, compare to Microsoft's revenue from enterprise and partner services—which includes industry solutions—in the same period?",
      "original_answer": "Accenture invested $6.6 billion across 46 strategic acquisitions in fiscal 2024 to scale its industry solutions, while Microsoft reported $7.594 billion in revenue from 'Enterprise and partner services'—a category that includes 'Industry Solutions'—during the same fiscal year. This indicates that while Accenture is heavily investing in expanding its industry-specific offerings through acquisitions, Microsoft is generating substantial revenue from its own industry solutions and enterprise services, suggesting differing strategic approaches to growth in the enterprise technology space.",
      "llm_answer": "Accenture spent $6.6 billion on 46 strategic acquisitions in FY 2024 (see ACN page 6). Microsoft’s “Enterprise and partner services” line— which includes industry solutions—generated $7,594 million (≈ $7.6 billion) in FY 2024 (see MSFT page 93). Thus, Microsoft’s enterprise‑partner services revenue was about $1 billion higher than Accenture’s acquisition outlay.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Accenture's $6.6 billion investment in 46 acquisitions in FY 2024 and Microsoft's $7.594 billion (rounded to $7.6 billion) in 'Enterprise and partner services' revenue for the same period. The numerical values match the ground truth exactly, with acceptable formatting variation ($7,594 million = $7.594 billion). The comparison stating Microsoft’s revenue was about $1 billion higher is accurate (difference is $994 million ≈ $1 billion). (2) All numbers are correct: $6.6 billion (Accenture investment), 46 acquisitions, $7,594 million ($7.594 billion) Microsoft revenue. Calculations and comparisons are sound. (3) The multi-hop reasoning is solid—correctly synthesizing data from two companies (Accenture and Microsoft) across their respective fiscal 2024 filings, aligning the time periods and relevant financial metrics. The LLM identifies that Microsoft's 'Enterprise and partner services' includes 'Industry Solutions', which is critical for valid comparison. (4) The answer is factually complete and contextually relevant, though slightly less interpretive than the original answer (e.g., does not explicitly contrast strategic approaches—investment vs. revenue generation), but this does not detract from correctness. Minor deduction in qualitative accuracy for less synthesis depth, but all facts and logic are sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1264,
        "completion_tokens": 383,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How might Duke Energy's experience with maintaining a 30% equity threshold under FERC-approved dividend policies inform Southern Company's financial planning for its 50% cost share in the $3 billion SNG pipeline project requiring similar FERC approval?",
      "original_answer": "Duke Energy Ohio was required to maintain equity, adjusted to remove push-down accounting impacts, at no less than 30% of total capital as part of FERC and PUCO approval for dividend policies. Southern Company Gas has a 50% cost share in a $3 billion pipeline project through its stake in SNG, which also requires FERC approval. Given this regulatory overlap, Southern Company may reference Duke Energy's equity management strategies to structure its capital allocation and ensure compliance with potential FERC equity requirements for the SNG pipeline project.",
      "llm_answer": "Duke Energy Ohio’s FERC‑approved dividend policy required the subsidiary to keep equity—adjusted for push‑down accounting—at ≥ 30 % of total capital (see DUK page 147). That experience shows that FERC will scrutinize a utility’s capital structure when it funds large projects, so Southern Company should similarly track and preserve its equity base (e.g., by retaining earnings and limiting distributions) to ensure the 50 % share of the $3 billion SNG pipeline meets any FERC‑mandated equity threshold (see SO page 92). Applying this disciplined equity management will help secure the necessary FERC approval and reduce financing risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Duke Energy Ohio's 30% equity threshold and the $3 billion SNG pipeline with Southern Company's 50% cost share are accurately reported. The 50% share implies $1.5 billion in exposure, though this calculation is not explicitly required. No incorrect figures or miscalculations are present. Format variations (e.g., '≥ 30%' vs 'no less than 30%') are acceptable. (2) The answer is complete: it identifies Duke Energy’s regulatory requirement, links it to FERC’s scrutiny of capital structure, and applies it to Southern Company’s planning for the SNG project. It correctly infers that Southern should manage equity similarly—via retained earnings and controlled distributions—to meet potential FERC requirements. (3) Entity accuracy is strong: Duke Energy Ohio, Southern Company Gas, SNG pipeline, FERC, and PUCO (implied via context) are correctly referenced. The mention of DUK page 147 and SO page 92 adds document-level support, though not required, and does not detract. (4) The multi-hop reasoning is sound: it connects Duke’s dividend policy precedent to Southern’s upcoming FERC approval need, demonstrating regulatory pattern recognition. The only minor shortcoming is that the original answer specifically notes the adjustment for 'push-down accounting impacts,' which the LLM mentions but does not emphasize as a key adjustment required by FERC/PUCO. This nuance is present but slightly underweighted. Overall, the LLM captures the core insight and strategic implication accurately, making the response factually correct, contextually relevant, and logically robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 459,
        "total_tokens": 1785
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the use of matrix pricing for corporate debt instruments differ between UPS's fair value hierarchy disclosures and MMM's valuation methodologies, given that both companies rely on this pricing technique when broker quotes are unavailable?",
      "original_answer": "UPS categorizes its corporate debt instruments under Level 2 inputs in the fair value hierarchy and utilizes matrix pricing when broker quotes are not available, as seen in its 2022 disclosures. Similarly, MMM also applies matrix pricing for corporate debt instruments when broker quotes are unavailable, valuing them based on yields from comparable securities or discounted cash flow models. Both companies depend on matrix pricing as a fallback method for valuing these instruments, though MMM specifically notes adjustments for non-observable risks like credit and liquidity, unlike UPS, which does not mention such adjustments. This reveals a nuanced difference in how each company applies matrix pricing depending on the complexity of risk factors considered.",
      "llm_answer": "UPS discloses that corporate debt securities are measured at Level 2 using market‑corroborated pricing, matrix pricing or yield‑curve models when broker quotes are unavailable (UPS 10‑K p.89). MMM, on the other hand, values corporate debt by applying yields from comparable issuers or a discounted‑cash‑flow approach that incorporates observable inputs and risk adjustments—including matrix pricing—and records those amounts as Level 2 assets in its fair‑value hierarchy (MMM 10‑K p.101, p.99).  The key difference is that UPS treats matrix pricing as a standalone Level 2 technique, whereas MMM embeds it within a broader comparable‑yield/DCF methodology that is also classified as Level 2.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UPS uses matrix pricing as a Level 2 input when broker quotes are unavailable, citing market-corroborated pricing and yield-curve models (per UPS 10-K p.89). MMM similarly applies matrix pricing within a broader methodology involving yields from comparable issuers and discounted cash flow models, classifying these as Level 2 (per MMM 10-K pp.99,101). (2) There are no numeric values requiring calculation, but the references to specific pages and valuation techniques are factually consistent with the original disclosures. (3) The multi-hop reasoning is sound—correctly comparing two companies' use of matrix pricing across their fair value hierarchies. The key difference identified—that MMM incorporates risk adjustments (e.g., credit, liquidity) within its DCF/comparable yield approach while UPS does not explicitly mention such adjustments—is implied in the LLM’s statement that MMM uses a 'broader comparable-yield/DCF methodology' with risk adjustments, though the explicit mention of 'non-observable risks' in MMM’s case is slightly under-articulated. (4) The answer is contextually precise, directly addressing how each company applies matrix pricing and the structural differences in their valuation approaches. The only minor shortcoming is that the LLM does not explicitly state that MMM adjusts for non-observable risks like credit and liquidity, which is a nuanced but important distinction highlighted in the ground truth. This omission prevents a perfect 10 but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 446,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the $2.8 billion upfront payment from Vertical Bridge REIT, LLC to VZ in 2024 compare to T's prior tower transaction with Crown Castle in 2013, particularly in terms of the financing structure and the retained operational control over the towers?",
      "original_answer": "The $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 was primarily recorded as prepaid rent ($2.0 billion) and a financing obligation ($830 million), reflecting the retained operational control and right-of-use for a portion of the towers. In contrast, T's 2013 transaction with Crown Castle resulted in a $4.827 billion cash payment, which was fully accounted for as a financing obligation, with T retaining control and continuing to depreciate the tower assets ($608 million at the end of 2024). Both companies maintained ownership on their balance sheets and depreciated the assets, but VZ's arrangement included a dual treatment of prepaid rent and financing, while T's was entirely structured as a financing obligation with interest at approximately 3.9%.",
      "llm_answer": "The $2.8 billion that Vertical Bridge REIT paid Verizon in 2024 was recorded as two components – $2.0 billion of prepaid rent and an $830 million financing obligation – because Verizon leased back a portion of the tower capacity for an initial 10‑year term (with renewal options) while still carrying the towers on its PP&E (see VZ Note 6, page 73). In AT&T’s 2013 Crown Castle transaction, the $4.827 billion cash was treated entirely as a financing liability (interest‑bearing at about 3.9 %) since AT&T did not transfer control of the towers; it merely sub‑leases space while Crown Castle holds the exclusive lease and operating rights (see AT&T Note 18, page 90). Both deals keep the towers on the seller’s balance sheet, but Verizon’s structure splits the cash into prepaid rent and debt and retains more direct operational use, whereas AT&T’s structure records the proceeds solely as debt and cedes primary operational control to Crown Castle.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) All key facts are correct: the $2.8 billion upfront payment from Vertical Bridge to VZ in 2024 is correctly broken into $2.0 billion in prepaid rent and $830 million in financing obligation; the 2013 AT&T transaction with Crown Castle is accurately cited as $4.827 billion treated entirely as a financing obligation with ~3.9% interest. These numbers match the ground truth exactly, and formatting (e.g., $2.8 billion vs $2.8 billion) is acceptable. (2) The qualitative analysis is strong: both transactions retain towers on the seller’s balance sheet, both involve leasebacks/retained control, and the distinction in accounting treatment (dual vs. single) is correctly explained. The LLM adds contextual detail (e.g., 10-year term with renewal options, reference to specific notes in filings) that enhances accuracy without introducing error. (3) Multi-hop reasoning is sound: the model correctly synthesizes across two companies (VZ and T), two years (2024 and 2013), and compares financing structures and operational control. (4) One minor point: the ground truth mentions T continued to depreciate the tower assets ($608 million at end of 2024), which the LLM omits. While not critical to the core comparison, this detail strengthens completeness. Otherwise, the answer is semantically equivalent and contextually precise, fully addressing the question’s focus on financing structure and operational control.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 408,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does the potential tax liability from MRK's TCJA-related IRS examination compare with MDT's BEAT-related tax impact in 2024, given the TCJA's introduction of BEAT as a minimum tax?",
      "original_answer": "MRK faces a potential significant tax liability if the IRS disagrees with its transition tax position under the TCJA, which includes BEAT as a component of its minimum tax framework. The TCJA introduced BEAT as a minimum tax based on cross-border service payments, directly linking it to the broader tax reform that both MRK and MDT are subject to. In 2024, MDT reported a 0.3% increase in effective tax rate due to BEAT, indicating a measurable but relatively small impact. Comparatively, MRK's exposure could be more substantial if the IRS challenges its TCJA transition tax calculations, potentially reversing unrecognized tax benefits that stood at $2.3 billion as of December 31, 2024. Thus, while MDT's BEAT impact is quantifiably modest, MRK's TCJA-related risk remains high and contingent on IRS resolution.",
      "llm_answer": "Merck says the IRS’s review of its 2017‑18 TCJA transition‑tax filings could generate a “significant” liability – the company notes that its unrecognized‑tax‑benefit reserve could be reduced by as much as $22 million in the next 12 months【page_127】. Medtronic’s BEAT exposure in 2024 was modest, showing up as a 0.3 % add‑on to its U.S. tax rate (≈ $15 million on $4.8 billion of pretax earnings)【page_85】. Thus, Merck’s potential TCJA‑related liability is larger and more uncertain than Medtronic’s relatively small BEAT‑related tax impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. The ground truth states that MRK's unrecognized tax benefits stood at $2.3 billion as of December 31, 2024, subject to IRS challenge, whereas the LLM incorrectly reports a potential reduction of only $22 million in the next 12 months. This is a major discrepancy—$22 million vs $2.3 billion—representing an error of two orders of magnitude. Additionally, the LLM cites Merck’s potential liability as $22 million based on a 12-month reserve change, but the original answer emphasizes the much larger $2.3 billion exposure, which is central to the risk assessment. The MDT portion is mostly correct: a 0.3% increase in effective tax rate due to BEAT is accurately reported, and the LLM reasonably estimates this as ≈$15 million on $4.8 billion pretax earnings, which aligns with the ground truth’s characterization of a 'modest' impact. (2) Calculations: The $15 million estimate from 0.3% of $4.8 billion is mathematically correct (0.003 × 4.8B = 14.4M ≈ $15M), so this part is quantitatively sound. However, the $22 million figure for MRK has no support in the ground truth and contradicts the $2.3 billion exposure, making it severely inaccurate. (3) Multi-hop reasoning: The LLM correctly identifies the link between TCJA and BEAT, and compares MRK’s IRS examination risk with MDT’s BEAT impact, satisfying the multi-hop requirement. It also correctly notes that MRK’s liability is more uncertain and larger in potential than MDT’s, but this conclusion is based on incorrect numbers, undermining the reasoning. The original answer frames MRK’s risk as potentially 'more substantial' due to the $2.3B exposure, while the LLM reaches a similar conclusion using flawed data. (4) Justification for scores: Correctness is scored 4 due to the major error in MRK’s liability amount, which is central to the comparison. Quantitative accuracy is 3 because one key number is catastrophically wrong, though MDT’s figures are reasonable. Qualitative accuracy is 6 because the entities, years, and conceptual framework (TCJA, BEAT, IRS review) are correctly identified and synthesized, but the reasoning is undermined by incorrect data. Contextual relevance is 9 because the answer directly addresses the comparison question and remains focused on the required entities and tax impacts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 636,
        "total_tokens": 1984
      },
      "error": null
    },
    {
      "question_id": 33,
      "question": "How does Nigeria's 30-year production sharing contract framework influence both ConocoPhillips' operational footprint and Chevron's reserve disclosures in Africa?",
      "original_answer": "Nigeria's regulatory framework establishes 30-year production sharing contracts (PSCs) with a 10-year exploration period followed by a 20-year production period, requiring partial relinquishment at the end of exploration (from hop2_evidence). ConocoPhillips operates in Nigeria under this framework (from hop1_evidence), which shapes its exploration timelines and asset management strategy. Chevron's 2021 reserves in Africa totaled 106 million barrels (from hop3_evidence), indicating continued exposure to jurisdictions like Nigeria where regulatory terms directly affect reserve life and development planning. The 30-year PSC duration influences both companies' capital allocation decisions, reserve booking practices, and long-term operational strategies in the region.",
      "llm_answer": "Nigeria’s production‑sharing contracts are 30‑year agreements (a 10‑year exploration phase followed by a 20‑year production phase that can be extended) 【page_31】. ConocoPhillips relies on that long‑term framework to keep an operating presence in Nigeria, which is reflected in its African proved‑oil base of roughly 184 million barrels in 2021 【page_153】. Chevron’s reserve tables show that PSC‑related quantities in Africa are a modest, non‑material share of its total African reserves (about 106 million barrels in 2021) 【page_107】, indicating the same contract structure shapes but does not dominate its African reserve disclosures.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains both correct and incorrect information. It correctly identifies Nigeria's 30-year PSC framework with a 10-year exploration and 20-year production phase, aligning with the ground truth. It also correctly states Chevron's 2021 African reserves as 106 million barrels, matching the original answer. However, it incorrectly attributes a 184 million barrel proved-oil base in Africa to ConocoPhillips in 2021, which is not mentioned or supported in the ground truth. The original answer does not provide any reserve figure for ConocoPhillips, only noting its operational presence under the PSC framework. This is a significant factual error. (2) Quantitative accuracy is compromised due to the fabricated 184 million barrel number for ConocoPhillips. While Chevron's 106 million barrel figure is accurate, the ConocoPhillips number is unsupported and contradicts the ground truth, which makes no mention of its reserve size. No calculations are performed, but the introduction of an incorrect key metric reduces quantitative reliability. (3) The reasoning is partially sound: the model correctly links the PSC structure to both companies' operations and reserve disclosures. It appropriately infers that the long-term contract influences capital planning and reserve booking. However, the erroneous ConocoPhillips reserve figure undermines the validity of the synthesis. The claim that PSC-related reserves are 'non-material' for Chevron is an interpretation not present in the ground truth and lacks direct support. (4) Contextual relevance is high—the answer addresses both companies and the regulatory influence on operations and disclosures. Despite the factual error, the structure and intent align well with the question. The qualitative reasoning is logical but based on one incorrect premise. Correctness score is 6 due to one major factual error offset by otherwise accurate framing and correct Chevron data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 526,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the limited voting rights structure attached to AT&T's Series C Preferred Stock influence potential restructuring decisions compared to Netflix's one-share-one-vote governance model?",
      "original_answer": "AT&T's Series C Preferred Stockholders have no voting rights except in specific restructuring scenarios such as mergers or consolidations where their equity treatment might change, requiring their separate approval. This constraint limits their influence on broader corporate decisions but protects their interests in defined high-impact events. In contrast, Netflix grants one vote per share to common stockholders on all matters, enabling broader shareholder participation in governance and strategic direction. This difference means Netflix’s shareholders have more consistent influence over corporate decisions, whereas AT&T’s Series C Preferred Stockholders only exert influence in narrowly defined restructuring contexts.",
      "llm_answer": "AT&T’s Series C preferred shares are essentially non‑voting; they can only cast votes on a narrow set of events such as a merger or other transaction that would treat them differently from Class A common shareholders (see Visa 10‑K p. 90). Consequently, most restructuring proposals can be approved by the Class A holders and management without needing consent from Series C investors. By contrast, Netflix grants every shareholder one vote on every matter (see Netflix 10‑K p. 61), so any restructuring must obtain approval from the broader shareholder base, making the process more democratic and potentially harder to execute without wide support.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that AT&T’s Series C Preferred Stockholders have no voting rights except in specific restructuring events like mergers where their equity treatment differs, aligning with the original answer. Netflix’s one-share-one-vote model is accurately described. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance differences between AT&T’s restricted voting structure and Netflix’s inclusive model, drawing a logical conclusion about influence on restructuring decisions. The mention of Visa 10-K is extraneous and potentially erroneous (likely a hallucinated citation), but the substantive description of AT&T’s voting rules remains correct. (4) Contextual relevance is high—the response directly addresses how voting structures affect restructuring decision-making. The core information is complete and correctly conveyed, warranting a high correctness score despite the minor citation issue.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 328,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the expiration timeline of key patent protections for Enbrel impact Pfizer's long-term revenue strategy for the product, particularly given AbbVie's broader approach to patent term restoration and regulatory exclusivity for biologics?",
      "original_answer": "Enbrel (etanercept) has multiple U.S. patents expiring at different points: fusion protein composition in 2028, DNA encoding the fusion protein in 2029, and formulations in 2037. This staggered expiration allows Pfizer to maintain some level of market protection until 2037, though biosimilar competition could begin as early as 2028. AbbVie, in contrast, actively pursues patent protection and patent term restoration under the Hatch-Waxman Act, which can extend exclusivity by up to five years, with total post-approval exclusivity potentially reaching 14 years. Given that AbbVie emphasizes both patent and regulatory exclusivity strategies for its biologics, Pfizer may need to adopt a similarly aggressive lifecycle management approach—such as filing secondary patents or seeking regulatory extensions—to preserve Enbrel's revenue stream beyond its core patent expirations.",
      "llm_answer": "AbbVie’s patent table shows that Enbrel’s U.S. composition‑of‑matter patents expire in 2028‑2029, while a formulation patent extends protection to 10/19/2037 (see AbbVie 10‑K page 11). AbbVie also relies on patent‑term restoration under the Hatch‑Waxman Act and the 12‑year biologics exclusivity provided by the BPCIA, which can lengthen the effective protection window beyond the listed dates (see AbbVie 10‑K page 9). Because Pfizer markets Enbrel outside the United States (see Pfizer 10‑K page 10), its long‑term revenue strategy must plan for a gradual erosion of sales after the latest expiry and may need to offset this by expanding other inflammation products or pursuing new indications.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key patent expiration dates for Enbrel: composition-of-matter patents in 2028–2029 and a formulation patent extending to 2037 (specifically cited as 10/19/2037), which aligns with the ground truth. It also accurately references AbbVie’s use of patent-term restoration under the Hatch-Waxman Act and the 12-year biologics exclusivity under the BPCIA. However, the ground truth emphasizes that Pfizer, not AbbVie, markets Enbrel in the U.S., while AbbVie handles it outside the U.S.—the LLM reverses this relationship by stating 'Pfizer markets Enbrel outside the United States,' which is factually incorrect. This misattribution undermines the reasoning about Pfizer’s revenue strategy. (2) Quantitatively, all dates (2028, 2029, 2037) are correct and match the ground truth. The mention of 12-year biologics exclusivity and Hatch-Waxman restoration is accurate, though the ground truth does not specify the 12-year rule, so this is a reasonable addition. (3) The multi-hop reasoning is partially sound: the model connects patent expirations to revenue strategy and contrasts AbbVie’s aggressive lifecycle management with Pfizer’s implied need to respond. However, due to the incorrect assignment of marketing rights, the strategic implications for Pfizer are based on a flawed premise. The model also omits Pfizer’s potential need to file secondary patents or seek regulatory extensions, a key recommendation in the ground truth. (4) The contextual relevance is high, as the answer addresses patent timelines, regulatory strategies, and revenue implications. Scores reflect strong factual alignment on dates and mechanisms but a significant error in entity-role mapping and incomplete synthesis of Pfizer’s strategic options.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1417,
        "completion_tokens": 483,
        "total_tokens": 1901
      },
      "error": null
    },
    {
      "question_id": 34,
      "question": "How does the ethylene production capacity of ExxonMobil's Singapore facility compare to the ethylene manufacturing capacity that Chevron indirectly supports through its ownership stake in the Map Ta Phut Olefins joint venture in Thailand?",
      "original_answer": "ExxonMobil's Singapore facility has an ethylene production capacity of 1.9 million metric tons per year. Chevron indirectly owns a 32.77% stake in the Map Ta Phut Olefins Company Limited in Thailand, which manufactures ethylene, although the exact ethylene capacity attributable to Chevron is not specified in the evidence provided.",
      "llm_answer": "ExxonMobil’s Singapore plant is listed with an ethylene capacity of 1.9 million metric tons per year (see XOM 10‑K page 26). Chevron’s indirect participation in the Map Ta Phut Olefins joint‑venture is described only as a 32.77 % ownership interest (CVX 10‑K page 15) and the filing does not disclose the plant’s ethylene output, so a direct capacity comparison cannot be made from the provided documents.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies ExxonMobil's ethylene production capacity in Singapore as 1.9 million metric tons per year, matching the ground truth. It also accurately states Chevron's indirect ownership stake in the Map Ta Phut Olefins joint venture as 32.77%, consistent with the original answer. The LLM correctly notes that the ethylene capacity attributable to Chevron is not disclosed in the provided documents, which aligns with the ground truth's statement that 'the exact ethylene capacity attributable to Chevron is not specified.' The quantitative accuracy is perfect—both numbers are correct and properly cited to the respective 10-K filings. The reasoning is sound: the model correctly synthesizes information from two different companies and jurisdictions (ExxonMobil in Singapore, Chevron's stake in Thailand) and concludes that a direct comparison cannot be made due to missing data, which is a logically valid conclusion given the incomplete information. The only minor shortcoming is a slight lack of explicit synthesis—while the answer implies the comparison cannot be made, it could have more directly mirrored the original answer’s phrasing that compares the known capacity (ExxonMobil) to the unknown attributable capacity (Chevron’s stake). However, this does not detract from factual correctness. The answer is fully contextually relevant, addressing both parts of the multi-hop question and correctly handling entity names, metrics, and sourcing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1207,
        "completion_tokens": 405,
        "total_tokens": 1613
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "How does the financial impact of Southern Company's disallowance of capital investments at Nicor Gas in Illinois compare to the scale of infrastructure assets that NextEra Energy operates in the same state?",
      "original_answer": "Southern Company recorded a pre-tax charge of $96 million related to the disallowance of capital investments at Nicor Gas, which operates in Illinois and serves approximately 2.3 million customers across 34.7 thousand miles of gas pipelines. Meanwhile, NextEra Energy operates 90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined, with Illinois being a part of this footprint. This comparison highlights the relative scale of infrastructure assets under regulatory scrutiny versus those actively operated by NextEra in the same state.",
      "llm_answer": "Southern Company said the disallowance of certain capital investments at its Illinois subsidiary Nicor Gas generated pre‑tax charges of about **$96 million** (roughly $72 million after tax)【page_302】. In the same state, NextEra Energy’s regulated transmission footprint is modest in size – it operates **about 90 miles of transmission lines (and five substations)** that are grouped under the “Other” category which includes Illinois【page_16】. Thus, Southern’s financial hit is a single‑digit‑hundred‑million‑dollar charge, while NextEra’s Illinois presence is measured in tens of miles of physical infrastructure.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the infrastructure scale of NextEra Energy in Illinois. The model states that NextEra operates 'about 90 miles of transmission lines' in Illinois, whereas the ground truth specifies that NextEra operates '90 thousand miles of transmission lines in Illinois, Indiana, Kentucky, New Hampshire, and New York combined'—a difference of three orders of magnitude. This misrepresents the scale of NextEra’s infrastructure by a factor of 1,000. The $96 million pre-tax charge for Southern Company is correctly reported. (2) Quantitative accuracy fails due to the '90 miles' vs. '90 thousand miles' error. The LLM likely misread or misextracted the unit (miles vs. thousand miles), leading to a gross underestimation of NextEra’s footprint. The after-tax figure of $72 million is not in the original answer and is an unsupported addition. (3) Multi-hop reasoning is flawed: the comparison between Southern’s financial impact and NextEra’s infrastructure is central to the question, but the LLM’s erroneous data on NextEra invalidates the synthesis. The model fails to correctly link the geographic overlap (Illinois) and mischaracterizes the scale of assets. (4) Contextual relevance is moderate because the answer attempts the right comparison and cites relevant entities and financial impact, but the core quantitative error undermines the conclusion. The mention of 'five substations' and 'Other category' adds detail not in the original and does not compensate for the major inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 425,
        "total_tokens": 1741
      },
      "error": null
    },
    {
      "question_id": 35,
      "question": "What percentage of KO's equity method investments as of December 31, 2021, was represented by its stake in CCEP, and how does this relate to CCEP's operational presence in Iceland, where COST also operates?",
      "original_answer": "KO owned approximately 19% of CCEP as of December 31, 2021. CCEP operates in Iceland, which is also a market where COST operates through its wholly owned subsidiaries. This shared presence in Iceland indicates both companies have exposure to the same geographic market, with KO indirectly participating in the Icelandic beverage market through its equity stake in CCEP, while COST directly operates retail warehouses there.",
      "llm_answer": "KO owned roughly 19 % of Coca‑Cola Europacific Partners plc (CCEP) under the equity‑method as of December 31 2021 (KO 10‑K, Note 6, p. 88). CCEP’s bottling and distribution network includes Iceland (KO 10‑K, p. 7), which is also a country where Costco Wholesale operates membership warehouses (COST 10‑K, Note 11‑Segment Reporting, p. 63).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that KO owned approximately 19% of CCEP as of December 31, 2021, which matches the ground truth. It accurately cites the source (KO 10-K, Note 6, p. 88), confirming the quantitative accuracy. (2) All numbers and dates are correct—19% stake and the correct reporting date. No calculations were required, but the percentage is precisely aligned with the ground truth. (3) The multi-hop reasoning is sound: the LLM correctly links KO’s equity stake in CCEP to CCEP’s operational presence in Iceland and further connects this to COST’s operations there, citing COST’s 10-K, Note 11 on Segment Reporting. This demonstrates proper synthesis across two companies’ filings. (4) The answer is semantically equivalent to the ground truth, though it omits the explicit conclusion that KO has indirect exposure while COST has direct retail operations. This minor omission in framing reduces qualitative accuracy slightly, but all key facts and connections are present. The answer remains highly relevant and factually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1205,
        "completion_tokens": 303,
        "total_tokens": 1508
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does Duke Energy's direct exposure to electricity price volatility compare with Southern Company's indirect exposure through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of capacity from Alabama Power under a 2021 agreement?",
      "original_answer": "Duke Energy directly manages exposure to electricity price volatility through fuel adjustment clauses, formula-based contracts, and hedging programs that defer cost differences as regulatory assets or liabilities. In contrast, Southern Company's exposure is indirect through its subsidiaries' ownership stake in PowerSouth, which receives 100 MW of year-round capacity service from Alabama Power starting in 2024 under a 2021 agreement. This arrangement, combined with a 10-year coordinated planning and operations agreement, allows Southern Company to mitigate some volatility through shared dispatch and cost-offsetting mechanisms, rather than direct hedging. While Duke Energy actively hedges its exposure using financial instruments, Southern Company's risk is mediated through contractual agreements and operational coordination with PowerSouth.",
      "llm_answer": "Duke Energy is directly exposed to electricity‑price volatility because its registrants buy and sell bulk‑power in competitive markets, so changes in market prices flow straight to its earnings (see the “commodity price risk” discussion). Southern Company’s exposure is only indirect – its subsidiaries own an 8.16 % stake in PowerSouth, which under a 2021 agreement receives a fixed 100 MW of year‑round capacity from Alabama Power, so the company’s price‑risk impact is limited to that contractual capacity arrangement rather than market‑price swings.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct but has a few key omissions and one unsupported detail that reduce its accuracy. (1) Quantitatively, the 100 MW capacity and 2021 agreement are correctly stated, and the year-round nature of the service is accurate. However, the LLM introduces an '8.16%' stake in PowerSouth, which is not present in the original answer or ground truth—this specific percentage is unverified and appears to be hallucinated or inferred incorrectly, hurting quantitative accuracy. (2) The original answer specifies the capacity service starts in 2024, which the LLM omits, a notable date missing from the multi-hop timeline. (3) Qualitatively, the LLM correctly distinguishes Duke Energy’s direct exposure via market trading and commodity price risk from Southern Company’s indirect exposure through contractual arrangements. However, it fails to mention key mechanisms cited in the ground truth: Duke Energy’s use of fuel adjustment clauses, formula-based contracts, and hedging programs that defer costs as regulatory assets/liabilities, and Southern Company’s 10-year coordinated planning agreement and shared dispatch mechanisms. These omissions weaken the reasoning and completeness. (4) The LLM captures the core contrast—direct vs. indirect exposure—and correctly identifies Alabama Power’s role and the fixed capacity arrangement, so the semantic meaning is partially aligned. Contextual relevance is high as it directly addresses the comparison asked. Overall, the answer gets the main idea right but lacks depth in mechanisms and includes an unsupported percentage, warranting a 7 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 441,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How does the growth in Starbucks' store count in Taiwan compare to Nike's revenue contribution from the Greater China region, considering that Taiwan is included within the Greater China geographic segment?",
      "original_answer": "Starbucks reported a net increase of 21 stores in Taiwan from fiscal year 2021 to 2022, bringing its total store count in Taiwan to 544. Nike, which includes Taiwan within its Greater China segment, reported total revenues of $7.547 billion from that region in fiscal year 2022. Given that Greater China includes mainland China, Hong Kong, and Taiwan, Starbucks’ store presence in Taiwan is a component of the broader regional market that contributes to Nike’s revenue, though the specific revenue contribution from Taiwan alone is not disclosed by Nike.",
      "llm_answer": "Starbucks added 21 net licensed stores in Taiwan in fiscal 2022, increasing the count from 523 to 544【page_12】. In the same year Nike generated roughly $7.5 billion of revenue from its Greater China segment—which includes Taiwan—accounting for about 16 % of Nike’s total $46.7 billion revenue【page_88】. Thus, Starbucks’ Taiwan growth was a modest increase in store count, while Nike’s Greater China region contributed a multi‑billion‑dollar revenue amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports that Starbucks added 21 net stores in Taiwan in fiscal 2022, increasing the total to 544, which matches the ground truth. It also accurately states Nike's Greater China revenue as approximately $7.5 billion in fiscal 2022 (ground truth: $7.547 billion), a minor rounding difference that is acceptable under semantic equivalence. The LLM adds contextual detail—Nike’s total revenue of $46.7 billion and that Greater China accounted for about 16%—which is consistent with the data and enhances completeness without introducing error. (2) All numbers are quantitatively accurate or acceptably rounded; the store count increase (544 - 523 = 21) is correct, and $7.5 billion is a valid approximation of $7.547 billion. (3) The multi-hop reasoning is sound: the model correctly identifies that Taiwan is part of Nike’s Greater China segment and contrasts Starbucks’ physical expansion (store count growth) with Nike’s financial performance (regional revenue), aligning with the comparative intent of the question. It does not falsely attribute Nike’s revenue to Taiwan alone, acknowledging the broader segment—consistent with the ground truth’s caveat. (4) The only minor shortcoming is that the LLM does not explicitly state that Nike does not disclose Taiwan-specific revenue, though this is implied by referencing the entire Greater China segment. This omission slightly affects completeness but does not detract from factual correctness. Overall, the answer is factually precise, contextually appropriate, and logically synthesized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 433,
        "total_tokens": 1701
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How do the supplier finance disclosures required by ASU 2022-04 affect the visibility of 3M's $0.3 billion in confirmed invoice obligations, and how does FedEx's adoption of the same standard compare in terms of transparency?",
      "original_answer": "ASU 2022-04 significantly enhances the visibility of 3M's supplier finance obligations, which stood at $0.3 billion as of December 31, 2024, by mandating detailed disclosures such as key terms, balance sheet presentation, and roll-forward information. This requirement was adopted by 3M starting in 2023, with full roll-forward reporting effective in 2024. Similarly, FedEx adopted ASU 2022-04 effective June 1, 2023, and also included disclosures related to its supplier finance program obligations. Both companies now provide stakeholders with clearer insights into their supplier finance activities, aligning their reporting practices under the new standard to enhance transparency.",
      "llm_answer": "ASU 2022‑04 obliges 3M to disclose its supplier‑finance program in detail; Note 16 shows that about $0.3 billion of confirmed invoices were outstanding at year‑end (with $1.5 billion of invoices confirmed and paid during 2024), so the liability is fully visible within accounts payable. FedEx likewise notes that it adopted ASU 2022‑04, but its filing only says the adoption had no material effect and does not quantify the outstanding balance, making its supplier‑finance exposure far less transparent than 3M’s.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that ASU 2022-04 enhances visibility of 3M's supplier finance obligations and notes the $0.3 billion outstanding as of year-end, which aligns with the ground truth. However, it introduces a new figure—$1.5 billion of invoices confirmed and paid during 2024—that is not present in the original answer or supported by the knowledge graph, making it factually unsupported. This undermines quantitative accuracy. (2) The date of 3M’s adoption is implied to be 2024 reporting (consistent with ground truth), but the LLM does not explicitly confirm adoption started in 2023 with full roll-forwards in 2024. For FedEx, the LLM correctly states adoption effective June 1, 2023, per the standard, but incorrectly claims FedEx did not quantify the balance—while the original answer confirms FedEx provided disclosures, though possibly less detailed. The claim that FedEx’s exposure is 'far less transparent' is a subjective interpretation not fully substantiated by the ground truth, which states both companies now provide clearer insights. (3) The multi-hop reasoning is partially sound: the model compares two companies’ adoption and disclosure practices under ASU 2022-04. However, it overreaches by asserting FedEx lacks quantification when the ground truth affirms both included disclosures. The synthesis is therefore incomplete and slightly misleading. (4) Despite the unsupported $1.5B figure and overstatement of transparency differences, the core point—that ASU 2022-04 improves 3M’s visibility and that FedEx also adopted the standard—is correct. Hence, the answer is partially accurate with significant but not fatal flaws, justifying a score of 6/10 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 471,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "How might the dual-class stock structures at CMCSA and META, particularly the 15-vote-per-share advantage for Class B stockholders at CMCSA and the 35% Class B voting power threshold for blocking change-of-control transactions at META, similarly expose minority shareholders to governance risks?",
      "original_answer": "At CMCSA, Class B common stockholders, led by Brian L. Roberts, hold 33⅓% of the combined voting power due to a 15-vote-per-share advantage, which can influence corporate decisions disproportionately relative to their economic stake. Similarly, at META, Class B stockholders control key governance decisions, including blocking change-of-control transactions, as long as they hold at least 35% of the combined voting power. Both structures concentrate decision-making authority in a small group, potentially undermining minority shareholder influence and making the companies less attractive to investors, which could depress stock valuations.",
      "llm_answer": "Both companies give a tiny group of shareholders outsized voting power – Comcast’s Class B shares carry 15 votes each (page 33) giving Mr. Roberts effective control of the board, while Meta’s charter requires that as long as Class B holds at least 35 % of the combined voting power it can block any change‑of‑control transaction (page 50). Because a small, often insider‑controlled class can dominate key votes, ordinary (Class A) investors have limited ability to influence director elections, mergers or other strategic actions, exposing them to governance risk and reduced protection of their interests.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CMCSA's Class B shares have 15 votes per share (correctly cited from page 33), and META's Class B shareholders can block change-of-control transactions if they hold at least 35% of the combined voting power (cited from page 50). These numbers match the original answer exactly. (2) The answer correctly identifies Brian L. Roberts as the controlling shareholder at CMCSA (implied via 'Mr. Roberts'), and notes the disproportionate influence of insiders, which matches the ground truth's emphasis on concentrated control. (3) The multi-hop reasoning is sound: it synthesizes governance risks across two companies, linking the structural features (voting premium, blocking rights) to their impact on minority shareholders—limited influence over director elections, mergers, and strategic decisions. (4) The core concept of governance risk due to voting concentration is clearly conveyed, with semantically equivalent phrasing to the original answer. The only minor shortcoming is that the LLM does not explicitly state CMCSA Class B holders have 33⅓% of voting power, though it implies effective control. This omission slightly reduces completeness but does not undermine the overall correctness. All other elements—context, entities, numbers, logic—are accurate and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 381,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 36,
      "question": "What percentage of V's U.S. pension plan assets classified as Level 2 in 2022 consists of investments in collective investment funds, and how does this allocation strategy compare to COF's use of 'other securities' in terms of investment focus and yield profile?",
      "original_answer": "In 2022, V reported $319 million in collective investment funds under Level 2 assets, out of a total of $960 million in U.S. pension plan assets, representing approximately 33.2%. These funds are described as unregistered investment vehicles that commingle assets from multiple fiduciary clients to invest in portfolios of stocks, bonds, or other securities, including equity and debt instruments. In contrast, COF held $2,834 million in 'other securities' as part of its available-for-sale securities, with a weighted-average yield of 1.57%. While V's collective investment funds focus on diversified portfolios for institutional investors, COF's 'other securities' likely reflect a different risk-return profile given the lower yield and potentially different asset composition.",
      "llm_answer": "Visa’s U.S. pension plan held $319 million of collective‑investment‑fund assets out of $733 million of total Level 2 assets in 2022 – about 43.5% of its Level 2 holdings【page_87】. In contrast, Capital One’s “other securities” total $2.834 billion and deliver a weighted‑average yield of roughly 1.57%, indicating a more income‑focused, fixed‑income orientation versus Visa’s diversified pooled‑fund strategy.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical error in the denominator for the percentage calculation. The original answer states that V's collective investment funds of $319 million are part of $960 million in total U.S. pension plan assets, yielding 33.2%. However, the LLM uses $733 million as the total Level 2 assets, resulting in an incorrect 43.5%. This $733 million figure is not supported by the ground truth and misrepresents the scope of the pension plan assets. While the $319 million figure for collective investment funds is correct, the incorrect base leads to a wrong percentage. COF's $2,834 million in 'other securities' and 1.57% yield are accurately reported. (2) Calculations: The correct percentage is $319M / $960M ≈ 33.2%, not $319M / $733M ≈ 43.5%. The LLM's calculation is mathematically correct but based on an incorrect total, leading to a significant factual error. (3) Multi-hop reasoning: The LLM correctly identifies the two companies (V and COF), the relevant asset categories, and attempts a qualitative comparison between diversified pooled funds and income-oriented fixed income. However, it fails to correctly contextualize V's allocation within the full U.S. pension plan assets as required by the question, instead narrowing the base to Level 2 assets only—though the question asks for the percentage of total U.S. pension plan assets. This misalignment breaks the multi-hop logic. (4) The contextual relevance is high because the answer addresses both parts of the question and draws a reasonable qualitative contrast. Qualitative accuracy is moderate due to correct entity identification and partial reasoning, but undermined by the incorrect asset base. Quantitative accuracy is low due to the incorrect total asset figure and resulting percentage. Correctness score is 5 due to one major factual/calculation error despite otherwise relevant structure and correct data points for COF.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 521,
        "total_tokens": 1847
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How do Adobe's compliance costs related to Saudi Arabia's data localization laws compare to Microsoft's financial exposure from similar regulations, and what does this reveal about their respective cloud service strategies?",
      "original_answer": "Adobe faces significant compliance costs due to its global operations, including exposure to Saudi Arabia's data localization requirements, which could 'adversely impact our business and our enterprise customers' business, our financial condition and our results of operations in those jurisdictions' (ADBE_10k_2024.pdf). Saudi Arabia is explicitly mentioned as one of the jurisdictions implementing data localization requirements that mandate data to remain stored within national borders (MA_10k_2024.pdf). Microsoft discloses that such localization laws globally 'may require changes in services, business practices, or internal systems that result in increased costs, lower revenue, reduced efficiency' and specifically references compliance engineering costs that 'involve substantial expense and the diversion of engineering resources from other projects' (MSFT_10k_2024.pdf). The comparison reveals Adobe's vulnerability through its enterprise customer contracts in Saudi Arabia, while Microsoft faces broader systemic challenges due to its cloud infrastructure and AI services that rely heavily on cross-border data flows.",
      "llm_answer": "Adobe says that complying with Saudi Arabia’s data‑localisation rules will require “substantial expense” and the diversion of engineering resources (ADBE p. 29‑30), whereas Microsoft only warns of a “potential financial exposure” – higher compliance costs, possible fines and litigation risk – from similar data‑sovereignty regulations, without quantifying an amount (MSFT p. 29‑30). This contrast shows Adobe is actively budgeting and investing to keep its cloud services locally compliant, while Microsoft is taking a more defensive, risk‑mitigation stance that could limit or delay cloud offerings in jurisdictions with strict data‑localisation requirements.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in attributing specific disclosures to each company. The claim that Adobe states compliance will require 'substantial expense' and 'diversion of engineering resources' is incorrectly attributed — this language actually comes from Microsoft's 10-K (MSFT_10k_2024.pdf), not Adobe's. Adobe’s actual disclosure emphasizes the adverse impact on its business and enterprise customers due to data localization in jurisdictions like Saudi Arabia, but does not use the specific phrasing about engineering costs. Conversely, the LLM incorrectly claims Microsoft only refers to 'potential financial exposure' without quantification, when in fact Microsoft explicitly discusses 'substantial expense' and 'diversion of engineering resources' — the very terms wrongly assigned to Adobe. (2) There are no numerical values or calculations in either the original or LLM answer, so quantitative accuracy is not heavily applicable; however, the misattribution of qualitative financial impact language constitutes a factual error in disclosure content, which is critical in this context. (3) The multi-hop reasoning is partially sound in that it attempts to compare Adobe’s and Microsoft’s exposures and infer strategic differences. However, because the underlying facts are swapped, the conclusion is flawed: the LLM suggests Adobe is actively investing in compliance while Microsoft takes a defensive stance, when the evidence shows Microsoft is the one explicitly investing engineering resources, indicating proactive adaptation, whereas Adobe highlights risk without detailing mitigation efforts. (4) The contextual relevance is fair — the answer addresses data localization in Saudi Arabia and compares corporate strategies — but the reversal of key disclosures undermines the validity of the comparison. Thus, while the structure and intent are appropriate, the factual inversion leads to an incorrect interpretation of each company's strategy, warranting a low correctness score despite some accurate contextual framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1467,
        "completion_tokens": 558,
        "total_tokens": 2025
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Duke Energy's divestiture of KO Transmission's pipeline facilities impact its FERC regulatory exposure, and how does this contrast with Southern Company's ongoing capital expenditure risks tied to FERC rule changes?",
      "original_answer": "Duke Energy Ohio divested all of KO Transmission's pipeline facilities on February 1, 2023, for approximately book value, which reduces its direct exposure to FERC-regulated interstate pipeline operations. This contrasts with Southern Company’s ongoing capital expenditure programs, which are subject to FERC rule changes that could materially affect construction costs and recovery of investments. Southern Company specifically notes uncertainty in recovering costs related to capital expenditures due to potential changes in FERC regulations. While Duke Energy has mitigated its FERC-related risk in the pipeline business through divestiture, Southern Company remains exposed to regulatory shifts that could impact its construction programs and cost recovery.",
      "llm_answer": "Duke Energy eliminated a FERC‑regulated asset when KO Transmission sold its 90‑mile natural‑gas pipeline (and the 70‑mile co‑owned portion) to Columbia Gas Transmission on Feb 1 2023, thereby reducing the company’s exposure to FERC oversight of interstate gas‑transport operations【page_18】. In contrast, Southern Company’s 2024‑2028 capital‑expenditure plan flags “changes in FERC rules and regulations” as a key uncertainty that could raise costs, delay or reshape projects, leaving the company’s spending still vulnerable to future FERC rule‑change risk【page_104】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key event — Duke Energy's divestiture of KO Transmission's pipeline facilities on February 1, 2023 — which matches the ground truth date and action. It accurately states that this divestiture reduces Duke Energy’s FERC regulatory exposure, aligning with the original answer’s claim about reduced direct exposure to FERC-regulated operations. For Southern Company, the LLM correctly notes ongoing capital expenditure risks tied to FERC rule changes, citing uncertainty in cost recovery and project execution, which reflects the original answer’s emphasis on material impact and recovery risk. (2) Quantitatively, the date (Feb 1, 2023) is correct. While the LLM adds specific details not in the ground truth (e.g., 90-mile pipeline, 70-mile co-owned portion, buyer Columbia Gas Transmission), these are consistent with plausible details from source documents and do not contradict the ground truth. The absence of a dollar amount (e.g., 'approximately book value') is a minor omission but does not impair factual correctness, as the focus is on regulatory impact rather than financial terms. (3) The multi-hop reasoning is sound: the model contrasts Duke’s risk reduction via divestiture with Southern’s continued exposure due to active capital programs, correctly synthesizing information across two companies and regulatory contexts. The use of document citations (page_18, page_104) suggests proper grounding. (4) The LLM answer is semantically equivalent to the original, with slightly more operational detail but no factual deviation. The only reason for not scoring a 10 is the addition of granular pipeline specifics (length, buyer) not present in the ground truth, which, while likely accurate, are not confirmed by the provided truth and slightly exceed the scope. However, they do not detract from correctness. All core elements — entities, dates, regulatory impacts, and contrast — are accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 533,
        "total_tokens": 1885
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $2.7 billion in unfunded commitments to private debt and private equity funds reported by UPS compare to Caterpillar's allocation of $55 million in NAV-measured assets for its other postretirement benefit plans, in terms of liquidity and investment strategy?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private debt and private equity funds, which are illiquid and typically have redemption restrictions for 10–15 year terms, indicating a long-term investment horizon. In contrast, Caterpillar allocates $55 million in NAV-measured assets for its other postretirement benefits, which include less complex instruments like U.S. corporate bonds and short-term instruments, suggesting a more liquid and conservative investment approach. The difference highlights UPS's focus on alternative investments for long-term growth versus Caterpillar's preference for liquidity and stability in managing postretirement obligations.",
      "llm_answer": "UPS reports that it has unfunded commitments of roughly **$2.7 billion** to limited‑partnership interests in private‑debt and private‑equity funds, which are expected to be funded over the next three‑to‑six years and have limited redemption rights (i.e., are illiquid)【page_93】.  \nCaterpillar’s “other post‑retirement benefit” assets include **$55 million** measured at NAV, a relatively small portion of its total post‑retirement portfolio that is held in market‑valued securities and cash, providing greater liquidity for benefit payments【page_102】.  \n\nThus, UPS’s commitment is orders of magnitude larger and represents a long‑term, illiquid alternative‑investment strategy, whereas Caterpillar’s NAV‑measured allocation is modest and focused on maintaining liquidity for its benefit obligations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $2.7 billion unfunded commitments by UPS and Caterpillar's $55 million NAV-measured assets, both matching the ground truth in amount and context. Number formats are consistent and accurate. (2) Quantitative accuracy is perfect: both figures are correctly cited, and the comparison of scale (orders of magnitude) is logically sound. (3) The reasoning correctly contrasts UPS’s illiquid, long-term alternative investment strategy with Caterpillar’s more liquid, conservative approach. While the LLM does not explicitly name the underlying instruments (e.g., U.S. corporate bonds, short-term instruments) as in the original answer, it captures the essence of liquidity and portfolio purpose—supporting benefit payments—thus maintaining strong qualitative accuracy. (4) The answer is fully relevant, directly addressing the comparison in terms of liquidity and investment strategy. The only minor shortcoming is slightly less specificity on Caterpillar’s asset composition, but the core inference remains correct. Hence, high scores across all dimensions with a 9 on correctness due to near-complete semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 330,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does Alphabet's selective repurchase of Class A and Class C shares, while retaining Class B shares with enhanced voting rights, contrast with Netflix's uniform voting rights structure, and what might this imply about Alphabet's governance strategy?",
      "original_answer": "Alphabet selectively repurchased $62.2 billion of Class A and Class C shares in 2023 while retaining Class B shares, which carry 10 votes per share, suggesting a strategy to maintain concentrated voting control. In contrast, Netflix provides one vote per share across all common stock, indicating a more egalitarian governance approach. This contrast implies that Alphabet's repurchase strategy may be designed to preserve the influence of stakeholders holding Class B shares, which could include insiders or long-term investors, rather than diluting their control through broader ownership.",
      "llm_answer": "Alphabet’s board repurchases only its Class A (one‑vote) and Class C (no‑vote) shares, leaving the 10‑vote Class B shares untouched – the only shares that carry enhanced voting power (see GOOGL 10‑K p. 81). Netflix, by contrast, states that every share of its common stock is entitled to one vote per share (see NFLX 10‑K p. 61). This dual‑class, selective‑repurchase approach lets Alphabet concentrate voting control with insiders while still returning cash to all shareholders, whereas Netflix’s uniform one‑share‑one‑vote structure reflects a more egalitarian governance model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Alphabet repurchased Class A and C shares while preserving Class B shares with 10 votes per share, and Netflix maintains a one-vote-per-share structure. The dollar amount of $62.2 billion from the ground truth is not mentioned in the LLM answer, which is a minor omission but does not affect the core reasoning. (2) Quantitative accuracy is strong—no incorrect numbers are presented, and the absence of the $62.2B figure does not introduce inaccuracy, though it reduces completeness slightly. (3) Multi-hop reasoning is sound: the model correctly synthesizes governance differences between Alphabet’s dual-class selective repurchase strategy and Netflix’s uniform voting structure, and infers the implication about control preservation vs. egalitarian governance. (4) The answer is contextually relevant, directly addressing the contrast in share structures and governance implications. The only reason for not scoring a 10 is the omission of the specific repurchase amount ($62.2B), which was present in the original answer and adds quantitative precision. However, since the focus is on the structural and strategic contrast, the omission is minor. Semantic equivalence is maintained in all key aspects.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1319,
        "completion_tokens": 365,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How did the Tax Reform Act's GILTI provisions impact Coca-Cola's 2022 effective tax rate, and how does this compare to Philip Morris International's 2021 effective tax rate benefit from the corporate income tax reduction enacted in the Philippines where it operates and completed business combinations?",
      "original_answer": "The Tax Reform Act's GILTI provisions impacted Coca-Cola's 2022 effective tax rate by requiring the company to account for these taxes in the period subject to such tax, contributing to a $431 million net tax expense (4.4% impact on effective tax rate). For Philip Morris International, the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a 0.1 percentage point decrease in its 2021 effective tax rate, which stood at 21.8%. This tax benefit occurred in a jurisdiction where PMI completed business combinations, including in the Philippines, as part of its global expansion strategy.",
      "llm_answer": "Coca‑Cola said the Global Intangible Low‑Taxed Income (GILTI) provisions of the Tax Reform Act were accounted for in the period and are reflected in its full‑year tax provision, which helped push its 2022 effective tax rate to about 21.1% (KO 10‑K, p. 107). By contrast, Philip Morris International’s 2021 effective tax rate of 21.8% was partially offset by the corporate‑income‑tax reduction enacted in the Philippines—where it operates and completed business combinations—so the net increase was only 0.1 percentage point (PMI 10‑K, p. 94).",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial correctness but has significant factual inaccuracies. It correctly identifies Coca-Cola's 2022 effective tax rate (21.1%) and references GILTI provisions, but fails to report the $431 million net tax expense and the specific 4.4% impact on the effective tax rate from GILTI, which is central to the question. Instead, it vaguely states GILTI 'helped push' the rate to 21.1%, which misrepresents the causal relationship and omits the quantitative impact. For Philip Morris International (PMI), the LLM incorrectly frames the Philippines' tax reduction as a factor that 'partially offset' the tax rate, implying it increased the rate, when in fact it was a benefit that decreased it by 0.1 percentage point. The ground truth states the reduction contributed to a 0.1 pp decrease, but the LLM says the net increase was 0.1 pp, which is factually wrong. However, it does correctly state PMI’s 2021 effective tax rate as 21.8% and links the tax change to the Philippines where PMI completed business combinations. (2) Quantitative accuracy is compromised: the $431M expense and 4.4% impact for Coca-Cola are missing; for PMI, the direction of the tax impact is reversed (increase vs decrease), though the 0.1 pp magnitude and 21.8% rate are correct. (3) Multi-hop reasoning is partially sound—linking GILTI to Coca-Cola’s tax rate and Philippine tax changes to PMI’s rate and business combinations—but the synthesis is flawed due to incorrect interpretation of the impact direction for PMI and omission of key data for Coca-Cola. (4) Contextual relevance is high as the answer addresses both companies, relevant tax provisions, jurisdictions, and business combinations. However, due to key numerical omissions and a critical error in interpreting the direction of PMI’s tax rate impact, the overall correctness is only moderate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 506,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 37,
      "question": "How does the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 influence the risk exposure of MET's $12.392 billion portfolio of pass-through mortgage-backed securities, given that these securities are directly secured by mortgage loans serviced by institutions like BAC?",
      "original_answer": "BAC sold $3.1 billion in mortgage loans to GSEs in 2023, which are part of the broader pool of loans that can be securitized into pass-through mortgage-backed securities (MBS). MET holds $12.392 billion in such pass-through MBS as of 2023, which are directly secured by mortgage loans—often serviced by institutions like BAC. If BAC, as a servicer, experiences issues in fulfilling its obligations (e.g., due to cybersecurity incidents or servicing breaches), this could lead to disruptions in cash flows or increased credit risk for the underlying loans, which in turn affects the value and performance of MET’s pass-through MBS portfolio.",
      "llm_answer": "Bank of America disclosed that it sold roughly $3.1 billion of mortgage loans to the GSEs (mainly Freddie Mac) in 2023 【page_18】. Those loans are now backed by GSE guarantees, which can lower the credit risk of any pass‑through securities that BAC services. MetLife’s pass‑through RMBS holdings amount to $12.392 billion and are broadly diversified across many issuers 【page_98】, so the $3.1 billion sale represents only a modest slice of the underlying loan pool and therefore only marginally reduces MetLife’s overall risk exposure.",
      "correctness_score": 4,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "1) The LLM answer correctly identifies the $3.1 billion in mortgage loans sold by BAC to GSEs in 2023 and MetLife's $12.392 billion pass-through MBS portfolio, matching the ground truth numerically. These values are accurate and properly attributed, earning high marks for quantitative accuracy. 2) However, the reasoning and qualitative interpretation diverge significantly from the ground truth. The LLM claims that the sale 'marginally reduces MetLife’s overall risk exposure' because the $3.1B is a 'modest slice' of the underlying pool, implying a de-risking effect due to GSE guarantees. This contradicts the original answer, which emphasizes that BAC’s role as a servicer introduces risk (e.g., from cybersecurity or servicing failures) that could negatively impact MET’s MBS portfolio—i.e., a risk transmission channel, not a reduction. 3) The multi-hop reasoning is flawed: while the LLM connects BAC’s loan sales to GSEs with MET’s MBS holdings, it inverts the risk implication. The ground truth focuses on operational/servicing risk from BAC affecting cash flows to MET’s securities, not on credit risk reduction via GSE backing. The LLM fails to mention any potential for BAC’s servicing issues to disrupt MET’s portfolio, which is the core of the original answer. 4) Contextually, the answer is relevant and addresses the entities and question scope, but the conclusion is partially incorrect in logic and directionality of risk. Thus, while numbers are correct, the qualitative and overall correctness scores are significantly reduced due to flawed risk interpretation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 431,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the valuation complexity of NKE's embedded derivatives, which result in Level 3 classification, compare to LOW's use of unobservable inputs for fair value measurements, particularly in terms of reliance on non-market-based assumptions?",
      "original_answer": "NKE disclosed $5 million in embedded derivatives as of May 31, 2022, which resulted in Level 3 classification due to the use of significant unobservable inputs such as extrapolation beyond observable limits and policyholder behavior assumptions. Similarly, Level 3 classifications—as described in MET_10k_2022—rely on non-market-based assumptions like actuarial inputs for policyholder behavior and mortality, which cannot be corroborated by observable market data. LOW, however, reported no material fair value measurements on a nonrecurring basis and emphasized that its financial assets and liabilities not measured at fair value on a recurring basis (such as long-term debt) primarily use observable inputs like quoted market prices or discounted cash flow analyses with incremental borrowing rates, indicating a lesser reliance on unobservable assumptions compared to NKE's Level 3 embedded derivatives.",
      "llm_answer": "NKE’s embedded derivatives are valued with option‑pricing models that require significant unobservable inputs—such as extrapolated swap‑yield curves, implied volatilities, actuarial assumptions about policy‑holder behavior, non‑performance risk and a cost‑of‑capital risk margin—so the fair‑value estimates fall into Level 3 because those inputs cannot be corroborated by market data (see MetLife discussion of Level 3 embedded derivatives, pp. 264‑265). In contrast, Lowe’s fair‑value measurements are based on quoted market prices or pricing models that use observable market inputs (benchmark yields, broker‑dealer quotes, issuer spreads, etc.), and the company reported no Level 3 items, indicating far less reliance on non‑market‑based assumptions (see Lowe’s fair‑value note, p. 56).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts or dates are incorrectly stated; while the original answer mentions NKE's $5 million in embedded derivatives as of May 31, 2022, the LLM omits this figure but does not contradict it—this is a minor omission, not an error. All other qualitative financial disclosures (e.g., absence of Level 3 items at LOW) are correctly represented. (2) The LLM correctly identifies that NKE uses significant unobservable inputs (e.g., policyholder behavior, extrapolated curves, cost-of-capital margin) leading to Level 3 classification, consistent with the ground truth’s reference to MET_10k_2022 and NKE’s disclosures. It accurately contrasts this with LOW’s reliance on observable inputs (quoted prices, benchmark yields, broker quotes) and explicitly notes the absence of Level 3 items, which matches LOW’s reported lack of material nonrecurring fair value measurements. (3) Multi-hop reasoning is sound: the model synthesizes information across NKE, MET (as a reference for Level 3 context), and LOW, correctly drawing a comparative conclusion about relative reliance on non-market-based assumptions. (4) The only minor shortcoming is the omission of the specific $5 million value for NKE’s embedded derivatives, which was present in the original answer and adds precision. However, since the focus is on valuation complexity and assumption reliance—not magnitude—the omission does not undermine the core correctness. Wording differs but semantic meaning and analytical conclusion are equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, 10 for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 469,
        "total_tokens": 1917
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "As defense industry peers managing significant pension assets, how do GD's and LMT's approaches to Level 3 asset valuations differ, given GD's use of valuation models with observable inputs for fixed-rate notes versus LMT's reliance on unobservable inputs for its $4,951 million private equity fund holdings?",
      "original_answer": "GD values its Level 3 assets, including fixed-rate notes, using valuation models that incorporate observable inputs such as interest rates and quoted prices for similar assets. In contrast, LMT's $4,951 million in private equity funds, which are also Level 3 assets, are valued using NAV based on valuation models that rely on unobservable inputs not corroborated by verifiable market data. This highlights a key difference in their fair value accounting methodologies for similar asset classifications, with GD relying on more market-validated inputs while LMT uses internally-derived assumptions for its private equity investments.",
      "llm_answer": "GD values its fixed‑rate notes with a market‑based approach that uses observable inputs—interest‑rate curves, bond yields and comparable quoted prices—so the fair value is derived from data that can be verified in the market (see GD 10‑K p. 83‑84; fixed‑rate note schedule p. 76). In contrast, Lockheed Martin’s $4.951 billion of private‑equity fund holdings are classified as Level 3 and are measured at NAV using valuation models that rely on unobservable inputs that cannot be corroborated by market data (see LMT 10‑K p. 87‑88). Thus GD’s Level‑3‑related valuations are grounded in observable market information, whereas LMT’s Level‑3 assets depend on judgment‑heavy, unobservable assumptions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: GD uses observable inputs (interest rates, quoted prices) for its fixed-rate notes in Level 3, while LMT’s $4,951 million (expressed as $4.951 billion, which is numerically equivalent) in private equity funds relies on unobservable inputs via NAV-based models. (2) Quantitative accuracy is perfect: $4,951 million = $4.951 billion, and no other numbers are misstated. (3) Multi-hop reasoning is sound—answer correctly synthesizes valuation methodologies across two companies (GD and LMT), links them to Level 3 asset classification, and contrasts observable vs. unobservable inputs. (4) The answer addresses all parts of the question: differences in valuation approaches, specific asset types (fixed-rate notes vs. private equity), and the role of input observability. Wording differs slightly but meaning is identical. Citations to 10-K pages further support accuracy. No factual, numerical, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 298,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 38,
      "question": "How does the legal exposure from Slack's shareholder litigation, including the timeline and procedural history of the motion to dismiss, compare to Disney's recent antitrust litigation strategy involving motions to dismiss in the Biddle and Fendelander actions?",
      "original_answer": "Slack faced a multi-year shareholder litigation process beginning in 2019, with the motion to dismiss filed in January 2020, partial denial in April 2020, and eventual reversal by the Ninth Circuit on February 10, 2025, leading to dismissal with prejudice. In contrast, Disney filed motions to dismiss in both the Biddle and Fendelander actions on January 31, 2023, which were granted in part and denied in part by September 30, 2023. Disney then filed another motion to dismiss the consolidated amended complaint on December 1, 2023, which was also granted in part and denied in part on June 25, 2024. While Slack’s litigation reached the U.S. Supreme Court and resulted in a definitive dismissal, Disney’s antitrust cases remain ongoing with class certification deadlines set for March 27, 2026.",
      "llm_answer": "Slack’s shareholder suits have been pending since September 2019, and Slack filed its first motion to dismiss in January 2020. The district court granted the motion in part in April 2020, the decision was appealed through the Ninth Circuit (affirmed Sept 2021, rehearing denied May 2022) and the U.S. Supreme Court (vacated June 2023), and the Ninth Circuit finally ordered dismissal with prejudice on Feb 10 2025 (page 91). By contrast, Disney’s antitrust claims were filed in Nov 2022 (the Biddle and Fendelander actions) and Disney moved to dismiss them on Jan 31 2023; the court partially granted/denied those motions on Sept 30 2023, consolidated the cases, and after a second motion to dismiss the consolidated complaint (filed Dec 1 2023) the court again granted and denied parts on June 25 2024, leaving the litigation active with a class‑certification deadline in 2026 (page 116). Thus Slack’s exposure has largely been resolved after a multi‑year appellate battle, whereas Disney’s exposure remains unresolved, with only partial dismissals and the case still in its early stages.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Correct elements: The timeline for Slack's litigation is accurate—shareholder suits began in 2019, motion to dismiss filed January 2020, partial denial in April 2020 (described as 'granted in part'), Ninth Circuit ultimately ordered dismissal with prejudice on February 10, 2025. Disney’s motions to dismiss were correctly dated: filed January 31, 2023, partial grant/denial on September 30, 2023; second motion filed December 1, 2023, and partially granted/denied on June 25, 2024. The class certification deadline of 2026 is correctly noted. (2) Quantitative accuracy: All dates and procedural milestones are correct. One minor discrepancy: the LLM mentions the Supreme Court vacated the decision in June 2023 and the Ninth Circuit rehearing was denied in May 2022, which adds detail not in the original answer but does not contradict it—the original simply states the final reversal occurred on February 10, 2025. These additional procedural steps are plausible and consistent with appellate process, so they do not reduce accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes timelines, outcomes, and procedural posture across two companies and multiple cases, and draws a valid comparison—Slack’s litigation is resolved after appellate review, while Disney’s remains ongoing. (4) The answer is contextually excellent, directly addressing the comparison of legal exposure, timeline, and motion-to-dismiss history. The only reason for not scoring 10 is that the original answer does not mention the Supreme Court vacatur or rehearing denial, so including them—while potentially accurate—introduces unverified intermediate steps. However, since they don’t contradict and may reflect deeper detail, the score remains high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1500,
        "completion_tokens": 491,
        "total_tokens": 1991
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Intel's tax benefit from operations in Hong Kong compare to Apple's revenue contribution from the Greater China region, considering the inclusion of Hong Kong within Apple's Greater China reporting?",
      "original_answer": "Intel reported deriving effective tax rate benefits from operations in Hong Kong, where statutory tax rates range from 12.5% to 24.0%, as part of its broader non-US tax strategy. Meanwhile, Apple reported $74.2 billion in net sales from the Greater China region in 2022, which includes Hong Kong. This indicates that while Intel leverages Hong Kong for tax optimization, Apple generates significant revenue from the broader Greater China region, which encompasses Hong Kong.",
      "llm_answer": "Intel says the tax benefit it receives from its Hong Kong operations “primarily” lowers its effective tax rate by about 5.9 percentage points (the “Non‑US income taxed at different rates” line in its 2022 10‑K). By contrast, Apple’s Greater China segment – which includes Hong Kong – contributed roughly $74.2 billion of net sales in 2022, a far larger absolute amount than Intel’s modest tax‑rate reduction.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Intel's tax benefit lowering its effective tax rate by 5.9 percentage points (from the 'Non-US income taxed at different rates' line in its 2022 10-K) and Apple's $74.2 billion in net sales from Greater China in 2022 are factually accurate and match the knowledge graph. (2) The answer correctly identifies both companies (Intel and Apple), the relevant financial metrics (effective tax rate impact and net sales), and the correct year (2022). (3) The multi-hop reasoning is sound: it compares Intel’s tax benefit from Hong Kong operations to Apple’s revenue from Greater China (which includes Hong Kong), correctly noting the difference in nature (tax reduction vs. revenue generation) and scale. (4) The LLM adds specific detail not in the original answer—namely the 5.9 percentage point impact—demonstrating deeper insight from the 10-K, which strengthens the response. The only minor limitation is that it does not explicitly mention Hong Kong’s statutory tax rate range (12.5%–24.0%) as in the original answer, but this detail is secondary to the core comparison. Overall, the answer is factually correct, contextually relevant, and synthesizes information appropriately across filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 363,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does the 70% CO₂ emissions reduction target set by North Carolina's HB 951 impact Duke Energy's Carolinas Resource Plan, and how does this regulatory requirement compare with NextEra Energy's operational exposure in North Carolina?",
      "original_answer": "North Carolina passed HB 951 in 2021, directing the NCUC to develop and approve a carbon reduction plan targeting a 70% reduction in CO₂ emissions from Duke Energy Progress' and Duke Energy Carolinas' electric generation by 2030. In response, Duke Energy filed its 2023 Carolinas Resource Plan, recommending Portfolio 3 as the most prudent path forward, which includes retiring coal by 2035 and leveraging nuclear and energy storage to meet the emissions targets. Meanwhile, NextEra Energy operates in North Carolina, exposing it to the same regulatory environment, though it is not directly subject to HB 951. This creates a differentiated regulatory burden and transition pathway between the two companies in the same state.",
      "llm_answer": "HB 951’s mandate for a 70 % CO₂ cut by 2030 compelled the NCUC to adopt a carbon‑reduction plan, and Duke Energy’s 2023 Carolinas Resource Plan reflected this by recommending Portfolio 3—a low‑cost pathway that retires coal by 2035 and expands renewables, storage and demand‑response to meet the target (see pages 69 & 71). In contrast, NextEra Energy’s 10‑K does not cite a comparable state‑mandated emissions target for North Carolina, indicating its exposure there is limited to competitive generation assets and not bound by the HB 951 requirement (see page 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the 70% CO₂ reduction target by 2030, the 2035 coal retirement date, and the reference to Duke Energy's 2023 Carolinas Resource Plan and Portfolio 3 are all factually accurate. The mention of HB 951 being passed in 2021 is implied contextually and not contradicted. (2) The LLM correctly identifies that Duke Energy is directly subject to HB 951 and has responded with a specific resource plan, while NextEra Energy is not bound by the mandate, which matches the ground truth. (3) The multi-hop reasoning is sound: it connects HB 951 → NCUC → Duke’s regulatory obligation → Duke’s operational response (Portfolio 3, coal retirement, renewables/storage), and contrasts this with NextEra’s lack of direct regulatory exposure. (4) The only minor shortcoming is that the LLM does not explicitly name Duke Energy Progress and Duke Energy Carolinas as the regulated entities under HB 951, nor does it clarify that NextEra is still exposed to the same regulatory environment competitively—though it correctly notes NextEra is not bound by the mandate. This omission slightly reduces completeness but does not impair the core accuracy. Wording differences (e.g., 'low-cost pathway' vs 'most prudent path') are semantically acceptable. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 395,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How do MDLZ's use of weighted-average assumptions for measuring postretirement healthcare costs differ from KO's application of these assumptions in the Black-Scholes-Merton model for stock option valuation?",
      "original_answer": "MDLZ uses weighted-average assumptions to determine its net periodic postretirement healthcare costs, which resulted in costs of $14 million in 2021, $12 million in 2022, and a benefit of $5 million in 2023. These assumptions are applied to liability cash flows using spot rates along a yield curve to measure service and interest costs. In contrast, KO uses weighted-average assumptions as inputs in the Black-Scholes-Merton option-pricing model to estimate the fair value of stock options granted, which are then expensed on a straight-line basis over a four-year vesting period. The key difference lies in the financial valuation context: MDLZ applies the assumptions for postretirement benefit accounting, while KO uses them for equity compensation valuation.",
      "llm_answer": "MDLZ applies weighted‑average **actuarial** assumptions – a discount rate (e.g., 5.53 % for U.S. plans in 2023) and a health‑care cost‑trend rate (e.g., 7.0 % in 2023) – to calculate the net periodic cost of its post‑retirement health‑care benefits【page_107】.  \nKO, by contrast, uses weighted‑average **market** inputs – risk‑free interest rate, expected volatility, dividend yield and expected term (e.g., 4.1 % risk‑free, 17.5 % volatility, 6‑year term) – in its Black‑Scholes‑Merton option‑pricing model to determine the fair value of stock options【page_108】【page_95】.  \n\nThus, MDLZ’s weighted‑average assumptions are for actuarial measurement of benefit costs, whereas KO’s are for financial valuation of stock options.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly distinguishes MDLZ's use of weighted-average actuarial assumptions (discount rate and healthcare cost-trend rate) for postretirement healthcare cost measurement from KO's use of weighted-average market inputs in the Black-Scholes-Merton model for stock option valuation. The specific examples (e.g., 5.53% discount rate, 7.0% healthcare trend for MDLZ; 4.1% risk-free rate, 17.5% volatility, 6-year term for KO) are consistent with typical disclosures and plausibly extracted from the cited pages, though the original answer does not include these granular percentages. (2) Quantitatively, the LLM omits the actual dollar amounts of postretirement costs/benefits ($14M, $12M, -$5M) mentioned in the ground truth, which is a minor omission but does not contradict any data. No calculations are required, so no errors there. (3) The multi-hop reasoning is sound: the model correctly synthesizes that MDLZ applies assumptions in an actuarial context for benefit liabilities, while KO uses them in a financial valuation context for equity compensation. (4) The semantic meaning fully captures the key distinction in application context as stated in the original answer. The inclusion of specific input types and examples enhances clarity without introducing inaccuracies. The answer is fully relevant and directly addresses the comparative aspect of the question. A score of 9 is justified due to the omission of the exact financial impacts (costs/benefits in dollars), but the core conceptual and qualitative analysis is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 440,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does JPMorgan Chase's exposure to derivatives under the Dodd-Frank Act compare to Bank of America's resolution planning obligations under the Orderly Liquidation Authority, particularly in terms of liquidity risk management during financial distress?",
      "original_answer": "JPMorgan Chase is subject to Dodd-Frank regulations that govern its use of derivatives through enforceable set-off and close-out netting provisions under ISDA Master Agreements, which are constrained by the Orderly Liquidation Authority (OLA) under Title II of Dodd-Frank. Similarly, Bank of America must submit resolution plans under the OLA that outline a 'single point of entry' strategy, restricting liquidity flows from subsidiaries to the parent company during financial distress. Both firms face regulatory constraints on liquidity: JPMorgan through enforceable netting limitations and Bank of America through intercompany liquidity contribution arrangements that prioritize subsidiary solvency over parent company funding needs.",
      "llm_answer": "JPMorgan’s derivative exposure is largely mitigated by ISDA‑governed netting and collateral arrangements that, under the Orderly Liquidation Authority in Dodd‑Frank, allow the firm to set‑off receivables against payables and apply posted collateral without an automatic stay, thereby limiting liquidity strain if a counter‑party defaults (JPM 10‑K p. 261). In contrast, Bank of America’s resolution‑planning obligations under the OLA require the parent to maintain capital and liquidity buffers at key subsidiaries and may restrict inter‑company funding in a crisis, so liquidity risk is managed through broader capital‑and‑liquidity requirements that could be constrained during distress (BAC 10‑K p. 13).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor differences in emphasis. (1) All factual elements are correct: JPMorgan Chase's derivative exposure is governed by ISDA Master Agreements with close-out netting and set-off rights under the Orderly Liquidation Authority (OLA), which mitigates liquidity risk during distress—this aligns with the original answer. Bank of America’s resolution plan obligations under OLA require liquidity and capital buffers at subsidiaries and restrict intercompany funding, consistent with the 'single point of entry' strategy mentioned in the ground truth. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable in a traditional sense, but all referenced regulatory mechanisms and contractual frameworks (ISDA, OLA, netting, collateral) are correctly identified—thus a score of 10 is justified. (3) The multi-hop reasoning is sound: the model correctly links JPMorgan’s derivatives framework to Dodd-Frank/OLA constraints and contrasts it with Bank of America’s resolution planning and liquidity restrictions. The synthesis across two firms, two regulatory mechanisms, and their implications for liquidity risk is logically coherent. The only minor shortcoming is that the LLM does not explicitly mention 'enforceable netting limitations' for JPMorgan or the prioritization of subsidiary solvency over parent funding in BAC’s case—phrasing present in the original—though the concept is implied through 'restrict inter-company funding' and 'liquidity buffers at key subsidiaries'. (4) Contextual relevance is perfect: the response directly addresses the comparison of liquidity risk management under Dodd-Frank frameworks for both institutions. Overall, the answer is semantically equivalent to the ground truth with high precision and appropriate sourcing cues (10-K page references), warranting a correctness score of 9.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 531,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 39,
      "question": "How does Ohio's continued reliance on coal influence the contrasting energy transition strategies of XOM and CVX, particularly considering XOM's European coal tax burden and CVX's 2024 renewable natural gas investments in the state?",
      "original_answer": "XOM faced a significant $1.8 billion after-tax charge in 2022 due to the EU's new tax on coal and other energy sectors, which targeted companies with surplus profits, signaling regulatory pressure to reduce fossil fuel dependency. Meanwhile, Duke Energy Ohio, a subsidiary operating in the state, held only $23 million in coal inventory as of December 31, 2024, suggesting a cautious but ongoing reliance on coal. In contrast, CVX made targeted investments in Ohio through Brightmark RNG Holdings LLC, achieving commercial operations at renewable natural gas projects in 2024, aligning with a cleaner energy transition. This divergence highlights how regulatory penalties in Europe are pushing XOM toward compliance, while CVX is proactively investing in low-carbon alternatives like RNG in coal-reliant states such as Ohio.",
      "llm_answer": "Ohio’s power mix still leans on coal – Duke Energy reported $23 million of coal inventory in Ohio in 2024 (down from $28 million in 2023)【page_124】. ExxonMobil’s global exposure to coal is being penalized by Europe’s new 33 % “surplus‑profits” tax on coal‑related earnings, which added roughly $1.8 billion to its Q4‑2022 results and $0.2 billion in 2023【page_115】, pushing the company toward de‑coal‑ing its portfolio. By contrast, Chevron is using Ohio’s coal reliance as a catalyst for a low‑carbon shift, expanding its 2024 renewable natural‑gas (RNG) footprint in the state through Brightmark projects in Ohio (among other states)【page_19】, illustrating a divergent transition strategy that substitutes RNG for coal.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key figures are correct: the $1.8 billion after-tax charge for XOM in 2022 (attributed to Q4-2022 in the LLM answer) and the $23 million coal inventory for Duke Energy Ohio as of 2024 are consistent with the original answer. The mention of a $0.2 billion charge in 2023 adds detail not in the original but does not contradict it, assuming it refers to ongoing tax impacts. The 33% surplus-profits tax rate is a precise addition that contextualizes the EU tax, though not specified in the ground truth—this is a reasonable inference and improves clarity. (2) The coal inventory decrease from $28M to $23M is an additional detail not in the original answer but is plausible and consistent with a declining trend; it does not detract from accuracy. (3) Entity accuracy is strong: XOM, CVX, Duke Energy Ohio, Brightmark RNG Holdings LLC (implied via 'Brightmark projects'), and the EU tax are all correctly identified and linked to appropriate actions and timelines. (4) Multi-hop reasoning is sound: the LLM correctly synthesizes how EU regulatory pressure (tax) influences XOM’s strategy, contrasts it with CVX’s proactive RNG investments in Ohio, and uses Ohio’s continued coal reliance as a strategic backdrop. The conclusion that CVX is using coal reliance as a 'catalyst' for low-carbon shift is a valid interpretation. (5) Semantic equivalence is high—wording differs but core facts, causality, and strategic contrast are preserved. The only minor gap is that the original specifies CVX’s RNG projects achieved 'commercial operations' in 2024, which the LLM implies but does not explicitly state. This slight omission prevents a perfect 10. Overall, the answer is factually robust, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 491,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 40,
      "question": "How does the structure of MS's CLNs, which embed credit protection sold by the issuer, compare with JPM's credit-related notes in terms of payout mechanics upon a credit event, given that both instruments involve the transfer of credit risk on reference entities?",
      "original_answer": "Morgan Stanley structures CLNs as hybrid instruments where it purchases credit protection from the issuer, and if a credit event occurs with the reference entity, the principal balance of the note may not be repaid in full. JPMorgan, on the other hand, sells credit protection through credit-related notes, where the issuer pays the investor the difference between the par value and the fair value of the defaulted reference obligation upon a credit event. Both instruments transfer credit risk on reference entities, but MS acts as the buyer of protection while JPM often acts as the seller, affecting payout obligations differently based on their respective positions in the transaction.",
      "llm_answer": "Morgan Stanley’s CLNs are hybrid notes in which the issuer buys credit protection from the investor – the firm is effectively the protection seller.  Consequently, if a credit event occurs the CLN’s principal can be reduced or not repaid in full, with any recovery limited to the underlying reference‑obligation’s recovery value 【page_109】.  \n\nJPMorgan’s credit‑related notes work the opposite way: the issuer purchases protection from the note‑holder, so the investor pays par up‑front and receives periodic coupons and, at maturity, the full par unless a credit event occurs.  If a credit event does occur, the issuer pays the investor the shortfall between the note’s par value and the fair‑value of the defaulted reference obligation 【page_224】.  Thus, MS’s CLNs expose the investor to a loss of principal, whereas JPM’s credit‑related notes provide a defined payout to the investor equal to the loss on the reference entity.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains a critical factual error in the characterization of Morgan Stanley's role in its CLNs. The original answer (ground truth) states that Morgan Stanley *purchases* credit protection from the issuer, meaning MS is the *buyer* of protection. However, the LLM answer incorrectly states that in MS's CLNs, 'the issuer buys credit protection from the investor – the firm is effectively the protection seller,' which reverses the roles: this would make MS the seller of protection, which contradicts the ground truth. This error fundamentally undermines the comparison, as the core distinction between MS and JPM is their opposing positions in the credit protection transaction (MS as buyer, JPM as seller). Despite this, the payout mechanics described for both instruments are semantically aligned with the ground truth: MS CLNs result in potential principal loss (investor bears loss), while JPM’s notes involve a payment from issuer to investor equal to the loss on the reference obligation. There are no numerical values in the question or answers, so quantitative accuracy is not applicable but assumed correct. The structure and contextual relevance are strong—the answer addresses payout mechanics and credit risk transfer as required. However, due to the reversal of MS’s position, the multi-hop reasoning fails at a critical juncture, leading to a low qualitative and overall correctness score. The citation of page numbers suggests source grounding but does not compensate for the conceptual inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 418,
        "total_tokens": 1852
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the application of the reduced disclosure format differ between Georgia Power Company (a subsidiary of Southern Company) and Florida Power & Light Company (a subsidiary of NextEra Energy) in their respective 2022 Form 10-K filings, particularly in terms of their compliance with General Instruction I.(1)(a) and (b) of Form 10-K?",
      "original_answer": "Georgia Power Company, as part of Southern Company's consolidated 10-K filing, explicitly states that it meets the conditions in General Instructions I(1)(a) and (b) of Form 10-K and therefore uses the reduced disclosure format specified in General Instructions I(2)(b), (c), and (d). Similarly, Florida Power & Light Company also asserts compliance with General Instruction I.(1)(a) and (b), qualifying for the reduced disclosure format in its 2022 Form 10-K filing. However, while Georgia Power is one of multiple registrants in a combined filing with Southern Company, Florida Power & Light Company is one of only two registrants in its combined filing, the other being NextEra Energy, Inc., which holds all 1,000 shares of its common stock. Both companies file information only on their own behalf and disclaim responsibility for the other registrants’ data.",
      "llm_answer": "Both subsidiaries say they qualify for the “reduced‑disclosure” filing because they satisfy General Instruction I.(1)(a) and (b). Georgia Power’s statement appears in the Southern Company combined 10‑K as part of a list of subsidiaries – “Each of Georgia Power … meets the conditions set forth in General Instructions I(1)(a) and (b) … and is therefore filing this Form 10‑K with the reduced‑disclosure format specified in General Instructions I(2)(b), (c) and (d).” By contrast, Florida Power & Light’s filing (within the NextEra Energy combined 10‑K) simply notes, “Florida Power & Light Company meets the conditions set forth in General Instruction I.(1)(a) and (b) of Form 10‑K and is therefore filing this Form with the reduced disclosure format,” without the broader subsidiary list or the explicit reference to I(2)(b)‑(d).  Thus, while both comply with I.(1)(a) and (b), Georgia Power’s reduced‑disclosure language is embedded in a multi‑subsidiary disclosure and cites the specific reduced‑disclosure provisions, whereas Florida Power & Light’s is a standalone declaration for that single subsidiary.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Both Georgia Power Company and Florida Power & Light Company are correctly identified as qualifying for the reduced disclosure format under General Instruction I.(1)(a) and (b) of Form 10-K in their 2022 filings—this core fact is correctly stated. (2) There are no numeric values (e.g., dollar amounts, percentages, share counts) in the original or LLM answer that require verification, so quantitative accuracy is not compromised; all references to filing structures and instructions are factually correct. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes information across the two companies’ filings, noting differences in presentation—Georgia Power is part of a multi-subsidiary list within Southern Company’s combined filing and explicitly references I(2)(b)-(d), while Florida Power & Light makes a standalone declaration in the NextEra Energy combined filing without citing the specific reduced-disclosure subsections. This distinction is present in the LLM answer and supported by the ground truth. (4) The only minor omission is that the ground truth mentions NextEra Energy, Inc. holds all 1,000 shares of FP&L’s common stock—a detail absent in the LLM response. While this adds context about control, it is not central to the question about disclosure format application under I.(1)(a) and (b). The LLM captures the key comparative insight about filing structure and language specificity. Thus, the answer is semantically equivalent in substance, with only a slight reduction in completeness on ancillary ownership detail. Scores reflect high accuracy with a minor deduction in qualitative accuracy for partial completeness on structural context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1540,
        "completion_tokens": 475,
        "total_tokens": 2016
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does RTX's revenue recognition timing on U.S. government fixed-price contracts, influenced by FAR guidelines, compare to GD's cost allocation practices under the same regulatory framework, particularly in relation to performance-based payments and contract modifications?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to performance-based payments (PBPs) or progress payments, where the customer retains a portion of the contract price until completion. This practice is guided by the Federal Acquisition Regulation (FAR), which outlines allowable cost structures and payment mechanisms. Similarly, GD operates under the FAR and Cost Accounting Standards (CAS), which regulate cost allowability and allocation across contracts. GD's cost allocation practices are subject to audits and reviews by the government, ensuring that costs charged to contracts comply with FAR stipulations. Both companies must manage contract modifications and revenue or cost adjustments in response to FAR-mandated acquisition phases, including planning, competition, and contractor qualifications, though RTX specifically highlights the impact of these regulations on contract assets and liabilities, while GD emphasizes compliance and auditability under FAR and CAS.",
      "llm_answer": "RTX recognizes revenue on U.S. government fixed‑price contracts over time, using a percentage‑of‑completion method based on costs incurred, so that performance‑based payments (PBPs) and progress payments often generate contract‑asset balances when revenue exceeds billings; contract modifications are accounted for on a cumulative catch‑up or prospective basis (pages 78 & 79). By contrast, GD’s disclosures state that its U.S. government contracts are governed by the FAR for cost allowability and by the Cost Accounting Standards for allocating those allowable costs to contracts, focusing on cost allocation rather than an over‑time revenue‑recognition model, and it treats contract modifications as part of the cost‑allocation process under those standards (page 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies RTX's revenue recognition practice under FAR, using the percentage-of-completion method, leading to contract assets when revenue exceeds billings due to performance-based or progress payments—this matches the original answer’s emphasis on revenue in excess of billings and FAR influence. It also accurately contrasts GD’s focus on cost allocation under FAR and CAS, highlighting auditability and compliance, which is consistent with the original. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised; the LLM correctly references disclosure pages (78, 79, 19), suggesting fidelity to source documents. (3) The multi-hop reasoning is sound: the model synthesizes RTX’s revenue timing with GD’s cost allocation practices under the same FAR framework, correctly distinguishing their accounting models (over-time revenue recognition vs. cost allocation) and treatment of contract modifications. The only minor gap is that the original answer adds context about both companies managing modifications in response to FAR-mandated acquisition phases (planning, competition, etc.), which the LLM omits. Also, the original notes RTX highlights impacts on contract assets/liabilities while GD emphasizes auditability—this nuance is partially captured but less explicitly stated in the LLM response. (4) Despite this slight reduction in completeness, the LLM answer captures the core comparison accurately, uses correct entities (RTX, GD, FAR, CAS, PBPs), and maintains semantic equivalence. Thus, correctness is rated 9 (not 10) due to minor contextual omissions, but all critical facts and reasoning are preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 488,
        "total_tokens": 1968
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does the difference in voting rights structure between Class A and Class B shares at GOOGL compare to CMCSA's disclosure regarding its lack of voting rights in Atairos, and what implications does this have for corporate governance control in both entities?",
      "original_answer": "At GOOGL, Class A shares carry one vote per share while Class B shares carry ten votes per share, creating a dual-class structure that concentrates voting power among holders of Class B shares. This structure allows certain shareholders to maintain control over corporate decisions despite owning a minority of shares. In contrast, CMCSA explicitly discloses that it has no voting rights in Atairos, which is accounted for as an equity method investment, limiting its influence over Atairos’s operations. While GOOGL uses differentiated voting rights to preserve control through a structured share class system, CMCSA lacks such control mechanisms entirely in its investment in Atairos, affecting its corporate governance influence in that entity.",
      "llm_answer": "Alphabet’s capital structure gives Class B shares ten votes per share versus one vote for Class A (and Class C has no voting rights) — concentrating control in the hands of Class B holders 【page_82】. In contrast, Comcast disclosed that it holds no voting rights in Atairos and therefore cannot direct the VIE’s activities 【page_85】. As a result, Alphabet retains strong internal governance leverage through its high‑vote shares, while Comcast’s stake in Atairos is a non‑controlling financial investment with no ability to influence corporate‑governance decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) Quantitatively, it correctly states that Class B shares have ten votes and Class A have one, matching the original answer; it also accurately notes CMCSA has no voting rights in Atairos. The mention of Class C shares (no voting rights) adds context not in the original but is factually correct and does not detract. (2) Completeness: the response addresses both parts of the multi-hop question—GOOGL’s dual-class voting structure and CMCSA’s lack of voting rights in Atairos—and contrasts their implications for corporate governance control. (3) Entity accuracy is correct: GOOGL (Alphabet) and CMCSA (Comcast) are properly identified, and Atairos is correctly referenced as a VIE with no voting rights held by CMCSA. (4) Reasoning is sound: the LLM correctly infers that Alphabet’s structure concentrates control internally, while Comcast lacks governance influence in Atairos. The only minor gap is that the original emphasizes GOOGL’s structure enables control by minority shareholders, while the LLM focuses on 'internal governance leverage'—a slightly less precise phrasing but still accurate. Overall, the answer demonstrates strong multi-hop synthesis and contextual understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 356,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "How does Amgen's reliance on McKesson Corporation for 33% of its gross product sales in 2021 compare to Merck's risk disclosures about pharmaceutical product distribution concentration, given Amgen's specific exposure to wholesaler distribution risks outlined in its 2022 filing?",
      "original_answer": "Amgen's 2022 filing reveals that McKesson Corporation accounted for 33% of its gross product sales in 2021, highlighting a significant dependency on a single wholesaler. This concentration risk is explicitly acknowledged in Amgen's disclosure that the substantial majority of its U.S. product sales are made to just three distributors, including McKesson, and that financial or operational difficulties at any of these could significantly disrupt its business. Merck's 2022 filing similarly warns that 'pharmaceutical products can develop unexpected safety or efficacy concerns' and that 'reliance on third-party relationships and outsourcing arrangements could materially adversely affect the business,' reinforcing the industry-wide sensitivity to distribution chain vulnerabilities. Together, these disclosures underscore the material financial and operational risk both companies face from overreliance on a concentrated pharmaceutical distribution network.",
      "llm_answer": "Amgen’s 2022 filing makes the concentration very concrete – McKesson alone generated about 33 % of Amgen’s gross product sales in 2021 (page 114) and the company warns that a problem with any of its three big wholesale distributors could “significantly disrupt” its business (page 46). Merck’s 10‑K, however, only notes a generic reliance on third‑party distributors and outsourcing arrangements as a risk (pages 11 and 31) and does not quantify a similar single‑distributor exposure, so Amgen’s distribution risk is both higher‑valued and more explicitly disclosed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, it correctly states that McKesson accounted for 33% of Amgen’s gross product sales in 2021, matching the original answer exactly. The citation of page numbers (114 and 46) adds precision, though not required, and does not detract from accuracy. (2) The answer correctly identifies both companies (Amgen and Merck), the relevant year (2021 for sales data, 2022 filings for risk disclosures), and the correct financial metric (gross product sales). (3) Reasoning is sound: it synthesizes multi-hop information by comparing Amgen’s specific, quantified exposure to McKesson with Merck’s more generic risk disclosure about third-party distributors, concluding that Amgen’s risk is both more significant in magnitude and more explicitly disclosed. This is a valid inference supported by the ground truth. (4) While the original answer includes additional context about Merck’s mention of safety/efficacy concerns, the LLM correctly focuses on distribution concentration and notes the absence of quantified exposure at Merck, which is a key differentiator. The omission of Merck’s broader risk language does not undermine the core comparison about distribution concentration. Semantic equivalence is maintained, and the LLM provides a slightly more pointed conclusion about Amgen’s higher and more transparent risk, which is a reasonable interpretation. No calculation errors; all facts are correctly presented. Minor deduction in qualitative accuracy only because it omits the shared industry-wide vulnerability framing present in the original, but the core reasoning remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 455,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 41,
      "question": "What is ConocoPhillips' financial exposure from its ownership in Alba Plant LLC, given Chevron's production of condensate and the plant's role in processing natural gas from the Alba Unit in Equatorial Guinea?",
      "original_answer": "ConocoPhillips has a 56.0% ownership interest in EG LNG and a 52.2% interest in Alba Plant LLC, which processes natural gas from the Alba Unit and extracts condensate and LPG for sale at market prices. According to COP's 2024 10-K, ConocoPhillips has $116 million in maximum potential future payments related to guarantees for Alba Plant LLC’s agreements to process third-party gas. This exposure is tied to Chevron’s upstream production of condensate, which feeds into the Alba Unit’s gas stream, and the downstream monetization through the LPG plant and EG LNG’s liquefaction facility.",
      "llm_answer": "ConocoPhillips owns 52.2 % of Alba Plant LLC, the joint‑venture that processes natural‑gas from the Alba Unit (extracting condensate and LPG) 【page_12】.  Because it has guaranteed payment obligations for the plant, the company faces a maximum potential exposure of roughly **$116 million** in future payments (the guarantee is recorded at about $4 million on the balance sheet) 【page_102】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: ConocoPhillips' 52.2% ownership in Alba Plant LLC and the $116 million maximum potential future exposure are accurately reported, matching the original answer. The mention of the $4 million recorded liability on the balance sheet adds detail not in the ground truth but does not contradict it and may reflect additional context from the 10-K. (2) The answer correctly identifies the key entities: ConocoPhillips, Alba Plant LLC, and the Alba Unit, and correctly links the financial exposure to ConocoPhillips' guarantee obligations. (3) The multi-hop reasoning is sound—connecting ownership, processing role, and financial exposure via guarantees. (4) While the LLM answer does not explicitly mention Chevron’s condensate production feeding into the Alba Unit (a minor omission), it still fully addresses the core of the question—ConocoPhillips’ financial exposure—making the answer contextually complete and semantically equivalent. The absence of EG LNG’s 56% ownership is not critical as the question focuses on Alba Plant LLC. Overall, the answer is factually correct, well-supported, and highly relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1259,
        "completion_tokens": 343,
        "total_tokens": 1603
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "How does the use of valuation models incorporating observable market inputs by General Dynamics' Level 2 assets compare with Union Pacific's disclosure of real estate funds at NAV, given that real estate funds are typically valued using unobservable inputs over 8-10 year terms?",
      "original_answer": "General Dynamics values its Level 2 fixed-income assets using valuation models with observable inputs like interest rates and bond yields, contrasting with Union Pacific's $30 million allocation to real estate funds that are valued at NAV based on unobservable inputs according to LMT's explanation of real estate fund valuation practices which involve long-term valuations over 8-10 year periods.",
      "llm_answer": "General Dynamics says its Level 2 assets are priced with a market‑approach valuation model that uses observable inputs such as interest rates, bond yields and quoted prices for similar securities (GD 10‑K p. 83). Union Pacific, however, discloses that its real‑estate fund holdings are valued at NAV based on property appraisals—inputs that are not readily observable and are typically applied over 8‑ to 10‑year terms (UNP 10‑K p. 57).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers and dollar amounts are correct—though the LLM does not explicitly state Union Pacific's $30 million allocation, this is the only minor omission. The absence of the specific dollar figure reduces completeness slightly but does not affect the core correctness. (2) The qualitative aspects are strong: the LLM correctly identifies General Dynamics' use of observable inputs (interest rates, bond yields, quoted prices) for Level 2 assets, citing the correct document (GD 10-K p.83), and contrasts this with Union Pacific's use of NAV for real estate funds based on unobservable inputs like property appraisals, with a reference to UNP 10-K p.57. (3) The multi-hop reasoning is sound—linking General Dynamics' valuation approach to observable inputs and contrasting it with Union Pacific's NAV-based, unobservable-input method for long-duration real estate funds (8–10 years) demonstrates proper synthesis across two companies and valuation methodologies. (4) The LLM correctly attributes real estate fund valuation practices to long-term unobservable inputs, consistent with the ground truth's reference to LMT's explanation, even if LMT is not explicitly cited here. Wording differs slightly but maintains semantic equivalence. The answer is contextually relevant, directly addressing the comparison asked. The only reason for not scoring a 10 is the missing $30 million figure, which is part of the original answer’s quantitative specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1241,
        "completion_tokens": 423,
        "total_tokens": 1664
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "Given Citibank's co-branding role in Costco's credit card program and its administrative role in Colgate's five-year credit agreement, how does the nature of Citibank's involvement differ in these two financial arrangements?",
      "original_answer": "Citibank's involvement with Costco is characterized by a co-branded credit card program that has undergone twelve amendments since 2015, most recently on October 11, 2023, indicating an ongoing consumer financial product partnership. In contrast, Citibank's role with Colgate is as administrative agent and arranger for a five-year credit agreement most recently amended on November 4, 2022, which represents a corporate lending facility rather than a consumer credit product. The Costco relationship centers on a retail financial service partnership while the Colgate arrangement involves managing a syndicated corporate credit facility.",
      "llm_answer": "Citibank’s role with Costco is that of a co‑branded credit‑card partner – it issues and services the Costco‑branded card and shares the brand in the consumer program (see Costco’s Exhibit 10.8 “Citibank, N.A. Co‑Branded Credit Card Agreement”) 【page_68】. In contrast, with Colgate‑Palmolive Citibank is the administrative agent and arranger for the company’s five‑year credit facility, handling loan administration and syndication rather than branding the product (see Colgate’s Exhibit 10‑I “Amended and Restated Five‑Year Credit Agreement…Citibank, N.A., as Administrative Agent and Arranger”) 【page_67】. Thus, Citibank is a consumer‑facing co‑branding partner in the Costco arrangement, but a behind‑the‑scenes financial intermediary in the Colgate credit agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Citibank's co-branded credit card role with Costco and its administrative agent/arranger role in Colgate's five-year credit agreement are accurately described. The nature of the two arrangements—consumer-facing co-branding vs. corporate lending intermediary—is correctly contrasted. (2) There are no numeric values, dates, or financial figures in the LLM answer that conflict with the ground truth; while the original answer mentions specific amendment dates (October 11, 2023 for Costco, November 4, 2022 for Colgate), the LLM omits these but does not contradict them. Since the question does not explicitly ask for dates, their absence is not a critical omission, though including them would have strengthened completeness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two different companies (Costco and Colgate) and two distinct financial roles (co-branding partner vs. administrative agent), drawing a valid qualitative distinction between consumer and corporate financial services. (4) Semantic equivalence is strong—the LLM uses different phrasing (e.g., 'behind-the-scenes financial intermediary') but accurately reflects the nature of the relationships. The reference to specific exhibits and page numbers adds evidentiary support not in the original answer, enhancing credibility. Only a minor deduction in qualitative accuracy due to omission of amendment history mentioned in the ground truth (12 amendments since 2015), which provides context about the longevity and evolution of the Costco relationship. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 477,
        "total_tokens": 1849
      },
      "error": null
    },
    {
      "question_id": 42,
      "question": "What is Chevron's net daily crude oil production contribution from its stake in QatarEnergy LNG, considering the average daily net production and Chevron's ownership percentage in 2023?",
      "original_answer": "Chevron's net daily crude oil production from its stake in QatarEnergy LNG in 2023 was 3.9 MBD (thousand barrels per day), calculated as 30% ownership of the 13 MBD average daily net crude oil production from QatarEnergy LNG.",
      "llm_answer": "In 2023 the QatarEnergy LNG joint venture reported an average daily net crude‑oil output of 13 thousand barrels (MBD)【page_12】.  Chevron’s 30 % ownership stake translates to an attributable production of roughly 13 × 30 % ≈ 3.9 MBD of crude oil per day.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth. (1) All key facts are accurate: the average daily net crude oil production from QatarEnergy LNG is correctly stated as 13 MBD, Chevron's ownership percentage is accurately given as 30%, and the resulting net production is correctly calculated as 3.9 MBD. (2) The calculation 13 × 30% = 3.9 is mathematically correct and clearly explained. Minor formatting such as 'MBD' and spacing (e.g., '30 %') does not affect meaning or accuracy. (3) The reasoning is sound and demonstrates proper multi-hop synthesis: it combines ownership percentage with production data to derive attributable production, which is the core of the question. (4) The answer is semantically equivalent to the original, with no omissions or inaccuracies. All evaluation dimensions—quantitative, qualitative, and contextual—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1129,
        "completion_tokens": 255,
        "total_tokens": 1384
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How does Caterpillar's use of pricing models for valuing Level 3 non-U.S. pension assets compare to Lockheed Martin's valuation methodology for fixed income investments categorized as Level 3, particularly in terms of the inputs and approaches used?",
      "original_answer": "Caterpillar values its Level 3 non-U.S. pension assets, which include insurance contracts, using pricing models that reflect management's judgment of assumptions a market participant would use. In contrast, Lockheed Martin categorizes fixed income investments as Level 3 when observable inputs are unavailable and uses discounted cash flow approaches or indicative quotes from vendors and brokers, with significant inputs including projected annuity payments and discount rates. Both companies rely on unobservable inputs for Level 3 assets, but Caterpillar focuses on pricing models based on management assumptions, while Lockheed Martin employs a broader set of valuation techniques including discounted cash flows and third-party indicative quotes.",
      "llm_answer": "Caterpillar’s non‑U.S. pension Level 3 assets (insurance contracts) are valued with internal pricing models that management says “reflect the assumptions a market participant would use” 【page_102】. Lockheed Martin’s Level 3 fixed‑income holdings, by contrast, are priced using indicative quotes or bid evaluations from vendors and, where needed, a discounted‑cash‑flow approach that relies on projected annuity‑type cash flows and the discount rate applied to those payments 【page_89】. Thus, Caterpillar leans on market‑participant‑based modeling for insurance‑contract assets, while Lockheed Martin combines external quote‑based inputs with explicit cash‑flow and discount‑rate assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Caterpillar uses internal pricing models based on management's judgment of market participant assumptions for its Level 3 non-U.S. pension assets (insurance contracts), while Lockheed Martin uses indicative quotes from vendors/brokers and discounted cash flow models with inputs like projected annuity payments and discount rates for its Level 3 fixed income investments. (2) There are no numeric values, dates, or financial figures in the question or answer that require verification—thus, quantitative accuracy is not applicable in a traditional sense, but no numbers are misstated. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation methodologies across two different companies, asset types, and disclosure contexts. (4) The only minor shortcoming is that the LLM answer does not explicitly state that both companies rely on unobservable inputs (a key characteristic of Level 3 assets), though this is implied by the context. It also omits the phrase 'significant inputs' when describing Lockheed Martin’s approach, slightly reducing completeness. However, the core comparison—Caterpillar’s reliance on management-based pricing models vs. Lockheed Martin’s use of third-party quotes and DCF models—is clearly and correctly articulated. Wording differs slightly but maintains semantic equivalence. Contextual relevance is perfect as it directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 421,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How might the expiration of Enbrel's formulation patents in 2037 impact Pfizer's Specialty Care segment revenue concentration risk, especially considering Bristol Myers Squibb's external innovation strategy focused on future pipeline assets?",
      "original_answer": "Enbrel remains a key product in Pfizer's Specialty Care segment, where it is listed among major inflammation & immunology offerings. The expiration of its formulation patents in 2037 could expose Pfizer to increased generic competition, potentially exacerbating revenue concentration risk if other pipeline or partnered products have not sufficiently diversified the segment's portfolio by then. Meanwhile, Bristol Myers Squibb's external innovation strategy, which emphasizes acquiring and developing disruptive therapies beyond internal R&D, may position it to enter the post-patent market with new assets, assuming favorable clinical and regulatory outcomes. This dynamic could shift competitive positioning in the inflammation & immunology space if BMY successfully brings alternative therapies to market ahead of the 2037 timeline.",
      "llm_answer": "The 2037 expiry of Enbrel’s formulation patents (U.S. filing 10/19/2037) will likely invite biosimilar competition and erode a major revenue source in Pfizer’s Specialty Care portfolio, which currently lists Enbrel among its key inflammation‑immunology products (Pfizer 10‑K p. 10; patent table p. 11). That erosion would reduce the segment’s reliance on a single blockbuster, lowering its concentration risk but also increasing overall revenue volatility, especially as Bristol‑Myers Squibb’s strategy of sourcing external innovation and building a pipeline of new immunology assets (BMS 10‑K p. 11) could accelerate the launch of competing therapies that further diminish Enbrel’s share.",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in the patent expiration date — it states 'U.S. filing 10/19/2037' as if that is the expiration date, but the ground truth only mentions '2037' as the expiration year. Interpreting a filing date as an expiration date is incorrect and misleading, as patent expiration typically occurs 20 years from filing, not in the same year. This undermines quantitative accuracy. (2) The LLM incorrectly frames the impact on revenue concentration risk: it claims that erosion of Enbrel revenue would 'lower concentration risk', which is partially correct (reducing reliance on one product lowers concentration), but fails to emphasize the core risk highlighted in the original answer — that concentration risk could *increase* if no sufficient pipeline diversification occurs by 2037. The original answer stresses vulnerability *due to lack of diversification*, whereas the LLM implies risk is reduced, which reverses the intended logic. (3) The multi-hop reasoning is partially sound — it connects Enbrel’s patent cliff to biosimilar competition, links Pfizer’s Specialty Care segment exposure, and references BMS’s external innovation strategy. However, the synthesis is flawed in outcome: BMS’s strategy is correctly cited but framed as accelerating competition, while the original emphasizes BMS potentially *filling the gap* post-patent with new assets, altering competitive dynamics. (4) Contextual relevance is high — all entities (Pfizer, BMS, Enbrel, Specialty Care, inflammation-immunology) are correct, and the answer draws on appropriate segments of 10-Ks. Wording and structure are clear, but the reversal in risk interpretation and incorrect patent date significantly reduce correctness. Number format is acceptable, but the false precision of '10/19/2037' as an expiration date is a serious error. Thus, the answer is partially correct with significant flaws in reasoning and factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 528,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 43,
      "question": "How do AIG's market risk stress testing practices compare with COF's credit loss forecasting methods in terms of their reliance on scenario-based modeling and sensitivity analysis?",
      "original_answer": "AIG employs stress testing as part of its market risk management to evaluate the impact of adverse market developments, including through sensitivity analysis and scenario analysis, which are aligned with its corporate risk appetite. This includes analyzing the effects of hypothetical shocks to interest rates, credit spreads, and equity prices. On the other hand, COF uses scenario-based forecasting models to estimate its allowance for credit losses (ACL), which totaled $13.0 billion as of December 31, 2024, incorporating both quantitative forecasts and qualitative adjustments for current and forward-looking economic conditions. Both firms rely on scenario and sensitivity analysis, but AIG applies these techniques to market risk exposures while COF integrates them into credit risk modeling for consumer loan portfolios.",
      "llm_answer": "AIG’s market‑risk framework explicitly uses scenario analysis, sensitivity analysis and stress‑testing techniques to gauge how a range of hypothetical market moves would affect its positions (see AIG 10‑K p. 83). By contrast, Capital One’s credit‑loss forecasting for its credit‑card portfolio is driven by quantitative loss‑forecasting models and qualitative management judgments about economic conditions, with no explicit reliance on scenario‑based or sensitivity‑analysis modeling (see COF 10‑K p. 135). Thus AIG leans heavily on scenario‑driven stress testing, whereas COF’s approach is model‑centric and judgment‑based rather than scenario‑or sensitivity‑focused.",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a major factual inaccuracy in its characterization of COF's credit loss forecasting methods. While it correctly states that AIG uses scenario analysis, sensitivity analysis, and stress testing for market risk (aligned with the ground truth), it incorrectly claims that Capital One (COF) does *not* use scenario-based or sensitivity analysis. The ground truth explicitly states that COF *does* use scenario-based forecasting models for its allowance for credit losses (ACL), incorporating both quantitative forecasts and qualitative adjustments based on current and forward-looking economic conditions. This is a critical error in the core comparison. (2) There are no numeric values in the LLM answer that contradict the ground truth—the $13.0 billion ACL figure is not mentioned but also not misstated—so quantitative accuracy is acceptable. (3) The multi-hop reasoning fails because the model incorrectly synthesizes information from the COF 10-K, asserting a lack of scenario or sensitivity analysis when in fact COF integrates these into its credit risk modeling. The comparison is therefore fundamentally flawed. (4) Contextual relevance is moderate because the answer addresses the right companies and general topic, but the conclusion (AIG uses scenarios, COF does not) is incorrect. The LLM misrepresents COF’s methodology, undermining the qualitative and overall correctness. Semantic equivalence is not achieved due to this key contradiction.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 411,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Qualcomm's exposure to EAR regulations on advanced semiconductor technologies compare with AMD's specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, given both companies' involvement in high-performance computing markets?",
      "original_answer": "Qualcomm's business and products, including those of its customers and licensees, are subject to a broad range of regulations, including the U.S. Export Administration Regulations (EAR), which govern the export and re-export of advanced technologies, potentially affecting its business operations and results. In contrast, AMD faces specific export constraints under EAR, including requirements to file a Notified Advanced Computing (NAC) notification 25 days before shipping certain Versal VC2602 and VE2602 FPGAs to China or to customers outside the U.S. whose ultimate parent is headquartered in a D5 country, including China. These FPGAs are part of AMD's Data Center segment, which includes Field Programmable Gate Arrays (FPGAs) and other adaptive computing products. While both companies are impacted by EAR regulations, AMD's exposure is more directly constrained in terms of specific product lines and geographic markets, particularly affecting its ability to serve Chinese customers without prior regulatory approval, whereas Qualcomm's exposure is more diffuse across its broader regulatory risk profile.",
      "llm_answer": "Qualcomm warns that government export controls – including U.S. Export Administration Regulations – could restrict the sale of its advanced semiconductor technologies to certain customers or regions, creating a broad regulatory risk for its high‑performance‑computing products【page_31】. AMD, by contrast, is subject to narrowly‑targeted BIS rules that prohibit shipping its Versal VC2602 and VE2602 FPGAs to China (or to downstream buyers with a Chinese ultimate parent) without a license and require a 25‑day Notified‑Advanced‑Computing filing【page_33】. Thus Qualcomm’s exposure is a general, market‑wide limitation under EAR, while AMD’s constraints are product‑specific licensing and notification requirements.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm faces broad EAR-related export control risks affecting its advanced semiconductor technologies, while AMD has specific constraints on exporting Versal VC2602 and VE2602 FPGAs to China, requiring a 25-day Notified Advanced Computing (NAC) notification before shipment. The mention of 'license' in the LLM answer slightly extends beyond the ground truth, which specifies only a notification requirement, not a license — this is a minor overstatement but does not materially misrepresent the situation. (2) Quantitative accuracy is perfect: the 25-day NAC filing requirement is correctly cited, and no other numbers are involved. Format and timing are consistent with the original. (3) Multi-hop reasoning is sound: the model correctly contrasts Qualcomm’s diffuse regulatory exposure with AMD’s product- and geography-specific constraints, synthesizing information about two companies, their respective products (FPGAs vs. broader semiconductor portfolio), and regulatory mechanisms. (4) Semantic equivalence is strong — the LLM captures the core distinction: general vs. specific constraints — and remains fully relevant to the comparative question about EAR exposure in high-performance computing. Only a slight lack of detail on AMD’s Data Center segment context prevents a perfect 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1483,
        "completion_tokens": 387,
        "total_tokens": 1870
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does CMCSA's relinquishment of voting rights in Hulu contrast with META's dual-class stock structure in terms of control retention strategies?",
      "original_answer": "CMCSA relinquished substantially all voting rights associated with its investment in Hulu in 2019, including board seats, in exchange for a put/call arrangement with Disney that guaranteed a minimum equity value of $27.5 billion for its interest and resulted in an $8.6 billion payment from Disney in 2023. This contrasts with META's dual-class stock structure where Class B shares carry 10 votes per share compared to 1 vote for Class A shares, allowing certain stockholders to maintain significant voting power while owning a minority of economic interests. CMCSA's approach involved transferring control to Disney in exchange for financial guarantees, whereas META retains internal control differentiation through its stock classification framework.",
      "llm_answer": "CMCSA gave up its board seats and “substantially all voting rights” in Hulu, allowing Disney to take full operational control while Comcast kept only a financial interest (the right to fund capital calls and a put/call option) 【page_85】. Meta, by contrast, retains control through a dual‑class share system that gives insiders’ Class B stock ten votes per share, while public Class A shares have one vote and Class C shares have none 【page_82】. This shows Comcast’s strategy of ceding governance in exchange for a passive stake, whereas Meta’s strategy concentrates voting power to preserve decision‑making authority.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core contrast between CMCSA's relinquishment of voting rights in Hulu and META's dual-class stock structure. (1) All key facts are correct: CMCSA gave up board seats and substantially all voting rights in Hulu, transferring control to Disney while retaining financial rights including a put/call arrangement. The answer correctly contrasts this with META’s dual-class structure where insiders hold Class B shares with 10 votes per share versus 1 for Class A (though mention of Class C with no votes is accurate but not in the ground truth, it is contextually valid). (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or dollar amounts were stated. While the $27.5B minimum equity value and $8.6B payment from Disney in 2023 are omitted, these are quantitative details absent from the LLM response but present in the ground truth. Their absence prevents a perfect 10 on correctness, but they do not invalidate the overall accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two distinct corporate governance strategies—CMCSA’s external control transfer via contractual arrangement vs. META’s internal control retention via share structure. (4) Semantic equivalence is strong: the LLM captures the essence of control vs. financial interest trade-offs. The only minor gap is the omission of specific financial terms (e.g., $27.5B guarantee, $8.6B payment), which reduces completeness slightly but does not affect qualitative reasoning. Contextual relevance is excellent, directly addressing the question’s focus on control retention strategies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 449,
        "total_tokens": 1791
      },
      "error": null
    },
    {
      "question_id": 44,
      "question": "How does Goldman Sachs' $113.9 billion in broker-dealer assets influence its approach to managing conflicts of interest under Regulation Best Interest, compared to Morgan Stanley's compliance framework for the same regulatory obligations?",
      "original_answer": "Goldman Sachs manages $113.9 billion in broker-dealer assets as of December 2024, which necessitates a robust compliance framework under Regulation Best Interest to ensure recommendations align with retail customers' best interests, especially given the SEC's requirement that broker-dealers avoid placing their own interests ahead of clients. This asset size increases the complexity of conflict management, particularly in areas like variable insurance product sales and investment strategy recommendations. Similarly, Morgan Stanley explicitly states it is subject to Regulation Best Interest, which governs its broker-dealer sales practices and customer relationships, including conflict mitigation. Both firms must maintain stringent internal controls, but Goldman's larger broker-dealer asset base may require more extensive monitoring and disclosure protocols to satisfy the same impartial conduct standards outlined in the regulation, particularly as both firms face potential litigation and regulatory scrutiny tied to compliance.",
      "llm_answer": "Goldman Sachs’ $113.9 billion of broker‑dealer assets (shown in the GCLA table on page 106) are held as dedicated high‑quality liquid assets for its broker‑dealer subsidiaries, giving the firm a substantial capital‑and‑liquidity cushion that is built into its overall risk‑governance framework and thereby supports its conflict‑of‑interest controls under the SEC’s Regulation Best Interest. Morgan Stanley’s compliance approach, described on page 9, relies on a regulatory‑driven framework that obligates its broker‑dealers to act in the retail customer’s best interest and is enforced through internal policies, supervisory oversight and net‑capital rules, rather than being anchored to a similarly large broker‑dealer asset pool.",
      "correctness_score": 5,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer correctly states Goldman Sachs' $113.9 billion in broker-dealer assets, matching the ground truth in quantitative terms (Quantitative Accuracy = 10). However, the qualitative reasoning diverges significantly from the original answer. The LLM incorrectly frames the $113.9 billion as 'dedicated high-quality liquid assets' used for capital-and-liquidity cushioning, which is not supported by the ground truth. The original answer emphasizes that this asset base increases the complexity of conflict-of-interest management under Regulation Best Interest, requiring more extensive monitoring and disclosure—particularly due to the scale of client assets being advised upon—not that the assets serve as a liquidity buffer. This mischaracterization reflects a fundamental misunderstanding of the nature of broker-dealer assets in this context. Additionally, while the LLM correctly identifies that Morgan Stanley is subject to Regulation Best Interest and uses internal policies and supervisory oversight, it invents a distinction by claiming Morgan Stanley’s framework is 'not anchored to a similarly large broker-dealer asset pool,' which is not present or implied in the ground truth. Both firms are subject to the same regulatory obligations, and the original answer makes a comparative point about scale-driven complexity, not structural divergence in compliance anchoring. The LLM introduces speculative, document-specific references (e.g., 'GCLA table on page 106', 'page 9') not available in the provided context, undermining factual reliability. While the answer addresses both firms and Regulation Best Interest (Contextual Relevance = 7), the flawed reasoning and invented details reduce Qualitative Accuracy to 5. Correctness Score is 5 due to partial factual alignment but significant conceptual and inferential errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 496,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How might Intel's IDM 2.0 strategy, which includes expanding manufacturing capacity with the aim of attracting foundry customers, be affected by Samsung's development of in-house integrated circuits, and what implications could this have for Qualcomm's semiconductor business given its reliance on external integrated circuit customers?",
      "original_answer": "Intel's IDM 2.0 strategy involves significant capital expenditures to expand manufacturing capacity with the goal of attracting foundry customers (chunk 1). However, Samsung, a key potential customer for Intel's foundry services, is developing its own integrated circuit products, which it may increasingly use in its own devices and potentially sell to third parties in competition with others in the market (chunk 2). This vertical integration by Samsung could limit Intel's ability to secure foundry business from Samsung, making Intel's IDM 2.0 capacity investments riskier and potentially leading to underutilized facilities or increased pricing pressure to attract other customers. Qualcomm, which derives a significant portion of its revenues from sales of its own integrated circuit products to OEMs (chunk 3), could face intensified competition if Samsung's in-house chips gain market traction, particularly in segments like mobile and automotive. Additionally, if Intel responds by lowering prices to attract other foundry clients, it could indirectly affect the broader semiconductor pricing environment, potentially impacting Qualcomm's cost structure or competitive positioning.",
      "llm_answer": "Intel’s IDM 2.0 plan hinges on building extra fab capacity to win third‑party “foundry” business, but the company notes that its new Intel Foundry Services (IFS) will have to compete with established foundries such as Samsung and that “under‑utilization risks may be heightened” as it expands capacity (Intel 10‑K p. 53‑54).  If Samsung continues to develop and ship its own integrated‑circuit products rather than outsourcing, the pool of potential IFS customers could shrink, leaving Intel’s added capacity under‑used.  Qualcomm flags the same threat – it warns that “our business, particularly our semiconductor business, may suffer as a result of our customers vertically integrating (i.e., developing their own integrated circuit products). Certain of our largest integrated‑circuit customers (for example, Samsung) develop their own integrated‑circuit products… rather than our products” (Qualcomm 10‑K p. 20, 19).  Consequently, Samsung’s in‑house IC strategy could both blunt Intel’s IDM 2.0 foundry ambitions and erode Qualcomm’s semiconductor revenues, which rely on external IC customers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Intel's IDM 2.0 strategy involves expanding manufacturing capacity to attract foundry customers, Samsung's development of in-house ICs poses a risk to both Intel's foundry ambitions and Qualcomm's semiconductor business, and both companies acknowledge vertical integration as a competitive threat. The LLM correctly cites Intel’s 10-K (pp. 53–54) and Qualcomm’s 10-K (pp. 19–20) to support these points. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense, but the qualitative references to risks like 'under-utilization' and 'vertically integrating customers' are accurately represented. (3) The multi-hop reasoning is sound: the LLM correctly links Samsung’s in-house IC development to reduced opportunities for Intel’s foundry services and to competitive pressure on Qualcomm’s semiconductor sales. It synthesizes information across Intel and Qualcomm’s filings, demonstrating strong cross-document reasoning. (4) The only minor shortcoming is that the LLM does not explicitly mention the potential broader pricing pressure Intel might exert in the foundry market to attract customers—though it implies underutilization risk, the downstream effect on market pricing (noted in the ground truth) is omitted. This is a small gap in completeness but does not undermine the core accuracy. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, well-supported, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1620,
        "completion_tokens": 449,
        "total_tokens": 2069
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How does VZ's monetization of wireless tower infrastructure through exclusive arrangements with American Tower Corporation compare to NFLX's reliance on exclusive content rights in terms of upfront capital impact and long-term strategic control?",
      "original_answer": "VZ received an upfront payment of $5.0 billion from American Tower Corporation in 2015 for exclusive rights to 11,300 wireless towers, while retaining operational control through subleased capacity and continuing depreciation of the towers. This allowed VZ to monetize infrastructure assets while maintaining network usage flexibility. In contrast, NFLX pursues exclusive content rights to differentiate its service, which requires ongoing licensing costs and exposes the company to risks of content withdrawal and increased programming expenses. Unlike VZ's capital-generating tower arrangement, NFLX's exclusive content strategy represents a cost center rather than a revenue source, with no upfront payments received and instead involves financial commitments to secure programming advantages.",
      "llm_answer": "Verizon’s tower‑monetisation deals give it a large cash boost – the 2015 transaction with American Tower transferred exclusive rights to about 11,300 towers for an upfront $5 billion payment (recorded as prepaid rent and a financing obligation) while Verizon leases back capacity for ten‑year terms and continues to own and depreciate the towers, preserving operational use and long‑term control of the network【page_73】. Netflix, by contrast, spends cash up‑front on licensing and producing exclusive content – a core part of its strategy that does not generate cash but secures exclusive rights that drive subscriber differentiation and long‑term strategic control over its content library【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the $5.0 billion upfront payment from American Tower Corporation in 2015 for 11,300 wireless towers, matching the ground truth. It accurately notes Verizon's retention of ownership, depreciation, and operational control via leaseback — all key facts. For Netflix, it correctly characterizes exclusive content as a cash outflow (cost center), driving subscriber differentiation without generating revenue. (2) Quantitative accuracy is perfect: $5 billion, 11,300 towers, and 2015 are all correctly stated; no calculations were required. Format variation ($5 billion vs $5.0 billion) is acceptable. (3) Multi-hop reasoning is sound: the model synthesizes VZ’s capital-generating infrastructure deal with NFLX’s content-driven cost structure, contrasting their strategic and financial implications. It captures the core distinction — VZ receives upfront capital while maintaining control, whereas NFLX pays upfront for strategic content without revenue generation. (4) The only minor shortcoming is slightly less explicit emphasis on the ongoing risk exposure for NFLX (e.g., content withdrawal, rising programming costs) compared to the original answer, but the essence is conveyed. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1398,
        "completion_tokens": 375,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 45,
      "question": "How did the Tax Reform Act's GILTI provisions impact KO's effective tax rate in 2022, and how does this contrast with the effect of the corporate income tax rate reduction in the Philippines on PEP's operations in that market?",
      "original_answer": "KO's effective tax rate in 2022 was impacted by the Tax Reform Act's GILTI provisions, which required the inclusion of foreign subsidiaries' excess earnings in U.S. income tax returns, contributing to a 1.2% impact on KO's effective tax rate through pretax charges of $710 million related to equity method investee impairments. In contrast, PEP's operations in the Philippines experienced low-single-digit growth, and the corporate income tax rate reduction enacted in the Philippines in Q1 2021 contributed to a favorable impact on PEP's effective tax rate, lowering it by an unspecified but notable amount. This illustrates how the same U.S. tax reform had divergent effects—raising KO's tax burden through GILTI while enabling PEP to benefit from lower local corporate taxes.",
      "llm_answer": "The GILTI rules under the Tax Reform Act added roughly $375 million of tax expense – about a 3‑percentage‑point increase to Coca‑Cola’s effective tax rate for 2022. By contrast, the corporate‑income‑tax cut in the Philippines lowered the tax burden on PepsiCo’s Philippine operations, partially offsetting other tax pressures and keeping its effective tax rate lower in that market.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant quantitative inaccuracies. According to the ground truth, KO's GILTI-related impact was a 1.2% increase in the effective tax rate due to $710 million in pretax charges, not a 3-percentage-point increase from $375 million in tax expense. These numbers are materially different and not within acceptable rounding or formatting variation. The LLM underreports the pretax charge by nearly 50% and more than doubles the stated impact on the tax rate. (2) The qualitative aspects are partially correct: the GILTI provisions did increase KO's tax burden, and the Philippines' corporate tax rate reduction did benefit PEP's operations, helping lower its effective tax rate. The contrast in effects—U.S. global minimum tax rules increasing KO's rate while local tax cuts reduced PEP's—is conceptually sound and aligns with the multi-hop reasoning required. (3) However, the reasoning is undermined by incorrect figures. The synthesis across companies (KO vs. PEP), jurisdictions (U.S. vs. Philippines), and tax regimes (GILTI vs. local rate cuts) is appropriate and relevant, showing understanding of how different tax policies affect MNCs differently. (4) The contextual relevance is high because the answer addresses both parts of the question and draws a meaningful contrast. But due to the critical errors in financial figures and their impacts, the correctness and quantitative accuracy scores are significantly reduced. The answer is not completely wrong but is only partially accurate with major factual discrepancies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1310,
        "completion_tokens": 430,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does the $1.3 billion in restricted retained earnings at Nicor Gas impact Southern Company's ability to receive dividends from its subsidiaries, given that Nicor Gas is a key subsidiary under Southern Company Gas?",
      "original_answer": "Nicor Gas, as a regulated subsidiary under Southern Company Gas, has $1.3 billion in retained earnings that are restricted from being distributed as dividends or loans to affiliates. This restriction directly limits Southern Company's ability to receive dividend payments from Nicor Gas, which in turn affects the consolidated cash flows and financial flexibility of Southern Company, especially since Southern Company relies on equity earnings and dividends from its subsidiaries for a significant portion of its income.",
      "llm_answer": "Because Nicor Gas is regulated so that it may only pay dividends or make affiliate loans up to the amount of its retained‑earnings balance, the $1.3 billion of retained earnings that are restricted at Nicor Gas caps the cash it can distribute. As a result, Southern Company’s ability to receive dividends from Nicor Gas (and therefore from Southern Company Gas) is limited to that $1.3 billion, reducing the amount of earnings that can be passed up to the parent.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in both quantitative and qualitative aspects. (1) Quantitatively, the $1.3 billion figure is accurately cited and correctly attributed to restricted retained earnings at Nicor Gas. There are no calculation errors. (2) The reasoning correctly identifies that Nicor Gas is a regulated subsidiary and that dividend distributions are limited by retained earnings restrictions, which in turn limits Southern Company's ability to receive dividends through Southern Company Gas. (3) However, the LLM slightly misrepresents the nature of the restriction: the ground truth specifies that the $1.3 billion is *restricted from distribution*, meaning it cannot be paid out at all, whereas the LLM implies that up to $1.3 billion *can* be distributed, which is the opposite of the intended meaning. This is a critical nuance in regulatory capital treatment—restricted retained earnings are *not available* for dividends, not a cap on what *can* be paid. (4) Despite this misinterpretation, the core entities (Nicor Gas, Southern Company, Southern Company Gas) and the financial impact on dividend flow are correctly identified and logically connected. The answer remains contextually relevant and mostly accurate, but the error in interpreting the restriction direction prevents a top score. Hence, correctness is rated 8/10, with full marks for quantitative accuracy and contextual relevance, and a slight deduction in qualitative accuracy due to flawed reasoning on the restriction mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1263,
        "completion_tokens": 415,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How do Tesla's and GM's compliance costs related to evolving vehicle safety standards compare, given the increasing regulatory complexity under the National Traffic and Motor Vehicle Safety Act?",
      "original_answer": "Tesla faces rising compliance costs due to evolving international vehicle safety standards, particularly for its Autopilot and FSD (Supervised) features, which must meet varying requirements across jurisdictions and may delay or restrict functionality. GM similarly notes that compliance with the National Traffic and Motor Vehicle Safety Act is costly, with global regulatory divergence—especially between North American and UN-ECE based standards—adding complexity and expense to vehicle development. Both companies emphasize the financial burden of maintaining compliance as safety standards evolve and expand globally, with GM specifically highlighting the lack of harmonization as a key driver of increased costs.",
      "llm_answer": "Tesla notes that complying with the Safety Act – especially the rapidly changing standards for its Autopilot and Full‑Self‑Driving features – “adds complexity and cost” to its vehicles, but it does not disclose a specific dollar amount for those safety‑related expenses【page_28】. In contrast, General Motors explicitly quantifies its safety‑compliance exposure, stating that meeting the Safety Act’s standards already incurs substantial costs and that a 10 % increase in the take‑rate for recall campaigns would raise its estimated recall cost by roughly **$0.4 billion**【page_13】【page_43】. Thus, GM provides a concrete, sizable cost figure for safety‑standard compliance, whereas Tesla’s cost impact remains qualitative and undisclosed.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The claim that GM quantifies a $0.4 billion increase in recall costs from a 10% rise in recall take-rate is not supported by the original answer (ground truth), which does not mention any specific dollar figures or recall cost calculations for GM. This number appears to be fabricated or misattributed. (2) The original answer emphasizes both Tesla and GM facing rising compliance costs due to global regulatory divergence and lack of harmonization, particularly between North American and UN-ECE standards. However, the LLM answer incorrectly frames GM as providing 'concrete, sizable cost figure' while Tesla only offers qualitative input—this contrast is not present in the ground truth, which states both companies describe the financial burden qualitatively. (3) The multi-hop reasoning is partially sound in comparing Tesla and GM on compliance costs, but the synthesis is flawed due to the introduction of unsupported quantitative data. (4) While the LLM correctly identifies Tesla's challenges with Autopilot/FSD and regulatory complexity, and GM's concerns about the Safety Act, it distorts the comparison by adding unverified financial metrics. Semantic equivalence fails on key points: the original does not contain any dollar amounts or recall cost modeling. The contextual relevance is high because the response addresses evolving safety standards and compliance costs, but the quantitative inaccuracy severely reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 422,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 46,
      "question": "How does General Dynamics' deferral of $305 million in other contract costs under FAR regulations compare to Raytheon Technologies' exposure to cost overruns under its fixed-price U.S. government contracts, given the differing financial risk profiles associated with these contract cost management approaches?",
      "original_answer": "General Dynamics defers $305 million in other contract costs under FAR regulations that govern cost allowability and allocation to U.S. government contracts, with recovery expected through existing backlog and follow-on contracts. These costs are not currently allocable but are maintained as assets pending future allocation. In contrast, Raytheon Technologies faces financial risk on its fixed-price contracts, particularly firm fixed-price (FFP) contracts, where it bears the full burden of cost overruns without reimbursement. This creates a more direct financial exposure compared to General Dynamics’ deferred cost model. The difference in risk stems from the fact that FAR-regulated cost recovery allows General Dynamics to defer recognition of certain costs until allocable, while Raytheon must absorb overruns on fixed-price contracts, which constitute a significant portion of its U.S. government contract portfolio.",
      "llm_answer": "General Dynamics reports that $305 million of other contract costs are being deferred under FAR rules and are held in other current assets until they can be allocated to contracts, with the expectation that those costs will be recovered through future work (GD 10‑K p. 59). Raytheon, by contrast, states that its firm‑fixed‑price U.S. government contracts place the full burden of any cost overruns on the company, so overruns would directly reduce profitability (RTX 10‑K p. 16). Thus, GD’s risk is deferred and contingent on later recoveries, whereas RTX’s risk is immediate and can impact earnings as soon as overruns occur.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $305 million deferral by General Dynamics is correctly reported, with proper context on FAR regulations and classification in other current assets (per GD 10-K p. 59). Raytheon's exposure under firm fixed-price contracts is accurately described, including the financial impact of cost overruns (per RTX 10-K p. 16). No numerical or factual inaccuracies are present. (2) The answer addresses all parts of the multi-hop question: it compares General Dynamics’ deferral of costs under FAR (a cost-reimbursement framework with deferred recovery) to Raytheon’s fixed-price contract risk (where overruns directly hit profitability). (3) Entity accuracy is strong—correct company names (General Dynamics, Raytheon Technologies), correct contract types (FAR-regulated, firm fixed-price), and correct financial implications are identified. (4) The reasoning is sound: it correctly contrasts deferred, contingent risk (GD) with immediate, direct risk (RTX), capturing the core difference in financial risk profiles. The only minor limitation is that the LLM does not explicitly mention that General Dynamics’ deferred costs are expected to be recovered through backlog and follow-on contracts—a detail in the ground truth—but this does not undermine the overall correctness. Semantic equivalence is maintained, and the answer is contextually precise and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 399,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the compound annual growth rate (CAGR) of Intel's Taiwan revenue from 2019 to 2021 compare to Apple's Greater China segment revenue growth over the same period, given that Taiwan is included within Apple's Greater China reporting?",
      "original_answer": "Intel's Taiwan revenue grew from $10,058 million in 2019 to $13,461 million in 2021, representing a CAGR of approximately 15.6%. Apple's Greater China revenue increased from $40,308 million in 2019 to $68,366 million in 2021, yielding a CAGR of approximately 30.8%. Therefore, Apple's Greater China segment revenue grew at more than double the rate of Intel's Taiwan-specific revenue during this period.",
      "llm_answer": "Intel’s Taiwan revenue rose from $10,058 million in 2019 to $13,461 million in 2021, giving a compound‑annual‑growth‑rate of about (13,461/10,058)^(½)‑1 ≈ 15.6% per year【page_87】.  \nApple’s Greater‑China net sales (which includes Taiwan) increased from $40,308 million in 2020 to $68,366 million in 2021, a one‑year rise of roughly (68,366/40,308)‑1 ≈ 70% (CAGR ≈ 70%)【page_52】.  \n\nThus Apple’s Greater‑China growth over the same period was far stronger—about four‑to‑five times the rate of Intel’s Taiwan revenue growth.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Intel's Taiwan revenue figures ($10,058M in 2019 and $13,461M in 2021) and accurately calculates the CAGR of approximately 15.6%, which matches the ground truth. However, it makes a critical error in the Apple portion by using 2020 instead of 2019 as the starting year, stating Apple’s Greater China revenue increased from $40,308M in 2020 to $68,366M in 2021. The original answer correctly uses 2019 as the base year with $40,308M, meaning the LLM uses the wrong time period for calculating Apple’s CAGR. This leads to an incorrect one-year growth rate of ~70% instead of the correct two-year CAGR of ~30.8%. (2) The calculation for Apple is therefore fundamentally flawed: the correct CAGR from 2019 to 2021 is (68,366 / 40,308)^(1/2) - 1 ≈ 30.8%, not 70%. The LLM incorrectly treats it as a one-year change, misrepresenting both the magnitude and the nature of the growth. (3) The multi-hop reasoning fails because the comparison is based on inconsistent time periods—Intel’s growth is measured over two years (2019–2021), while Apple’s is incorrectly assessed over one year (2020–2021). This undermines the synthesis required to fairly compare the two CAGRs. (4) Despite accurate data for Intel and correct identification of entities and reporting segments (e.g., Taiwan included in Greater China), the major quantitative and reasoning errors in Apple’s growth calculation significantly reduce correctness. The conclusion that Apple grew four-to-five times faster than Intel is false (correct ratio is ~30.8% vs ~15.6%, or roughly double, not quadruple). Thus, while contextually relevant and partially accurate, the answer contains a critical error in timeframe and calculation that distorts the core comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 479,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "Given Alphabet's $70 billion share repurchase authorization targeting Class A and Class C shares in 2024, how might the repurchase activity influence Class B shareholders' decisions to convert shares to Class A, especially in light of Meta's disclosure of a significantly larger Class A share base compared to Class B outstanding shares?",
      "original_answer": "Alphabet's $70 billion share repurchase program, which includes Class A shares, could reduce the supply of Class A shares in the market, potentially increasing their relative value. This may incentivize Class B shareholders—who hold shares with 10x voting rights but often face restrictions on holding Class A shares after conversion—to convert and sell Class A shares before further scarcity and price appreciation occur. However, Meta's 2024 disclosure shows that it has 2,189,898,148 Class A shares and only 343,761,117 Class B shares outstanding, indicating a much larger float of Class A shares in the market. This abundance of Class A shares at Meta may temper conversion urgency compared to Alphabet, as Class A shares at Meta are likely more liquid and less affected by repurchase-induced scarcity.",
      "llm_answer": "Alphabet’s April 2024 board authorization of a $70 billion buy‑back of Class A and Class C stock (with $44.7 billion still available at year‑end) shrinks the pool of Class A shares, which can lift the price and earnings per share of the remaining Class A stock and give Class B holders—who may convert at any time—greater incentive to swap for voting‑rich Class A shares. By contrast, Meta’s 2025 filing shows a far larger Class A base (≈2.19 billion shares) versus a modest Class B pool (≈0.34 billion shares), suggesting that conversion there would have a relatively muted effect on price or voting power, making Alphabet’s repurchase‑driven scarcity a stronger catalyst for Class B conversions.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies Alphabet's $70 billion share repurchase authorization in 2024 targeting Class A and Class C shares, and notes the effect of reducing Class A share supply, which may incentivize Class B shareholders to convert. The comparison to Meta is appropriately drawn. (2) Quantitatively, the LLM states Alphabet had $44.7 billion remaining at year-end—this is plausible and consistent with typical repurchase pacing, though this specific remaining amount is not in the original answer and cannot be verified from the ground truth; however, it does not contradict it. Meta's Class A (≈2.19 billion) and Class B (≈0.34 billion) share counts are accurate approximations of the original 2,189,898,148 and 343,761,117 figures. The LLM incorrectly references 'Meta’s 2025 filing' instead of 2024, which is a minor factual error in timing. (3) The multi-hop reasoning is sound: it connects Alphabet’s repurchase program to potential Class B conversion incentives, then contrasts this with Meta’s capital structure to explain differential conversion pressures. The logic that a larger Class A float at Meta dilutes the impact of repurchases or conversions is well-reasoned and matches the original intent. (4) The answer is contextually excellent, addressing all parts of the question with strong synthesis across companies and share classes. The only deductions are for the unverified $44.7B remaining detail and the incorrect reference to Meta’s 2025 filing instead of 2024, preventing a perfect 10. Overall, the answer is factually strong, well-reasoned, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 459,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does the treatment of dividend equivalents in RSU awards differ between PepsiCo and Philip Morris International in terms of vesting conditions and financial obligations as of 2023?",
      "original_answer": "PepsiCo accrues dividend equivalents during the vesting period for both RSUs and PSUs, which are paid out in cash when the award vests. Philip Morris International also accrues dividend equivalents on RSU awards, but its RSUs generally vest on the third anniversary of the grant date and do not carry voting rights. As of December 31, 2023, PMI had $160 million of total unrecognized compensation costs related to non-vested RSU awards, which are being amortized over the restriction period or upon specific life events.",
      "llm_answer": "PepsiCo’s 2023 filing says that RSUs (and PSUs) accrue dividend‑equivalent cash that is paid without interest only when the award actually vests – RSUs vest at the end of the employee’s service period and PSUs vest only if the specified performance metrics are met. Philip Morris International’s 2023 filing notes that its RSU awards vest on the third anniversary of the grant date (subject to continued employment) and also earn dividend equivalents, creating a cash‑payment obligation at that fixed vesting date. Thus, PepsiCo’s dividend equivalents are tied to a service‑ or performance‑based vesting schedule, whereas PMI’s are tied to a predetermined three‑year vesting date with forfeiture risk.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: PepsiCo accrues dividend equivalents on RSUs and PSUs, paid in cash upon vesting, which depends on service or performance conditions. PMI’s RSUs vest on the third anniversary of the grant date (subject to continued employment), also accrue dividend equivalents, and carry no voting rights (implied by standard RSU treatment, though not explicitly mentioned in the LLM answer). The LLM correctly identifies the financial obligation tied to dividend equivalents as cash payments at vesting. (2) Quantitative accuracy is perfect: while no specific dollar amounts appear in the LLM answer, the ground truth’s $160 million unrecognized cost is not mentioned. However, the question does not explicitly ask for financial figures, so this omission does not constitute a major error. The vesting timeline (third anniversary) and accrual mechanism are correctly stated. (3) Multi-hop reasoning is sound: the model successfully compares two companies’ RSU dividend equivalent treatments across vesting conditions and obligations, synthesizing information from both filings. (4) The only minor shortcoming is the absence of the $160 million unrecognized cost detail from PMI’s filing, which adds financial context but is not central to the core comparison about vesting conditions and dividend treatment. Wording differs but meaning is semantically equivalent. Thus, the answer earns a 9/10 for correctness—excellent, but slightly less complete than the full ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 429,
        "total_tokens": 1744
      },
      "error": null
    },
    {
      "question_id": 47,
      "question": "How does DHR's use of NAV and discounted cash flow in valuing private investments compare to LLY's reliance on fair value estimation for acquired intangible assets, considering the inherent subjectivity in both approaches as highlighted in their respective disclosures?",
      "original_answer": "DHR utilizes NAV based on fund manager inputs and applies discounted cash flows, earnings multiples, and third-party appraisals to estimate the fair value of private investments, acknowledging that these methods may not reflect net realizable value or future fair values. LLY, on the other hand, applies fair value estimation to acquired intangible assets such as IPR&D, which required $3.80 billion in charges in 2023 alone, and admits that final valuations may change significantly as fair values are finalized within one year post-acquisition. Both companies recognize the subjectivity involved in fair value estimation, with DHR noting that different methodologies can yield materially different results and LLY emphasizing the need for considerable judgment in determining the fair value of acquired assets, especially under limited access to pre-acquisition data.",
      "llm_answer": "Danaher values its private‑equity, venture‑capital and real‑estate holdings by first using a net‑asset‑value (NAV) “practical expedient” and then applying a mix of discounted‑cash‑flow models, earnings or market multiples, third‑party appraisals, or quoted market prices to arrive at a fair‑value estimate 【page_98】.  The company warns that the choice of methodology and the assumptions used can materially affect the valuation 【page_99】.  Eli Lilly, by contrast, records the assets and liabilities acquired in business combinations at their estimated fair values on the acquisition date, and acknowledges that management must make significant estimates and assumptions in that fair‑value determination 【page_77】.  Both firms therefore rely on inherently subjective judgments, but Danaher’s approach is applied to ongoing private‑investment portfolios using multiple valuation techniques, whereas Lilly’s approach is applied at acquisition to intangible assets and goodwill.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: DHR uses NAV as a practical expedient and supplements it with discounted cash flows, earnings multiples, and third-party appraisals; LLY applies fair value estimation to acquired intangible assets at acquisition date. The LLM correctly notes the subjectivity in both approaches, citing methodology choice and assumptions as key drivers of valuation differences. (2) Quantitative accuracy is perfect: while the LLM answer does not include the $3.80 billion charge for LLY in 2023, this omission does not misrepresent facts—it simply lacks a specific figure present in the ground truth. No incorrect numbers are stated. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (DHR and LLY), two types of assets (private investments vs. acquired intangibles), and two valuation contexts (ongoing portfolio vs. post-acquisition), drawing a valid comparison. (4) Semantic equivalence is strong: the LLM captures the core idea that both firms use subjective fair value methods, though applied in different contexts. The only minor shortcoming is the omission of LLY’s $3.80 billion charge and the one-year finalization window for valuations, which are present in the original answer and add specificity. However, the absence of these details does not undermine the correctness of the response, which remains factually sound and contextually appropriate. Hence, a score of 9 is warranted—excellent but not fully complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 428,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does NVIDIA's revenue from Taiwan in 2022 compare to Apple's reported revenue from the Greater China segment, given that Apple's geographic reporting includes Taiwan within Greater China?",
      "original_answer": "NVIDIA reported $8,544 million in revenue from Taiwan in 2022, while Apple reported $74,200 million in net sales from the Greater China segment in the same year. Since Apple explicitly includes Taiwan within its Greater China geographic reporting, NVIDIA's Taiwan-specific revenue constitutes a subset of the broader regional revenue that Apple reports, reflecting different levels of geographic granularity in their respective segment disclosures.",
      "llm_answer": "NVIDIA reported $8,544 million of revenue from Taiwan in fiscal 2022 (NVDA 10‑K, page 100). Apple’s Greater China segment – which by definition includes Taiwan – generated $74,200 million of net sales in 2022 (Apple 10‑K, page 52). Thus NVIDIA’s Taiwan revenue is roughly $8.5 billion, or about one‑tenth of Apple’s $74 billion Greater China revenue.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all key aspects. (1) Quantitative accuracy: The revenue figures are correctly reported as $8,544 million for NVIDIA from Taiwan and $74,200 million for Apple's Greater China segment in 2022, with acceptable rounding to $8.5 billion and $74 billion. These values match the original answer exactly in substance. (2) Completeness: The answer addresses both companies, the relevant geographic segments, and the year 2022. It correctly notes that Apple includes Taiwan within Greater China, which is central to the comparison. (3) Entity accuracy: Companies (NVIDIA and Apple), financial metrics (revenue/net sales), and time period (2022) are all correctly identified. The citations to the 10-K pages add precision. (4) Reasoning: The multi-hop reasoning is sound—comparing NVIDIA’s country-specific revenue to Apple’s broader regional segment while acknowledging the granularity difference. The conclusion that NVIDIA’s Taiwan revenue is about one-tenth of Apple’s Greater China revenue is mathematically accurate (~11.5%, which rounds to roughly one-tenth). (5) Semantic equivalence: The LLM conveys the same core insight as the original answer—that NVIDIA’s Taiwan revenue is a subset of Apple’s Greater China revenue due to differing geographic reporting levels—using slightly more concise language. No factual or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1210,
        "completion_tokens": 388,
        "total_tokens": 1599
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the concentrated voting power in CMCSA's Class B common stock compare to the shareholder structure disclosed for GOOGL's Class A common stock in terms of control and ownership distribution?",
      "original_answer": "CMCSA's Class B common stock, held entirely by Brian L. Roberts, represents 33⅓% of the combined voting power with each share carrying 15 votes, creating significant control concentration. In contrast, GOOGL's Class A common stock, with 300,754,904 shares outstanding as of January 25, 2022, is broadly distributed among non-affiliates, with voting rights presumably more dispersed given the large number of shares and absence of similar super-voting structures described for CMCSA. This indicates a stark difference in governance dynamics, with CMCSA maintaining centralized control through Class B shares, while GOOGL's structure suggests more distributed shareholder influence.",
      "llm_answer": "Comcast’s Class B shares concentrate voting power – they represent a non‑dilutable 33 ⅓ % of the combined voting power of all Comcast common stock and are all beneficially owned by Chairman/CEO Brian L. Roberts, giving him substantial control despite only three record holders【page_35】【page_38】. In contrast, Alphabet’s Class A shares – the primary voting class for public investors – total roughly 300.8 million shares outstanding and are held by a broad base of shareholders, with no single holder identified as dominating the voting power, indicating a far more dispersed ownership structure【page_2】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: CMCSA's Class B stock holds 33⅓% of voting power (correctly stated as non-dilutable), and GOOGL's Class A shares outstanding are reported as ~300.8 million, closely matching the original 300,754,904 as of January 25, 2022 (rounding is acceptable). The 15-vote per share detail for CMCSA is omitted but implied through the concentration effect. (2) The entity identification is accurate—CMCSA (Comcast) and GOOGL (Alphabet) are correctly referenced with appropriate share classes. (3) The reasoning is sound: the contrast between concentrated control (Roberts holding all Class B shares) and broad, dispersed public ownership in GOOGL is logically drawn and directly addresses the question about control and ownership distribution. (4) Minor deduction in qualitative accuracy due to omission of explicit mention of super-voting rights (15 votes/share), though the effect is still clearly conveyed. Otherwise, the synthesis across companies and governance structures is strong. Contextual relevance is perfect—the response directly compares control mechanisms as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 337,
        "total_tokens": 1671
      },
      "error": null
    },
    {
      "question_id": 48,
      "question": "How does the ratio of securities remaining available for future issuance to those issuable upon exercise of outstanding options differ between UnitedHealth Group and Johnson & Johnson under their respective equity compensation plans approved by security holders?",
      "original_answer": "For UnitedHealth Group, the ratio is approximately 9.64 (241 million remaining available / 25 million issuable upon exercise), while for Johnson & Johnson, the ratio is approximately 1.79 (240,344,013 remaining available / 133,794,708 issuable upon exercise). This indicates that UnitedHealth Group has a significantly higher proportion of remaining available securities compared to those already issuable, relative to Johnson & Johnson.",
      "llm_answer": "UnitedHealth Group’s approved equity‑compensation plans show ≈ 241 million shares still available versus ≈ 25 million shares that could be issued on exercise – a ratio of about **9.6 to 1**【page_77】.  \nJohnson & Johnson’s approved plans show ≈ 240.3 million shares available versus ≈ 133.8 million exercisable – a ratio of roughly **1.8 to 1**【page_118】.  \n\nThus UnitedHealth’s “available‑to‑exercisable” ratio is roughly five‑times higher than Johnson & Johnson’s.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers provided are accurate: UnitedHealth Group has approximately 241 million shares remaining available and 25 million issuable upon exercise, yielding a ratio of 9.64, which the model correctly rounds to 'about 9.6 to 1'. Johnson & Johnson has 240,344,013 available and 133,794,708 exercisable, resulting in a ratio of approximately 1.79, which the model accurately rounds to 'roughly 1.8 to 1'. These values match the ground truth exactly within acceptable rounding. (2) The answer is complete, addressing both companies, their respective equity compensation plan figures, and the calculated ratios. It also includes a correct comparative conclusion that UnitedHealth's ratio is roughly five times higher, which is logically sound (9.6 / 1.8 ≈ 5.3). (3) Entity accuracy is perfect: both company names are correct, the metrics ('shares available', 'exercisable') are correctly interpreted, and the source pages are cited appropriately. (4) The multi-hop reasoning—extracting data from two different companies, computing ratios, and comparing them—is flawlessly executed. The semantic meaning and factual content are equivalent to the original answer, with only minor, acceptable rewording and rounding. All scoring categories warrant full marks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 374,
        "total_tokens": 1629
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does AMD's reliance on third-party motherboard suppliers compare to Intel's dependency on Dell Inc. as a major customer, particularly in terms of revenue concentration risk?",
      "original_answer": "AMD depends on third-party companies for the design, manufacture, and supply of motherboards that support its microprocessor, GPU, and APU offerings, making it vulnerable to supply chain disruptions. In contrast, Intel reports that Dell Inc. accounted for 21% of its net revenue in 2021, highlighting a significant revenue concentration risk tied to a single customer. While AMD's risk centers on supply chain limitations that could prevent product delivery, Intel's exposure is tied directly to customer dependency, with Dell representing a substantial portion of both revenue and accounts receivable.",
      "llm_answer": "AMD’s 2022 filing notes that it “depends on third‑party companies for the design, manufacture and supply of motherboards, graphics cards, software, memory and other components” and that a loss of those partners would hurt its business, but the risk is framed as a supply‑chain dependency rather than a concentration of sales to any one customer【page_28】. In contrast, Intel’s 2022 filing shows that Dell alone accounted for about 21 percent of Intel’s net revenue in 2021, making Dell a single, large revenue source and creating a clear revenue‑concentration risk for Intel【page_87】. Thus, AMD’s exposure is spread across many suppliers, while Intel’s exposure is concentrated in one major customer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the 21% of Intel's net revenue attributed to Dell in 2021 matches the original answer, and the reference to 2022 filings for both AMD and Intel is consistent with available data. No calculations were required, but the percentage is accurately cited. (2) The answer correctly identifies the entities: AMD, Intel, and Dell Inc., and appropriately associates the risk types—supply chain for AMD and customer revenue concentration for Intel. (3) The reasoning is sound and reflects proper multi-hop synthesis: it contrasts AMD’s reliance on third-party suppliers (a supply-side risk) with Intel’s dependency on Dell (a demand-side risk), which is the core of the comparison. (4) The LLM slightly omits the mention of accounts receivable exposure that Intel has with Dell, which is a minor but relevant detail in the original answer regarding financial risk. However, this does not undermine the central point about revenue concentration. Wording differs but maintains semantic equivalence. Overall, the response is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 339,
        "total_tokens": 1672
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How do Louisiana's corporate tax rate reductions impact the financial exposure of both Boeing and Union Pacific, given Boeing's dependence on federal appropriations influenced by broader legislative dynamics and Union Pacific's direct operations in the state?",
      "original_answer": "Louisiana enacted legislation to reduce its corporate income tax rate for future years, resulting in a $34 million reduction of Union Pacific’s deferred tax expense in 2024. Union Pacific directly benefits from this tax reduction due to its operational presence in Louisiana, as evidenced by its major classification yard in Livonia. Boeing, on the other hand, does not directly benefit from Louisiana’s tax changes but faces exposure to broader legislative uncertainty, particularly in terms of federal appropriations for the U.S. Department of Defense and other government agencies. A lapse or delay in federal funding could disrupt Boeing’s operations, delay aircraft certifications, or impact future orders. Therefore, while Union Pacific experiences a quantifiable financial benefit ($34 million reduction in deferred tax expense) from Louisiana’s tax legislation, Boeing’s exposure is indirect and tied to the uncertainty of federal budget dynamics influenced by the same legislative environment.",
      "llm_answer": "Louisiana’s corporate‑tax cuts cut Union Pacific’s tax bill – the 2024 legislation in Louisiana (and Arkansas) lowered its deferred‑tax expense by roughly $34 million, directly reducing the railroad’s tax liability and financial exposure in the state【page_29】. Boeing, however, does not cite a state‑tax impact; its risk is tied to the timing and level of U.S. defense appropriations and other federal legislative actions, which can affect its revenue and cash flow independent of Louisiana’s tax rate changes【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $34 million reduction in Union Pacific’s deferred tax expense in 2024 is correctly stated, matching the original answer exactly. The year (2024) and amount ($34 million) are both factually correct, with no calculation errors. (2) The answer is complete: it addresses both Boeing and Union Pacific, explains Union Pacific’s direct benefit due to its operations in Louisiana (supported by reference to page 29), and correctly states that Boeing does not face a direct state tax impact. Instead, Boeing’s exposure is tied to federal appropriations, particularly defense funding, which matches the original answer’s emphasis on legislative uncertainty affecting federal budgets. (3) Entity accuracy is strong: both companies are correctly identified, the financial metric (deferred tax expense) is accurate, and the years and legislative context are properly attributed. (4) Multi-hop reasoning is sound—LLM synthesizes tax policy changes in Louisiana with company-specific financial impacts and distinguishes between direct operational exposure (Union Pacific) and indirect federal funding exposure (Boeing). The only minor shortcoming is that the LLM does not explicitly mention Union Pacific’s physical presence in Louisiana (e.g., the Livonia classification yard), which adds contextual support in the original answer. However, the reference to page 29 implies operational presence, and the financial impact is correctly attributed. Wording differs slightly (e.g., 'tax bill' vs 'deferred tax expense'), but the semantic meaning and financial implication are equivalent. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 475,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does Netflix's one-vote-per-share governance model contrast with Meta's dual-class stock structure, particularly in relation to Charter Communications' disclosure about the link between Class A common stock and voting rights?",
      "original_answer": "Netflix operates under a one-vote-per-share governance model for its common stock, as explicitly stated in its 2024 10-K filing. In contrast, Charter Communications' 2024 financial statements clarify that its Class A common stock carries one vote per share, while its Class B common stock has variable voting rights tied to A/N's economic interests. Meta's 2024 10-K filing discloses the existence of both Class A and Class B common stock, a dual-class structure that suggests differentiated voting rights similar to Charter's framework, though Meta does not specify the exact voting power of each class in the provided chunk. This creates a contrast between Netflix's egalitarian voting model and the more complex, tiered voting structures used by both Charter and Meta.",
      "llm_answer": "Netflix’s charter states that “the holders of each share of common stock shall be entitled to one vote per share on all matters to be voted upon by the Company’s stockholders” (NFLX 10‑K p. 60). Meta, by contrast, has a dual‑class capital structure that includes both Class A and Class B common stock, each with different voting entitlements (Meta 10‑K shows separate Class A and Class B shares p. 1). Charter’s filing similarly discloses that “holders of Class A common stock are entitled to one vote per share,” explicitly linking voting rights to the Class A shares (Charter 10‑K p. 95), highlighting that Netflix’s uniform one‑vote‑per‑share model differs from Meta’s differentiated dual‑class voting scheme.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Netflix's one-vote-per-share model is properly cited from its 10-K (p. 60), Meta's dual-class structure is accurately described with reference to Class A and Class B shares (Meta 10-K p. 1), and Charter's disclosure of one vote per share for Class A common stock is correctly cited (Charter 10-K p. 95). (2) There are no numerical values requiring calculation, but all references to voting rights (one vote per share) are factually consistent and correctly attributed. Format and citation styles vary slightly but do not affect accuracy. (3) The multi-hop reasoning is sound: the model correctly contrasts Netflix’s uniform voting structure with Meta’s and Charter’s dual-class frameworks, synthesizing information across three companies’ filings. It correctly infers that Meta’s dual-class structure implies differentiated voting rights, even if exact voting power is unspecified, and uses Charter’s disclosure to reinforce the contrast. (4) The only minor shortcoming is that the LLM omits Charter’s detail about Class B stock having variable voting rights tied to A/N's economic interests, which slightly reduces completeness in the qualitative synthesis. However, the core contrast—Netflix’s egalitarian model vs. Meta’s and Charter’s tiered structures—is clearly and correctly conveyed. Thus, the answer is semantically equivalent to the ground truth with only a minor omission, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 425,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 49,
      "question": "How does the daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing impact the valuation methodology used by MDLZ for its Level 1 financial liabilities, given that both companies rely on quoted market prices from commodity exchanges?",
      "original_answer": "The daily cash-settlement mechanism for exchange-traded commodity futures described in PEP's 2022 filing aligns with the valuation methodology used by MDLZ for its Level 1 financial liabilities, which are also based on quoted market prices from commodity exchanges. PEP notes that exchange-traded commodity futures are 'cashsettled on a daily basis' and therefore not included in the balance sheet table as of year-end, indicating a standard market practice. MDLZ explicitly states that the fair value of its Level 1 financial assets and liabilities 'is determined based on quoted market prices on commodity exchanges.' This shows that the market standard of daily cash settlement directly informs MDLZ's valuation approach for Level 1 liabilities, as both companies are subject to the same pricing and settlement mechanisms in commodity futures markets.",
      "llm_answer": "PEP’s filing explains that exchange‑traded commodity futures are cash‑settled each day, so they do not appear as a standing liability on the balance sheet at period‑end【page_107】. MDLZ classifies those same futures as Level 1 financial liabilities and values them at fair value using the quoted market price on the commodity exchange on the measurement date【page_112】. Because the contracts settle daily at the exchange price, MDLZ can rely directly on that quoted price for its Level 1 valuation, eliminating any additional modeling or adjustment beyond the daily market price.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: PEP’s daily cash settlement mechanism is accurately described, and MDLZ’s use of quoted market prices for Level 1 financial liabilities is correctly cited. There are no numeric values (e.g., dollar amounts, percentages) in the question or answer, so quantitative accuracy is not applicable in a numerical sense, but the logical consistency of the mechanism (daily settlement → reliance on exchange prices) is preserved. (2) The answer addresses all parts of the multi-hop question: it connects PEP’s description of settlement practices to MDLZ’s valuation methodology, both relying on exchange-traded commodity futures and quoted prices. (3) Entities (PEP, MDLZ, Level 1 financial liabilities, commodity exchanges) and years (implied 2022 filing context) are correctly identified. (4) The reasoning is sound: the LLM correctly infers that because futures are daily cash-settled, they do not persist on the balance sheet (PEP) and that MDLZ can use the exchange price directly for fair value without adjustments—this reflects proper synthesis across the two companies’ disclosures. The only minor shortcoming is that the LLM does not explicitly state that this represents a 'market standard' or 'aligns with industry practice' as emphasized in the original answer, slightly weakening the generalization of the mechanism’s broader impact. However, the core logic and factual content are equivalent. Wording differs but meaning is preserved. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 463,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Apple's 2022 net sales performance in the Greater China region, which includes Taiwan, compare with AMD's 2022 sales in Taiwan alone, given both companies' exposure to the technology market in that geographic area?",
      "original_answer": "Apple reported $74,200 million in net sales in the Greater China region in 2022, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales specifically in Taiwan for the same year. This indicates that while Apple has a significantly larger overall presence in the broader Greater China region, AMD's direct sales in Taiwan are much smaller in scale.",
      "llm_answer": "Apple’s 2022 net sales in the Greater China segment (which includes Taiwan) were $74.2 billion【page_52】. AMD’s sales to customers in Taiwan for the same filing year were about $2.1 billion【page_78】. Thus Apple’s Greater China revenue was roughly thirty‑five times the size of AMD’s Taiwan‑only sales.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: Apple's $74.2 billion (i.e., $74,200 million) in Greater China and AMD's $2.1 billion (approximation of $2,091 million) in Taiwan are correctly reported, with acceptable rounding. The comparison stating Apple's revenue was 'roughly thirty-five times' AMD's is mathematically sound: 74,200 / 2,091 ≈ 35.5, which supports the 'thirty-five times' characterization. (2) The answer is complete, addressing both companies, the correct geographic regions (Greater China for Apple, Taiwan-only for AMD), and the 2022 time frame. (3) Entities are accurately identified: Apple and AMD are correct, as are the financial metrics (net sales) and regions. (4) The multi-hop reasoning—comparing two companies' sales in overlapping but different geographies—is logically synthesized and clearly explained. (5) The semantic meaning is equivalent to the original answer, with slightly more concise wording and a useful comparative ratio. All criteria are met with high precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1194,
        "completion_tokens": 308,
        "total_tokens": 1502
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does Duke Energy's exposure to environmental remediation liabilities compare to Southern Company's ability to recover similar costs through regulatory mechanisms, given that Duke Energy's remediation costs are typically expensed as incurred unless recovery is probable, while Southern Company Gas' natural gas utilities specifically include environmental remediation in their approved cost recovery mechanisms?",
      "original_answer": "Duke Energy faces environmental remediation liabilities at multiple sites, with costs typically expensed as incurred unless regulatory recovery is deemed probable. In contrast, Southern Company Gas explicitly includes environmental remediation among the costs eligible for recovery through regulatory riders in its natural gas distribution utilities. This means that while Duke may bear these costs directly unless recovery is approved, Southern Company has a more structured pathway to recover such expenses through approved rate mechanisms, reducing its direct financial exposure to environmental remediation liabilities.",
      "llm_answer": "Duke Energy’s remediation liabilities are recorded as reserves and are normally charged to operations as incurred, with recovery only when it is deemed probable (see DUK page 163). In contrast, Southern Company’s natural‑gas utilities have regulatory riders that expressly allow environmental‑remediation costs to be recovered through rates, so those expenses can be passed on to customers (see SO page 22). Thus, Duke bears the remediation costs directly, whereas Southern Company can largely offset them via approved cost‑recovery mechanisms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly states that Duke Energy typically expenses remediation costs as incurred unless recovery is probable, while Southern Company Gas has regulatory riders allowing recovery of these costs through rates—this aligns with the original answer. (2) There are no numeric values (e.g., dollar amounts, dates, percentages) in either answer, so quantitative accuracy is not applicable; however, the absence of such numbers is consistent with the source information, and no errors are present. (3) The multi-hop reasoning is sound: the model correctly synthesizes contrasting regulatory treatment between Duke Energy and Southern Company Gas using entity-specific mechanisms (DUK p.163 and SO p.22 references support this). (4) Minor wording differences exist (e.g., 'recorded as reserves' appears in LLM but not original), but this does not contradict the ground truth and may reflect additional nuance from the source document. The conclusion that Duke bears costs directly while Southern can offset them via recovery mechanisms matches the original. One point deducted from qualitative accuracy due to slight overstatement with 'largely offset them'—'structured pathway' in original is slightly more cautious—but overall reasoning remains strong. Contextual relevance is perfect: all parts of the question are addressed with precise, relevant comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 400,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does LOW's use of broker/dealer quotes for Level 2 fair value measurements compare to GM's reliance on valuation models for product warranty reserves, given the role of industry-standard models in both companies' financial reporting?",
      "original_answer": "LOW uses broker/dealer quotes as inputs to Level 2 fair value measurements for financial assets when quoted prices in active markets are not available, relying on third-party pricing models with observable market inputs like issuer spreads and benchmark securities. GM, on the other hand, applies valuation models to estimate product warranty reserves, incorporating significant assumptions such as warranty claims frequency, average cost per claim, and historical claims data. Both companies utilize industry-standard valuation models, but LOW's approach is market-driven with observable inputs (Level 2), while GM's involves more management judgment and forward-looking assumptions. This highlights different applications of valuation models: LOW's fair value measurements are more directly tied to current market data, whereas GM's depend on internal forecasts and historical performance.",
      "llm_answer": "Lowe’s Level 2 fair‑value measurements are derived from industry‑standard pricing models that are fed with observable market data—specifically broker‑dealer quotes, reported trades, spreads and other market inputs (see LOW 10‑K p. 54‑67). In contrast, GM’s product‑warranty reserves are calculated using industry‑standard actuarial/valuation models that project future claim frequency and cost based on internal historical experience and assumptions (see GM 10‑K p. 56). Both companies rely on standard models, but Lowe’s inputs are market‑driven quotes, whereas GM’s are internally‑generated forecasts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) All factual elements are correct: LOW uses broker/dealer quotes and observable market inputs (e.g., spreads, reported trades) in industry-standard pricing models for Level 2 fair value measurements, while GM uses actuarial/valuation models based on internal historical data and assumptions about future claim frequency and cost. These align with the ground truth. (2) There are no numeric values to verify (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in numbers, dates, or calculations. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (LOW and GM), two distinct financial reporting areas (fair value measurements vs. warranty reserves), and compares their reliance on industry-standard models with different input types (market-driven vs. internally-generated). (4) The only minor shortcoming is a slight reduction in completeness compared to the original answer: the LLM does not explicitly contrast the degree of management judgment or clarify that GM’s approach involves more forward-looking assumptions and less observable inputs, which the original answer emphasizes. However, this is implied by stating that GM’s inputs are 'internally-generated forecasts.' Wording differences are acceptable under semantic equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 421,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How would the implementation of the Basel III Finalization Proposal's Expanded Risk-Based Approach impact both Capital One and Citigroup's regulatory capital requirements, considering the phased-in effective date of July 1, 2025, and the requirement to use the lower of the two calculated risk-based capital ratios?",
      "original_answer": "The Basel III Finalization Proposal introduces a new Expanded Risk-Based Approach that would require both Capital One and Citigroup to calculate their risk-based capital ratios under both this new framework and the existing Basel III standardized approach, using the lower of the two ratios for compliance. For Capital One, this includes a three-year transition period starting July 1, 2025, during which risk-weighted assets under the Expanded Risk-Based Approach would be phased in. Citigroup has indicated that, if the proposal is finalized as written, it would materially increase its required regulatory capital. Both banks must also comply with all capital buffer requirements regardless of which approach yields the lower ratio, further constraining capital flexibility.",
      "llm_answer": "The Basel III Finalization Proposal forces both Capital One and Citi to compute risk‑weighted assets under the new Expanded Risk‑Based Approach and under the existing standardized approach and to apply the lower of the two resulting risk‑based capital ratios. Because the expanded approach generally yields higher RWA, it will push each bank’s required capital upward – Citi’s table already shows the expanded‑approach CET1 ratio at 10.5 % versus 12.1 % under the standardized method, and Capital One would face a similar increase – and the impact will be phased in starting July 1 2025, with full application by July 1 2028.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core regulatory mechanism correctly—both banks must calculate risk-based capital ratios under the Expanded Risk-Based Approach and the existing standardized approach, using the lower of the two. It also correctly notes the July 1, 2025, start date and the phased-in implementation. However, it introduces specific quantitative claims not present in the ground truth: the assertion that Citigroup's CET1 ratio is 10.5% under the expanded approach versus 12.1% under the standardized method is unsupported by the original answer, which only states that the impact would be 'material' without citing exact figures. These numbers may be plausible but are not verifiable from the provided ground truth, making them factually inaccurate in this evaluation context. (2) The date July 1, 2028, for full application is not mentioned in the ground truth, which only specifies a three-year transition starting July 1, 2025 (implying full effect by 2028), so this is a reasonable inference but not explicitly confirmed. The phasing is qualitatively correct but the end date is an extrapolation. (3) The multi-hop reasoning is sound in structure—understanding that a higher RWA leads to lower capital ratios and thus higher capital requirements when the lower ratio governs compliance—but the use of unverified specific percentages undermines factual accuracy. The model synthesizes the regulatory logic correctly but adds unsupported data points. (4) The correctness score is 6 due to these significant quantitative inaccuracies despite correct qualitative framework. Quantitative accuracy is low (4) because of the fabricated percentages. Qualitative accuracy is 7—core concepts, entities, and timeline are correct. Contextual relevance is high (9) as the response directly addresses the regulatory impact and phasing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 501,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 50,
      "question": "How does ConocoPhillips' exposure to condensate production through its ownership in Alba Plant LLC compare to Chevron's direct condensate production volumes in 2024, given Chevron reports zero condensate reserves in its 2024 10-K filing?",
      "original_answer": "ConocoPhillips holds a 52.2% interest in Alba Plant LLC, which extracts condensate from the Alba Unit natural gas stream and sells it at market prices, with COP's share reflected in 'Equity in earnings of affiliates.' In contrast, Chevron's 2024 10-K shows no condensate production or reserves across all categories, including both consolidated and affiliated companies. This indicates that while COP has exposure to condensate through its Alba Plant investment, Chevron had no direct condensate production in 2024.",
      "llm_answer": "ConocoPhillips does have condensate exposure – it owns 52.2 % of Alba Plant LLC, a joint‑venture that processes gas from the Alba Unit and extracts condensate (and LPG) for sale【page_12】.  By contrast, Chevron’s 2024 10‑K shows no condensate production (the “Crude Oil Condensate” column is blank/zero for all regions) and it reports zero condensate reserves【page_109】.  So ConocoPhillips’ joint‑venture gives it a non‑zero condensate exposure, whereas Chevron’s direct condensate output in 2024 is nil.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the 52.2% ownership stake in Alba Plant LLC is accurately reported, and the statement that Chevron reports zero condensate production and reserves in its 2024 10-K is factually correct, with specific reference to the 'Crude Oil Condensate' column being blank. (2) The answer is complete, addressing both ConocoPhillips' indirect exposure via a joint venture and Chevron's lack of direct production or reserves. (3) Entities—ConocoPhillips, Chevron, Alba Plant LLC, Alba Unit—are correctly identified, and the time frame (2024) aligns with the 10-K filing year. (4) The reasoning is sound: it correctly synthesizes multi-hop information—COP’s equity interest leads to condensate exposure through earnings in affiliates, while Chevron’s disclosed zero reserves and production confirm no exposure. The semantic meaning is equivalent to the original answer, with minor but acceptable rewording (e.g., 'non-zero condensate exposure' vs 'has exposure'). All citations to page numbers are consistent with document evidence. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 328,
        "total_tokens": 1606
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How did the application of ASU 2020-04 to contract modifications impact both AVGO's revenue recognition practices and ORCL's financial reporting, particularly in relation to reference rate reform?",
      "original_answer": "AVGO evaluates contract modifications to determine whether additional products or services should be accounted for as a separate contract or part of the existing contract, using standalone selling prices adjusted for specific contract circumstances. ORCL adopted ASU 2020-04 related to reference rate reform, which allowed optional expedients for contract modifications affected by changes in reference rates such as LIBOR. According to the evidence, AVGO uses standalone selling prices to allocate consideration in bundled arrangements, and modifications are accounted for prospectively, cumulatively, or a combination depending on the nature of the change. ASU 2020-04 applied to contract modifications made between March 12, 2020, and December 31, 2024, and both AVGO and ORCL reported no material impact on their consolidated financial statements from applying this guidance. ORCL finalized its adoption of ASU 2020-04 in Q1 of fiscal 2024, with no material effect on its financial statements or notes.",
      "llm_answer": "AVGO now applies ASU 2020‑04 to its contract‑modification accounting – it must determine whether a modification creates a distinct performance obligation and, if not, record the added items on a prospective or cumulative‑catch‑up basis, which governs the timing of revenue recognition for those changes (the effect was not material)【page_63】. Oracle disclosed that it completed its adoption of ASU 2020‑04 for reference‑rate reform in the first quarter of FY 2024 and that the change had no material impact on its consolidated financial statements or notes for the year ended May 31 2024【page_72】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the essential information from the ground truth. (1) Quantitatively, all dates and fiscal periods are correct: ORCL's adoption completed in Q1 of fiscal 2024 (year ended May 31, 2024), and the ASU 2020-04 application period (March 12, 2020 – December 31, 2024) is correctly implied by context, though not explicitly restated. The statement that both companies reported no material impact is accurately reflected. (2) The LLM correctly identifies that AVGO evaluates contract modifications for distinct performance obligations and applies prospective or cumulative catch-up accounting, aligning with the ground truth on revenue recognition practices. It also correctly states that ORCL adopted the ASU for reference rate reform with no material impact. (3) The multi-hop reasoning is sound: the answer synthesizes information across AVGO and ORCL, linking ASU 2020-04 to both companies’ contract modification practices and financial reporting outcomes. (4) Minor omission: the ground truth mentions AVGO’s use of standalone selling prices in allocating consideration in bundled arrangements, which the LLM omits. While not critical to the core question, this detail adds depth to AVGO’s revenue recognition methodology. However, the LLM captures the key outcome—no material impact—and correctly addresses both companies and the reference rate reform context. Wording differs but meaning is semantically equivalent. Thus, the answer is excellent but not perfect, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 427,
        "total_tokens": 1841
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the dual-class stock structure at META, which negatively impacts the attractiveness of its Class A Common Stock, compare to CMCSA's Class B Common Stock convertibility policy in terms of governance control and shareholder influence?",
      "original_answer": "META's dual-class structure gives disproportionate voting control to Class B shareholders like Mark Zuckerberg, requiring a majority of Class B shares to approve change-of-control transactions until they fall below 35% of combined voting power. In contrast, CMCSA allows Class B Common Stock (with 15 votes per share) to convert share-for-share into Class A Common Stock, maintaining a non-dilutable 33⅓% aggregate voting power for Class B shares. While both structures concentrate governance influence, META's system entrenches control more rigidly through class-vote requirements, whereas CMCSA enables gradual dilution through conversion.",
      "llm_answer": "Meta’s charter creates a dual‑class system that lets Mark Zuckerberg control all shareholder‑approval matters even though he owns far less than a majority of the total shares, and the anti‑takeover provisions tied to the Class B voting bloc make the ordinary Class A stock less attractive because its holders have limited voting power and fewer protective rights【page_50】.  By contrast, Comcast’s Class B shares carry a fixed 15‑vote per share (about 33 % of total voting power), are non‑dilutable and can be converted share‑for‑share into Class A stock under certain restrictions, giving B‑shareholders a clear path to equalize their influence and retain meaningful governance rights【page_91】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: META's dual-class structure gives Mark Zuckerberg outsized control despite owning a minority of shares, and Class A stock has limited voting power, reducing its attractiveness. CMCSA’s Class B shares have 15 votes per share and represent about 33⅓% of total voting power, which is non-dilutable. The conversion policy allowing share-for-share conversion into Class A stock is correctly noted. (2) Quantitatively, all numbers match: 15 votes per share, ~33% voting power (approximating 33⅓%), and the structural features are accurately represented. No calculation errors. (3) The multi-hop reasoning is sound—comparing governance control and shareholder influence across two companies’ stock structures. The LLM correctly identifies that META entrenches control more rigidly (via class-vote requirements for change-of-control), while CMCSA allows a path to equalize influence through conversion, implying more flexibility. (4) The only minor shortcoming is that the LLM does not explicitly mention META’s 35% threshold for Class B shares to maintain approval rights over change-of-control transactions, which is a specific governance mechanism in the ground truth. This omission slightly weakens completeness but does not distort the overall comparison. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent—directly addresses governance control and shareholder influence as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 420,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does PEP's use of exchange-traded commodity futures, which are cash-settled daily, compare with COST's disclosure regarding the absence of Level 1 financial assets measured at fair value on a recurring basis, given that Level 1 financial assets typically include exchange-traded commodity futures?",
      "original_answer": "PEP utilizes exchange-traded commodity futures that are cash-settled daily to manage market risk, and these are excluded from the fair value table as of December 25, 2021. These commodity futures fall under Level 1 financial assets, as defined by MDLZ's disclosure, which includes exchange-traded commodity futures valued at quoted market prices. However, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a distinct difference in financial instrument usage between PEP and COST.",
      "llm_answer": "PEP’s 10‑K notes that it does hold exchange‑traded commodity futures, but because they are cash‑settled each day they are excluded from the fair‑value hierarchy table (PEP 10‑K p. 107). In contrast, Costco’s 10‑K states that it did not hold any Level 1 (or Level 3) financial assets measured at fair value on a recurring basis, which means it has no exchange‑traded commodity futures (Costco 10‑K p. 51). Thus, PEP reports having such futures but omits them from the fair‑value table, whereas Costco reports having none at all.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that PEP uses exchange-traded commodity futures that are cash-settled daily and are excluded from the fair value hierarchy table, consistent with the original answer. It also accurately states that COST reported no Level 1 financial assets measured at fair value on a recurring basis, implying no such futures. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not compromised—dates and page references (e.g., PEP 10-K p. 107, Costco 10-K p. 51) are cited appropriately though not required for scoring; their inclusion supports accuracy. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across PEP and COST filings, understands the implication that exchange-traded commodity futures are Level 1 assets, and contrasts PEP’s usage (but exclusion from table) with COST’s absence of such assets. (4) The only minor limitation is that the LLM does not explicitly define why cash-settled daily derivatives are excluded from the fair value table or reference MDLZ’s disclosure as context for Level 1 classification, which the original answer includes for completeness. However, this does not detract from the core factual correctness. Semantic equivalence is maintained, and the conclusion is logically sound and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 397,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 51,
      "question": "How does the value of securities loaned with maturities of 31-90 days at Goldman Sachs compare to the total securities loaned value reported by Morgan Stanley, and what does this suggest about their relative exposure to short-term securities lending risk?",
      "original_answer": "Goldman Sachs reports $1,634 million in securities loaned with maturities of 31-90 days, while Morgan Stanley reports a total of $281 million in securities loaned (U.S. and Non-U.S. combined). This suggests that Goldman Sachs has a significantly higher exposure to short-term securities lending risk compared to Morgan Stanley.",
      "llm_answer": "Goldman Sachs had $1,634 million of securities loaned that mature in the 31‑90‑day bucket 【page_187†L31-L34】.  Morgan Stanley’s 10‑K shows total securities‑loaned balances of $6,277 million (U.S.) + $7,669 million (non‑U.S.) ≈ $13,946 million 【page_149†L31-L38】.  \n\nThus, Goldman’s short‑term loaned securities are only about one‑tenth of Morgan Stanley’s overall loaned‑securities portfolio, suggesting Goldman Sachs has a relatively modest exposure to short‑term securities‑lending risk compared with Morgan Stanley’s much larger total exposure.",
      "correctness_score": 1,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors. It incorrectly states that Morgan Stanley's total securities loaned amount to $13,946 million ($6,277M U.S. + $7,669M non-U.S.), which directly contradicts the ground truth value of $281 million. This error completely undermines the conclusion. The Goldman Sachs figure of $1,634 million is correct. (2) The calculation for Morgan Stanley’s total is numerically accurate based on the cited numbers, but those numbers are factually wrong per the ground truth. The comparison that Goldman’s amount is 'one-tenth' of Morgan Stanley’s is therefore false — in reality, Goldman’s $1,634M is nearly six times larger than Morgan Stanley’s $281M. (3) The multi-hop reasoning fails because the model used incorrect source data for Morgan Stanley, leading to an inverted conclusion. The correct reasoning should show that Goldman Sachs has significantly higher short-term securities lending exposure than Morgan Stanley, not lower. (4) Due to the severe quantitative inaccuracy and resulting incorrect conclusion, the correctness score is very low. The answer is contextually relevant in structure but factually opposite to the truth, hence low scores across all dimensions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 344,
        "total_tokens": 1590
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "What percentage of PowerSouth's owned generating capacity comes from its undivided interest in Alabama Power's Plant Miller Units 1 and 2, and how does this compare to Duke Energy's total electricity generation in GWh for 2021?",
      "original_answer": "PowerSouth owns an undivided 8.16% interest in Alabama Power's Plant Miller Units 1 and 2, which contributes to its total generating capacity of over 1,600 MWs. In comparison, Duke Energy generated a combined total of 22,344 GWh of electricity in 2021 across all its operating segments. This comparison highlights the relative scale of PowerSouth’s partial ownership in a specific plant versus Duke Energy’s full system-wide electricity generation.",
      "llm_answer": "PowerSouth’s undivided 8.16 % ownership stake in Alabama Power’s Plant Miller Units 1 and 2 accounts for about 8.16 % of its total owned generating capacity【page_17】. By comparison, Duke Energy produced roughly 22,344 GWh of electricity in 2021【page_187】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies PowerSouth's 8.16% undivided interest in Plant Miller Units 1 and 2 and accurately states Duke Energy's 2021 total generation as 22,344 GWh. These numbers match the ground truth exactly, with acceptable formatting variations (e.g., 22,344 GWh). (2) Quantitative accuracy is perfect: both percentages and GWh values are correct, and no calculations were required beyond accurate reporting. (3) The multi-hop reasoning is mostly sound—linking PowerSouth’s ownership stake to its capacity and comparing it to Duke Energy’s system-wide generation. However, the LLM slightly misrepresents the original answer by stating the 8.16% stake accounts for 'about 8.16% of its total owned generating capacity,' whereas the original clarifies that the stake contributes to a total capacity of over 1,600 MW without specifying the exact percentage contribution of that stake to overall capacity. This is a subtle but important distinction—the 8.16% refers to ownership of Plant Miller, not necessarily the share of total PowerSouth capacity. (4) Despite this minor misinterpretation, the core facts, entities, and comparison are correct and relevant. The answer effectively conveys the scale difference between a partial plant ownership and full system generation. Thus, correctness is high but not perfect due to the slight reasoning inaccuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1196,
        "completion_tokens": 383,
        "total_tokens": 1579
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does NIKE's exposure to interest rate risk in its $11.6 billion portfolio of fixed-income investments compare to McDonald's sensitivity to market inputs like interest rate yield curves, given both companies rely on pricing models that use observable market data for valuation?",
      "original_answer": "NIKE holds $11.6 billion in short-term investments, including investment-grade fixed-income securities, which are exposed to interest rate risk. These investments are valued using pricing models that incorporate observable market data such as interest rates and yield curves. Similarly, McDonald’s discloses that its derivatives are valued using pricing models that rely on observable market parameters, including interest rate yield curves. While NIKE’s risk stems from changes in interest rates affecting investment returns, McDonald’s exposure is tied to derivative valuations that reflect market fluctuations. Both companies depend on observable inputs for fair value measurements, though the nature and magnitude of risk differ based on the type of financial instrument involved.",
      "llm_answer": "NIKE’s $11.6 billion cash‑and‑short‑term investment portfolio is “exposed to … interest‑rate risk” but the securities have a very short weighted‑average maturity of only 65 days, limiting the impact of rate moves【page_50】. McDonald’s, however, holds derivatives that are “valued using … pricing models … that incorporate observable market parameters, such as interest‑rate yield curves” (Level 2 inputs), so changes in those curves can affect the fair value of its hedges and earnings more directly【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: NIKE's $11.6 billion portfolio and the 65-day weighted-average maturity are accurately reported (though the 65-day detail is not in the original answer, it is factually consistent and adds precision without contradiction). (2) The LLM correctly identifies that both NIKE and McDonald’s use pricing models based on observable market data—NIKE for its fixed-income investments and McDonald’s for derivatives—highlighting interest rate yield curves as a shared input. (3) The reasoning is sound: it distinguishes NIKE’s indirect interest rate risk (via investment returns) from McDonald’s more direct earnings impact through derivative valuations, which reflects accurate multi-hop synthesis across the two companies’ disclosures. (4) The only minor gap is that the original answer emphasizes the broader category of 'short-term investments' and 'fair value measurements,' while the LLM focuses more narrowly on derivatives for McDonald’s and adds maturity detail for NIKE not in the original. However, this does not reduce factual accuracy—rather, it enhances context. The LLM answer is semantically equivalent and slightly more detailed, with no factual errors. Thus, correctness is high (9/10), with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 381,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class A common stock potentially influence their respective shareholder governance dynamics, given Netflix's uniform one-vote-per-share policy and Alphabet's multi-class structure with differential voting rights?",
      "original_answer": "Netflix's common stock provides each share with one vote, promoting a more egalitarian shareholder governance model. In contrast, Alphabet's multi-class structure, where Class A common stock grants one vote per share while Class B common stock grants 10 votes per share, concentrates voting power among holders of Class B shares. This structural difference means Alphabet's governance is more susceptible to control by a smaller group of insiders or major shareholders, while Netflix maintains a more evenly distributed voting environment.",
      "llm_answer": "Netflix’s common stock is a single‑class, one‑vote‑per‑share security, so each share’s voting power is exactly proportional to its economic ownership (“The holders of each share of common stock shall be entitled to one vote per share” – NFLX 10‑K p. 60). Alphabet, by contrast, has a multi‑class structure in which each Class A share gets one vote but each Class B share carries ten votes (and Class C carries none) – “Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to 10 votes per share” – GOOGL 10‑K p. 82. This disparity means Netflix’s governance is more egalitarian, with all shareholders influencing decisions proportionally, whereas Alphabet’s public shareholders (Class A) have relatively less voting power than insiders who hold the high‑voting Class B shares, allowing a concentrated control group to steer board and strategic decisions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Netflix's one-vote-per-share policy and Alphabet's multi-class structure with Class A (1 vote), Class B (10 votes), and Class C (0 votes) are accurately described. The citations to the respective 10-K filings (NFLX p. 60, GOOGL p. 82) add precision and authenticity. (2) Quantitative accuracy is perfect: the voting ratios (1:1 for Netflix, 1:10 for Alphabet's Class A vs B) are correctly stated with no calculation errors. (3) Multi-hop reasoning is sound—LLM correctly synthesizes governance implications across two companies, contrasting egalitarian voting at Netflix with concentrated control at Alphabet due to differential voting rights. It identifies that insiders typically hold Class B shares, which aligns with known ownership structures. (4) The answer fully addresses the question’s focus on how voting structure differences influence shareholder governance dynamics. Wording differs slightly from the original but conveys the same meaning with enhanced detail (e.g., mentioning Class C shares, which strengthens completeness). All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 341,
        "total_tokens": 1746
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How might the IRA's price-setting provisions for Medicare Part D drugs like Imbruvica and XARELTO differently impact AbbVie and Johnson & Johnson's revenue strategies, given their respective exposure to the Medicare program?",
      "original_answer": "The IRA's price-setting provisions for Medicare Part D drugs will likely impact AbbVie and Johnson & Johnson differently due to their distinct product portfolios and revenue strategies. AbbVie has Imbruvica selected for price-setting starting in 2026, which could significantly affect its revenue stream, especially if more high-revenue products are selected in the future. Johnson & Johnson has XARELTO selected under the same program, a major anticoagulant with substantial Medicare utilization. Both companies face uncertainty around the final government-set prices, but J&J has already filed litigation challenging the constitutionality of the IRA’s pricing mechanism, suggesting a more aggressive stance to protect revenue. AbbVie, on the other hand, is more focused on evaluating the broader strategic impact of the IRA, including potential acceleration of revenue erosion prior to patent expirations. The differing responses reflect their respective risk exposure and strategic priorities within the Medicare program.",
      "llm_answer": "The Inflation Reduction Act will cap the Medicare Part D price for any drug on the CMS “Selected Drug” list – which now includes AbbVie’s Imbruvica (co‑commercialized with Pharmacyclics) and J&J’s Xarelto (see J&J 10‑K p. 11). For AbbVie, the ceiling price will compress Imbruvica’s Medicare reimbursement and could accelerate revenue erosion before its patent expires, but the company can partly offset the hit because Imbruvica represents only one piece of a broader portfolio (see AbbVie 10‑K p. 19). By contrast, J&J’s Xarelto generates a larger share of its Medicare‑driven sales, so the same price‑setting rule is likely to bite more directly into J&J’s overall revenue strategy, forcing it to lean on growth in other segments or adjust its pricing and discount approaches.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and aligns well with the ground truth, earning a high correctness score. (1) All entities are correct: AbbVie and Johnson & Johnson are accurately identified with their respective drugs, Imbruvica and XARELTO (spelled as Xarelto, a minor but acceptable variation). The drugs are correctly linked to the IRA's Medicare Part D price-setting provisions, and the 2026 start date is implied through context (though not explicitly stated, which is a minor omission). (2) Quantitative accuracy is strong: no specific dollar amounts, percentages, or dates are misstated. The answer correctly references the 10-K pages, supporting its claims with appropriate document evidence. (3) Reasoning is sound and reflects multi-hop synthesis: it contrasts AbbVie’s diversified portfolio strategy with J&J’s heavier reliance on XARELTO in Medicare, logically concluding that J&J faces greater revenue risk. However, it omits a key element from the ground truth—J&J’s litigation against the IRA’s pricing mechanism, which is a significant part of their strategic response. This omission reduces completeness and qualitative accuracy slightly. (4) The answer is highly contextually relevant, directly addressing how the IRA impacts each company’s revenue strategy based on Medicare exposure. While the core financial and strategic implications are correctly conveyed, the absence of J&J’s legal challenge—a major strategic action—prevents a top score. Overall, the answer is semantically close to the original and factually solid, but missing one critical strategic differentiator.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 440,
        "total_tokens": 1911
      },
      "error": null
    },
    {
      "question_id": 52,
      "question": "How does Citi's governance structure for managing compliance risk specifically address the potential amplification of credit and liquidity risks stemming from transition climate risks as outlined in Morgan Stanley's risk disclosures?",
      "original_answer": "Citi's governance structure includes the Board and Executive Management Team, which oversee enterprise risk management (ERM) and hold management accountable for the effectiveness of internal controls and compliance with legal and regulatory requirements. This includes ensuring that compliance risk is effectively managed across the organization. Transition climate risks, as outlined in Morgan Stanley's disclosures, may amplify credit and liquidity risks by reducing customers' operating income or the value of their assets. These risks also expose firms to reputational, compliance, and litigation risks due to increased legal and regulatory scrutiny. Citi’s Internal Audit, which reports functionally to the Chair of the Citi Audit Committee, provides independent assurance over the effectiveness of governance, risk management, and controls, including those addressing climate-related risks. This structure ensures that compliance risk management processes are aligned with evolving regulatory expectations, such as those related to climate risk, which Morgan Stanley notes are increasingly focused on disclosure and regulation of carbon emissions.",
      "llm_answer": "Morgan Stanley warns that transition‑related climate risk can magnify credit and liquidity exposures, and Citi’s governance framework explicitly builds a safeguard for that scenario.  Citi’s second‑line Independent Compliance Risk Management (ICRM) function – led by the Group Chief Compliance Officer, with matrix reporting to the CRO and unrestricted access to the Board’s Risk Management Committee – sets and monitors compliance standards, escalates climate‑related compliance issues and works with the Climate‑Risk Committee (co‑chaired by the CRO and Chief Sustainability Officer) to embed transition‑risk impacts into credit‑ and liquidity‑risk oversight (see Citi’s lines‑of‑defense model and ICRM description, pages 70‑71).  The firm’s climate‑risk discussion notes that transition risk “may lead to and amplify credit or liquidity risk” (page 75), and the ICRM‑Board reporting structure ensures those amplified risks are identified, measured and acted on.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Citi’s governance structure involving the Board, Executive Management, and Independent Compliance Risk Management (ICRM) is accurately described, including the reporting lines to the Board’s Risk Management Committee and the role of the Climate-Risk Committee. The connection between transition climate risks and amplified credit and liquidity risks—specifically referencing Morgan Stanley’s disclosures—is correctly synthesized. (2) There are no numeric values in the question or answers that require verification; thus, quantitative accuracy is not applicable in a traditional sense, but all references to page numbers (e.g., pages 70–71, 75) are consistent with expected sourcing and do not conflict with the ground truth. (3) The multi-hop reasoning is sound: the model correctly links Morgan Stanley's risk disclosures about transition climate risks amplifying credit and liquidity risks to Citi’s governance mechanisms designed to manage such cross-cutting risks. It appropriately identifies how ICRM and the Climate-Risk Committee integrate climate risk into broader risk oversight. (4) The LLM adds detail not in the original answer—such as the matrix reporting structure and co-chairing of the Climate-Risk Committee—which may come from deeper document analysis but do not contradict the ground truth and enhance precision. The only minor gap is that the original emphasizes Internal Audit’s role in providing independent assurance over climate-related controls, which the LLM omits; however, it compensates by detailing ICRM’s proactive monitoring. Overall, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 476,
        "total_tokens": 2027
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does QCOM's reliance on Chinese OEMs for 30% of its licensing revenue create different supply chain risks compared to TXN's strategy of expanding internal 300mm wafer fabrication capacity?",
      "original_answer": "QCOM derives a significant portion of its licensing revenues from Chinese OEMs, with 30% of total licensing revenue coming from this group of manufacturers. Delays or disputes in license agreements with these OEMs can directly impact QCOM's revenue and cash flows. In contrast, TXN is expanding internal 300mm wafer fabrication capacity through investments in RFAB2, LFAB1, and SM1 facilities, aiming to achieve greater supply chain control and reduce dependency on external foundries. While QCOM's business model depends heavily on maintaining licensing agreements with external manufacturers, particularly in China, TXN's strategy reduces exposure to external supply chain disruptions by vertically integrating manufacturing. This creates different risk profiles: QCOM faces higher exposure to geopolitical and contractual risks in China, while TXN mitigates manufacturing risks through capital investments in internal capacity.",
      "llm_answer": "Qualcomm’s licensing model ties roughly 30 % of its royalty stream to Chinese OEMs, so the company is exposed to geopolitical and trade‑policy shocks, licensing‑payment disputes and concentration risk – the filing notes that a “significant portion of our revenues… comes from a limited number of Chinese OEMs” and that U.S./China tensions could “limit or prevent us from transacting business” with those customers (QCOM p.18‑19, 35). In contrast, Texas Instruments is building additional 300 mm wafer fabs (RFAB2, LFAB1, SM1/SM2, LFAB2) to “provide us with lower costs and greater control of our supply chain,” thereby reducing reliance on external foundries and the associated geopolitical or supplier‑availability risks (TXN p.7).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 30% figure for QCOM's licensing revenue from Chinese OEMs is correctly stated. The mention of TXN's 300mm wafer fab expansions (RFAB2, LFAB1, SM1/SM2, LFAB2) matches the facilities noted in the original answer (RFAB2, LFAB1, SM1), with SM2 and LFAB2 being additional but consistent with TXN's broader strategy—minor expansion beyond the original but not incorrect. (2) The LLM correctly identifies the core risk contrast: QCOM faces geopolitical and contractual risks due to reliance on Chinese OEMs, while TXN reduces supply chain risk via vertical integration through internal fab investments. It supports this with relevant excerpts from the filings (QCOM pp.18–19, 35; TXN p.7), enhancing credibility. (3) Multi-hop reasoning is sound: it synthesizes QCOM’s revenue dependency and associated risks with TXN’s capital investment strategy to contrast two different supply chain risk profiles. (4) The only minor shortcoming is that the original answer emphasizes TXN’s goal of reducing dependency on external foundries and achieving cost control, which the LLM mentions, but it slightly overstates the facility list (includes SM2 and LFAB2 not in the original). However, these are part of TXN’s actual expansion plans and do not constitute factual errors. Wording differs but semantic meaning and factual content are equivalent. All key entities (QCOM, TXN, Chinese OEMs, 300mm wafers, licensing vs. fabrication strategies) are correct. The answer fully addresses the comparative supply chain risk question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1427,
        "completion_tokens": 438,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does Southern Company's evaluation of ASU 2020-04 in relation to interest rate derivatives compare with Duke Energy's assessment of the same accounting standard's impact on its LIBOR-indexed financial contracts?",
      "original_answer": "Southern Company continues to evaluate the provisions of ASU 2020-04 and its impact on transitioning to alternative interest rates, particularly in relation to its interest rate derivatives as noted in Note 14, while Duke Energy is assessing the optional expedients provided by the same standard to manage contractual amendments or terminations for LIBOR-indexed financial arrangements, including variable-rate debt and interest rate swaps, which may extend beyond the 2023 LIBOR phase-out. Both companies recognize the uncertainty around the ultimate financial impact, with Duke Energy specifically noting it is not expected to be material.",
      "llm_answer": "Southern Company says it is still evaluating the provisions of ASU 2020‑04 for its interest‑rate derivatives, has elected to apply the amendment to debt‑modification arrangements and expects the transition to an alternative rate to have no material effect, although the ultimate outcome remains uncertain. Likewise, Duke Energy is reviewing its LIBOR‑indexed variable‑rate debt and interest‑rate swaps, is assessing the optional expedients under the same ASU, and also concludes that the move away from LIBOR is unlikely to be material, but the final impact cannot yet be determined.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Southern Company is still evaluating ASU 2020-04 in relation to interest rate derivatives and has applied the debt-modification amendment, expecting no material impact with uncertainty remaining. Duke Energy is assessing optional expedients under the same ASU for LIBOR-indexed instruments (variable-rate debt and interest rate swaps), also concluding the impact is unlikely to be material but not yet fully determinable. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and their respective assessments of ASU 2020-04, accurately comparing their approaches and conclusions. (4) The only minor discrepancy is that the LLM answer states Southern Company 'has elected to apply the amendment to debt-modification arrangements,' which is slightly more specific than the original answer’s 'continues to evaluate,' though this detail may be supported by external filings and does not contradict the overall uncertainty expressed. The original answer emphasizes ongoing evaluation, while the LLM implies a partial decision has been made. This nuance prevents a perfect 10 but does not undermine correctness. Overall, the answer is semantically equivalent, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 433,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the exposure of AMZN's foreign currency assets to British Pounds and Euros compare to NKE's reliance on option contracts for managing similar currency risks, given their differing approaches to foreign exchange risk management?",
      "original_answer": "AMZN holds foreign currency assets in British Pounds, Euros, and other currencies, and is exposed to foreign exchange risk due to fluctuations that may materially impact translated values of these assets. NKE actively manages its foreign exchange risk using option contracts, specifically hedging exposures related to product costs, external sales, and other costs denominated in currencies like the British Pound and Euro. While AMZN discloses its exposure to these currencies, it does not specify the use of derivative instruments like options to hedge this risk. In contrast, NKE explicitly states its use of option contracts as part of its foreign currency risk management program to hedge forecasted transactions and balance sheet exposures. This suggests that NKE takes a more proactive and structured approach to mitigating foreign exchange impacts through financial instruments, while AMZN's strategy remains less transparent in terms of derivative usage.",
      "llm_answer": "Amazon’s 10‑K notes that it “holds cash equivalents and/or marketable securities in foreign currencies such as British Pounds … and Euros” (page 9), so its balance‑sheet and results are directly exposed to the dollar’s movements against those currencies. Nike, by contrast, does not rely on such currency‑denominated assets; it “elects to use currency forward and option contracts to hedge” its product‑cost and other non‑functional‑currency exposures and runs a foreign‑currency‑adjustment program that uses options (and forwards) to offset risk (page 48, 47, 55). Thus Amazon’s risk is a passive exposure to pound and euro holdings, whereas Nike actively manages similar risk with derivative options rather than holding the currencies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies that AMZN holds foreign currency assets in British Pounds and Euros, exposing it to foreign exchange risk, while NKE uses option and forward contracts to actively hedge currency risks related to product costs and other exposures. The characterization of AMZN's exposure as 'passive' and NKE's approach as 'active' is semantically equivalent to the original answer's conclusion that NKE takes a more proactive, structured approach using derivatives while AMZN does not disclose such usage. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable in a numerical sense; however, the LLM accurately cites page numbers from the 10-K (e.g., page 9, 48, 47, 55), which supports its claims and matches the expected sourcing—this enhances credibility and precision. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (AMZN and NKE), compares their differing FX risk management strategies, and draws a valid contrast between holding foreign currency assets (AMZN) versus using derivative instruments (NKE). (4) The only minor shortcoming is that the LLM slightly overstates that Nike 'does not rely on such currency-denominated assets'—the original answer does not make this claim, as it focuses on NKE's use of options rather than denying any asset holdings. However, this does not contradict known facts and is a reasonable inference. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning with full coverage of the question's requirements.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1447,
        "completion_tokens": 472,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 53,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the dynamic relationship between share class voting rights?",
      "original_answer": "At META, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders hold 33 1/3%, with each share of Class B having 15 votes. In contrast, at GOOGL, each share of Class A has one vote and each share of Class B has 10 votes, with no specific percentage provided for their distribution. This indicates that META grants significantly more voting influence to Class B shares relative to Class A compared to GOOGL's structure.",
      "llm_answer": "Meta’s 2024 filing shows it has 2.19 billion Class A shares and 344 million Class B shares outstanding【page_1】.  Like Alphabet, each Meta Class A share carries one vote and each Class B share carries ten votes, so voting power is concentrated in the much smaller Class B pool—a dual‑class structure identical to Alphabet’s 1‑vote‑Class A/10‑vote‑Class B arrangement described in its 10‑K【page_82】, though Alphabet also issues a non‑voting Class C series that Meta does not have.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains multiple factual inaccuracies. It incorrectly states that Meta's Class B shares have 10 votes per share, while the ground truth specifies 15 votes per Class B share. It also falsely claims Meta's structure is 'identical' to GOOGL's, which has 10 votes for Class B—this misrepresents the comparative voting influence. Additionally, the LLM asserts that Meta has 2.19 billion Class A and 344 million Class B shares based on a '2024 filing', but this specific share count data is not present in the original answer and cannot be verified from the provided ground truth. (2) The quantitative inaccuracies are severe: vote counts per share class are wrong for Meta (10 vs. actual 15), and the voting power distribution percentages (66 2/3% for Class A and 33 1/3% for Class B at Meta) are entirely omitted. The answer fabricates precise share counts without basis in the original answer. (3) The multi-hop reasoning fails: the model incorrectly equates the two companies' structures despite Meta granting significantly more relative power to Class B shares (15:1 vs. 10:1), which is the key insight in the ground truth. The synthesis is flawed because it overlooks the core comparative dynamic. (4) While the answer addresses the general topic of dual-class structures and mentions both companies, the severe factual errors in vote ratios, missing percentage distributions, and invented numerical data drastically reduce correctness. Contextual relevance is moderate because it attempts the comparison, but accuracy and reasoning are poor.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1245,
        "completion_tokens": 432,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Southern Company's (SO) investment in SNG and SNG's need for FERC approval on its pipeline project compare to Duke Energy Ohio's (DUK) experience with FERC approval in terms of regulatory constraints and capital implications?",
      "original_answer": "Southern Company's (SO) investment in SNG was $1,245 million as of December 31, 2024. SNG is developing a $3 billion pipeline project requiring FERC approval, with Southern Company Gas owning 50% of the project. This regulatory dependency could delay the project until 2029 if approvals are not met. Similarly, Duke Energy Ohio (DUK) requires FERC and PUCO approval to pay dividends from specific equity accounts, with a condition to maintain equity at no less than 30% of total capital. Both entities face regulatory constraints from FERC, but while SNG's challenge centers on project execution and timing, DUK's is tied to capital structure and dividend policy.",
      "llm_answer": "Southern Company’s equity‑method stake in Southern Company Gas (SNG) ties it to a roughly $3 billion pipeline expansion—about $1.5 billion of which Southern Company will fund—and the project cannot proceed until all required regulator sign‑offs, including FERC approval, are obtained (page 92). By contrast, Duke Energy Ohio’s FERC involvement has been limited to obtaining FERC and state‑PUC clearance to pay dividends and to the fact that FERC does not set wholesale rates for Ohio (pages 147 & 133), so its regulatory constraint is on the distribution of existing capital rather than on a large, conditional capital outlay.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer captures the core comparison between Southern Company's (SO) investment in SNG and Duke Energy Ohio's (DUK) regulatory experience with FERC, correctly identifying that SNG's challenge is tied to project execution requiring FERC approval, while DUK's constraint relates to dividend distribution and capital structure. However, key quantitative inaccuracies reduce factual precision. (2) The original answer states SO's investment in SNG was $1,245 million as of December 31, 2024, but the LLM does not mention this figure. Instead, it estimates Southern Company will fund 'about $1.5 billion' of the $3 billion pipeline, implying 50% ownership—which aligns with the ground truth (SNG project 50% owned by Southern Company Gas). While the $1.5 billion funding share is logically derived and acceptable, the omission of the actual reported investment ($1,245M) is a significant gap. Additionally, the LLM fails to mention the potential 2029 delay if approvals are not met, a key temporal implication in the original answer. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face FERC-related constraints but of different types—capital outlay/project delay for SNG vs. dividend policy for DUK. It appropriately contrasts the nature of regulatory involvement. However, it omits DUK’s specific requirement to maintain equity at no less than 30% of total capital, a critical detail in the original answer that defines the capital structure constraint. (4) Despite missing specific numbers and conditions, the LLM conveys a qualitatively accurate and contextually relevant comparison. The reasoning is logical and addresses the central theme of differing regulatory impacts. Hence, correctness is reduced primarily due to missing key figures and conditions, not flawed logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 498,
        "total_tokens": 1842
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does Lowe's share repurchase activity through financial institutions in 2021-2022 compare with Home Depot's use of dividend equivalents in terms of shareholder value distribution mechanisms?",
      "original_answer": "Lowe's authorized $13.0 billion in additional share repurchases in December 2021, bringing total authorization to $28.0 billion since 2020, and executed a $3.0 billion accelerated share repurchase (ASR) with a financial institution, receiving 11.9 million shares. Meanwhile, Home Depot pays dividend equivalents on unvested restricted stock units and performance shares, which accrue and are paid out in the form of additional shares upon vesting or payout. This shows Lowe's prioritized direct share reduction through financial intermediaries, while Home Depot focused on equity-based dividend equivalent compensation aligned with vesting timelines.",
      "llm_answer": "Lowe’s returned capital to shareholders by using an Accelerated Share Repurchase (ASR) with a third‑party financial institution – it paid $3 billion in November 2021, received an initial 10.3 million shares and a further 1.6 million shares in January 2022, effectively buying back stock on behalf of investors【page_23】. In contrast, Home Depot’s equity‑compensation programs distribute shareholder value through dividend equivalents that accrue on restricted stock, performance shares and RSUs and are paid as additional shares when the awards vest, providing an indirect, employee‑focused mechanism rather than a direct buy‑back【page_69】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is largely correct and aligns well with the ground truth. It accurately identifies Lowe's $3.0 billion ASR with a financial institution, though it specifies $3 billion paid in November 2021 (vs. December 2021 in the original answer) and breaks down share receipt into 10.3 million initially and 1.6 million later (totaling 11.9 million), which matches the ground truth. The timing discrepancy (November vs. December) is minor and may reflect different reporting interpretations, but the core financial outlay and share count are correct. (2) The quantitative details—$3 billion, 10.3 million + 1.6 million = 11.9 million shares—are accurate and consistent with the original. However, the LLM omits Lowe's broader $13.0 billion additional authorization in December 2021 and the cumulative $28.0 billion since 2020, which is a notable but not critical omission for the comparison focus. (3) The reasoning is sound: it correctly contrasts Lowe’s direct share repurchase via financial intermediaries with Home Depot’s indirect, employee-focused dividend equivalents on unvested equity awards, accurately describing payout mechanics and shareholder value distribution differences. (4) The answer is contextually excellent, directly addressing the comparison of shareholder value mechanisms between the two companies. While missing the full scope of Lowe’s repurchase authorization, it captures the key multi-hop elements—specific transaction, financial institution involvement, and structural contrast with Home Depot’s dividend equivalents—making it semantically equivalent in intent and conclusion. Minor omission prevents a perfect 10, but overall highly accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 462,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure of supplier finance program obligations for both Caterpillar and Honeywell, particularly in terms of the rollforward requirement effective in 2024?",
      "original_answer": "Caterpillar and Honeywell both adopted ASU 2022-04, which mandates enhanced disclosures for supplier finance programs. The guidance requires annual disclosure of key terms, balance sheet presentation, and a rollforward of obligations, with the rollforward specifically becoming effective on January 1, 2024. Caterpillar included the rollforward in its 2024 disclosures, showing $830 million in obligations at year-end. Honeywell also adopted the rollforward requirement for 2024, aligning with the new standard. Both companies now provide more transparent reporting of their supplier finance obligations, which were $830 million for Caterpillar and would be similarly detailed for Honeywell under the new rules.",
      "llm_answer": "Both companies now must show a roll‑forward of the amounts confirmed under their supplier‑finance programs because of ASU 2022‑04, whose roll‑forward provision became effective on 1 January 2024. Honeywell’s filing explicitly cites the ASU, notes that the roll‑forward was adopted on that date and presents the beginning balance, invoices confirmed, payments and ending balance (e.g., $830 million at 12/31/2024). Caterpillar’s 2024 Note 19 likewise provides the same roll‑forward of obligations ($803 million at 12/31/2023 and $830 million at 12/31/2024), satisfying the ASU requirement even though it does not name the standard. This change adds only the required roll‑forward disclosure; it does not affect the recognition or measurement of the supplier‑finance liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the key dollar amounts are correct: both Caterpillar and Honeywell report $830 million in supplier finance obligations at year-end 2024, which matches the original answer. The LLM adds additional detail (Caterpillar’s $803 million beginning balance) not in the original but consistent with a proper rollforward and does not contradict the ground truth. The effective date of January 1, 2024, is correctly stated. (2) The answer is complete: it addresses both companies, the impact of ASU 2022-04, the new rollforward requirement effective in 2024, and correctly notes that the standard enhances disclosure without affecting recognition or measurement. (3) Entity accuracy is strong—both companies are correctly identified, along with the correct ASU, note (Caterpillar’s Note 19), and disclosure type. (4) Multi-hop reasoning is sound: the LLM synthesizes that both companies adopted the rollforward in 2024, even if Caterpillar does not explicitly name the ASU, and correctly infers compliance. The only minor deviation is the mention of Honeywell presenting a full rollforward including beginning balance, payments, etc., which is implied but not explicitly confirmed in the ground truth—this is a reasonable inference but slightly beyond the provided information. Overall, the answer is factually correct, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1387,
        "completion_tokens": 397,
        "total_tokens": 1784
      },
      "error": null
    },
    {
      "question_id": 54,
      "question": "How does the $49,549 million in credit card loans due within 1 year reported by Company C compare to Visa's strategy of driving growth through credit card issuance, given the $20 trillion global opportunity they identify in converting non-card payments to digital credentials?",
      "original_answer": "Company C reports holding $49,549 million in credit card loans due within 1 year, indicating a significant portion of short-term consumer credit exposure. This aligns with Visa's strategic focus on expanding credit card usage to capture a share of the $20 trillion global opportunity in converting non-card payments to digital credentials on their network. Visa's emphasis on growing credit card programs through financial institution partnerships suggests a continued push to increase the volume and velocity of credit card transactions, which would likely feed into larger short-term loan balances across institutions like Company C.",
      "llm_answer": "Company C’s credit‑card portfolio shows about $49.5 billion of loans due within one year (see page 86), which is only a tiny slice of Visa’s $20 trillion global opportunity to convert cash, checks, ACH and other non‑card payments into digital credentials (see page 8). In other words, the $49.5 billion represents roughly 0.25 % of the market size Visa is targeting, underscoring that Visa’s growth strategy is aimed at a market that is orders of magnitude larger than the current short‑term credit‑card loan balance.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant quantitative error in the percentage calculation. It states that $49.5 billion is 'roughly 0.25%' of $20 trillion. However, the correct calculation is ($49.5 billion / $20 trillion) * 100 = 0.2475%, which rounds to 0.25% — so this part is approximately correct. However, the original answer does not make this quantitative comparison at all; it focuses on strategic alignment rather than market share percentage. The LLM introduces a new calculation not present in the ground truth, which risks misrepresenting the intent of the original answer. While the numbers themselves are close in magnitude ($49,549 million ≈ $49.5 billion), the LLM fabricates a '0.25%' comparison that is not in the original reasoning, thus failing to reflect the actual multi-hop synthesis. (2) The dollar amounts are acceptably converted ($49,549 million → $49.5 billion), and $20 trillion is correctly cited. The calculation, while mathematically close, is not part of the original answer and introduces a false precision not supported by the ground truth. (3) The multi-hop reasoning is partially sound — it connects Company C’s short-term loans to Visa’s broader market opportunity — but it mischaracterizes the relationship by reducing it to a market share percentage, whereas the original emphasizes strategic alignment through network expansion and partnerships. The LLM misses the key point about Visa’s partnership model driving transaction volume and loan balances across institutions. (4) The contextual relevance is high because it addresses both entities and the general strategic context. However, the qualitative accuracy is reduced due to the invented metric and omission of the core strategic mechanism (partnerships increasing transaction velocity). The correctness score is 6 because the answer gets some facts right but introduces misleading analysis not grounded in the original synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1320,
        "completion_tokens": 523,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the impact of weather conditions on Southern Company's gas distribution revenues compare to the exposure of NextEra Energy's electricity demand, considering their respective risk mitigation strategies?",
      "original_answer": "Southern Company Gas' earnings are affected by customer consumption patterns that are largely a function of weather conditions and natural gas price levels. For example, in 2023, Southern Company Gas experienced a 6.2% decrease in net income compared to 2022, partly due to lower gas volumes sold driven by weather patterns. However, the company utilizes mechanisms like weather normalization and weather derivative instruments to limit exposure to typical weather variations. In contrast, NextEra Energy (NEE) faces more direct and severe operational risks from weather conditions, such as hurricanes, extreme temperatures, and disruptions to power generation from wind and solar facilities. NEE's Florida-based operations are particularly vulnerable to hurricanes, which can cause power outages, infrastructure damage, and increased costs for service restoration. While NEE also seeks cost recovery through regulatory mechanisms, its exposure to unpredictable weather events poses a more immediate threat to both operations and financial performance compared to Southern Company Gas' structured risk management approach.",
      "llm_answer": "Southern Company’s gas‑distribution earnings do rise and fall with weather‑driven consumption – its 2023 firm‑gas volume fell 11.6 % as colder weather reduced demand (see p. 85) – but the utility cushions that swing with regulatory “weather‑and‑revenue normalization” mechanisms and weather‑derivative contracts that limit exposure to typical weather variations (p. 86, 200). NextEra Energy’s electricity sales are likewise weather‑sensitive – severe storms, heat waves or cold snaps can sharply shift demand and even cause outages that cut revenue (p. 26) – and the company relies on hedging, trading, insurance and cost‑recovery provisions to manage that demand volatility (p. 27‑28).",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. It claims Southern Company's 2023 firm-gas volume fell by 11.6% due to colder weather reducing demand, which contradicts the ground truth: colder weather typically increases gas demand, not reduces it, and the actual reported impact was a 6.2% decrease in net income (not volume) partly due to lower gas volumes from weather patterns. The 11.6% figure and its attribution are not supported by the original answer and appear fabricated or misattributed. (2) The original answer does not mention page numbers (e.g., p. 85, 86, 200, 27-28), suggesting the LLM may be referencing external documents not in the context, undermining reliability. (3) While the LLM correctly identifies that both companies face weather-related risks and use mitigation strategies (e.g., weather normalization, derivatives, cost recovery), it fails to capture the key qualitative distinction: Southern Company Gas manages relatively predictable consumption volatility, whereas NextEra Energy faces more severe, operational threats from hurricanes and extreme weather, especially in Florida. This critical comparative insight—central to the question—is underdeveloped. (4) The LLM mentions hedging, insurance, and cost recovery for NextEra, which aligns generally with the original, but misses the emphasis on physical infrastructure vulnerability and service restoration costs. Overall, the reasoning is partially sound and contextually relevant, but major quantitative errors and incomplete multi-hop synthesis—especially in comparing risk severity and mitigation effectiveness—reduce correctness. Semantic equivalence is partially achieved but undermined by incorrect data and flawed cause-effect logic (e.g., colder weather reducing demand).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1468,
        "completion_tokens": 491,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does McDonald's revenue model relying on affiliates compare to General Motors' production strategy for crossovers through nonconsolidated affiliates, particularly in terms of revenue contribution and operational structure?",
      "original_answer": "McDonald's generates revenue from affiliates through royalty payments based on a percentage of sales, along with initial fees, as part of its franchise model. This structure allows McDonald's to maintain a steady income stream tied directly to the performance of affiliate-operated restaurants. In contrast, General Motors produces crossovers through nonconsolidated affiliates involved in development, manufacturing, and marketing, where GM engages in purchasing and selling transactions with these entities. While McDonald's affiliate model centers on brand licensing and royalty income, GM's affiliate relationships focus on vehicle production and distribution. This results in distinct revenue contributions: McDonald's sees recurring revenue from affiliate royalties, whereas GM's revenue from affiliates is transactional and tied to the volume of crossover production and sales.",
      "llm_answer": "McDonald’s franchise system is a core revenue driver – in 2024 franchised‑restaurant fees (royalties, rent and other franchise fees) were $15.7 billion, roughly 60 % of the company’s $25.9 billion total revenue (see MCD 10‑K p. 40) and the firm also records a modest equity‑earnings line from unconsolidated affiliates (‑$157 million in 2024, p. 18). In contrast, General Motors uses non‑consolidated affiliates (mainly China joint‑ventures) to produce crossovers, but the revenue it books from those affiliates is tiny – automotive sales and revenue from non‑consolidated affiliates were only $90 million in 2024 versus $144 billion of total automotive net sales (see GM 10‑K p. 77 and p. 106) – and the affiliates are equity‑stakes with limited voting control, serving primarily as a production and supply‑chain outlet rather than a major revenue source (see GM 10‑K p. 103).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer introduces specific financial figures from 2024 (e.g., $15.7 billion in franchised-restaurant fees, $25.9 billion total revenue, $90 million from GM's non-consolidated affiliates) and percentages (60%) that are not present in the original answer and cannot be verified against the ground truth, which provides no quantitative data. These numbers may be plausible but are not supported by the provided knowledge graph, making them potentially inaccurate or hallucinated. The negative equity earnings of -$157 million for McDonald's and $90 million for GM’s affiliate revenue are specific claims absent from the original and introduce unverified precision. (2) The calculations (e.g., 60% of revenue) and exact dollar figures fail the quantitative accuracy test because they are not in the ground truth and cannot be confirmed as correct within this evaluation framework. The original answer focuses on structural and conceptual differences, not numerical breakdowns. (3) The multi-hop reasoning is sound in that the LLM correctly identifies McDonald's franchise model as revenue-generating via royalties and contrasts it with GM’s use of nonconsolidated affiliates for production, particularly in crossovers, with minimal revenue contribution. It captures the core distinction: McDonald's relies on affiliates for recurring royalty-based revenue, while GM uses affiliates for operational production with transactional revenue. This reflects good qualitative understanding and synthesis across the two companies’ models. (4) Despite strong contextual relevance and a conceptually accurate comparison, the inclusion of unsupported numerical data significantly undermines factual correctness. The answer goes beyond the ground truth with specific financials, which risks misinformation. Thus, while the reasoning and structure are strong, the hallucinated numbers reduce the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 525,
        "total_tokens": 1985
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the voting power dilution protection for Class B Common Stock at CMCSA compare with the automatic conversion provisions for Class B Common Stock at GOOGL, particularly in light of CMCSA's share-for-share conversion restriction and GOOGL's voluntary and transfer-triggered conversion policy?",
      "original_answer": "At CMCSA, the Class B Common Stock has a non-dilutable 33 1/3% aggregate voting power, which cannot be diluted by additional issuances of any other class of common stock, and is convertible share-for-share into Class A Common Stock, subject to certain restrictions. In contrast, at GOOGL, Class B Common Stock is entitled to 10 votes per share and can be voluntarily converted to Class A Common Stock at any time, with automatic conversion upon sale or transfer. This means CMCSA’s Class B shares maintain structural voting protection unaffected by issuance volumes, while GOOGL’s Class B shares lose enhanced voting rights upon transfer, making CMCSA's Class B shares more resilient to voting dilution.",
      "llm_answer": "CMCSA’s charter locks the 33 ⅓ % voting block of its Class B shares in place – the aggregate voting power “cannot be diluted by additional issuances of any other class of common stock” and the shares may only be converted into Class A on a share‑for‑share basis subject to specific restrictions, preserving that voting power【page_91】. By contrast, Alphabet’s Class B shares (each with ten votes) can be converted at any time by the holder and automatically convert to Class A (non‑voting) upon any sale or transfer, so the high‑voting shares can be turned into low‑voting shares, providing no comparable dilution‑protection mechanism【page_82】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: CMCSA's Class B shares have a non-dilutable 33 1/3% voting power, convertible share-for-share into Class A with restrictions; GOOGL's Class B shares have 10 votes per share and convert automatically upon sale or transfer, with voluntary conversion allowed. (2) Quantitative elements—33 1/3%, 10 votes per share—are correctly stated. No calculations are required, but the comparison of voting protection mechanisms is precise. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (CMCSA and GOOGL), contrasting structural voting protection (CMCSA) with transfer-triggered loss of voting rights (GOOGL). (4) The answer fully addresses the question’s components: voting dilution protection, conversion restrictions, and the comparative resilience of voting power. Wording differs slightly but meaning is preserved. Citations to page numbers (e.g., 【page_91】, 【page_82】) suggest grounding in source documents. All evaluation dimensions are satisfied at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 319,
        "total_tokens": 1694
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does AXP's valuation methodology for Level 3 investment securities expose it to the risks of illiquid market conditions, and how might this impact MS's ability to manage market risk during periods of asset devaluation?",
      "original_answer": "AXP relies on internal credit models and third-party valuations for its Level 3 investment securities, which include debt securities from Community Development Financial Institutions and an embedded derivative in GBT JerseyCo Limited valued using Monte Carlo simulations. These valuation techniques are sensitive to changes in market inputs and assumptions, particularly in illiquid market conditions where observable data is scarce. JPM_10k_2024.pdf confirms that illiquid markets make it extremely difficult to value financial instruments, and valuations may materially change when market conditions shift, leading to potential losses upon disposition. MS_10k_2024.pdf further states that during periods of market volatility and illiquidity, the firm faces challenges in valuing and monetizing financial instruments, which can negatively affect its results of operations and risk management strategies, including hedging inefficiencies and increased counterparty risk.",
      "llm_answer": "AXP values its Level 3 debt securities – which are not quoted in active markets – by using the carrying amount as a proxy for fair value unless its internal credit model flags cash‑flow concerns (see AXP page 146). Because that proxy relies on unobservable inputs, a sudden loss of market liquidity can cause the securities to be materially over‑ or under‑stated, exposing AXP to valuation risk. When such illiquid, potentially mis‑valued assets decline, Morgan Stanley (MS) may find it harder to accurately price, hedge or unwind its positions, as its own market‑risk disclosures note that illiquid conditions “make it difficult to value and monetize certain…financial instruments” and can blunt the effectiveness of its risk‑management strategies (see MS page 13, 22).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. (1) It correctly identifies AXP's use of internal credit models and unobservable inputs (carrying amount as proxy) for Level 3 securities, which aligns with the original answer's emphasis on reliance on internal models and third-party valuations under illiquid conditions. The reference to potential over-/under-statement due to illiquidity is consistent with the ground truth's point about valuations materially changing when market conditions shift. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10 by default. (3) The multi-hop reasoning is sound: it connects AXP's valuation methodology to its exposure in illiquid markets, then links that to MS's risk management challenges during devaluation periods. The LLM correctly cites MS's disclosures about difficulty in valuing and monetizing instruments and the impact on hedging and risk strategies, which matches MS_10k_2024.pdf content in the original. (4) Minor omission: the LLM does not mention specific examples of Level 3 assets like the Community Development Financial Institutions debt or the GBT JerseyCo Limited embedded derivative valued via Monte Carlo simulations, which were in the original. While not critical to the main point, their absence slightly reduces completeness. However, the core logic, entities (AXP, MS), and synthesis across both firms' disclosures are correct. Wording differences (e.g., 'carrying amount as proxy' vs 'internal credit models') are acceptable as they reflect different phrasings of the same concept. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 492,
        "total_tokens": 1946
      },
      "error": null
    },
    {
      "question_id": 55,
      "question": "How does the valuation approach for Chevron's Level 2 derivatives compare to Exxon's use of discounted cash flow models in valuing upstream assets acquired from Pioneer, particularly in terms of observable market inputs and management judgment?",
      "original_answer": "Chevron classifies its derivatives as Level 2 when valued using third-party broker quotes, industry pricing services, and exchanges, relying on observable market data like interest rates and foreign exchange rates, with minimal adjustments. In contrast, Exxon used discounted cash flow models incorporating management judgment and unobservable inputs—such as projected production volumes, commodity prices based on third-party industry experts, and risk-adjusted discount rates—to determine the fair value of upstream assets acquired from Pioneer. While Chevron's Level 2 derivatives rely on largely consistent and observable inputs, Exxon's valuation required significant assumptions about future market conditions and asset performance, reflecting a higher degree of subjectivity and forward-looking judgment.",
      "llm_answer": "Chevron’s Level 2 derivatives are measured using observable market data – third‑party broker quotes, industry pricing services and exchange prices – and the company does not materially adjust those inputs, so the fair value is driven largely by market quotes with minimal management discretion (CVX p. 78). Exxon values the Pioneer upstream assets with discounted‑cash‑flow models that use observable commodity‑price inputs from third‑party experts but also require significant management judgment to estimate future production, drilling and development costs and risk‑adjusted discount rates (XOM p. 71‑72).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Chevron's Level 2 derivatives rely on observable market inputs (broker quotes, pricing services, exchange prices) with minimal adjustments, indicating low management judgment. Exxon used discounted cash flow models for Pioneer upstream assets involving both observable inputs (commodity prices from third-party experts) and significant unobservable inputs requiring management judgment (production forecasts, costs, discount rates). (2) There are no numeric values to verify in this qualitative comparison question, so quantitative accuracy is scored as 10. (3) The multi-hop reasoning is sound—correctly contrasting Chevron’s derivative valuation (Level 2, market-based) with Exxon’s asset valuation (Level 3-like, judgment-intensive), synthesizing across two companies and valuation contexts. (4) The only minor shortcoming is that the LLM does not explicitly mention 'foreign exchange rates' or 'interest rates' as specific observable inputs for Chevron, nor does it directly label Exxon’s inputs as 'unobservable' or emphasize the 'higher degree of subjectivity' as in the original. However, the essence—that Exxon’s approach requires 'significant management judgment'—is preserved. Thus, qualitative accuracy is slightly reduced, but overall correctness remains high due to semantic equivalence and contextual precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 400,
        "total_tokens": 1779
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does Duke Energy's negotiation of PPAs for renewable facilities compare with Southern Power's investment in solar facilities in terms of financial structure and tax credit utilization, given the role of PPAs in financing solar assets?",
      "original_answer": "Duke Energy negotiates PPAs as part of its commercial renewables strategy, which significantly influences the economic performance of its renewable energy VIEs, particularly through siting, PPA negotiation, and ongoing operations. These PPAs are also central to Southern Power's financial structure, where they are accounted for as operating leases with terms up to 25 years for solar facilities. Southern Power utilizes federal tax credits (ITCs and PTCs), with $1.2 billion of unutilized credits at the Southern Company level as of December 31, 2021, largely tied to solar and wind investments. This indicates that while both companies rely on PPAs in the development and operation of solar facilities, Southern Power integrates tax equity partnerships and federal incentives more directly into its investment model, affecting cash flows and net income differently than Duke’s VIE and guarantee-based financing.",
      "llm_answer": "Duke Energy’s PPAs are negotiated as part of VIEs that are backed by corporate guarantees for debt‑service and O&M reserves and are paired with tax‑equity arrangements that let third‑party investors claim the renewable tax credits (DUK 10‑K p.202‑204). Southern Power’s solar investments, by contrast, are financed through PPAs recorded as operating (or sales‑type) leases and rely on tax‑equity partnership contributions—where the tax partner takes the bulk of the ITCs—to provide the cash‑flow needed to service those lease obligations (SO 10‑K p.268, 108, 97, 270).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Duke Energy's use of PPAs within VIEs backed by corporate guarantees and tax-equity structures where third parties claim tax credits, consistent with the original answer's emphasis on VIEs and financing structure. It also accurately describes Southern Power's use of PPAs as operating or sales-type leases and reliance on tax-equity partnerships where the tax partner takes most of the ITCs—this matches the original answer's point about tax credit utilization affecting cash flows. (2) There are no explicit numerical values in the LLM answer, but the original answer includes a specific figure: $1.2 billion of unutilized tax credits at Southern Company as of December 31, 2021. This quantitative detail is missing in the LLM response, which prevents a perfect score despite the otherwise correct qualitative description. All other entities (Duke Energy, Southern Power, VIEs, tax equity, ITCs, PPAs as operating leases) are correctly identified and contextualized. (3) The multi-hop reasoning is sound: the model synthesizes information across both companies, compares their financial structures (VIEs vs. lease-based financing), and correctly links tax credit utilization to financing mechanisms. It captures the core distinction: Duke uses guarantees and third-party tax equity in VIEs, while Southern Power uses lease accounting and tax equity contributions to fund lease obligations. (4) The omission of the $1.2 billion figure and the specific date (Dec 31, 2021) is a minor but notable gap in completeness, hence the 9/10 on correctness and qualitative accuracy. However, the reasoning, structure, and contextual relevance are excellent, fully addressing the comparative financial and tax credit aspects of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 494,
        "total_tokens": 1887
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the concentration of voting power in NKE's Class A Common Stock, which elects three-quarters of the Board of Directors, compare with HD's treatment of voting rights for restricted stock awards in terms of governance influence?",
      "original_answer": "NKE's Class A Common Stockholders elect three-quarters of the Board of Directors, consolidating governance control within a single class of shares. In contrast, HD grants voting rights to recipients of restricted stock awards at the grant date, allowing them to vote on matters even before the restrictions lapse. This indicates that HD distributes voting influence more broadly across equity compensation recipients, while NKE centralizes it among Class A shareholders. Neither company allows Class B or C common stockholders to vote on most matters, but HD’s approach introduces earlier voting participation through restricted shares.",
      "llm_answer": "Nike’s dual‑class structure gives holders of Class A common stock a disproportionate say in governance – they elect three‑quarters of the Board of Directors (rounded down)【page_27】. In contrast, Home Depot’s restricted‑stock awards simply grant the awardees voting rights on the shares they receive, without concentrating board‑election power and spreading influence across many individual holders【page_67】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the key governance distinction: NKE's Class A shareholders elect three-quarters of the Board, giving them disproportionate control, while HD grants voting rights on restricted stock awards at grant date, distributing influence more broadly. The quantitative claim about 'three-quarters' is accurate and matches the ground truth. The LLM correctly attributes these practices to the right companies (NKE and HD), satisfying entity accuracy. However, the LLM omits two important nuances present in the original answer: (1) it does not mention that HD allows voting rights *before* restrictions lapse, which is a key point about early voting participation; and (2) it fails to note that neither company allows Class B or C shareholders to vote on most matters, which provides context for the broader governance framework. While the core comparison is sound and the reasoning is logically valid—correctly synthesizing governance influence across two companies—the omission of these details reduces completeness and slightly weakens the qualitative accuracy. The answer remains semantically aligned with the ground truth and highly relevant to the question, hence high scores in contextual relevance and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1283,
        "completion_tokens": 350,
        "total_tokens": 1633
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How does the foreign exchange risk exposure of Netflix's forecasted revenue transactions compare to Disney's VAR model estimates, given both companies' use of financial instruments to hedge against currency fluctuations?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on forecasted revenue transactions denominated in non-U.S. dollar currencies, while Disney employs a VAR model that excludes forecasted transactions from its risk estimation. Netflix's foreign currency transactions resulted in a $293 million loss in 2023, indicating volatility in unhedged positions, whereas Disney's VAR estimate for maximum one-day loss decreased to $255 million in 2024 from $284 million in 2023 due to lower interest rate volatility. This suggests that while both companies manage FX risk, Disney's modeled approach excludes certain forecasted exposures that Netflix explicitly hedges.",
      "llm_answer": "Netflix hedges the foreign‑exchange risk on its forecasted revenue streams with short‑term forward contracts, but the company still reports material currency‑related gains and losses – a $293 million loss in 2023 (offset by a $282 million gain in 2022 and a $403 million gain in 2021). Disney’s approach excludes those forecasted transactions from its risk‑measurement and, using a VAR model, estimates the maximum one‑day loss on its currency‑sensitive instruments at roughly $40‑$45 million, indicating Disney’s exposure is far lower than Netflix’s.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the quantitative details. While it correctly states that Netflix incurred a $293 million loss in 2023 (matching the ground truth), it adds extraneous and unverified data about a $282 million gain in 2022 and $403 million gain in 2021, which are not present in the original answer and cannot be confirmed from the provided context. More critically, the LLM incorrectly reports Disney's VAR estimate as 'roughly $40-$45 million', which directly contradicts the ground truth stating Disney's maximum one-day loss estimate decreased to $255 million in 2024 from $284 million in 2023. This is a major quantitative error. (2) The entity accuracy is mostly correct—Netflix and Disney are properly identified, and the use of forward contracts by Netflix and VAR by Disney is accurately noted. However, the LLM misrepresents Disney's VAR figures and timeframes. The original specifies a decrease from $284M (2023) to $255M (2024), but the LLM cites a completely different range and omits the correct years. (3) The reasoning partially captures the multi-hop comparison: both companies use different methods (hedging vs. VAR), and Disney excludes forecasted transactions. However, the conclusion that 'Disney’s exposure is far lower than Netflix’s' is not supported by the ground truth, which does not make a direct comparative claim about the magnitude of exposure—only that Disney’s model excludes forecasted transactions while Netflix hedges them. The LLM overreaches in its interpretation. (4) Contextual relevance is strong—the answer addresses hedging practices, risk models, and financial impacts. However, due to severe quantitative inaccuracies and flawed comparative reasoning, the correctness score is low. The answer is partially correct in structure and intent but fails on key facts essential to the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1323,
        "completion_tokens": 514,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 56,
      "question": "How do the Value at Risk (VAR) calculations for MDLZ and PM differ in terms of the time periods used to estimate expected return distributions under normal market conditions, and what does this imply about their respective risk assessment horizons?",
      "original_answer": "MDLZ uses the prior quarter's interest rate, currency exchange, and commodity price movements to estimate return distributions for VAR calculations at year-end (December 31, 2024 and 2023), and the four prior quarters for average VAR amounts. In contrast, PM primarily uses the preceding quarter for year-end VAR calculations and the four preceding quarters for average, high, and low VAR amounts. This indicates that while both companies rely on recent market data, MDLZ explicitly applies a multi-quarter approach for average VAR, suggesting a slightly more extended risk assessment horizon compared to PM.",
      "llm_answer": "Both Mondelēz International and Philip Morris use a one‑day, 95 %‑confidence VAR that assumes normal market conditions, and each derives the expected‑return distribution from market moves observed over the **most recent quarter** for the point‑in‑time VAR and over the **four preceding quarters** for the average (and, for PMI, also the high/low) VAR. This common use of recent quarterly data shows that both firms assess risk on a short‑term horizon, relying on near‑term market behavior to gauge potential daily losses.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has a minor omission in comparative nuance. (1) Quantitatively, all key data points are accurate: both MDLZ and PM use the most recent quarter for point-in-time VAR and four preceding quarters for average VAR; the 95% confidence level and one-day horizon are correctly stated. These match the original answer’s implied assumptions, even if not explicitly cited from the knowledge graph. (2) The answer addresses both parts of the question—time periods used and implications for risk assessment horizons—but slightly underemphasizes the distinction highlighted in the ground truth: MDLZ's explicit use of a multi-quarter approach for average VAR is noted in both answers, but the original emphasizes that this suggests a 'slightly more extended risk assessment horizon' compared to PM, which the LLM answer does not clearly contrast. Instead, it concludes both have a 'short-term horizon,' which is contextually valid but glosses over the subtle difference in synthesis depth. (3) Entity accuracy is strong: MDLZ (Mondelēz) and PM (Philip Morris/PMI) are correctly identified, time periods (recent quarter, four preceding quarters) are accurately attributed, and the metrics (VAR, average, high/low) are properly contextualized. (4) Reasoning is sound and reflects multi-hop synthesis across both companies’ methodologies. However, the implication drawn about risk assessment horizons could be more precise—while both use similar data windows, the original answer correctly infers a marginally longer horizon for MDLZ due to its structured use of four quarters for averages, which the LLM overlooks in favor of emphasizing similarity. (5) Semantic equivalence is high—wording differs but core facts are preserved. The LLM uses 'common use of recent quarterly data' and 'short-term horizon,' which is acceptable but less nuanced than the original’s comparative insight. Overall, this is a strong answer with only minor loss in qualitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 542,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 relate to the auditor's evaluation of significant assumptions, and how does this compare to the auditor's approach in testing significant assumptions at NFLX related to content amortization estimates?",
      "original_answer": "The $0.6 billion goodwill impairment charge recorded by DIS in fiscal 2024 was directly tied to the fair value assessment of the entertainment linear networks reporting unit, which relied on significant assumptions such as future revenues, operating margins, terminal growth rates, and discount rates. The auditor, PricewaterhouseCoopers LLP, evaluated the reasonableness of these assumptions by comparing them to historical performance, external market data, and evidence obtained elsewhere in the audit. Similarly, at NFLX, the auditor (also PricewaterhouseCoopers LLP) tested significant assumptions used in content amortization estimates, including forecasted viewing hour consumption and historical viewing patterns, by comparing them to current trends and prior actual results. Both audits involved sensitivity analyses and the use of professionals with specialized skills to assess the impact of changes in these assumptions on financial outcomes.",
      "llm_answer": "Disney’s $0.6 billion goodwill impairment recorded in fiscal 2024 resulted from management’s quantitative fair‑value test, and the auditor treated it as a critical audit matter by testing the controls and data behind the discounted‑cash‑flow model and evaluating the reasonableness of the key assumptions—future revenues, operating expenses, margins, terminal growth rates and discount rates—used to determine the impairment (DIS page 72). Netflix’s auditor took a similar approach to testing significant assumptions, but focused on the content‑amortization process, examining controls over the amortization method and the assumptions about historical and forecasted viewing‑hour consumption, comparing them to actual usage and performing sensitivity analyses (NFLX page 40). Both audits emphasized rigorous testing of management’s significant assumptions and underlying data, though Disney’s related to goodwill valuation inputs and Netflix’s to consumption‑based amortization estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key facts are correct: the $0.6 billion goodwill impairment by DIS in fiscal 2024 is accurately stated, and there are no numerical errors. The fiscal year and dollar amount match the original answer exactly. (2) The LLM correctly identifies that the auditor (PricewaterhouseCoopers LLP, though not explicitly named in the LLM answer) evaluated significant assumptions including future revenues, operating margins, terminal growth rates, and discount rates for DIS’s goodwill impairment, and that these were tested via controls, data validation, and reasonableness checks—consistent with the original. For NFLX, the LLM correctly notes the focus on content amortization assumptions like forecasted and historical viewing hours, comparison to actual usage, and sensitivity analyses. (3) The multi-hop reasoning is sound: the answer synthesizes information across two companies (DIS and NFLX), two different financial estimates (goodwill impairment vs. content amortization), and compares auditor approaches appropriately, highlighting both similarities (rigorous testing, sensitivity analysis) and differences in focus. (4) The only minor omission is that the LLM does not explicitly name the auditor (PricewaterhouseCoopers LLP) for both companies, which is included in the original answer and reinforces the consistency in audit approach. However, this does not detract significantly from the overall accuracy, as the audit procedures are correctly described. Wording differs but semantic meaning is equivalent. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1520,
        "completion_tokens": 473,
        "total_tokens": 1993
      },
      "error": null
    },
    {
      "question_id": 57,
      "question": "How does the cost-sharing structure between Gilead and Merck for long-acting HIV injectable products compare to Gilead's other collaboration agreements, such as the one with Arcellx, in terms of financial commitment and milestone-based payments?",
      "original_answer": "Gilead and Merck share global development and commercialization costs for long-acting HIV injectable products at 60% and 40%, respectively, with no material expenses recognized under the agreement through 2024. This contrasts with Gilead's collaboration with Arcellx, where Gilead made a $313 million upfront payment and a $299 million equity investment in 2023, and paid $68 million in development milestones in 2024. Unlike the Merck agreement, which involves shared costs and revenue splits upon approval, the Arcellx collaboration includes significant upfront and milestone-based payments, profit sharing in the U.S., and royalties outside the U.S., indicating a more financially committed and risk-shared structure with Arcellx compared to the cost-sharing model with Merck.",
      "llm_answer": "The Merck deal is structured mainly as a cost‑share – Gilead funds roughly 60 % of development and commercialization costs (Merck 40 %) and the parties split product revenues 50/50 until the injectable combo exceeds $3.5 billion in sales, at which point Gilead’s share rises to 65 % – and no upfront or milestone payments are disclosed【page_74】. By contrast, the Arcellx collaboration involved a $313 million upfront payment, a $299 million equity investment, and performance‑based development and regulatory milestone payments of up to $1.5 billion (with $68 million paid in 2024), plus a 50/50 U.S. profit split and royalties outside the U.S., indicating a far larger cash commitment and milestone‑driven payout structure【page_74】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the cost-sharing percentages (60% Gilead, 40% Merck) and the significant upfront and milestone payments in the Arcellx deal, including the $313 million upfront, $299 million equity investment, and $68 million in milestones paid in 2024. However, it introduces a revenue split (50/50 until $3.5 billion, then 65% to Gilead) that is not present in the original answer or ground truth, which only states that the Merck agreement involves shared costs and revenue splits upon approval without specifying thresholds or percentages. This is a significant factual addition not supported by the ground truth. (2) Quantitative accuracy is partially compromised due to the fabricated revenue milestone and split structure. While the dollar amounts for Arcellx are correct and match the ground truth, the Merck revenue-sharing terms are incorrect. The original answer states there are 'no material expenses recognized through 2024' and does not mention any revenue-sharing mechanics, making the LLM's detailed revenue triggers inaccurate. (3) The multi-hop reasoning is sound in comparing the two agreements and highlighting that Arcellx involves greater upfront financial commitment versus Merck's cost-sharing model. The synthesis across entities (Gilead, Merck, Arcellx) and financial structures (upfront payments, milestones, profit sharing) is appropriate and addresses the comparative nature of the question. (4) The contextual relevance is high as the answer directly addresses the comparison of financial commitment and milestone-based payments. Despite the incorrect revenue-sharing detail, the core contrast — cost-sharing with Merck vs. large upfront and milestone payments with Arcellx — is preserved, warranting a correctness score of 7. The qualitative accuracy is strong due to correct entity identification and logical structure, but quantitative accuracy is reduced due to unsupported numerical claims about revenue splits.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 534,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How do Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced battery cells compare to GM's battery procurement cost exposure in terms of contractual stability and long-term cost predictability?",
      "original_answer": "Tesla has structured long-term pricing agreements with Panasonic Corporation for both Gigafactory 2170 cells (executed June 9, 2020) and Japan-sourced cells (executed December 29, 2020), providing multi-year cost predictability. In contrast, GM's 2023 10-K filing on page 78 indicates a dependency on battery procurement costs without equivalent visibility into long-term pricing agreements, suggesting greater exposure to market volatility. This creates a differentiated risk profile where Tesla has locked in pricing through 2020+ agreements while GM's battery cost structure appears more variable.",
      "llm_answer": "Tesla locks in battery pricing through a series of multi‑year agreements with Panasonic – a 2020 pricing agreement for Gigafactory 2170 cells and 2019/2021 pricing agreements for Japan‑sourced cells – that extend the original 2011 supply contract and its amendments, thereby giving Tesla contractual stability and long‑term cost predictability (TSLA exhibits 10.35‑10.37 on p. 107 and the underlying supply agreements on p. 106). By contrast, GM’s battery costs are reflected only in its general automotive purchases (see “Automotive purchases, net” on p. 78) and are not tied to long‑term pricing contracts, leaving GM more exposed to market price swings and less able to predict battery procurement costs over time.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Tesla's multi-year pricing agreements with Panasonic for Gigafactory 2170 and Japan-sourced cells, emphasizing long-term cost predictability, and contrasts this with GM's lack of long-term contracts, aligning with the ground truth. However, there is a minor inaccuracy in dating: the LLM states '2019/2021 pricing agreements for Japan-sourced cells', while the ground truth specifies the agreement was executed on December 29, 2020. The mention of a 2011 supply contract and amendments is contextually plausible but not present in the original answer and may introduce unsupported detail. (2) Quantitative accuracy is mostly correct—dates are close but not fully accurate (2019/2021 vs. Dec 29, 2020), and the June 9, 2020 date for the Gigafactory agreement is omitted. The LLM references correct document locations (e.g., p. 106–107 for Tesla exhibits), but the original answer does not include these, so their inclusion is extra, not erroneous. (3) Multi-hop reasoning is strong: the model correctly synthesizes Tesla’s contractual stability from specific agreements and contrasts it with GM’s exposure based on the absence of long-term pricing visibility in its 10-K (p. 78), demonstrating sound cross-document and cross-company analysis. (4) The answer is contextually highly relevant, directly addressing contractual stability and cost predictability for both companies. The core conclusion—that Tesla has greater cost predictability while GM faces more volatility—is semantically equivalent to the ground truth. The score of 8 reflects minor date inaccuracies but strong overall factual alignment, reasoning, and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 459,
        "total_tokens": 1810
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Coca-Cola's use of non-derivative instruments to hedge foreign exchange risk compare to Procter & Gamble's exposure to foreign exchange fluctuations, given that both operate in similar international markets such as the United Kingdom and Germany?",
      "original_answer": "Coca-Cola actively uses non-derivative instruments, such as foreign currency-denominated third-party debt, to hedge foreign exchange risk related to its net investments in foreign subsidiaries, with these instruments designated in hedging relationships to offset currency exposure. In contrast, Procter & Gamble discloses that it is significantly exposed to foreign exchange fluctuations due to its international operations — particularly in the United Kingdom and Germany, which are among its largest markets — and while it employs strategies to manage these risks, it explicitly acknowledges that exchange rate movements have historically negatively impacted its net sales, earnings, and cash flows. Therefore, while Coca-Cola appears to have a more structured hedging approach, Procter & Gamble reports a more direct and material financial sensitivity to FX volatility.",
      "llm_answer": "Coca‑Cola explicitly mitigates its foreign‑exchange risk by using non‑derivative net‑investment hedges—such as euro‑denominated senior notes—and, beginning in 2024, forward contracts on intercompany transactions, which “may reduce, but do not entirely eliminate, the effect of foreign currency exchange fluctuations” in markets like the United Kingdom and Germany【page_30】. Procter & Gamble, on the other hand, does not detail comparable hedging; its 10‑K reports foreign‑currency translation gains/losses of $66 million (2024), $(197) million (2023) and $515 million (2022) in other comprehensive income, indicating that its earnings are exposed to FX fluctuations from its international operations, including the UK and Germany【page_38】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Coca-Cola's use of non-derivative instruments (e.g., euro-denominated senior notes) for hedging foreign exchange risk in its net investments, which matches the original answer's description of using foreign currency-denominated third-party debt. It also adds forward contracts starting in 2024, which is consistent with updated disclosures and does not contradict the ground truth. (2) For Procter & Gamble, the LLM accurately reports specific FX translation gains/losses in other comprehensive income: $66M (2024), $(197M) (2023), $515M (2022), which are correct in magnitude, sign, and year—demonstrating strong quantitative accuracy. These figures substantiate P&G’s exposure to FX fluctuations, as stated in the ground truth. (3) The multi-hop reasoning is sound: the model compares Coca-Cola’s structured hedging approach with P&G’s lack of detailed hedging disclosures and material FX impact, correctly inferring that P&G has greater reported sensitivity to FX volatility. (4) The only minor limitation is that the LLM does not explicitly state that both companies operate in similar markets (UK and Germany) as a basis for comparison, though it does mention these markets in context. Also, while the original answer emphasizes Coca-Cola’s designation of hedges in formal hedging relationships, this nuance is slightly underdeveloped in the LLM response. However, the core facts, numbers, and comparative logic are correct and semantically equivalent. Wording differences do not affect meaning, and number formats are acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 445,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does Amgen's exposure to state-level drug affordability regulations in Maryland, through PDAB laws, compare to Gilead's operational risks in the same state, particularly in relation to their respective biopharma manufacturing and pricing strategies?",
      "original_answer": "Amgen is subject to Maryland’s PDAB laws that grant authority to set upper payment limits on certain drugs for in-state patients, payers, and providers, which affects its pricing strategy and rebate obligations under Medicaid and the 340B Drug Pricing Program. These laws are part of a broader regulatory framework that includes the Inflation Reduction Act’s Medicare price-setting provisions, which began with ENBREL being selected among the first ten drugs for Medicare price negotiation. Meanwhile, Gilead operates a CAR T-cell therapy manufacturing facility in Maryland, exposing it to operational risks such as quality control, production delays, and regulatory compliance. Unlike Amgen, whose primary risk in Maryland is regulatory and pricing-related, Gilead faces logistical and manufacturing risks tied to the complexity of cell therapy production and delivery. Both companies are impacted by Maryland’s healthcare ecosystem, but through different risk vectors—Amgen through pricing regulation and Gilead through manufacturing execution.",
      "llm_answer": "Amgen’s 10‑K notes that Maryland is one of the four states whose Prescription‑Drug Affordability Board (PDAB) can impose upper‑payment limits on drugs (see page 18) and that such state‑level pricing rules are adding “complexity … and may already be affecting industry pricing decisions” (page 38). By contrast, Gilead’s filing highlights that its Maryland risk is largely operational – its in‑house CAR‑T manufacturing facility in Maryland (along with sites in California and the Netherlands) could suffer quality, capacity or supply‑chain disruptions (page 19) – while its pricing exposure is described more generally as state‑level affordability pressure (e.g., state review boards, see page 21) rather than a specific PDAB price‑cap. Thus Amgen’s Maryland exposure is primarily a regulatory price‑cap risk, whereas Gilead’s Maryland exposure centers on manufacturing reliability, with pricing pressures being broader and less tied to a PDAB‑imposed ceiling.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Amgen is exposed to Maryland’s PDAB laws, which can impose upper payment limits on drugs, affecting pricing strategy and rebate obligations—consistent with the original answer’s emphasis on regulatory and pricing risks. It references Amgen’s 10-K (page 18 and 38) to support this, noting increased complexity and impact on pricing decisions. (2) For Gilead, the LLM correctly states that its primary Maryland risk is operational, tied to its CAR T-cell manufacturing facility in the state, with potential disruptions in quality, capacity, or supply chain—matching the ground truth’s focus on manufacturing execution risks. It also correctly notes that Gilead’s pricing exposure is more general (e.g., state review boards) rather than specific PDAB price caps. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies, distinguishing between regulatory pricing risks (Amgen) and operational manufacturing risks (Gilead) within the same state, which is the core of the question. (4) No numeric values are in dispute; the answer relies on qualitative disclosures from filings, which are accurately represented. The only minor shortcoming is that the LLM does not mention ENBREL being selected for Medicare price negotiation under the Inflation Reduction Act—a detail in the original answer that adds context to Amgen’s broader pricing risk environment. While this is a relevant point, its omission does not undermine the core accuracy of the comparison. Wording differs but semantic meaning is equivalent. All entities (Amgen, Gilead, PDAB, CAR T-cell facility, Maryland) are correct. The answer is fully contextually relevant and well-supported by cited filing pages.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1528,
        "completion_tokens": 489,
        "total_tokens": 2017
      },
      "error": null
    },
    {
      "question_id": 58,
      "question": "How does AIG's use of separate accounts for policyholder-directed investments compare to MET's utilization of investment management firms in managing ERISA plan assets, particularly in terms of asset diversification strategies and risk mitigation through sub-advisory discretion?",
      "original_answer": "AIG discloses that its separate accounts are legally segregated funds where investment gains and losses accrue directly to policyholders who bear the investment risk, with assets primarily including fixed maturity securities, equity securities, and derivatives. MET utilizes separate accounts backed by similar asset classes (cash, fixed maturities, equities, derivatives, real estate, and private equity) for its ERISA pension and postretirement plans, engaging investment management firms with discretionary authority to manage these assets. Both companies emphasize diversification across asset categories and multiple managers to minimize risk concentration, with MET explicitly stating that its investment policies aim to maximize funded status and minimize volatility, aligning with the long-term nature of benefit obligations. The use of derivatives is restricted to risk mitigation and duration management in both contexts.",
      "llm_answer": "AIG’s policy‑holder‑directed separate accounts are “stand‑alone” funds whose assets are legally segregated, carried at fair value and accrue income and gains directly to the policyholder who bears the investment risk (see AIG 10‑K p. 195).  The filing does not describe any sub‑advisor role or a formal diversification program across managers for those accounts.  \n\nMetLife’s ERISA‑plan assets, by contrast, are held in insurance separate accounts that are run by external investment‑management firms (“Managers”) with portfolio‑management discretion, and the assets are intentionally spread across multiple asset categories and a number of managers to limit concentration risk (see MetLife 10‑K p. 304).  Thus AIG relies on policy‑holder‑directed risk in isolated accounts, whereas MetLife uses sub‑advisory discretion and broad diversification to mitigate risk.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is partially correct but contains significant omissions and mischaracterizations in the qualitative analysis, particularly regarding AIG's diversification and risk mitigation practices. (1) Quantitatively, there are no numerical errors—no specific numbers were cited in either the ground truth or LLM response, and all referenced document locations (AIG 10-K p.195, MetLife 10-K p.304) are consistent with the source disclosures. (2) However, the LLM incorrectly states that AIG’s filing 'does not describe any sub-advisor role or a formal diversification program across managers,' which contradicts the ground truth that both companies emphasize diversification across asset categories and multiple managers. The original answer explicitly states AIG uses similar asset classes and that both firms use derivatives for risk mitigation—details omitted in the LLM response. (3) The multi-hop reasoning is partially sound: the model correctly identifies that AIG’s separate accounts are policyholder-directed with legal segregation and that MET uses external managers with discretionary authority. It also correctly contrasts policyholder risk-bearing (AIG) with institutional risk management (MET). However, it fails to synthesize the key commonality—both employ diversification and derivatives for risk mitigation—leading to an imbalanced comparison. (4) The contextual relevance is high as the response addresses asset segregation, risk allocation, and management structure. But the failure to acknowledge shared strategies in diversification and derivative use—explicitly highlighted in the ground truth—results in a misleading contrast. Thus, while factually consistent where information is provided, the answer is incomplete and distorts the comparative analysis, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1481,
        "completion_tokens": 491,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How might the structural differences in voting rights between NKE's Class B Common Stock, which grants no voting rights except on certain defined matters, and HD's restricted stock awards, which grant voting rights from the grant date, impact investor influence on corporate governance decisions such as board composition or takeover defenses?",
      "original_answer": "NKE's Class B Common Stockholders have limited voting rights, only participating on certain defined matters such as exiting the core payments business or major corporate transactions, and do not influence the election of the Board of Directors, which is controlled by Class A Common Stockholders. In contrast, HD's restricted stock recipients are granted voting rights immediately upon grant, allowing them to influence governance matters throughout the vesting period. This structural difference means that NKE's Class B investors have significantly less influence over corporate governance, including board composition and takeover defenses, compared to HD shareholders who hold restricted stock and can exercise voting rights from the outset.",
      "llm_answer": "Nike’s Class B common stock is a non‑voting class that only votes on narrowly defined matters such as certain merger or charter‑amendment proposals (Nike 10‑K p. 27), so holders cannot influence the election of directors or broader takeover‑defense votes. By contrast, Home Depot’s restricted‑stock awards grant full voting rights from the grant date (Home Depot 10‑K p. 67), allowing award‑recipients to vote on board elections and merger proposals and thus giving them a much stronger direct voice in corporate‑governance decisions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and semantically equivalent to the ground truth. It accurately captures the key structural differences in voting rights between NKE's Class B Common Stock and HD's restricted stock awards. Quantitatively, there are no numerical values to verify, so quantitative accuracy is scored as 10. The LLM correctly identifies that NKE’s Class B shares have no voting rights except on narrowly defined matters (e.g., mergers or charter amendments), citing the correct page (p. 27) from the 10-K, and explicitly notes they cannot influence director elections or broader governance issues. It also correctly states that HD’s restricted stock grants full voting rights from the grant date (citing p. 67), allowing influence over board elections and merger proposals. The reasoning is sound and reflects proper multi-hop synthesis across two companies’ governance structures. The only minor omission is not explicitly mentioning that HD’s voting rights persist during the vesting period, though this is implied by 'from the grant date.' Also, the term 'takeover defenses' is addressed less directly than in the original answer, but merger proposals are a core component. Wording differs slightly but meaning is preserved. Contextual relevance is perfect—directly addresses investor influence on governance decisions. Thus, correctness is 9 due to slight reduction in completeness on vesting-period nuance and takeover-defense specificity, but all core facts and logic are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 412,
        "total_tokens": 1781
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the voting structure for Class B common stock at META compare to NFLX's general voting rights framework, considering the specific limitations outlined in the voting rights policies of both companies?",
      "original_answer": "NFLX provides one vote per share to all common stockholders on all matters, while META restricts voting rights for Class B common stockholders to specific defined matters such as amendments to the certificate of incorporation affecting Class B or C stock, decisions to exit the core payments business, or certain consolidation or merger transactions. In these limited cases, Class B stockholders vote together either as a single class or alongside Class A stockholders, but they do not have voting rights on all matters like NFLX's common stockholders.",
      "llm_answer": "Meta’s Class B common stock is essentially non‑voting – it can only vote on a narrow set of defined actions (e.g., a decision to exit the core‑payments business, a merger or certain charter amendments) and, when it does vote, each share carries ten votes (or votes equal to the share count multiplied by the applicable conversion rate)【page_90】. Netflix, by contrast, has a single class of common stock in which every share receives one vote on **all** shareholder matters, with no special restrictions【page_61】. Thus Meta’s Class B shares have limited voting rights and a higher vote‑per‑share weight only for specific events, whereas Netflix’s shares enjoy universal, one‑vote‑per‑share voting rights.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly states that NFLX provides one vote per share on all matters, matching the original answer. It also accurately describes META's Class B stock as having voting rights only on specific, limited matters such as exiting the core payments business, mergers, or charter amendments. (2) There are no numeric values requiring calculation (e.g., vote counts, financial figures), but the statement that each Class B share carries ten votes when voting occurs is consistent with typical Meta capital structure, though this specific detail (10 votes per share) is not in the ground truth provided. However, since the ground truth does not specify vote weight and the LLM’s addition of 'ten votes' is plausible and does not contradict the core comparison, it does not constitute a factual error. (3) The multi-hop reasoning is sound: the model correctly synthesizes voting rights across two companies (META and NFLX), compares their structures, and draws a valid contrast between limited vs. universal voting rights. (4) The answer is contextually relevant and fully addresses the question. The only minor deviation is the addition of vote weight (ten votes), which, while likely accurate, is not confirmed in the ground truth; however, it does not distort the central comparison. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 410,
        "total_tokens": 1739
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the use of the parametric delta-gamma approximation technique under normal market conditions by PM compare to MDLZ's application of the same method in their VAR model for estimating potential one-day losses in pre-tax earnings?",
      "original_answer": "PM uses the parametric delta-gamma approximation technique under normal market conditions to estimate the risk of underlying positions in its portfolio, observing interest rate and forward currency rate movements primarily over the preceding quarter for determining value at risk (VAR) at year-end. Similarly, MDLZ applies the same technique to estimate the expected return distribution in interest rates, currencies, and commodity prices for calculating VAR, also observing movements over the prior quarter for year-end calculations. Both companies estimate potential one-day losses using a 95% confidence interval and a one-day holding period, with MDLZ specifically reporting the estimated potential one-day loss in pre-tax earnings from currency and commodity instruments as part of its VAR computation.",
      "llm_answer": "Both companies rely on the same “parametric delta‑gamma” approach under normal‑market assumptions (95 % confidence, one‑day horizon) and calibrate the model from recent interest‑rate, currency and commodity moves. Philip Morris (PM) uses the technique to compute a VaR that estimates the maximum probable daily loss in the fair‑value of its interest‑rate and foreign‑currency‑sensitive instruments, but it does not translate that loss into a pre‑tax earnings figure. Mondelēz (MDLZ), by contrast, applies the same delta‑gamma approximation in its VAR model to quantify the potential one‑day loss in pre‑tax earnings from currency and commodity exposures (and also reports the fair‑value impact for interest‑rate instruments). Thus, PM’s use is limited to fair‑value VaR, whereas MDLZ extends the method to directly estimate earnings‑impact VaR.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) It accurately identifies that both PM and MDLZ use the parametric delta-gamma approximation under normal market conditions with a 95% confidence interval and one-day holding period, which aligns with the original answer. (2) The quantitative elements—95% confidence level and one-day horizon—are correctly stated and consistent with the ground truth; no specific dollar amounts or dates beyond these parameters are required. (3) The multi-hop reasoning is sound: the model correctly synthesizes that while both firms use the same core methodology and data window (prior quarter for year-end), MDLZ applies it to estimate potential one-day losses in pre-tax earnings from currency and commodity instruments, whereas PM uses it for fair-value risk without translating into pre-tax earnings impact. (4) The LLM adds clarity by distinguishing between 'fair-value VaR' (PM) and 'earnings-impact VaR' (MDLZ), which is a semantically accurate and insightful interpretation of the original answer. All entities (PM, MDLZ, interest rates, currencies, commodities) are correctly identified and compared. The response is contextually precise, directly addressing the comparative use of the technique in estimating one-day pre-tax earnings losses. Minor wording differences (e.g., 'recent moves' vs 'preceding quarter') do not affect factual accuracy as they convey the same meaning. No errors in fact, logic, or synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1435,
        "completion_tokens": 410,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 59,
      "question": "How does the application of the 2.5% Capital Conservation Buffer for Bank of America under the Advanced Approach compare with American Express's reliance on the Stress Capital Buffer under the Standardized Approach for meeting Basel III regulatory requirements?",
      "original_answer": "Bank of America applies a 2.5% Capital Conservation Buffer under the Advanced Approach as part of its CET1 capital regulatory minimum to meet Basel III requirements, while American Express uses the Stress Capital Buffer under the Standardized Approach, which is also a component of its Basel III compliance framework. The two institutions thus rely on different buffer mechanisms depending on their regulatory frameworks, with BAC using the Capital Conservation Buffer and AXP referencing the Stress Capital Buffer as part of their respective capital adequacy strategies.",
      "llm_answer": "Bank of America’s CET1 regulatory minimum includes a 2.5 % capital‑conservation buffer that is applied under the Advanced Approach 【page_146】. In contrast, American Express meets its Basel III CET1 floor by relying on a 2.5 % stress‑capital buffer that is applied under the Standardized Approach for the parent company 【page_151】. Thus, both firms add the same 2.5 % cushion above the base CET1 requirement, but Bank of America does so via the Advanced‑approach buffer, whereas American Express uses the Standardized‑approach stress‑capital buffer.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: both institutions apply a 2.5% buffer, and the percentages match the original answer. The formatting variation (2.5 % vs 2.5%) is acceptable and does not affect accuracy. (2) The answer correctly identifies the entities: Bank of America (BAC) under the Advanced Approach and American Express (AXP) under the Standardized Approach. It accurately associates BAC with the Capital Conservation Buffer and AXP with the Stress Capital Buffer. (3) The multi-hop reasoning is sound—comparing two different firms, their respective regulatory approaches (Advanced vs Standardized), and how each satisfies Basel III through a 2.5% CET1 buffer despite different mechanisms. (4) The semantic meaning fully matches the original: both convey that while the buffer size is the same (2.5%), the type and regulatory framework differ. The only minor shortcoming is that the LLM answer does not explicitly mention that these buffers are part of the 'capital adequacy strategies' or 'regulatory minimums' in the same conceptual framing as the original, but this is implied through context. Thus, the answer is factually complete and correct with only slight room for enhanced conceptual alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 360,
        "total_tokens": 1669
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does LMT's use of a discounted cash flow approach in valuing certain fixed income investments compare with HON's application of the same methodology in testing goodwill and intangible asset impairments, particularly in terms of the significance and sensitivity of the discount rate assumptions used?",
      "original_answer": "LMT applies the discounted cash flow approach to value certain Level 3 fixed income investments, where significant inputs include projected annuity payments and the discount rate applied to those payments. This valuation method introduces sensitivity due to the reliance on unobservable inputs. Similarly, HON uses a discounted cash flow approach to estimate the fair value of goodwill and indefinite-lived intangible assets during impairment testing, incorporating strategic and annual operating plans with terminal value assumptions. HON also acknowledges the sensitivity of these valuations to changes in assumptions, particularly the discount rate, and performs sensitivity analyses to address uncertainty. Both companies rely on the discounted cash flow method with key assumptions around discount rates, making the valuation outcomes at both firms sensitive to changes in these inputs, though applied in different asset contexts—fixed income investments at LMT and intangible assets at HON.",
      "llm_answer": "LMT applies a discounted‑cash‑flow model only to certain Level‑3 fixed‑income holdings, using projected annuity payments and a market‑derived discount rate as the key inputs, but the filing does not quantify how changes in that rate would affect the valuation. Honeywell, on the other hand, uses a DCF to estimate the fair value of goodwill and indefinite‑life intangibles and explicitly notes that the discount‑rate assumption is material, running sensitivity analyses that show even a 0.25‑percentage‑point shift can alter projected obligations by more than $200 million—highlighting a far greater emphasis on the rate’s significance and its impact.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core comparison between LMT and HON in their use of discounted cash flow (DCF) methodologies and correctly identifies the different asset contexts—Level 3 fixed income investments for LMT and goodwill/intangible assets for HON. It accurately notes that both companies use discount rates as key assumptions and that HON performs sensitivity analyses. However, the LLM introduces a specific quantitative claim not present in the original answer or ground truth: that a 0.25-percentage-point shift in HON’s discount rate can alter projected obligations by more than $200 million. This figure is not mentioned in the ground truth, which only states that HON acknowledges sensitivity and performs sensitivity analyses without quantifying the magnitude. This introduces a factual inaccuracy in the quantitative details, lowering the quantitative accuracy score. Additionally, the ground truth emphasizes that both firms’ valuations are sensitive to discount rate changes, while the LLM implies HON places a 'far greater emphasis'—a comparative judgment not directly supported by the source. While the reasoning is logically sound and the entities and contexts are correctly identified (LMT, HON, DCF applications), the unsupported numerical claim and slight overstatement in comparative emphasis prevent a higher score. The answer remains contextually relevant and qualitatively strong in synthesizing multi-hop information across two companies and applications of DCF.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1451,
        "completion_tokens": 408,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA influence the potential impact of share repurchases on voting control, given Alphabet's dual-class share structure where Class B shares convert to Class A with voting dilution?",
      "original_answer": "At CMCSA, holders of Class B common stock maintain a non-dilutable 33 1/3% of the voting power, with each Class B share entitled to 15 votes, whereas voting rights for Class A shares fluctuate based on the number of shares outstanding. This contrasts with Alphabet (GOOGL), where Class B shares convert to Class A shares with a 10:1 voting dilution, and repurchases of Class A and Class C shares totaled $62.0 billion in 2024. Since CMCSA’s Class B shares are convertible share-for-share into Class A stock, but retain a fixed voting percentage, repurchases of Class A shares could increase the relative voting power of Class B holders, unlike Alphabet’s structure where repurchases of Class A and C shares do not create a similar fixed voting skew due to the dilutive conversion mechanism.",
      "llm_answer": "CMCSA’s charter gives Class B shareholders a fixed one‑third (33 ⅓ %) of the total voting power – each of the 9.44 million Class B shares carries 15 votes and this share of voting power cannot be diluted by issuing or repurchasing other classes (CMCSA 10‑K, p. 91; p. 67). Therefore, the company’s ongoing repurchase of Class A (and Class C) shares does not affect the voting influence of Class B holders. In Alphabet’s dual‑class structure, Class B shares have ten votes each and may be converted into one‑vote Class A shares, which would dilute the voting power of remaining Class B shares, although Alphabet’s repurchase program targets only Class A and Class C shares (Alphabet 10‑K, p. 82). Thus, CMCSA’s voting control is insulated from share‑repurchase effects, whereas Alphabet’s voting control can be diluted only through conversion of Class B shares, not by the repurchases themselves.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several correct elements but also significant factual and reasoning errors that impact overall correctness. (1) Quantitatively, the claim that Class B shareholders have a fixed 33 1/3% voting power is correct, and the 15 votes per Class B share aligns with the ground truth. However, the LLM incorrectly states that this voting power 'cannot be diluted by issuing or repurchasing other classes' and concludes that repurchases 'do not affect the voting influence of Class B holders.' This is incorrect: because CMCSA’s Class B voting power is fixed at one-third, repurchasing Class A shares (which have fluctuating voting rights) actually increases the relative influence of Class B shares indirectly by reducing the total voting pool, thereby reinforcing their fixed share. The LLM misinterprets the mechanism, suggesting insulation when in fact the structure amplifies Class B’s relative control post-repurchase. (2) The LLM introduces a specific number—'9.44 million Class B shares'—that does not appear in the original answer or context, introducing unverified data. (3) Regarding Alphabet, the LLM correctly notes that Class B shares have 10 votes and can convert to Class A with dilution, and that repurchases target Class A and C shares. However, it omits the key quantitative fact from the ground truth that Alphabet repurchased $62.0 billion in shares in 2024, a material detail. (4) The reasoning contrast between the two companies is partially sound but flawed: the LLM fails to recognize that in CMCSA’s case, repurchases do affect relative voting control (by increasing Class B’s effective influence), whereas in Alphabet, since Class B shares are not repurchased and conversion causes dilution, repurchases of A and C shares do not alter the fixed-vote dominance of B shares unless conversion occurs. The LLM incorrectly frames CMCSA’s structure as 'insulated' from repurchase effects when it is, in fact, structurally amplified—this is a critical multi-hop reasoning failure. (5) Despite these issues, the answer remains contextually relevant and attempts a proper comparison. Semantic equivalence is partially achieved but undermined by key inaccuracies in logic and unsupported specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1448,
        "completion_tokens": 593,
        "total_tokens": 2041
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How does TGT's beverage sales mix compare to PEP's beverage revenue contribution in the APAC region, given both companies' exposure to this market?",
      "original_answer": "TGT includes beverages as part of its grocery segment, which is a key category within its retail operations. PEP, on the other hand, reports that beverages contribute 23% of its revenue in the APAC region. Additionally, PEP's APAC segment generated $10 million in reported revenue for 2024. This indicates that while both companies operate in the beverages category in APAC, PEP provides a specific quantification of its beverage exposure in the region, whereas TGT does not break down beverage sales separately from its broader grocery offering.",
      "llm_answer": "Target’s “Food & beverage” category generated **$23.8 bn of its $106.6 bn total net sales in 2024**, which works out to roughly **22 % of its overall revenue**【page_49】.  PepsiCo reports that **beverages account for 23 % of net revenue in its APAC division** (the rest is convenient foods)【page_73】.  Thus, both companies rely on beverages for about one‑fifth to one‑quarter of sales, with PepsiCo’s APAC beverage share slightly higher than Target’s overall beverage mix.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. The ground truth states that PEP's APAC segment generated $10 million in revenue in 2024, but the LLM does not mention this figure at all, omitting a key data point. Additionally, the LLM claims that Target's 'Food & beverage' category generated $23.8 billion of $106.6 billion in net sales (22%), but the original answer does not provide any such data for TGT—specifically noting that TGT does not break out beverage sales separately from grocery. Thus, the $23.8B and 22% figures are fabricated or misattributed, as they are not supported by the ground truth. (2) Quantitatively, the 23% beverage revenue contribution for PEP in APAC is correctly stated, matching the ground truth. However, the TGT revenue numbers ($23.8B, $106.6B, 22%) are not present in the original answer and contradict its explicit statement that TGT does not disclose beverage sales separately. The calculation of 22% may be mathematically correct if the inputs were valid, but the inputs themselves are unsupported. (3) The multi-hop reasoning is flawed: the model incorrectly assumes that because PEP breaks out beverage revenue, TGT must also have a comparable disclosed mix, and then invents a parallel metric. The original answer emphasizes that only PEP provides specific beverage revenue data in APAC, while TGT does not, making the comparison invalid. The LLM fails to recognize this asymmetry in disclosure. (4) Despite the reasoning error, the answer is contextually relevant—it attempts to compare beverage sales mix between TGT and PEP in APAC and references the right companies and region. However, due to the invention of unsupported financial data for TGT and omission of PEP's $10M APAC revenue, the correctness score is low. The qualitative accuracy is penalized for incorrect synthesis, and quantitative accuracy is partially credited only for the correct 23% PEP figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 523,
        "total_tokens": 1777
      },
      "error": null
    },
    {
      "question_id": 60,
      "question": "How might the Medicare price negotiation under the IRA, which will apply to Otezla starting in 2027, impact Amgen's $5.2 billion intangible asset valuation for Otezla, considering that Bristol-Myers Squibb (BMY) also markets Otezla under a licensing agreement?",
      "original_answer": "The Medicare price negotiation under the IRA, which will apply to Otezla starting January 1, 2027, introduces regulatory and financial risk that could impair Amgen's $5.2 billion intangible asset valuation for Otezla. Since BMY also markets Otezla under a licensing agreement, the negotiated price could affect overall revenue from the drug, further influencing Amgen's ability to recover the carrying value of the asset. Amgen has explicitly stated that future changes in estimates related to IRA price negotiations could unfavorably impact the intangible asset's recoverability.",
      "llm_answer": "The IRA will force CMS to set a Medicare price for Otezla beginning 1 Jan 2027 – a change Amgen already warned could “unfavorably impact the Company’s ability to recover the carrying value of the related intangible asset” (the Otezla technology right valued at $5.2 billion) 【page_36†L1-L8】【page_137†L1-L5】.  Because Bristol‑Myers Squibb also markets Otezla under a licensing deal (the filing notes Otezla is a trademark of Amgen) 【page_140†L1-L3】, any CMS‑mandated price cuts would reduce both BMY’s sales and the royalty income Amgen receives, increasing the risk that the $5.2 billion intangible‑asset valuation will need to be impaired.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: the IRA's Medicare price negotiation applies to Otezla starting January 1, 2027; Amgen has a $5.2 billion intangible asset valuation for Otezla; Bristol-Myers Squibb markets Otezla under a licensing agreement; and Amgen has explicitly warned that IRA-related price negotiations could impair the asset's recoverability. (2) Quantitative elements—$5.2 billion valuation and the 2027 start date—are correctly stated with no calculation errors. Format variations (e.g., $5.2 billion vs $5.2B) are acceptable and do not affect accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across entities (Amgen, BMY, CMS, IRA), connects the licensing arrangement to royalty income, and explains how reduced prices would impact both BMY’s sales and Amgen’s revenue, thereby increasing impairment risk. (4) The answer is contextually precise, directly addressing the financial, regulatory, and contractual dimensions of the question. Citations from specific pages (e.g., page_36, page_137) further support the accuracy and traceability of claims. No factual or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1333,
        "completion_tokens": 343,
        "total_tokens": 1676
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does AMD's production of FPGAs for hyperscale data centers compare to Altera's FPGA offerings, given Intel's strategic decision to operate Altera as a standalone business?",
      "original_answer": "Altera, now operated as a standalone business by Intel, offers programmable semiconductors primarily FPGAs, targeting embedded, communications, and cloud and enterprise markets. Intel is pursuing monetization opportunities with Altera, including a potential IPO. Meanwhile, AMD produces FPGAs and Adaptive SOCs that are directly incorporated into servers and data center appliances used by hyperscale customers, including for AI workloads such as generative AI models. This positions both companies in competitive yet distinct roles within the FPGA market, with AMD directly serving hyperscale data centers and Intel seeking to unlock value through Altera's standalone structure.",
      "llm_answer": "AMD’s Versal FPGA portfolio—combining a processing system, programmable logic, AI engines and DSP engines—is being produced specifically for hyperscale data‑center workloads and is a core part of AMD’s data‑center strategy (AMD page 9; Intel page 11). By contrast, Intel’s Altera line offers programmable‑semiconductor FPGAs for embedded, communications and cloud/enterprise markets, but Intel has chosen to run Altera as a standalone business, focusing on monetization and a potential IPO (Intel page 23; Intel page 70).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AMD's Versal FPGAs are indeed targeted at hyperscale data centers and are part of its data-center strategy, while Altera (under Intel) serves embedded, communications, and cloud/enterprise markets and is being operated as a standalone business with potential IPO considerations. There are no numbers, dates, or financial figures in dispute, so quantitative accuracy is perfect. (2) The answer correctly cites document pages (e.g., AMD page 9, Intel pages 11, 23, 70), which supports traceability, though the ground truth does not require page numbers—this is a strength, not an error. (3) Multi-hop reasoning is sound: the model synthesizes information about AMD’s FPGA use in hyperscale environments and contrasts it with Intel’s strategic handling of Altera, correctly identifying the competitive yet distinct positioning. (4) The only minor shortcoming is that the LLM does not explicitly mention AMD’s Adaptive SOCs or their use in AI/generative AI workloads—a detail present in the original answer—but it does reference AI engines in Versal, which implies AI capability. This omission is minor and does not undermine the core accuracy. Semantic equivalence is maintained. Contextual relevance is excellent as it directly addresses the comparison asked in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 383,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the ownership structure of Class A common stock at GOOGL, given the relative number of shares outstanding and holder concentration?",
      "original_answer": "At CMCSA, the Class B common stock represents 33⅓% of the combined voting power, with all shares beneficially owned by Brian L. Roberts, and only 3 record holders as of December 31, 2021. In contrast, GOOGL’s Class A common stock had 300,754,904 shares outstanding as of January 25, 2022, with a much broader base of non-affiliate ownership contributing to a market value of approximately $1,451.1 billion as of June 30, 2021. Both structures tie voting rights to distinct stock classes, but CMCSA’s Class B shares grant concentrated control to a single individual, while GOOGL’s Class A shares are more widely distributed.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each and together represent roughly 33 ⅓ % of the company’s total voting power, yet all of those shares are beneficially owned by a single individual – Brian L. Roberts – (the filing shows only three record holders for Class B)【page_38†L9-L15】【page_38†L22-L24】. By contrast, Alphabet’s Class A stock – which confers one vote per share – has about 300.8 million shares outstanding as of January 2022【page_2†L13-L15】and is held by a broad base of investors, so voting influence is far more dispersed.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: CMCSA Class B has 33⅓% voting power (correctly stated as 'roughly 33⅓%'), Brian L. Roberts is the beneficial owner, and there are only 3 record holders. For GOOGL, the LLM reports ~300.8 million shares outstanding as of January 2022, which aligns with the ground truth figure of 300,754,904 as of January 25, 2022 (rounding is acceptable). The market value of $1,451.1 billion from June 30, 2021 is omitted, but this is a minor detail not critical to the comparison of ownership concentration. (2) The LLM correctly notes the 15 votes per share for CMCSA Class B (contextual detail not in the original answer but factually accurate and adds value), and correctly states GOOGL Class A has one vote per share. (3) The multi-hop reasoning is sound: the model compares voting power concentration at CMCSA (single individual control) with the broad distribution at GOOGL, directly addressing the question about relative ownership structure and holder concentration. (4) The only minor shortcoming is the omission of the exact market value for GOOGL’s Class A shares, which slightly reduces completeness but does not affect the core conclusion. Wording differs but semantic meaning is equivalent. All entities (CMCSA, GOOGL, Class A/B shares, Brian L. Roberts) are correctly identified with accurate timeframes. Thus, the answer is factually excellent with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 415,
        "total_tokens": 1723
      },
      "error": null
    },
    {
      "question_id": 61,
      "question": "How does the change in Keytruda royalty structure post-2023 impact Bristol-Myers Squibb's revenue dependency on Merck, considering Merck's co-development and financial obligations tied to Keytruda in combination therapies?",
      "original_answer": "The royalty rate Merck pays to Bristol-Myers Squibb (BMS) and Ono for Keytruda drops from 6.5% to 2.5% starting January 1, 2024, which will reduce BMS’s royalty income from Merck. This is significant because Merck co-develops Keytruda-based combination therapies like V940 (mRNA-4157) with Moderna, where Merck bears 50% of development costs and receives 50% of any future profits. Since BMS's revenue from Merck is partly tied to Keytruda's global sales through this licensing agreement and has been a growing component of BMS's income (noted by the 2023 increase in royalties), the reduced royalty rate may diminish the financial upside BMS experiences from Keytruda's continued use in these new combination regimens.",
      "llm_answer": "The Keytruda royalty rate falls from 6.5 % of global sales through 2023 to 2.5 % from 2024‑2026, cutting BMS’s royalty income (which was $1.186 billion in 2023) and thus reducing its direct revenue reliance on Merck 【page_90】【page_55】. However, Merck still bears substantial co‑development and cost‑sharing obligations for Keytruda‑based combos—e.g., the $250 million upfront and equal‑share cost/profit arrangement with Moderna on the V940‑Keytruda Phase 3 program—so BMS’s overall exposure to Merck’s Keytruda success remains, albeit with a lower royalty component 【page_90】【page_91】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key change in royalty rate—from 6.5% pre-2024 to 2.5% starting in 2024—aligning with the ground truth. It accurately notes the reduction in BMS’s royalty income and references the $1.186 billion received in 2023, which is consistent with the knowledge graph’s implication of growing royalty income. The mention of the 2024–2026 period for the reduced rate is slightly more specific than the ground truth (which only states 'starting January 1, 2024') but does not contradict it and may reflect additional context from the source pages. (2) All numbers are correct: 6.5%, 2.5%, $1.186 billion, $250 million upfront payment, 50% cost/profit share (implied as 'equal-share'). No calculation errors. Format variations are acceptable and clear. (3) The multi-hop reasoning is sound: the answer connects the reduced royalty rate to lower direct revenue for BMS, acknowledges the continued financial exposure via Merck’s co-development obligations (e.g., V940 combo with Moderna), and correctly infers that while direct royalty dependency decreases, indirect exposure remains due to Merck’s ongoing role in Keytruda-based therapies. This synthesizes licensing terms, financial flows, and development partnerships across entities. (4) The only minor shortcoming is that the LLM does not explicitly state that BMS shares the royalty with Ono, which is a small omission but not central to the revenue dependency analysis. Otherwise, the answer is factually robust, contextually precise, and semantically equivalent to the ground truth. Hence, high scores across all dimensions with a 9/10 on correctness due to near-perfect alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 459,
        "total_tokens": 1804
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the adoption of ASU 2022-06, which CAT has listed as applicable to its financial reporting, impact the treatment of contract modifications under U.S. government agreements that BA identified as a material risk in its 2023 disclosures?",
      "original_answer": "ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform through December 31, 2024. This allows companies like BA to apply simplified accounting treatments for contract modifications made in response to reference rate changes, such as replacing LIBOR, during that period. BA, which reported that 37% of its 2023 revenues came from U.S. government contracts—where modifications can occur without prior notice—benefits from reduced operational complexity and financial impact when adjusting contracts affected by reference rate reform. CAT, in its 2023 10-K, listed ASU 2022-06 under recently adopted accounting standards, confirming its applicability and alignment with broader corporate practices around reference rate reform.",
      "llm_answer": "ASU 2022‑06, which Caterpillar adopted, gives companies optional expedients that ease the accounting for contract modifications that replace a reference rate (such as LIBOR) and extends those relief provisions through Dec 31 2024. As a result, any U.S.‑government contract modifications that qualify under the standard would be recorded with reduced operational and financial impact, but Caterpillar notes the adoption had no material effect on its financial statements—so the material risk Boeing flags for government‑contract modifications remains essentially unchanged, albeit with a potentially lighter accounting burden.",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is mostly correct in its explanation of ASU 2022-06, accurately stating that it extends optional expedients for contract modifications related to reference rate reform (e.g., LIBOR transition) through December 31, 2024, which aligns with the ground truth. The mention of Caterpillar (CAT) adopting the standard is consistent with the original answer. Quantitatively, all dates and references are accurate—no errors in numbers or timeframes. However, the LLM incorrectly implies that the material risk Boeing (BA) identified regarding U.S. government contract modifications remains 'essentially unchanged' due to CAT’s adoption having no material effect. This misrepresents the causal relationship: the question asks how ASU 2022-06 impacts the treatment of contract modifications under U.S. government agreements that BA identified as a risk—not whether CAT’s adoption materially affected CAT’s financials. The ground truth clarifies that BA benefits from reduced complexity in modifying contracts due to the extended relief, especially given that 37% of its revenue comes from U.S. government contracts. This key point—BA’s exposure and the mitigation via ASU 2022-06—is underemphasized and distorted in the LLM response. While the LLM correctly identifies the accounting relief, it fails to fully synthesize the multi-hop link: (1) ASU 2022-06 extends relief, (2) BA faces material risk from government contract modifications, (3) the relief reduces the financial and operational burden of such modifications, thus directly mitigating BA’s risk. The LLM instead focuses on CAT’s lack of material impact, which is irrelevant to BA’s risk context. Therefore, while the core accounting concept is sound and well-articulated, the reasoning falters in connecting the entities and their respective disclosures correctly, leading to a partially incomplete and slightly misleading conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 511,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does the $4.8 billion transaction with Crown Castle in 2013 compare to Verizon's 2024 $2.8 billion deal with Vertical Bridge REIT in terms of asset treatment and financing obligations, particularly given both companies retained depreciation responsibilities and structured payments as financing obligations?",
      "original_answer": "Both AT&T’s 2013 transaction with Crown Castle and Verizon’s 2024 deal with Vertical Bridge REIT involved transferring exclusive rights to operate wireless towers while retaining depreciation responsibilities on their balance sheets. AT&T received $4.827 billion from Crown Castle, accounted for as a financing obligation with an effective interest rate of ~3.9%, and continues to sublease space on the towers. Similarly, Verizon received $2.8 billion from Vertical Bridge, of which $830 million was recorded as a financing obligation related to the towers Verizon continues to use, with the remainder treated as prepaid rent. Both arrangements reflect a structured financing model where the original owner maintains accounting control and depreciation charges, rather than achieving sale-leaseback treatment.",
      "llm_answer": "AT&T’s 2013 Crown Castle deal (≈ $4.8 billion) was accounted as a financing liability – the company kept the 9,048 towers on its Property, Plant & Equipment, continued to depreciate them ($39 million per year) and recorded the cash proceeds as a financing obligation that accrues interest at roughly 3.9 % (Note 18, p.90). Verizon’s 2024 Vertical Bridge REIT transaction (≈ $2.8 billion) likewise leaves the towers on its balance sheet and subject to depreciation, but the upfront cash is split into $2.0 billion of prepaid rent and an $830 million financing obligation, with the lease‑back payments reflected as financing outflows (Note 6, p.73). Thus, both companies retain depreciation expense and treat the cash received as financing obligations, but Verizon adds a prepaid‑rent component while AT&T recorded the entire proceeds as a financing liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all key figures are correct: AT&T's $4.827 billion is accurately rounded to $4.8 billion; Verizon's $2.8 billion total with $830 million as a financing obligation and the remainder (~$1.97 billion) as prepaid rent aligns with the original answer (LLM states $2.0 billion prepaid rent, a minor rounding difference). The 3.9% effective interest rate and continued depreciation are correctly noted. The mention of $39 million annual depreciation for AT&T is an additional precise detail not in the ground truth but consistent with plausible data. (2) The answer addresses all parts of the question: asset treatment (towers remain on balance sheet, depreciation retained), financing obligations (structured as liabilities), and the comparison between the two deals. (3) Entities are correct: AT&T (implied by context, though Verizon is explicitly mentioned), Crown Castle (2013), Vertical Bridge REIT (2024), and proper accounting terms (financing obligation, prepaid rent, depreciation). (4) Multi-hop reasoning is sound—correctly synthesizes that both deals avoid sale-leaseback treatment by retaining control and depreciation, while highlighting a key difference: Verizon splits proceeds between financing and prepaid rent, whereas AT&T treats the full amount as financing. The only minor shortcoming is the lack of explicit mention that AT&T's entire proceeds were treated as financing (vs. partial in Verizon’s case), though this is implied. Overall, the answer is factually robust, contextually precise, and semantically equivalent to the ground truth with only negligible rounding and phrasing differences.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 461,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does PEP's direct operational presence in New Zealand's beverage market compare to KO's financial influence through its 19% stake in CCEP, which bottles and distributes Coca-Cola products in the same region?",
      "original_answer": "PEP operates in New Zealand through its APAC regional structure, selling branded beverages and convenient foods directly and through partners. CCEP, in which KO holds a 19% stake, is responsible for bottling and distributing Coca-Cola products in New Zealand under a bottler's agreement. KO's financial stake allows it to influence CCEP's operations indirectly, while PEP maintains full operational control over its New Zealand beverage activities. This creates two distinct models—direct operation for PEP and equity influence for KO through CCEP—both active in the New Zealand beverage market.",
      "llm_answer": "PepsiCo’s APAC segment explicitly includes New Zealand, where the company “makes, markets, distributes and sells beverage concentrates, fountain syrups and finished goods” such as Pepsi, Mountain Dew and 7UP to local bottlers and retailers 【page_5】【page_6】. Coca‑Cola, by contrast, does not operate its own plants there; its presence is financial – it holds roughly a 19 % equity stake in Coca‑Cola Europacific Partners (CCEP), the independent bottler that “has bottling and distribution operations in … New Zealand” 【page_7】, and accounts for CCEP under the equity‑method investment 【page_69】【page_88】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PEP operates directly in New Zealand through its APAC segment, manufacturing and distributing beverages; KO does not operate directly but holds a 19% stake in CCEP, which bottles and distributes Coca-Cola products there. The 19% stake is correctly stated and matches the original answer. (2) Quantitative accuracy is perfect—no calculations required, but the 19% equity stake is correctly reported. (3) Multi-hop reasoning is sound: the model synthesizes information about PEP’s operational presence from one part of the filing and KO’s equity-method investment in CCEP from another, correctly contrasting direct operation vs. financial influence. (4) The only minor shortcoming is that the LLM does not explicitly state that KO’s stake allows 'indirect influence' over operations or that the two models are 'distinct'—phrasing present in the original—but this conceptual contrast is strongly implied by the accurate description of the operational and financial arrangements. Wording differences do not affect factual correctness. The answer is contextually rich, well-supported with citation markers, and fully addresses the comparative structure of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 354,
        "total_tokens": 1670
      },
      "error": null
    },
    {
      "question_id": 62,
      "question": "How does AIG's use of internal valuation models for mortgage-backed securities compare to SCHW's reliance on broker/dealer quotes for similar asset classes like commercial mortgage-backed securities in determining fair value?",
      "original_answer": "AIG utilizes internal valuation models and third-party asset managers to determine fair values for mortgage-backed securities, subject to management review to ensure model reasonableness. These models incorporate inputs like interest rates, borrower creditworthiness, collateral, and market pricing for comparable loans. In contrast, SCHW primarily relies on broker/dealer quotes and third-party pricing services for similar asset classes such as commercial mortgage-backed securities, using observable market data like trades, spreads, and maturity information to validate pricing. GILD’s evidence further supports that broker/dealer quotes are commonly used alongside valuation models with observable inputs for fair value estimation, indicating a shared industry practice that bridges AIG's internal modeling and SCHW's external pricing reliance.",
      "llm_answer": "AIG values its residential and commercial mortgage‑backed securities by applying its own valuation models (with discounted‑cash‑flow analysis and, where available, dealer quotations) that are reviewed by management for reasonableness. In contrast, Schwab determines the fair value of comparable fixed‑income assets—such as non‑agency CMBS—primarily from independent third‑party pricing services that use observable trades and broker/dealer quotes, adjusting the price only if it conflicts with the fair‑value definition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison between AIG's and SCHW's fair value determination methods for mortgage-backed securities. (1) AIG's use of internal valuation models, including discounted cash flow analysis and management review, is correctly stated and aligns with the ground truth. The mention of dealer quotations as a supplementary input is consistent with the original answer's reference to third-party inputs. (2) For SCHW, the reliance on third-party pricing services and broker/dealer quotes for non-agency CMBS is factually correct, and the use of observable market data (trades, spreads) is accurately implied through 'observable trades and broker/dealer quotes.' The note about price adjustments if inconsistent with fair value definition adds a detail not in the original but does not contradict it and reflects reasonable judgment. (3) Multi-hop reasoning is sound: the answer correctly contrasts AIG’s model-driven approach with SCHW’s market-data-driven approach across similar asset classes. (4) The only minor shortcoming is the omission of GILD’s supporting evidence about industry practices, which adds contextual depth in the original answer about the convergence of practices. However, this does not detract from the direct comparison asked. No numbers, dates, or financial metrics are incorrect (quantitative accuracy is perfect). Wording differs but semantic equivalence is strong. Contextual relevance is excellent as it directly addresses the comparison in methodology for fair value determination.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 425,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "How does AVGO's valuation methodology for Level 2 securities compare to ADBE's reliance on matrix pricing, given the use of observable market inputs like yield curves and benchmark rates in their fair value determinations?",
      "original_answer": "AVGO categorizes its investments, including equity and short-term money market instruments, as Level 2 securities when they are valued using inputs such as interest rates, yield curves, and broker quotes. These inputs are observable but not quoted prices in active markets, distinguishing them from Level 1 securities. Matrix pricing, which is used for Level 2 securities like corporate bonds and asset-backed securities, relies on observable market data such as yield curves to estimate fair value. ADBE also categorizes its fixed income available-for-sale debt securities as Level 2 and explicitly uses matrix pricing techniques that incorporate benchmark yields, issuer spreads, interest rates, and U.S. Treasury or swap curves to determine fair value. Both companies rely on similar observable inputs, indicating a shared dependence on market-derived data rather than direct quotations for active trading in valuing their Level 2 portfolios.",
      "llm_answer": "AVGO says its Level 2 securities (asset‑backed, corporate and municipal bonds) are priced with market‑corroborated or matrix‑pricing models that draw on observable market data – not only yield curves but also interest‑rate levels, pre‑payment speeds, collateral performance, broker‑dealer quotes and other indices. Adobe’s fair‑value approach for comparable fixed‑income securities likewise relies on matrix‑pricing from independent vendors, using observable inputs such as benchmark yields, issuer spreads, interest rates and U.S. Treasury or swap curves. Both companies classify these instruments as Level 2, but AVGO’s description explicitly cites a broader set of observable inputs beyond the yields and spreads emphasized by Adobe.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: both AVGO and ADBE classify their fixed-income securities as Level 2, and both use observable inputs such as yield curves, interest rates, and benchmark rates. The LLM correctly identifies that ADBE uses matrix pricing via third-party vendors and that AVGO uses matrix or market-corroborated pricing models with observable data. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation methodologies across two companies (AVGO and ADBE), compares their use of Level 2 inputs, and notes a subtle but important distinction—AVGO references a broader set of inputs (e.g., prepayment speeds, collateral performance, broker quotes) compared to ADBE’s emphasis on benchmark yields and spreads. This nuance is not in the original answer but is factually consistent and adds value. (4) The answer is contextually fully relevant, directly addressing the comparison of valuation methodologies and the role of observable inputs. The only reason for not scoring a 10 in correctness and qualitative accuracy is that the original answer emphasizes the shared reliance on similar inputs as the key takeaway, while the LLM highlights differences in input breadth—slightly shifting emphasis but not misrepresenting facts. Overall, the answer is semantically equivalent and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 430,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 63,
      "question": "What percentage of Coca-Cola's non-U.S. unit case volume is managed by Coca-Cola HBC, and in how many of its operational countries—including the Czech Republic—does it coordinate distribution for Coca-Cola's trademark beverages?",
      "original_answer": "Coca-Cola HBC manages 17% of Coca-Cola's non-U.S. unit case volume and coordinates distribution for Coca-Cola's trademark beverages in 30 countries, including the Czech Republic.",
      "llm_answer": "The excerpts do not give a specific share of non‑U.S. unit‑case volume that Coca‑Cola HBC handles. However, the filing lists Coca‑Cola HBC’s bottling and distribution footprint in 28 countries—including the Czech Republic (Armenia, Austria, Belarus, Bosnia‑Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Greece, Hungary, Italy, Latvia, Lithuania, Moldova, Montenegro, Nigeria, North Macedonia, Northern Ireland, Poland, Republic of Ireland, Romania, Russia, Serbia, Slovakia, Slovenia, Switzerland and Ukraine)【page_7】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer fails to provide the correct percentage of Coca-Cola's non-U.S. unit case volume managed by Coca-Cola HBC, which is 17% according to the ground truth. Instead, it states that this information is not available in the excerpts, which is incorrect. This is a major factual omission affecting quantitative accuracy. (2) Regarding the number of countries, the LLM lists 28 countries based on the filing and explicitly names them, including the Czech Republic. However, the ground truth states that distribution coordination occurs in 30 countries. The LLM underreports this number by 2, likely due to incomplete extraction or outdated data in the excerpt it referenced. While the mention of the Czech Republic is correct, the total count is inaccurate. (3) The multi-hop reasoning is partially sound—the model correctly identifies that Coca-Cola HBC coordinates distribution in multiple countries and that the Czech Republic is among them. However, it fails to retrieve or compute the correct percentage for volume share, indicating a failure in synthesizing a key piece of information required by the question. (4) The contextual relevance is fair because the response addresses both parts of the question and provides supporting detail (list of countries), but the inaccuracies in both key numbers—especially the missing 17% figure—severely limit correctness. The qualitative accuracy is moderate because entity identification (Coca-Cola HBC, Czech Republic) is correct, but critical data synthesis is incomplete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1199,
        "completion_tokens": 423,
        "total_tokens": 1623
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How do Duke Energy's 50% equity stake in Hardy Storage in West Virginia and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in the same region reflect divergent strategic approaches to natural gas infrastructure investment, particularly in light of regulatory and market challenges?",
      "original_answer": "Duke Energy's 50% equity stake in Hardy Storage, an interstate underground natural gas storage facility in West Virginia, indicates a strategic focus on stable, long-term infrastructure assets that support regulated gas operations. This aligns with Duke's broader approach of investing in FERC-regulated infrastructure such as Pine Needle and Hardy Storage to ensure reliable supply and service. In contrast, NextEra Energy's 31.9% ownership in a 303-mile pipeline project in West Virginia and Virginia reflects a more ambitious and risk-exposed strategy aimed at expanding transportation capacity into new markets, despite facing regulatory delays and legal challenges. While both companies are investing in West Virginia's natural gas ecosystem, Duke's approach emphasizes secure, operational assets, whereas NextEra's involvement in a pipeline under construction—subject to permitting and legal hurdles—suggests a higher tolerance for uncertainty in pursuit of future capacity and market access.",
      "llm_answer": "Duke Energy’s 50 % equity interest in Hardy Storage is a regulated, underground interstate gas‑storage facility (FERC‑regulated) that gives the utility a stable, low‑risk asset for supply flexibility and predictable returns 【page_19】. In contrast, NextEra Energy’s 31.9 % stake in a 303‑mile pipeline that is still under construction in West Virginia and Virginia is subject to pending regulatory approvals and legal challenges, making it a higher‑risk, growth‑oriented investment that depends on market demand for gas transportation 【page_17】. Thus, Duke is pursuing a conservative, regulated‑infrastructure strategy, while NextEra is taking a more speculative approach that exposes it to greater regulatory and market uncertainty.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Duke Energy's 50% stake in Hardy Storage and NextEra Energy's 31.9% ownership in a 303-mile pipeline under construction in West Virginia and Virginia are accurately reported. The characterization of Hardy Storage as FERC-regulated and Duke's focus on stable, low-risk infrastructure matches the original. Similarly, NextEra's higher-risk, growth-oriented strategy facing regulatory and legal challenges is correctly conveyed. (2) Quantitative accuracy is perfect: percentages (50%, 31.9%), pipeline length (303 miles), and geographic scope (West Virginia and Virginia) are all correct. No calculations were required, but factual numbers are precise and match the ground truth. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, two types of infrastructure (storage vs. pipeline), and contrasts strategic approaches (regulated stability vs. expansion with risk). The inference about Duke’s conservative strategy and NextEra’s speculative approach is logically supported and semantically equivalent to the original. (4) Minor wording differences exist—'speculative' is slightly stronger than 'higher tolerance for uncertainty'—but the overall meaning and strategic contrast are preserved. The answer fully addresses the question’s focus on divergent strategies in light of regulatory and market challenges. Only a 9 due to slightly less nuanced phrasing compared to the original’s detailed regulatory and operational context, but no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1473,
        "completion_tokens": 437,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How does the difference in voting rights between Class A and Class B shares at META compare to GOOGL's dual-class structure, and what implications might this have on ownership concentration given META's 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding as of January 24, 2025, versus GOOGL's 10:1 voting ratio for Class B shares and $62.0 billion in 2024 share repurchases?",
      "original_answer": "META discloses two classes of stock—Class A and Class B—with the latter carrying greater voting rights, though the exact ratio is not quantified in the filing. As of January 24, 2025, META had 2,189,898,148 Class A shares and 343,761,117 Class B shares outstanding, indicating a significant concentration of voting power within Class B. In contrast, GOOGL explicitly states that each Class B share carries 10 votes, creating a defined 1:10 voting disparity. GOOGL also repurchased $62.0 billion in shares during 2024, predominantly from Class A and Class C, which may further consolidate voting control in Class B shares held by insiders. This suggests that while both companies utilize dual-class structures to concentrate voting power, GOOGL's is more explicitly weighted and reinforced through aggressive capital allocation, whereas META’s structure lacks detailed disclosure on voting disparity but similarly reflects a concentrated ownership base through disproportionate Class B shareholding.",
      "llm_answer": "Both META and Alphabet use a dual‑class system in which Class B shares carry ten votes per share while Class A shares have one vote each (Alphabet’s 10‑K notes each Class A share has one vote and each Class B share has ten votes【page_82】). META’s 2,189,898,148 Class A and 343,761,117 Class B shares outstanding as of Jan 24 2025【page_1】 mean Class B shares—though only about 13.5 % of total shares—control roughly 60 % of the voting power, concentrating control in a small group; Alphabet’s identical 10‑to‑1 voting split, together with its $62 billion share‑repurchase program in 2024【page_82】, shrinks the overall share pool and further concentrates voting power among its Class B shareholders.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: it claims that META's Class B shares carry ten votes per share, which is not supported by the original answer or the knowledge graph. The ground truth explicitly states that META does not disclose the exact voting ratio between Class A and Class B shares, whereas the LLM confidently asserts a 10:1 ratio identical to GOOGL’s, which is incorrect. This undermines the core of the comparison. (2) Quantitatively, the share counts for META (2,189,898,148 Class A and 343,761,117 Class B) are correctly cited, and the calculation that Class B shares represent approximately 13.5% of total shares is accurate (343.76M / (343.76M + 2,189.90M) ≈ 13.5%). However, the claim that Class B controls 'roughly 60%' of voting power is speculative and not verifiable without the actual voting ratio, which META does not disclose. The $62 billion share repurchase figure for GOOGL is correctly cited (matches $62.0 billion). (3) The multi-hop reasoning is partially sound—comparing dual-class structures and discussing how repurchases may concentrate voting power—but fails on the key point of differing disclosure practices: GOOGL explicitly states its 10:1 ratio, while META does not. The LLM incorrectly equates the two structures as 'identical', when the original answer emphasizes that GOOGL’s is more explicitly weighted. (4) Contextual relevance is high because the answer addresses both companies, share counts, voting rights, and repurchases. However, due to the major factual inaccuracy regarding META’s voting ratio and the resulting flawed synthesis, the correctness score is significantly reduced. The answer would score higher if it acknowledged the lack of disclosed voting ratio at META rather than inventing one.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1486,
        "completion_tokens": 483,
        "total_tokens": 1969
      },
      "error": null
    },
    {
      "question_id": 65,
      "question": "How did the enactment of TRAF in Switzerland impact JNJ's effective tax rate in 2020, and how does this compare to MRK's tax benefit from its Swiss tax holiday that began in 2021?",
      "original_answer": "The enactment of TRAF in Switzerland allowed JNJ to adjust the tax basis of certain assets to fair value under transitional provisions, resulting in an incremental Swiss tax deduction and contributing to a 1.9% decrease in JNJ's 2020 effective tax rate compared to 2019. Meanwhile, MRK benefited from a Swiss tax holiday for a newly active legal entity, effective through 2030, which began yielding favorable tax impacts starting in 2021. These provisions in Switzerland contributed to both companies experiencing lower effective tax rates due to localized tax incentives, albeit through different mechanisms and in different fiscal years.",
      "llm_answer": "The TRAF reform that took effect in Switzerland on 1 Jan 2020 gave Johnson & Johnson a net $0.4 billion tax benefit – roughly a 2.6 % lift to its effective tax rate – and lowered its overall effective tax rate by about 1.9 percentage points (from 12.7 % in 2019 to 10.8 % in 2020)【page_69】【page_70】.  \n\nMerck’s new Swiss “tax‑holiday” that began in 2021 is reflected in its tax reconciliation as a major driver of the drop in its effective tax rate from 22.9 % in 2020 to 11.0 % in 2021 – a reduction of roughly 12 percentage points【page_135】【page_136】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 1.9 percentage point decrease in JNJ's effective tax rate from 12.7% in 2019 to 10.8% in 2020 is correct and matches the impact attributed to TRAF in Switzerland. The mention of a $0.4 billion tax benefit is consistent with the financial impact, though the original answer does not specify this dollar amount—this is an acceptable addition from the source documents and not a contradiction. The description of a '2.6% lift to its effective tax rate' is ambiguous but likely refers to a relative increase in tax benefit magnitude; however, this phrasing could be misinterpreted and slightly detracts from precision. (2) For MRK, the drop in effective tax rate from 22.9% in 2020 to 11.0% in 2021 (a ~11.9 percentage point reduction) is accurately reported as approximately 12 points, and the timing of the Swiss tax holiday starting in 2021 is correct. (3) The multi-hop reasoning is sound: the answer correctly distinguishes between JNJ’s 2020 TRAF-related benefit and MRK’s 2021 tax holiday impact, synthesizing information across companies and years. (4) All entities (JNJ, MRK, Switzerland, TRAF, tax holiday), years (2019, 2020, 2021), and financial metrics (effective tax rate) are correctly identified. The LLM adds specific numerical context (e.g., exact tax rates, dollar figures) not in the original answer but supported by cited pages, enhancing completeness without introducing error. The only minor issue is the unclear phrasing around '2.6% lift,' which may confuse absolute vs. relative changes but does not invalidate the core correctness. Overall, the answer is factually robust, contextually relevant, and semantically equivalent to the ground truth with minor wording caveats.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1306,
        "completion_tokens": 484,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How do MCD's foreign currency asset hedging practices compare with NKE's transactional FX risk management strategies using options, particularly regarding notional amounts and objectives?",
      "original_answer": "MCD manages FX exposure by holding diversified foreign currency net asset positions, with its largest exposures denominated in major global currencies (chunk_1). To mitigate associated risks, MCD uses option and forward contracts to hedge forecasted foreign currency transactions, with $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024 (chunk_2). NKE also uses option contracts as part of its FX risk management, focusing on transactional exposures such as product costs and external sales in non-functional currencies, with hedging strategies aimed at stabilizing U.S. Dollar inventory costs amid FX fluctuations (chunk_3). While both companies use options, MCD's strategy centers on protecting existing foreign currency assets, whereas NKE's approach is more transaction-focused, targeting forecasted cash flows and cost stability.",
      "llm_answer": "McDonald’s hedges foreign‑currency risk mainly with forward contracts that show up as derivative fair‑value positions of roughly $1.3 billion of foreign‑exchange assets and $0.8 billion of liabilities (MCD 10‑K p.119‑120), the purpose being to offset the impact of currency moves on its net foreign‑currency asset exposures. Nike, by contrast, runs a much larger transactional‑FX program that uses both forwards and options designated as cash‑flow hedges, covering $9.9 billion of net notional in 2024 (NKE 10‑K p.121) and is intended to protect the value of its assets, liabilities, firm commitments and forecasted cash‑flows and to smooth earnings and cash‑flow volatility.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details and misattribution of hedging notional amounts between MCD and NKE. (1) Quantitative Accuracy: The LLM incorrectly states that MCD's derivative positions are $1.3 billion in assets and $0.8 billion in liabilities, which does not match the ground truth of $9.9 billion in notional amounts of net foreign exchange cash flow hedges as of September 28, 2024. Instead, the $9.9 billion figure is wrongly attributed to NKE in the LLM answer, claiming it as NKE's notional amount, when in fact the ground truth assigns this amount to MCD. This is a critical error that reverses key data between the two companies. (2) Completeness: While the answer attempts to address both companies' FX strategies and objectives, it fails to correctly represent MCD's use of both options and forwards or NKE's specific focus on stabilizing U.S. Dollar inventory costs. (3) Entity Accuracy: Company names are correct, and the general use of forwards and options is mentioned, but the misassignment of the $9.9 billion notional to NKE instead of MCD is a major entity-metric mismatch. (4) Reasoning: The multi-hop comparison is structurally sound—comparing objectives and instruments—but the reasoning is based on incorrect data, undermining the validity of the conclusion. The LLM suggests NKE has a 'much larger' program based on incorrect notional assignment, when in fact the ground truth attributes the $9.9 billion to MCD. (5) Semantic Equivalence: The overall intent to contrast MCD’s asset-hedging with NKE’s transactional focus is partially aligned, but the reversal of key figures and lack of clarity on objectives (e.g., NKE’s cost stabilization) reduces fidelity. The answer would be more accurate if it correctly assigned the $9.9 billion to MCD and clarified that NKE uses options for transactional cost stability, not broad cash flow and balance sheet hedging as implied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1399,
        "completion_tokens": 526,
        "total_tokens": 1925
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the exclusive use of RTX's PW800 engine on Gulfstream's G500 support General Dynamics' strategy to position the G500 as a next-generation replacement for the G450 and G550 models?",
      "original_answer": "The G500, developed by General Dynamics, is positioned as a next-generation replacement for the G450 and G550 models with a clean-sheet design that includes a new wing and advanced avionics. RTX's Pratt & Whitney Canada produces the PW800 engine, which exclusively powers the G500 (along with the G400 and G600). This exclusive engine-airframe pairing enhances the G500's performance with improved fuel efficiency, range, and speed, aligning with General Dynamics' investment in new technologies to differentiate the G500 as a modern, high-performance aircraft in the business jet market.",
      "llm_answer": "The PW800 engine’s exclusive fit on the G500 gives the jet a modern, high‑efficiency powerplant that boosts speed, range and fuel‑burn performance, which dovetails with Gulfstream’s all‑new wing, avionics and other technologies that GD is promoting as a next‑generation replacement for the legacy G450 and G550 fleet【page_5】. By pairing the clean‑sheet G500 with a state‑of‑the‑art engine, GD can market the aircraft as a superior, more capable successor to the older models【page_4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. It correctly identifies the exclusive use of RTX's PW800 engine on the G500 and links it to General Dynamics' (GD) strategy of positioning the G500 as a next-generation replacement for the G450 and G550. The answer highlights key performance improvements—speed, range, and fuel efficiency—attributed to the engine-airframe pairing, and correctly ties this to GD's broader technological investment, including the clean-sheet design, new wing, and advanced avionics. All entities (RTX, PW800, G500, G450, G550, Gulfstream, General Dynamics) are accurately referenced. There are no numeric values in the question or answers requiring quantitative verification, so quantitative accuracy is scored as 10 by default. The only minor omission is that the original answer notes the PW800 also powers the G400 and G600, which the LLM answer leaves out—this does not detract significantly from the core reasoning but slightly reduces completeness. The multi-hop reasoning (linking engine exclusivity to strategic positioning) is sound and well-articulated. Contextual relevance is perfect, directly addressing the strategic rationale behind the engine-airframe choice.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 347,
        "total_tokens": 1625
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the voting power distribution in META's dual-class structure compare to CMCSA's, particularly regarding the non-dilutable provisions under their respective articles of incorporation and the specific voting percentages allocated to Class A and Class B shareholders?",
      "original_answer": "META's Class B common stock is not publicly traded and as of December 31, 2023, there were only 23 stockholders of record of Class B common stock, suggesting concentrated voting control. In contrast, CMCSA explicitly states that holders of Class A common stock hold 66 2/3% of the combined voting power, while Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power. CMCSA's Class B common stock has 15 votes per share and its non-dilutable nature is specifically tied to the terms of its articles of incorporation, which preserves the voting power percentage regardless of additional Class A share issuances.",
      "llm_answer": "Meta’s dual‑class structure gives each Class A share one vote and each Class B share ten votes; with 2,211 million Class A shares and 350 million Class B shares outstanding, Class B holders control roughly 61 % of the total voting power (≈3.5 billion votes) and Class A about 39 % (≈2.2 billion votes) (see page 120). The Meta filing excerpt does not call out a non‑dilutable clause, but the super‑voting Class B shares concentrate control. In contrast, Comcast’s Class B shares carry 15 votes each and represent about one‑third (33 %) of voting power, while Class A shares carry one vote and represent about two‑thirds (67 %) of voting power, and Comcast’s articles of incorporation expressly state that the Class B voting power is generally non‑dilutable (see page 33).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the voting power distribution for CMCSA (Class A: ~67%, Class B: ~33%) and notes the non-dilutable provision in its articles of incorporation, which aligns with the ground truth. However, for META, the LLM provides specific share counts (2,211 million Class A, 350 million Class B) and calculates voting power (61% for Class B, 39% for Class A), which are not present in the original answer and appear to be fabricated or inferred from external data not in the knowledge graph. The ground truth only states that Class B has concentrated control with 23 stockholders of record as of December 31, 2023, but does not provide share counts or exact voting percentages. Thus, the quantitative details for META are unsupported and incorrect. (2) The calculation of voting power (3.5 billion vs 2.2 billion votes) assumes 10 votes per Class B share and 1 vote per Class A, which may be accurate in general but is not confirmed in the provided ground truth, making this an unsupported inference. The ground truth does not specify vote multiples for META’s classes. (3) The multi-hop reasoning is sound in comparing the two companies’ structures and correctly identifying CMCSA’s non-dilutable clause and vote allocation. It also correctly contrasts META’s lack of an explicit non-dilutable clause. However, the synthesis for META relies on extraneous numerical data not present in the ground truth, undermining factual accuracy. (4) Despite the incorrect numbers, the qualitative comparison—concentrated control in META vs. fixed 66.6%/33.3% split in CMCSA with non-dilutable provisions—is conceptually correct. The answer is contextually relevant and addresses all parts of the question, but the inclusion of fabricated quantitative data reduces the correctness and quantitative accuracy scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 498,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the risk of losing market exclusivity due to patent challenges for BMY's Revlimid in Europe compare to LLY's reliance on data protection for orphan drug designations, given that both companies depend on intellectual property frameworks to extend commercial exclusivity?",
      "original_answer": "BMY faces earlier-than-expected market exclusivity loss for Revlimid in Europe due to patent settlements allowing generic entry in the UK starting January 18, 2022, and in other European countries beginning February 18, 2022. This highlights the vulnerability of market exclusivity when patent rights are challenged or settled. In contrast, LLY leverages regulatory data protection, including orphan drug designations that provide seven years of market exclusivity independent of patent expiration. While BMY's exclusivity is determined largely by patent rights and settlements, LLY benefits from parallel regulatory protections that do not rely solely on patent enforcement, especially in markets where orphan designations apply.",
      "llm_answer": "BMY warns that Revlimid’s European exclusivity could evaporate quickly because patent settlements may permit generic entry in the United Kingdom on Jan 18 2022 and in other EU countries on Feb 18 2022, exposing the product to loss of market protection well before its patents expire (see page 36). In contrast, LLY’s strategy depends on regulatory data‑package protection that, under orphan‑drug law, provides a statutory exclusivity period (seven years in the U.S. and up to ten years of data protection in Europe) and is therefore less vulnerable to direct patent challenges, though it still relies on the continued integrity of data‑protection rules (see page 10). Thus BMY faces a more immediate, litigation‑driven risk of losing exclusivity, while LLY’s risk is tied to the regulatory data‑protection framework for orphan drugs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates (Jan 18, 2022, and Feb 18, 2022) are correct, and the mention of seven years of U.S. orphan exclusivity and up to ten years in Europe is factually consistent with regulatory frameworks, even though the original answer only specified seven years. This additional detail does not contradict but rather complements the ground truth. (2) The entities—BMY (Bristol Myers Squibb), LLY (Eli Lilly), Revlimid, and the distinction between patent-based and regulatory data protection—are correctly identified and contrasted. (3) The reasoning is sound: the LLM correctly synthesizes the multi-hop concept that BMY’s risk stems from patent settlements enabling early generic entry in Europe, while LLY relies on regulatory orphan drug exclusivity that is structurally more insulated from patent challenges. (4) The answer is contextually relevant, directly addressing the comparative risk profile based on differing IP strategies. The only minor shortcoming is that the original answer emphasizes orphan exclusivity in Europe (seven years), while the LLM mentions ten years in Europe—this is technically accurate for EU data protection for orphan drugs but slightly over-specified compared to the ground truth’s focus. This does not constitute an error but adds nuance. Overall, the answer is factually correct, well-reasoned, and complete, warranting a 9/10 due to slight over-elaboration without contradiction.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 413,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 66,
      "question": "How does the sensitivity of MS's asset management revenues to fixed income market fluctuations compare with PYPL's exposure to market risk through its use of pricing models for derivatives and debt securities?",
      "original_answer": "MS's asset management revenues are sensitive to changes in fixed income markets due to their reliance on fee-based client assets, which include fixed income investments valued using pricing models with observable market data like interest rates and credit spreads. MS specifically notes that revenues may not fully correlate with market changes due to factors like client behavior and asset mix. Meanwhile, PYPL also depends on pricing models for valuing its derivatives and available-for-sale debt securities, using observable inputs such as currency rates, interest rate yield curves, and equity prices. However, unlike MS, PYPL has elected the fair value option for foreign currency-denominated debt securities, directly tying gains and losses to market fluctuations. Both firms face market risk through their use of pricing models, but MS's exposure is more indirect through asset management fees, while PYPL's is direct through its investment and derivative valuations.",
      "llm_answer": "Morgan Stanley says that a portion of its Wealth‑Management and Investment‑Management fees are tied to client holdings that include fixed‑income assets, so a downturn in fixed‑income markets can reduce fee revenue, although the effect “may not correlate completely with changes in the related markets” (MS 10‑K p. 62). PayPal’s market‑risk exposure is more direct: it values most of its derivatives and debt securities with pricing models that use observable market inputs, and changes in those inputs generate unrealized gains or losses that flow through earnings and other‑comprehensive‑income (PYPL 10‑K p. 93, 97).  Thus, MS’s sensitivity is an indirect revenue impact from fixed‑income market moves, whereas PayPal’s exposure is a direct valuation‑model‑driven market‑risk effect.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core distinction between MS's indirect sensitivity to fixed income market fluctuations through asset management fees and PYPL's direct exposure via fair value changes in derivatives and debt securities. (1) All factual elements are correct: MS’s fee-based revenue model tied to client assets including fixed income, the non-linear correlation due to client behavior and asset mix, and PYPL’s use of observable inputs in pricing models for derivatives and debt securities are all correctly represented. The LLM correctly notes that PYPL recognizes unrealized gains/losses in earnings and other comprehensive income, reflecting its fair value option election, which aligns with the ground truth. (2) There are no numerical values, dates, or percentages in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect figures or miscalculations supports a score of 10. (3) The multi-hop reasoning is sound: the model synthesizes information from both MS and PYPL 10-Ks, compares their risk exposures, and correctly distinguishes indirect revenue sensitivity (MS) from direct valuation impact (PYPL). The only minor shortcoming is that the LLM does not explicitly mention PYPL’s election of the fair value option for foreign currency-denominated debt securities—a key nuance in the ground truth—but it does convey the outcome (direct market impact on earnings), so this is a slight omission rather than an error. (4) The answer is fully contextually relevant, directly addressing the comparative structure of the question and providing a clear, concise contrast between the two firms’ market risk profiles.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1455,
        "completion_tokens": 466,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 67,
      "question": "How do Oracle's integration of generative AI in MySQL HeatWave and Qualcomm's investment in IoT applications reflect their respective strategies for on-device AI processing in enterprise and consumer markets?",
      "original_answer": "Oracle integrates generative AI into Oracle MySQL HeatWave, offering it as a managed cloud service that combines transactions, real-time analytics, machine learning, and generative AI capabilities. This enables enterprise customers to deploy AI-driven analytics and applications more efficiently. In contrast, Qualcomm is investing heavily in expanding generative AI into IoT and edge devices, projecting that 46% of smartphones sold in 2027 will be generative AI capable, up from 19% in 2024. Qualcomm’s QCT segment develops integrated circuits for IoT applications, including consumer electronics, industrial devices, and edge networking products, emphasizing on-device processing for immediacy, privacy, and personalization. While Oracle focuses on cloud-native AI integration for enterprise database workloads, Qualcomm is driving AI capabilities into edge devices across multiple industries, particularly IoT, to capitalize on the growing demand for on-device intelligence.",
      "llm_answer": "Oracle is embedding generative‑AI functions directly into its MySQL HeatWave service – a managed OCI database that “combines transactions, real‑time analytics, machine learning and generative AI in one managed cloud service” (ORCL 12) – so that enterprise customers can run AI‑driven analytics and inference inside the database itself rather than sending data to a separate cloud model. Qualcomm, by contrast, is pouring resources into AI‑enabled IoT products, highlighting its “AI Engine” and Hexagon NPU that deliver “high‑performance and low‑power on‑device” AI (QCOM 9) and stating that “generative AI … must run on‑device … to maximize utility … in IoT …” (QCOM 7). Together, Oracle’s approach reflects an enterprise‑focused strategy of integrating AI at the data‑service layer, while Qualcomm’s strategy emphasizes pushing generative AI onto edge and consumer IoT devices for low‑latency, privacy‑preserving processing.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Oracle integrates generative AI into MySQL HeatWave as a managed cloud service combining transactions, analytics, ML, and AI—enabling enterprise AI-driven analytics within the database. Qualcomm is investing in on-device generative AI for IoT and edge devices, emphasizing its AI Engine and Hexagon NPU for low-power, high-performance processing. The core strategies—Oracle’s cloud-native enterprise focus vs. Qualcomm’s edge and consumer IoT focus—are correctly contrasted. (2) Quantitative accuracy is perfect: while the original answer includes specific projections (19% of smartphones in 2024 and 46% in 2027 being generative AI capable), the LLM answer does not mention these numbers but does not contradict them either. Since the LLM response omits these figures but doesn’t make any false claims, this is a minor omission rather than an error. (3) Multi-hop reasoning is sound: the model correctly synthesizes Oracle’s enterprise cloud strategy and Qualcomm’s edge/IoT strategy from distinct domains and contrasts them appropriately. (4) Semantic equivalence is strong—wording differs (e.g., 'on-device processing' vs. 'run on-device to maximize utility') but meaning is preserved. The only reason for not scoring a 10 is the omission of the specific smartphone AI adoption percentages, which were present in the ground truth and would have strengthened quantitative completeness. However, since the question does not explicitly ask for statistics, this is not a critical gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1491,
        "completion_tokens": 435,
        "total_tokens": 1926
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How might the compliance costs associated with the EU AI Act, which Adobe anticipates will require costly changes to its AI development practices, affect its competitive positioning against Salesforce, which relies heavily on its AI-powered Agentforce platform for sales and service offerings?",
      "original_answer": "Adobe anticipates that the EU AI Act, which will be implemented in phases through 2030, may require costly changes to its AI development practices, including delays or halts in development, changes to monetization strategies, and increased compliance costs. Meanwhile, Salesforce relies heavily on its AI-powered Agentforce platform across sales, service, and marketing offerings to drive productivity and growth. If Adobe is forced to divert resources to comply with the new regulations, it could slow the pace of its AI innovation, potentially giving Salesforce a competitive edge through its more established and integrated AI capabilities like Agentforce for Sales and Service. The GS_10k_2024 chunk reinforces that evolving AI regulations increase compliance costs and operational risks for companies relying on AI, suggesting both firms face similar pressures, but Salesforce’s deeper integration of AI across its platform may make it better positioned to absorb such regulatory changes.",
      "llm_answer": "Adobe cautions that the EU AI Act will likely raise its compliance, governance and R&D expenses and could force costly changes to its AI‑development practices (see page 23). Those added costs could slow Adobe’s AI innovation and limit pricing flexibility, leaving it at a disadvantage to Salesforce, whose AI‑powered Agentforce platform already fuels sales‑ and service‑productivity and faces fewer immediate regulatory cost pressures (see page 6; also note Salesforce’s broader regulatory exposure in page 30).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Adobe anticipates increased compliance, governance, and R&D costs due to the EU AI Act, which may slow innovation. Salesforce’s Agentforce platform is correctly identified as a key AI-driven asset in sales and service. The LLM correctly references regulatory cost pressures and differential impacts, citing appropriate page numbers (23, 6, 30), though these are assumed accurate per context. (2) There are no numeric values (dates, dollar amounts, percentages) in either answer, so quantitative accuracy is not compromised—score is 10 by default. (3) The multi-hop reasoning is sound: the model connects Adobe’s anticipated compliance burden with potential innovation slowdown and contrasts it with Salesforce’s established AI integration via Agentforce, concluding a possible competitive disadvantage. This synthesis across companies and regulatory impact is logically valid. The only minor shortcoming is that the original answer notes the EU AI Act’s phased implementation through 2030 and Salesforce’s similar exposure to regulatory risks (per GS_10k_2024), which the LLM omits. However, the core competitive dynamic is preserved. (4) Contextual relevance is perfect—the response directly addresses how compliance costs might affect Adobe’s competitive positioning against Salesforce in AI, using accurate entities and causal logic. Minor omission of the 2030 timeline and shared regulatory risks prevents a perfect 10, but the answer remains substantially correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1412,
        "completion_tokens": 436,
        "total_tokens": 1848
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does the payout structure of HD's deferred shares, which includes dividend equivalents paid in additional shares, compare with LOW's receipt of additional shares through ASR agreements, in terms of stock-based value distribution to stakeholders?",
      "original_answer": "HD issues additional shares as dividend equivalents to non-employee directors upon the payout of deferred shares following termination of service, based on accrued dividends. This represents a stock-based compensation mechanism tied to director retention and long-term alignment. In contrast, LOW receives additional shares from third-party financial institutions as part of variable notional ASR agreements, which are tied to repurchase efficiency and final notional value calculations. These additional shares in LOW's case are not compensation-related but are part of capital return strategy execution. Both companies issue additional shares, but the context, stakeholders, and triggers differ significantly, reflecting distinct financial strategies.",
      "llm_answer": "HD’s deferred‑share awards give each non‑employee director a share that vests when his or her board service ends, and the awards also accrue dividend equivalents that are paid out as **additional shares of stock** at the time of payout (see HD 10‑K p. 68). In contrast, Lowe’s ASR transactions are a corporate‑level financing tool: the company pays a maximum notional amount up‑front, receives an initial block of shares, and at settlement **receives extra shares (and cash)** from the counter‑party equal to the difference between the pre‑payment and the final notional amount (see Lowe’s 10‑K p. 62). Thus HD distributes stock‑based value directly to individual directors, whereas Lowe’s ASRs add shares to the company’s treasury for repurchase or other shareholder‑benefiting uses.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that HD issues additional shares as dividend equivalents to non-employee directors upon payout of deferred shares, tied to accrued dividends, and cites the correct page (p.68) from HD's 10-K. This matches the original answer’s description of a stock-based compensation mechanism for directors. (2) It accurately describes LOW’s ASR agreements: up-front payment, initial share delivery, and receipt of additional shares (and cash) at settlement based on final notional value, citing Lowe’s 10-K p.62. The characterization of ASRs as a capital return tool that increases treasury shares for shareholder benefit is consistent with the ground truth’s emphasis on repurchase efficiency and non-compensation purpose. (3) The multi-hop reasoning is sound—correctly contrasting HD’s stakeholder-specific compensation mechanism with LOW’s corporate-level capital return strategy. The only minor omission is not explicitly stating that LOW’s additional shares go to the company (not external stakeholders), but this is implied by 'adds shares to the company’s treasury'. (4) All entities (HD, LOW, non-employee directors, third-party counterparties), financial instruments (deferred shares, ASRs), and mechanisms (dividend equivalents, notional calculations) are correctly identified. No numerical inaccuracies; no calculations required. Wording differs slightly but maintains semantic equivalence. Thus, the answer is factually complete and contextually precise, warranting a 9/10 for correctness (perfect but slightly less explicit than ground truth on stakeholder distinction).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 455,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 68,
      "question": "How does AT&T's adoption of ASU 2020-04, which facilitates contract modifications triggered by reference rate reform, compare to Verizon's disclosure of contract modifications in terms of impact on their respective revenue recognition timing and contract performance obligations?",
      "original_answer": "AT&T adopted ASU 2020-04, which provides optional expedients for contract modifications triggered by reference rate reform (e.g., LIBOR transition), and stated that the adoption did not materially impact its financial statements. Meanwhile, Verizon disclosed that contract modifications affect the timing and scope of performance obligations, with $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond, respectively. The connection through ASU 2020-04 to contract modifications shows that while AT&T experienced minimal financial impact from reference rate-related modifications, Verizon's broader contract modification landscape significantly influences its future revenue recognition patterns.",
      "llm_answer": "AT&T notes that its adoption of ASU 2020‑04 – which provides optional expedients for contract modifications tied to reference‑rate reform – “does not materially impact our financial statements” (page 53), implying no material shift in when revenue is recognized or how performance obligations are measured. By contrast, Verizon explicitly discloses that contract modifications can alter the timing and scope of its obligations, affecting the amount of transaction price allocated to unsatisfied performance obligations and therefore the timing of revenue recognition (page 67).",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AT&T's adoption of ASU 2020-04 and its statement that the impact was not material, which aligns with the ground truth. It also accurately captures Verizon's disclosure that contract modifications affect the timing and scope of performance obligations and revenue recognition. However, the LLM answer omits all quantitative figures provided in the ground truth—specifically, Verizon's $25.7 billion, $18.7 billion, and $7.5 billion expected to be recognized in 2024, 2025, and beyond—making it significantly incomplete in terms of numerical accuracy. (2) These dollar amounts are critical to the question’s focus on 'impact on revenue recognition timing' and are explicitly part of the ground truth; their absence constitutes a major quantitative omission. While no incorrect numbers are stated (none are given at all), the failure to include these key figures results in a low quantitative accuracy score. (3) The multi-hop reasoning is otherwise sound: the model correctly contrasts AT&T’s minimal impact with Verizon’s more significant contractual effects, synthesizing information across both companies and linking ASU 2020-04 to revenue recognition implications. The logic and entity identification (AT&T, Verizon, ASU 2020-04, contract modifications, performance obligations) are accurate. (4) The contextual relevance is perfect—the answer directly addresses the comparison asked in the question. The qualitative accuracy is high due to correct reasoning and terminology, but the correctness score is limited to 7 because the missing quantitative data prevents full factual completeness, despite no explicit errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 457,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How do Union Pacific's and Lockheed Martin's pension plan disclosures reflect differences in their reliance on Level 2 valuation methodologies for municipal bonds, and what does this imply about their adherence to ASC 820 fair value measurement standards?",
      "original_answer": "Union Pacific discloses that its pension plan classifies municipal bonds as Level 2 investments, which are valued using a bid evaluation process with bid data from independent pricing sources. Lockheed Martin's pension plan also discloses the use of Level 2 valuation methodologies for fixed income securities, where indicative quotes from pricing vendors are used if corroborated. UPS's filing explicitly confirms that municipal bonds fall under Level 2, valued via market-corroborated pricing or matrix pricing models using observable inputs like yield curves. The alignment in Level 2 classification for these instruments suggests both companies are applying ASC 820 consistently for fair value measurements, though UNP provides more specificity regarding municipal bonds, while LMT focuses on general fixed income treatment.",
      "llm_answer": "Union Pacific’s 2023 pension‑plan note explicitly places state‑ and local‑government (municipal) bonds in the Level 2 tier of the ASC 820 fair‑value hierarchy, indicating they are valued with observable market inputs such as yield curves and credit spreads (UNP p. 57). Lockheed Martin’s pension‑plan fair‑value table, however, lists only corporate debt, government‑secured and other fixed‑income assets and provides no separate municipal‑bond line, so its Level 2 reliance is limited to those other securities (LMT p. 87). Both firms therefore satisfy ASC 820 by disclosing the hierarchy and using observable inputs where required, but Union Pacific shows a more direct reliance on Level 2 methods for municipal‑bond holdings than Lockheed Martin.",
      "correctness_score": 5,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but diverges significantly from the ground truth in key aspects of entity accuracy and reasoning. (1) Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are provided in either answer, so there are no numeric inaccuracies—format and references to pages (UNP p.57, LMT p.87) are plausible and do not contradict the knowledge graph, earning a high quantitative score. (2) However, the LLM incorrectly asserts that Lockheed Martin does not separately disclose municipal bonds in its Level 2 valuation, claiming LMT only lists corporate debt and other fixed income. The ground truth states that LMT does use Level 2 methodologies for fixed income securities with indicative quotes from pricing vendors when corroborated, and while it may not single out municipal bonds explicitly, it does not exclude them—implying they are likely included within broader fixed income categories. The LLM overinterprets the absence of a separate line item as absence of inclusion, which is a flawed inference under ASC 820 disclosure practices. (3) This reflects a breakdown in multi-hop reasoning: the question asks how disclosures reflect differences in reliance on Level 2 methods, but the LLM concludes a difference in actual reliance based solely on presentation format, whereas the ground truth emphasizes that both companies apply Level 2 methodologies consistently under ASC 820, with only differences in specificity. (4) The original answer highlights alignment in ASC 820 application, while the LLM implies a divergence in practice, which is not supported. Thus, while the answer is contextually relevant and well-structured, it misrepresents the qualitative comparison and fails to recognize that disclosure granularity does not necessarily reflect differences in valuation methodology adherence. Hence, correctness and qualitative accuracy are moderate due to significant reasoning errors despite accurate use of terminology and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 537,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 69,
      "question": "How does KO's reliance on Coca-Cola FEMSA for distribution in Argentina compare to MDLZ's exposure to economic volatility in the same market, given Coca-Cola FEMSA's specific operational footprint and MDLZ's inflation-related financial impacts?",
      "original_answer": "KO relies on Coca-Cola FEMSA for distribution in parts of Argentina, specifically the federal capital of Buenos Aires and surrounding areas, as part of its broader network of equity method investees to whom it sold $14.471 billion in net sales in 2021. Coca-Cola FEMSA operates in Argentina, a market that has been classified as highly inflationary since mid-2018, which directly affects MDLZ’s operations there. MDLZ reported a $13 million remeasurement loss in 2021 due to the volatility of the Argentine peso, with Argentina contributing $401 million (1.4%) to MDLZ’s consolidated net revenues. This highlights how both companies are exposed to Argentina, but through different mechanisms: KO through a distribution dependency and MDLZ through direct financial exposure to currency and inflation risks.",
      "llm_answer": "KO’s Argentine sales are routed through its largest bottling partner, Coca‑Cola FEMSA, which only handles the federal capital of Buenos Aires and the surrounding area (KO 10‑K page 7 lists FEMSA’s footprint in Argentina). By contrast, Mondelēz International notes that Argentina’s hyper‑inflation directly hits its own balance sheet—creating remeasurement losses and higher costs that make the company vulnerable to the country’s economic volatility (MDLZ 10‑K inflation discussion). Thus KO’s risk is indirect and tied to a single bottler’s limited territory, whereas MDLZ bears direct macro‑economic exposure to Argentina’s inflationary environment.",
      "correctness_score": 9,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between KO's indirect distribution reliance on Coca-Cola FEMSA and MDLZ's direct financial exposure to Argentina's inflation. It correctly identifies that Coca-Cola FEMSA operates only in Buenos Aires and surrounding areas, aligning with the ground truth. It also accurately notes MDLZ's exposure to hyperinflation and remeasurement losses, though it omits the specific $13 million loss and $401 million revenue contribution (1.4%) figures from the original answer, which are key quantitative details. While the term 'hyper-inflation' is used instead of 'highly inflationary' (a minor semantic difference), the financial mechanism described—remeasurement losses due to peso volatility—is correctly attributed to MDLZ. The reasoning is sound: it synthesizes information across KO’s and MDLZ’s 10-Ks to contrast indirect vs. direct exposure. The absence of exact dollar amounts and percentage reduces quantitative precision slightly, but the qualitative and contextual accuracy remains strong. All entities (KO, MDLZ, Coca-Cola FEMSA), markets (Argentina), and mechanisms (distribution dependency vs. currency risk) are correctly identified and logically compared.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 343,
        "total_tokens": 1731
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the voting rights structure of META's Class B common stock influence its shareholder equity strategy compared to Alphabet's dual-class stock framework, particularly in light of Alphabet's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "META's Class B common stock grants 10 votes per share, compared to 1 vote per share for Class A, giving certain shareholders disproportionate voting power. Similarly, Alphabet follows a dual-class structure where Class B shares also carry 10 votes each, while Class A shares have one vote, and Class C shares have no voting rights. In 2024, Alphabet repurchased $62.0 billion of its Class A and Class C shares, prioritizing repurchases based on economic cost and market conditions. This suggests that both companies maintain strategic flexibility in managing shareholder equity by leveraging their dual-class structures to preserve voting control while repurchasing shares to enhance shareholder value.",
      "llm_answer": "Meta’s Class B common stock carries ten votes per share, concentrating voting power in the hands of insiders (the 2025 filing shows 343 million Class B shares outstanding 【page_1】). In contrast, Alphabet separates voting (Class A = 1 vote) and non‑voting (Class C = 0 votes) equity, and it used a $62.0 billion share‑repurchase program in 2024 to buy back both Class A and Class C shares while retaining control through its undisclosed Class B shares 【page_82】. Thus, Meta’s high‑voting Class B structure steers its equity strategy toward long‑term, insider‑driven decisions rather than large buy‑backs, whereas Alphabet’s dual‑class framework supports aggressive buy‑backs to return capital to all shareholders while preserving control.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "1) The LLM answer correctly identifies the voting rights structure for both Meta and Alphabet, with accurate vote allocations: Meta Class B has 10 votes per share (vs. 1 for Class A), and Alphabet Class A has 1 vote, Class C has 0 votes, with Class B holding 10 votes (though not explicitly stated, it's implied by context). The $62.0 billion share repurchase by Alphabet in 2024 is accurately reported, matching the ground truth in amount, year, and targeted share classes (Class A and C). These quantitative elements are fully correct.\n\n2) Quantitative accuracy is perfect: all numbers (343 million shares, $62.0 billion, 10 votes, 1 vote, 0 votes) are correctly stated or logically inferred. No calculation errors.\n\n3) However, the qualitative reasoning introduces a speculative distinction not present in the ground truth: the claim that Meta's structure 'steers its equity strategy toward long-term, insider-driven decisions rather than large buy-backs' is an interpretation not supported by the original answer. The ground truth does not compare the scale or preference for buybacks between Meta and Alphabet, nor does it suggest Meta avoids large buybacks due to its structure. This misrepresents the strategic implication. The original answer emphasizes that both companies use dual-class structures to preserve control while using repurchases to enhance shareholder value—highlighting similarity, not contrast.\n\n4) The LLM answer synthesizes information across entities (Meta and Alphabet) and correctly references multi-hop elements (voting rights, share repurchases, control preservation). However, the reasoning diverges by framing the strategies as contrasting rather than parallel, which undermines the qualitative accuracy. The contextual relevance remains high because the answer addresses all components of the question and uses appropriate financial concepts.\n\nOverall, the answer is factually sound on numbers and entities but introduces an unsupported strategic contrast, reducing the correctness score to 7.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1391,
        "completion_tokens": 545,
        "total_tokens": 1936
      },
      "error": null
    },
    {
      "question_id": 70,
      "question": "How does the decline in GILD's Veklury sales in 2024, influenced by the availability of alternative treatments, compare to the negative impact AMGN reports from alternative treatments in competitive therapeutic markets?",
      "original_answer": "GILD reported that Veklury sales in 2024 were $1,799 million globally, a decline from $2,184 million in 2023, attributed to reduced demand linked to the availability and uptake of alternative treatments for COVID-19. This reflects a direct impact on revenue due to competitive therapeutic options. Similarly, AMGN notes that in competitive treatment markets such as those for ENBREL, Otezla, Repatha, and Aimovig, payers and PBMs are increasingly using formulary restrictions and cost-containment measures to shift patients toward alternative treatments, which has limited Amgen's product usage and sales. Both companies experience revenue pressure from alternative treatments, though GILD’s impact is more directly tied to pandemic-related dynamics, while AMGN faces systemic payer-driven shifts in competitive markets.",
      "llm_answer": "Gilead’s Veklury revenue fell from $2.184 billion in 2023 to $1.799 billion in 2024 – a drop of roughly $385 million (about an 18 % decline) that the company attributes to the “availability, uptake and effectiveness of vaccines and alternative treatments for COVID‑19” (see GILD 10‑K p. 66 and p. 19). Amgen, by contrast, describes a broader, qualitative hit: in its highly competitive markets (e.g., ENBREL, Otezla, Repatha, Aimovig), “the use of … stricter utilization criteria … and formulary exclusion … in favor of competitor drugs or alternative treatments” has “limited Amgen product usage and sales,” but it does not quantify the loss (see Amgen 10‑K p. 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth. (1) Quantitatively, all numbers are correct: Veklury sales declined from $2.184 billion in 2023 to $1.799 billion in 2024, a difference of $385 million (~18% decline), which aligns with the original answer. The formatting variation ($2.184 billion vs $2,184 million) is acceptable. (2) The LLM correctly identifies GILD’s attribution of the decline to alternative treatments and vaccines, citing the correct context from the 10-K. (3) For AMGN, the LLM accurately summarizes the qualitative impact of formulary restrictions and utilization management favoring alternative treatments in competitive markets (ENBREL, Otezla, Repatha, Aimovig), and correctly notes that Amgen does not quantify the financial impact—this matches the original answer’s emphasis on systemic, payer-driven shifts. (4) The multi-hop reasoning is sound: the model compares a quantified revenue decline (GILD) with a non-quantified but structurally similar challenge (AMGN), highlighting the difference in nature (pandemic-specific vs. systemic therapeutic competition). The only minor shortcoming is a slight omission of the explicit comparison in the original answer that both face revenue pressure, though this is implied. Wording differs but semantic equivalence is preserved. All entities, years, and metrics are correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 379,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How does AMD's interest payment schedule on its $312 million 7.50% Senior Notes compare with QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes, particularly in terms of payment frequency and fiscal year obligations?",
      "original_answer": "AMD's $312 million 7.50% Senior Notes require semi-annual interest payments on February 15 and August 15 of each year, as stated in the indenture governing the notes. In contrast, QCOM's interest payment structure on its $14.0 billion aggregate fair value of notes includes semi-annual payments for fixed-rate notes and quarterly payments for floating-rate notes. While AMD's interest obligations are tied to a specific fixed schedule with a final maturity in fiscal 2022, QCOM has significant upcoming principal payments starting in fiscal 2023 ($1.4 billion) and continuing through future fiscal years, with no principal due in fiscal 2026.",
      "llm_answer": "AMD’s $312 million 7.50 % senior notes pay interest **semi‑annually** – on February 15 and August 15 each year – and the entire principal is scheduled to be repaid in fiscal 2022 (the only debt‑payment obligation listed for 2022)【page_66】. Qualcomm’s $14.0 billion of notes (fair‑value) have interest **paid quarterly** on the floating‑rate portion and **semi‑annually** on the fixed‑rate portion, and their principal is amortized over multiple fiscal years (e.g., $1.4 billion in FY 2023, $914 million in FY 2024, $1.4 billion in FY 2025, $2.0 billion in FY 2027 and the remainder thereafter)【page_79】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers, dates, and amounts are correct: AMD's semi-annual interest payments on February 15 and August 15 are correctly stated, as is the fiscal 2022 principal repayment. For QCOM, the $14.0 billion aggregate fair value is accurately noted, and the interest payment structure—semi-annual for fixed-rate and quarterly for floating-rate notes—is correctly described. The principal amortization schedule ($1.4B in FY2023, $914M in FY2024, etc.) matches the knowledge graph, and the absence of FY2026 principal is implied by the listed years. (2) The answer correctly identifies both companies (AMD and QCOM), financial instruments, and fiscal years, with no entity errors. (3) Multi-hop reasoning is sound: the model synthesizes payment frequency and fiscal obligations across two different companies and debt structures, directly addressing the comparison asked. (4) The only minor shortcoming is that the original answer explicitly notes QCOM has 'no principal due in fiscal 2026,' which the LLM omits—though this is inferable from the listed payments. This small omission prevents a perfect 10 on qualitative accuracy, but factual and quantitative precision is complete. Wording differs slightly but maintains semantic equivalence. Overall, the response is factually correct, comprehensive, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 391,
        "total_tokens": 1728
      },
      "error": null
    },
    {
      "question_id": 71,
      "question": "How might the impending loss of U.S. patent protection for Prolia/XGEVA in February 2025 impact Merck's competitive position, given its reliance on strong patent rights to defend against generic competition and Amgen's own exposure to biosimilar threats in international markets?",
      "original_answer": "The loss of U.S. patent protection for Prolia/XGEVA in February 2025 will likely expose Amgen's product to biosimilar competition, reducing its market exclusivity and potentially decreasing revenue. This dynamic is particularly relevant for Merck, which emphasizes its reliance on strong patent rights to protect its portfolio from generic challenges. Given Merck's acknowledgment of increased global pricing pressure and weakened patent protection in international markets, the erosion of exclusivity for key competitors like Prolia/XGEVA could intensify biosimilar threats across markets, thereby indirectly affecting Merck’s own competitive strategy and market positioning in the therapeutic category.",
      "llm_answer": "The U.S. patents covering Merck’s denosumab products (Prolia/XGEVA) expire in February 2025, removing a key barrier that the company relies on to fend off generic competition and protect pricing power (Merck 10‑K p. 11; p. 33). At the same time, Amgen’s own Prolia/XGEVA patents also lapse in 2025 and biosimilars are already approved in Asia‑Pacific and under review in the U.S. and Europe, so the loss of exclusivity will intensify market‑wide price pressure and erode Merck’s competitive advantage both domestically and internationally (Amgen 10‑K p. 10; p. 15).",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error: Prolia/XGEVA are Amgen's products, not Merck's. The LLM incorrectly states that 'Merck’s denosumab products (Prolia/XGEVA)' exist, which is false—Merck does not own or market Prolia/XGEVA. This misattribution undermines the entire reasoning chain. (2) Quantitatively, the February 2025 patent expiration date is correct and aligns with the ground truth. However, the claim about biosimilars 'already approved in Asia-Pacific and under review in the U.S. and Europe' is not present in the original answer and cannot be verified from the provided ground truth, introducing unsupported details. (3) The multi-hop reasoning is flawed due to the incorrect assignment of product ownership. The original answer correctly frames the situation as Amgen losing patent protection, which indirectly affects Merck’s competitive environment. The LLM instead suggests Merck is losing protection on these drugs, which reverses the cause-effect relationship and misrepresents Merck’s exposure. (4) Despite the major factual error, the answer captures the broader context—increased biosimilar competition, market-wide price pressure, and implications for companies reliant on patent protection—so it retains some contextual relevance. However, the core entity confusion (Merck vs. Amgen) severely limits factual correctness and reasoning quality.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1350,
        "completion_tokens": 387,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "What portion of Broadcom's VMware Cloud Foundation revenue in fiscal year 2024 was directly tied to enabling AI workloads, and how does this align with Cisco's strategic focus on providing infrastructure for AI training and inference?",
      "original_answer": "In fiscal year 2024, $1,380 million of Broadcom's $2,900 million VMware Cloud Foundation revenue was recognized, and this platform specifically enables advanced AI and machine learning workloads at enterprise scale. This aligns with Cisco's strategic focus on providing network infrastructure to power AI training and inference workloads through high-density routers and switches, improved network management, and high-performance optics, as stated in their 2024 10-K filing.",
      "llm_answer": "Broadcom’s 2024 filing does not break out a separate amount of VMware Cloud Foundation (VCF) revenue that is attributable specifically to AI workloads – the only reference is that VCF “enables advanced AI and machine‑learning workloads at enterprise scale” (AVGO page 8), but no AI‑only revenue figure is disclosed. Cisco, by contrast, states that its strategy is to “provide network infrastructure to power AI training and inference workloads for both web‑scalers and enterprises” (CSCO page 4). Thus, while Broadcom’s AI‑related VCF revenue is not quantified, both companies are targeting the same AI market, with Broadcom offering a software platform that supports AI and Cisco focusing on the underlying networking infrastructure for AI training and inference.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is factually incorrect in asserting that Broadcom's 2024 filing does not break out AI-related VMware Cloud Foundation revenue. The ground truth states that $1,380 million of the $2,900 million VMware Cloud Foundation revenue was directly tied to enabling AI workloads, which is a specific quantitative disclosure. The LLM incorrectly concludes no such figure is provided, contradicting the original answer derived from the knowledge graph. (2) Quantitative accuracy is severely lacking: the correct figures ($1,380 million and $2,900 million) are entirely omitted and replaced with a claim of non-disclosure. This is a critical error, as the question hinges on a specific financial figure. (3) While the LLM correctly identifies Cisco's strategic focus on AI infrastructure from its 10-K, and notes the complementary nature of Broadcom’s software platform and Cisco’s networking infrastructure, it fails the multi-hop synthesis by not connecting the disclosed $1.38B AI-related revenue to Cisco’s parallel strategy. The reasoning is sound in structure but based on a false premise regarding data availability. (4) Contextual relevance is high because the response addresses both companies and the AI infrastructure alignment, but correctness score is low due to the central factual inaccuracy about revenue disclosure. The answer would have been strong if it had accurately reported the $1.38B figure and linked it to Cisco’s strategy as the ground truth does.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 411,
        "total_tokens": 1743
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the $1,851 million in assets from NEE's consolidated solar VIEs compare to Southern Power's exposure through PPAs accounted for as operating leases, given both entities operate solar facilities under long-term power sales agreements?",
      "original_answer": "NEE consolidates solar VIEs with approximately $1,851 million in assets at year-end 2021, which sell electricity under long-term PPAs expiring between 2035 and 2052. Southern Power, a subsidiary of SO, operates PPAs related to solar facilities accounted for as operating leases with remaining terms of up to 25 years. While NEE's VIEs directly own the solar assets and bear construction and operational risk, Southern Power's exposure is structured as lessor under operating leases, receiving lease payments tied to energy production. Both entities demonstrate significant long-term commitments to solar generation through contractual arrangements, though NEE holds direct ownership and asset risk while SO participates through lease financing structures.",
      "llm_answer": "NEE’s eight consolidated solar VIEs carried about **$1,851 million of assets** at year‑end 2021 (with $1,258 million of liabilities)【page_97】.  By contrast, Southern Power’s exposure to its solar (and wind) PPAs that are accounted for as operating leases is reflected in the undiscounted cash‑flow estimate of roughly **$652 million** for those leases【page_270】.  In other words, NEE’s solar‑VIE asset base is roughly three times larger than Southern Power’s operating‑lease PPA exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies NEE's $1,851 million in assets from consolidated solar VIEs at year-end 2021, which matches the ground truth. However, it introduces a figure of $652 million for Southern Power’s operating lease PPAs, which is not present in the original answer and lacks direct comparison in the ground truth. The original answer does not provide a quantitative value for Southern Power’s exposure, only a qualitative description of its lease structure and up to 25-year terms. Thus, the $652 million figure appears to be factually unsupported by the ground truth and likely drawn from an external or incorrect source. Additionally, the claim that NEE’s asset base is 'roughly three times larger' is based on this unsupported number and therefore invalid. (2) While the $1,851 million figure is accurate, the $652 million and the resulting comparison are incorrect, significantly undermining quantitative accuracy. (3) The LLM correctly identifies the structural difference between NEE’s consolidation of VIEs (owning assets) versus Southern Power’s lease-based exposure, showing sound multi-hop reasoning in contrasting ownership vs. lease models. However, it fails to mention that Southern Power’s PPAs are with third-party facilities where SO acts as lessor, a key qualitative distinction in risk and structure. (4) The answer remains contextually relevant by addressing the core comparison of solar exposure through long-term agreements and correctly framing NEE’s direct ownership versus Southern Power’s lease model. Despite the incorrect number, the intent and direction of the comparison are appropriate. Overall, the answer is partially correct but undermined by a critical factual error in quantitative data, warranting a moderate correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 485,
        "total_tokens": 1820
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the structure of Starbucks' stock-based compensation grants under Stock Appreciation Rights compare to Tesla's use of the 2019 Plan in terms of equity instruments available and vesting timelines?",
      "original_answer": "Starbucks grants Stock Appreciation Rights as part of its equity incentive plans, though it notes that stock options have not been broadly used recently. In contrast, Tesla's 2019 Plan, adopted in June 2019, explicitly includes Stock Appreciation Rights among the equity instruments available for grant, along with stock options, RSUs, and performance shares. Tesla's stock options and RSUs generally vest over four years and are exercisable over a maximum period of 10 years from grant dates. Starbucks records compensation expense based on the fair value of awards at grant date and recognizes it over the service period, with performance-based RSUs tied to metrics like earnings per share and return on invested capital. Tesla also uses vesting schedules and forfeitures estimates but does not specify performance-based conditions in this excerpt.",
      "llm_answer": "Starbucks grants Stock Appreciation Rights as one of several awards under its equity‑incentive plans (non‑qualified options, incentive options, restricted stock, RSUs and SARs) and records the related expense over the service period using a graded‑vesting schedule, but the filing does not spell out a fixed vesting term for the SARs【page_63】. Tesla’s 2019 Equity Incentive Plan also includes SARs, but it expands the menu to stock options (incentive and non‑statutory), restricted stock, RSUs, performance units and performance shares, and the plan states that “stock options and RSUs vest over four years” (with options exercisable up to ten years)【page_83】. Thus, Tesla’s plan provides a broader set of equity instruments with a clearly defined four‑year vesting schedule, whereas Starbucks’ SARs are part of a more limited award set and vest on a graded service‑period basis rather than a set four‑year timetable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: both Starbucks and Tesla include Stock Appreciation Rights (SARs) in their equity incentive plans; Tesla’s 2019 Plan includes a broader set of instruments (stock options, RSUs, performance shares, etc.), and its stock options and RSUs vest over four years with a 10-year exercisable window—this matches the original answer exactly. Starbucks uses SARs but does not broadly use stock options recently, and it recognizes compensation expense over the service period, which is consistent with the ground truth. (2) Quantitative accuracy is perfect: no incorrect numbers, dates, or timeframes are presented. The four-year vesting and 10-year exercisability for Tesla are correctly cited. While the LLM notes Starbucks uses a 'graded-vesting schedule' and lacks a fixed term for SARs, this is a reasonable interpretation of the original answer stating expense is recognized over the service period without specifying a uniform vesting timeline. (3) Multi-hop reasoning is sound: the model correctly synthesizes differences in equity instruments available and vesting structures between the two companies. It accurately contrasts Tesla’s clearly defined four-year vesting with Starbucks’ more generalized service-period-based recognition. (4) The only minor shortcoming is that the LLM implies Starbucks’ award set is 'more limited' without explicitly noting that Starbucks has not broadly used stock options recently—this nuance is in the original answer but only lightly covered in the LLM version. However, this does not distort the meaning. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1456,
        "completion_tokens": 477,
        "total_tokens": 1934
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the difference in voting rights structure between META's Class B common stock and GOOGL's Class A common stock affect the potential influence of large shareholders on corporate governance decisions at each company?",
      "original_answer": "META's Class B common stock has no voting rights except for certain defined matters, such as exiting the core payments business or specific amendments to the certificate of incorporation, limiting the influence of large shareholders on most corporate governance decisions. In contrast, GOOGL's Class A common stock provides one vote per share, allowing shareholders of this class to have a more direct say in company decisions. This structural difference means that at META, significant shareholders holding Class B shares have limited ability to impact governance outside of specific scenarios, while at GOOGL, shareholders with Class A shares can exert more consistent influence on corporate decisions through their voting power.",
      "llm_answer": "Meta’s dual‑class structure gives its Class B shares ten votes per share, so insiders who hold a relatively small proportion of the equity can dominate board elections and other governance matters (META_10k_2024.pdf: page 1). Alphabet’s Class A shares carry only one vote per share, meaning voting power is directly tied to the number of shares owned and large shareholders with Class A stock cannot control decisions without owning a majority of the equity (GOOGL_10k_2024.pdf: page 82).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains fundamental factual errors that severely undermine its correctness. (1) It incorrectly states that Meta's Class B shares have ten votes per share; in fact, according to the ground truth, Meta's Class B common stock has *no voting rights* except in limited circumstances. This is a direct contradiction and a critical error. (2) The LLM misrepresents the structure of Meta's dual-class system: typically, it is Meta's Class B shares (held by insiders like Mark Zuckerberg) that have superior voting rights (e.g., 10 votes per share), while Class A shares (not Class B) have one vote and are publicly traded. However, the ground truth explicitly states that Class B has *no voting rights*, which contradicts standard public knowledge and suggests a possible error in the ground truth or its interpretation. Nevertheless, the LLM answer contradicts the provided ground truth, which is our source of truth for evaluation. (3) Regarding GOOGL, the LLM correctly notes that Class A shares have one vote per share, aligning with the ground truth. However, it adds that large shareholders 'cannot control decisions without owning a majority,' which overreaches—while true in general, this inference is not present in the original answer and slightly misrepresents influence (e.g., large minority shareholders can still exert influence). (4) The multi-hop reasoning fails because the LLM mischaracterizes the core voting structure at Meta, leading to an incorrect comparison. The ground truth emphasizes limited influence for Class B holders at Meta, while the LLM implies strong influence by Class B holders—exactly the opposite. Thus, despite some structural understanding of dual-class systems, the answer is factually inverted on the key point. Quantitative accuracy is low due to the incorrect vote count (10 vs. 0). Qualitative accuracy is poor due to incorrect entity-property mapping. Contextual relevance is moderate as it addresses corporate governance and voting rights, but with wrong facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 540,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 72,
      "question": "How does the use of foreign currency derivatives in risk management activities differ between BAC and JPM, based on their respective derivative asset and liability disclosures?",
      "original_answer": "BAC includes foreign currency derivatives under 'Risk Management Activities' as part of its derivative assets and liabilities, which are presented on a gross basis before netting adjustments as of December 31, 2024, and 2023. JPM specifically states that foreign currency derivatives are used to manage foreign exchange risk associated with non-U.S. dollar-denominated assets, liabilities, and forecasted transactions, and that gains or losses on these instruments are expected to substantially offset this variability. The fair value of these derivatives is reflected in the balance sheets, either in 'Other' or shown separately under 'Risk Management Activities.'",
      "llm_answer": "BAC’s 10‑K actually splits its foreign‑exchange contracts into a “Trading and Other Risk‑Management Derivatives” column, showing the amounts used for risk‑management (e.g., ≈ $46.8 m in swaps, $55.4 m in spot/forward contracts and $10.5 m in purchased options) and a much smaller portion designated as hedge accounting (Note 3, page 105). JPM’s filing, by contrast, only narratively states that foreign‑currency derivatives are employed to hedge non‑USD assets, liabilities and forecasted transactions and does not present a separate quantitative risk‑management versus hedge‑accounting line‑item (Note 5, page 211).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a reasonable qualitative comparison between BAC and JPM in how they disclose foreign currency derivatives in risk management, aligning with the core intent of the question. It correctly identifies that BAC presents quantitative risk-management derivative data (e.g., swaps, forwards, options) in a dedicated column, while JPM relies on narrative disclosure without separate line-item quantification. This reflects accurate synthesis across the two companies’ filings and addresses the comparative aspect of the question (multi-hop reasoning is sound). However, the quantitative accuracy is problematic: the dollar amounts cited (e.g., $46.8M, $55.4M, $10.5M) are not present in the ground truth and cannot be verified from the original answer, which does not include any specific numerical values for derivative positions. The original answer only states that BAC presents derivatives on a gross basis before netting, without specifying amounts or breakdowns by instrument type. Thus, the inclusion of precise figures introduces factual inaccuracies not supported by the ground truth. While the qualitative distinction in disclosure practices (quantitative vs. narrative) is valid and contextually relevant, the fabricated numbers significantly undermine factual correctness. The years referenced (implied 2024/2023) are consistent with the original, and entities (BAC, JPM) are correctly identified. Overall, the answer captures the structural difference in disclosures but fails on numerical fidelity, warranting a partial correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 427,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does Duke Energy's exposure to economic downturns through industrial customers compare to Southern Company's risk from environmental compliance costs affecting similar customer segments, given both companies' regulated rate recovery mechanisms?",
      "original_answer": "Duke Energy notes that industrial customers reducing production during economic downturns can lead to reduced electricity consumption, lowering revenues and cash flows. Southern Company, on the other hand, faces risks that increased environmental compliance costs—estimated to impact capital expenditures through 2028—could be passed through regulated rates, potentially reducing demand from commercial and industrial customers. Both companies rely on rate mechanisms for cost recovery: Duke through periodic adjustment clauses and Southern through ECO Plan, CNP Compliance, and ECCR tariff mechanisms. However, while Duke's risk centers on demand volatility from macroeconomic conditions, Southern's exposure stems from regulatory-driven cost increases that may dampen industrial customer demand despite efforts to recover those costs through rates.",
      "llm_answer": "Duke Energy’s downside comes mainly from a drop in industrial consumption when the economy slows – the registrants note that “industrial customers reduce production and therefore consumption of electricity and natural gas…overall declines…could reduce revenues and cash flows” even though regulated rates let them recover fuel‑cost and other allowable expenses (see DUK 10‑K p. 27 & p. 25). Southern Company’s parallel risk is that rising environmental‑compliance costs – which it can largely recover through regulated rates – may push rates higher and “contribute to reduced demand for electricity and natural gas” among commercial and industrial customers, creating a cost‑pass‑through exposure (see SO 10‑K p. 26 & p. 89). Thus Duke’s exposure is demand‑side volatility, while Southern’s is cost‑recovery‑side pressure that could also suppress industrial demand.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Duke Energy's risk stems from industrial demand volatility during economic downturns, while Southern Company faces demand suppression risk due to higher rates from environmental compliance costs. Both companies rely on regulated rate recovery mechanisms, with Duke using adjustment clauses and Southern using specific tariffs (ECO Plan, CNP Compliance, ECCR), though the LLM does not name these explicitly but refers correctly to the general concept. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the question or ground truth that require verification—the only time reference is Southern’s costs extending through 2028 in the original, which the LLM omits. This is a minor omission but does not affect core correctness. (3) Multi-hop reasoning is sound: the model correctly identifies two distinct risk types (demand-side vs. cost-recovery-side), links them to the respective companies, and contrasts them appropriately. It synthesizes information from both 10-Ks and aligns with the comparative structure of the question. (4) The LLM uses slightly different phrasing (e.g., 'cost-pass-through exposure') but captures the essence of Southern’s risk accurately. The only small gap is the lack of specific tariff mechanism names, which were in the original answer but not critical to the central comparison. Overall, the response is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 422,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is fully owned by Brian Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have different voting rights?",
      "original_answer": "CMCSA's Class B common stock, which is fully owned by Brian Roberts, holds 33 1/3% of the combined voting power with each share carrying 15 votes, creating a concentrated control mechanism that is non-dilutable under the company's articles of incorporation. This contrasts with GOOGL's structure, where Class A shares have 1 vote each and Class B shares have 10 votes each, and Class B shares automatically convert to Class A upon sale or transfer. While both companies utilize dual-class structures to preserve founder control, CMCSA's system entrenches Brian Roberts' influence more securely due to the non-dilutable nature and high per-share voting weight of the Class B stock, whereas GOOGL's structure allows for more fluidity in ownership and voting power distribution.",
      "llm_answer": "Comcast’s Class B common stock – wholly owned by Brian L. Roberts – accounts for roughly one‑third of the company’s total voting power (33 % of the combined voting power) and each share carries ten votes, giving Roberts a fixed, decisive block that can dominate director elections and other shareholder votes even though he holds a small share of the equity 【page_31】. Alphabet’s dual‑class system likewise concentrates control: its publicly‑traded Class A shares have one vote per share, while the non‑public Class B shares (held by founders and insiders) have ten votes per share, providing those insiders with majority voting control despite a minority economic stake 【page_66】. Thus, both companies use high‑voting‑right shares to concentrate governance, but Comcast’s power is concentrated in a single individual, whereas Google’s is spread among a group of insiders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer captures the core idea that both CMCSA and GOOGL use dual-class structures to concentrate voting power, with high-vote shares held by insiders. It correctly identifies that Brian Roberts holds all of CMCSA's Class B stock and that this gives him significant voting power, and it accurately contrasts this with Alphabet's broader insider group control. However, there are key quantitative inaccuracies: the LLM states that CMCSA Class B shares carry 'ten votes' each, while the ground truth specifies '15 votes'. Additionally, while the 33% voting power figure is approximately correct, the LLM rounds it to 'roughly one-third' and omits the precise '33 1/3%' and the critical fact that the voting power is 'non-dilutable under the company's articles of incorporation'—a major structural difference. For GOOGL, the LLM correctly notes the 1 vs. 10 vote split but omits the key detail that Class B shares automatically convert to Class A upon sale or transfer, which limits long-term entrenchment and introduces fluidity absent in CMCSA's structure. 2) Quantitative accuracy is compromised by the incorrect vote ratio (10 vs. 15) for CMCSA Class B shares. This is a significant factual error affecting the precision of the governance mechanism description. The 33% vs. 33 1/3% is minor, but the missing non-dilutable clause is a qualitative and structural oversight. 3) The reasoning is logically sound in comparing concentrated control in both firms and noting individual vs. group control, but it fails to fully synthesize the multi-hop nuance: CMCSA’s structure is more entrenched due to non-dilutability and higher per-share votes, while GOOGL’s is more fluid due to conversion upon transfer. This key differentiator is missing, weakening the comparative analysis. 4) Despite these issues, the answer remains contextually relevant, addresses the comparative governance question, and conveys a largely accurate high-level comparison. The omission of structural durability (non-dilutability and transfer-triggered conversion) reduces completeness and precision, but the central contrast in control concentration is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 572,
        "total_tokens": 2011
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How did KO's indirect exposure to Taiwan through Swire Beverages' operations compare to PEP's direct growth performance in the Taiwanese beverage market in 2022?",
      "original_answer": "KO had indirect exposure to Taiwan through Swire Beverages, one of its top five bottling partners, which operated in Taiwan and accounted for 17% of KO’s worldwide unit case volume in 2021. Meanwhile, PEP directly reported low-single-digit beverage unit volume growth in Taiwan as part of its APAC division's 34% net revenue increase in 2022. This highlights KO’s reliance on a third-party bottler versus PEP’s direct market performance in the same geography.",
      "llm_answer": "Coca‑Cola’s link to Taiwan is indirect – it comes from its bottling partner Swire Beverages, which “has bottling and distribution operations … in … Taiwan” (KO 10‑K p. 7). PepsiCo, by contrast, reports a direct performance metric for Taiwan, noting that “Taiwan … experienced low‑single‑digit growth” in 2022 (PEP 10‑K p. 48).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly identifies the core contrast in exposure: KO's indirect presence in Taiwan via Swire Beverages versus PEP's direct reporting of low-single-digit beverage volume growth in Taiwan in 2022. It accurately cites the PEP 10-K page reference for the 'low-single-digit growth' metric, aligning with the ground truth. However, the LLM omits a key quantitative element from the original answer: Swire Beverages accounted for 17% of KO’s worldwide unit case volume in 2021. While the indirect relationship is noted, this significant scale metric is missing, weakening the quantitative comparison. Additionally, the LLM does not mention that PEP’s growth was reported as part of its APAC division’s 34% net revenue increase in 2022, which provides important context. The entity accuracy (KO, PEP, Swire, Taiwan, 2022) and reasoning logic are sound—correctly distinguishing indirect vs. direct market exposure. The answer is semantically aligned in direction but lacks completeness in numerical detail, particularly the 17% volume contribution, which is critical for assessing KO’s level of indirect exposure. Thus, while the qualitative reasoning and contextual relevance are strong, the quantitative accuracy is reduced due to missing key data points.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1200,
        "completion_tokens": 352,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 73,
      "question": "How might the expiration of Trulicity's patent protection impact LLY's revenue trajectory in light of MRK's strategic reliance on strong patent protection to maintain market exclusivity and competitive positioning?",
      "original_answer": "The expiration of Trulicity's patent protection, as noted in LLY's 2024 10-K, is expected to lead to a rapid and severe decline in revenue, as seen in 2024 where Trulicity's U.S. revenue decreased by 32% due to competitive dynamics and supply constraints. This aligns with the broader risk LLY faces as products lose exclusivity, typically resulting in generic competition and steep revenue drops. Similarly, MRK acknowledges that loss of patent protection leads to generic substitutes entering the market, adversely affecting sales and cash flows. Given MRK's emphasis on actively defending patent rights to maintain market exclusivity and profitability, the erosion of Trulicity's patent protection signals a critical vulnerability for LLY, especially if it lacks a robust pipeline or alternative strategies to offset the anticipated revenue losses.",
      "llm_answer": "The 2024 data show Trulicity’s sales already fell 26 % to $5.3 billion as competition and supply constraints took hold (LLY 2024 product‑revenue table, p. 49). Because Eli Lilly notes that “loss of effective patent protection … typically leads to a severe and rapid decline in revenues” (LLY 10‑K, IP overview, p. 10), the imminent expiration of Trulicity’s patents is expected to accelerate that drop, eroding the drug’s contribution to Lilly’s top line. Merck’s filing makes the same point for its own portfolio – it stresses that strong patent protection is essential to preserve market exclusivity and that losing it “could have a material adverse effect on the sales of any such products” (MRK 10‑K, p. 31‑33) – underscoring that Lilly will likely see a similar revenue‑trajectory hit unless new products replace Trulicity’s earnings.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in content and reasoning but contains a discrepancy in the reported percentage decline of Trulicity's sales. The LLM states a 26% decline, while the ground truth reports a 32% decrease in U.S. revenue. This is a material difference, though both indicate a significant drop. The $5.3 billion figure is plausible and contextually consistent, though the original answer does not specify the exact revenue figure, so this cannot be confirmed or rejected definitively. (2) The calculation of the percentage decline is inaccurate—26% vs. 32%—and no source page numbers (e.g., p. 49, p. 10) were present in the original data, making those citations suspect or fabricated. However, the direction and implication of the decline (rapid and severe) are consistent. (3) The multi-hop reasoning is sound: the LLM correctly synthesizes LLY's exposure to patent expiration using its own risk disclosures and parallels it with MRK's strategic emphasis on patent protection, drawing a valid cross-company inference about revenue trajectory risks. It correctly identifies that loss of exclusivity leads to generic competition and revenue erosion, citing appropriate logic from both firms’ 10-Ks. (4) The qualitative and contextual accuracy is high—entities (LLY, MRK, Trulicity), financial implications, and strategic comparisons are accurate and relevant. The correctness score is 8 due to the incorrect percentage, which affects quantitative precision, but the core argument and synthesis remain valid.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1439,
        "completion_tokens": 422,
        "total_tokens": 1862
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How might FedEx's operational reliance on leased retail locations at hotels, such as the 200 stores located at hotels and convention centers, compare with UPS's financial exposure to real estate funds—like the $10.1 billion in pension assets invested in real estate, private debt, and hedge funds—in terms of strategic risk during periods of real estate market volatility?",
      "original_answer": "FedEx maintains a direct operational exposure to hotels through its 200 leased retail locations at hotels and convention centers, positioning it in high-traffic hospitality venues but exposing it to lease renegotiations or relocations if hotel operators change tenants. These leases are typically for five to ten years, and FedEx's ability to maintain these locations depends on the ongoing operation of the hotels themselves. In contrast, UPS holds an indirect financial exposure to real estate through its pension and postretirement plan assets, which include $10.1 billion in investments in real estate funds, private debt, and hedge funds as of December 31, 2024. These funds may include investments in hotels and other commercial properties, meaning UPS’s exposure is tied to the performance of these funds rather than direct occupancy or lease agreements. During real estate market volatility, FedEx could face operational disruptions or increased leasing costs if hotel properties experience financial strain, while UPS could see fluctuations in the value of its pension assets, affecting long-term liability projections and funding obligations. Thus, while both companies are exposed to the real estate sector, the nature of their risk—operational for FedEx and financial for UPS—differs significantly in both timing and impact.",
      "llm_answer": "FedEx’s risk is primarily operational: about 200 FedEx Office stores are leased in hotels, convention centers, hospitals and universities (FedEx Office “operates approximately 200 stores at hotels, convention centers, hospitals, universities” – page 44), so a volatile real‑estate market could raise lease rates, make renewals harder or force relocations, directly increasing its cost structure and footprint stability. UPS’s risk is financial: its pension and post‑retirement plans hold $10.1 billion in real‑estate, private‑debt and hedge‑fund investments (valued at $10.1 billion as of 12/31/2024 – page 61), so a downturn in real‑estate values would depress asset valuations and could create pension‑funding gaps or affect earnings, rather than impacting day‑to‑day operations.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $10.1 billion in pension assets as of December 31, 2024, and the 200 leased retail locations are accurately reported. The LLM correctly cites the source pages (44 and 61), indicating proper grounding. (2) The LLM slightly expands the list of locations to include hospitals and universities, which is consistent with typical FedEx Office placements and does not contradict the ground truth—though the original answer specifies only hotels and convention centers, the broader context is still factually plausible and does not introduce error. (3) The reasoning correctly distinguishes FedEx’s operational risk (lease renewals, relocations, cost increases) from UPS’s financial risk (pension asset devaluation, funding gaps), capturing the core multi-hop comparison between direct operational exposure and indirect financial exposure. (4) The answer is contextually relevant, directly addressing the strategic risk comparison during real estate market volatility. The only minor shortcoming is the slight broadening of location types without noting that the 200 stores specifically include hotel and convention center leases as emphasized in the original, which slightly affects qualitative precision. Otherwise, the semantic meaning, risk categorization, and implications are equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1585,
        "completion_tokens": 396,
        "total_tokens": 1982
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the voting rights structure of GOOGL's Class B Common Stock compare to CMCSA's disclosure around voting rights in its investment in Atairos, particularly in terms of control and influence over strategic decisions?",
      "original_answer": "GOOGL's Class B Common Stock provides its holders with 10 votes per share, significantly enhancing their influence over corporate decisions compared to Class A shares, which carry one vote per share. This structure allows holders of Class B Common Stock to maintain greater control over strategic decisions despite owning fewer shares. In contrast, CMCSA disclosed that it has no voting rights in Atairos, a VIE in which it holds a significant investment, and only retains certain consent rights. As a result, CMCSA lacks the power to direct Atairos’s activities that most significantly impact its economic performance, which limits its control and influence over strategic decisions at Atairos.",
      "llm_answer": "Alphabet’s Class B shares carry ten votes per share, giving their holders a disproportionate voting power that can dominate board elections and strategic decisions. By contrast, Comcast’s filing on its Atairos investment states it has “no voting rights and only certain consent rights,” meaning it cannot direct or control the VIE’s key activities. Thus, GOOGL’s Class B structure provides strong control, while CMCSA’s Atairos stake provides no voting influence over strategic choices.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly states that GOOGL's Class B shares have 10 votes per share, giving disproportionate control, which matches the original answer. It also accurately notes that CMCSA has 'no voting rights and only certain consent rights' in Atairos, limiting its control—this aligns with the ground truth's statement that CMCSA lacks power to direct key activities of the VIE. (2) There are no numerical inaccuracies; the 10 votes per share is correctly cited, and no calculations are required. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two different companies (GOOGL and CMCSA) and structures (share classes vs. VIE investment), drawing a valid contrast in control mechanisms. (4) The only minor shortcoming is that the LLM does not explicitly mention that Class A shares have one vote per share (though implied by contrast), nor does it use the term 'VIE' when describing Atairos (though it later refers to it as a VIE). These omissions do not detract significantly from the overall correctness but prevent a perfect score. Wording differences are semantically equivalent and acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 343,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 74,
      "question": "How does the use of commercial paper financing by Duke Energy Ohio compare to PepsiCo's short-term debt strategy, given Duke Energy Ohio's specific disclosures and PepsiCo's broader commercial paper obligations?",
      "original_answer": "Duke Energy Ohio reported $25 million in commercial paper obligations as of December 31, 2023, as part of its overall short-term financing strategy. In comparison, PepsiCo disclosed $2,286 million in commercial paper obligations in 2023, representing a significant portion of its broader short-term debt obligations totaling $6,510 million. This highlights a stark contrast in the scale of commercial paper usage between the two companies, with PepsiCo relying more heavily on this form of short-term financing.",
      "llm_answer": "Duke Energy Ohio’s commercial‑paper financing is modest—only $25 million in 2023—and is shown as a short‑term borrowing that the company classifies as long‑term debt because it intends to refinance it on a longer horizon (see Duke Energy Ohio commercial‑paper line in the “Short‑Term Obligations Classified as Long‑Term Debt” table)【page_165】. PepsiCo, by contrast, relies heavily on commercial paper, carrying $2.286 billion of it in 2023 as a core component of its $6.5 billion short‑term debt portfolio, and uses senior‑note issuances to repay that paper (see PepsiCo’s “Commercial paper (5.5%)” line and note on using senior‑note proceeds for repayment)【page_100】【page_101】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports Duke Energy Ohio's $25 million in commercial paper obligations as of December 31, 2023, and PepsiCo's $2,286 million (i.e., $2.286 billion) in commercial paper and $6,510 million (~$6.5 billion) in short-term debt for 2023. All numeric values match the ground truth exactly, with acceptable formatting variations (e.g., $2.286 billion = $2,286 million). (2) Quantitative accuracy is perfect: all dollar amounts, time periods, and implied comparisons are factually correct. The LLM even adds contextual precision by noting that Duke Energy classifies its commercial paper as long-term debt due to refinancing intent, which aligns with disclosure practices and enhances accuracy. (3) The multi-hop reasoning is sound—information is correctly synthesized across two companies and their respective filings, with appropriate comparison of scale and strategy. The LLM correctly infers that PepsiCo relies more heavily on commercial paper as a 'core component' of its short-term financing, which is consistent with the ground truth's emphasis on 'stark contrast' and 'heavier reliance.' The only minor gap is that the LLM does not explicitly state the comparative scale difference as 'stark,' though the implication is clearly conveyed through quantitative contrast. (4) Scores reflect near-perfect factual alignment, with full quantitative accuracy and high qualitative accuracy due to correct entity identification, proper contextualization, and logical synthesis. Contextual relevance is excellent as all information directly addresses the comparative financing strategies posed in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 449,
        "total_tokens": 1762
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given Duke Energy's expectation of increasing commercial gas customers in the Carolinas, Ohio, and Kentucky, how might Southern Company's reliance on regulated rate recovery for environmental compliance costs be affected if commercial demand declines due to environmental regulations impacting industrial operations in these same regions?",
      "original_answer": "Duke Energy's gas utility operations expect an increase in the number of commercial and industrial customers over time, particularly in North Carolina, South Carolina, Ohio, and Kentucky. Southern Company, on the other hand, relies heavily on regulated rate recovery mechanisms to offset rising environmental compliance costs, which include upgrades to gas distribution infrastructure and compliance with GHG regulations. However, Southern Company also acknowledges that increased costs recovered through regulated rates could lead to reduced demand for natural gas from commercial and industrial customers—many of whom may be directly impacted by environmental requirements such as emission limits or carbon constraints. If these regulations lead to operational changes or reduced production among industrial users, the anticipated growth in commercial gas demand may not materialize, thereby undermining the effectiveness of rate recovery mechanisms and creating financial pressure on Southern Company's gas operations.",
      "llm_answer": "Duke Energy says its commercial‑gas customer count in the Carolinas, Ohio and Kentucky “is expected to increase over time” (DUK 10‑K p. 17). Southern Company, however, notes that most environmental‑compliance spending is expected to be recovered through retail and wholesale rates and that “increased costs that are recovered through regulated rates could contribute to reduced demand for electricity and natural gas” and that a decline in commercial demand would “adversely affect” its ability to recover those costs (Southern 10‑K p. 26 & 89). Thus, if environmental rules curb industrial activity and commercial demand falls, Southern’s reliance on regulated‑rate recovery would be weakened—shrinking the rate base and making it harder to pass through compliance expenses, potentially leaving more costs unrecovered.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Duke Energy expects growth in commercial gas customers in the Carolinas, Ohio, and Kentucky (correctly cited from DUK 10-K p.17), and Southern Company relies on regulated rate recovery for environmental compliance costs, while acknowledging that higher rates could reduce demand for natural gas and electricity (accurately cited from Southern 10-K pp.26 & 89). (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, or dates), so quantitative accuracy is not compromised—no figures are misstated. (3) The multi-hop reasoning is sound: the model correctly links Duke’s customer growth outlook with Southern’s rate recovery model, then introduces the risk that environmental regulations could suppress industrial demand, undermining the rate base and cost recovery. This synthesis across two companies and their regulatory and market risks is logically coherent. (4) The LLM slightly simplifies the original answer by not explicitly mentioning GHG regulations or infrastructure upgrades, but the core causal chain—environmental rules → industrial operational changes → lower demand → weakened rate recovery—is preserved. Wording differs but semantic meaning matches. Minor omission of specific compliance cost types does not detract from correctness. Contextual relevance is perfect: the response directly addresses the conditional scenario posed in the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 414,
        "total_tokens": 1922
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "Given that Comcast's Class B shares carry 15 votes each and represent 33 1/3% of the combined voting power, how does the absence of repurchase activity for these shares (only Class A shares were repurchased in 2023) impact Mr. Roberts' ownership control relative to the broader shareholder base?",
      "original_answer": "Comcast's Class B shares, which carry 15 votes per share and represent 33 1/3% of the combined voting power, are not being repurchased, while Class A shares (with fewer votes) are being actively repurchased. This selective repurchase activity reduces the number of outstanding Class A shares, thereby increasing the relative voting influence of the non-repurchased Class B shares. Since Mr. Brian L. Roberts owns all outstanding Class B shares, this dynamic strengthens his control over corporate decisions, even as the broader shareholder base sees its equity diluted through the retirement of Class A shares.",
      "llm_answer": "Mr. Roberts continues to own all 9,444,375 Class B shares—each worth 15 votes—so his stake still accounts for roughly one‑third (33 ⅓ %) of Comcast’s total voting power (see page 33). Because the 2023 share‑repurchase program bought back only Class A shares, the pool of voting shares held by other investors fell, leaving Roberts’ absolute voting power unchanged but his relative influence unchanged or slightly higher as the broader shareholder base shrank (see page 69 for Class B share count).",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor issues in precision and completeness. (1) Quantitatively, the LLM correctly states that Mr. Roberts owns all Class B shares (9,444,375), each with 15 votes, and that they represent 33 1/3% of voting power—this matches the ground truth. The claim that only Class A shares were repurchased in 2023 is accurate. However, the ground truth does not specify the exact number of Class B shares (9,444,375), so including this detail—while possibly from the cited page 33—goes beyond the original answer and introduces a specific figure not confirmed in the reference. This doesn't make it wrong, but adds unverified granularity. (2) The reasoning is sound: repurchasing only Class A shares reduces the total voting pool outside of Roberts, thus increasing his relative influence. The LLM correctly notes his absolute voting power is unchanged but relative influence increases, which is consistent with the ground truth. However, it says 'unchanged or slightly higher'—the 'or unchanged' part slightly undercuts the certainty of the conclusion. The ground truth clearly states his control is strengthened, so the LLM's phrasing is slightly weaker. (3) The multi-hop reasoning is appropriate: connecting share repurchases (Class A only), no repurchase of Class B, Roberts' full ownership of Class B, and the resulting shift in voting power balance. All entities (Comcast, Mr. Roberts, Class A/B shares, 2023 repurchases) are correct. (4) The answer is contextually relevant and addresses all parts of the question. The minor deduction is for the slightly cautious phrasing on influence ('unchanged or slightly higher') and the introduction of a specific share count not in the ground truth, which, while possibly accurate, isn't necessary and could be misleading if unverified. Overall, the core facts and logic are correct, warranting a high score but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1314,
        "completion_tokens": 521,
        "total_tokens": 1835
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does the contractual structure of Amgen's performance units, which are subject to specific payout simulations based on stockholder returns, compare to Bristol-Myers Squibb's exposure to financial agreements that include counterparty credit risk mitigation strategies, particularly in terms of payout or risk management predictability?",
      "original_answer": "Amgen's performance units in 2023 were valued at $121 million and are subject to payout simulations that model stockholder returns based on correlations and volatilities of comparator company stocks over the performance period, as dictated by contractual terms. This creates a structured but variable payout mechanism tied to relative performance metrics. In contrast, Bristol-Myers Squibb enters into financial agreements that include counterparty credit risk mitigation strategies such as limiting exposure to individual counterparties, using conventional instruments, and requiring high credit quality standards. These strategies are designed to ensure predictability and minimize financial risk in derivative and other financial instrument transactions. The contractual frameworks differ in that Amgen’s focus is on performance-linked payout predictability, while BMY emphasizes counterparty risk control and financial stability in its agreements.",
      "llm_answer": "Amgen’s performance‑unit awards are equity awards that only vest for a share‑for‑share payout if Amgen meets stock‑holder‑return targets (relative to a comparator group) and its own financial goals; the company estimates the grant‑date fair value with a “payout simulation” that models stock‑price correlations and volatilities, so the actual number of shares ultimately paid out can vary with market performance (see Amgen 10‑K p. 126). BMS, by contrast, does not have such variable equity payouts – its exposure stems from financial contracts that carry counter‑party credit risk, which it manages by capping exposures, dealing only with high‑credit counterparties and using derivative hedges, making the potential impact on the balance sheet far more predictable and limited (see BMS 10‑K p. 97).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, while the LLM does not explicitly state the $121 million value of Amgen's performance units mentioned in the original answer, this omission does not appear to be a factual error but rather a focus on mechanism over specific dollar figures. All other financial and structural details are correctly represented. (2) The explanation of Amgen’s payout simulation—using correlations and volatilities of comparator company stocks to model shareholder returns—is factually correct and aligns with the contractual structure described in the ground truth. (3) For Bristol-Myers Squibb, the LLM accurately describes counterparty credit risk mitigation strategies: limiting exposure, requiring high credit quality, and using derivatives, which matches the original answer. It correctly contrasts BMY’s focus on balance sheet predictability with Amgen’s variable, performance-linked payouts. (4) The multi-hop reasoning is sound—comparing two different risk/payout frameworks across companies, synthesizing information about equity awards vs. financial agreements. (5) Semantic equivalence is strong: though wording differs, the LLM captures the essential contrast in contractual predictability—Amgen’s market-dependent payout variability vs. BMY’s controlled, risk-mitigated financial agreements. The only minor shortcoming is the missing $121M figure, which reduces completeness slightly but does not impair the overall correctness of the comparison. Hence, a score of 9 is warranted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 433,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 75,
      "question": "How does MetLife's exposure to derivatives governed by ISDA Master Agreements under the Orderly Liquidation Authority compare to Bank of America's resolution planning risks, given both companies' regulatory obligations under Dodd-Frank?",
      "original_answer": "MetLife manages credit risk in its derivatives transactions through ISDA Master Agreements that allow for close-out netting, which is subject to financial regulations such as the Orderly Liquidation Authority (OLA) under Dodd-Frank. This means that in the event of a counterparty's bankruptcy, MetLife can offset receivables and apply collateral without being subject to the automatic stay. Similarly, Bank of America Corporation is required to submit resolution plans to the FDIC and Federal Reserve that outline a 'single point of entry' strategy under the U.S. Bankruptcy Code or potentially the OLA. If Bank of America were resolved under the OLA, the FDIC could replace the corporation with a bridge holding company, and security holders could face significant losses. Both firms are therefore subject to Dodd-Frank provisions that alter the treatment of their financial obligations and risk profiles during insolvency, with MetLife exposed through its derivative contracts and BAC through its parent company resolution strategy.",
      "llm_answer": "MetLife’s derivative risk is largely confined to the credit‑risk side of its OTC‑bilateral trades, which are covered by ISDA Master Agreements that, under the Orderly‑Liquidation Authority (Title II of Dodd‑Frank), let the company net‑off receivables against payables and apply collateral without the automatic stay of bankruptcy 【page_261】. By contrast, Bank of America’s Dodd‑Frank obligations are far broader: its parent must file a resolution plan with the FDIC and Federal Reserve, and if the plan is deemed inadequate the agencies can impose stricter capital, leverage or liquidity limits and even invoke the Orderly‑Liquidation Authority to wind‑down the bank, threatening its ability to fund subsidiaries and meet obligations 【page_13】.  Thus MetLife’s exposure is limited to derivative netting under OLA, whereas Bank of America faces systemic resolution‑planning risks that could materially constrain its capital and liquidity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that MetLife's exposure to derivatives under ISDA Master Agreements allows for close-out netting and collateral application under the Orderly Liquidation Authority (OLA), exempting it from the automatic stay in bankruptcy—this matches the original answer's core claim. (2) It accurately contrasts this with Bank of America's broader resolution planning obligations under Dodd-Frank, including the requirement to file resolution plans with the FDIC and Federal Reserve, and the potential invocation of OLA leading to systemic risks, capital constraints, and liquidity impacts. (3) The multi-hop reasoning is sound: it synthesizes MetLife’s derivative-specific risk with BAC’s firm-wide resolution strategy, correctly distinguishing the scope and implications of OLA for each entity. (4) While the original answer mentions the 'single point of entry' strategy and bridge holding company concept, the LLM answer captures the practical effect (e.g., threat to funding subsidiaries and meeting obligations) without explicitly naming the mechanism—this is a minor omission but does not detract from factual correctness. No numbers, dates, or financial figures are incorrect (quantitative accuracy is perfect). Wording differs slightly but semantic equivalence is maintained. The answer is fully contextually relevant and addresses all parts of the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1515,
        "completion_tokens": 403,
        "total_tokens": 1918
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does Nike's revenue from the Greater China region, which includes Taiwan, compare to Starbucks' store count in Taiwan specifically, and what might this suggest about their relative market presence in that geographic area?",
      "original_answer": "Nike generated $7,547 million in revenue from the Greater China region in 2022, which includes Taiwan along with mainland China and Hong Kong. In contrast, Starbucks operated 544 stores in Taiwan as of October 2, 2022. Given that Nike's revenue figure represents a broader regional performance across multiple countries while Starbucks' store count is specific to Taiwan, the comparison highlights different dimensions of market presence—Nike's being revenue-based across a larger geographic cluster, and Starbucks' being operationally focused with a localized footprint in Taiwan.",
      "llm_answer": "Nike reported ≈ $7.5 billion in FY 2022 revenue from its Greater China segment (which includes Taiwan)【page_88】.  Starbucks, by contrast, had 544 licensed stores operating in Taiwan at the end of its fiscal year 2022【page_12】.  The comparison shows that Nike’s business in the broader China market generates billions of dollars in sales, far outweighing Starbucks’ modest physical footprint of a few hundred stores in Taiwan, suggesting Nike enjoys a much larger monetary market presence in the region.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Nike's $7.5 billion (≈$7,547 million) revenue from the Greater China region in FY 2022 and Starbucks' 544 stores in Taiwan as of the end of fiscal year 2022, which matches the ground truth. The use of '≈$7.5 billion' is an acceptable rounding of $7,547 million. (2) All numeric values are accurate and properly attributed to the correct companies and timeframes. The fiscal year alignment (2022) is correct for both entities. (3) The reasoning correctly synthesizes multi-hop information—comparing Nike’s regional revenue (Greater China, including Taiwan) with Starbucks’ localized operational footprint (stores in Taiwan only). However, the LLM slightly oversimplifies the interpretation by stating Nike has a 'much larger monetary market presence' without fully acknowledging that the comparison is between a broad regional revenue metric and a narrow operational count in a sub-region, which the original answer clarifies. The ground truth emphasizes that the metrics reflect different dimensions of market presence (revenue vs. physical footprint), while the LLM leans toward a direct comparison of scale. (4) Despite this nuance, the LLM captures the core facts, entities, and context accurately. The answer is semantically close to the original, with only minor reduction in qualitative precision. Hence, correctness is high but not perfect—warranting an 8. Quantitative accuracy is strong (9), qualitative reasoning is sound but slightly less nuanced (8), and contextual relevance is excellent (10).",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 426,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does the $5.0 billion upfront payment from American Tower Corporation in March 2015 compare to the $2.8 billion received from Vertical Bridge in December 2024 in terms of Verizon's retained obligations and asset treatment related to the exclusive rights transactions?",
      "original_answer": "The $5.0 billion transaction with American Tower in 2015 and the $2.8 billion transaction with Vertical Bridge in 2024 both involved Verizon transferring exclusive rights to operate wireless towers while retaining ownership and depreciation responsibilities. In both cases, Verizon subleases capacity back from the acquiring entity and continues to include the towers in 'Property, Plant and Equipment - Net' on its balance sheet. However, the Vertical Bridge deal resulted in a $2.0 billion prepaid rent and $830 million financing obligation split based on usage, whereas the American Tower deal did not specify such a breakdown, indicating a potentially different structure in how the financing and lease obligations were allocated between the two transactions.",
      "llm_answer": "The $5 billion upfront that Verizon received from American Tower in March 2015 was treated only as a sub‑lease arrangement – the towers remain on Verizon’s property‑plant‑and‑equipment balance and are depreciated, with no separate prepaid‑rent or financing liability recorded. In contrast, the $2.8 billion received from Vertical Bridge in December 2024 is split between $2.0 billion of prepaid rent and an $830 million financing obligation, reflecting Verizon’s retained right‑of‑use for part of the towers and a continuing liability on its balance sheet【page_73】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: the $5.0 billion from American Tower in March 2015 and $2.8 billion from Vertical Bridge in December 2024 are correctly stated, including the $2.0 billion prepaid rent and $830 million financing obligation split for the Vertical Bridge deal. These figures match the original answer exactly, and date formatting (March 2015, December 2024) is accurate. (2) Quantitative accuracy is perfect—dollar amounts and their breakdowns are correct, and the sum of $2.0B + $830M ≈ $2.83B is consistent with the reported $2.8B (rounded). (3) The reasoning correctly contrasts the two transactions: both involve retained ownership, continued depreciation, and subleasing, but only the Vertical Bridge deal explicitly splits the consideration into prepaid rent and a financing obligation. The LLM correctly infers a structural difference in accounting treatment, which is supported by the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly reiterate that towers remain on the balance sheet in both cases—though it mentions they remain in property, plant, and equipment, the parallel treatment could have been emphasized more clearly. However, this is implied and not omitted entirely. Overall, the answer is semantically equivalent, contextually precise, and demonstrates sound multi-hop reasoning across time, entities, and accounting treatments.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 403,
        "total_tokens": 1767
      },
      "error": null
    },
    {
      "question_id": 76,
      "question": "How does JPMorgan's operational risk capital estimation under Basel III, which includes fraud risk as a key component, compare to Citigroup's exposure to fraud-related losses in emerging markets, particularly in scenarios involving asset confiscation or loss of control in Russia?",
      "original_answer": "JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III to estimate operational risk capital, incorporating internal and external losses, scenario analysis, and business environment metrics, with fraud being a key risk category. Meanwhile, Citigroup reports exposure to fraud and political instability in emerging markets, with a specific scenario in Russia involving potential losses of $1.6 billion in CTA (Cumulative Translation Adjustment) and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These figures highlight how both firms face fraud-related risks but experience them through different financial mechanisms and geographic exposures.",
      "llm_answer": "JPMorgan’s Basel III operational‑risk capital is calculated with the Advanced Measurement Approach – a loss‑distribution‑approach model that simulates the frequency and severity of operational losses (including fraud) over a one‑year horizon at a 99.9 % confidence level【page_155】. By contrast, Citi’s emerging‑market fraud exposure is expressed as a concrete, “what‑if” loss: if its Russian subsidiary AO Citibank were confiscated or control were lost, Citi would have to write off the investment and record roughly a $1.6 billion loss (plus about $0.9 billion on related inter‑company liabilities)【page_64】. Thus JPMorgan’s risk is a model‑based capital charge that aggregates fraud risk, while Citi faces a specific, sizable potential loss from asset confiscation or loss of control in Russia.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: JPMorgan uses the Advanced Measurement Approach (AMA) under Basel III for operational risk capital, which includes fraud risk; Citigroup faces a specific fraud- and political risk-related exposure in Russia involving potential losses of $1.6 billion in CTA and $0.9 billion on intercompany liabilities if control of AO Citibank is lost. These numbers match the original answer exactly, satisfying quantitative accuracy. (2) The explanation correctly distinguishes between JPMorgan’s model-based, aggregated capital estimation approach and Citigroup’s scenario-based, concrete loss exposure, capturing the core contrast in how the two firms experience fraud risk. (3) Multi-hop reasoning is sound—information is synthesized across two different firms, risk frameworks (Basel III AMA vs. emerging market political/fraud risk), and financial mechanisms (capital modeling vs. asset write-offs). (4) Minor deduction in qualitative accuracy due to the LLM referring to 'loss-distribution-approach model' and '99.9% confidence level', which, while technically accurate details about AMA, are not present in the original answer and slightly extend beyond the provided ground truth. However, these are not incorrect—just additional context. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 391,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact Qualcomm's chipset supply chain differently than Intel's operational footprint in the region, given Qualcomm's reliance on Taiwan-based foundry partners and Intel's $6.867 billion in 2023 revenue tied to the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan would impact Qualcomm and Intel through different mechanisms. For Qualcomm, the risk is operational, as the company explicitly states its 'business depends on our ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan.' A disruption would 'severely limit or prevent us from receiving chipset supply,' directly threatening its product availability. In contrast, Intel's exposure is primarily financial, with $6.867 billion in 2023 revenue tied to Taiwan, but no explicit mention of reliance on Taiwan-based manufacturing in its disclosures. While both face risks from instability in Taiwan, Qualcomm's dependency is on supply continuity, whereas Intel's is on market demand and revenue generation in the region.",
      "llm_answer": "Qualcomm’s chipset supply chain is tightly tied to Taiwan‑based foundry partners, so a prolonged China‑Taiwan conflict could sharply curtail or stop the flow of chips it needs to sell, creating a material adverse impact on its business【page_35】. Intel’s exposure is largely revenue‑driven – it generated $6.867 billion of net revenue from customers in Taiwan in 2023【page_88】 – so a conflict would mainly depress sales in that market rather than disrupt a core manufacturing supply chain that is less dependent on Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Qualcomm's reliance on Taiwan-based foundries and the risk of supply disruption is accurately described, and Intel's $6.867 billion in 2023 revenue from Taiwan is correctly cited. (2) Quantitative accuracy is perfect: the dollar amount ($6.867 billion) and year (2023) match the original answer exactly. (3) The multi-hop reasoning is sound—LLM correctly distinguishes between Qualcomm’s operational/supply chain risk and Intel’s financial/revenue risk, synthesizing information about two different companies and types of exposure. (4) The only minor shortcoming is that the LLM does not explicitly quote Qualcomm’s disclosure language about business dependence on foundry partners (e.g., 'severely limit or prevent us from receiving chipset supply') as in the original, slightly reducing qualitative precision. However, the semantic meaning is preserved, and the core contrast between supply dependency and revenue exposure is clearly and correctly conveyed. Wording differences are acceptable under semantic equivalence. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 339,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does RTX's valuation methodology for private equity limited partnerships differ from BA's approach to valuing Level 3 assets measured on a nonrecurring basis, given that both companies report these investments through fair value processes?",
      "original_answer": "RTX values its private equity limited partnerships on a quarterly basis using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results, financial condition, or prospects of the applicable portfolio company. In contrast, BA applies an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, such as impaired customer financing assets, which include operating lease equipment and investments in finance leases valued using median collateral values from third-party aircraft publications. While RTX actively adjusts valuations quarterly based on portfolio company performance, BA relies on third-party publications and adjusts values only under specific circumstances, such as unique aircraft attributes or expected net sales prices.",
      "llm_answer": "RTX values its private‑equity limited‑partnership interests on a **quarterly** basis, applying a blend of valuation techniques – discounted‑cash‑flow models, earnings multiples and market multiples – and then adjusting the fair value for changes in the portfolio companies’ operating results, financial condition or prospects (RTX 10‑K p. 102). By contrast, Boeing’s Level 3 assets that are measured only on a **non‑recurring** basis are valued using a single **income‑approach** that relies on discounted‑cash‑flow analysis of the underlying assets, without the use of earnings or market multiples (BA 10‑K p. 124).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of core facts and reasoning. (1) It accurately states that RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, adjusting for changes in portfolio company performance—this matches the original answer and is supported by the cited RTX 10-K reference. (2) It correctly identifies that BA uses an income approach based on discounted cash flows for Level 3 assets measured on a nonrecurring basis, and notes the absence of earnings or market multiples, which is consistent with the ground truth. (3) The multi-hop reasoning is sound: it contrasts RTX’s recurring, performance-adjusted methodology with BA’s nonrecurring, DCF-only approach. However, the LLM omits a key differentiating detail present in the original answer: BA’s use of third-party aircraft valuation publications (e.g., median collateral values) and adjustments based on unique aircraft attributes or expected net sales prices. This contextual nuance strengthens the contrast in data sources and update frequency between the two firms. While the core entities, valuation methods, and timing (quarterly vs. nonrecurring) are correctly identified and compared, this omission reduces completeness. (4) All terminology and entity references (RTX, BA, Level 3 assets, private equity limited partnerships) are accurate, and no numerical inaccuracies exist—there are no explicit numbers to verify, but the qualitative descriptors are factually sound. The answer is highly relevant and well-structured, but the missing detail about third-party data sources and specific adjustment triggers for BA prevents a perfect score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 469,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 77,
      "question": "How does Netflix's use of forward contracts to manage foreign exchange risk on firm commitments compare to Disney's VAR model estimates in terms of potential one-day loss exposure, given the specific metrics disclosed in their respective financial reports?",
      "original_answer": "Netflix uses forward contracts to hedge foreign exchange risk on firm commitments related to foreign currency-denominated content assets, aiming to reduce cash flow volatility. However, Disney's Value at Risk (VAR) model estimates a maximum potential one-day loss of $255 million (as of September 28, 2024) across its interest rate, foreign exchange, commodities, and equity-sensitive instruments. While Netflix does not disclose a specific VAR metric, Disney's $255 million VAR figure provides a quantified estimate of its exposure, allowing for a comparative view of how each company assesses and manages financial risk in their operations.",
      "llm_answer": "Netflix’s 10‑K says it enters into forward contracts that are designated as cash‑flow hedges of foreign‑currency firm commitments (generally with maturities of 24 months or less) to reduce operating‑income and cash‑flow volatility, but it does not disclose a dollar‑amount estimate of the potential loss from those contracts. In contrast, Disney’s filing quantifies the risk: its VAR model estimates a maximum one‑day loss of about $45 million for currency‑sensitive financial instruments (and $284 million for the combined portfolio of interest‑rate, currency, equity and commodity derivatives) at a 95 % confidence level. Thus Disney provides a specific one‑day loss exposure figure, whereas Netflix only describes the hedging strategy without a quantified loss amount.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in key quantitative disclosures. Most critically, it reports Disney's one-day VAR loss for currency-sensitive instruments as $45 million and the combined portfolio as $284 million, whereas the ground truth states Disney's total VAR (across interest rate, foreign exchange, commodities, and equity-sensitive instruments) is $255 million as of September 28, 2024. The $45 million figure for currency-only exposure and $284 million total are not supported by the original answer and contradict the disclosed $255 million figure. These are major quantitative errors that undermine the comparison. (2) The LLM incorrectly implies Disney breaks down VAR into separate components ($45M for currency, $284M total), which is not stated in the original answer. The original does not provide a currency-specific VAR for Disney, only an aggregate $255M figure. Additionally, the LLM invents a 95% confidence level, which is not mentioned in the ground truth. (3) On qualitative accuracy, the LLM correctly identifies that Netflix uses forward contracts as cash-flow hedges to manage FX risk on firm commitments and does not disclose a VAR metric, which aligns with the original. It also correctly frames the comparison around Disney providing a quantified loss estimate while Netflix does not. However, the multi-hop reasoning is flawed due to reliance on incorrect numbers. (4) Contextually, the answer is well-structured and addresses the core question about comparing risk quantification methods between Netflix and Disney. Despite incorrect numbers, it maintains relevance by focusing on the right concepts—hedging strategies vs. VAR disclosure. However, the quantitative inaccuracies severely limit factual correctness, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 493,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How did the corporate income tax rate reduction in the Philippines enacted in Q1 2021 impact AMD's tax provision compared to Texas Instruments' operational investments in the country, given both companies' exposure to international tax regulations?",
      "original_answer": "The corporate income tax rate reduction in the Philippines enacted in Q1 2021 had a favorable impact on AMD’s effective tax rate by partially offsetting increases from other tax factors, such as GILTI-related foreign tax credit limitations. Meanwhile, Texas Instruments had $370 million in property, plant, and equipment at its two sites in the Philippines as of December 31, 2021, indicating significant operational exposure that would be directly affected by the lower tax rate. AMD’s 2021 effective tax rate increased by 0.1 percentage point to 21.8%, with the Philippines tax reduction noted as a mitigating factor, while TXN’s capital investment in the country suggests a strategic commitment that would benefit from the lower corporate tax rate.",
      "llm_answer": "The corporate‑income‑tax cut that the Philippines enacted in the first quarter of 2021 helped AMD lower its 2021 income‑tax provision to $513 million (down from a $1.2 billion benefit in 2020) as part of a modest effective tax rate, reflecting foreign‑tax benefits that offset other international tax items【page_74†L31-L38】. By contrast, Texas Instruments’ exposure to the Philippines is shown through its operational spending – property, plant and equipment at its two Philippine sites rose to $370 million in 2021 (from $333 million in 2020)【page_33†L36-L40】, indicating capital investment rather than a direct tax‑provision effect, although the Philippines tax reduction was noted as a factor that partially offset other tax‑rate changes for multinational firms【page_94†L13-L16】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly in the quantitative details. It claims AMD's tax provision was $513 million in 2021, down from a '$1.2 billion benefit' in 2020. This is incorrect: a 'benefit' of $1.2 billion would imply a negative tax provision (i.e., income from taxes), which is not standard and contradicts the ground truth. The original answer does not provide AMD’s actual tax provision dollar amount, only that its effective tax rate increased slightly to 21.8% (up 0.1 percentage point), with the Philippines tax cut acting as a mitigating factor. The LLM invents specific dollar figures not present in the ground truth and misrepresents the nature of the tax impact. (2) The $370 million PPE figure for Texas Instruments in the Philippines is correct and matches the ground truth (as of December 31, 2021), and the increase from $333 million in 2020 is accurate per the citation. However, the ground truth does not mention this year-over-year change, so while numerically correct, it adds detail not in the original and slightly misaligns focus. (3) The reasoning partially captures the multi-hop nature: it contrasts AMD’s tax provision impact with TXN’s operational investment, which is correct in structure. However, it misattributes the primary effect on AMD as a direct reduction in tax provision via dollar amounts, whereas the ground truth emphasizes the tax rate reduction helped offset other rate-increasing factors (like GILTI), resulting in only a small net increase in the effective rate. The LLM overstates the impact and misrepresents the mechanism. (4) Contextually, the answer is relevant and attempts synthesis between two companies and tax vs. operational exposure. The qualitative reasoning is sound in direction but flawed in precision. The citation references suggest grounding in documents, but the interpretation of AMD’s tax provision is factually incorrect. Thus, while the answer captures the general narrative, it fails on key quantitative accuracy, dragging down the overall correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 558,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How do GM's and McDonald's different approaches to affiliate relationships reflect their respective business models, particularly in terms of vehicle production and franchise operations?",
      "original_answer": "GM engages in transactions with nonconsolidated affiliates for the development, production, and marketing of trucks, crossovers, cars, and automobile parts, which are integral to its automotive manufacturing business model. These affiliates are primarily located in China and produce vehicles under the Baojun, Buick, Cadillac, Chevrolet, and Wuling brands. In contrast, McDonald's relies on affiliates for franchise operations, where revenues are generated through royalties based on a percentage of sales and initial fees. This reflects McDonald's asset-light business model centered on franchising and brand licensing. While GM's affiliate relationships are production-focused and tied to physical goods, McDonald's approach emphasizes service-based revenue through franchisee support and brand management, highlighting the distinct operational structures of the two companies.",
      "llm_answer": "GM’s affiliates—such as its battery‑cell joint‑ventures, automotive China JVs and the GM Financial VIEs—are accounted for as non‑consolidated entities because GM lacks voting control, yet it retains financial exposure to secure key components and financing needed for vehicle production (GM 10‑K p. 79, 77). By contrast, McDonald’s does not consolidate its franchisees or advertising cooperatives because it does not have the power to direct them; instead it earns rent, royalties and other fees that reflect a franchise‑based model in which independent affiliates own and operate most restaurants (McDonald’s 10‑K p. 48, 46).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its description of GM's and McDonald's affiliate relationships, with correct references to their 10-K filings and appropriate accounting rationale (non-consolidation due to lack of voting control). It correctly identifies GM's production-focused affiliates (e.g., joint ventures in China, battery JVs, GM Financial VIEs) and McDonald's franchise-based model involving royalties, rent, and fees. There are no numeric inaccuracies—though no specific numbers (e.g., dollar amounts, percentages) are cited, none are required for this qualitative comparison, and the absence does not detract from correctness. The reasoning is sound: it draws a valid contrast between GM’s asset-heavy, production-oriented use of affiliates and McDonald’s asset-light, franchise-driven model. However, the LLM omits specific brand names produced by GM’s affiliates in China (Baojun, Buick, Cadillac, Chevrolet, Wuling), which were included in the original answer and add concrete detail about the scope of GM’s operations. Additionally, while the LLM mentions GM Financial VIEs, it does not fully clarify how these relate to vehicle production (they support financing, not direct manufacturing), which slightly weakens the synthesis. Despite these minor omissions, the core multi-hop reasoning—linking affiliate structure to business model differences—is logically sound and contextually appropriate. Semantic equivalence is largely preserved, with only slight loss in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 411,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "Given Alphabet's significant share repurchase activity of $62.0 billion in Class A and Class C shares in 2024, and the automatic conversion of Class B shares to Class A upon sale or transfer, how might the reduction in outstanding Class A shares impact the relative voting power of remaining Class B shareholders, especially in light of the fact that Class B shares carry 10 votes per share compared to 1 vote for Class A?",
      "original_answer": "Alphabet repurchased $62.0 billion of Class A and Class C shares in 2024, reducing the number of outstanding Class A shares. Since Class B shares convert automatically to Class A shares upon sale or transfer, this limits the ability of Class B holders to retain higher-vote shares if they transact. With fewer Class A shares in circulation due to buybacks, the relative voting concentration among remaining Class B shareholders—who hold 10 votes per share—would increase, potentially consolidating control among long-term holders.",
      "llm_answer": "Alphabet’s $62 billion repurchase of Class A (and Class C) shares in 2024 shrank the pool of 1‑vote shares outstanding. Because each Class B share retains ten votes and only converts to a 1‑vote Class A share when it is sold or transferred, the remaining Class B shares now represent a larger slice of total voting power, increasing their relative influence (see the voting‑right description, automatic conversion clause, and 2024 repurchase totals – page 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $62 billion repurchase amount and the year 2024 are correctly stated, matching the original answer. There are no calculations required beyond correct interpretation of the dollar value, which is accurate. (2) The answer correctly identifies that Class A and Class C shares were repurchased, reducing the pool of 1-vote shares, and notes the automatic conversion of Class B to Class A upon sale or transfer—this is a key multi-hop element and is properly synthesized. (3) The reasoning is sound: by reducing the number of outstanding low-vote shares (Class A/C), the relative voting power of the remaining high-vote Class B shares (10 votes per share) increases, which strengthens the control of long-term Class B holders. The LLM captures this dynamic clearly. (4) The only minor shortcoming is that it does not explicitly mention the 'consolidation of control among long-term holders' as in the original answer, which adds a slight interpretive depth. However, the implication is clearly conveyed through 'larger slice of total voting power' and 'increasing their relative influence.' Wording differs slightly but semantic equivalence is strong. All entities—Alphabet, Class A, B, and C shares, voting rights, repurchase activity—are correctly identified and contextualized. The reference to 'page 82' appears to be a citation artifact but does not detract from factual accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 405,
        "total_tokens": 1722
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the adoption of ASU No. 2020-01 impact the accounting treatment for equity securities by both Colgate-Palmolive and The Coca-Cola Company, particularly in light of the clarification provided by the standard on the interaction between equity securities, equity method investments, and derivative contracts?",
      "original_answer": "ASU No. 2020-01 clarifies the interaction between the accounting for equity securities under Topic 321, equity method investments under Topic 323, and derivative contracts under Topic 815. Colgate-Palmolive adopted this guidance effective January 1, 2021, and concluded that it did not have a material impact on its Consolidated Financial Statements. Similarly, The Coca-Cola Company, which is also subject to the same accounting standard, applies the clarified guidance to its equity securities, including the calculation of net unrealized gains and losses recognized during the year related to equity securities still held at the end of the year (as disclosed in its financial statements). Both companies benefit from the standard’s clarification on when observable transactions should be considered before applying or upon discontinuing the equity method, and how derivatives linked to equity securities should be accounted for without considering whether the underlying securities would be accounted for under the equity method or fair value option.",
      "llm_answer": "ASU 2020‑01 tells companies that equity‑security holdings are measured at fair value and that any forward contracts, purchase options or other derivatives on those securities are accounted for under ASC 815 rather than as equity‑method investments. Colgate‑Palmolive notes that the ASU became effective on 1 January 2021 and “did not have a material impact on the Company’s consolidated financial statements,” while Coca‑Cola’s disclosures show equity securities already recorded at fair value with unrealized gains/losses recognized in earnings and its derivatives carried at fair value under ASC 815—treatment that is consistent with the ASU’s clarification and therefore also did not materially change its accounting.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: ASU No. 2020-01 clarifies the accounting interaction between equity securities (ASC 321), equity method investments (ASC 323), and derivatives (ASC 815). The LLM correctly states that Colgate-Palmolive adopted the standard on January 1, 2021, and concluded it had no material impact—this matches the original answer. Coca-Cola’s treatment is also accurately described: equity securities at fair value with unrealized gains/losses in earnings and derivatives under ASC 815, consistent with the standard. (2) Quantitatively, the date (January 1, 2021) is correct, and there are no numerical inaccuracies. While the original answer references Coca-Cola’s disclosure of net unrealized gains/losses, the LLM captures this conceptually by noting unrealized gains/losses are recognized in earnings. (3) The multi-hop reasoning is sound: the LLM synthesizes the standard’s effect across two companies and links it to their respective accounting policies. It correctly infers that because both companies already accounted for equity securities and derivatives in a manner consistent with the ASU, adoption did not materially change their financial statements. (4) Minor deduction in qualitative accuracy because the LLM omits explicit mention of the guidance on observable transactions affecting the transition into or out of the equity method—a key clarification in the standard noted in the original answer. However, this does not undermine the overall correctness. The answer is contextually complete and directly responsive to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 453,
        "total_tokens": 1938
      },
      "error": null
    },
    {
      "question_id": 78,
      "question": "How does the difference in the Stress Capital Buffer (SCB) components of the CET1 capital ratio requirements between Goldman Sachs and Citibank reflect their respective approaches to regulatory capital adequacy under the Standardized Capital Rules as of December 2024?",
      "original_answer": "As of December 2024, Goldman Sachs is subject to a Stress Capital Buffer (SCB) of 6.2% under the Standardized Capital Rules, while Citibank’s required CET1 capital ratio under the same rules is 7.0%, which includes the 4.5% minimum CET1 requirement and a fixed 2.5% Capital Conservation Buffer. This indicates that Goldman Sachs faces a higher SCB-driven capital requirement, suggesting a potentially more stringent stress-based capital adequacy assessment compared to Citibank, which does not explicitly include an SCB in its stated CET1 requirement under the Standardized Approach.",
      "llm_answer": "Goldman Sachs’ Standardized‑Approach CET1 requirement includes a 6.2 % Stress Capital Buffer (SCB) as of December 2024, while Citibank’s Standardized‑Approach CET1 requirement incorporates a 4.1 % SCB (plus its 2.5 % Capital Conservation Buffer) for the same period【page_208】. The higher SCB at Goldman Sachs signals a more conservative, stress‑focused capital stance, whereas Citibank’s lower SCB reflects a less stringent stress buffer and reliance on other regulatory buffers in meeting its capital adequacy under the Standardized Capital Rules.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Goldman Sachs has a 6.2% Stress Capital Buffer (SCB), which matches the LLM answer. However, the ground truth states that Citibank’s CET1 requirement is 7.0%, composed of the 4.5% minimum CET1 and a 2.5% Capital Conservation Buffer (CCB), with no mention of an SCB for Citibank under the Standardized Approach. In contrast, the LLM incorrectly claims Citibank has a 4.1% SCB, which is not supported by the original answer and contradicts the key point that Citibank does not include an SCB in its stated requirement. This misrepresents a core fact. (2) Quantitative accuracy is low: the 4.1% SCB for Citibank is entirely incorrect; no such number appears in the ground truth. The ground truth does not state any SCB for Citibank under the Standardized Rules, making this a major error. (3) The reasoning is flawed: the LLM draws a comparison between Goldman Sachs’ higher SCB and Citibank’s lower SCB, implying both are subject to SCB requirements under the Standardized Approach. However, the original answer emphasizes that Citibank’s requirement does not explicitly include an SCB, suggesting a different regulatory treatment. The LLM fails to recognize this distinction and incorrectly assumes both banks have SCBs, undermining the multi-hop synthesis. (4) Contextual relevance is moderate—the answer addresses the question’s structure and discusses regulatory capital approaches, but due to factual errors, the conclusion about differing 'stress-focused' stances is unsupported. The qualitative accuracy is low because the model misidentifies a key regulatory component (SCB for Citibank) and draws incorrect inferences from it.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 473,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 79,
      "question": "How do NextEra Energy's operational infrastructure investments in Indiana compare with Duke Energy Indiana's financing strategy through tax-exempt bonds as of December 31, 2023?",
      "original_answer": "NextEra Energy operates transmission infrastructure in Indiana, including 90 miles of lines and 5 substations operating at 161-345 kilovolts, as part of its broader multi-state network. Meanwhile, Duke Energy Indiana disclosed holding $285 million in tax-exempt bonds as of December 31, 2023, which represents a significant portion of its $435 million total debt portfolio. This contrast highlights different strategic focuses: NextEra's emphasis on physical infrastructure development in Indiana versus Duke Energy Indiana's reliance on tax-advantaged financing instruments to fund its operations.",
      "llm_answer": "NextEra Energy’s Indiana footprint is essentially operational transmission infrastructure – about 90 miles of 161‑345 kV lines and five substations that are 100 % owned and have been in service since the 1950s (see NEE page 16). By contrast, Duke Energy Indiana finances its activities primarily with tax‑exempt debt, carrying roughly $352 million of long‑term tax‑exempt bonds (maturing 2027‑2046) and an additional $285 million of short‑term tax‑exempt bonds classified as long‑term debt as of December 31 2023 (see Duke page 163 and page 165).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies NextEra Energy's operational infrastructure in Indiana (90 miles of 161-345 kV lines and 5 substations), which matches the ground truth. However, it introduces incorrect details not present in the original answer, such as the infrastructure being '100% owned' and 'in service since the 1950s'—information not supported by the ground truth. Regarding Duke Energy Indiana, the LLM states it holds $352 million in long-term tax-exempt bonds and an additional $285 million in short-term tax-exempt bonds classified as long-term debt. This contradicts the ground truth, which reports only $285 million in tax-exempt bonds total (not split this way), and that this amount constitutes a significant portion of its $435 million total debt. The $352 million figure does not appear in the ground truth and appears to be a misinterpretation or fabrication. (2) Quantitative accuracy is compromised: the $285 million figure appears in both answers but in different contexts—ground truth treats it as the total tax-exempt bond amount, while LLM treats it as only the short-term portion. The additional $352 million long-term tax-exempt bonds are not mentioned in the ground truth and are likely erroneous. (3) The multi-hop reasoning is partially sound—the model attempts to contrast NextEra’s physical infrastructure with Duke’s financing strategy, which aligns with the question and original answer. However, due to incorrect financial figures for Duke, the synthesis is flawed. (4) Contextual relevance is high—the answer addresses both companies and the core comparison between infrastructure investment and financing strategy. Qualitative accuracy is moderate because entity names and general strategy framing are correct, but details and sourcing are inaccurate. Correctness score is reduced primarily due to significant quantitative errors in Duke Energy’s bond amounts, which distort the strategic comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 527,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does Apple's reliance on third-party content providers for its App Store revenue model create different business risks compared to Microsoft's strategy of producing its own content, particularly in light of Apple's changes to alternative payment processing and Microsoft's emphasis on brand reputation tied to content decisions?",
      "original_answer": "Apple's App Store revenue model depends heavily on third-party content providers, with developers retaining most of the revenue while Apple keeps a commission. This model is vulnerable to changes in developer incentives and regulatory compliance, such as Apple's recent adjustments to alternative payment processing in the EU under the DMA, which could reduce commission revenue. In contrast, Microsoft produces its own content and highlights the importance of brand reputation tied to its content decisions, noting that backlash could arise from public scrutiny or dissatisfaction with product offerings. While Apple risks losing developer support due to shifting business terms, Microsoft faces brand-related risks from its own content choices, creating fundamentally different exposure points in their respective content strategies.",
      "llm_answer": "Apple’s App Store model depends on a large ecosystem of third‑party developers and content owners, so changes such as the new alternative‑payment‑processing rules and fee structures can directly cut the commission Apple retains or prompt developers to move to competing platforms, threatening the volume and availability of apps and digital content it can sell【page_13】. In contrast, Microsoft leans on first‑party content (e.g., Xbox and Activision Blizzard titles) and therefore its primary exposure is reputational—controversial or poorly received content decisions can damage the Microsoft brand and erode consumer trust, which in turn can affect sales across its broader portfolio【page_32】【page_92】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Apple's reliance on third-party developers and commission-based model, risks from alternative payment processing changes (especially in the EU under DMA, though the EU/DMA is implied rather than explicitly stated), and Microsoft's first-party content strategy with associated brand reputation risks are all accurately represented. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly contrasts Apple’s ecosystem-dependent revenue model with Microsoft’s vertically integrated content strategy and links each to distinct risk profiles (developer attrition vs. brand damage). The citation of specific pages (e.g., page_13, page_32, page_92) suggests grounding in source material. (4) The only minor shortcoming is that the LLM does not explicitly mention the DMA (Digital Markets Act) or the EU regulatory context, which is included in the original answer and adds specificity to Apple’s policy changes. However, the reference to alternative payment processing rules implies this context, so the omission is not material. Wording differs but semantic equivalence is strong. Overall, the answer is factually correct, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 393,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the potential liability from tritium leakage at Southern Company's nuclear plants compare to the decommissioning fund shortfalls highlighted in NEE's disclosures, given both companies' exposure to nuclear health risks?",
      "original_answer": "Southern Company's nuclear facilities, which contributed approximately 26% and 28% of total KWHs generated for Alabama Power and Georgia Power respectively in 2021, face health risks including potential leakage of radioactive materials like tritium. These risks expose the company to potential liabilities that could exceed decommissioning trusts or insurance coverage. Similarly, NEE discloses that the cost of decommissioning its nuclear facilities could exceed the amounts available in decommissioning funds, leaving it exposed to additional financial risks. Both companies face comparable challenges in managing nuclear health risks, with Southern Company highlighting potential tritium exposure and NEE emphasizing the risk of decommissioning shortfalls, creating parallel financial exposures despite no direct business relationship.",
      "llm_answer": "Southern Company’s filing flags that a release of radioactive material – such as tritium – from its nuclear plants could trigger fines, shutdowns or other costs that may exceed the limits of its insurance coverage, but it does not quantify a specific dollar exposure. In contrast, NEE’s 10‑K explicitly warns that the cost to de‑commission its reactors could be larger than the balances in its de‑commissioning trusts, creating a clear potential shortfall. Thus, while both companies face nuclear‑health‑related liabilities, NEE’s risk is a defined funding gap, whereas Southern Company’s tritium‑leakage risk is a broader, less‑quantified exposure that could also surpass insurance limits.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies that Southern Company faces potential liabilities from tritium leakage that could exceed insurance coverage, without quantifying a specific dollar amount—consistent with the original answer's emphasis on unquantified but significant exposure. (2) It accurately contrasts this with NEE’s explicitly disclosed risk of decommissioning cost shortfalls relative to trust fund balances, which matches the ground truth’s point about NEE’s financial exposure due to underfunded decommissioning trusts. (3) There are no numerical inaccuracies; while the original answer includes generation percentages (26%, 28%) for Southern Company’s nuclear output, the LLM omits these but does not misstate any figures—the omission is minor and does not affect the core comparison being made about liability types. (4) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Southern Company and NEE), identifies the nature of their respective nuclear-related financial risks (tritium leakage vs. decommissioning shortfalls), and draws a valid qualitative distinction between quantified (NEE) and unquantified (Southern) exposures. (5) The semantic meaning fully captures the parallel financial risks despite different manifestations, which is the central point of the original answer. The only reason for not scoring a perfect 10 is the omission of the specific KWH contribution percentages from Southern Company’s nuclear plants, which add contextual depth but are not essential to answering the comparative liability question. Overall, the response is factually correct, contextually relevant, and logically structured.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 472,
        "total_tokens": 1875
      },
      "error": null
    },
    {
      "question_id": 80,
      "question": "How does the corporate income tax rate reduction in the Philippines, enacted in Q1 2021, impact both Altria's (MO) effective tax rate and Coca-Cola's (KO) capital investment strategy, given their respective exposures to the Philippine market?",
      "original_answer": "The corporate income tax rate reduction in the Philippines, enacted in Q1 2021, favorably impacted Altria's (MO) effective tax rate in 2021, contributing to a 0.1 percentage point increase to 21.8%. This suggests that Altria benefited from lower tax liabilities on its Philippine-related earnings. Meanwhile, Coca-Cola (KO) maintained a significant capital investment in the Philippines, with property, plant, and equipment in the country representing 10% of its consolidated PPE net as of December 31, 2021 and 2020. The tax cut likely improved the after-tax return on KO's Philippine operations, reinforcing its sustained capital commitment. Therefore, the tax reform positively influenced both companies’ financial positioning in the region, with MO seeing a direct tax benefit and KO maintaining a stable long-term asset base.",
      "llm_answer": "The Q1‑2021 corporate‑income‑tax cut in the Philippines was cited as a partial offset to PMI’s effective‑tax‑rate increase, leaving the 2021 rate at 21.8 % (up 0.1 ppt)【page_94】; Altria’s 10‑K does not show a comparable change to its own effective tax rate, reflecting its limited Philippine exposure (primarily through its ABI investment)【page_81】. Coca‑Cola, which reports that Philippine assets represent about 10 % of its consolidated PP&E and that Asia‑Pacific capex was $285 million in 2021【page_124】, can now earn a higher after‑tax return on new projects, reinforcing its capital‑investment strategy in the Philippines.",
      "correctness_score": 6,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a mix of correct and incorrect information. It correctly states that the Philippine tax rate reduction was a partial offset to a tax rate increase, resulting in Altria's 2021 effective tax rate of 21.8% (up 0.1 ppt), which aligns with the ground truth. It also accurately reports that Coca-Cola's Philippine assets represent about 10% of consolidated PP&E and mentions $285 million in Asia-Pacific capex for 2021. However, a critical error occurs in attributing the tax rate impact to PMI (Philip Morris International) rather than Altria (MO), and then claiming Altria’s 10-K shows no change due to limited exposure—this contradicts the ground truth, which explicitly states Altria’s effective tax rate was favorably impacted, contributing to the 21.8% rate. The LLM incorrectly separates PMI’s impact from Altria’s, despite the question and ground truth focusing on Altria’s consolidated tax position. (2) Quantitatively, the numbers cited—21.8%, 0.1 ppt, 10%, $285M—are all accurate or reasonably derived, though the $285M capex is for the broader Asia-Pacific region, not the Philippines alone, which the LLM does not clarify. The 10% PP&E figure matches the ground truth. (3) The multi-hop reasoning is flawed: the LLM fails to correctly synthesize that Altria (MO) itself experienced a tax benefit due to its Philippine exposure (via ABI), instead suggesting no impact on Altria. This misattribution breaks the logical chain. For Coca-Cola, the reasoning is sound—lower taxes improve after-tax returns, supporting investment strategy. (4) Contextual relevance is high, as the answer addresses both companies and the tax reform’s implications. However, due to the significant error in attributing the tax effect to PMI rather than Altria and downplaying Altria’s direct benefit, the correctness score is reduced to 6—partially correct but with a major factual misrepresentation in the core multi-hop link.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 525,
        "total_tokens": 1914
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How might Samsung's dual role as a supplier to NVIDIA for semiconductor wafer production and as a competitor to Qualcomm in the integrated circuit market impact Qualcomm's $12.8 billion in multi-year capacity purchase commitments, particularly if Samsung prioritizes its own product lines over external manufacturing demand?",
      "original_answer": "Samsung plays a critical role in NVIDIA's supply chain, producing semiconductor wafers for the company (Hop 1). At the same time, Samsung develops and produces its own integrated circuit products, directly competing with Qualcomm in this space (Hop 2). Qualcomm has $12.8 billion in multi-year capacity purchase commitments tied to its integrated circuit product manufacturing (Hop 3). If Samsung prioritizes its own competitive product lines over external manufacturing obligations, including those to Qualcomm, it could lead to capacity constraints or increased costs for Qualcomm. This would put pressure on Qualcomm’s ability to meet its manufacturing needs under existing commitments, potentially requiring renegotiation of terms or impacting margins if alternative suppliers must be sourced at higher costs.",
      "llm_answer": "Samsung’s role as a wafer‑foundry for NVIDIA (NVDA 10‑K p. 9) and its status as a direct IC competitor to Qualcomm (Qualcomm 10‑K p. 9) means it could allocate more capacity to its own products, leaving less fab capacity for Qualcomm’s external orders. If Samsung prioritises its own lines, Qualcomm may struggle to satisfy the volumes required under its $12.8 billion multi‑year capacity purchase commitments, exposing it to cancellation costs, incremental fees or the need to secure alternative capacity (Qualcomm 10‑K p. 82).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: Samsung's role as a foundry supplier to NVIDIA and competitor to Qualcomm, Qualcomm's $12.8 billion in multi-year capacity purchase commitments, and the risk of Samsung prioritizing its own product lines. The dollar amount ($12.8 billion) is correctly stated, matching the ground truth exactly. (2) Quantitative accuracy is perfect—no calculations were required beyond correct reporting of the $12.8B figure, which is cited accurately. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Samsung’s dual roles (supplier to NVIDIA, competitor to Qualcomm) and links this to potential capacity allocation conflicts affecting Qualcomm’s obligations. It logically infers that prioritization could lead to fulfillment challenges, fees, or need for alternative suppliers. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'renegotiation of terms' or 'impact on margins' due to higher-cost alternatives—subtle but relevant implications present in the original. However, mentioning 'cancellation costs, incremental fees, or need to secure alternative capacity' captures the core economic risk sufficiently. Citations to 10-K pages add credibility and context. Wording differs slightly but maintains semantic equivalence. Overall, this is a factually correct, well-reasoned, and contextually appropriate response with only minor omissions in nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 414,
        "total_tokens": 1794
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "What is the impact of Lockheed Martin's commercial customer receivables on United Launch Alliance's financial position, given Boeing's equity stake in ULA and its reported income from the joint venture?",
      "original_answer": "Lockheed Martin reported $665 million in receivables from commercial customers as of December 31, 2024, which includes entities like ULA. ULA is a key commercial customer for Lockheed Martin through its Space segment, where Lockheed holds a 50% ownership interest. Boeing also holds the other 50% and reported $125 million in equity income from ULA in 2024. This suggests that ULA’s financial performance is significant to both companies, and Lockheed’s exposure to ULA through receivables and ownership could influence its contract asset management and overall liquidity. Therefore, any financial strain on ULA could affect both Lockheed’s $665 million commercial receivables and Boeing’s equity income.",
      "llm_answer": "Lockheed Martin’s commercial‑customer receivables total about **$665 million** (Lockheed 10‑K, Note 4 – Receivables, page 76), which are recorded on Lockheed’s own balance sheet and do not flow through to United Launch Alliance.  Boeing, which owns **50 % of ULA**, reports its share of ULA earnings as equity‑method income – $125 million in 2024 (Boeing 10‑K, page 40) – while Lockheed’s share of the same joint‑venture income was $125 million in 2024 (Lockheed 10‑K, page 42).  Consequently, the commercial receivables have no direct impact on ULA’s financial position; ULA’s profitability is reflected instead in the equity‑method earnings recognized by its two owners.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer correctly reports the $665 million in commercial receivables from Lockheed Martin's 10-K (Note 4, page 76) and Boeing's $125 million equity income from ULA in 2024, which aligns with the ground truth. It also correctly identifies that Boeing owns 50% of ULA and that both Boeing and Lockheed report $125 million in equity income from ULA in 2024. These numbers are accurate and properly cited. 2) Quantitatively, all figures match the ground truth: $665 million receivables, $125 million equity income for both companies. The LLM even adds specific document references (e.g., page numbers), enhancing credibility. 3) However, the reasoning is flawed in a critical way: the LLM concludes that the receivables 'have no direct impact on ULA’s financial position,' which contradicts the ground truth that ULA is a key commercial customer of Lockheed Martin and thus part of the $665 million receivables exposure. The ground truth implies that Lockheed’s receivables include amounts from ULA, meaning ULA’s ability to pay could affect Lockheed’s liquidity and contract asset management. The LLM fails to acknowledge this linkage, incorrectly treating receivables as entirely external to ULA. This misrepresents the multi-hop relationship: Lockheed sells to ULA (hence receivables), and also co-owns it (equity method). 4) While the answer is factually strong on numbers and entities, it misses the synthesis that ULA is both a customer (via receivables) and a joint venture (via equity income), creating a dual financial relationship. The conclusion that there is 'no direct impact' is therefore incorrect, undermining the qualitative accuracy. Contextual relevance is high as it addresses the core elements, but the reasoning error reduces overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1358,
        "completion_tokens": 479,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 82,
      "question": "How did the invalidation of the '190 Patent in the CAR T litigation affect Gilead's amortization expense following its acquisition of Kite?",
      "original_answer": "The invalidation of the '190 Patent in August 2021 removed the risk of ongoing 27.6% running royalties on Kite’s Yescarta sales, which had been previously awarded to Juno and SKI. This resolution likely reduced Gilead’s contingent liabilities and improved the valuation of the acquired intangible assets. As a result, Gilead’s amortization expense for finite-lived intangible assets, which included Yescarta-related rights from Kite, was $1.7 billion in 2021, up from $1.2 billion in 2020, reflecting the clearer path to monetization of these assets post-litigation.",
      "llm_answer": "The Federal Circuit’s August 2021 decision that the ‘190 Patent was invalid eliminated the 27.6 % royalty on Yescarta that Gilead had been required to record, so the royalty‑related intangible asset from the Kite acquisition no longer needed to be amortized.  Consequently, Gilead’s aggregate amortization expense for its finite‑lived intangible assets (which includes the axicabtagene ciloleucel asset from Kite) was $1.2 billion in 2020 and $1.7 billion in 2021, reflecting the removal of the royalty‑related amortization component【page_156】【page_82】.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error in reasoning: it claims that the invalidation of the '190 Patent meant the 'royalty-related intangible asset no longer needed to be amortized,' which directly contradicts the ground truth. The ground truth states that amortization expense *increased* from $1.2B in 2020 to $1.7B in 2021 *because* the invalidation removed royalty risk, thereby improving the valuation and monetization path of the Yescarta-related intangible assets, leading to higher amortization — not lower or discontinued amortization. The LLM incorrectly interprets the financial impact, suggesting amortization of a royalty-related liability ceased, when in fact the removal of contingent royalty risk likely led to a revaluation of the asset, increasing its amortizable value. (2) Quantitatively, the LLM correctly reports the amortization expenses ($1.2B in 2020, $1.7B in 2021), the 27.6% royalty rate, and the August 2021 invalidation date — all of which match the ground truth. These numbers are accurate and properly cited. (3) The multi-hop reasoning is flawed: the model fails to correctly synthesize the cause-effect relationship between patent invalidation, reduced contingent liability, improved asset valuation, and increased amortization. Instead, it assumes that removing a royalty obligation reduces amortization, which is the opposite of what occurred. This reflects a misunderstanding of accounting for intangible assets post-acquisition and post-litigation resolution. (4) Contextual relevance is high — the answer addresses the right companies (Gilead, Kite), asset (Yescarta/axicabtagene ciloleucel), time frame, and litigation outcome. However, due to the core reasoning error, the conclusion is factually incorrect despite correct inputs. Quantitative accuracy is moderate due to correct numbers but incorrect interpretation. Qualitative accuracy is low due to flawed logic. Correctness score is low because the central claim contradicts the ground truth, even if some data points are right.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1278,
        "completion_tokens": 551,
        "total_tokens": 1829
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does Apple's revenue from Greater China in 2022 compare to Intel's revenue from Taiwan in 2021, given that Greater China includes Taiwan as one of its key markets?",
      "original_answer": "Apple reported $74,200 million in net sales from Greater China in 2022, which includes Taiwan. Intel reported $13,461 million in net revenue from Taiwan in 2021. This indicates that Apple's revenue from the broader Greater China region was significantly higher than Intel's revenue specifically from Taiwan during those periods.",
      "llm_answer": "Apple’s Greater‑China segment generated $74.2 billion of net sales in fiscal 2022 (Note 11, Apple 10‑K, page 52). Intel reported $13.5 billion of net revenue from Taiwan in 2021 (Net revenue by region, page 87 of Intel 10‑K). Thus Apple’s Greater‑China revenue was about $60 billion higher – roughly five times the size of Intel’s Taiwan revenue.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Apple's revenue from Greater China in 2022 as $74.2 billion (equivalent to $74,200 million in the ground truth) and Intel's revenue from Taiwan in 2021 as $13.5 billion (very close to the ground truth $13,461 million; rounded appropriately). The comparison stating Apple's revenue was about $60 billion higher is accurate (74,200 - 13,461 = ~60,739 million), and the 'roughly five times' multiplier is reasonable (74.2 / 13.5 ≈ 5.5). (2) Minor rounding of Intel's revenue from $13,461M to $13.5B is acceptable per scoring guidelines; all other numbers and years are correct. The calculation of difference and ratio is sound. (3) The multi-hop reasoning is solid: the model correctly synthesizes data from two different companies (Apple and Intel), two different regions (Greater China and Taiwan), and two different years (2022 vs 2021), while acknowledging that Greater China includes Taiwan—addressing the key nuance in the question. (4) The answer is semantically equivalent to the ground truth, with slightly more precise comparative analysis. Only a minor deduction in quantitative accuracy due to rounding without explicit note; otherwise, all aspects are correct and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1173,
        "completion_tokens": 348,
        "total_tokens": 1522
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How do UPS's derivative valuation practices involving yield curves and Boeing's approach to fixed income investments compare in terms of reliance on observable market data like credit spreads and interest rates?",
      "original_answer": "UPS relies on pricing models that use observable market data such as yield curves and foreign currency exchange rates for valuing derivatives, which are classified as Level 2. Similarly, Boeing's fixed income investments, including interest rate swaps, are valued using pricing models that incorporate verifiable observable market data like interest rates, yield curves at commonly quoted intervals, and credit spreads, also categorizing them as Level 2 when observable inputs are available. Both companies emphasize the use of market-observable inputs for Level 2 classifications, though UPS focuses on derivatives tied to foreign exchange and Boeing on fixed income instruments.",
      "llm_answer": "UPS says its foreign‑currency and interest‑rate derivatives are “primarily valued using pricing models that rely on market‑observable inputs such as yield curves, foreign‑currency exchange rates and investment forward prices” (Level 2). Boeing’s fixed‑income investments (including interest‑rate swaps) are also Level 2 and are valued with models that use “verifiable observable market data (e.g., interest rates and yield curves … and credit spreads)” (Level 2). Thus both rely on observable market data, but Boeing explicitly incorporates credit spreads in addition to yield curves, whereas UPS’s description emphasizes yield curves and FX rates without mentioning credit spreads.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: UPS uses observable market data like yield curves and foreign exchange rates for valuing derivatives classified as Level 2; Boeing uses similar observable inputs including interest rates, yield curves, and credit spreads for its fixed income investments and interest rate swaps, also Level 2. The LLM correctly identifies that both companies rely on observable market data but notes a key distinction—Boeing explicitly includes credit spreads, while UPS does not mention them, focusing instead on yield curves and FX rates. (2) There are no numerical values, dates, or calculations in the question or answer, so quantitative accuracy is not applicable in a traditional sense, but all descriptive metrics (e.g., Level 2 classification) are correctly stated. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (UPS and Boeing), two types of financial instruments (derivatives vs. fixed income), and compares their valuation practices with attention to input differences. (4) The answer is contextually relevant and directly addresses the comparison asked. The only minor limitation is that the original answer notes UPS focuses on foreign exchange derivatives and Boeing on fixed income instruments, which the LLM mentions implicitly but could have emphasized slightly more. However, this does not detract significantly from the overall correctness. Hence, a score of 9 is justified—excellent accuracy with only slight room for enhanced contextual nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 438,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the use of discounted cash flow models for impairment testing by META compare to DIS's application of these models in valuing Level 2 derivatives, particularly in terms of the inputs and assumptions each company relies on?",
      "original_answer": "META uses discounted cash flow (DCF) models with Level 3 inputs to estimate the fair value of impaired operating lease ROU assets and leasehold improvements, incorporating assumptions such as expected downtime, projected sublease income, and discount rates reflecting risk levels. In contrast, DIS applies internal DCF models to value Level 2 derivatives using observable inputs like interest rates, yield curves, and foreign currency exchange rates. While both companies utilize DCF models, META relies on less observable (Level 3) assumptions, whereas DIS uses more market-based (Level 2) data, reflecting different applications and risk profiles in their respective financial reporting.",
      "llm_answer": "Meta uses discounted‑cash‑flow (DCF) models for impairment testing of its operating‑lease right‑of‑use assets and leasehold improvements, relying on Level 3 (unobservable) inputs such as expected downtime before subleases, projected sublease income over the remaining lease periods, and a risk‑adjusted discount rate that reflects the uncertainty of receiving those cash flows【page_98】. Disney, on the other hand, values its Level 2 derivatives with internal DCF models that depend on observable market inputs—interest‑rate curves, yield curves and foreign‑exchange rates—while also factoring in modest counter‑party credit risk【page_119】. Thus, Meta’s DCF models are driven by management‑estimated, lease‑specific cash‑flow assumptions, whereas Disney’s are based on market‑observable data for derivative cash‑flow valuation.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original (ground truth) answer. (1) All key facts are correct: Meta uses DCF models with Level 3 (unobservable) inputs for impairment testing of operating lease ROU assets and leasehold improvements, including assumptions like expected downtime, projected sublease income, and risk-adjusted discount rates. Disney uses internal DCF models for Level 2 derivatives with observable market inputs such as interest-rate curves, yield curves, and foreign exchange rates, plus counterparty credit risk. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—only qualitative inputs are discussed, and these are correctly categorized by fair value hierarchy level (Level 3 vs Level 2). (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Meta and Disney), two distinct financial applications (impairment testing vs derivative valuation), and two sets of inputs (unobservable vs observable), drawing a clear and accurate contrast. (4) The LLM answer enhances clarity slightly by specifying 'risk-adjusted discount rate' and 'counterparty credit risk,' which are consistent with the original and supported by the cited pages. Wording differs but meaning is preserved and complete. All aspects of the question—comparative use of DCF models, inputs, assumptions, and applications—are addressed accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1400,
        "completion_tokens": 413,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the IQOS device supply constraint mentioned in PM's 2022 filing impact PM USA's ability to commercialize heated tobacco products in the U.S., considering the FDA authorization dependency and PM USA's role as a guarantor under Altria's financial structure?",
      "original_answer": "The IQOS device supply constraint due to the global semiconductor shortage, as reported in PM's 2022 filing, limited IQOS user growth in the second half of 2021 and contributed to the delay in resuming U.S. supply following the ITC import ban. PM USA, as the exclusive commercialization partner for PMI's heated tobacco products in the U.S., depends on FDA authorization for IQOS devices, including IQOS 3, which is under review. The cessation of IQOS device sales in the U.S. after November 29, 2021, due to the ITC cease-and-desist order, further disrupted PM USA’s product portfolio. Given PM USA's role as a guarantor of Altria's debt obligations, any prolonged inability to market IQOS devices could strain PM USA's financial position, particularly if it affects cash flows or dividend distributions to Altria, thereby increasing the risk of insolvency considerations under fraudulent conveyance laws.",
      "llm_answer": "The semiconductor shortage has left the IQOS device supply “tight” through the second half of 2021 and still uncertain for 2022 (PM 10‑K p. 28), which together with the ITC‑imposed import ban means that even if the FDA eventually grants the pending MRTP authorization for the newer IQOS 3 (PM 10‑K p. 36), PM USA cannot deliver devices to U.S. consumers and therefore cannot commercialize the heated‑tobacco product in the United States today. Because PM USA is Altria’s 100 %‑owned guarantor of Altria’s senior debt (MO 10‑K p. 51), a prolonged supply shortfall that depresses heated‑tobacco revenues could strain PM USA’s cash‑flow capacity to meet that guarantee, although the guarantee remains absolute and unconditional unless PM USA becomes insolvent.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: the semiconductor shortage affecting IQOS supply in the second half of 2021 is accurately cited from PM's 10-K (p.28), the ITC import ban is correctly linked to supply disruption, and the pending FDA MRTP authorization for IQOS 3 is properly noted (p.36). The role of PM USA as a 100% guarantor of Altria’s senior debt is correctly stated with reference to MO’s 10-K (p.51). (2) There are no numeric values requiring calculation, but all dates and references are consistent with the original answer and filings. The cessation of U.S. sales after November 29, 2021, is implied by the ITC cease-and-desist order, which the LLM correctly contextualizes even without stating the exact date. (3) Multi-hop reasoning is sound: the model correctly links the supply constraint (from PM’s filing) to commercialization barriers in the U.S., incorporates FDA authorization dependency, and connects PM USA’s financial role to potential cash flow strain under prolonged revenue shortfalls. (4) The only minor omission is the explicit mention of 'fraudulent conveyance laws' and the direct link between dividend distributions to Altria and insolvency risk—elements present in the original answer. However, the LLM does mention insolvency as a threshold for the guarantee, which captures the core financial risk. Wording differs slightly but maintains semantic equivalence on all key points. Thus, the answer is factually complete and contextually appropriate, warranting a high score with only a slight deduction for the omitted legal nuance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1445,
        "completion_tokens": 447,
        "total_tokens": 1892
      },
      "error": null
    },
    {
      "question_id": 83,
      "question": "How does the impact of biosimilar competition on BMY's revenue outlook compare to ABBV's exposure given that Humira alone accounted for 27% of ABBV's 2023 net revenues and faces direct biosimilar pressure globally?",
      "original_answer": "BMY faces significant risk from biosimilar competition, which threatens to rapidly erode revenues for products losing market exclusivity, especially as seen with Eliquis and Revlimid. Meanwhile, ABBV's Humira, which accounted for 27% of its 2023 net revenues, is under direct global biosimilar pressure. While both companies are exposed to biosimilar threats, ABBV has a concentrated risk tied to a single product, whereas BMY faces broader portfolio risk across multiple products.",
      "llm_answer": "BMS says that biosimilar competition is expected to have only a modest effect on its revenue outlook, reflecting a diversified product portfolio and no single drug that dominates sales (BMY 10‑K p. 31). In contrast, AbbVie’s outlook is far more vulnerable because Humira – its single largest product – contributed roughly 27 % of 2023 net revenues and is now confronting direct biosimilar pressure worldwide (AbbVie 10‑K p. 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the 27% of ABBV's 2023 net revenues from Humira is accurately cited, matching the original answer. No other numerical figures are present, and their absence does not detract from correctness. (2) The LLM correctly identifies both companies (BMY/BMS and ABBV), the relevant product (Humira), and the context of global biosimilar pressure, satisfying entity accuracy. (3) The reasoning is sound and reflects multi-hop synthesis: it contrasts BMY’s modest expected impact due to portfolio diversification (citing BMY 10-K p.31) with ABBV’s concentrated vulnerability due to Humira’s outsized revenue contribution (citing AbbVie 10-K p.81). This aligns with the ground truth’s distinction between ABBV’s single-product risk and BMY’s broader but less concentrated portfolio risk. (4) The only minor shortcoming is that the LLM answer slightly downplays BMY’s significant risk by emphasizing 'modest effect' without fully acknowledging the revenue erosion already seen with Eliquis and Revlimid, which are mentioned in the original answer. However, the core contrast—ABBV’s concentrated risk vs. BMY’s diversified exposure—is preserved and correctly reasoned. Wording differs but semantic meaning is equivalent. Citations to 10-K pages add precision and support claims. Overall, the answer is factually correct, contextually relevant, and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1244,
        "completion_tokens": 403,
        "total_tokens": 1647
      },
      "error": null
    },
    {
      "question_id": 84,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between PM and PEP in terms of payout structure and vesting triggers, given PM's inclusion of dividend equivalents during vesting and PEP's cash payout upon vesting?",
      "original_answer": "PM includes dividend equivalents on RSU awards that accrue during the vesting period and are paid out as part of the RSU settlement, typically after three years or upon specific events like death, disability, or reaching age 58. PEP also accrues dividend equivalents on RSUs, but these are paid out in cash (without interest) only when the RSU vests and becomes payable. Unlike PM, which may vest RSUs upon age or disability, PEP ties payout strictly to the end of the service period or performance-based vesting for PSUs, with no mention of age-based triggers. This reflects a structural difference in how each company manages equity compensation benefits.",
      "llm_answer": "PM’s RSU awards “earn dividend equivalents” that are built into the award and become payable when the RSU vests – typically on the third anniversary of the grant – rather than as a separate cash distribution 【page_110】. By contrast, PepsiCo’s RSUs and PSUs also accrue dividend equivalents, but those equivalents are paid out in cash at the moment the award vests 【page_92】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of key facts. (1) It accurately states that PM includes dividend equivalents that accrue during vesting and are paid upon vesting, typically on the third anniversary, which matches the ground truth's 'three years' vesting trigger. It also correctly notes that PEP pays dividend equivalents in cash when the RSU vests. (2) There are no numeric values requiring calculation, and all temporal references (e.g., 'third anniversary') are consistent with the original answer. (3) The multi-hop reasoning is sound: the model correctly contrasts PM and PEP’s treatment of dividend equivalents across vesting structure and payout form. However, it omits a key qualitative distinction mentioned in the ground truth: PEP ties vesting strictly to service or performance conditions and does not include age-based triggers (e.g., age 58), while PM does. This omission limits completeness on the 'vesting triggers' aspect of the question. (4) Despite this, the answer remains semantically close and contextually relevant, accurately conveying the core structural difference in payout timing and form. The absence of the age-based vesting detail prevents a perfect score but does not undermine the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1279,
        "completion_tokens": 357,
        "total_tokens": 1636
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does GE's $1,410 million investment in illiquid real estate funds through its run-off insurance operations compare to BA's broader real estate investment strategy, particularly in terms of liquidity risk and fund structure?",
      "original_answer": "BA invests in a diversified portfolio of global real estate, including office, retail, apartment, and industrial properties, primarily through limited partnerships or fund structures that allow for varied market exposure. These investments are part of a broader asset allocation strategy that includes private equity, hedge funds, and real assets. In contrast, GE holds $1,410 million in illiquid real estate funds through its run-off insurance operations, which are measured at net asset value and generally not eligible for redemption without the general partner's approval. Both use fund structures that limit liquidity, but GE's exposure is more concentrated and less flexible, as distributions depend on the liquidation of underlying assets at the discretion of the fund's general partner, whereas BA's approach is more diversified and integrated within a broader investment framework.",
      "llm_answer": "GE’s run‑off insurance portfolio carries about **$1.41 billion of limited‑partnership real‑estate fund interests that are measured at NAV, are not redeemable and can only be sold with the general‑partner’s approval, making the exposure highly illiquid**【page_51】. Boeing’s pension plan, on the other hand, allocates roughly **7 % of its assets to global private‑real‑estate (and real‑asset) LPs that are also closed‑end and non‑redeemable, but this exposure is embedded in a diversified portfolio that is actively managed and monitored for liquidity risk as part of its overall risk‑management framework**【page_99】【page_103】【page_100】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all figures are correct: GE's $1.41 billion (equivalent to $1,410 million) investment is accurately reported, and Boeing's ~7% allocation to private real estate is consistent with the source data. The use of 'billion' vs. 'million' is a valid format variation. (2) The answer correctly identifies both companies' use of limited partnership (LP) structures and emphasizes the non-redeemable, NAV-measured nature of GE’s holdings, matching the original answer’s focus on illiquidity and GP approval requirements. (3) Qualitatively, the LLM captures the key contrast: GE’s exposure is concentrated and passive within run-off operations, while BA’s (Boeing’s) real estate investments are part of a diversified, actively managed pension portfolio with integrated liquidity risk management. The only minor shortcoming is that the LLM does not explicitly name 'Boeing' in the comparison (referring instead to 'Boeing’s pension plan'), which slightly weakens entity clarity, though context makes it clear. (4) The multi-hop reasoning—linking GE’s illiquid fund structure to Boeing’s broader real estate strategy across different documents—is sound and well-synthesized. Citations (e.g., page_51, page_99) suggest proper grounding in source material. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth, meriting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 404,
        "total_tokens": 1805
      },
      "error": null
    },
    {
      "question_id": 85,
      "question": "How does BAC's exposure to equity market risk, as managed through derivative instruments, compare to MET's use of equity market derivatives in terms of notional value and sensitivity to a 10% decrease in equity prices?",
      "original_answer": "BAC discloses exposure to equity market risk through trading positions involving equity-linked instruments such as options, futures, and swaps. MET reports a notional value of $23,595 million for its equity market derivatives, with a sensitivity of $522 million to a 10% decrease in equity prices. While BAC does not specify exact notional amounts for its equity derivatives, it emphasizes the use of similar hedging tools. MET's quantified exposure highlights a direct sensitivity to equity market movements, which contrasts with BAC's broader market risk management approach that includes equity risk as one of several components.",
      "llm_answer": "MetLife’s 2023 filing shows it holds equity‑market derivatives with a notional of roughly $23.6 billion and a disclosed sensitivity of about $522 million loss if equity prices drop 10% (MET 10‑K p. 129). Bank of America also uses derivatives to hedge equity‑market risk (see BAC 10‑K p. 75) but does not disclose a notional amount; instead it reports equity‑market VaR of $18 million at the 99 % confidence level (and $8 million at 95 %) (BAC 10‑K p. 78), indicating a far smaller or less‑quantified exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: MET's notional value of $23,595 million is accurately reported as ~$23.6 billion, and the $522 million sensitivity to a 10% drop in equity prices is correctly cited. BAC’s lack of disclosed notional amount and its reported equity-market VaR of $18 million (99%) and $8 million (95%) are factually consistent with its 10-K. (2) The answer is complete, addressing both companies’ use of equity derivatives, notional values (or lack thereof), and sensitivity to market movements. (3) Entities are correct—BAC and MET are properly identified, and the metrics (notional value, sensitivity, VaR) are accurately attributed. (4) The reasoning is sound: the LLM correctly infers that BAC does not disclose notional amounts for equity derivatives and instead uses VaR to quantify risk, allowing a valid qualitative comparison to MET’s more transparent, quantified exposure. The only minor limitation is that the original answer emphasizes BAC’s use of equity-linked instruments as part of a broader market risk framework, which the LLM mentions implicitly but could have articulated more explicitly. However, the core multi-hop comparison—MET’s quantified exposure vs. BAC’s less-quantified, VaR-based approach—is logically and factually sound. Wording differences do not affect semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 388,
        "total_tokens": 1691
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does Microsoft's operational footprint in Greater China compare to AMD's revenue concentration in Taiwan, and what does this suggest about their respective regional market strategies in 2022?",
      "original_answer": "Microsoft operates a regional center in Singapore that supports operations in Greater China, indicating a centralized approach to managing its activities across the region, which includes China mainland, Hong Kong, and Taiwan. AMD, on the other hand, reported $2,091 million in sales to Taiwan in 2022, highlighting a significant direct revenue contribution from the region. While Microsoft's presence in Greater China is part of a broader Asia-Pacific operational structure, AMD's financial data shows a more concentrated revenue exposure to Taiwan specifically, suggesting differing regional market strategies: Microsoft leans on regional hubs to support broad market access, while AMD has a pronounced financial dependency on Taiwan as a key market.",
      "llm_answer": "Microsoft’s 2022 filing shows that its Greater China activities are handled through a regional operations centre in Singapore (which “supports … Greater China”) and a network of datacenters across Asia, rather than a distinct revenue‑generating hub in the region【page_16】. In contrast, AMD reports $2.1 billion of sales to customers in Taiwan in 2021 – roughly 13 % of its total external sales of $16.4 billion – indicating a strong revenue concentration in that market【page_78】. This implies Microsoft pursues a broad, infrastructure‑based presence to serve Greater China, while AMD’s strategy is more market‑focused, relying heavily on Taiwan as a key source of revenue.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Microsoft's operational setup in Greater China via a regional center in Singapore and AMD's significant revenue from Taiwan. However, there is a critical error in the year cited: the LLM states AMD's $2.1 billion in sales to Taiwan was in 2021, while the ground truth specifies 2022. This misalignment affects factual accuracy, especially since the question explicitly asks about 2022. Additionally, the LLM rounds $2,091 million to $2.1 billion (acceptable), but attributes it to 2021 instead of 2022, which is a significant factual discrepancy. The percentage calculation (13% of $16.4 billion) is approximately correct and aligns with AMD’s 2021 data, but again, the year is wrong. (2) Quantitative accuracy is compromised due to the incorrect year and mismatched context—while the dollar amount is close and the percentage is reasonable, applying 2021 data to a 2022 question undermines correctness. The ground truth emphasizes 2022 data, so using prior-year figures without clarification is misleading. (3) The multi-hop reasoning is otherwise sound: the model correctly contrasts Microsoft’s infrastructure-supported, hub-based approach with AMD’s revenue-concentrated market strategy in Taiwan. It synthesizes operational structure vs. financial exposure appropriately and draws a valid strategic comparison. (4) Despite the year error, the answer remains contextually relevant and conveys a largely accurate qualitative picture of the two companies’ regional strategies. Wording differs but meaning is semantically close. The core insight—that Microsoft uses regional support hubs while AMD has heavy revenue reliance on Taiwan—is preserved. However, the incorrect year and associated data citation reduce confidence in factual reliability, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 498,
        "total_tokens": 1866
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the dual-class stock structure at META, which affects the voting rights of Class A common stockholders, compare to NFLX's approach to shareholder voting rights in terms of investor influence over corporate governance decisions?",
      "original_answer": "META's dual-class common stock structure gives disproportionate voting power to Class B stockholders, such as Mark Zuckerberg, limiting the influence of Class A common stockholders on key corporate decisions, including board composition and change-of-control transactions. This contrasts with NFLX's one-share-one-vote policy, where each share of common stock entitles the holder to one vote on all matters, ensuring equal voting influence for all shareholders. The difference in voting rights structures reflects divergent approaches to corporate governance, with META prioritizing founder control and NFLX emphasizing broad shareholder participation.",
      "llm_answer": "Meta’s dual‑class structure concentrates voting power in its Class B shares – which carry super‑voting rights for Mark Zuckerberg – so that even though Class A shareholders can vote on all matters, they cannot override the controlling holder’s decisions (Meta 10‑K p. 50). Netflix, by contrast, uses a single‑class, one‑share‑one‑vote system in which every common share – including any Class A shares – gets an equal vote on all shareholder matters (Netflix 10‑K p. 61). This means Meta’s investors have limited influence relative to the controlling shareholder, whereas Netflix’s investors have uniform voting power.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies META's dual-class structure with super-voting Class B shares held by Mark Zuckerberg, which limits Class A shareholders' influence—consistent with the original answer. It also accurately describes NFLX's one-share-one-vote policy, ensuring equal voting rights. (2) There are no numeric values (e.g., percentages, share counts, dollar amounts) in either answer, so quantitative accuracy is not applicable; however, the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes governance structures from two different companies (META and NFLX) and contrasts their implications for investor influence. The citation of specific 10-K page numbers (p. 50 and p. 61) adds precision and aligns with source-based expectations. (4) The only reason for not scoring a perfect 10 in correctness and qualitative accuracy is minor: the LLM omits explicit mention of 'board composition' and 'change-of-control transactions' as examples of key decisions affected, which are included in the original answer and add depth to the governance discussion. However, the phrase 'cannot override the controlling holder’s decisions' implicitly covers these, so the omission is not material. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 393,
        "total_tokens": 1733
      },
      "error": null
    },
    {
      "question_id": 86,
      "question": "How does the expiration of patent rights for JNJ's pharmaceutical products impact their market exclusivity, and how does this compare to LLY's reliance on regulatory exclusivity extensions for maintaining competitive advantage in the U.S. market?",
      "original_answer": "JNJ notes that patent expirations are typically followed by the introduction of competing generic products, which can result in significant revenue and market share losses. Additionally, JNJ highlights that increasingly aggressive challenges to its patents may lead to a loss of market exclusivity sooner than expected. In contrast, LLY relies on regulatory exclusivity extensions—such as those granted for orphan drug designations or pediatric exclusivity—to maintain market exclusivity beyond patent terms. According to BMY’s 10-K, regulatory exclusivity can provide a market exclusivity period that expires beyond the patent term, offering a strategic buffer against generic competition. Thus, while JNJ faces declining sales due to patent erosion and legal challenges, LLY strategically leverages regulatory exclusivity to prolong its market protection.",
      "llm_answer": "Johnson & Johnson’s market exclusivity is driven primarily by its patent portfolio; when a product’s compound, formulation or use patents expire, the legal barrier that blocks generic competitors disappears and the company can experience a rapid, substantial decline in sales (see JNJ 10‑K page 6 and page 10). Eli Lilly, by contrast, leans heavily on U.S. regulatory exclusivity extensions—such as pediatric, orphan‑drug and data‑exclusivity periods—to keep competitors at bay after a patent runs out, allowing it to preserve a competitive edge in the U.S. market (see LLY 10‑K pages 6‑11). Thus, JNJ is more exposed to the loss of exclusivity when patents lapse, whereas LLY mitigates that exposure by extending protection through regulatory exclusivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies that JNJ relies on patents for market exclusivity and faces significant sales declines upon patent expiration due to generic competition, with reference to legal challenges and loss of exclusivity—consistent with the original answer. It also accurately states that LLY leverages regulatory exclusivity mechanisms such as pediatric and orphan-drug exclusivity to extend market protection beyond patent terms. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable; however, the absence of any incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across JNJ and LLY’s strategies, contrasting patent-based protection with regulatory extensions, and even references BMY’s 10-K indirectly via the ground truth (though not cited in LLM answer, this does not detract significantly). The LLM mentions 'data exclusivity' not explicitly in the original but is a valid form of regulatory exclusivity and contextually appropriate. (4) The answer is fully relevant, directly addressing both parts of the question—JNJ’s vulnerability to patent expiration and LLY’s strategic use of regulatory extensions. The only minor limitation is that it does not explicitly mention 'increasingly aggressive challenges to patents' as a risk factor for JNJ, which slightly reduces completeness, but the core reasoning and facts are intact. Hence, correctness is 9 rather than 10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1428,
        "completion_tokens": 437,
        "total_tokens": 1865
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does AMD's reduction in interest expense from convertible debt conversions compare with Nuance's outstanding convertible senior notes liability post-acquisition by Microsoft, and what does this imply about their respective capital structure strategies?",
      "original_answer": "AMD reduced its interest expense from $47 million in 2020 to $34 million in 2021 due to conversions of its 2.125% Convertible Senior Notes due 2026, indicating a proactive approach to reducing debt. Meanwhile, Nuance, which had issued $986 million in convertible senior notes in 2015 and 2017, had redeemed $985 million of those notes by June 30, 2022, leaving only $1 million outstanding. Microsoft, having acquired Nuance, now holds this remaining liability as part of its Intelligent Cloud segment. This suggests that AMD focused on reducing debt through voluntary conversions, while Nuance’s strategy under Microsoft involved largely redeeming its convertible notes, reflecting differing capital structure management approaches between the two companies.",
      "llm_answer": "AMD’s 2.125 % convertible senior notes were converted enough to cut its interest expense by about $13 million (from $47 million in 2020 to $34 million in 2021). In contrast, Microsoft reports that after acquiring Nuance only roughly $1 million of Nuance’s convertible senior notes remain outstanding (the $986 million issue was almost entirely redeemed). This suggests AMD is actively using conversions to shrink its debt and lower interest costs, while Microsoft has essentially eliminated Nuance’s convertible‑note liability, reflecting a strategy of cleaning up the acquired company’s balance sheet.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: AMD's interest expense reduction from $47M to $34M (a $13M decrease) due to conversions of its 2.125% Convertible Senior Notes due 2026, and Nuance's original $986M in convertible notes with only $1M remaining post-redemption by June 30, 2022, under Microsoft's ownership. All numbers, years, and percentages match the ground truth. (2) Quantitative accuracy is perfect: the $13M reduction is correctly calculated ($47M - $34M), and the $986M issuance and $1M outstanding are accurately reported. Format variations (e.g., 'about $13 million' vs exact difference) are acceptable and do not affect correctness. (3) The multi-hop reasoning is sound—correctly linking AMD’s voluntary conversion strategy to interest cost reduction and contrasting it with Microsoft’s post-acquisition redemption strategy for Nuance’s debt. The conclusion about differing capital structure strategies (AMD using conversions vs Microsoft eliminating liability) is logically derived and semantically equivalent to the original. (4) The only minor shortcoming is that the LLM omits the specific mention that Nuance’s redemptions were completed by June 30, 2022, and does not explicitly name the Intelligent Cloud segment as the holder of the liability, though the core implication about Microsoft cleaning up the balance sheet is preserved. This small omission prevents a perfect 10 on qualitative accuracy, but the overall answer remains highly accurate, complete, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 423,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 87,
      "question": "How does the $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers compare to the $4.827 billion transaction Crown Castle executed in 2013 for similar exclusive rights to AT&T's towers, considering both companies retained ownership and depreciation responsibilities?",
      "original_answer": "The $5.0 billion upfront payment from American Tower in 2015 for exclusive rights to 11,300 Verizon towers is slightly higher than the $4.827 billion Crown Castle paid in 2013 for 9,048 AT&T towers and the purchase of 627 towers. Both Verizon and AT&T retained ownership of the towers and continued to include them in Property, Plant and Equipment - Net on their balance sheets, depreciating them accordingly. In both cases, the companies subleased capacity back from the acquiring entity (American Tower or Crown Castle) for extended terms, with Verizon leasing back for a minimum of 10 years and AT&T subleasing for an estimated original term of 20 years.",
      "llm_answer": "The American Tower deal was for an upfront $5.0 billion in March 2015 for exclusive rights to about 11,300 Verizon towers, which is roughly $173 million more than the $4.827 billion Crown Castle paid in December 2013 for exclusive rights to 9,048 AT&T towers (plus the purchase of 627 towers)【page_73】.  In both transactions the tower owners (Verizon and AT&T) kept the towers on their Property‑Plant‑and‑Equipment balances, continued to depreciate them, and recorded the cash proceeds as financing obligations rather than a sale‑lease‑back【page_90】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: the $5.0 billion American Tower payment in March 2015 for 11,300 Verizon towers, the $4.827 billion Crown Castle transaction in December 2013 for 9,048 AT&T towers plus 627 purchased towers, and the fact that both Verizon and AT&T retained ownership and depreciation responsibilities. The $173 million difference ($5.0B - $4.827B) is accurately calculated. (2) All numeric values, dates, and financial amounts match the ground truth. The comparison of deal sizes is quantitatively sound. (3) The multi-hop reasoning is strong—correctly synthesizing data across two separate transactions (Verizon/American Tower and AT&T/Crown Castle), identifying structural similarities (retained ownership, depreciation, financing obligations), and contrasting scale. The only minor omission is that the ground truth mentions Verizon’s leaseback term (minimum 10 years) and AT&T’s estimated 20-year sublease, which the LLM answer does not include. This reduces completeness slightly but does not undermine the core accuracy. (4) The LLM uses semantically equivalent and accurate language, including correct treatment of accounting implications (PP&E, depreciation, financing obligations vs sale-leaseback). All entities, years, and financial terms are correct. Contextual relevance is perfect—directly addresses the comparison and structural similarities as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 393,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How does Southern Power's use of tax equity partnerships for wind facilities, which are connected to long-term PPAs with up to 25-year terms, compare with Duke Energy's approach to structuring PPAs for its renewable VIEs, particularly in terms of monetizing federal tax credits like PTCs?",
      "original_answer": "Southern Power utilizes tax equity partnerships for its wind facilities, allowing a tax partner to capture most of the federal tax benefits, including PTCs tied to the first 10 years of energy production. These partnerships are consolidated using the HLBV method, and the associated PPAs have remaining terms of up to 25 years. The PPAs are critical in monetizing these tax credits through long-term revenue streams. Similarly, Duke Energy structures PPAs as part of its renewable VIEs, where it is the primary beneficiary and makes key decisions including PPA negotiations. These PPAs are also essential in monetizing tax credits, but Duke does so under a model involving third-party tax equity investors to finance eligible assets. Both companies rely on PPAs for revenue predictability, but Southern Power explicitly ties its PPA terms and tax equity structures to the PTC window, while Duke’s focus is on broader VIE financing and guarantees.",
      "llm_answer": "Southern Power monetizes the production‑tax credits on its wind farms by placing the projects in tax‑equity partnerships that take essentially all of the federal tax benefits, while the wind assets are covered by long‑term power‑purchase agreements (PPAs) that are accounted for as operating leases with terms of up to 25 years 【page_97】【page_268】. Duke Energy also uses tax‑equity arrangements to capture PTCs, but it does so through renewable‑energy VIEs in which Duke shares control and provides guarantees for debt service and O&M; the PPAs are embedded in those VIE structures rather than being single, dedicated long‑term contracts 【page_202】【page_204】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that Southern Power uses tax equity partnerships to monetize PTCs, with long-term PPAs (up to 25 years) that are treated as operating leases, which matches the original answer's description of PPAs being critical for revenue predictability and tied to the PTC window. The mention of HLBV consolidation is missing, but the core structure is correct. (2) For Duke Energy, the LLM correctly identifies the use of tax equity through renewable VIEs, third-party investors, and Duke’s role involving guarantees and shared control. It also correctly notes that PPAs are embedded in VIE structures rather than being standalone long-term contracts, which reflects the original answer’s point about Duke’s broader VIE financing model. (3) The multi-hop reasoning is sound: the LLM synthesizes information across Southern Power and Duke Energy, comparing their use of tax equity, PPAs, and VIEs appropriately. The only minor gap is that the original answer emphasizes Southern Power’s explicit alignment of PPA terms with the 10-year PTC window, which the LLM implies but does not explicitly state. (4) All numeric values (e.g., 'up to 25 years') are correct and match the ground truth. No calculation errors. Wording differs slightly but maintains semantic equivalence. The answer is highly contextually relevant, directly addressing the comparison asked. Thus, correctness is high but not perfect due to slight omission of the PTC-PPA timing linkage in Southern Power’s case.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 427,
        "total_tokens": 1864
      },
      "error": null
    },
    {
      "question_id": 88,
      "question": "How do the differences in voting rights structures between CMCSA's Class B common stock and GOOGL's dual-class stock system affect their respective corporate governance models, particularly in terms of shareholder influence on major corporate decisions?",
      "original_answer": "CMCSA's Class B common stock has no voting rights, limiting shareholder influence on major decisions unless specific conditions are met, such as exiting the core payments business or undergoing a merger. In contrast, GOOGL's dual-class structure allows Class B stockholders to have 10 votes per share, significantly concentrating voting power in the hands of a few, while Class A stockholders have 1 vote per share and Class C stockholders have no voting rights. This creates a governance model at GOOGL where a small group of insiders can dominate decision-making, whereas CMCSA maintains a more uniform governance structure among its voting shareholders. The differential voting rights at GOOGL can lead to more decisive strategic direction but less democratic shareholder oversight compared to CMCSA.",
      "llm_answer": "Alphabet’s filing makes clear that its dual‑class structure concentrates voting power: Class A shares carry one vote, Class B shares carry ten votes per share, and Class C shares have no voting rights (see GOOGL 10‑K, p. 82). Comcast’s 10‑K only lists a separate Class B common‑stock series (75 million authorized, 9.44 million issued) but does not grant it any special voting privileges, implying that Class B holders vote on a parity basis with other common shareholders (see CMCSA 10‑K, p. 67). Consequently, Comcast’s governance is more conventional and broadly democratic, whereas Alphabet’s structure lets insiders who own Class B stock dominate major corporate decisions despite holding a minority of the economic interest.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies regarding CMCSA's Class B common stock voting rights, which directly undermines the correctness of the corporate governance comparison. According to the ground truth, CMCSA's Class B common stock has *no voting rights* except under specific conditions (e.g., merger or exit from core business), but the LLM incorrectly states that Class B holders 'vote on a parity basis with other common shareholders'—this is false. The LLM claims CMCSA Class B has no 'special voting privileges' and implies they have standard voting rights, which contradicts the ground truth that they have *no voting rights at all* under normal circumstances. This is a critical error in both entity and qualitative accuracy. On the GOOGL side, the LLM correctly describes the dual-class structure: Class A (1 vote), Class B (10 votes), Class C (no votes), so this part is factually accurate and well-supported. The quantitative details (e.g., 75 million authorized, 9.44 million issued for CMCSA Class B) are correctly cited from the 10-K, so quantitative accuracy is acceptable. Contextually, the answer addresses the question about governance models and shareholder influence, so relevance is high. However, due to the fundamental misrepresentation of CMCSA’s voting structure—reversing its actual impact on governance (from disenfranchised to equal voting)—the reasoning and conclusion about CMCSA being 'more conventional and broadly democratic' is invalid. This failure in multi-hop reasoning (synthesizing correct facts from both companies) results in a misleading comparison. Thus, while some data points are accurate, the core analysis is flawed, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 466,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How might the difference in voting rights structures between GOOGL (with 1 vote per Class A share and 10 votes per Class B share) and NFLX (1 vote per common share) affect control dynamics, especially considering GOOGL's $62.2 billion in share repurchases during 2023?",
      "original_answer": "GOOGL's dual-class share structure, where Class B shares carry 10 votes per share compared to Class A's 1 vote, allows certain major shareholders to maintain outsized voting control despite owning a smaller economic stake. In 2023, GOOGL repurchased $62.2 billion of its Class A and Class C shares, which likely further consolidated voting power among remaining Class B shareholders. In contrast, NFLX maintains a one-share-one-vote structure, distributing control more evenly across all shareholders. This structural difference means GOOGL’s leadership has greater insulation from shareholder influence compared to NFLX, even as both companies manage capital through stock repurchases and equity grants.",
      "llm_answer": "Alphabet’s dual‑class structure gives its insiders a built‑in voting advantage—each Class B share carries ten votes while each Class A share carries only one (GOOGL 10‑K p.81). By repurchasing $62.2 billion of Class A and non‑voting Class C shares in 2023 (GOOGL 10‑K p.81‑84), the pool of low‑vote shares shrinks, raising the proportion of total votes held by the 10‑vote Class B stock and further concentrating control. Netflix, by contrast, has a single‑class system with one vote per common share (NFLX 10‑K p.61), so any buy‑back would dilute voting power uniformly and does not concentrate control in a small group.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: GOOGL's dual-class structure (1 vote for Class A, 10 votes for Class B), the $62.2 billion in 2023 share repurchases targeting Class A and Class C shares, and NFLX's one-share-one-vote structure are all accurately represented. (2) Quantitative accuracy is perfect: the $62.2 billion repurchase amount is correctly cited, and no calculations are required beyond accurate reporting. (3) Multi-hop reasoning is sound: the answer correctly synthesizes how repurchasing low-vote shares (Class A and non-voting Class C) reduces their outstanding count, thereby increasing the relative voting power of Class B shares, which are held by insiders. This contrasts effectively with NFLX’s single-class structure, where buybacks do not disproportionately shift control. (4) The answer includes additional contextual precision by referencing specific 10-K page numbers (e.g., p.81, p.61), enhancing credibility. Wording differs slightly from the original answer but conveys the same core insights with equal or greater detail. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1361,
        "completion_tokens": 331,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "What is the financial significance of BMY's retained royalty rights related to Byetta*, given its divestiture of the diabetes business and the trademark's current ownership by LLY?",
      "original_answer": "BMY retains royalty rights related to Byetta*, a product originally associated with Amylin, even after divesting its diabetes business. According to BMY's 2022 10-K, pretax income from such royalties was approximately $1.9 billion in 2021, and a decline in these royalty streams could adversely affect BMY's future financial performance. Although Eli Lilly (LLY) now holds the trademark for Byetta*, BMY still has financial exposure through its retained royalty rights, indicating a continued revenue relationship between BMY and LLY despite the divestiture.",
      "llm_answer": "BMS kept the right to receive royalties on Byetta (and other Amylin‑derived diabetes products) after it sold its diabetes business, and those royalties produced roughly $1.9 billion of pretax income in 2021 【page_48】. Although the Byetta trademark is now owned by Eli Lilly (Amylin Pharmaceuticals) 【page_127】, BMS’s retained royalty rights continue to represent a material, ongoing revenue stream.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is factually correct and aligns closely with the ground truth. It accurately states that BMS (BMY) retained royalty rights on Byetta after divesting its diabetes business and that these royalties generated approximately $1.9 billion in pretax income in 2021, which matches the original answer. The trademark ownership by Eli Lilly (LLY) is correctly noted, including the reference to Amylin Pharmaceuticals as part of LLY's portfolio. 2) Quantitatively, the $1.9 billion figure is accurate and correctly attributed to 2021 pretax income, consistent with BMY's 2022 10-K. No calculations are required, and the number is presented correctly. 3) The multi-hop reasoning is sound: the model correctly synthesizes information across entities (BMY, LLY, Amylin), events (divestiture, trademark ownership), and financial impact (retained royalties as ongoing revenue). The only minor shortcoming is the slightly imprecise phrasing 'Amylin Pharmaceuticals' in parentheses after Eli Lilly, which could imply Amylin is separate from LLY rather than a subsidiary; however, this does not invalidate the factual core. 4) Contextual relevance is excellent—the answer directly addresses the financial significance of retained royalty rights despite divestiture and trademark ownership change. Overall, the answer is semantically equivalent to the ground truth with only negligible wording issues, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 395,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 89,
      "question": "How does the difference in capital buffer structures between Schwab and JPMorgan Chase affect their respective minimum total risk-based capital ratio requirements, considering Schwab's requirement includes both a 2.5% stress capital buffer and 2.5% capital conservation buffer while JPMorgan Chase applies only a 2.5% capital conservation buffer?",
      "original_answer": "Schwab's minimum total risk-based capital ratio requirement is 10.5%, which incorporates both a 2.5% stress capital buffer and a 2.5% capital conservation buffer above the base regulatory minimum. In contrast, JPMorgan Chase's minimum total risk-based capital ratio is also 10.5%, but this only includes a 2.5% capital conservation buffer without an additional stress capital buffer component. This reflects different regulatory treatments where Schwab is subject to both buffers while JPMorgan Chase only applies the capital conservation buffer.",
      "llm_answer": "Schwab must meet a 10.5 % minimum total risk‑based capital ratio that reflects both a 2.5 % stress‑capital buffer and a 2.5 % capital‑conservation buffer (see SCHW 10‑K page 122). JPMorgan Chase Bank, N.A. is required to meet the same 10.5 % minimum total risk‑based capital ratio, but that figure includes only the 2.5 % capital‑conservation buffer (no stress buffer) (see JPM 10‑K page 291). Thus Schwab’s ratio is built from two buffers, whereas JPMorgan’s is built from a single buffer, even though the headline minimum total risk‑based capital ratio is identical.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all percentages are accurate: both Schwab and JPMorgan Chase have a 10.5% minimum total risk-based capital ratio, with Schwab including both a 2.5% stress capital buffer and a 2.5% capital conservation buffer, while JPMorgan includes only the 2.5% capital conservation buffer. The base regulatory minimum is implied to be 5.5% (10.5% - 2.5% - 2.5% for Schwab), which aligns with regulatory standards. (2) The answer is complete, addressing both firms' capital requirements and explaining the structural difference in buffers despite the same headline ratio. (3) Entities are correctly identified: Schwab (SCHW) and JPMorgan Chase (JPM), with accurate references to their respective 10-K filings and page numbers. (4) The reasoning is sound and reflects proper multi-hop synthesis: it correctly infers that different buffer compositions can lead to the same total requirement due to differing regulatory treatments. The semantic meaning is equivalent to the original answer, with added citation details that enhance credibility without introducing error. All criteria—factual accuracy, completeness, entity identification, and logical reasoning—are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1328,
        "completion_tokens": 352,
        "total_tokens": 1680
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the transition from LIBOR to alternative reference rates impact both LMT's credit facility and GE's floating-rate debt and preferred stock, considering the accounting relief provided under ASU 2020-04?",
      "original_answer": "The transition from LIBOR to alternative rates impacts LMT’s credit facility and derivatives through fallback provisions like SOFR, with LMT expecting minimal financial impact due to ASU 2020-04's accounting relief that limits the effect of contract modifications. Similarly, GE’s floating-rate debt and preferred stock will transition to SOFR plus a spread adjustment under New York law, with any financial impact also being accounted for under ASU 2020-04. Both companies rely on the same accounting standard to ease the financial reporting burden during the LIBOR transition, despite differing in the types of financial instruments affected.",
      "llm_answer": "Lockheed Martin’s credit facility already includes fallback language that will replace LIBOR with an alternative rate (e.g., SOFR) and the company has adopted the ISDA 2020 IBOR Fallbacks Protocol; under ASU 2020‑04 the required contract modifications are expected to have no material effect on its operating results, financial position or cash flows. General Electric’s floating‑rate debt and preferred‑stock are governed by New York‑state fallback provisions that will deem them replaced by SOFR + a spread adjustment when LIBOR ends, and the transition will be accounted for under ASU 2020‑04, which limits any accounting impact of the change. (See LMT 10‑K p. 85; GE 10‑K p. 37).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) All key facts are correct: LMT’s credit facility uses fallback provisions (e.g., SOFR) and it has adopted the ISDA 2020 IBOR Fallbacks Protocol; GE’s floating-rate debt and preferred stock transition under New York law to SOFR plus a spread adjustment; both companies apply ASU 2020-04 to limit accounting impact. (2) There are no numeric values requiring calculation in this question, but references to accounting standards and legal frameworks are correctly cited. (3) The multi-hop reasoning is sound—information is correctly synthesized across two companies (LMT and GE), their respective financial instruments (credit facility, derivatives, floating-rate debt, preferred stock), and the common application of ASU 2020-04. (4) The LLM answer even improves upon the original by citing specific page numbers from the 10-Ks (p. 85 for LMT, p. 37 for GE), enhancing verifiability. Wording differs slightly but conveys identical meaning. All evaluation criteria are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 307,
        "total_tokens": 1655
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "What is the significance of CMCSA's issuance of 9,444,375 shares of Class B common stock in 2023, and how does this structure compare to GOOGL's dual-class system where Class B shares automatically convert to Class A shares upon sale or transfer?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B common stock in 2023, indicating a strategic move to maintain control while potentially raising capital without diluting voting power significantly. This mirrors GOOGL's dual-class structure, where Class B shares carry 10 votes per share and convert to single-vote Class A shares upon sale or transfer, preserving founder control. However, unlike GOOGL, which actively repurchased $62.2 billion of Class A and Class C shares in 2023, CMCSA's equity strategy appears more focused on maintaining a stable capital structure with no mention of a similar buyback program for Class B shares.",
      "llm_answer": "CMCSA’s 2023 balance sheet shows that it issued 9,444,375 shares of Class B common stock, a class that carries ten votes per share and therefore concentrates voting power with the holders of those shares【page_69】. Alphabet’s dual‑class structure also uses ten‑vote Class B shares, but those shares are required to convert automatically into one‑vote Class A shares whenever they are sold or transferred, so the extra voting power stays with the original insiders rather than passing to new owners【page_81】.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its quantitative claims: CMCSA did issue 9,444,375 shares of Class B common stock in 2023, and Class B shares carry 10 votes per share, as correctly stated. The comparison to GOOGL (Alphabet) is also accurate—GOOGL’s Class B shares carry 10 votes and automatically convert to Class A upon sale or transfer, which is correctly described. All entities (CMCSA, GOOGL), years (2023), and share class structures are correctly identified. However, the LLM answer omits a key part of the original answer: the contrast in capital return strategies, specifically that GOOGL repurchased $62.2 billion of shares in 2023, while CMCSA had no such buyback program. This missing element weakens the completeness of the multi-hop comparison, particularly around strategic implications beyond voting control. While the core reasoning about voting power concentration and structural similarities is sound and contextually relevant, the absence of the buyback contrast—a significant aspect of the equity strategy comparison—prevents a perfect score. The answer is semantically aligned with the ground truth on the main points but lacks full depth in strategic context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 333,
        "total_tokens": 1641
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How do the vesting-related financial commitments in MDLZ's multiemployer pension plans compare with WMT's equity compensation vesting schedules in terms of duration and cost recognition patterns?",
      "original_answer": "MDLZ has long-term financial obligations tied to multiemployer pension plans, with vesting periods governed by union agreements that result in multi-year liabilities such as a $526 million withdrawal liability paid over 19 years. These costs are recognized through ongoing contributions and interest accruals (e.g., $11 million in 2021). In contrast, WMT structures its employee incentives through equity compensation with defined vesting periods—such as restricted stock units that vest 25% annually over four years—with fair value discounted for expected dividends (e.g., 3.8% in fiscal 2022) and expensed ratably over the vesting term. While MDLZ's obligations are shaped by collective bargaining and multiemployer fund rules, WMT's vesting schedules are internally designed to align with shareholder interests and are accounted for as equity or expense over shorter, fixed timeframes.",
      "llm_answer": "MDL Z’s multi‑employer pension obligations are modest (e.g., $402 m contributed in 2022, $289 m in 2021 and $221 m in 2020) and are recorded as expense when the contributions are made; the plans’ vesting periods are set by collective‑bargaining agreements but are not quantified in the filing, so the cost is recognized up‑front rather than spread over time. By contrast, Walmart’s equity‑compensation awards have explicit vesting schedules—restricted‑stock units generally vest 25 % per year over a four‑year period (and performance‑based units over 1‑3 years)—and the associated compensation expense is recognized ratably over the vesting horizon (unrecognized RSU cost of $1.7 bn is expected to be recognized over a weighted‑average of about 1.3 years). Thus MDL Z’s vesting‑related commitments are short‑term and expensed immediately, whereas Walmart’s are longer‑term and amortized over the defined vesting period.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding MDLZ's pension cost recognition and financial commitments. The ground truth states that MDLZ has a $526 million withdrawal liability paid over 19 years with ongoing interest accruals (e.g., $11 million in 2021), indicating long-term, spread-out cost recognition. However, the LLM claims MDLZ's costs are 'recorded as expense when contributions are made' and characterizes them as 'short-term' and 'expensed immediately,' which contradicts the multi-year amortization implied by the 19-year payment plan. Additionally, the LLM cites contribution amounts ($402M in 2022, etc.) not present in the original answer, introducing unverified data. While WMT's vesting schedule (25% annually over four years) and ratable expense recognition are correctly described, the $1.7B unrecognized RSU cost and 1.3-year weighted average recognition period are not in the ground truth and appear fabricated. (2) Quantitative accuracy is low: the original answer mentions a $526M liability and $11M interest in 2021 for MDLZ; the LLM instead reports annual contributions of $402M, $289M, $221M—none of which appear in the ground truth. The WMT equity figures ($1.7B, 1.3 years) are also unsupported. Only the 25% annual vesting for RSUs matches. (3) Multi-hop reasoning is partially sound—the model correctly contrasts MDLZ's union-governed plans with WMT's internal equity plans and identifies different accounting treatments—but it misrepresents the nature of MDLZ's cost recognition, failing to reflect the long-term, structured repayment (19 years) and interest accruals. (4) Contextual relevance is high because the answer addresses duration and cost recognition patterns for both companies as asked. However, due to major factual and quantitative errors, especially on the MDLZ side, the correctness score is low despite structurally attempting the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1464,
        "completion_tokens": 524,
        "total_tokens": 1988
      },
      "error": null
    },
    {
      "question_id": 90,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for BAC under the Advanced Approach compare to MS's requirement, considering both institutions' application of the 2.5% Capital Conservation Buffer and the zero Countercyclical Capital Buffer?",
      "original_answer": "Both BAC and MS apply the 2.5% Capital Conservation Buffer and face a zero Countercyclical Capital Buffer under the Advanced Approach. For BAC, this buffer combines with a 2.5% G-SIB surcharge, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratio. Similarly, MS also computes its capital buffer as the sum of the 2.5% Capital Conservation Buffer and the 2.5% G-SIB surcharge, leading to an identical total buffer requirement of 5.0% above the minimum risk-based capital ratio. Thus, both institutions have the same total capital buffer requirement above minimums under the Advanced Approach.",
      "llm_answer": "Under the Advanced Approach, Bank of America must hold a buffer of 2.5 % capital‑conservation buffer plus a 2.5 % G‑SIB surcharge (CCyB = 0 %), i.e., 5.0 % above the regulatory minimum【page_146】. Morgan Stanley’s buffer under the same approach is 2.5 % capital‑conservation buffer plus a 3.0 % G‑SIB surcharge (CCyB = 0 %), i.e., 5.5 %【page_54】. Thus Morgan Stanley’s combined buffer is 0.5 percentage point higher than Bank of America’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors in key quantitative components. While it correctly identifies the 2.5% Capital Conservation Buffer and zero Countercyclical Capital Buffer (CCyB) for both institutions, it incorrectly states that Morgan Stanley (MS) has a 3.0% G-SIB surcharge. The ground truth confirms that both BAC and MS have a 2.5% G-SIB surcharge, resulting in identical total buffer requirements of 5.0%. The LLM's claim of a 3.0% G-SIB surcharge for MS leads to an incorrect total buffer of 5.5% and an erroneous conclusion that MS's buffer is 0.5 percentage points higher. (2) Calculations: The sum of 2.5% + 2.5% = 5.0% is correct for BAC, but 2.5% + 3.0% = 5.5% for MS is factually wrong per the ground truth. The comparison stating a 0.5 percentage point difference is therefore invalid. (3) Multi-hop reasoning: The model attempts to synthesize buffer components across institutions, but fails in entity-specific accuracy—specifically misidentifying MS's G-SIB surcharge. This breaks the multi-hop logic required to correctly compare the two institutions. (4) Despite incorrect numbers, the answer is contextually relevant and structured appropriately, referencing the correct regulatory framework (Advanced Approach, CCyB, G-SIB surcharge), and attempting the correct comparison. However, the core factual inaccuracy in MS's G-SIB surcharge severely undermines correctness and quantitative accuracy, warranting low scores in those areas.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 409,
        "total_tokens": 1711
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the sensitivity of AVGO's $56.3 billion fixed rate senior notes to interest rate changes compare to ORCL's effective interest rate management through swaps, considering the role of interest rate swaps in converting fixed-rate debt to floating-rate as demonstrated by CSCO's $0.5 billion swap?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes is highly sensitive to interest rate changes, with a 50 basis point shift affecting fair value by $1.7 billion. In contrast, ORCL uses interest rate swaps to stabilize its borrowing costs, achieving an effective interest rate of 4.74% for fiscal 2024 and 2023 on its floating-rate debt after converting it to fixed-rate debt with a 3.07% base rate. CSCO's use of a $0.5 billion interest rate swap illustrates how such instruments convert fixed-rate debt into floating-rate debt to offset fair value fluctuations, aligning with AVGO's and ORCL's broader strategies to manage interest rate exposure through financial hedging instruments.",
      "llm_answer": "AVGO’s $56.3 billion of fixed‑rate senior notes are highly rate‑sensitive – a 50‑basis‑point move in market rates would swing their fair value by roughly $1.7 billion (AVGO 10‑K p. 49). In contrast, Oracle uses interest‑rate swaps to reshape the economics of its debt (e.g., cross‑currency swaps that yield an 8.76 %/8.36 % effective rate on its July 2025 notes and swaps that lock a 3.07 %‑plus‑margin fixed rate, resulting in an effective 4.74 % rate for fiscal 2024/23 – Oracle 10‑K p. 88). Cisco’s $0.5 billion swap (Cisco 10‑K p. 89) shows how a swap can convert a fixed‑rate note to a floating‑rate exposure, effectively neutralizing the fair‑value impact; similarly, Oracle’s swaps dampen its interest‑rate sensitivity, whereas AVGO’s large fixed‑rate pool remains directly exposed to rate changes.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All numeric values are correct: AVGO's $56.3 billion fixed-rate notes, $1.7 billion fair value sensitivity to a 50 bps rate change, ORCL's 4.74% effective interest rate for fiscal 2024/23, 3.07% base rate, and CSCO's $0.5 billion swap are all accurately reported. Format variations (e.g., '50‑basis‑point' vs '50 basis point') are acceptable. (2) The answer addresses all parts of the multi-hop question: it compares AVGO's interest rate sensitivity, ORCL's use of swaps to achieve a stable effective rate, and CSCO's illustrative use of a swap to convert fixed to floating, linking all three companies' strategies. (3) Entities are correctly identified: AVGO, ORCL, CSCO, fiscal years 2023/2024, and financial instruments (interest rate swaps) are all accurate. (4) The reasoning is sound: the LLM correctly infers that ORCL uses swaps to convert floating to fixed (contrary to CSCO's fixed-to-floating), thereby reducing rate sensitivity, while AVGO remains exposed. One minor issue: the LLM mentions 'cross-currency swaps' and an '8.76%/8.36% effective rate' on July 2025 notes, which is not in the original answer and may be extraneous or misaligned context, though not directly contradicting. This slightly affects qualitative accuracy but does not undermine the core correctness. Overall, the answer is factually precise, contextually relevant, and synthesizes across all three companies appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1410,
        "completion_tokens": 412,
        "total_tokens": 1823
      },
      "error": null
    },
    {
      "question_id": 91,
      "question": "How does the voting power distribution tied to Class B common stock at META compare to GOOGL's repurchase strategy across its multiple stock classes, given the interplay between voting rights and share structure?",
      "original_answer": "META's Class B common stock, which represents 33 1/3% of the combined voting power and has 15 votes per share, is non-dilutable and held entirely by a single individual, creating concentrated voting control. In contrast, GOOGL has a structure where Class B common stock has 10 votes per share and can be converted to Class A (1 vote per share), with no mention of non-dilutable voting power. Additionally, GOOGL actively repurchased $62.0 billion worth of shares in 2024 across both Class A and Class C shares, which have differing voting rights, suggesting a strategy that considers both capital allocation and governance dynamics.",
      "llm_answer": "Meta’s dual‑class structure gives each Class B share ten votes, so the roughly 344 million Class B shares (about 13 % of the total 2.53 billion shares outstanding) control the overwhelming majority of voting power (well over 80 %)【page_1】. In contrast, Alphabet’s repurchase program is aimed at its publicly‑traded Class A (one‑vote) and Class C (no‑vote) shares, buying back billions of dollars of those securities while leaving the high‑voting, non‑public Class B shares untouched; thus the repurchases shrink the pool of voting Class A shares but do not alter the control held by Class B【page_82】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. First, it states that Meta's Class B shares have 'ten votes' per share, while the ground truth specifies 15 votes per share. Second, it claims Class B shares represent 'about 13% of total shares outstanding' and control 'well over 80%' of voting power, but the original answer states Class B holds exactly 33 1/3% of combined voting power. These quantitative discrepancies are significant. The LLM also introduces specific figures like '344 million Class B shares' and '2.53 billion shares outstanding' not present in the ground truth, which lacks such granular data. (2) Regarding GOOGL, the LLM correctly notes that repurchases target Class A and C shares (one-vote and no-vote) and do not affect Class B control, aligning with the ground truth. However, it omits the key fact that GOOGL repurchased $62.0 billion in 2024, a specific figure missing in the LLM response. (3) The multi-hop reasoning is partially sound: the model correctly infers that repurchasing lower-vote shares preserves concentrated control, and contrasts Meta’s control structure with Alphabet’s capital allocation strategy. However, it misrepresents Meta’s voting mechanics and introduces unsupported numbers, undermining the synthesis. (4) Despite incorrect numbers, the LLM captures the strategic contrast: Meta has entrenched voting control via high-vote shares, while Alphabet uses repurchases to maintain control dynamics without altering voting share supply. This conceptual understanding supports a moderate qualitative and contextual score, but the quantitative errors—especially vote count and ownership percentage—severely limit correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1324,
        "completion_tokens": 462,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 92,
      "question": "How does Qualcomm's projected growth in generative AI-capable smartphone shipments by 2027 influence its strategic focus on AI and connectivity technologies, as compared to Salesforce's investment in generative and agentic AI across its CRM products?",
      "original_answer": "Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, which directly informs its strategic focus on developing on-device AI and advanced connectivity technologies like 5G and 5G Advanced to support edge computing and AI workloads. Meanwhile, Salesforce is investing in generative and agentic AI across its CRM products, including the introduction of Agentforce, a new platform layer enabling autonomous AI agents for sales, service, marketing, and commerce. While Qualcomm's strategy centers on enabling AI at the device level through hardware innovation, Salesforce is embedding AI into its cloud-based CRM platform to enhance customer engagement and productivity. The convergence lies in their shared emphasis on AI capabilities—Qualcomm enabling them at the edge, Salesforce deploying them in enterprise workflows—though neither company has stated a direct business relationship or dependency.",
      "llm_answer": "Qualcomm says analysts expect 46 % of smartphones sold in 2027 to be generative‑AI capable, up from 19 % in 2024 (page 7).  That outlook is pushing Qualcomm to double‑down on on‑device AI, edge‑computing power and advanced wireless connectivity (5G/5G‑Advanced, Snapdragon SoCs and RFFE) so its chips and licensing can support the surge in AI‑enabled handsets (page 7).  By contrast, Salesforce is directing its AI spend toward embedding generative and “agentic” AI across its cloud‑based CRM suite—e.g., the new Agentforce layer that lets customers build autonomous AI agents for sales, service, marketing and commerce—rather than on device connectivity (page 41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Qualcomm's projection of 46% of smartphones being generative AI-capable by 2027 (up from 19% in 2024), its strategic focus on on-device AI, edge computing, and advanced connectivity (5G/5G-Advanced, Snapdragon SoCs, RFFE), and Salesforce's investment in generative and agentic AI via the Agentforce platform across CRM functions. All entities (Qualcomm, Salesforce, Agentforce), timeframes (2024, 2027), and strategic directions are accurate. (2) Quantitative accuracy is perfect: percentages (46%, 19%) and years (2024, 2027) match the ground truth exactly. No calculations were required, but the comparison over time is correctly framed. (3) The multi-hop reasoning is sound—correctly contrasting Qualcomm’s hardware-driven, edge-focused AI strategy with Salesforce’s cloud-based, enterprise AI integration. The synthesis across companies and domains (semiconductors vs. SaaS/CRM) is logically coherent. (4) The only minor shortcoming is that the LLM answer omits the explicit statement from the ground truth that there is no direct business relationship or dependency between the two companies. While not critical to the core comparison, this nuance slightly reduces completeness in the qualitative dimension. Otherwise, the answer is semantically equivalent, contextually precise, and factually robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 382,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does Adobe's focus on enhancing user experience through AI-driven digital media tools align with Qualcomm's projections for generative AI-capable edge devices in 2027, particularly in relation to on-device AI processing and user interface improvements?",
      "original_answer": "Adobe emphasizes that the intuitiveness and visual appeal of user interfaces are key competitive factors in its Digital Media segment, particularly as it integrates AI capabilities for digital media generation and editing. Qualcomm projects that 46% of smartphones sold in 2027 will be generative AI-capable, up from 19% in 2024, and highlights that on-device AI processing enhances user experiences with immediacy, privacy, and personalization. Qualcomm’s advancements in edge AI processing and user interface technologies are positioned to support Adobe’s strategic direction by enabling more powerful, responsive, and secure AI-driven tools directly on devices, aligning with Adobe’s need to deliver best-in-class user experiences across platforms.",
      "llm_answer": "Adobe’s 2023 roadmap makes the Creative Cloud experience more intuitive by embedding generative‑AI models (Firefly) into Photoshop, Express and other apps, delivering AI‑driven creation tools, real‑time content‑first workflows and cross‑device UI enhancements. Qualcomm expects that by 2027 roughly 46 % of smartphones and about 50 % of PCs will be generative‑AI‑capable, with on‑device AI engines (Hexagon NPU, AI Engine) providing low‑power, real‑time inference that enables the kind of on‑device, latency‑free, privacy‑preserving UI features Adobe is building.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Qualcomm's projection of 46% of smartphones being generative AI-capable by 2027 matches the original answer. The LLM adds a specific projection for PCs (~50%), which is not in the ground truth but does not contradict it and is consistent with Qualcomm's broader edge AI narrative. No calculation errors. (2) Entity accuracy is strong: Adobe, Qualcomm, Firefly, Creative Cloud, Hexagon NPU, and AI Engine are correctly identified. The reference to Adobe’s 2023 roadmap is contextually appropriate, though not explicitly mentioned in the original answer. (3) Multi-hop reasoning is sound: the LLM correctly links Adobe’s AI-driven UI enhancements with Qualcomm’s on-device AI capabilities, emphasizing low-latency, privacy-preserving processing as an enabler for Adobe’s tools. (4) The answer is semantically equivalent to the original, capturing the alignment between Adobe’s user experience goals and Qualcomm’s edge AI projections. The only minor gap is that the original emphasizes Qualcomm’s focus on 'immediacy, privacy, and personalization' more explicitly, while the LLM focuses on 'latency-free, privacy-preserving' features—slightly less comprehensive but still accurate. Overall, the response is factually correct, well-synthesized, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 382,
        "total_tokens": 1738
      },
      "error": null
    },
    {
      "question_id": 93,
      "question": "How does the treatment of dividend equivalents on RSU awards differ between Lockheed Martin's and Honeywell's compensation plans, based on the specific vesting terms and payment structures disclosed?",
      "original_answer": "Lockheed Martin discloses that dividend equivalents on vested stock units for non-employee directors may be paid on the first business day of April following the one-year anniversary of the grant, indicating a delayed payment structure tied to director tenure and stock ownership guidelines. In contrast, Honeywell does not specify a delayed payment schedule for dividend equivalents on RSUs, focusing instead on vesting periods ranging from three to six years with payment in common stock upon vesting. Additionally, Lockheed Martin’s Deferred Management Incentive Compensation Plan (DMICP) credits dividend equivalents as stock units at dividend payment times, while Honeywell’s RSU awards are more focused on performance-based vesting tied to company goals.",
      "llm_answer": "Lockheed Martin’s RSU awards are part of a deferred plan: dividend equivalents are credited as phantom‑stock units when a dividend is paid and are only delivered as actual shares when the award is settled – typically upon termination of employment or on a designated post‑grant date for directors (LMT 10‑K p. 100). Honeywell’s RSUs simply vest over three‑to‑six years and are paid in common stock at vesting, with no separate dividend‑equivalent credit (Honeywell 10‑K p. 92).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its core facts but omits key qualitative distinctions present in the ground truth. Quantitatively, all details are accurate: Lockheed Martin defers dividend equivalent payments, crediting them as stock units at dividend times and delivering upon settlement (e.g., termination or post-grant date for directors), and Honeywell vests RSUs over 3–6 years with payout in stock at vesting. The LLM correctly identifies that Honeywell does not separately credit dividend equivalents, which aligns with the original answer’s implication that Honeywell lacks a delayed payment structure for such equivalents. However, the LLM fails to mention Lockheed Martin’s specific April payment timing for non-employee directors or the role of stock ownership guidelines, which are important contextual elements in the ground truth. Additionally, the LLM omits Honeywell’s performance-based vesting tied to company goals, a key differentiator in compensation design. While the reasoning is sound in comparing deferral mechanisms and payout forms, the answer lacks full synthesis on the structural intent behind each plan (e.g., DMICP’s role, performance linkage). Wording differences are acceptable under semantic equivalence, but the omission of performance-based vesting and director-specific timing reduces completeness. Contextual relevance is high, as the response directly addresses the comparative structure of dividend treatment in RSUs.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 401,
        "total_tokens": 1724
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the reliance of Texas Instruments (TXN) on subcontractors for 40% of its assembly and test services compare with NVIDIA's (NVDA) exposure to third-party manufacturers, given the shared dependency on external production capacity and the risks highlighted by AMD's experience with third-party suppliers?",
      "original_answer": "Texas Instruments relies on subcontractors for 40% of its assembly and test services, supplementing internal capacity to meet customer demand. This external dependency aligns with NVIDIA’s reliance on third-party manufacturers for semiconductor fabrication, assembly, and testing, which exposes them to risks such as limited control over delivery schedules, quality assurance, and potential prioritization of other customers. AMD's experience highlights the vulnerability in this model, as their dependence on third-party manufacturers—including GF and ATMP joint ventures—can lead to supply disruptions, capacity constraints, and financial penalties if purchase targets are not met. Therefore, both TXN and NVDA face similar exposure to third-party production risks, though NVDA's exposure is amplified by the complexity of its products and global supply chain dependencies.",
      "llm_answer": "Texas Instruments disclosed that in 2021 it sourced about 40 % of its assembly‑and‑test services from subcontractors (TXN 10‑K p. 9). NVIDIA likewise relies entirely on third‑party foundries and contract manufacturers for wafer fabrication, assembly, test and packaging, with no owned fab and limited long‑term contracts, exposing it to the same supply‑capacity constraints, price volatility and potential prioritization of competitors that AMD warns about in its own filing (AMD 10‑K pp. 22‑23, 25). Both companies therefore share a dependence on external production capacity, but NVIDIA’s exposure covers the full manufacturing chain while TXN’s disclosed reliance is specifically 40 % of assembly/test services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and percentages are correct: TXN's 40% reliance on subcontractors for assembly and test services is accurately cited from the 10-K (p. 9), and no incorrect figures are presented. The year 2021 is contextually appropriate and consistent with available filings. (2) The answer correctly identifies the entities: Texas Instruments (TXN), NVIDIA (NVDA), and AMD, and accurately reflects their manufacturing models. It correctly states that NVIDIA relies entirely on third-party manufacturers across the full production chain (fabrication, assembly, test, packaging), which is consistent with NVDA’s business model and disclosures. (3) The multi-hop reasoning is sound: it connects TXN’s partial outsourcing to NVDA’s full reliance, then links both to AMD’s disclosed risks (supply constraints, prioritization, capacity issues) as found in AMD’s 10-K (pp. 22–23, 25), demonstrating proper synthesis across three companies’ filings. (4) The answer captures the core comparison: both firms depend on external capacity, but NVIDIA’s exposure is broader in scope (entire manufacturing chain) versus TXN’s 40% in assembly/test only. This nuance is correctly highlighted and matches the ground truth’s conclusion. The only minor shortcoming is that the LLM does not explicitly mention AMD’s joint ventures (GF and ATMP) or financial penalties for unmet purchase commitments, which are part of the risk illustration in the original answer. However, it does reference AMD’s warnings about supply constraints and prioritization, capturing the essential risk theme. Wording differences are semantically equivalent and do not affect factual accuracy. Overall, the answer is factually correct, well-supported, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 493,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "What is the total estimated cost of Duke Energy Florida's 10 new solar facilities, and how does this investment relate to Southern Power's use of PPAs as operating leases with terms up to 25 years for similar renewable energy projects?",
      "original_answer": "Duke Energy Florida's 10 new solar facilities have an estimated total cost of $1 billion over the next three years. These facilities are part of a voluntary solar program approved by the FPSC in January 2021. Southern Power, a subsidiary of Southern Company, utilizes Power Purchase Agreements (PPAs) related to solar and wind facilities, which are accounted for as operating leases with remaining terms of up to 25 years. This indicates that both Duke Energy Florida and Southern Power are investing in long-term renewable energy infrastructure, with Duke making direct investments included in base rates and Southern Power leveraging PPAs as a financial mechanism to support similar projects.",
      "llm_answer": "Duke Energy Florida’s Clean Energy Connection program calls for ten new solar facilities with an estimated total cost of about **$1 billion** over the next three years【page_153】. Southern Power, by contrast, acquires solar (and wind) output through power‑purchase agreements that it records as **operating leases with terms that can extend up to 25 years**【page_268】, using long‑term lease financing rather than a direct upfront capital outlay like Duke Energy’s $1 billion investment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the $1 billion estimated cost for Duke Energy Florida's 10 solar facilities and accurately states that Southern Power uses PPAs accounted for as operating leases with terms up to 25 years. These key facts match the ground truth exactly. (2) Quantitative accuracy is perfect: the $1 billion figure and 25-year term are correctly reported, with no calculation errors. Format variations (e.g., $1 billion vs $1 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—LLM correctly contrasts Duke’s direct capital investment model with Southern Power’s use of PPAs as operating leases, capturing the core comparison in the question. It synthesizes information across two entities and financial models appropriately. (4) The only minor shortcoming is that the LLM omits mention of the FPSC approval in January 2021 and the voluntary nature of the program, which are contextual details present in the original answer. However, these omissions do not affect the core factual accuracy or the comparative insight. Thus, while highly accurate and contextually relevant, it loses one point on qualitative accuracy for slight incompleteness in background context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1317,
        "completion_tokens": 346,
        "total_tokens": 1663
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the difference in voting rights structure between Netflix's common stock and Alphabet's Class C capital stock influence the strategic allocation of Alphabet's $62.0 billion share repurchase in 2024 between Class A and Class C shares?",
      "original_answer": "Netflix's common stock provides one vote per share, establishing a straightforward voting rights framework. In contrast, Alphabet's Class C capital stock carries no voting rights except as required by law, while Class A shares have one vote per share and Class B shares have 10 votes per share. Given this differentiated voting structure and Alphabet's 2024 repurchase of $62.0 billion in Class A and Class C shares, the lack of voting rights in Class C likely influences the company's repurchase strategy by prioritizing liquidity and cost efficiency over governance influence, allowing Alphabet to retire shares without diluting control held by voting-class shareholders.",
      "llm_answer": "Netflix’s common stock gives every share one vote (“The holders of each share of common stock shall be entitled to one vote per share” – NFLX 10‑K p. 60), whereas Alphabet’s Class C capital stock carries no voting rights (“Class C capital stock has no voting rights, except as required by applicable law” – Alphabet 10‑K p. 82). Because Class C shares do not affect voting control, Alphabet can return a larger portion of its $62 billion 2024 repurchase program to non‑voting shareholders (≈ $50.2 bn for 306 M Class C shares versus $11.9 bn for 73 M Class A shares – Alphabet 10‑K p. 82), preserving voting power while still reducing equity, a consideration that does not arise for Netflix’s uniformly‑voted shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: Netflix's common stock has one vote per share, and Alphabet's Class C shares have no voting rights except as required by law. The $62.0 billion 2024 share repurchase is correctly attributed to Alphabet, with a breakdown of approximately $50.2 billion for 306 million Class C shares and $11.9 billion for 73 million Class A shares, which matches the data in the 10-K (p. 82). These figures sum to $62.1 billion, a negligible $0.1 billion discrepancy likely due to rounding—acceptable under format variation. (2) Quantitative accuracy is excellent: the specific dollar amounts, share counts, and their implied allocation between share classes are factually correct and properly cited to the source. (3) The reasoning is sound and captures the multi-hop logic: it correctly infers that because Class C shares carry no voting rights, repurchasing them allows Alphabet to return capital without affecting voting control, thus preserving governance influence for insiders holding Class A and B shares. This strategic nuance is well articulated and directly addresses the influence of voting structure on repurchase allocation. (4) The answer is contextually relevant and comprehensive, addressing both the structural difference in voting rights and its strategic implication on the $62 billion repurchase. The only minor limitation is that it does not explicitly mention Class B shares (10 votes per share), which are part of the full capital structure context, but this omission does not impair the core reasoning about why repurchasing non-voting Class C shares is strategically favorable. Overall, the answer demonstrates strong multi-hop synthesis across Netflix and Alphabet’s structures and correctly applies that to the repurchase strategy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 500,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 94,
      "question": "How does the activation of voting rights for preferred stockholders in BAC due to dividend arrears compare to the limited voting rights of Class C common stockholders at V, particularly in the context of corporate governance during financial stress?",
      "original_answer": "At BAC, if dividends on certain preferred stock series are in arrears for three or more semi-annual or six or more quarterly periods, holders gain voting rights to elect two additional directors, which terminate once dividends are paid for at least two semi-annual or four quarterly periods following the arrearage. This mechanism serves as a governance safeguard for preferred stockholders during financial distress. In contrast, V’s Class C common stockholders have no general voting rights except in specific defined matters, such as exiting the core payments business or certain corporate restructurings, and they do not participate in amendments solely affecting preferred stock. Unlike BAC’s contingent voting rights tied to dividend performance, V’s Class C stockholders’ voting power is structurally limited and not directly linked to financial performance metrics like dividend arrears.",
      "llm_answer": "In Bank of America, preferred‑stock holders normally have no voting power, but if dividends fall into arrears for three semi‑annual (or six quarterly) periods the holders of those series (and any equally‑ranked preferred series) are granted the right to vote for two additional directors, giving them a governance safeguard that kicks in during financial stress. Visa’s Class C common shareholders, by contrast, only vote on a narrow set of pre‑defined matters (e.g., a merger, exit of the core payments business or certain charter amendments) and their voting rights do not expand in a distress scenario, leaving them with far less influence than BAC’s conditional‑activation mechanism.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast in voting rights mechanisms between BAC and V. (1) All key facts are correct: BAC's preferred stockholders gain voting rights to elect two additional directors after three semi-annual or six quarterly dividend arrears, which aligns with the ground truth. The termination condition (after two semi-annual or four quarterly periods of payment) is omitted but implied in the 'conditional' nature described. (2) Quantitative elements—'three semi-annual' and 'six quarterly'—are precisely stated and match the original. (3) Entity accuracy is strong: BAC (Bank of America) and V (Visa) are correctly identified, and the distinction between preferred stockholders (BAC) and Class C common stockholders (V) is maintained. (4) The reasoning correctly synthesizes the multi-hop comparison: BAC’s voting rights are performance-contingent (dividend arrears), while V’s Class C voting rights are structurally limited and not tied to financial stress. The LLM omits the specific detail that V’s Class C shareholders do not vote on amendments affecting only preferred stock, and slightly simplifies the list of triggering events (e.g., 'merger' vs. 'exit from core payments business'), but the semantic meaning remains intact. Wording differences are acceptable under semantic equivalence. No calculation errors. The answer is contextually focused and directly addresses corporate governance during financial stress. One minor omission prevents a perfect 10, but overall correctness is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1421,
        "completion_tokens": 423,
        "total_tokens": 1844
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does Disney's licensing revenue from Star Wars-branded merchandise influence its ability to fund content development for Disney+ in European markets where it competes with CMCSA's Sky Glass and XClass TV platforms?",
      "original_answer": "Disney earns licensing royalties from third-party products featuring Star Wars characters, which contributes to funding content development for its DTC services, including Disney+ in European markets. Disney+ includes Star Wars programming as a core content tile, which is critical to attracting subscribers in competitive regions like Europe. CMCSA competes in this market with its own video services and DTC-aligned platforms like Sky Glass and XClass TV, which integrate with its European broadband offerings. Therefore, licensing revenue from Star Wars enhances Disney's content investment capacity, directly supporting its competitive positioning against CMCSA’s integrated hardware and content strategy in Europe.",
      "llm_answer": "Disney’s licensing business – which includes royalties on Star Wars‑branded toys, apparel and other merchandise (see DIS 10‑K p. 22) – provides a steady cash stream that Disney uses to fund its direct‑to‑consumer (DTC) initiatives, including the new content pipeline for Disney+ (the company highlighted its re‑organization of DMED and ad‑supported Disney+ plans as a way to “advance our DTC strategies” and “realign costs” – DIS 10‑K p. 26).  That licensing‑derived cash helps Disney invest in European‑focused Disney+ programming, giving it financial resources to compete with Comcast’s Sky Glass and XClass TV smart‑TV/OTT platforms that are targeting the same European market (CMCSA 10‑K p. 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth, with strong multi-hop reasoning. It correctly identifies that Disney's Star Wars licensing revenue (citing DIS 10-K p.22) provides a financial stream used to fund DTC initiatives like Disney+, including content development for European markets. It links this to Disney's strategic reorganization (DIS 10-K p.26) and explicitly connects the funding mechanism to competitive positioning against CMCSA’s Sky Glass and XClass TV platforms in Europe (CMCSA 10-K p.18), which is contextually and factually correct. There are no numeric inaccuracies—though no specific dollar figures are mentioned in either answer, the qualitative financial linkage is appropriately described. The only minor shortcoming is a slightly less explicit articulation of how Star Wars programming itself serves as a core content pillar to attract European subscribers, which is implied but not directly stated as in the original answer. However, the core logic chain—licensing revenue → content investment → competitive positioning against CMCSA in Europe—is fully preserved and well-supported with correct entity references and document citations. Thus, the answer is highly accurate, contextually relevant, and demonstrates sound reasoning across entities and filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 368,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 95,
      "question": "How does the sensitivity of AXP's net interest income to a 200 basis point increase in interest rates relate to MS's use of interest rate caps in securitization transactions, considering the role of repricing risk in both firms' financial strategies?",
      "original_answer": "AXP estimates that a 200 basis point increase in interest rates would negatively impact its net interest income, based on its repricing risk assumptions which include the effect of interest rate caps or floors. This sensitivity is linked to the repricing dynamics of interest-rate sensitive assets and liabilities, where certain deposits reprice at lower magnitudes than benchmark rate movements. On the other hand, MS enters into interest rate caps as part of its securitization transactions, which are designed to manage interest rate exposure. These caps are subject to similar repricing risk dynamics, suggesting that both firms are managing interest rate volatility through derivative instruments, though in different business contexts—AXP through its core interest income and MS through structured finance activities involving SPEs.",
      "llm_answer": "American Express’s analysis shows that a parallel 200‑basis‑point rise in market rates would reduce its annual net‑interest income by roughly **$560 million**, because its interest‑rate‑sensitive assets and liabilities are assumed to reprice in line with benchmark moves, subject only to any caps or floors (AXP 10‑K p.81). Morgan Stanley, by contrast, **uses interest‑rate caps in many securitization transactions** to limit the cash‑flow impact of rising rates on the assets transferred to SPEs, thereby hedging the same repricing‑risk exposure that drives AXP’s earnings sensitivity (MS 10‑K p.128).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies AXP's sensitivity to a 200 basis point increase in interest rates and quantifies the impact on net interest income as $560 million, which aligns with typical disclosures in AXP's 10-K (though the exact figure is not in the ground truth answer, it is plausible and contextually consistent with the type of quantitative sensitivity analysis firms provide; the ground truth does not specify a dollar amount, so this addition does not contradict it). The mention of repricing assumptions and caps/floors matches the original answer. For MS, the use of interest rate caps in securitization transactions is accurately stated and linked to managing repricing risk, consistent with the ground truth. (2) Quantitatively, the $560 million figure is specific and likely derived from actual AXP filings (e.g., page 81 as cited), and while not present in the ground truth, it does not conflict and enhances precision. The absence of a number in the ground truth doesn't invalidate the LLM's inclusion, especially since it's sourced. (3) Multi-hop reasoning is sound: the LLM connects AXP’s net interest income sensitivity to repricing risk and derivative features (caps/floors), then contrasts with MS’s use of caps in securitizations, correctly identifying repricing risk as a common thread managed via derivatives in different business contexts. (4) The answer is semantically equivalent and adds value with specific dollar impact and page references. Minor deduction from 10 due to introducing a specific number ($560M) not in the ground truth, which, while likely accurate, cannot be fully verified against the provided truth. Otherwise, entity accuracy (AXP, MS, SPEs, interest rate caps), reasoning, and relevance are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1386,
        "completion_tokens": 482,
        "total_tokens": 1868
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the impact of a weaker U.S. dollar on MDLZ's consolidated earnings compare to the favorable currency effects experienced by Coca-Cola's Europe, Middle East and Africa segment, given both companies explicitly call out exchange rate fluctuations involving the euro and British pound?",
      "original_answer": "MDLZ states that a weaker U.S. dollar benefits its consolidated earnings and net assets, as many subsidiaries operate in non-dollar functional currencies. KO specifically notes that a weaker U.S. dollar compared to the euro and British pound had a favorable impact on its Europe, Middle East and Africa segment. Both companies explicitly identify these two currencies as key drivers of their respective foreign exchange impacts, showing a direct parallel in how they are affected by similar currency dynamics.",
      "llm_answer": "MDLZ says that a weaker U.S. dollar “benefits our consolidated earnings and net assets” (MDLZ 10‑K Item 7A, p. 65). Coca‑Cola likewise notes that a weaker dollar versus the euro and British pound “had a favorable impact on our Europe, Middle East and Africa … operating segment” (Coca‑Cola 10‑K, p. 51). Thus, both companies view a weaker dollar as a positive currency effect, but MDLZ’s benefit is described at the consolidated‑company level, whereas Coca‑Cola’s benefit is confined to the Europe, Middle East and Africa segment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately captures that both MDLZ and Coca-Cola (KO) benefit from a weaker U.S. dollar due to exchange rate fluctuations involving the euro and British pound, with direct citations from their respective 10-K filings. There are no numeric values to verify (e.g., percentages or dollar amounts), so quantitative accuracy is not applicable beyond correct referencing—no errors here. (2) The answer is complete: it addresses both companies, the direction of currency impact (favorable), the relevant currencies (euro and British pound), and the scope of impact (consolidated for MDLZ vs. segment-level for KO). (3) Multi-hop reasoning is sound—correctly synthesizing disclosures from two different companies and comparing the level (consolidated vs. segment) at which currency effects are reported. (4) The only minor shortcoming is that it doesn’t explicitly state the 'direct parallel' in exposure to the same currencies as emphasized in the original answer, which slightly weakens the qualitative synthesis. However, the core insight—that both are positively affected by similar FX dynamics—is clearly conveyed. Wording differs but semantic meaning matches. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 354,
        "total_tokens": 1650
      },
      "error": null
    },
    {
      "question_id": 96,
      "question": "How does the voting power concentration in MA's dual-class share structure compare to V's, given the relationship between their respective Class A and Class B shares and the 15-vote weighting per Class B share?",
      "original_answer": "MA's dual-class structure includes 907 Class A shares and 7 Class B shares outstanding, with Class B shares carrying 15 votes each, resulting in a voting power concentration of approximately 10.4% for Class B shares. V has 125 Class B shares outstanding as of September 30, 2024, against 1,733 Class A shares, and if following the same 15-vote weighting per Class B share from the intermediary evidence, Class B would hold approximately 68.5% of the voting power despite representing just 6.7% of total shares. This indicates significantly more concentrated control at V compared to MA.",
      "llm_answer": "Both Mastercard and Visa employ a dual‑class structure in which each Class B share carries 15 votes, so a very small number of Class B shares control a disproportionate share of the total voting rights. Mastercard’s seven Class B shares (page 68) represent a tiny fraction of its roughly 1,400 Class A shares yet command a sizable voting block, and Visa’s similarly weighted Class B shares give a small group of insiders an outsized voting stake, making the concentration of voting power comparable between the two companies.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and omits key quantitative comparisons. It incorrectly states that Mastercard has 'roughly 1,400 Class A shares', while the ground truth specifies 907 Class A shares. It also fails to mention Visa's 1,733 Class A shares and 125 Class B shares, instead vaguely referring to 'similarly weighted' shares without providing the actual figures. The critical voting power percentages—10.4% for MA and 68.5% for V—are entirely missing, which are central to the comparison. (2) The calculation of voting concentration is absent in the LLM response. For MA: 7 Class B shares × 15 votes = 105 votes; 907 Class A shares × 1 vote = 907 votes; total votes = 1,012; Class B share voting power = 105 / 1,012 ≈ 10.4%. For V: 125 × 15 = 1,875; 1,733 × 1 = 1,733; total = 3,608; Class B voting power = 1,875 / 3,608 ≈ 68.5%. These calculations are not attempted or referenced. (3) While the LLM correctly identifies the 15-vote weighting per Class B share and recognizes that both companies use dual-class structures with concentrated control, it fails to perform the multi-hop reasoning required to compare the degree of concentration. The conclusion that the concentration is 'comparable' is factually incorrect—the ground truth shows V's control is vastly more concentrated (68.5% vs 10.4%), which the model misses entirely. (4) Scores reflect partial credit for correct structural understanding and relevance to the topic, but major deductions for incorrect numbers, missing calculations, and flawed comparative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1293,
        "completion_tokens": 436,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do the financial risks associated with nuclear power plants at NEE compare to those at Southern Company, particularly in terms of potential exposure from decommissioning costs exceeding available reserves?",
      "original_answer": "NEE and FPL face potential financial risks from decommissioning costs of their nuclear facilities possibly exceeding the available decommissioning funds. Similarly, Southern Company's subsidiaries Alabama Power and Georgia Power also face exposure if decommissioning costs exceed available reserves or insurance coverage. In both cases, the companies acknowledge that the financial impact could be material if the costs surpass the accumulated funds, which are subject to uncertainties in estimation and long-term planning.",
      "llm_answer": "Both NextEra Energy (NEE) and Southern Company flag essentially the same nuclear‑related financial risk: each maintains decommissioning trusts and insurance, but each warns that the ultimate cost of shutting down and de‑commissioning its reactors could exceed the amounts set aside. NEE states that “the cost of decommissioning nuclear generation facilities could exceed the amount available in NEE’s … decommissioning funds” (10‑K page 30), while Southern Company notes that “damages, decommissioning, or other costs could exceed the amount of decommissioning trusts or external insurance coverage” (10‑K page 29). Thus, the potential exposure from decommissioning overruns is a comparable financial risk for both companies.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies both NEE and Southern Company as facing similar financial risks related to nuclear decommissioning costs potentially exceeding available reserves. The core factual content—both companies acknowledge material financial exposure if decommissioning costs surpass accumulated funds—is preserved. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer, so quantitative accuracy is not compromised; the LLM correctly cites page numbers from the 10-Ks (page 30 for NEE, page 29 for Southern Company), which adds precision and supports verifiability. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures from two different companies (NEE and Southern Company) and correctly compares them, noting the parallel structure of risk—trusts and insurance in place, but potential for cost overruns. It appropriately references subsidiaries (implied for NEE via FPL, though not named) and acknowledges the materiality of the risk. (4) The only minor shortcoming is that the original answer explicitly names Southern Company’s subsidiaries (Alabama Power and Georgia Power), while the LLM omits them. This is a small omission in entity specificity but does not undermine the overall correctness or comparability conclusion. Wording differs but semantic meaning is equivalent. The answer is fully relevant, directly addressing the comparative financial risk exposure question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1327,
        "completion_tokens": 420,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How does the $9.9 billion valuation of UPS's pension plan investments in real estate funds compare to the valuation approaches used by General Dynamics for its Level 3 assets, given that both companies rely on valuation models through real estate or private equity fund investments?",
      "original_answer": "UPS valued its $9.9 billion in pension plan investments in real estate funds using net asset value (NAV) as a practical expedient, based on audited and unaudited financial reports from fund managers, with adjustments for investment activity between reporting dates. These real estate funds rely on valuation models, as stated in the second chunk, which notes that real estate funds use NAV based on such models and periodic appraisals. General Dynamics, on the other hand, disclosed that its Level 3 assets include direct private equity investments that are measured using unobservable inputs—essentially internal or fund-level valuation models. Thus, while both companies depend on valuation models for real estate or private equity fund investments, UPS relies on NAV with manager reporting and adjustments, whereas GD directly uses unobservable inputs for its Level 3 private equity holdings.",
      "llm_answer": "UPS reports that its pension‑plan real‑estate fund holdings were valued at $9.9 billion using a net‑asset‑value (NAV) practical expedient – the company reviews audited and unaudited fund manager reports and adjusts for activity between reporting dates because the investments are not actively traded【page_58】. By contrast, General Dynamics classifies its Level 3 assets – mainly direct private‑equity investments – at fair value using valuation models that depend on unobservable inputs (i.e., assumptions that cannot be corroborated in the market) rather than a NAV calculation【page_83】. Thus UPS relies on a NAV‑based estimate, while GD relies on more judgment‑intensive, model‑driven valuations for its Level 3 holdings.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately conveyed: UPS's $9.9 billion pension plan investment in real estate funds is valued using the NAV practical expedient based on fund manager reports (audited and unaudited), with adjustments for activity between reporting dates. General Dynamics values its Level 3 assets—specifically direct private equity investments—using valuation models with unobservable inputs, not NAV. (2) Quantitative accuracy is perfect: the $9.9 billion figure is correctly cited, and no other numbers or calculations are involved. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and General Dynamics), two types of investments (real estate funds vs. private equity), and two valuation approaches (NAV as a practical expedient vs. unobservable inputs for Level 3 assets). (4) The answer clearly contrasts the two approaches, highlighting that both involve models but differ in methodology—UPS relies on NAV derived from fund-level models and reporting, while GD uses more judgment-intensive, internally derived models. Wording differs slightly but meaning is preserved. All evaluation criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1438,
        "completion_tokens": 354,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "Given PepsiCo's 30% beverage revenue exposure in the Africa and Middle East region and Target's vendor arrangements where they only pay for merchandise after guest sale, what potential impact could a supply disruption in this region have on Target's inventory turnover and cash flow timing for beverage SKUs?",
      "original_answer": "A supply disruption in the Africa and Middle East region, which accounts for 30% of PepsiCo's beverage revenue, could delay product availability at Target. Since Target only pays vendors after merchandise is sold to guests, this delay could reduce inventory turnover for beverage SKUs during the disruption period. This would temporarily lower cash flow generation from beverage sales, as Target recognizes revenue only upon guest purchase and does not pay vendors until then.",
      "llm_answer": "Because PepsiCo generates roughly 30 percent of its beverage revenue from the Africa‑Middle East (AME SA) region (PEP 10‑K p. 73), a disruption there would curtail the flow of PepsiCo beverages to Target. Under Target’s “pay‑upon‑sale” vendor model—where it does not purchase or record the merchandise in inventory until it is sold (Target 10‑K p. 49)—the shortfall would shrink on‑hand inventory, likely depress inventory turnover for those SKUs, and postpone both the cash outflow for the purchase and the cash inflow from the sale, tightening cash‑flow timing for the affected beverage items.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 30% beverage revenue exposure in the Africa-Middle East region is correctly cited, and no other numerical values require verification. The reference to PepsiCo’s 10-K page 73 and Target’s 10-K page 49 adds document-level precision. (2) The answer correctly identifies the key entities: PepsiCo, Target, beverage SKUs, and the supply chain dynamics between them. (3) The multi-hop reasoning is sound: it connects PepsiCo’s regional revenue exposure → potential supply disruption → impact on product availability at Target → effects under Target’s pay-upon-sale vendor model → consequences for inventory turnover and cash flow timing. (4) The only minor shortcoming is a slight mischaracterization of Target’s inventory accounting: the model states Target 'does not purchase or record the merchandise in inventory until it is sold,' which may conflate consignment-like arrangements with actual inventory recognition. However, this does not materially distort the conclusion. The core insight—that lower inventory availability reduces inventory turnover and delays both cash inflows and outflows—is correct and semantically equivalent to the original answer. Thus, the answer earns a 9 for correctness and qualitative accuracy due to this nuance, but full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 388,
        "total_tokens": 1696
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How have LLY and AMGN responded differently to payer-driven pricing pressures on their high-cost biologics, particularly in light of access restrictions affecting Repatha and insulin products?",
      "original_answer": "LLY faces increasing public and private payer scrutiny on pricing, especially for insulin, with proposed legislation enabling government price negotiation and restrictive reimbursement policies like the Alzheimer’s Monoclonal Antibody NCD, which could materially affect revenue. In contrast, AMGN has responded to payer restrictions on Repatha—such as formulary exclusions, step therapy requirements, and copay accumulator programs—by reducing both net and list prices, discontinuing higher-priced NDCs in 2019, and directly partnering with payers to align on health outcomes. While LLY emphasizes regulatory and legislative uncertainty, AMGN has taken active pricing and partnership strategies to mitigate payer-imposed access barriers.",
      "llm_answer": "Lilly’s filing notes that it may face future government‑mandated price negotiations for its insulin products but has not announced any direct price cuts, taking a more defensive stance toward payer pressure (Lilly 10‑K p. 29). By contrast, Amgen has actively lowered the net price of Repatha, expanded discounts and rebates, and introduced lower‑list‑price NDCs to blunt payer‑driven access restrictions (Amgen 10‑K p. 41).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and aligns well with the ground truth. It correctly identifies that LLY (Lilly) faces potential government price negotiation for insulin without having implemented direct price cuts, reflecting a defensive posture—consistent with the original answer's emphasis on regulatory and legislative uncertainty. The LLM also accurately captures AMGN's (Amgen's) active response to payer restrictions on Repatha by lowering net prices, expanding discounts, and introducing lower-list-price NDCs, which matches the ground truth's description of price reductions and discontinuation of higher-priced NDCs in 2019. The citation of specific 10-K pages adds precision. Quantitatively, no explicit numbers (e.g., dollar amounts, percentages, or exact dates like 2019) are missing or incorrect—the absence of '2019' is a minor omission but does not affect the factual core. The LLM omits some details from the original answer, such as Amgen's direct partnerships with payers to align on health outcomes and specific access restrictions like step therapy or copay accumulators. However, the key multi-hop synthesis—contrasting LLY’s passive, policy-focused response with AMGN’s proactive pricing and access strategies—is sound and semantically equivalent. Wording differs but meaning is preserved. Thus, the answer is highly accurate, with only slight room for added detail.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 385,
        "total_tokens": 1686
      },
      "error": null
    },
    {
      "question_id": 97,
      "question": "How do BAC and SCHW's approaches to meeting capital buffer requirements compare under the current regulatory framework where the Countercyclical Capital Buffer remains at zero?",
      "original_answer": "BAC applies a Stress Capital Buffer of 2.5% under the Standardized approach as of December 31, 2023, while SCHW's subsidiary CSB maintains a Capital Conservation Buffer of 2.5%. Both institutions benefit from the Federal Reserve's current setting of the Countercyclical Capital Buffer at zero, which reduces their overall capital requirements. However, BAC's capital strategy incorporates a G-SIB surcharge of 2.5% alongside its buffer requirements, whereas SCHW structures its capital to meet minimum ratios of 7.0%, 8.5%, and 10.5% for Common Equity Tier 1, Tier 1, and Total Risk-Based Capital respectively, inclusive of buffers.",
      "llm_answer": "Bank of America satisfies its buffer requirement with a 2.5 % stress‑capital buffer under the Standardized approach and, under the Advanced approach, a 2.5 % capital‑conservation buffer plus a 2.5 % G‑SIB surcharge (the CCyB is zero). Charles Schwab, by contrast, relies on a larger 5.4 % supplementary capital buffer under the Standardized approach and a 2.5 % capital‑conservation buffer plus a 3 % G‑SIB surcharge under the Advanced approach, giving total buffer requirements of 8.4 % (Standardized) and 5.5 % (Advanced) while the CCyB remains at zero.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies and misrepresents both BAC's and SCHW's capital buffer approaches. (1) Quantitative Accuracy: The claim that Bank of America (BAC) uses a 2.5% capital-conservation buffer under the Advanced approach and a 2.5% G-SIB surcharge is incorrect — the ground truth states BAC applies a 2.5% Stress Capital Buffer (SCB), not a capital-conservation buffer, and while the G-SIB surcharge of 2.5% is correctly attributed, it is not framed as part of a dual-method approach. More critically, the LLM falsely attributes a 5.4% supplementary capital buffer and a 3% G-SIB surcharge to Charles Schwab (SCHW), which contradicts the ground truth: SCHW’s subsidiary CSB maintains only a 2.5% Capital Conservation Buffer and is not subject to a G-SIB surcharge (SCHW is not a G-SIB). The total buffer requirements of 8.4% (Standardized) and 5.5% (Advanced) are entirely fabricated. (2) Completeness: While the answer addresses the zero CCyB environment and attempts to compare both firms, it introduces non-existent buffer structures and calculation frameworks. (3) Entity Accuracy: Misidentifies SCHW as subject to a G-SIB surcharge (3% vs actual 0%), incorrectly assigns a 'supplementary capital buffer' not mentioned in the truth, and conflates SCB with CCyB. (4) Reasoning: The multi-hop synthesis fails — the model invents a parallel regulatory treatment between BAC and SCHW that does not exist, incorrectly implying both use Advanced and Standardized approaches with G-SIB surcharges. In reality, only G-SIBs like BAC face G-SIB surcharges; SCHW does not. (5) Semantic Equivalence: The overall meaning is distorted due to false numerical and structural claims. Despite correct mention of the zero CCyB and some correct percentages (e.g., 2.5% buffers), the core capital strategy descriptions are factually wrong, leading to a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 509,
        "total_tokens": 1813
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How does Southern Company's investment in solar facilities, which are connected to power purchase agreements (PPAs), compare with Duke Energy's reliance on PPAs in terms of renewable energy facility financing strategies and tax credit utilization timelines?",
      "original_answer": "Southern Company has approximately $1.2 billion of unutilized federal ITCs and PTCs as of December 31, 2021, which are expected to be fully utilized by 2024, and uses tax equity partnerships for solar and wind projects where the tax partner captures most of the federal tax benefits. These solar facilities are connected to PPAs that are accounted for as operating leases with remaining terms of up to 25 years. In contrast, Duke Energy negotiates PPAs as part of its commercial renewables strategy and enters into tax equity arrangements to finance renewable assets eligible for tax credits. Duke's PPAs significantly impact the economic performance of its renewable facilities, and Duke is the primary beneficiary of these VIEs due to its control over siting, PPA negotiation, and operations. The connection between Southern Company's solar investments and PPAs, and Duke's PPA-driven renewable financing, reveals differing approaches to leveraging long-term contracts and tax incentives in renewable energy development.",
      "llm_answer": "Southern Company’s solar projects are tied to long‑term PPAs that are accounted for as operating leases (terms of up to 25 years) and are primarily financed through tax‑equity partnerships; the company disclosed about $1.2 billion of un‑used federal ITCs and PTCs that it expects to fully utilize by 2024, with the solar ITC rate falling from 30 % (pre‑2020) to 26 % (2020‑2022) and 22 % in 2023 (see pages 97, 268, 108). Duke Energy also relies on PPAs—e.g., its inter‑company power agreement with OVEC and other renewable‑asset PPAs—but structures these through VIEs and guarantee‑backed debt, using tax‑equity arrangements without a disclosed timeline for when the tax credits will be consumed (see pages 202, 204). Thus, Southern’s approach couples PPAs with a clear, near‑term tax‑credit utilization schedule, whereas Duke’s PPA‑based financing is centered on VIE and guarantee structures with no explicit credit‑use timetable.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Southern Company's $1.2 billion in unutilized ITCs and PTCs as of December 31, 2021, and the expectation to fully utilize them by 2024 are accurately reported. The solar ITC rate timeline (30% pre-2020, 26% 2020–2022, 22% in 2023) is factually correct and consistent with public IRS guidance, though not explicitly in the original answer; however, it adds context without contradicting the ground truth. (2) The LLM correctly identifies both companies’ use of PPAs and tax equity financing. It accurately notes Southern’s use of operating leases for PPA-connected solar facilities and Duke’s use of VIEs where it is the primary beneficiary due to control over siting, PPA negotiation, and operations—though the LLM rephrases this as 'VIE and guarantee structures,' which is semantically valid. (3) Multi-hop reasoning is sound: the model synthesizes financing mechanisms (tax equity), contractual structures (PPAs as operating leases vs. VIEs), and tax credit utilization timelines to contrast the two companies’ strategies. The key insight—that Southern has a clear near-term tax credit utilization schedule while Duke does not disclose one—is directly supported by the original answer. (4) Minor deduction in qualitative accuracy due to the addition of ITC rate details not present in the ground truth, which, while accurate, slightly shifts focus; however, this does not detract from correctness. Overall, the answer is factually robust, contextually relevant, and demonstrates strong synthesis across entities and financial structures.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1516,
        "completion_tokens": 451,
        "total_tokens": 1967
      },
      "error": null
    },
    {
      "question_id": 98,
      "question": "How might the automatic conversion of Class B shares to Class A shares upon transfer at Google, combined with Comcast's non-dilutable Class B voting structure, influence investor sentiment toward Meta's dual-class governance model that grants disproportionate voting control to its founder?",
      "original_answer": "Google's Class B shares automatically convert to Class A shares upon transfer, reducing long-term concentration of voting power. In contrast, Comcast's Class B shares retain 33 1/3% of voting power and are non-dilutable, preserving control. Meta's governance risks highlight concerns that its dual-class structure could make Class A stock less attractive to investors. When considering these three elements together, the contrast in how voting power is preserved or diluted across these companies may shape investor perceptions of governance fairness and control concentration, particularly in Meta's case where founder control remains strong despite lower ownership percentages.",
      "llm_answer": "Google’s charter says that Class B shares “may be converted … at any time … and automatically convert upon sale or transfer to Class A common stock” (Alphabet 10‑K p. 81), which erodes voting power when the shares change hands. Comcast, by contrast, locks in a fixed 33 % of the combined voting power in its Class B stock that “cannot be diluted by additional issuances of any other class of common stock” (Comcast 10‑K p. 91). Because Meta’s dual‑class structure gives Mark Zuckerberg “disproportionate voting control” without a conversion or anti‑dilution safeguard (Meta 10‑K p. 50), investors may view its governance as riskier and less aligned with shareholder interests, heightening skepticism toward Meta’s model.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Google's Class B shares automatically convert to Class A upon transfer (citing Alphabet 10-K p.81), Comcast's Class B shares have non-dilutable 33 1/3% voting power (citing Comcast 10-K p.91), and Meta's dual-class structure grants Zuckerberg disproportionate control without conversion or anti-dilution safeguards (citing Meta 10-K p.50). The 33% figure in the LLM answer is a minor rounding of the exact 33 1/3% in the original, but this does not affect factual accuracy. (2) Quantitative accuracy is excellent—no calculations required, and all percentages and references are correct. (3) Multi-hop reasoning is sound: the model correctly contrasts Google’s dilutive mechanism, Comcast’s anti-dilutive structure, and Meta’s lack of either mechanism, leading to the conclusion that Meta’s governance may appear riskier to investors. (4) The answer is contextually relevant and directly addresses investor sentiment toward Meta’s governance model in light of the other two companies’ structures. The only minor shortcoming is a slightly narrower discussion of investor sentiment compared to the original’s broader reflection on 'governance fairness and control concentration,' but the core insight is preserved. Thus, the answer earns a 9/10 for correctness—excellent but not perfect in depth of synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 389,
        "total_tokens": 1775
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "Given CVS's launch of Cordavis to co-produce biosimilars with pharmaceutical manufacturers, and UnitedHealth's (UNH) $12.5 billion in rebates receivable from those same manufacturers, how might the increased market availability of lower-cost biosimilars impact UNH's rebate structure and revenue recognition timing, considering rebates are based on product utilization and contract terms?",
      "original_answer": "CVS launched Cordavis to work directly with pharmaceutical manufacturers to commercialize and/or co-produce high-quality biosimilar products, aiming to increase market access and reduce costs. This initiative could increase the utilization of biosimilars, which are typically less expensive than branded biologics. UnitedHealth (UNH) has $12.5 billion in rebates receivable from pharmaceutical manufacturers as of December 31, 2024, which are accrued monthly based on utilization, historical data, and contract terms. Since rebates are influenced by the volume and type of products used, a shift toward greater biosimilar adoption could reduce the rebate amounts negotiated by manufacturers, especially if biosimilars are priced lower and displace branded drugs. Additionally, changes in utilization patterns may affect the timing and predictability of rebate collections for UNH, as lower-cost biosimilars may alter the dynamics of rebate accruals and payment cycles outlined in manufacturer contracts.",
      "llm_answer": "CVS’s new Cordavis subsidiary is intended to expand the supply of lower‑cost biosimilars (CVS 10‑K p. 12). UnitedHealth records manufacturer rebates each month based on the volume of drugs used and the specific contract terms, and it carries $12.5 billion of such rebates receivable (UNH 10‑K p. 50). If biosimilars become widely adopted, the per‑prescription rebate amount may fall because of lower drug prices, but higher utilization could offset the decline, reshaping the overall rebate mix; because rebates are accrued as utilization occurs, a rapid shift to biosimilars would likely accelerate rebate‑related revenue recognition, whereas renegotiated contracts reflecting new pricing could defer accruals to later periods.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $12.5 billion in rebates receivable from UNH's 10-K is accurately cited, and the reference to CVS's Cordavis initiative aligns with its 10-K disclosure (p. 12). The fiscal year context (as of December 31, 2024, implied in the original answer) is consistent, though not explicitly stated in the LLM response—this is a minor omission but does not affect correctness. (2) The LLM correctly identifies both entities (CVS and UnitedHealth), their respective initiatives (Cordavis and rebate receivables), and the financial metric ($12.5B). (3) The reasoning is sound and captures the multi-hop logic: it connects CVS’s biosimilar expansion to potential changes in drug utilization, links that to rebate calculations based on volume and pricing, and considers both the per-prescription rebate decline and possible offset from higher volume. It also correctly addresses revenue recognition timing, noting that faster adoption could accelerate accruals (due to utilization-based recognition), while contract renegotiations could delay them—this reflects a nuanced understanding of the interplay between utilization, contracts, and accounting. (4) The only reason for not scoring a 10 is that the LLM slightly underemphasizes the structural risk to rebate *amounts* due to lower biosimilar pricing displacing high-rebate branded drugs—a key point in the original answer. However, it does imply this by noting lower per-prescription rebates. Overall, the answer is factually correct, contextually relevant, and demonstrates strong synthesis across filings and concepts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1493,
        "completion_tokens": 456,
        "total_tokens": 1950
      },
      "error": null
    },
    {
      "question_id": 99,
      "question": "How might the SEC's Regulation Best Interest, which requires broker-dealers to act in the best interest of retail consumers, influence Goldman Sachs' compliance costs and competitive positioning against Morgan Stanley, given their differing approaches to consumer protection regulations and retail client expansion?",
      "original_answer": "Goldman Sachs faces increased compliance costs due to consumer protection regulations like Regulation Best Interest, which applies to its consumer-oriented activities, including transaction banking and retail client services. The MET_10k_2024.pdf evidence shows that Regulation Best Interest imposes conduct standards on broker-dealers when recommending securities, including variable insurance products, and that state-level extensions could allow private litigation, increasing legal exposure. Meanwhile, Morgan Stanley's 2024 10-K acknowledges intense competition in the U.S. and globally, particularly from firms offering similar products and services to retail and institutional clients, and notes that some competitors may operate under less stringent regulatory regimes. This suggests that while both firms are subject to Regulation Best Interest, Morgan Stanley may have a more established retail client infrastructure, giving it a competitive edge in adapting to the regulation with lower incremental costs compared to Goldman Sachs, which is expanding in this space and facing higher compliance investments.",
      "llm_answer": "Regulation Best Interest forces Goldman Sachs to devote extra resources to consumer‑protection controls, systems and procedures, which it flags as a source of higher compliance and operational costs in its consumer‑oriented activities (GS 10‑K p. 61).  By contrast, Morgan Stanley points out that some competitors operate under less‑stringent regulatory regimes and can pursue retail‑client growth with lower cost pressure (MS 10‑K p. 23), so the RBI‑driven cost burden could erode Goldman Sachs’ competitive edge versus Morgan Stanley in the retail market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Regulation Best Interest increases compliance costs for Goldman Sachs, citing its 10-K (p. 61), and contrasts this with Morgan Stanley's acknowledgment that some competitors face less stringent regulation, citing MS 10-K (p. 23). These citations match the evidence in the original answer, even if not explicitly quoting the same passages. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of numerical errors and correct referencing of document pages supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across both firms’ 10-Ks to infer that Goldman Sachs faces higher incremental compliance costs due to its retail expansion, while Morgan Stanley may have a competitive advantage due to lower cost pressure and potentially more established infrastructure. The only minor shortcoming is that the LLM does not explicitly mention Morgan Stanley’s more established retail presence as a factor in lower incremental costs, which slightly weakens the completeness of the competitive positioning analysis. (4) The answer is fully contextually relevant, directly addressing how Regulation Best Interest affects compliance costs and competitive dynamics between the two firms. Overall, the response is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a slight omission in elaborating on Morgan Stanley’s structural advantage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 447,
        "total_tokens": 1908
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare with GOOGL's approach to Class B common stock in terms of concentrated control, given that CMCSA's Class B stock carries 15 votes per share and GOOGL's Class B stock carries 10 votes per share?",
      "original_answer": "CMCSA's Class A and Class B common stock structure allocates 66 2/3% of the combined voting power to Class A shares held broadly, while the Class B shares, which carry 15 votes per share and are entirely owned by Brian L. Roberts, control the remaining 33 1/3% of voting power. In contrast, GOOGL's Class B common stock carries 10 votes per share, and although the company also maintains a dual-class structure, the voting power distribution is not explicitly quantified in the evidence provided. However, GOOGL's Class B shares can be converted to Class A shares upon sale or transfer, which could potentially dilute concentrated control over time—unlike CMCSA’s Class B shares, which are non-dilutable.",
      "llm_answer": "Comcast’s capital structure gives its single‑holder Class B stock a very high voting weight – each share carries 15 votes and, because all 9.44 million Class B shares are owned by Brian L. Roberts, they account for about one‑third of the company’s total voting power (≈33 %). Alphabet’s Class B shares also concentrate voting power among insiders, but each share carries 10 votes rather than 15, providing a slightly lower per‑share voting multiplier and a broader (though still insider‑heavy) ownership base. Thus, both firms use dual‑class stock to concentrate control, with Comcast’s Class B shares giving a higher vote‑per‑share impact and being held by a single individual, while Alphabet’s Class B shares give a somewhat smaller vote‑per‑share advantage to its insiders. 【page_31】【page_82】",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, it correctly states that CMCSA's Class B shares carry 15 votes per share and account for approximately one-third (≈33%) of total voting power, which matches the ground truth's 33 1/3%. It accurately notes GOOGL's Class B shares carry 10 votes per share. The mention of Brian L. Roberts as the sole holder of CMCSA Class B shares is correct. (2) The answer does not include the exact figure of 66 2/3% for Class A voting power, but stating that Class B accounts for about one-third implies the remaining two-thirds, which is semantically equivalent. (3) Qualitatively, the reasoning correctly compares the higher vote-per-share (15 vs 10) and highlights concentrated control in both firms, noting CMCSA’s single-holder structure versus Alphabet’s broader insider base. (4) The LLM omits the point about GOOGL’s Class B shares being convertible to Class A upon sale—this is a minor omission affecting completeness but not core correctness. It also does not mention that CMCSA’s Class B shares are non-dilutable, a nuance present in the original. However, these omissions do not undermine the central comparison of concentrated control via voting power. The answer remains factually sound, contextually relevant, and well-reasoned, warranting a high score with only minor room for improvement in completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 386,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does the increase in illicit trade prevalence in Turkey, which negatively impacted PM's cigarette volume growth, compare to PG's exposure to Turkey's foreign exchange volatility, and what does this reveal about the dual operational risks each company faces in the same market?",
      "original_answer": "PM reported that Turkey's cigarette market grew by 8.2%, primarily due to the easing of pandemic restrictions and increased tourism, but this growth was partially offset by a higher estimated prevalence of illicit trade. This illicit trade directly impacts PM's market dynamics by reducing legitimate sales volume and potentially eroding brand loyalty. Meanwhile, PG disclosed that Turkey is one of several countries where it faces significant foreign exchange exposure, with currency fluctuations having historically impacted its net sales, costs, and earnings. Given Turkey's economic instability, PG's exposure includes both transaction and translation risks that affect margins and cash flows. Together, these facts highlight that while PM is grappling with illicit trade undermining its cigarette sales in Turkey, PG is simultaneously facing financial risks from the country's volatile currency, illustrating how different types of market-specific risks—operational and financial—can concurrently challenge multinational corporations in the same geopolitical environment.",
      "llm_answer": "- Philip Morris said that in Turkey the market grew 8.2 % but that growth was “partially offset by a higher estimated prevalence of illicit trade,” which dampened its cigarette‑volume gains (PM 10‑K p. 56).  \n- Procter & Gamble notes that Turkey is one of the countries where “significant exchange‑rate fluctuations” have “significantly impacted … net sales, costs and net earnings” and could do so again (PG 10‑K p. 23).  \n\nTogether, these disclosures show that the two firms face different but complementary risks in the same market: PM’s operational risk comes from illegal trade eroding legal volume, while PG’s risk stems from macro‑economic currency volatility that can hurt its financial results.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 8.2% market growth in Turkey and attributes the partial offset to higher illicit trade prevalence for PM, which aligns with the original answer. It also accurately captures PG's exposure to foreign exchange volatility in Turkey, citing 'significant exchange-rate fluctuations' impacting net sales, costs, and earnings—consistent with the ground truth. All key facts are present and factually correct. (2) Quantitatively, the 8.2% figure is accurate and properly attributed. No calculations are required in this question, but the comparative framing is sound. Number formats and references (e.g., 10-K page numbers) are correctly reported. (3) The multi-hop reasoning is strong: the model synthesizes risk types across two different companies (PM and PG) operating in the same country but facing distinct challenges—illicit trade (operational) vs. currency volatility (financial). It correctly infers that these represent complementary risks in the same market, which is the core insight of the original answer. The only minor shortcoming is that it does not explicitly name 'transaction and translation risks' or mention Turkey's economic instability as context for PG's exposure, slightly reducing depth in qualitative synthesis. (4) The answer is highly contextually relevant, directly addressing both parts of the question—comparison of risks and what they reveal about dual operational risks. Wording differs but semantic meaning and factual content are equivalent to the ground truth. Minor omission of PG's specific risk types prevents a perfect 10, but overall accuracy and reasoning are excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1478,
        "completion_tokens": 454,
        "total_tokens": 1932
      },
      "error": null
    },
    {
      "question_id": 100,
      "question": "How does JPMorgan's approach to identifying and managing transition risk compare to Bank of America's exposure to reputational risk in the context of their climate-related commitments, particularly given JPM's Firmwide Climate Risk Framework and BAC's $1.5 trillion sustainable finance goal?",
      "original_answer": "JPMorgan addresses transition risk through its Firmwide Climate Risk Framework, which includes setting policies, developing metrics and stress testing mechanisms, and establishing a climate risk data strategy to assess financial impacts. This structured approach is designed to integrate climate risk considerations across its business lines. In contrast, Bank of America identifies reputational risk as a potential consequence of failing to meet its climate-related commitments, such as its $1.5 trillion sustainable finance goal, which includes $1 trillion dedicated to supporting the transition to a low-carbon economy. While both institutions recognize climate risk broadly, JPMorgan emphasizes proactive identification and scenario-based analysis of transition risks, whereas BAC focuses on reputational risk mitigation tied to its public climate goals and stakeholder expectations.",
      "llm_answer": "JPMorgan tackles transition risk through a dedicated Climate Risk Management function that, under its Firmwide Climate Risk Framework, sets policies, standards, metrics, scenarios and stress‑testing to identify, assess, monitor and control transition‑related exposures, with regular reporting to the Board Risk Committee (see pages 148 & 78). In contrast, Bank of America’s climate commitments – especially its $1.5 trillion sustainable‑finance goal – create a reputational‑risk exposure that is overseen by its ERC, CGESC and Climate Risk Council and mitigated through governance, communication and monitoring processes aimed at preventing damage if the targets are not met (see page 83).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all figures are correct: JPMorgan's Firmwide Climate Risk Framework and Bank of America's $1.5 trillion sustainable finance goal (including the $1 trillion low-carbon component, implied in the original answer) are accurately referenced. No calculations are required, and the dollar amounts match exactly. (2) The LLM correctly identifies the governance structures—JPMorgan’s Board Risk Committee and BAC’s ERC, CGESC, and Climate Risk Council—adding detail not in the original but consistent with plausible reporting practices. (3) The reasoning is sound: it correctly contrasts JPMorgan’s proactive, framework-driven approach to transition risk with BAC’s reputational risk focus tied to public commitments. The multi-hop synthesis—linking JPM’s framework to risk identification and BAC’s goal to reputational exposure—is logically and factually valid. (4) The only minor gap is that the LLM does not explicitly mention BAC’s $1 trillion low-carbon economy allocation, which is part of the $1.5 trillion goal and noted in the original. However, this detail is contextually implied in 'sustainable-finance goal' and does not undermine the core accuracy. Wording differs but semantic equivalence is maintained. The inclusion of page references (148, 78, 83) suggests document grounding, enhancing credibility. Overall, the answer is factually robust, contextually appropriate, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 416,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the timing of Microsoft's revenue recognition for hardware sales, which combines hardware and software as a single performance obligation, align with Cisco's average loan receivable terms for financing hardware purchases, and what is Cisco's total credit loss allowance for these financing arrangements as of July 29, 2023?",
      "original_answer": "Microsoft recognizes revenue for hardware sales at the point in time when ownership is transferred to resellers or end customers, treating the hardware and software as a single performance obligation. Cisco offers loan receivables with average terms of one to three years to finance hardware purchases. As of July 29, 2023, Cisco's total credit loss allowance for financing arrangements, including loan and lease receivables, was $72 million.",
      "llm_answer": "Microsoft records revenue for hardware that is sold together with a software license as a single performance‑obligation and recognizes it at the point in time ownership is transferred to the reseller or end‑customer【page_62】. Cisco’s financing of such hardware purchases is provided through loan receivables that have average terms of one to three years【page_82】, and the company carried a total credit‑loss allowance of $72 million for these financing receivables (loan $53 m + lease $19 m) as of July 29 2023【page_84】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, all numbers are accurate: the credit loss allowance is correctly stated as $72 million, with a breakdown of $53 million for loans and $19 million for leases, summing to the total, and the date July 29, 2023, is correctly cited. The average loan term of one to three years is accurately reported. (2) The answer is complete, addressing all parts of the multi-hop question: Microsoft's revenue recognition timing for combined hardware/software sales, Cisco's financing terms for hardware, and the credit loss allowance amount. (3) Entities are correctly identified: Microsoft and Cisco are accurately attributed with their respective financial policies and metrics. (4) The reasoning is sound and synthesizes information across multiple domains—revenue recognition (Microsoft) and financing terms/credit risk (Cisco)—without confusion. The semantic meaning is equivalent to the original answer, with only minor formatting differences (e.g., use of em dashes, page references) that do not affect accuracy. All components are factually correct and properly contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1287,
        "completion_tokens": 328,
        "total_tokens": 1615
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How might potential delays in FAA certification of Gulfstream's G700 aircraft impact FedEx's compliance costs under ICAO's 2028 production cutoff for non-compliant aircraft, given FedEx's reliance on fuel-efficient fleets to manage CORSIA obligations?",
      "original_answer": "Delays in FAA certification of Gulfstream's G700 aircraft could limit FedEx’s ability to acquire newer, more fuel-efficient aircraft before the 2028 cutoff date for non-compliant models, potentially increasing FedEx’s CORSIA compliance costs. FedEx noted in its 2023 10-K that its CORSIA-related expenses depend on factors including the fuel efficiency of its fleet and the availability of qualifying sustainable aviation fuels. Gulfstream’s 2023 inventory ramp-up for the G700 was explicitly tied to FAA certification timing, meaning a delay could slow the introduction of next-generation aircraft into FedEx’s fleet. This would prolong the use of older, less-efficient aircraft, increasing the company’s carbon offset or allowance purchase obligations under CORSIA and ETS, especially as free allowances are phased out by 2026.",
      "llm_answer": "If FAA certification of the G700 is delayed, FedEx will be unable to add this next‑generation, fuel‑efficient jet to its fleet as soon as planned and will have to keep operating older, higher‑emitting aircraft. Because FedEx’s CORSIA‑related expenses depend on fleet fuel efficiency and ICAO will deem any aircraft delivered after 1 Jan 2028 that does not meet the 2017 emissions standards “non‑compliant,” a postponed G700 rollout would likely increase the number of flights subject to offsets or sustainable‑fuel purchases, raising FedEx’s compliance costs. (FedEx 10‑K, p. 18; Gulfstream 10‑K, p. 71)",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: FAA certification delays for the G700 could prevent FedEx from acquiring fuel-efficient aircraft before the 2028 ICAO cutoff, increasing CORSIA compliance costs due to reliance on older, less-efficient planes. The mention of ICAO’s 1 January 2028 deadline for non-compliant aircraft (those not meeting 2017 emissions standards) is factually correct and matches the regulatory context. (2) Quantitative accuracy is strong: the date '1 Jan 2028' is correctly cited, and while no explicit numbers (e.g., fuel efficiency percentages or cost figures) are present in either answer, the LLM correctly references the structural deadline that drives compliance obligations. (3) Multi-hop reasoning is sound: the model correctly links FAA certification timing (Gulfstream) → aircraft delivery eligibility (ICAO 2028 rule) → fleet fuel efficiency (FedEx’s 10-K disclosures) → CORSIA compliance costs (offsets and sustainable fuel purchases). It also appropriately cites FedEx’s and Gulfstream’s 10-Ks as sources. (4) The only minor shortcoming is that the LLM omits mention of the phaseout of free allowances under ETS by 2026, which adds nuance to the cost pressure. While not critical, this detail was present in the original answer and contributes to a fuller picture of compliance cost drivers. Otherwise, the answer is semantically equivalent, well-reasoned, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 407,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 101,
      "question": "How does the voting power distribution tied to Class A and Class B common stock at CMCSA compare to the voting rights structure of Class A and Class B common stock at GOOGL, particularly in terms of the per-share voting ratio?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, with each share of Class A common stock receiving a variable number of votes depending on the outstanding shares, while each share of Class B common stock has 15 votes and collectively holds 33 1/3% of the voting power. In contrast, at GOOGL, each share of Class A common stock has 1 vote, and each share of Class B common stock has 10 votes, though the specific ownership percentages of each class are not disclosed. This indicates that CMCSA's structure grants significantly more voting weight to Class B shares compared to GOOGL's 10:1 ratio.",
      "llm_answer": "Comcast’s (CMCSA) dual‑class structure gives each Class B share **15 votes** and the voting power is split roughly **66 % to Class A and 33 % to Class B**, so a Class B share votes about **15 times** a Class A share【page_33】. Alphabet’s (GOOGL) structure gives each Class A share **1 vote** and each Class B share **10 votes**, a **10‑to‑1** per‑share voting ratio【page_81】. Thus, Comcast’s Class B shares carry a higher per‑share voting multiplier (15 vs 10) than Alphabet’s.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: CMCSA Class B shares have 15 votes per share, GOOGL Class B shares have 10 votes per share, and Class A shares at GOOGL have 1 vote—these match the original answer exactly. The voting power split at CMCSA (66 2/3% to Class A, 33 1/3% to Class B) is correctly summarized as approximately 66% and 33%, which is acceptable for rounding. (2) The per-share voting ratio comparison (15:1 for CMCSA Class B vs Class A implied ratio, and 10:1 for GOOGL) is correctly interpreted and compared. (3) The reasoning correctly synthesizes the multi-hop comparison between two companies' dual-class structures and draws the valid conclusion that CMCSA’s Class B shares have a higher per-share voting weight than GOOGL’s. (4) The only minor shortcoming is that the LLM simplifies the CMCSA Class A voting mechanism—stating that Class B has 15 votes and Class A has roughly 1/15th of that, but the original answer notes that Class A votes are variable depending on outstanding shares, which the LLM omits. This nuance is important for full qualitative accuracy but does not invalidate the core comparison. Overall, the answer is factually sound, contextually relevant, and correctly focused on the per-share voting ratio as requested.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 371,
        "total_tokens": 1666
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to GOOGL's dual-class structure, particularly in terms of the relative influence of holders of Class B shares?",
      "original_answer": "At CMCSA, holders of Class B common stock (owned entirely by Brian L. Roberts) have 15 votes per share and represent 33 1/3% of the combined voting power, while Class A common stockholders hold 66 2/3% of the voting power. In contrast, at GOOGL, Class B common stockholders have 10 votes per share, and upon conversion, these shares convert to Class A common stock, which has only one vote per share. This means that while both companies use a dual-class structure to concentrate voting power among certain shareholders, CMCSA’s Class B shares carry more per-share voting weight (15 votes vs. 10 votes) and are non-dilutable, giving the holder a fixed minority voting control compared to GOOGL’s structure, which allows for more fluidity through conversion.",
      "llm_answer": "Comcast’s single‑holder Class B stock carries 15 votes per share and, because it is the only Class B holder, it represents roughly one‑third (≈33 %) of the combined voting power of the company’s common stock (see CMCSA page 33). Alphabet’s dual‑class structure gives each Class B share ten votes, providing insiders super‑voting rights that dominate the vote (and far exceed the one‑vote Class A shares and the non‑voting Class C shares) – a concentration of control that is even greater than Comcast’s one‑third share, though the filing does not spell out the exact percentage (see GOOGL page 81).",
      "correctness_score": 6,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures some correct elements but contains significant inaccuracies and omissions that affect the overall correctness. (1) Quantitatively, the statement that CMCSA's Class B has 15 votes per share and represents approximately one-third (33%) of voting power is correct and matches the ground truth. However, the claim about GOOGL is problematic: while it correctly states that GOOGL Class B shares have 10 votes per share, it asserts that this results in a 'concentration of control that is even greater than Comcast’s one-third share' — this contradicts the ground truth, which does not support that GOOGL’s Class B holders have more than one-third voting power, nor does it indicate their control exceeds CMCSA’s in percentage terms. In fact, the ground truth emphasizes CMCSA’s fixed minority control (exactly 33 1/3%) versus GOOGL’s more fluid structure, not a comparison of total voting power magnitude. (2) The LLM admits the GOOGL filing 'does not spell out the exact percentage,' yet still makes a comparative claim about relative control, which is speculative and unsupported. This undermines quantitative and qualitative accuracy. (3) The multi-hop reasoning is partially sound — it identifies both companies’ dual-class structures and per-share vote counts correctly — but fails in synthesizing the comparative influence: it misrepresents GOOGL’s structure as having greater concentration than CMCSA’s, when the ground truth focuses on structural differences (non-dilutable vs. convertible) rather than asserting one has more control. (4) The answer omits key qualitative distinctions: that CMCSA’s Class B is non-dilutable and held entirely by one person, and that GOOGL’s Class B can convert to Class A, affecting long-term control dynamics. These are central to the original answer and missing here. While contextually relevant and addressing the core question, the factual errors in comparative analysis reduce correctness. Minor formatting like '≈33%' is acceptable, but incorrect inferences from missing data lower scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 549,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 102,
      "question": "How does the FDA approval timeline for BMY's Zeposia in ulcerative colitis compare with the regulatory milestone achieved by MRK for Welireg in von Hippel-Lindau disease, and what were the respective impacts on each company's 2021 oncology and immunology portfolios?",
      "original_answer": "BMY received FDA approval for Zeposia in May 2021 for the treatment of moderately to severely active ulcerative colitis (UC), based on the Phase III True North trial, which demonstrated its efficacy and led to expanded market access in immunology. In contrast, MRK received FDA approval for Welireg (belzutifan) in August 2021 for the treatment of von Hippel-Lindau (VHL) disease, marking a key oncology milestone. The approval of Zeposia contributed to BMY's immunology pipeline growth, while Welireg's approval led to a $50 million milestone payment to former Peloton shareholders and positioned MRK more strongly in the oncology space with a novel HIF-2α inhibitor.",
      "llm_answer": "BMY’s S1P‑modulator Zeposia was granted FDA approval for ulcerative colitis in May 2021【page_93】, while Merck’s HIF‑2α inhibitor Welireg received FDA approval as a monotherapy for von Hippel‑Lindau disease in August 2021【page_101】【page_52】—about three months later. Zeposia’s approval added a new UC indication to BMY’s immunology portfolio, whereas Welireg’s clearance introduced a first‑in‑class oncology therapy for VHL into Merck’s oncology portfolio and generated a $50 million milestone payment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: BMY's Zeposia was approved in May 2021 for ulcerative colitis, and MRK's Welireg was approved in August 2021 for VHL disease—correct dates and indications. The three-month difference is accurate. (2) Quantitative accuracy is perfect: the $50 million milestone payment is correctly stated. (3) Entity accuracy is strong: both companies (BMY, MRK), drug names (Zeposia, Welireg), mechanisms (S1P modulator, HIF-2α inhibitor), and disease indications are correctly identified. (4) Multi-hop reasoning is sound: the answer compares timelines and correctly attributes portfolio impacts—Zeposia expanding BMY’s immunology portfolio and Welireg marking a first-in-class oncology approval for MRK with financial and strategic implications. (5) The only minor omission is that the ground truth mentions the True North trial as the basis for Zeposia’s approval, which the LLM answer does not include. However, this detail is contextual and does not affect the core factual claims. Semantic equivalence is maintained, and the answer fully addresses the comparative timeline and portfolio impact. Wording differences (e.g., 'first-in-class' vs 'novel HIF-2α inhibitor') are acceptable and convey similar meaning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 363,
        "total_tokens": 1685
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the vesting period structure for restricted stock at EMR compare to the vesting requirements in the multiemployer pension plans that UPS contributes to, given the differences in funding risk and benefit delivery mechanisms?",
      "original_answer": "EMR applies cliff vesting periods ranging from three to ten years for restricted stock awards, with compensation expense recognized ratably over these periods. In contrast, UPS contributes to multiemployer pension plans where vesting periods are defined by collective bargaining agreements and are tied to retirement, death, or termination benefits. These plans are subject to shared funding risks, where assets contributed by one employer may be used to fund benefits for employees of other employers, and UPS may face additional liabilities such as withdrawal liability or surcharge contributions if plans enter critical status. This highlights a fundamental difference in both the structure and risk exposure of vesting mechanisms between EMR’s equity-based compensation and UPS’s pension obligations.",
      "llm_answer": "Emerson’s (EMR) restricted‑stock awards vest only after a service “cliff” – the stock itself vests after three to ten years of employment and the RSUs vest after a three‑year cliff (the awards are earned at the end of the service period)【page_72】. UPS’s multi‑employer pension plans, by contrast, vest according to the eligibility and participation rules set out in the collective‑bargaining agreements – the plans specify vesting periods but they are tied to union‑defined service thresholds rather than a fixed calendar schedule, and the benefit is paid by the pension fund itself【page_110】. Thus EMR’s equity awards impose a defined, employee‑service‑based vesting horizon on a market‑risk‑bearing asset, whereas UPS’s pension vesting is a statutory/contractual requirement for a defined‑benefit plan whose funding risk is borne by the plan (and potentially other employers) and whose benefits are delivered regardless of market performance.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all details are correct: EMR's restricted stock has a cliff vesting period of 3 to 10 years, and RSUs specifically have a 3-year cliff, which matches the broader range in the original answer. The mention of ratable expense recognition is omitted but implied in the service-based vesting structure. (2) The comparison to UPS’s multiemployer pension plans correctly identifies that vesting is governed by collective bargaining agreements and tied to service thresholds, not fixed calendar periods. The explanation of funding risk being shared across employers and potential withdrawal liability is accurately reflected in the reference to 'funding risk borne by the plan (and potentially other employers)'. (3) Multi-hop reasoning is sound: the model synthesizes EMR’s equity-based compensation structure with UPS’s pension obligations, contrasting their risk mechanisms and benefit delivery. (4) Minor omission: the LLM does not explicitly mention 'critical status' or 'surcharge contributions' as specific risks, which slightly reduces completeness. However, the core concepts of shared funding risk and potential additional liabilities are conveyed. Wording differs but semantic meaning is equivalent. No factual errors; only slight gap in full contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 376,
        "total_tokens": 1834
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does NFLX's exposure to data privacy risks under the Communications Act compare to CMCSA's regulatory obligations under the same Act, particularly in terms of potential financial penalties and operational constraints related to handling personal information?",
      "original_answer": "NFLX faces potential financial penalties and reputational damage due to unauthorized data breaches involving member personal information, including billing data, which could result in material costs and regulatory fines without insurance coverage. CMCSA, being subject to the Communications Act, must comply with privacy and data protection restrictions that govern the collection, use, and disclosure of personal information, which could lead to legal consequences if violated. Both companies are exposed to regulatory scrutiny and potential penalties under the Communications Act, though NFLX lacks insurance to mitigate such risks, whereas CMCSA’s obligations are framed within a broader regulatory compliance framework that includes audits and potential changes in law.",
      "llm_answer": "Netflix warns that the Communications Act (and related privacy statutes) limits its ability to collect, transfer and use personal information, exposing it to regulatory fines, liability for data‑breach claims and the need to alter its data‑handling practices – a risk it notes could be material and for which it carries no breach‑insurance (see NFLX page 13). Comcast, by contrast, acknowledges that the Communications Act and FCC rules impose broad restrictions on the collection, use, disclosure and retention of personal data across its entire communications portfolio, subjecting it to administrative enforcement actions, civil‑ and criminal‑penalties and significant compliance costs and operational changes (see CMCSA pages 17 and 27).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: NFLX faces regulatory fines, liability for data breaches, and operational changes due to limitations under the Communications Act and related privacy laws, with explicit mention of no breach insurance (matching the original answer's point about lack of insurance coverage). CMCSA is correctly described as being subject to broader regulatory obligations under the Communications Act, including restrictions on data handling and exposure to enforcement actions and compliance costs. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any numerical inaccuracies supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk disclosures from both companies, contrasting NFLX’s exposure (especially uninsurance) with CMCSA’s structural compliance obligations. The only minor shortcoming is that the LLM does not explicitly mention 'reputational damage' for NFLX or 'audits and changes in law' for CMCSA, which slightly reduces completeness but does not undermine the core accuracy. (4) The answer is fully contextually relevant, directly addressing the comparison of financial penalties and operational constraints under the Communications Act for both firms. Wording differs but semantic meaning matches the original answer closely.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 412,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the commercialization of Platform 5 nicotine pouches in Sweden by PM compare to CCEP's role as a bottler for KO in the same market, particularly in terms of their respective market entry strategies and product dependencies?",
      "original_answer": "Coca-Cola Europacific Partners (CCEP) serves as a key bottler for The Coca-Cola Company (KO) in Sweden, handling the distribution of Coca-Cola trademark beverages under contractual agreements that require CCEP to purchase concentrates from KO. In 2021, KO's five largest bottlers, including CCEP, represented 41% of KO’s total worldwide unit case volume. Meanwhile, Philip Morris International (PM) launched its Platform 5 nicotine pouch product in Sweden in January 2022 under the Shiro brand, following the acquisition of AG Snus. This launch represents a direct market entry strategy by PM, contrasting with CCEP’s role as a contracted third-party distributor for KO, where product supply is dependent on KO’s concentrate pricing and availability. Both companies operate in Sweden, but PM’s strategy involves direct product innovation and brand acquisition, while CCEP relies on KO for product inputs and brand authorization.",
      "llm_answer": "Philip Morris entered Sweden by directly launching a new product category – a reformulated Platform 5 nicotine‑pouch (the Shiro brand) – in January 2022, controlling the brand, formulation and supply chain (pharmaceutical‑grade nicotine, flavors and cellulose) through its recent AG Snus and Fertin Pharma acquisitions【page_46】. By contrast, Coca‑Cola Europacific Partners (CCEP) operates in Sweden solely as an independent bottler under a bottler’s agreement, preparing, packaging and distributing Coca‑Cola’s beverages after purchasing the concentrates or syrups from Coca‑Cola, so its market entry is a distribution partnership that depends on the parent‑company’s product supply rather than on its own product development【page_7】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All key facts are correct: PM launched Platform 5 (Shiro brand) in Sweden in January 2022, following the acquisition of AG Snus; CCEP acts as a bottler for KO under contractual agreements. The dates (January 2022) and company roles are correctly identified. (2) Quantitative accuracy is perfect—no numerical claims were made beyond the January 2022 launch date, which matches the original answer. There are no calculations, but the temporal data is correct. (3) The multi-hop reasoning is sound: the model correctly contrasts PM’s direct market entry via product innovation and acquisitions (AG Snus, Fertin Pharma) with CCEP’s dependent role as a distributor reliant on KO’s concentrates. This synthesis across corporate strategies and ownership structures is accurate. (4) The LLM adds slightly more detail than the original (e.g., mentioning pharmaceutical-grade nicotine, cellulose, Fertin Pharma), which is contextually appropriate and supported by typical 10-K disclosures, though not in the ground truth. However, it omits the specific statistic that CCEP and KO’s other top bottlers represented 41% of KO’s global unit case volume in 2021—a minor omission affecting completeness but not core correctness. Overall, the answer captures the essence of the comparison in market entry strategies and product dependencies with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1437,
        "completion_tokens": 391,
        "total_tokens": 1828
      },
      "error": null
    },
    {
      "question_id": 103,
      "question": "How does the 8% decline in UNH's Medicare Part D enrollment from 2023 to 2024 interact with the IRA's manufacturer discount requirements and reinsurance shifts to assess CVS's financial exposure under its Medicare Advantage contracts?",
      "original_answer": "The 8% decline in UNH's Medicare Part D enrollment from 3,315,000 in 2023 to 3,050,000 in 2024 suggests a reduction in the number of Part D beneficiaries served by UNH, which may reflect broader market adjustments under the IRA's redesign of Medicare Part D. The IRA introduced significant changes, including capping beneficiary out-of-pocket costs and reducing Federal reinsurance in the catastrophic phase starting January 1, 2025, which shifts more financial responsibility to Part D plans and manufacturers through required manufacturer discounts. For CVS, this creates a dual exposure: first, as a provider of Medicare Advantage plans, it must manage the financial risk associated with the reduced reinsurance and increased member cost-sharing volatility; second, the IRA's rebate mechanism, which Amgen began accruing for in 2022, introduces further pricing pressures that may impact the pharmacy benefit manager's (PBM) drug acquisition costs and rebate negotiations. Thus, the enrollment decline at UNH, combined with the IRA's structural changes and Amgen's experience with manufacturer discounts, collectively signal a complex risk environment for CVS under its Medicare contracts.",
      "llm_answer": "UnitedHealth’s 8 % drop in stand‑alone Part D members (3,050 k in 2024 vs 3,315 k in 2023) 【page_31】 reduces the pool over which CVS can spread the higher drug‑cost burden that the Inflation‑Reduction Act now places on plans – mandatory manufacturer discounts and a cut‑back in catastrophic‑phase reinsurance that shift more liability onto Part D sponsors 【page_53】. Because CVS’s Medicare Advantage premiums are fixed in advance and cannot be raised to offset unexpected cost growth 【page_40】, the combination of fewer Part D enrollees and the IRA‑driven cost shift (including lower reinsurance thresholds) amplifies CVS’s per‑member cost pressure and therefore its financial exposure under its Medicare Advantage contracts 【page_53】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the 8% decline in UNH's Medicare Part D enrollment, with accurate figures: 3,050,000 (2024) vs. 3,315,000 (2023), matching the ground truth. These numbers are correctly formatted as 3,050k and 3,315k, which is acceptable and semantically equivalent. 2) The explanation of the IRA's impact—specifically the shift in financial liability to Part D sponsors due to reduced federal reinsurance in the catastrophic phase and mandatory manufacturer discounts—is factually aligned with the original answer. The LLM correctly links this cost shift to increased per-member cost pressure on CVS as a Medicare Advantage plan sponsor. 3) The reasoning is sound and multi-hop: it connects UNH’s enrollment trend (as a market signal) to structural changes under the IRA, then to risk pooling and cost-spreading dynamics for CVS, and finally to financial exposure under fixed-premium contracts. This synthesis across entities (UNH, CVS, IRA) and mechanisms (enrollment, reinsurance, pricing) is logically coherent. 4) Minor omission: the original answer references Amgen’s rebate accruals as an example of manufacturer discount pressures, which the LLM omits. While not strictly necessary to answer the question, this detail adds depth to the manufacturer discount discussion. However, the core financial exposure argument is fully preserved. 5) All entities (CVS, UNH, IRA, Medicare Part D, Medicare Advantage), years (2023–2024), and mechanisms (reinsurance shifts, fixed premiums) are accurately identified and contextualized. 6) The LLM enhances clarity by explicitly stating that fixed premiums cannot be adjusted to offset cost growth, which strengthens the argument and is consistent with the ground truth. Overall, the answer is factually correct, well-reasoned, and contextually precise—just shy of perfect due to the omitted Amgen example, but not materially inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1503,
        "completion_tokens": 512,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How does Southern Company's use of cost recovery mechanisms for environmental remediation at its natural gas utilities compare to Duke Energy's financial exposure from environmental remediation liabilities, given the differences in their regulatory and liability frameworks?",
      "original_answer": "Southern Company utilizes cost recovery mechanisms approved by state regulatory agencies to recover environmental remediation costs at its natural gas distribution utilities, allowing it to pass on prudently-incurred expenses—including those related to infrastructure replacement and environmental cleanup—to customers through regulated rates. In contrast, Duke Energy faces environmental remediation liabilities at various current and former sites, with $X million (hypothetical placeholder based on typical reporting) in reserves for probable and estimable costs, but without guaranteed regulatory recovery, meaning these costs are often expensed directly as operational expenses unless recovery is deemed probable. While Southern Company benefits from structured cost recovery riders, Duke Energy must manage uncertain future costs without assured cost pass-through, leading to greater financial exposure.",
      "llm_answer": "Southern Company’s natural‑gas distribution utilities operate under state public‑service‑commission (PSC) rules that expressly allow “cost‑recovery mechanisms and regulatory riders” to be added to rates for items such as environmental‑remediation work (see SO 10‑K p. 22). In contrast, Duke Energy records its remediation exposure as a liability reserve – $73 million for the parent and a total of about $165 million across its subsidiaries as of 12/31/2024 – and the costs are generally expensed unless a regulator later permits recovery, leaving the company exposed to the full amount (see DUK 10‑K p. 163). Thus Southern Company can largely pass remediation costs through regulated rates, while Duke Energy bears a direct financial liability with uncertain recoverability.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) It correctly identifies Southern Company's use of cost recovery mechanisms via regulatory riders approved by state PSCs, allowing it to pass environmental remediation costs to customers, and contrasts this with Duke Energy's approach of recording liabilities and expensing costs unless recovery is probable. (2) The quantitative details are mostly correct: the LLM specifies Duke Energy's $73 million reserve for the parent and ~$165 million total across subsidiaries as of 12/31/2024. While the original answer uses a placeholder '$X million', the LLM provides actual figures consistent with typical 10-K disclosures (DUK 10-K p.163), enhancing precision. The date (12/31/2024) is plausible for a recent filing. (3) The multi-hop reasoning is sound—correctly synthesizing regulatory frameworks (Southern) vs. financial liability treatment (Duke)—and draws a valid comparison on financial exposure. (4) Minor deduction in quantitative accuracy due to lack of explicit confirmation that Southern’s mechanisms are tied to prudently incurred costs (implied but not stated), and the placeholder in the original prevents full verification of Duke’s numbers. However, the LLM’s use of specific, cited figures from filings improves factual depth. Semantic equivalence is strong, and all entities (SO, DUK, 10-K pages) are correctly referenced. Contextual relevance is perfect—directly addresses the comparative regulatory and financial frameworks.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 416,
        "total_tokens": 1869
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "What is the combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar and Johnson & Johnson, and how does this compare to 3M's total available securities under similar plans?",
      "original_answer": "The combined total of securities remaining available for future issuance under equity compensation plans approved by security holders for Caterpillar (40,873,176) and Johnson & Johnson (111,042,139) is 151,915,315. This is significantly higher than 3M's total of 39,563,000 available securities under the same category.",
      "llm_answer": "The equity‑compensation tables show that Caterpillar has 40,873,176 securities remaining available under plans approved by security holders and Johnson & Johnson has 111,042,139 such securities, for a combined total of 151,915,315 securities【page_127】【page_121】. 3M reports 39,563 (thousand) = 39,563,000 securities remaining available under its approved equity‑compensation plans【page_116】—about 112 million fewer, or roughly one‑quarter of the combined Caterpillar‑J&J amount.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) All numeric values are accurate: Caterpillar's 40,873,176 and Johnson & Johnson's 111,042,139 securities are correctly reported. The combined total of 151,915,315 is correctly calculated (40,873,176 + 111,042,139 = 151,915,315). 3M's available securities are correctly stated as 39,563,000 (noting that '39,563 (thousand)' equals 39,563,000). (2) The comparison is quantitatively and semantically accurate: stating that 3M's total is 'about 112 million fewer' is correct (151,915,315 - 39,563,000 ≈ 112.35 million), and describing it as 'roughly one-quarter of the combined Caterpillar-J&J amount' is a reasonable approximation (39.56M / 151.92M ≈ 26%). (3) Multi-hop reasoning is sound: the model correctly synthesizes data from three separate companies, computes a sum, and makes a valid comparative analysis. (4) Entities (Caterpillar, Johnson & Johnson, 3M), metric (securities available under equity compensation plans approved by security holders), and context are all accurately identified and used. Wording differs slightly but maintains full semantic equivalence. No factual, numerical, or logical errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 337,
        "total_tokens": 1566
      },
      "error": null
    },
    {
      "question_id": 104,
      "question": "How do Merck's Januvia and Janumet U.S. market exclusivity expiration timelines (May 2026) and IRA-imposed pricing constraints compare to Pfizer's regulatory exclusivity strategy, and what does this indicate about their respective post-2025 revenue protection mechanisms?",
      "original_answer": "Merck’s Januvia and Janumet are set to lose U.S. market exclusivity in May 2026 due to patent settlements and court rulings, with Janumet XR following in July 2026. Despite this, the IRA mandates government price-setting for Januvia starting in 2026 and for Janumet/Janumet XR in 2027, adding pricing pressure. In contrast, Pfizer relies on both patent rights and concurrent regulatory exclusivity periods upon drug approval to protect revenue beyond patent terms. This indicates that Merck is managing near-term exclusivity erosion through price adjustments and rebate reductions, while Pfizer’s strategy emphasizes regulatory exclusivity as a parallel shield alongside patents, suggesting divergent approaches to post-2025 revenue sustainability.",
      "llm_answer": "Merck’s filing notes that the key U.S. patent for Januvia and Janumet (the sitagliptin‑salt form) keeps the products exclusive until May 2026 (Janumet XR until July 2026) and that the IRA will impose a government‑set price on Januvia starting 1 Jan 2026 and on Janumet starting 1 Jan 2027, which will compress net pricing after that date【page_58】. By contrast, Pfizer’s 10‑K describes a regulatory‑exclusivity strategy that layers patent protection with statutory exclusivity periods (e.g., orphan‑drug, pediatric and other regulatory exclusivities) that run concurrently with patents across its portfolio【page_13】. Thus, Merck’s post‑2025 revenue protection rests on a single product’s fixed exclusivity window and mandatory price caps, whereas Pfizer relies on a broader, multi‑product exclusivity framework and pipeline to sustain earnings beyond 2025.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Merck’s Januvia and Janumet exclusivity ends in May 2026 (July 2026 for XR), IRA pricing starts Jan 1, 2026 for Januvia and Jan 1, 2027 for Janumet/Janumet XR — these dates match the original answer’s May/July 2026 and 2026/2027 timeline, with only a minor variation in specificity (exact day added by LLM, which is consistent with typical IRA implementation but not in the original). (2) Entity accuracy is strong: Merck, Januvia, Janumet, Pfizer, IRA, and regulatory exclusivity types (pediatric, orphan-drug) are correctly identified. (3) Multi-hop reasoning is sound: the model correctly contrasts Merck’s reliance on patent-based exclusivity with impending price controls under the IRA versus Pfizer’s strategy of layering regulatory exclusivities on top of patents. (4) The synthesis across companies and mechanisms is logical and relevant. The only minor shortcoming is that the LLM slightly reframes Merck’s strategy as relying on a 'single product’s fixed exclusivity window,' which oversimplifies Merck’s broader portfolio approach but does not contradict the core contrast in revenue protection mechanisms. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 371,
        "total_tokens": 1803
      },
      "error": null
    },
    {
      "question_id": 105,
      "question": "How does the credit event risk associated with MS's investments in CLNs, which embed credit protection sold to issuers, compare to BAC's use of credit derivatives to mitigate commercial credit exposure, particularly in terms of how each firm manages counterparty risk through derivative instruments?",
      "original_answer": "Morgan Stanley (MS) invests in CLNs and CDOs, which are hybrid instruments containing embedded derivatives in which credit protection has been sold to the issuer of the note. If there is a credit event of a reference entity underlying the instrument, the principal balance of the note may not be repaid in full to the firm, indicating a direct exposure to counterparty risk. This contrasts with Bank of America (BAC), which actively purchases credit protection to cover both funded and unfunded portions of certain credit exposures as part of its commercial credit risk management strategy. BAC also uses credit derivatives to hedge risk, with changes in fair value recorded in other income. Both firms utilize credit derivatives, but MS assumes risk by investing in instruments where it has sold protection, while BAC mitigates risk by purchasing protection.",
      "llm_answer": "MS’s CLN and CDO holdings embed credit protection that the firm sells to the issuers, so the firm is directly exposed to a credit‑event loss – the principal may not be repaid in full if a reference entity defaults, and the filing does not describe any net‑ting or collateral arrangement to offset that risk (MS 10‑K p.112). In contrast, Bank of America uses credit‑default swaps and other credit derivatives to hedge its commercial‑credit exposure and explicitly manages counter‑party risk by employing master‑netting agreements, cash‑collateral netting and offsetting of derivative positions, which are reflected in its derivative tables and net‑ting disclosures (BAC 10‑K pp. 64‑65).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Morgan Stanley (MS) invests in CLNs and CDOs where it effectively sells credit protection, leading to direct exposure to credit event risk, with potential non-repayment of principal upon a reference entity default. This matches the original answer's core claim. (2) It accurately contrasts this with Bank of America (BAC), which uses credit derivatives (e.g., CDS) to hedge commercial credit exposure—specifically by purchasing protection—thereby mitigating risk. (3) The LLM adds valuable detail not in the original answer but consistent with SEC filings: BAC employs master netting agreements, cash-collateral netting, and offsetting of derivative positions (citing BAC 10-K pp.64-65), which strengthens the response by explaining how BAC manages counterparty risk. (4) It notes that MS’s filings do not describe netting or collateral arrangements to offset its risk (citing MS 10-K p.112), a nuanced but important point that enhances the comparison. There are no numerical inaccuracies—no specific numbers are involved, but the qualitative financial mechanisms are correctly described. (5) The multi-hop reasoning is sound: it synthesizes information across two firms, their use of credit derivatives, and their opposing risk positions (selling vs. buying protection), and further differentiates them on counterparty risk management practices. The only reason for not scoring a 10 is that the original answer emphasizes BAC records fair value changes in other income, a minor detail omitted in the LLM response. However, this does not detract from the core comparison on risk exposure and counterparty management. Semantic equivalence is strong, with precise and contextually appropriate language.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 488,
        "total_tokens": 1913
      },
      "error": null
    },
    {
      "question_id": 106,
      "question": "How does the indemnification structure established by 3M in connection with Solventum's spin-off compare to RTX's indemnification arrangements for its financial guarantees, particularly regarding the transfer of liability and the recognition of potential losses?",
      "original_answer": "3M transferred certain liabilities to Solventum as part of the spin-off, including those related to the Bair Hugger and Federal False Claims Act/Qui Tam Litigation, with Solventum assuming indemnification and defense obligations. 3M records liabilities for legal proceedings when probable and estimable, and discloses possible losses when not accrued. Similarly, RTX is subject to indemnification for certain liabilities under its financial guarantees, which could affect its financial exposure. Both companies recognize indemnification rights or obligations as part of their liability management, but 3M explicitly transferred liability to a spun-off entity, whereas RTX retains exposure subject to third-party indemnification terms. This distinction affects how each company accounts for contingent liabilities and insurance receivables under ASC 450 and ASC 610-30.",
      "llm_answer": "3M’s spin‑off agreement moves the identified Solventum‑related liabilities to the new company and obligates Solventum to indemnify and defend 3M, so the risk is transferred out of the parent’s balance sheet and 3M does not record a liability for those items. In RTX’s case, the company retains its financial‑guarantee obligations on its books and only a portion of those guarantees is indemnified by third parties; RTX must accrue a liability for the probable loss and disclose the maximum potential payment as a contingent liability. Thus, 3M’s structure shifts the liability to the spin‑off with a full indemnity back to the parent, whereas RTX keeps the liability and recognizes the potential loss, receiving only partial indemnification.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly captures that 3M transferred liabilities to Solventum, with Solventum assuming indemnification and defense obligations, effectively removing those liabilities from 3M’s balance sheet. This contrasts with RTX, which retains financial guarantee obligations on its books and only receives partial indemnification from third parties. The core distinction—that 3M transferred liability via spin-off while RTX retains exposure subject to indemnification—is accurately conveyed. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable; however, the absence of fabricated or incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (3M and RTX), two types of indemnification structures (spin-off vs. financial guarantees), and accounting implications (liability recognition under ASC standards, though not explicitly named in the LLM answer). The LLM infers correct accounting treatment—3M does not record a liability because risk is transferred, while RTX must accrue for probable losses—even if ASC 450/610-30 are not mentioned. (4) The answer is contextually precise, directly addressing the comparison of indemnification structures, transfer of liability, and recognition of potential losses. The only minor shortcoming is the omission of specific litigation examples (Bair Hugger, False Claims Act) and the explicit reference to disclosure practices for unaccrued losses, which were in the original. However, these are contextual details rather than core inaccuracies. Overall, the LLM delivers a factually correct, well-reasoned, and semantically equivalent response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 497,
        "total_tokens": 1928
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the geographic revenue distribution of AMD in Taiwan compare to the potential supply chain risk NVIDIA faces through its foundry partners operating in the same region, given the geopolitical tensions mentioned in both companies' filings?",
      "original_answer": "AMD reported $1,841 million in sales to external customers from Taiwan in 2023, highlighting the region's significance in its revenue distribution. Meanwhile, NVIDIA explicitly states that its foundry partners—critical to its chipset supply—are primarily located in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent NVIDIA from receiving chipset supply. This indicates that while Taiwan is a notable market for AMD's sales, it represents a core supply chain vulnerability for NVIDIA due to its dependency on foundry partners operating in the region.",
      "llm_answer": "AMD generated $1.84 billion of sales in Taiwan for FY 2023 – roughly 8 % of its $22.7 billion total revenue (AMD 10‑K, page 71). By contrast, NVIDIA warns that its reliance on Taiwanese foundry partners – which produce chips for a “significant portion of our revenue” – creates a material supply‑chain risk if China‑Taiwan geopolitical tensions disrupt those fabs (NVIDIA 10‑K, page 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: AMD's $1.84 billion in sales to Taiwan (equivalent to $1,841 million in the original) is accurately reported, and the 8% of total revenue is correctly derived from AMD's $22.7 billion total revenue (1.84 / 22.7 ≈ 8.1%). The reference to NVIDIA’s 10-K page 17 and AMD’s page 71 adds document-level precision. (2) The answer correctly identifies that Taiwan is a significant sales region for AMD but poses a supply chain risk for NVIDIA due to its reliance on Taiwanese foundries. (3) The multi-hop reasoning is sound: it connects AMD’s geographic revenue data with NVIDIA’s supply chain disclosures and synthesizes the contrast in exposure—market vs. production. (4) The only minor shortcoming is that the LLM does not explicitly state that NVIDIA’s foundry partners are 'critical' or that a conflict could 'severely limit' supply, though the phrase 'material supply-chain risk' and reference to disruption captures the essence. Wording differences are acceptable under semantic equivalence. All entities (AMD, NVIDIA, Taiwan, 2023/FY2023, foundry partners) are correct. The answer fully addresses the comparative aspect of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1276,
        "completion_tokens": 350,
        "total_tokens": 1626
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does NEER's 15-year weighted average contract term for repowered wind facilities influence long-term revenue predictability, and how might this structural advantage compare to Southern Power's reliance on power sales agreements where specific contract terms are not disclosed?",
      "original_answer": "NEER benefits from a 15-year weighted average remaining contract term on its power sales agreements tied to repowered wind facilities, which enhances revenue predictability by locking in long-term pricing and output commitments. In contrast, Southern Power discloses its reliance on power sales agreements but does not specify contract durations, limiting visibility into its own revenue stability. This difference suggests NEER may have a more transparent and structured approach to securing long-term cash flows from renewable assets, which could influence investor confidence and financial planning strategies.",
      "llm_answer": "NEER’s repowered wind assets are covered by long‑term power‑sale contracts and production‑tax‑credit agreements that have a weighted‑average remaining term of about 15 years, which effectively locks in cash‑flows and gives the business a high degree of long‑term revenue predictability (NEE 13). By contrast, Southern Power’s earnings are derived from PPAs, but the filing does not disclose the length or specific terms of those agreements, making its revenue stream more dependent on market conditions and less transparent than NEER’s 15‑year‑term advantage (SO 81‑84).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 15-year weighted average remaining contract term for NEER's repowered wind facilities is correctly stated, matching the original answer. There are no calculations required, but the duration is cited accurately. (2) The LLM correctly identifies NEER’s structural advantage in revenue predictability due to long-term contracts and contrasts it with Southern Power’s lack of disclosed contract terms. It appropriately references NEE and SO filings as sources, indicating proper synthesis across documents. (3) The reasoning is sound: it logically connects longer, disclosed contract terms with greater revenue predictability and transparency, while noting that Southern Power’s undisclosed terms limit visibility—this mirrors the multi-hop comparison in the ground truth. (4) The only minor shortcoming is that the LLM mentions 'production-tax-credit agreements' as part of the 15-year term, which is not specified in the original answer and could conflate contract duration for revenue with tax incentives; this slightly overreaches the provided data. However, this does not materially distort the core conclusion. Overall, the answer is factually correct, well-reasoned, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1329,
        "completion_tokens": 360,
        "total_tokens": 1689
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does RTX's revenue recognition practices under FAR guidelines for U.S. government fixed-price contracts compare to Honeywell's exposure to contract termination risks under the same regulatory framework?",
      "original_answer": "RTX recognizes revenue in excess of billings under U.S. government fixed-price contracts due to performance-based or progress payments that typically cover only 80-90% of costs incurred, creating contract assets. These practices are governed by the FAR, which outlines allowable costs and payment structures. Honeywell, also subject to the FAR, faces unique risks such as the U.S. government's right to terminate contracts for convenience, which could impact its contract assets or liabilities similarly structured. Both companies are bound by the same FAR-regulated payment and cost frameworks, but Honeywell's risk profile includes potential contract termination that could disrupt revenue already recognized under FAR-compliant accounting practices.",
      "llm_answer": "RTX accounts for U.S. government fixed‑price work under FAR by recognizing revenue as performance‑based or progress payments are earned—often before the customer bills the full amount—so that revenue exceeds billings and is shown as contract assets (with long‑term contracts measured on a percentage‑of‑completion basis). Honeywell, by contrast, points out that the same FAR framework gives the government the right to terminate contracts for convenience or for performance failures, exposing it to potential loss of revenue, audit‑driven price adjustments and required refunds.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: RTX recognizes revenue in excess of billings under FAR due to progress or performance-based payments, resulting in contract assets, often using percentage-of-completion for long-term contracts. Honeywell faces termination-for-convenience risk under the same FAR framework, which could lead to revenue reversal, audits, or refunds. These points align with the original answer. (2) There are no numeric values (percentages, dollar amounts, dates) in either answer, so quantitative accuracy is not compromised—no discrepancies. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies operate under FAR, RTX’s accounting practice creates contract assets, and Honeywell faces termination risks that could affect those recognized revenues. The only minor gap is that the LLM does not explicitly state that both companies’ contract assets/liabilities are 'similarly structured' under FAR, slightly reducing completeness in synthesis. (4) Wording differs but semantic meaning is equivalent; the LLM captures the comparative risk and accounting treatment accurately. Contextual relevance is perfect—directly addresses the comparison asked. Thus, correctness is 9 (not 10) due to slight omission in structural similarity of contract accounting, but all key facts and reasoning are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 397,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "How does the absence of voting rights associated with Alphabet's Class C Capital Stock compare to Comcast's relinquishment of voting rights in Hulu, particularly in terms of governance control and financial outcomes?",
      "original_answer": "Alphabet's Class C Capital Stock has no voting rights except as required by law, which allows the company to maintain control through higher-vote Class A and Class B shares while repurchasing non-voting shares to optimize capital structure. In 2024, Alphabet had $44.7 billion remaining available for Class A and Class C share repurchases. In contrast, Comcast relinquished substantially all voting rights in Hulu in 2019, giving Disney full operational control, and exercised a put option in 2023 to sell its interest for a minimum equity value of $9.2 billion. This resulted in a $8.6 billion payment from Disney (net of $557 million for prior capital calls) and a recorded investment value of $883 million as of December 31, 2024. Both companies strategically managed voting rights to influence governance and financial returns, albeit through different mechanisms and outcomes.",
      "llm_answer": "Alphabet’s Class C capital stock carries **no voting rights** (except as required by law) but otherwise has the same economic rights as the other classes, so control of Alphabet remains with the Class B (10 votes per share) and Class A (one vote per share) shareholders and the shares simply participate in repurchases and dividends【page_82】. In contrast, Comcast **gave up its board seats and virtually all voting rights in Hulu**, ceding operational control to Disney; that relinquishment was linked to a put‑call deal that generated an **$8.6 billion cash payment (plus a tax gain) and a collateralized loan**, rather than merely altering voting power【page_85】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the absence of voting rights for Alphabet's Class C shares and contrasts it with Comcast relinquishing voting rights in Hulu, accurately capturing the governance implications. It correctly notes that control remains with Class A and B shareholders at Alphabet and that Comcast ceded operational control to Disney. However, it omits key quantitative details from the ground truth: the $44.7 billion share repurchase authorization remaining for Alphabet in 2024, the $9.2 billion minimum equity value of Comcast’s put option, and the $883 million recorded investment value as of December 31, 2024. The $8.6 billion payment from Disney is correctly mentioned, but the net amount (after $557 million for prior capital calls) is not explained, which affects full financial context. (2) The LLM mentions an $8.6 billion cash payment, which matches the ground truth, but fails to reference the $9.2 billion minimum equity value or the $883 million investment value, making the financial outcomes partially incomplete. The tax gain and collateralized loan are mentioned but not in the ground truth, introducing unverified elements. (3) The multi-hop reasoning is sound in comparing governance structures and strategic outcomes—Alphabet maintaining control via share structure while repurchasing non-voting shares, versus Comcast exiting control for financial return. However, the synthesis lacks full integration of all financial figures and timelines (e.g., 2019 relinquishment, 2023 put exercise). (4) The correctness score is 7 because core facts about voting rights and strategic outcomes are accurate, but significant financial details are missing or added without support. Quantitative accuracy is 6 due to missing numbers and unverified additions. Qualitative accuracy is 8 due to strong reasoning and correct entity identification. Contextual relevance is 9 as the response directly addresses the comparison in governance and financial outcomes.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 537,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 107,
      "question": "Given LLY's ongoing challenges scaling production of incretin products while relying on third-party manufacturers, and TMO's $26.92 billion in remaining performance obligations—many tied to contract manufacturing over 3-5 year durations—how might shared vulnerabilities in quality assurance and supply chain execution affect both companies' ability to fulfill long-term commitments?",
      "original_answer": "LLY is experiencing intermittent supply delays for incretin products like Mounjaro and Zepbound, with tight supply expected to persist until additional manufacturing capacity becomes operational 'in the next several years.' These production constraints are tied to reliance on third-party manufacturers, which face quality assurance risks that could lead to regulatory actions, product recalls, or delays in approvals. Meanwhile, TMO has $26.92 billion in remaining performance obligations, with a significant portion linked to contract manufacturing agreements that typically span 3-5 years. If third-party manufacturers fail to maintain quality standards or encounter capacity limitations—as AMD also highlights in its 10-K—both companies could face fulfillment risks: LLY may struggle to meet patient demand amid supply volatility, while TMO could face delays or defaults on long-term manufacturing contracts, impacting revenue recognition and customer relationships.",
      "llm_answer": "LLY warns that its incretin medicines are produced by external contract manufacturers and that “intermittent delays…tight supply” and “quality‑assurance…issues” could interrupt shipments and force allocation of limited product (LLY 10‑K p. 45; p. 44). Thermo Fisher’s $26.92 billion of remaining performance obligations are largely tied to three‑to‑five‑year contract‑manufacturing agreements, and its filing notes that “non‑compliance…with manufacturing regulations” and “supply interruptions” could restrict its ability to deliver those services (Thermo Fisher 10‑K p. 49; p. 7). Thus, both companies share a vulnerability: dependence on third‑party manufacturers makes them susceptible to quality‑assurance lapses and supply‑chain disruptions that could jeopardize their ability to fulfill long‑term product and service commitments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: LLY's reliance on third-party manufacturers, intermittent supply delays, quality-assurance issues, and tight supply are accurately cited from its 10-K. TMO (Thermo Fisher)’s $26.92 billion in remaining performance obligations is correctly stated and linked to 3-5 year contract manufacturing agreements. The risks of non-compliance with manufacturing regulations and supply interruptions are properly attributed to Thermo Fisher’s filing. (2) Quantitative accuracy is perfect: the $26.92 billion figure is exact and matches the ground truth; no other numbers require calculation. (3) Multi-hop reasoning is sound—LLM correctly synthesizes vulnerabilities across LLY and TMO (both reliant on third-party manufacturing), identifies shared risks in quality assurance and supply chain execution, and logically connects these to fulfillment of long-term commitments. The only minor shortcoming is that the answer does not explicitly mention AMD’s reference in the ground truth as an additional corroborating source, but this is not central to the core reasoning. (4) The answer is contextually fully relevant, directly addressing the question’s focus on shared vulnerabilities and their impact on fulfillment. Wording differs slightly from the original but maintains semantic equivalence. No factual errors or omissions affect the overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1510,
        "completion_tokens": 399,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "What was the total cumulative impairment charge recognized by NextEra Energy Resources on its investment in XPLR as of December 31, 2024, and how does this compare to the carrying value of the investment before the 2024 impairment?",
      "original_answer": "As of December 31, 2024, NextEra Energy Resources had recognized a cumulative impairment charge of $2.0 billion on its investment in XPLR, combining the $1.2 billion impairment from September 30, 2023, and the $0.8 billion impairment from December 31, 2024. The carrying value of the investment before the 2024 impairment was approximately $2.6 billion, which was then written down to $1.8 billion after the 2024 impairment.",
      "llm_answer": "The cumulative impairment on the XPLR investment is about $2.0 billion – the $1.2 billion impairment recorded in 2023 plus the $0.8 billion impairment recorded in 2024【page_92】.  Prior to the 2024 write‑down, the investment carried a value of roughly $2.6 billion, so the total impairments have erased about three‑quarters of that amount, leaving a post‑impairment carrying value of roughly $1.8 billion【page_92】.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately reported: the cumulative impairment charge of $2.0 billion is correctly calculated as the sum of the $1.2 billion impairment from 2023 and the $0.8 billion impairment from 2024. (2) The carrying value before the 2024 impairment is correctly stated as $2.6 billion, and the post-impairment carrying value of $1.8 billion is accurate, matching the ground truth calculation ($2.6B - $0.8B = $1.8B). (3) The multi-hop reasoning is sound—information from two different time points (September 30, 2023, and December 31, 2024) is correctly synthesized to compute the cumulative impairment and its impact on carrying value. (4) The mention of impairments erasing 'about three-quarters' of the value is a reasonable qualitative interpretation ($2.0B / $2.6B ≈ 77%) and does not detract from accuracy. All entities—NextEra Energy Resources, XPLR, and the relevant financial metrics—are correctly identified. The answer fully addresses both parts of the question and maintains contextual relevance with precise, well-supported details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1230,
        "completion_tokens": 321,
        "total_tokens": 1552
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does the adoption of ASU 2022-04 by GE impact its transparency around supplier finance obligations compared to MMM's disclosures under the same standard, particularly in terms of confirmed invoice balances and presentation in financial statements?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, which requires retrospective disclosures for supplier finance programs, with the annual roll-forward information applicable prospectively starting January 1, 2024. This means GE began disclosing key terms, balance sheet presentation, and confirmed amounts outstanding from its supplier finance programs in 2024. Similarly, MMM discloses that as of December 31, 2024 and 2023, its outstanding balances of confirmed invoices under supplier finance programs were approximately $0.3 billion each, and these amounts are included within accounts payable on MMM's consolidated balance sheet. Both companies now provide clearer visibility into their supplier finance obligations under the new standard, with MMM specifically quantifying its confirmed invoice balances and their classification in accounts payable, aligning with the enhanced disclosure requirements introduced by ASU 2022-04.",
      "llm_answer": "GE reports that it adopted ASU 2022‑04 on 1 January 2023 and that the change “did not have a material impact on the Company’s consolidated financial statements” (GE 10‑K p. 47). The filing does not break out the supplier‑finance obligations or give a confirmed‑invoice balance – the amounts are simply reflected in accounts payable. In contrast, 3M’s (MMM) note on supplier‑finance programs discloses the exact outstanding confirmed‑invoice balances (≈ $0.3 billion at 12/31/2024 and 2023) and the 2024 roll‑forward activity ($1.5 billion of invoices confirmed and paid), and explicitly states that these balances are included within accounts payable (MMM 10‑K p. 77). Thus, MMM’s disclosures under ASU 2022‑04 provide far more granular transparency than GE’s, which offers only a high‑level acknowledgment without specific amounts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: MMM's confirmed invoice balances of approximately $0.3 billion as of December 31, 2024 and 2023 are accurately reported, and the $1.5 billion of invoices confirmed and paid in 2024 (roll-forward activity) is consistent with enhanced disclosures under ASU 2022-04. The adoption date for GE (January 1, 2023) is correct. (2) The LLM correctly identifies that GE does not disclose specific supplier finance obligation balances or confirmed invoice amounts, only stating no material impact and including the amounts in accounts payable, while MMM provides detailed disclosures including roll-forward activity. This reflects a correct synthesis across both companies’ 10-Ks. (3) The multi-hop reasoning is sound: the model compares GE’s limited qualitative disclosure with MMM’s quantitative and structural transparency, correctly concluding that MMM offers greater granularity. (4) The only minor shortcoming is that the LLM does not explicitly mention that GE will begin providing roll-forward disclosures prospectively starting January 1, 2024, as noted in the original answer. However, this omission does not undermine the core factual accuracy or the valid conclusion about relative transparency. Wording differs but semantic meaning and factual content are equivalent. All entities (GE, MMM, ASU 2022-04, accounts payable, confirmed invoices) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1465,
        "completion_tokens": 416,
        "total_tokens": 1882
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does Altria's equity-method accounting for its Cronos investment expose it to financial risks tied to Cronos's compliance with FDA regulations, and how does this compare to Walmart's exposure through its pharmacy operations under the same regulatory framework?",
      "original_answer": "Altria's investment in Cronos is accounted for under the equity method, meaning its financial statements reflect Altria's share of Cronos's earnings or losses. Since Cronos operates in the cannabis-derived product space, it is subject to FDA regulations in the U.S., and any failure to comply could result in fines, penalties, or reputational harm, directly impacting Cronos's financial performance and, by extension, Altria's earnings. Walmart also faces exposure through its pharmacy operations, which must comply with FDA regulations governing the dispensing and sale of pharmaceuticals. Walmart notes that noncompliance could lead to significant sanctions and operational disruptions, mirroring the regulatory risk profile faced by Cronos. Both companies are thus financially exposed to the same regulatory framework, though through different business models and investment structures.",
      "llm_answer": "Altria records its 75 % stake in Cronos using the equity method, so it must recognize its proportionate share of Cronos’s earnings (or losses) and any related liabilities; because Cronos’s U.S. activities are subject to FDA, Controlled‑Substances and anti‑money‑laundering rules, a compliance failure could generate criminal, civil or tax penalties, impair Cronos’s cash flow and capital availability, and therefore hurt Altria’s reported income and reputation (Altria 10‑K p. 16; equity‑method accounting described on p. 60). In contrast, Walmart’s pharmacy business is directly regulated by the FDA, DEA and state pharmacy boards, so non‑compliance would expose Walmart itself—not a partner—to fines, product seizures, licence loss or other sanctions that could disrupt operations and reduce profitability (Walmart 10‑K p. 26; health‑and‑wellness regulatory exposure on p. 25).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 75% stake mentioned is consistent with Altria's actual investment in Cronos as disclosed in its 10-K, and no other numerical figures (e.g., dates, dollar amounts) are present that could introduce error—formatting and references to page numbers (p. 16, p. 60, etc.) match typical 10-K citation styles. (2) The qualitative analysis correctly identifies that Altria’s exposure arises through equity-method accounting, meaning it absorbs a share of Cronos’s financial performance, including losses from regulatory noncompliance. It expands on the original answer by including additional relevant regulations (Controlled Substances Act, anti-money laundering), which are contextually appropriate for a cannabis company like Cronos operating in the U.S., even if not explicitly mentioned in the ground truth. (3) The comparison to Walmart is sound: both face FDA-related compliance risks, but Walmart’s exposure is direct through its pharmacy operations, while Altria’s is indirect via an equity investee. The LLM correctly notes Walmart’s direct liability to sanctions such as license loss or product seizures, which is consistent with Walmart’s 10-K disclosures. (4) Minor deduction in qualitative accuracy due to the introduction of slightly broader regulatory scope (e.g., DEA, tax penalties) not emphasized in the original answer, but these do not contradict the ground truth and add reasonable context. Overall, the multi-hop reasoning—linking accounting method (equity) to financial exposure, then comparing across firms under shared regulatory frameworks—is logically sound and well-supported. Semantic equivalence is strong, and the answer is fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1471,
        "completion_tokens": 480,
        "total_tokens": 1951
      },
      "error": null
    },
    {
      "question_id": 108,
      "question": "How does LLY's reliance on Cardinal Health for U.S. distribution impact CVS's consolidated financial exposure to Red Oak Sourcing, given Cardinal's dual role in the joint venture?",
      "original_answer": "LLY depends on Cardinal Health for 15-20% of its U.S. revenue through distribution, which makes Cardinal a critical link in LLY's supply chain. Cardinal also co-owns Red Oak Sourcing with CVS, a generic pharmaceutical sourcing entity that CVS consolidates due to its primary beneficiary status. As part of the Red Oak arrangement, Cardinal makes quarterly payments to CVS (e.g., $183 million annually as of 2021), which reduce CVS's inventory costs. Therefore, any disruption in Cardinal's ability to distribute LLY products could affect Cardinal’s financial health, which in turn could impact its ability to meet its financial commitments to Red Oak—and consequently, CVS’s consolidated financial position.",
      "llm_answer": "LLY notes that Cardinal Health is one of three U.S. wholesalers that together account for 15‑20 percent of its consolidated revenue, making Cardinal a key distributor of LLY’s products (LLY 10‑K p. 7).  Cardinal is also a 50 percent owner of Red Oak Sourcing and, under the joint‑venture agreement, makes fixed quarterly payments to CVS – about $183 million each year – which are recognized in cost of goods sold and were described as immaterial to CVS’s overall results (CVS 10‑K p. 138).  Consequently, even though Cardinal’s cash flow is linked to LLY’s sales, CVS’s consolidated exposure to Red Oak remains limited to those contractual payments and is not materially affected by LLY’s reliance on Cardinal for distribution.",
      "correctness_score": 5,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "1) The LLM answer is partially correct in terms of factual content but contains a critical reasoning error that undermines the overall correctness. It accurately reports that Cardinal Health accounts for 15-20% of LLY's U.S. revenue (citing LLY 10-K p.7) and that Cardinal makes $183 million annually in fixed payments to CVS as part of the Red Oak Sourcing joint venture (citing CVS 10-K p.138). These quantitative figures match the ground truth and are correctly attributed. 2) Quantitative accuracy is high: all numbers ($183 million, 15-20%) are correct and contextually placed. Format variations are acceptable and do not distort meaning. 3) However, the qualitative reasoning is flawed. The LLM concludes that 'CVS’s consolidated exposure to Red Oak remains limited... and is not materially affected by LLY’s reliance on Cardinal,' citing the immateriality note from CVS’s 10-K. This contradicts the ground truth’s causal chain: while the payments may be individually immaterial, the question asks about *financial exposure through Cardinal’s dual role*—specifically, how a disruption in LLY distribution could impair Cardinal’s ability to make payments to Red Oak, thereby indirectly affecting CVS. The LLM fails to trace this multi-hop risk pathway and instead dismisses the linkage due to 'immateriality,' which addresses magnitude but not exposure mechanism. 4) Contextual relevance is strong—the answer engages the right entities (LLY, Cardinal, CVS, Red Oak), cites correct documents, and addresses the joint venture structure. But it misses the core analytical point: systemic risk transmission via Cardinal’s dual dependencies. Thus, while factually grounded, the conclusion is logically unsound in the context of financial exposure assessment. Correctness score reflects partial accuracy with a significant reasoning gap.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 495,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Oracle's use of its $6.0 billion commercial paper program for short-term financing compare to Cisco's debt structure, particularly in light of Cisco's $13.5 billion senior fixed-rate note issuance and the pari passu ranking of those notes with commercial paper obligations?",
      "original_answer": "Oracle utilizes a $6.0 billion commercial paper program for short-term financing, with $401 million in outstanding notes as of May 31, 2024, which mature through August 2024. These notes are unsecured and issued under a private placement exemption. In contrast, Cisco issued $13.5 billion in senior fixed-rate notes in February 2024, which are redeemable at any time with a makewhole premium and are ranked at par with Cisco’s own commercial paper obligations. This indicates that while both companies use commercial paper as part of their short-term financing strategies, Cisco has a significantly larger long-term debt component through its senior notes, which are hedged via interest rate swaps to manage interest rate exposure.",
      "llm_answer": "Oracle’s $6 billion commercial‑paper program is a short‑term financing tool that it uses to issue unsecured promissory notes for general corporate purposes; only about $401 million of paper was outstanding as of May 31 2024. By contrast, Cisco’s debt structure includes a $13.5 billion senior fixed‑rate note issuance, and the filing states that those senior notes “rank at par with the commercial‑paper notes…,” meaning the senior notes and Cisco’s commercial‑paper obligations are pari‑passu in priority. Thus Oracle keeps its commercial paper separate from other debt, while Cisco’s senior notes sit alongside its commercial paper with equal seniority.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Oracle's $6.0 billion commercial paper program with $401 million outstanding as of May 31, 2024, and Cisco's $13.5 billion senior fixed-rate note issuance in February 2024. The pari passu ranking of Cisco’s senior notes with its commercial paper obligations is accurately stated. (2) Quantitative accuracy is perfect: all dollar amounts ($6.0 billion, $401 million, $13.5 billion), dates (May 31, 2024), and structural details (unsecured, private placement for Oracle; makewhole redemption and interest rate swaps for Cisco) are consistent with the ground truth. Format variations (e.g., $6 billion vs $6.0 billion) are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound—comparing Oracle’s short-term financing focus via commercial paper to Cisco’s more complex debt structure that includes long-term senior notes with equal ranking to commercial paper. The conclusion that Cisco’s senior notes are pari passu with its commercial paper is correctly drawn and contrasts well with Oracle’s structure. (4) The only minor shortcoming is that the LLM omits the detail about Cisco using interest rate swaps to hedge its senior notes, which is present in the original answer and relevant to risk management. This is a small but notable omission in completeness, preventing a perfect 10. Otherwise, the answer is factually correct, well-reasoned, and directly responsive to the comparative question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1380,
        "completion_tokens": 410,
        "total_tokens": 1790
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does Duke Energy's reliance on wind energy in its Commercial Renewables segment compare with Southern Company's strategic commitment to the Skookumchuck wind project, given the 136 MW nameplate capacity and 20-year PPA term associated with Skookumchuck?",
      "original_answer": "Duke Energy's Commercial Renewables segment relies on wind as one of several generation sources, alongside solar, fuel cells, and batteries, but does not disclose specific capacity figures for wind. In contrast, Southern Company's Skookumchuck wind project has a defined 136 MW nameplate capacity and is supported by a 20-year PPA, indicating a concrete long-term commitment to wind energy in a specific geographic location (Lewis and Thurston Counties, WA). While both companies are engaged in wind energy, Southern's detailed disclosure around capacity and contract duration provides clearer evidence of a targeted wind strategy compared to Duke's broader renewable portfolio approach.",
      "llm_answer": "Duke Energy’s Commercial Renewables segment simply notes that it “relies on wind, solar, fuel cells and battery resources for its generation of electric energy” (see DUK 10‑K p. 22) without quantifying a specific wind capacity or contract term. Southern Company, however, has a concrete wind commitment: it owns the 136‑MW Skookumchuck project and has secured a 20‑year power‑purchase agreement for that facility (see SO 10‑K p. 330). Thus, Duke’s wind use is described in broad, mixed‑resource terms, whereas Southern’s strategy centers on a defined, long‑term wind asset.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and fully aligned with the ground truth. (1) All key information is correct: Duke Energy does not disclose specific wind capacity in its Commercial Renewables segment, and Southern Company's Skookumchuck project has a 136 MW nameplate capacity and a 20-year PPA, as confirmed in the respective 10-K filings. (2) Quantitative accuracy is perfect: the 136 MW and 20-year PPA term are correctly reported with no calculation errors. (3) The multi-hop reasoning is sound—LLM correctly contrasts Duke’s broad, non-quantified mention of wind among other renewables with Southern’s specific, long-term commitment to a defined wind asset, synthesizing information from two different companies and filings. (4) The answer is contextually relevant, directly addressing the comparative strategic commitment to wind energy as requested. Wording differs slightly from the original answer but maintains full semantic equivalence, with added citation references (DUK 10-K p.22, SO 10-K p.330) that enhance credibility. No factual, numerical, or reasoning errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 309,
        "total_tokens": 1652
      },
      "error": null
    },
    {
      "question_id": 109,
      "question": "How does the capital buffer requirement structure under the Advanced Approach for MS compare with SCHW's requirements, given the role of the Countercyclical Capital Buffer which is currently set at zero by the Federal Reserve?",
      "original_answer": "Morgan Stanley's (MS) capital buffer requirement under the Advanced Approach includes a fixed 2.5% Capital Conservation Buffer, a G-SIB capital surcharge, and the Countercyclical Capital Buffer (CCyB), which is currently set at zero by the Federal Reserve. Schwab (SCHW) is also subject to the same CCyB, which was zero as of December 31, 2023, and must maintain a 2.5% Capital Conservation Buffer. Therefore, both firms have identical Capital Conservation Buffer percentages and are influenced by the same CCyB policy, though SCHW is not subject to the G-SIB surcharge that applies to systemically important institutions like MS.",
      "llm_answer": "Under the Advanced Approach, Morgan Stanley’s buffer is built from a 2.5% capital‑conservation buffer plus a 3.0% G‑SIB surcharge (the Counter‑Cyclical Capital Buffer is set at 0%), giving a total buffer of 5.5%. Charles Schwab, by contrast, carries a 2.5% stress‑capital buffer for its holding company and a 2.5% capital‑conservation buffer for its bank subsidiary—also with a CCyB of 0%—resulting in roughly a 5% total buffer and no G‑SIB surcharge. The zero CCyB means it does not add to either firm’s buffer requirement.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several inaccuracies. While it correctly states that both Morgan Stanley (MS) and Schwab (SCHW) are subject to a 2.5% Capital Conservation Buffer and that the Countercyclical Capital Buffer (CCyB) is 0%, it introduces a '3.0% G-SIB surcharge' for MS without grounding this specific number in the original answer, which only mentions the existence of a G-SIB surcharge, not its magnitude. This specific percentage is not in the ground truth and cannot be verified from the provided information, making it a factual overreach. Additionally, the LLM claims SCHW has a '2.5% stress-capital buffer for its holding company and a 2.5% capital-conservation buffer for its bank subsidiary,' implying a total of ~5%, but the original answer only confirms a 2.5% Capital Conservation Buffer for SCHW and does not mention a stress-capital buffer or dual buffers. This misrepresents SCHW’s structure. (2) Calculations: The total buffer of 5.5% for MS is based on an unverified 3.0% G-SIB surcharge and is therefore incorrect. The 5% total for SCHW is also unsupported, as the original answer does not state SCHW maintains multiple buffers. (3) Multi-hop reasoning: The model correctly identifies that both firms are subject to the same CCyB (0%) and have the 2.5% Capital Conservation Buffer. It also correctly notes that SCHW is not subject to the G-SIB surcharge. However, it fails to accurately synthesize the structure of SCHW’s capital requirements and invents buffer types not mentioned in the ground truth, weakening the reasoning. (4) The contextual relevance is high because the answer addresses the comparison, buffers, and CCyB role. However, due to significant quantitative and qualitative inaccuracies in the specifics of buffer composition and magnitudes, the correctness score is reduced to 6—partially correct but with key errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1308,
        "completion_tokens": 506,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does Disney's use of discounted cash flow models for valuing Level 2 derivatives compare to Meta's application of the same models in assessing impairment losses on operating lease assets, given Disney's $383 million impairment charge in fiscal 2024?",
      "original_answer": "Disney utilizes internal discounted cash flow models with observable inputs like interest rates and foreign exchange rates to value its Level 2 derivatives, ensuring fair value estimates remain accurate and counterparty risk is mitigated. Meanwhile, Meta applies discounted cash flow models with Level 3 inputs—such as projected sublease income and downtime assumptions—to estimate the fair value of impaired operating lease assets, which led to a $383 million impairment charge in 2024. While both companies use discounted cash flow techniques, Disney applies them in a Level 2 fair value context for derivatives, whereas Meta uses them in a Level 3 context for non-recurring asset impairments.",
      "llm_answer": "Disney values its Level 2 derivatives with internal discounted‑cash‑flow models that rely on observable market inputs such as interest‑rate curves and foreign‑exchange rates (see DIS 10‑K p. 119). By contrast, Meta estimates the fair value of impaired operating‑lease right‑of‑use assets and leasehold improvements with discounted‑cash‑flow models that use unobservable, Level 3 assumptions (e.g., expected downtime, sublease cash flows and risk‑adjusted discount rates), which produced a $383 million impairment charge in fiscal 2024 (see META 10‑K p. 98).",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurate: Disney uses discounted cash flow (DCF) models with observable inputs (Level 2) for derivatives, while Meta uses DCF models with unobservable, Level 3 inputs (e.g., sublease income, downtime assumptions) to assess impairment of operating lease assets. The $383 million impairment charge by Meta in fiscal 2024 is correctly attributed and matches the original answer. (2) Quantitative accuracy is perfect: the dollar amount ($383 million), fiscal year (2024), and context (impairment charge) are all correct. The LLM correctly assigns the charge to Meta, not Disney, resolving a potential misinterpretation in the question’s phrasing. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (Disney and Meta), two distinct accounting contexts (Level 2 derivatives vs. Level 3 impairment), and two different uses of DCF models. It distinguishes between recurring fair value measurement (Disney) and non-recurring impairment (Meta). (4) The answer is contextually precise, directly addressing the comparison in modeling approach, input hierarchy (Level 2 vs. Level 3), and the specific financial impact. Minor wording differences (e.g., 'risk-adjusted discount rates' added) enhance clarity without altering meaning. Page references (DIS 10-K p. 119, META 10-K p. 98) add verifiability and align with expected sourcing from SEC filings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 409,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the 8.2% increase in Turkey's total tobacco market volume, partly offset by higher illicit trade prevalence, impact PM's market share dynamics, and how does this compare to MO's exposure to illicit trade risks in the broader context of their respective tobacco businesses?",
      "original_answer": "PM's shipments in Turkey increased to 55.7 billion units in 2021 from 47.5 billion in 2020, contributing to a rise in its market share from 41.3% to 44.8%. This growth was partly offset by a higher estimated prevalence of illicit trade in Turkey, which negatively impacts legitimate sales and tax revenues. Similarly, MO highlights that illicit trade in tobacco products, including counterfeit goods and untaxed sales, adversely affects its business by reducing lawful sales and potentially triggering regulatory actions. While PM directly benefits from increased volume in Turkey despite illicit trade, MO emphasizes the broader systemic risks illicit trade poses to the tobacco industry, including brand dilution and loss of tax revenues that could lead to stricter regulations.",
      "llm_answer": "The 8.2 % rise in Turkey’s total tobacco market (driven by post‑pandemic consumption and tourism but partly offset by higher illicit‑trade prevalence) lifted PMI’s shipments in the country from 47.5 million to 55.7 million units and pushed its market‑share from 41.3 % to 44.8 % (page 38), contributing to a 1.1‑point gain in PMI’s overall Middle‑East & Africa regional share to 23.1 % (page 56). In contrast, Altria (MO) only flags illicit trade as a broad, material‑risk factor that can erode sales, brand perception and trigger tax or regulatory actions across its tobacco operating companies and investees, without quantifying a specific offsetting volume gain (page 42), indicating a more vulnerable exposure to illicit‑trade impacts than PMI’s Turkey‑specific market‑share gain.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PM's shipment increase from 47.5 to 55.7 billion units and market share rise from 41.3% to 44.8%, as well as the context of Turkey's 8.2% total market growth and illicit trade impact. However, it incorrectly states '47.5 million' and '55.7 million' instead of '47.5 billion' and '55.7 billion'—a critical error of three orders of magnitude, severely affecting quantitative accuracy. (2) The reference to page numbers (38, 56, 42) suggests document-based sourcing but is not part of the ground truth evaluation; these are not factually incorrect per se but not verifiable from the provided data. The 1.1-point gain in PMI’s Middle East & Africa regional share to 23.1% is additional context not present in the original answer and may be accurate but is not confirmed by the ground truth, introducing unverified detail. (3) The qualitative reasoning is strong: the LLM correctly contrasts PM’s tangible market share gain in Turkey despite illicit trade with MO’s more generalized risk disclosure, capturing the multi-hop comparison between PM's localized growth and MO’s systemic risk exposure. It accurately reflects that MO does not report offsetting volume gains and treats illicit trade as a broad material risk. (4) Despite the major unit error (million vs. billion), the core facts—direction of change, percentages, and comparative dynamics—are correct, and the reasoning aligns with the ground truth. Hence, correctness is reduced but not failed due to the factual foundation in market share and comparative risk exposure. Quantitative accuracy is penalized heavily for the unit mistake, while qualitative and contextual scores remain high due to sound logic and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1424,
        "completion_tokens": 471,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 110,
      "question": "How does the redesign of the Medicare Part D program under the Inflation Reduction Act affect both CVS's financial exposure to Medicare Part D liabilities and AbbVie's pricing strategy for drugs like Imbruvica under Medicare Part D?",
      "original_answer": "The redesign of the Medicare Part D program under the Inflation Reduction Act shifts more claim liability to insurers like CVS, which could negatively impact their profitability due to increased financial risk and administrative complexity. At the same time, AbbVie is subject to government-set pricing for certain drugs, such as Imbruvica, starting in 2026, which will cap reimbursement rates at a statutory ceiling likely below current average prices, significantly affecting revenue projections. These changes create a dual pressure where CVS faces higher liability and AbbVie faces downward pricing pressure, both under the same regulatory framework.",
      "llm_answer": "The Inflation‑Reduction Act’s redesign of Medicare Part D moves much of the drug‑claim risk from the government onto the plan sponsors, so CVS will now bear a larger share of Part D liability – including higher claim costs, potential penalties and other financial exposures (see CVS 10‑K p. 57).  At the same time, the same law subjects certain single‑source drugs to government‑set pricing and a mandatory manufacturer discount under the new Part D benefit structure; AbbVie’s Imbruvica was named one of the first ten products to have a CMS‑determined price beginning in 2026 and will be subject to a 10 %/20 % discount tier for beneficiaries, forcing AbbVie to lower the price and reshape its Part D pricing strategy (see AbbVie 10‑K p. 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that the Inflation Reduction Act shifts more financial risk to Medicare Part D plan sponsors like CVS, increasing their liability—consistent with the original answer’s point about CVS facing higher financial exposure and administrative complexity. It references the correct page in the CVS 10-K (p. 57), supporting its claim. (2) For AbbVie, it accurately states that Imbruvica is subject to government-set pricing starting in 2026 and will face a mandatory 10%/20% discount under the new Part D structure, citing AbbVie’s 10-K (p. 19). While the original answer does not specify the discount tiers, the LLM adds detail that is consistent with public knowledge of the IRA’s discount structure and does not contradict the ground truth. The mention of a '10%/20% discount tier' is factually correct under the IRA’s design for high-cost drugs and enhances accuracy. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies (CVS and AbbVie), connects regulatory changes to financial and strategic impacts, and links both to the same legislative driver (the Inflation Reduction Act). (4) Minor deduction in quantitative and qualitative accuracy due to the addition of specific discount percentages not present in the original answer—though accurate, they slightly exceed the scope of the provided ground truth. However, this does not detract from correctness. Wording differs but semantic meaning is equivalent or richer. Contextual relevance is perfect—directly addresses both parts of the question with precise, relevant details.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 454,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does Boeing's use of third-party aircraft value publications for valuing impaired customer financing assets compare to RTX's quarterly valuation methodology for private equity limited partnerships, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "Boeing derives the fair value of impaired customer financing assets, including operating lease equipment, by calculating a median collateral value from a consistent group of third-party aircraft value publications, which are based on market trades and other market factors. Management reviews these publications quarterly and may adjust values based on specific aircraft attributes. In contrast, RTX values private equity limited partnerships quarterly using discounted cash flows, earnings multiples, and market multiples, with valuation adjustments reflecting changes in operating results or financial condition of the portfolio companies. Both approaches rely on unobservable inputs typical of Level 3 assets, but Boeing leans more on consistent third-party market data while RTX applies more forward-looking financial modeling.",
      "llm_answer": "Boeing values its impaired customer‑financing assets using a market‑approach that takes a median collateral value from a set of third‑party aircraft‑value publications, with adjustments for aircraft condition – a Level 3 fair‑value measurement that depends on unobservable inputs supplied by those publications. RTX, by contrast, values its private‑equity limited‑partnership interests each quarter with discounted‑cash‑flow, earnings‑multiple and market‑multiple models (and, for pension‑plan holdings, a NAV‑per‑unit expedient), also a Level 3 measurement but one that relies on internal estimates and assumptions rather than external publication data. Thus, both rely on unobservable inputs, but Boeing leans on external aircraft‑valuation sources, whereas RTX relies on its own valuation models and NAV estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: Boeing uses a median from third-party aircraft value publications for impaired customer financing assets, adjusts for aircraft-specific factors, and this is a Level 3 measurement. RTX uses discounted cash flows, earnings multiples, and market multiples for private equity limited partnerships, also Level 3. The contrast in reliance—Boeing on external market data, RTX on internal models—is correctly highlighted. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; the absence of specific numbers is consistent with the source. (3) Multi-hop reasoning is sound: the model correctly synthesizes valuation methodologies across two different companies (Boeing and RTX), asset types (customer financing vs. private equity), and approaches (market-based vs. model-based), concluding with a valid comparison on unobservable inputs. (4) Minor point: the LLM mentions NAV-per-unit for pension-plan holdings, which is not in the original answer—this is factually plausible but adds a detail not present in the ground truth. However, it does not contradict and is contextually relevant. Overall, the answer matches the original in semantic meaning, with only slight expansion, warranting a 9/10 for correctness and qualitative accuracy. Contextual relevance is perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1440,
        "completion_tokens": 405,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does the voting power disparity between Class A and Class B common stock at META and GOOGL affect the concentration of corporate control, particularly given META's outstanding share structure and GOOGL's recent share repurchase activity?",
      "original_answer": "At META, Class A common stock has full voting rights while Class B common stock has no voting rights except in limited circumstances, which concentrates control among Class A shareholders. As of January 24, 2025, META had 2,189,898,148 shares of Class A common stock and 343,761,117 shares of Class B common stock outstanding, indicating a significant majority of voting power is held by Class A shareholders. In contrast, at GOOGL, Class B common stockholders have 10 votes per share compared to 1 vote per share for Class A, giving disproportionate voting control to Class B holders. GOOGL repurchased $62.0 billion of Class A and Class C shares in 2024, which could further consolidate voting power among remaining Class B shareholders by reducing the overall number of voting shares in circulation.",
      "llm_answer": "Meta’s dual‑class structure gives each Class B share ten votes versus one vote for Class A; with 2.19 billion Class A shares and only 0.34 billion Class B shares outstanding (Meta 10‑K p. 1), Class B holders command roughly 60 % of the voting power while owning less than 15 % of the equity. Google’s comparable 10‑to‑1 voting split (Class A = 1 vote, Class B = 10 votes, Class C = 0 votes) and its recent repurchase of mainly Class A (and non‑voting Class C) shares (Google 10‑K p. 82) reduces the number of voting‑eligible Class A shares, thereby increasing the proportion of votes held by the relatively few Class B shares and concentrating corporate control among insiders.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains major factual errors in the voting structure of META. It incorrectly states that Class B shares have 10 votes and Class A have 1 vote, when in fact the opposite is true according to the ground truth: at META, Class A has full voting rights and Class B has no voting rights except in limited circumstances. This fundamental error invalidates the entire analysis of META's voting power distribution. The LLM also incorrectly calculates that Class B holders command 60% of voting power, which is unsupported by the data and based on a reversed voting structure. (2) Quantitative inaccuracies include the misrepresentation of voting rights and the fabricated 60% voting power figure. While the share counts (2.19 billion Class A and 0.34 billion Class B) are approximately correct (matching the ground truth of 2,189,898,148 and 343,761,117), the LLM misuses them by assuming a 10:1 voting ratio favoring Class B, which is false. The $62.0 billion repurchase amount by GOOGL is not mentioned in the LLM answer, though the general fact of repurchasing Class A and C shares is correct. (3) The multi-hop reasoning is flawed due to the incorrect premise about META’s voting structure. While the description of GOOGL’s structure (Class B with 10 votes, Class A with 1, Class C with 0) and the effect of repurchasing non-voting or low-voting shares is accurate and logically sound, the analysis of META is entirely incorrect, undermining the comparative assessment. (4) Contextual relevance is high because the answer attempts to address both companies, share structures, and repurchase effects on control concentration. However, due to the critical error in META's voting rights, the qualitative and quantitative accuracy scores are very low. The correctness score is 3 because while some data points (share counts, GOOGL repurchase behavior) are right, the core analysis of the primary company (META) is factually wrong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 526,
        "total_tokens": 1920
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How does PEP's 19% convenient foods unit volume growth in APAC, including low-single-digit growth in Taiwan, compare with PG's market position across Greater China, where Taiwan is explicitly included in its regional structure?",
      "original_answer": "PEP reported 19% convenient foods unit volume growth in APAC in 2022, with Taiwan contributing low-single-digit growth as part of that performance. In contrast, PG holds a leadership or significant market share position in many of its product segments across Greater China, a region that explicitly includes Taiwan according to Apple's segment reporting. This suggests PG maintains a strong competitive presence in the broader regional market, while PEP's exposure in Taiwan appears more modest but still positive.",
      "llm_answer": "PepsiCo reported that its convenient‑foods business in the APAC segment grew **19% in unit volume**, with the boost coming mainly from the Be & Cheery acquisition and “low‑single‑digit growth” in Taiwan (along with Australia and Indonesia)【page_48】.  \nIn contrast, Procter & Gamble says it is “well positioned … often holding a **leadership or significant market‑share position**” in the **Greater China** region, which it defines as including mainland China, Hong Kong and **Taiwan**【page_18】【page_40】.  \n\nThus, while PepsiCo is highlighting a strong quantitative volume increase in APAC (including modest growth in Taiwan), P&G emphasizes a qualitative market‑leadership standing across Greater China, a region that explicitly encompasses Taiwan.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies PEP's 19% convenient foods unit volume growth in APAC and the low-single-digit growth in Taiwan, matching the ground truth. It also accurately characterizes PG's market position as leadership or significant market share in Greater China, with Taiwan explicitly included. All key facts are present and correct. (2) Quantitatively, the percentages (19% and low-single-digit) are accurately reported, and no calculations are required beyond correct interpretation of growth figures. The mention of Be & Cheery acquisition as a driver is additional context from the source but does not contradict the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes PEP’s performance in APAC (including Taiwan) with PG’s regional market position in Greater China (which includes Taiwan), enabling a valid cross-company, cross-regional comparison. The contrast between PEP’s quantitative growth highlight and PG’s qualitative leadership claim is logically drawn and semantically aligned with the original answer. (4) The only minor shortcoming is that the LLM answer does not explicitly state that PEP’s exposure in Taiwan is 'more modest' compared to PG’s strong presence, which is a subtle but relevant inference in the ground truth. However, this is implied through the contrast, so the omission does not significantly detract from accuracy. Wording differences are acceptable under semantic equivalence. All sources are appropriately cited with page references.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 421,
        "total_tokens": 1757
      },
      "error": null
    },
    {
      "question_id": 111,
      "question": "How do the updated PCA Framework thresholds under Basel III affect capital requirements differently for banks like BAC and COF, particularly in terms of CET1 capital ratios and classification as well-capitalized institutions?",
      "original_answer": "Under Basel III, the PCA Framework thresholds were updated to require higher capital ratios for banks to be classified as well-capitalized. For COF, as a Category III institution, it must maintain a minimum CET1 capital ratio of 4.5%, Tier 1 capital ratio of 6.0%, and total capital ratio of 8.0%. However, to be considered well-capitalized under PCA, COF must meet higher thresholds: a CET1 capital ratio of 6.5% or more, Tier 1 capital ratio of 8% or more, and total risk-based capital ratio of 10% or more. Similarly, BAC is subject to these same PCA thresholds, with its CET1 capital regulatory minimum set at 4.5% under Basel III, but to be well-capitalized under PCA, it must maintain a CET1 ratio of 6.5% or more, reflecting the updated PCA requirements. This means both banks must hold significantly more capital to avoid PCA restrictions, impacting their capital planning and dividend capacity.",
      "llm_answer": "The Basel III final‑rule raised the “well‑capitalized’’ bar for insured depository institutions to a CET1 ratio of 6.5 % (plus any required buffers) and a leverage ratio of 5 % (vs. 4.5 %/4 % previously)【page_11】.  Bank of America’s CET1 ratios of 11.8 % (standardized) and 13.5 % (Bank of America N.A.) are far above the new 6.5 % threshold, so the change does not affect its well‑capitalized status【page_146】.  Capital One’s bank, however, must meet a regulatory CET1 minimum of 7.0 % (the 6.5 % threshold plus the 2.5 % capital‑conservation buffer) to be classified as well‑capitalized【page_10】, putting it much closer to the new floor and making the higher PCA limits a more material constraint for COF than for BAC.",
      "correctness_score": 5,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the general direction of Basel III's impact on PCA thresholds and correctly identifies that both BAC and COF are subject to higher CET1 requirements to be well-capitalized. However, there are significant factual inaccuracies that reduce correctness. First, the LLM states that the new 'well-capitalized' CET1 threshold is 6.5% plus buffers, implying that the buffer is part of the PCA definition — this is incorrect. The PCA framework itself sets the well-capitalized CET1 threshold at 6.5% (not 6.5% plus buffer); the capital conservation buffer is separate and not part of PCA classification. The original answer correctly separates the 4.5% minimum from the 6.5% PCA threshold, while the LLM conflates regulatory minimums with PCA classification. Second, the LLM claims COF must meet a 'regulatory CET1 minimum of 7.0% (6.5% + 2.5% buffer)' to be well-capitalized — this is wrong: the 2.5% buffer is not added to the PCA threshold. The PCA threshold is a standalone 6.5% CET1 ratio. The LLM also introduces a leverage ratio of 5%, which is not part of the original answer or the core Basel III PCA updates focused on risk-based capital. While BAC’s actual CET1 ratios (11.8%, 13.5%) are correctly cited as being well above the threshold, the comparative analysis that COF is 'closer to the floor' lacks support from the original answer, which does not provide COF’s actual CET1 ratio. The reasoning is partially sound in noting differential impact, but the multi-hop synthesis is flawed due to incorrect aggregation of buffer + PCA threshold. Quantitative accuracy is moderate: 6.5% CET1 for well-capitalized status is correct, but the derived 7.0% figure is not. Contextual relevance is high — the answer addresses the question’s focus on BAC and COF and Basel III’s impact. However, due to key factual and conceptual errors in capital framework design, the overall correctness is only partial.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 516,
        "total_tokens": 1942
      },
      "error": null
    },
    {
      "question_id": 112,
      "question": "How does the sensitivity of NFLX's content amortization to viewing pattern assumptions compare to T's sensitivity analyses around pension discount rates and goodwill impairment assumptions?",
      "original_answer": "NFLX's auditor performed sensitivity analyses on content amortization assumptions, particularly focusing on historical and forecasted viewing hour consumption, which directly affects the timing of content amortization recognition. T's auditor, on the other hand, conducted sensitivity analyses on two key areas: pension discount rates tied to corporate bond credit quality and timing of benefit payments, and goodwill impairment assumptions such as terminal growth rates, EBITDA margins, and weighted average cost of capital (WACC). While both companies undergo sensitivity testing, NFLX's focus is on consumption-based amortization estimates, whereas T's analyses center on long-term financial obligations and asset valuations.",
      "llm_answer": "Netflix’s amortization of its content assets is highly sensitive to the assumptions it makes about future viewing patterns, and the auditors run sensitivity analyses to see how changes in those viewing‑hour forecasts would affect the timing and amount of amortization [page_40]. AT&T’s sensitivity work, by contrast, concentrates on the discount rates used to measure its pension and post‑retirement obligations and on the valuation assumptions (terminal growth rates, long‑term EBITDA margins, weighted‑average cost of capital) underlying its goodwill‑impairment tests, which can materially change the measured amounts [page_44]. Thus, Netflix’s sensitivity is driven by consumer‑usage forecasts, whereas AT&T’s is driven by actuarial and financial valuation assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's sensitivity analysis focuses on viewing pattern assumptions (specifically forecasted viewing hours) affecting content amortization timing, while T's (AT&T's) analyses involve pension discount rates and goodwill impairment assumptions like terminal growth rates, EBITDA margins, and WACC. These match the original answer precisely. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense—however, the absence of any incorrect figures earns full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes auditor-level sensitivity analyses across two different companies (NFLX and T/AT&T), distinguishing between consumption-based amortization (NFLX) and actuarial/financial valuation assumptions (T). (4) Minor deduction in qualitative accuracy due to slightly less explicit mention of 'historical' viewing patterns (the original mentions both historical and forecasted), and the reference to 'corporate bond credit quality' and 'timing of benefit payments' in T's pension assumptions is condensed but not misrepresented. Overall, the semantic meaning and comparative insight are preserved. Contextual relevance is perfect—the response directly addresses the comparative sensitivity analysis question with appropriate focus and structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 407,
        "total_tokens": 1793
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Adobe's localized field office presence in Taiwan compare to Apple's broader Greater China segment strategy, particularly given Apple's $74.2 billion in net sales attributed to that region which includes Taiwan?",
      "original_answer": "Adobe maintains a localized field office in Taiwan as part of its global operations, allowing it to directly engage with customers in that market. Apple, on the other hand, reports its financial performance for the broader Greater China segment, which includes Taiwan along with mainland China and Hong Kong, and generated $74.2 billion in net sales in 2022. While Adobe's approach focuses on direct local engagement through physical offices, Apple manages the region as a consolidated market with a unified strategy, reflecting its larger scale and different operational model.",
      "llm_answer": "Adobe lists Taiwan as one of its individual local field offices, giving it a dedicated on‑the‑ground presence in that market 【page_15】. Apple, by contrast, does not highlight a separate Taiwan office; it groups Taiwan with mainland China and Hong Kong in its “Greater China” segment, a region that produced $74.2 billion of net sales in 2022 【page_52】【page_40】. Thus Adobe’s Taiwan footprint is a single, localized office, while Apple’s approach is a broader regional strategy that aggregates Taiwan’s activity into a much larger Greater China business.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. (1) All key facts are correct: Adobe has a localized field office in Taiwan, while Apple includes Taiwan in its Greater China segment, which generated $74.2 billion in net sales in 2022. The dollar amount and year match the original answer exactly. (2) Quantitative accuracy is perfect: $74.2 billion is correctly cited with proper context and year (2022), and no calculations were required beyond accurate reporting. (3) Multi-hop reasoning is sound—LLM correctly synthesizes information about two different companies' operational strategies (Adobe’s localized presence vs. Apple’s consolidated regional reporting) from potentially different parts of filings, as indicated by page references. (4) The answer captures the core contrast in business strategies: direct local engagement (Adobe) vs. aggregated regional management (Apple). The only minor shortcoming is a slight lack of explicit mention that Apple’s strategy reflects its larger scale and different operational model, which is included in the original answer and adds contextual depth. However, this does not detract from the factual correctness. Wording differs but maintains semantic equivalence. Overall, the response is complete, accurate, and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 361,
        "total_tokens": 1662
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "How does Lockheed Martin's exposure to LIBOR-based financing instruments compare to 3M's preparedness for reference rate reform, given the provisions of ASU 2020-04 that both companies reference in their filings?",
      "original_answer": "Lockheed Martin (LMT) has credit facilities and derivative instruments referencing LIBOR-based rates and has adhered to the ISDA 2020 IBOR Fallbacks Protocol, expecting minimal financial impact from the transition to alternative rates by December 31, 2022. 3M (MMM) also reviewed its relevant arrangements and concluded that ASU 2020-04 would not have a material impact on its financial statements, indicating a similar low expectation of disruption. Both companies rely on ASU 2020-04 to ease the accounting burden of transitioning from LIBOR to alternative rates like SOFR, showing parallel preparedness despite differing financial structures.",
      "llm_answer": "Lockheed Martin still has a credit facility and some derivative contracts that reference LIBOR, but those agreements contain fallback language and the company has adopted the ISDA 2020 IBOR Fallbacks Protocol, so it does not expect a material impact from the transition (LMT p. 85). 3M, by contrast, has already reviewed its arrangements, says it will apply the ASU 2020‑04 guidance to any contracts that are modified, and likewise expects no material effect on its results (3M p. 68).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Lockheed Martin has LIBOR-based instruments with fallback provisions and adopted the ISDA 2020 IBOR Fallbacks Protocol, expecting no material impact; 3M reviewed its arrangements, will apply ASU 2020-04 to modified contracts, and also expects no material effect. (2) There are no numeric values, dates, or calculations in the question or answer that require verification—both companies reference the same standard (ASU 2020-04) and similar conclusions about materiality, which are accurately reported. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and connects their responses to the same accounting standard (ASU 2020-04), highlighting parallel preparedness despite different financial instruments. (4) The only minor shortcoming is that the LLM answer does not explicitly mention SOFR or 'alternative rates' by name, nor does it directly state that both companies are relying on ASU 2020-04 to ease the accounting burden, which is a small omission in qualitative depth. However, the reference to applying ASU 2020-04 implies this understanding. Wording differs slightly but semantic equivalence is preserved. Contextual relevance is perfect—the response directly addresses the comparison of LIBOR exposure and preparedness in light of ASU 2020-04.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 394,
        "total_tokens": 1693
      },
      "error": null
    },
    {
      "question_id": 113,
      "question": "What is the voting power distribution between Class A and Class B common stock at CMCSA, and how does the structure of Class B common stock's 15 votes per share impact overall shareholder control?",
      "original_answer": "At CMCSA, holders of Class A common stock have 66⅔% of the combined voting power, while the Class B common stock, which has 15 votes per share, represents 33⅓% of the combined voting power. This structure gives disproportionate voting control to the holder(s) of Class B common stock, despite their minority ownership on a share count basis.",
      "llm_answer": "Comcast’s proxy statement shows that holders of Class A common stock control roughly 66 % of the total voting power, while the single holder of all Class B shares (Brian L. Roberts) controls about 33 % of the voting power【page_31】.  Because each Class B share carries 15 votes, the 9.44 million Class B shares (versus 3.78 billion Class A shares) command a disproportionate one‑third of all votes, giving the Roberts family effective control of the company despite owning only a tiny fraction of the equity【page_67】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the percentages (66% and 33%) are correctly reported as approximately 66⅔% and 33⅓% in the original; minor rounding to whole numbers is acceptable and common in reporting. The share counts (9.44 million Class B, 3.78 billion Class A) are precise and support the explanation of disproportionate voting power. (2) The LLM correctly identifies that Class B has 15 votes per share and explains the resulting control dynamic, which matches the ground truth's emphasis on disproportionate voting power despite minority ownership. (3) The qualitative reasoning is sound: it correctly synthesizes the structural impact of the 15:1 vote ratio and ties it to effective control by the Roberts family, which is a valid inference from the ownership and voting structure. (4) Contextually, the answer fully addresses both parts of the question—voting power distribution and the impact on shareholder control—and adds valuable context (naming Brian L. Roberts and citing equity fraction) not in the original but consistent with it. The only minor shortcoming is the lack of exact fractional percentages (66⅔%, 33⅓%), but the rounded figures do not distort meaning. No factual errors; excellent multi-hop synthesis across ownership, voting rights, and control implications.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1226,
        "completion_tokens": 373,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 114,
      "question": "How do the different uses of sensitivity analyses by CMCSA and NFLX reflect their distinct financial risk exposures, particularly given that both are audited by the same firm?",
      "original_answer": "CMCSA uses sensitivity analyses to assess its exposure to interest rate risk, which is critical given its reliance on derivative instruments like interest rate swaps that decreased consolidated interest expense by $56 million in 2023. In contrast, NFLX applies sensitivity analyses in the context of content amortization, a judgment-heavy process where changes in estimated viewing patterns can significantly affect the timing of amortization expenses. Both companies rely on the same auditor, who has served NFLX since 2012 and also reviews CMCSA’s market risk disclosures, suggesting a consistent audit approach despite the differing applications and financial impacts of sensitivity analyses at each firm.",
      "llm_answer": "Netflix’s auditor notes that the firm “performed sensitivity analyses to evaluate the potential changes in the content amortization recorded that could result from changes in the assumptions” — i.e., testing how different viewing‑pattern forecasts would alter the timing of content expense and thus its subscription‑revenue risk. Comcast’s auditor, by contrast, says the company “monitors our exposure to the risk of adverse changes in interest rates through the use of … sensitivity analyses,” i.e., modeling how rate shifts would affect the fair value of its debt and interest‑rate swaps. Thus, even though the same audit firm reviews both companies, Netflix uses sensitivity analysis to gauge content‑valuation risk, while Comcast uses it to gauge interest‑rate/financing risk, reflecting their distinct exposure profiles.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that CMCSA (Comcast) uses sensitivity analyses for interest rate risk related to debt and interest rate swaps, while NFLX (Netflix) uses it for content amortization driven by viewing-pattern assumptions. These uses reflect their distinct financial risk exposures—financing risk vs. content valuation risk—despite being audited by the same firm. (2) There are no numeric values in the LLM answer, but the ground truth includes a $56 million reduction in interest expense for CMCSA in 2023 due to derivatives. This specific figure is missing in the LLM response, which prevents a perfect score on completeness and quantitative accuracy, though the absence does not distort the overall correctness. (3) The multi-hop reasoning is sound: the model correctly links each company’s use of sensitivity analysis to its unique risk profile and acknowledges the shared auditor, implying consistent audit standards despite different applications. (4) The wording differs from the original but maintains semantic equivalence on all key points except the missing dollar amount. Contextual relevance is excellent, directly addressing the comparative use of sensitivity analysis and audit consistency. The omission of the $56M figure is minor in impact but notable for completeness, hence the 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 397,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How does the expiration timeline of Enbrel's key U.S. formulation patent in 2037 impact Pfizer's competitive positioning compared to AbbVie's regulatory exclusivity strategy for its biologics?",
      "original_answer": "Pfizer's Enbrel, marketed outside the U.S. and Canada, benefits from a U.S. formulation patent that expires in 2037, offering extended protection for its composition and preparation methods. This long runway could help Pfizer maintain market presence for Enbrel in key international markets by deterring biosimilar competition. In contrast, AbbVie relies on a broader regulatory exclusivity strategy, including 12-year exclusivity for biologics under the BPCIA and potential pediatric exclusivity extensions, which may allow it to manage competitive threats through both patent and regulatory mechanisms. While Pfizer’s formulation patent provides a specific technical barrier, AbbVie’s layered approach combines patent protection with statutory exclusivity to maximize market control post-approval.",
      "llm_answer": "Pfizer’s key U.S. formulation patent for Enbrel does not expire until 10 Oct 2037 (see Pfizer 10‑K Patents table, page 11), giving the company roughly two decades of protection beyond the standard biologics exclusivity period. In contrast, AbbVie’s biologics are shielded primarily by the 12‑year BPCIA regulatory exclusivity (with possible 180‑day pediatric or orphan extensions) that ends far earlier (see AbbVie 10‑K, “Intellectual Property Protection and Regulatory Exclusivity,” page 9). Thus, Pfizer enjoys a much longer, patent‑driven moat for Enbrel, whereas AbbVie must rely on a time‑limited regulatory exclusivity that leaves its products more vulnerable to biosimilar entry.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, but has minor issues in completeness and nuance. (1) Quantitatively, the date '10 Oct 2037' is more specific than the ground truth's '2037', but this is acceptable as a more precise version of the same information; no calculation errors are present. The reference to BPCIA's 12-year exclusivity and potential 180-day extensions (pediatric/orphan) is accurate. (2) The LLM correctly identifies Pfizer’s formulation patent as a key differentiator providing long-term protection beyond standard exclusivity, and contrasts it with AbbVie’s reliance on regulatory exclusivity. However, it omits mention that Enbrell is marketed outside the U.S. and Canada by Pfizer — a key contextual detail in the original answer affecting competitive positioning. (3) The reasoning is sound: it correctly synthesizes that Pfizer benefits from a longer, patent-based barrier while AbbVie faces earlier biosimilar vulnerability due to time-limited regulatory exclusivity. This captures the core multi-hop comparison between patent strategy vs. regulatory exclusivity. (4) The LLM slightly oversimplifies AbbVie’s strategy by not acknowledging its use of *both* patent and regulatory mechanisms (layered approach), which the original answer emphasizes. While the contrast is valid, this omission reduces qualitative accuracy. Overall, the answer is factually strong, contextually relevant, and well-reasoned, but misses some nuance in completeness and balance, warranting a score of 8/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 425,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 115,
      "question": "How would a potential shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge proposal impact JPMorgan Chase's capital requirements under a resolution scenario where the Parent Company enters bankruptcy, given the loss-absorbing structure of its eligible long-term debt?",
      "original_answer": "The proposed shift from 0.5-percentage-point to 0.1-percentage-point increments in the G-SIB surcharge under the Federal Reserve's proposal would likely allow for more granular calibration of capital requirements for systemically important institutions like JPMorgan Chase. For JPM, this could mean a more tailored capital burden, which would interact with its 'single point of entry' resolution strategy where losses would first be imposed on equity holders and then on unsecured creditors, including holders of eligible long-term debt. If this surcharge adjustment is adopted, JPM may experience either a marginal increase or decrease in required capital depending on its G-SIB score, which would influence how much loss-absorbing capacity it must maintain under its current regulatory framework.",
      "llm_answer": "The move from 0.5‑percentage‑point to 0.1‑percentage‑point increments would make the G‑SIB surcharge more granular and, if applied at a lower level, would reduce the extra capital charge that JPMorgan Chase must hold (page 60). Because the resolution plan relies on “eligible LTD” as the loss‑absorbing buffer for a parent‑company bankruptcy, a smaller surcharge would lower the amount of eligible long‑term debt that must be set aside to recapitalise subsidiaries, easing the capital requirement on the parent’s unsecured creditors (page 15).",
      "correctness_score": 7,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is largely correct in its quantitative and conceptual understanding but misses some key nuances present in the ground truth. (1) Quantitatively, the shift from 0.5- to 0.1-percentage-point increments is accurately described as increasing granularity, and there are no numerical errors—this aligns with the original answer. The reference to pages 60 and 15 suggests document-based support, though these are not evaluated here. (2) The LLM correctly identifies that a smaller increment could reduce JPMorgan Chase’s capital charge if applied at a lower level, which is consistent with the potential for more tailored calibration in the ground truth. However, it assumes a directional outcome (reduction in capital charge), whereas the original answer correctly states the impact could be either an increase or decrease depending on JPM’s G-SIB score—this is a significant omission in reasoning. (3) The explanation of the 'single point of entry' resolution strategy is partially accurate: the LLM correctly links eligible long-term debt (LTD) to loss absorption in a parent bankruptcy and notes that lower surcharges could reduce required eligible LTD. However, it oversimplifies by stating this 'would' happen, while the ground truth emphasizes conditional and potential outcomes. (4) Contextually, the answer is highly relevant, addressing the regulatory change, capital requirements, resolution mechanics, and impact on unsecured creditors. Despite missing the bidirectional possibility of capital impact and overstating certainty, the core logic and entities (JPMorgan Chase, G-SIB surcharge, eligible LTD, resolution scenario) are correct. Hence, correctness is scored 7 for accurate facts but incomplete reasoning, quantitative accuracy 9 for correct percentages and no math errors, qualitative accuracy 7 for sound but incomplete multi-hop logic, and contextual relevance 9 for strong alignment with the question’s focus.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 521,
        "total_tokens": 1896
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does LMT's use of a discounted cash flow approach in valuing Level 3 fixed income investments compare to HON's application of the same method in testing goodwill and indefinite-lived intangible assets, particularly in terms of the sensitivity to projected cash flows and discount rates?",
      "original_answer": "LMT applies the discounted cash flow approach to certain Level 3 fixed income investments, relying on projected annuity payments and a discount rate applied to those payments. This valuation method is used when observable market inputs are unavailable, and it introduces sensitivity to changes in these projected cash flows and discount assumptions. Similarly, HON utilizes a discounted cash flow approach for testing goodwill and indefinite-lived intangible assets, incorporating strategic and annual operating plans adjusted for terminal value assumptions. HON also performs sensitivity analyses on key estimates, including expected growth rates, sales volumes, and discount rates, to assess the impact of changes in assumptions. Both companies depend on forward-looking financial projections and discounting techniques, making their valuations highly sensitive to shifts in economic conditions and internal performance expectations.",
      "llm_answer": "Lockheed Martin (LMT) values Level 3 fixed‑income holdings with a discounted‑cash‑flow model that uses “projected annuity payments and the discount rate applied to those payments” 【page_88】, but the filing does not discuss any formal sensitivity testing of those inputs. Honeywell (HON), however, also uses a discounted‑cash‑flow approach for goodwill and indefinite‑life intangibles and explicitly states that it “performs sensitivity analyses on key estimates and assumptions” – including the projected cash‑flow assumptions and the discount rate – because changes in those inputs could materially affect the fair‑value measurement 【page_47】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and closely aligns with the ground truth. It correctly identifies that LMT uses a discounted cash flow (DCF) approach for Level 3 fixed income investments based on projected annuity payments and discount rates, citing sensitivity to these assumptions implicitly through the valuation method. It accurately contrasts this with HON's use of DCF for goodwill and indefinite-lived intangibles, highlighting HON’s explicit performance of sensitivity analyses on key inputs like cash flows and discount rates. The answer correctly reflects that while both companies rely on forward-looking projections and discounting, HON formally tests sensitivity—something not disclosed by LMT. There are no numerical inaccuracies (quantitative accuracy is perfect), and all entities (LMT, HON, Level 3 investments, goodwill, intangibles) are correctly identified. The reasoning is sound and synthesizes information across two companies and applications of DCF. The only minor shortcoming is that the original answer notes both companies' valuations are 'highly sensitive' to economic and performance shifts due to their reliance on projections, a point slightly underemphasized in the LLM response—though implied. This small omission prevents a perfect 10 on qualitative accuracy, but overall the response is excellent and contextually fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1430,
        "completion_tokens": 379,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does AT&T's use of discount rates tied to corporate bond credit quality in pension obligations compare to Netflix's reliance on forecasted viewing patterns in content amortization, given both are subject to auditor evaluation of significant assumptions?",
      "original_answer": "AT&T's pension obligations are sensitive to discount rates derived from corporate bonds' credit quality, which directly affects the measurement of $67,854 million in goodwill and postretirement liabilities. Netflix, on the other hand, relies on forecasted viewing patterns to amortize content assets, a process that is similarly judgmental and subject to auditor scrutiny. Both companies' financial statements depend heavily on significant assumptions—discount rates for AT&T and viewing forecasts for Netflix—that are evaluated by auditors using sensitivity analyses and comparisons to historical data. This highlights a parallel in how both firms manage subjectivity in long-term financial reporting, despite differing industries and asset types.",
      "llm_answer": "AT&T measures its defined‑benefit pension and post‑retirement obligations with discount rates that are built from the credit quality of corporate bonds and the match of those bonds’ cash flows to expected benefit payments – an actuarial assumption that auditors test by evaluating the bond‑credit analysis and the related controls (see AT&T page 44). Netflix, on the other hand, amortizes its content assets using historical and forecasted viewing‑hour patterns, and auditors assess the reasonableness of those forecasts, the data used and perform sensitivity analyses (see Netflix page 40). Both companies therefore rely on significant, judgment‑heavy assumptions that are scrutinized by their auditors, but AT&T’s assumptions are market‑rate‑based while Netflix’s are consumption‑pattern‑based.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, no specific dollar amounts or numerical values are misstated; the LLM does not repeat the $67,854 million figure from the original answer but this omission does not constitute a factual error—rather a difference in detail level. All other financial concepts (pension obligations, content amortization) are correctly represented. (2) The LLM correctly identifies both companies—AT&T and Netflix—and their respective significant assumptions: discount rates based on corporate bond credit quality for AT&T, and forecasted viewing patterns for Netflix. It accurately notes that both are subject to auditor evaluation, including sensitivity analyses and scrutiny of data and controls, referencing specific pages (44 for AT&T, 40 for Netflix), which enhances credibility. (3) The multi-hop reasoning is sound: it draws a valid comparison between two different firms in different industries using distinct but similarly judgmental assumptions in financial reporting, both subject to auditor review. The synthesis across entities and concepts is logical and complete. (4) Semantically, the LLM conveys the same core message as the original: both companies rely on significant, subjective assumptions that are audited using rigorous methods. The only minor shortcoming is the absence of the specific $67,854 million liability figure, which was present in the ground truth and adds concrete context to AT&T’s exposure. However, this omission does not undermine the correctness of the explanation, especially since the focus is on the nature of the assumptions and audit scrutiny. Wording differences are stylistic and do not affect factual equivalence. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 498,
        "total_tokens": 1912
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the adoption timeline of ASU No. 2023-07 differ between MO and PM, and what specific changes did each company implement in their segment reporting as a result?",
      "original_answer": "MO adopted ASU No. 2023-07 in 2024 and began including expanded footnote disclosures in Note 17, with interim disclosure requirements set to appear in Q1 2025. PM adopted the ASU retrospectively for the year ended December 31, 2024, and updated its segment reporting by incorporating the former Swedish Match segment into its four existing geographical segments starting in January 2024.",
      "llm_answer": "Altria (MO) applied ASU 2023‑07 to its 2024 annual filing, expanding the segment‑reporting footnote (Note 17) but leaving its segment structure unchanged【page_62】. Philip Morris International (PM) also adopted the update for 2024, added the expanded footnote disclosures (Note 17) and will begin the new interim‑segment disclosures in Q1 2025, and it used the change to re‑classify the former Swedish Match business into its four geographic segments, restating prior‑year amounts accordingly【page_63】【page_86】.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is mostly correct but contains a key discrepancy in the adoption timeline for PM. The ground truth states that PM adopted ASU No. 2023-07 retrospectively for the year ended December 31, 2024, and implemented segment changes starting January 2024. The LLM correctly notes PM's adoption in 2024, the inclusion of expanded footnote disclosures (Note 17), the reclassification of Swedish Match into geographic segments, and restatement of prior periods. However, it incorrectly states that PM will begin new interim disclosures in Q1 2025—this detail aligns with MO’s timeline, not PM’s. MO is the company that delays interim disclosures until Q1 2025; PM implemented the standard fully in 2024, including interim reporting. The LLM conflates the two companies’ timelines on this point. Quantitatively, no numbers are incorrect (no actual figures involved), and entity identification (MO, PM, Swedish Match, Note 17) is accurate. The reasoning is mostly sound but fails in synthesizing the correct interim disclosure timing for PM versus MO, a critical multi-hop distinction. Contextually, the response is fully relevant and addresses both parts of the question: adoption timelines and segment reporting changes. Wording is semantically equivalent where correct. Deduction is due to the misattribution of the Q1 2025 interim disclosure to PM instead of MO.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1229,
        "completion_tokens": 378,
        "total_tokens": 1607
      },
      "error": null
    },
    {
      "question_id": 116,
      "question": "How does the inclusion of Pomalyst in the Inflation Reduction Act's (IRA) drug price negotiation program impact BMY's revenue outlook compared to PFE's exposure under the same IRA provisions, given both companies' reliance on Medicare Part D sales and regulatory exclusivity timelines?",
      "original_answer": "BMY faces potential revenue erosion for Pomalyst starting in 2027 due to its selection by HHS for government-set pricing under the IRA, which could accelerate prior to the expiry of its intellectual property protections. Similarly, PFE anticipates a net unfavorable revenue impact of approximately $1 billion in 2025 due to IRA-driven Medicare Part D redesign changes and faces additional IRA pricing pressures on products like Ibrance and Xtandi, which were selected for price negotiation effective 2027. Both companies are exposed to the IRA’s long-term financial implications, but BMY’s risk is specifically tied to Pomalyst’s regulatory exclusivity and market dynamics, while PFE’s exposure spans a broader portfolio affected by Part D redesign and inflation rebates.",
      "llm_answer": "The IRA’s decision to place BMY’s pomalidomide (Pomalyst) in the Medicare Part D price‑negotiation program beginning in 2027 means that a drug still covered by five‑year regulatory exclusivity and contributing to BMY’s Part D sales will be forced to a government‑set price, eroding its revenue before exclusivity expires (BMY 10‑K p. 43; p. 18; p. 7). Pfizer, on the other hand, faces IRA pressure on several high‑volume products (e.g., Eliquis, Ibrance, Xtandi) that are also subject to Part D negotiation, but because the impact is spread across a broader portfolio and many of those drugs have later exclusivity dates, the hit to its overall revenue outlook is less concentrated than BMY’s single‑product exposure (Pfizer 10‑K p. 43; p. 16; p. 9).",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of reasoning and entity accuracy. It correctly identifies that BMY's Pomalyst (pomalidomide) is subject to IRA price negotiation starting in 2027, which will impact revenue prior to the expiration of its regulatory exclusivity, citing the correct risk as outlined in BMY's 10-K. It also accurately notes that PFE faces IRA pressures across multiple drugs (Ibrance, Xtandi, Eliquis), with broader portfolio exposure, leading to a less concentrated revenue impact compared to BMY’s single-product risk. However, the LLM omits PFE’s specific $1 billion net unfavorable revenue impact in 2025 due to Medicare Part D redesign, a key quantitative detail present in the original answer. While the qualitative comparison between BMY’s concentrated risk and PFE’s diversified exposure is sound and contextually relevant, the absence of this dollar figure and the 2025 timeline reduces quantitative completeness. The reasoning across entities (BMY vs. PFE) and synthesis of IRA impacts on Part D, exclusivity, and revenue outlook is strong, demonstrating accurate multi-hop logic. Number formats are consistent and acceptable, but missing explicit mention of $1B and 2025 prevents a top score in quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 358,
        "total_tokens": 1773
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does the exposure of MDLZ's Argentine operations, which contributed $401 million in 2021 net revenues, compare to KO's reliance on Arca Continental in Argentina, given that Arca Continental is one of KO's top bottlers and operates in northern Argentina?",
      "original_answer": "MDLZ's Argentine operations contributed $401 million in net revenues in 2021 and were subject to significant currency risk due to Argentina's highly inflationary status, resulting in a $13 million remeasurement loss in that year. Meanwhile, KO relies on Arca Continental, one of its top five bottlers, which operates in northern Argentina and contributes to KO's global unit case volume. Arca Continental is a key distribution partner in the region, and KO's bottler agreements require Arca to source concentrates exclusively from KO, making KO's exposure in Argentina indirect but strategically significant through this contractual relationship.",
      "llm_answer": "MDLZ’s Argentine business generated $401 million in 2021 – roughly 1.4 % of its total net revenues, giving it a clearly identified country‑level exposure. In contrast, KO’s Argentine exposure is embedded in its partnership with Arca Continental, a top‑five bottler that serves northern Argentina (as well as large parts of Mexico, Ecuador, Peru and U.S. states) and contributes to the 41 % of worldwide unit‑case volume that the five largest bottlers generate, so the Argentine portion is part of a broader, diversified bottling relationship rather than a standalone revenue figure.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states MDLZ's $401 million in net revenues from Argentina in 2021, matching the ground truth. It adds a calculated percentage (1.4%) of total MDLZ revenues, which is not in the original answer but is a reasonable inference if total MDLZ revenue was ~$28.6 billion in 2021 — this calculation is accurate and enhances context without introducing error. The mention that Arca Continental is a top-five bottler for KO and serves northern Argentina aligns with the ground truth. However, the LLM introduces a new statistic — that the top five bottlers account for 41% of KO’s global unit-case volume — which is not in the original answer and cannot be verified from the provided ground truth. While plausible, this number is unconfirmed and represents an unsupported addition. (2) All explicit numbers from the ground truth ($401M, $13M remeasurement loss) are partially addressed: the $401M is correct, but the $13M remeasurement loss due to inflation and currency risk — a key part of MDLZ’s exposure — is omitted. This is a significant qualitative gap. (3) The multi-hop reasoning is generally sound: the model correctly distinguishes MDLZ’s direct operational exposure from KO’s indirect exposure via a bottling partner. It synthesizes the relationship between KO and Arca Continental accurately in terms of exclusivity and regional operation, though it does not explicitly mention the contractual requirement for Arca to source exclusively from KO, which is a minor omission. (4) The answer is contextually excellent, directly addressing the comparison of exposure types (direct vs. indirect), and uses appropriate financial and strategic framing. The correctness score is 8 because core facts are accurate and the reasoning is strong, but the omission of the $13M remeasurement loss and the introduction of an unverified 41% figure prevent a top score. Quantitative accuracy is 9 due to correct use of $401M and plausible percentage, minus one for the unsupported 41%. Qualitative accuracy is 8 due to strong reasoning but missing risk exposure detail. Contextual relevance is 10 — fully on point.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 571,
        "total_tokens": 1906
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does BMY's engagement with the FDA's Fast Track Designation process inform the strategic value of LLY's acquisition of Prevail's PR006 gene therapy, given PR006's regulatory status and the CVR payment timeline tied to its approval?",
      "original_answer": "BMY's engagement with the FDA's Fast Track Designation process highlights the importance of expedited regulatory pathways in accelerating drug approvals and improving patient access to critical therapies. LLY acquired Prevail in 2021, including PR006, which was granted Fast Track Designation by the FDA for treating frontotemporal dementia with GRN mutations. The acquisition included a CVR entitling Prevail shareholders to up to an additional $4.00 per share (approximately $160 million total) upon the first regulatory approval of a Prevail product in specified countries by December 31, 2024. Given the Fast Track status of PR006, the likelihood of expedited approval may directly influence the timing and value of the CVR payout, thereby enhancing the strategic value of the acquisition if PR006 achieves regulatory approval within the stipulated timeline.",
      "llm_answer": "BMY’s filing notes that the FDA’s Fast Track designation is a key tool the agency uses to accelerate review and bring drugs to market more quickly (BMY 10‑K p. 18). LLY’s acquisition of Prevail includes PR006, which already carries Fast Track status, and the CVR tied to the deal pays up to $4 per share only if a first regulatory approval occurs by Dec 31 2024 (LLY 10‑K p. 70). Because Fast Track can shorten the approval timeline, it raises the probability that PR006 will meet the CVR deadline, thereby enhancing the strategic value of the acquisition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core multi-hop reasoning required. (1) All key facts are correct: BMY's mention of Fast Track as an accelerator (cited from BMY 10-K p.18), PR006's Fast Track status, the $4.00 per share CVR tied to first regulatory approval by December 31, 2024 (cited from LLY 10-K p.70), and the logical connection between Fast Track designation and increased probability of meeting the CVR deadline. (2) Quantitative elements are precise: $4 per share, Dec 31 2024 deadline, and the implication for payout timing match the ground truth. The total ~$160 million aggregate CVR value is omitted but not required for correctness since the per-share amount and trigger condition are accurately stated. (3) Multi-hop reasoning is sound: the model correctly links BMY’s general observation about Fast Track to the specific context of LLY’s acquisition of Prevail and PR006’s regulatory and financial implications. (4) Semantic equivalence is strong—while the LLM does not explicitly name frontotemporal dementia or GRN mutations, these details are contextually secondary to the main strategic logic about regulatory acceleration and CVR timing. The answer is concise, relevant, and factually aligned with the ground truth, warranting a high score with only minor room for added context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 365,
        "total_tokens": 1742
      },
      "error": null
    },
    {
      "question_id": 117,
      "question": "How does V's increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024 compare with MA's Class B-to-A conversion mechanism, especially considering MA's disclosure that only 7 shares of Class B common stock were outstanding in 2024, to assess the differing dynamics of shareholder structure evolution in both companies?",
      "original_answer": "V reported an increase in Class A common stock shares from 1,594 in 2023 to 1,733 in 2024, indicating an expansion in its Class A shareholder base. Meanwhile, MA disclosed that only 7 shares of Class B common stock were outstanding in 2024, showing minimal remaining shares eligible for conversion into Class A. This contrast highlights different dynamics in shareholder structure evolution: V is seeing organic growth or issuance in its Class A shares, while MA's structure is shaped by its conversion rules, which require Class B holders (typically principal or affiliate customers) to convert and then divest Class A shares, limiting long-term Class B retention.",
      "llm_answer": "Visa’s Class A common stock rose from 1,594 shares in 2023 to 1,733 shares in 2024 – an increase of 139 shares (V 10‑K, p. 58). Mastercard’s Class B shares, which are convertible on a one‑for‑one basis into Class A, numbered only seven at year‑end 2024, so any conversion could add at most seven Class A shares (MA 10‑K, p. 68) and the company requires B‑holders to sell the resulting A shares (MA 10‑K, p. 92). Consequently, Visa’s shareholder base is modestly expanding through new Class A issuances, whereas Mastercard’s structure remains essentially static, with a negligible conversion‑driven impact.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all key facts: Visa's Class A shares increased from 1,594 to 1,733 (a difference of 139 shares), and Mastercard had only 7 Class B shares outstanding in 2024. These numbers match the ground truth exactly. The LLM also accurately notes that Mastercard’s Class B shares are convertible on a one-for-one basis into Class A and that conversion would result in at most 7 additional Class A shares. (2) Calculations are correct: 1,733 - 1,594 = 139, and the cap of 7 convertible shares is properly interpreted. Number formats and references to 10-K pages (though not part of the ground truth) do not contradict factual accuracy. (3) Multi-hop reasoning is sound: the LLM synthesizes information across V and MA filings, contrasting Visa’s organic Class A share growth with Mastercard’s structurally constrained, conversion-limited mechanism. It correctly infers that Mastercard requires divestiture post-conversion (per MA 10-K, p. 92), which aligns with the ground truth’s point about limited long-term Class B retention. (4) The only minor shortcoming is that the LLM uses the term 'essentially static' to describe Mastercard’s structure, which slightly downplays the evolutionary dynamic implied in the original answer (i.e., the gradual conversion and divestiture process shaping the structure over time). However, this is a nuance in emphasis, not a factual error. Overall, the answer is factually complete, quantitatively precise, contextually relevant, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1365,
        "completion_tokens": 427,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How might Saudi Arabia's data localization requirements, which Adobe identifies as a risk to its international operations, affect NVIDIA's ability to deploy its H100 and L40S chips in the country under U.S. export control regulations?",
      "original_answer": "Saudi Arabia's implementation of data localization requirements mandates that data be stored and processed within the country, which Adobe notes could adversely impact its international business operations. NVIDIA, which relies on Saudi Arabia as a market for its high-performance chips like the H100 and L40S, faces U.S. export licensing restrictions on these products to Saudi Arabia under updated Country Group D4 rules. Since these chips require U.S. government approval for export and NVIDIA has not received such licenses for restricted products, the combination of Saudi regulatory requirements and U.S. export controls could significantly limit NVIDIA's ability to serve Saudi customers with these advanced AI chips, potentially reducing its market access and revenue opportunities in the region.",
      "llm_answer": "Adobe warns that Saudi Arabia’s new data‑localisation rules force companies to keep data inside the kingdom, which it cites as a risk to its international operations (MA 10‑K p. 23). NVIDIA’s filing shows that U.S. export‑control licensing is already required for its high‑performance H100 and L40S chips when shipped to Saudi Arabia, which is classified in Country Group D5 (NVDA 10‑K p. 27). If Saudi Arabia also requires that data processed by those chips remain on‑shore, NVIDIA would need additional U.S. licences or could be blocked from exporting the chips, making deployment in the country significantly more difficult.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key issue: Saudi Arabia's data localization requirements combined with U.S. export controls restrict NVIDIA's ability to deploy H100 and L40S chips. It accurately references Adobe’s risk disclosure and NVIDIA’s need for export licenses. However, there is a critical error in the Country Group classification: the ground truth states Saudi Arabia is in Country Group D4, while the LLM answer incorrectly cites D5 (NVDA 10-K p.27). This undermines the precision of the regulatory reasoning, as D4 and D5 have different control implications under U.S. export rules. Despite this, the overall logic—that export licensing is required and not granted, and that data localization exacerbates deployment challenges—is sound and aligns with the original answer. The answer is semantically close and contextually relevant, with no numerical inaccuracies (no specific numbers to verify). The multi-hop synthesis between Adobe’s risk disclosure and NVIDIA’s export constraints is appropriately made, though the incorrect Country Group weakens the qualitative accuracy. Hence, correctness is reduced to 7 due to this key regulatory misclassification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 341,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 118,
      "question": "How do FedEx's and GE's disclosures regarding the discontinuation of LIBOR reflect differing applications of the accounting relief provided by ASU 2020-04, as extended by ASU 2022-06?",
      "original_answer": "FedEx notes that there has been 'no material effect' from reference rate reform on its financial condition as of May 31, 2024, but continues to monitor contracts for potential application of ASU 2022-06, which extended the optional expedients in ASU 2020-04 through December 31, 2024. In contrast, GE explicitly states that the overall impact of LIBOR reform under ASU 2020-04 on its financial statements is 'immaterial.' This suggests that while both companies applied the same accounting framework (ASU 2020-04, extended by ASU 2022-06), FedEx maintained a more cautious stance with ongoing monitoring, whereas GE concluded the transition had no significant financial impact.",
      "llm_answer": "FedEx’s filing merely notes that the optional expedients of ASU 2020‑04 (deferred by ASU 2022‑06) are available, but as of the reporting date the company has seen no material effect from LIBOR’s phase‑out and is only monitoring its contracts for any future application. GE, by contrast, says it has already evaluated the LIBOR discontinuation under ASU 2020‑04 (the relief extended by ASU 2022‑06) and determined that the impact on its financial statements is immaterial, indicating a concrete use of the accounting relief.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) All key facts are correct: FedEx reports no material effect from LIBOR reform as of its reporting date (May 31, 2024, implied by context), continues monitoring contracts, and acknowledges the availability of ASU 2020-04 expedients extended by ASU 2022-06. GE explicitly evaluated the impact and concluded it was immaterial. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages), so quantitative accuracy is not applicable beyond correct referencing of ASU numbers and the December 31, 2024 deadline, which is correctly implied via 'deferred by ASU 2022-06'. (3) The multi-hop reasoning is sound: the model correctly contrasts FedEx's ongoing monitoring approach with GE's conclusion of immateriality, both under the same accounting framework (ASU 2020-04 extended by ASU 2022-06). (4) The only minor shortcoming is that the LLM does not explicitly name the end date (December 31, 2024) for the extended relief, though it references ASU 2022-06's deferral, which implies the extension. This omission is minor and does not affect the overall correctness. Wording differs slightly but maintains semantic equivalence. All entities (FedEx, GE, ASU 2020-04, ASU 2022-06, LIBOR) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 374,
        "total_tokens": 1683
      },
      "error": null
    },
    {
      "question_id": 119,
      "question": "How might geopolitical tensions involving Taiwan impact both Apple's and NVIDIA's supply chain operations, considering their reliance on manufacturing locations and foundry partners in the region?",
      "original_answer": "Apple's business is significantly impacted by geopolitical tensions involving Taiwan, as it relies heavily on outsourcing partners located in Taiwan for manufacturing critical components. A significant or prolonged conflict involving Taiwan could severely limit Apple's ability to manufacture and deliver products, creating delays and inefficiencies in its supply chain. Similarly, NVIDIA depends on foundry partners in Taiwan for chipset supply, and any disruption due to geopolitical tensions could severely limit or prevent NVIDIA from receiving this supply, which would have a material adverse impact on its business. Both companies face heightened risks due to their reliance on operations in a region with ongoing geopolitical instability.",
      "llm_answer": "Apple notes that most of its devices are assembled by contract manufacturers in Taiwan and that the company “depends on its ability to receive consistent and reliable chipset supply from our foundry partners, particularly in Taiwan” – a disruption caused by war‑or‑political tension could delay production, raise costs and curtail sales【page_8】. NVIDIA likewise relies on a small number of Taiwan‑based foundries for wafer fabrication; the filing warns that “geopolitical tensions… involving Taiwan and China… could severely limit or prevent us from receiving chipset supply from Taiwan,” which would interrupt GPU manufacturing and have a material adverse impact on its business【page_17】【page_21】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key facts are correct: both Apple and NVIDIA rely on Taiwan-based manufacturing and foundry partners, and geopolitical tensions involving Taiwan could disrupt their supply chains, leading to material adverse impacts. The LLM correctly identifies that Apple depends on contract manufacturers in Taiwan for assembly and chipset supply, and NVIDIA relies on a small number of foundries there for wafer fabrication. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of incorrect numbers supports a score of 10. (3) The multi-hop reasoning is sound: the model synthesizes information about both companies’ supply chain dependencies and correctly links geopolitical risk to operational impact. The only minor shortcoming is that the original answer emphasizes Apple's reliance on 'outsourcing partners in Taiwan for manufacturing critical components,' while the LLM focuses more on 'assembly' and 'chipset supply'—slightly narrower but still factually consistent. (4) The answer is fully contextually relevant, directly addressing how geopolitical tensions affect both companies’ supply chains via Taiwan’s role in manufacturing and foundry services. Citations to filing pages (e.g., page_8, page_17, page_21) suggest grounding in source material, enhancing credibility. Overall, the answer is semantically equivalent to the ground truth with excellent reasoning and no factual errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 438,
        "total_tokens": 1811
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "What percentage of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition is specifically tied to VMware Cloud Foundation, and how does this compare to Oracle's net value of developed technology as a percentage of its total intangible assets?",
      "original_answer": "Of Broadcom's $24,156 million developed technology intangible asset from the VMware acquisition, a 'significant portion' is tied to VMware Cloud Foundation (VCF), though the exact percentage is not disclosed. Oracle's net value of developed technology was $1,276 million as of May 31, 2024, which represents approximately 18.4% of Oracle's total intangible assets of $6,890 million. While Broadcom emphasizes that a significant portion of its developed technology relates to VCF, Oracle's developed technology is a much smaller share of its overall intangible asset base, indicating differing strategic valuations of technology assets post-acquisition.",
      "llm_answer": "Broadcom’s filing says that a “significant portion” of the $24,156 million developed‑technology intangible asset acquired in the VMware deal is tied to VMware Cloud Foundation, but it does not disclose a specific percentage 【page_51】. By contrast, Oracle’s net developed‑technology intangible asset of $1.276 billion represents roughly 18.5 % of its total net intangible assets of $6.89 billion (1.276 ÷ 6.890) 【page_86】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that Broadcom does not disclose the exact percentage of the $24,156 million developed technology intangible asset tied to VMware Cloud Foundation, only describing it as a 'significant portion,' which matches the ground truth. For Oracle, the LLM accurately reports the $1,276 million net developed technology value and total intangible assets of $6,890 million, and calculates the percentage as approximately 18.5%, which rounds correctly from 18.4% in the ground truth (1,276 ÷ 6,890 = 0.18505, or 18.51%, so 18.5% is acceptable). (2) All numeric values are correct and properly formatted: $24,156 million, $1.276 billion = $1,276 million, $6.89 billion = $6,890 million. The calculation is accurate and cited with correct source pages. (3) The multi-hop reasoning is sound: the model synthesizes information from two different companies (Broadcom and Oracle), two different acquisitions (VMware and Oracle’s intangible breakdown), and compares the relative importance of developed technology within each firm’s intangible asset base. It correctly infers that while Broadcom highlights strategic importance (without quantifying), Oracle’s figure is quantifiable and smaller in relative terms. (4) The only minor shortcoming is that the LLM does not explicitly state the 18.4% figure from the ground truth, instead rounding to 18.5%. However, this is a defensible rounding and does not constitute a factual error. The omission of the phrase 'differing strategic valuations' in the conclusion slightly reduces qualitative richness, but the comparison is still logically conveyed. Thus, the answer is factually correct, complete, and contextually appropriate with excellent quantitative precision.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1301,
        "completion_tokens": 473,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 120,
      "question": "How does the voting power distribution tied to Class B common stock at CMCSA compare to the relative stockholder ownership structure at GOOGL, particularly in terms of non-affiliate market value and class-based control mechanisms?",
      "original_answer": "At CMCSA, holders of Class B common stock, of which there are only 3 record holders, maintain 33⅓% of the combined voting power of the company’s common stock, with each share carrying 15 votes. This concentrated voting power is designed to preserve control, as the Class B shares are non-dilutable under the company's articles of incorporation. In contrast, GOOGL disclosed that as of June 30, 2021, the aggregate market value of shares held by non-affiliates was approximately $1,451.1 billion, with 300,754,904 shares of Class A common stock outstanding. While GOOGL’s structure also includes differentiated voting rights, the non-affiliate ownership suggests a more dispersed market-based control mechanism compared to CMCSA’s concentrated Class B structure.",
      "llm_answer": "CMCSA’s Class B shares carry 15 votes each and represent a non‑dilutable one‑third (≈33 %) of the company’s total voting power, a block that is owned entirely by Chairman/CEO Brian L. Roberts (see CMCSA page 38/35). In contrast, Alphabet’s 2021 filing shows that non‑affiliates hold roughly $1.45 trillion of market value and that the company has 300.8 million Class A, 44.6 million Class B and 315.6 million Class C shares outstanding, indicating a far more dispersed ownership structure without a single class concentrating voting control (see GOOGL page 2).",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 15 votes per share and ~33% voting power for CMCSA's Class B stock, aligning with the ground truth. However, it incorrectly states that the Class B shares are 'owned entirely by Brian L. Roberts'—the original answer notes only 3 record holders without naming them, so this specific attribution is unsupported and factually inaccurate. For GOOGL, the LLM introduces Class B and Class C shares (44.6M and 315.6M respectively), which are not mentioned in the original answer; while these may exist in Alphabet’s actual structure, they were not part of the provided ground truth and thus represent an overextension. The $1.45 trillion non-affiliate market value and 300.8 million Class A shares are accurate approximations of the original $1,451.1 billion and 300,754,904 shares. (2) Quantitative accuracy is partially compromised: while the GOOGL figures are rounded appropriately, the addition of unmentioned share classes introduces incorrect data. The CMCSA voting power and vote count are correct. (3) The multi-hop reasoning is generally sound—the model compares control mechanisms between CMCSA’s concentrated voting structure and GOOGL’s more dispersed ownership. However, it misrepresents the basis of GOOGL’s control mechanism by omitting that GOOGL also has differentiated voting rights (Class A: 1 vote, Class B: 10 votes), which the original answer explicitly notes. This weakens the qualitative comparison. (4) Scores reflect strong contextual relevance and reasonable qualitative reasoning, but quantitative accuracy is reduced due to unsupported numbers and incorrect ownership attribution. Core facts are mostly correct, but key details are either added or misrepresented, preventing a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 480,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the difference in issued Class A and Class B common stock shares between CMCSA and META reflect on their respective equity structure concentration as disclosed in their 2024 filings?",
      "original_answer": "CMCSA disclosed that it issued 4,651,093,045 Class A common shares and 9,444,375 Class B common shares as of December 31, 2024, indicating a significantly higher proportion of Class A shares in its equity structure. META, on the other hand, reported 2,189,898,148 Class A common shares and 343,761,117 Class B common shares outstanding as of January 24, 2025, showing a much higher relative weighting of Class B shares. The evidence from Alphabet's filing clarifies that Class B shares carry 10 votes per share versus 1 vote for Class A, and that Class B shares automatically convert to Class A upon sale or transfer. This suggests META's equity structure maintains stronger voting rights concentration among fewer shareholders compared to CMCSA, where ownership appears more diffused due to the dominance of standard voting Class A shares.",
      "llm_answer": "Comcast’s 2024 balance sheet shows it had roughly 4.65 billion Class A shares issued versus only 9.44 million Class B shares (≈0.2 % of total equity)【page_67】. Meta reported about 2.19 billion Class A shares and 0.344 billion Class B shares outstanding, giving Class B roughly 13 % of its equity【page_1】. Thus Comcast’s equity is overwhelmingly concentrated in a single class, while Meta’s dual‑class structure is far less concentrated, with a substantial share of voting‑weighted Class B stock.",
      "correctness_score": 4,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several correct quantitative elements but misrepresents the core conclusion about equity concentration. It correctly reports CMCSA's Class A (4.65 billion) and Class B (9.44 million) shares, aligning with the ground truth of 4,651,093,045 and 9,444,375 respectively. It also reasonably approximates META's Class A (2.19B vs 2.189B) and Class B (0.344B vs 343.76M). However, the calculation of Class B as '13% of equity' is misleading—it computes percentage of total shares outstanding but ignores voting rights, which is central to the question. (2) The quantitative accuracy is partially correct: numbers are rounded acceptably, but the interpretation of 'concentration' based solely on share count rather than voting power introduces a critical error. The LLM incorrectly concludes that Meta's structure is 'less concentrated', when in fact the opposite is true due to superior voting rights of Class B shares. (3) The multi-hop reasoning fails: while the model synthesizes data from both companies, it misses the key disclosure about voting rights (10 votes for Class B vs 1 for Class A) and automatic conversion upon transfer, which are essential to understanding control concentration. The original answer correctly infers that Meta maintains stronger voting control among insiders, whereas the LLM incorrectly equates numerical share distribution with control. (4) Contextual relevance is high—the response addresses the equity structure and compares both firms—but the qualitative inaccuracy in reasoning and conclusion severely undermines correctness. The model reverses the actual implication of the data, leading to a substantively incorrect interpretation of equity concentration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1345,
        "completion_tokens": 471,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 121,
      "question": "How does the exposure of CVS's Oak Street Health business to Medicare reimbursement risks compare to AbbVie's exposure under the IRA's price-setting provisions, given the IRA's impact on the Medicare program?",
      "original_answer": "CVS's Oak Street Health business derives a significant portion of its revenue from Medicare or Medicare Advantage plans and is exposed to risks such as reductions in reimbursement rates and changes in Medicare program rules. The IRA introduces new financial pressures on Medicare-participating drug manufacturers like AbbVie by enabling government price-setting for certain Part B and Part D drugs starting in 2026 and 2028, respectively. AbbVie specifically faces exposure as Imbruvica has already been selected for price-setting under the IRA, with government-dictated prices set to take effect in 2026. This regulatory shift under the IRA compounds the existing Medicare-related risks faced by CVS's Oak Street Health, as both are tied to the same evolving Medicare framework, albeit through different mechanisms—direct reimbursement risk for CVS and mandated pricing for AbbVie.",
      "llm_answer": "CVS’s Oak Street Health business is broadly vulnerable to Medicare‑related payment risk because a sizable share of its revenue comes from Medicare and Medicare‑Advantage plans, so any cuts to reimbursement rates or rule changes in the Medicare program would directly reduce its earnings (CVS 10‑K p.47). AbbVie’s exposure is more product‑specific: the IRA gives HHS authority to set statutory price caps for certain drugs covered under Medicare Part B and Part D, which could force lower prices and reimbursements for those selected products (AbbVie 10‑K p.19, p.37). Thus, CVS faces a general service‑reimbursement risk, while AbbVie faces a targeted price‑setting risk on individual drugs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core comparison between CVS's Oak Street Health and AbbVie's exposure to Medicare-related risks under the IRA. (1) All factual elements are correct: CVS's Oak Street Health relies significantly on Medicare/Medicare Advantage revenue and faces reimbursement risk (supported by CVS 10-K p.47), while AbbVie faces product-specific price-setting risk under the IRA for certain Part B and Part D drugs (supported by AbbVie 10-K pp.19, 37). (2) There are no numeric values, dates, or calculations in the LLM answer, but it correctly references the mechanisms of the IRA without introducing inaccuracies—this aligns with the ground truth, which specifies that Imbruvica was selected and pricing takes effect in 2026. The LLM omits this specific drug and date but does not contradict them; the absence is a minor completeness gap, not an error. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies and regulatory frameworks, distinguishing between service-level reimbursement risk (CVS) and manufacturer-level price-setting (AbbVie), both tied to Medicare under the IRA. (4) The answer is semantically equivalent to the ground truth in its core conclusion—different mechanisms, same overarching Medicare framework—though slightly less detailed. The omission of Imbruvica and the 2026 effective date prevents a perfect 10, but the reasoning and framing remain factually solid and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 410,
        "total_tokens": 1819
      },
      "error": null
    },
    {
      "question_id": 123,
      "question": "How does Microsoft's inclusion of operating systems in its product revenue influence AMD's dependency on Microsoft's operating system support for its x86-based microprocessor and graphics products?",
      "original_answer": "Microsoft's product revenue includes operating systems, which are critical components for PC functionality. AMD relies on Microsoft to design and develop its operating systems to support AMD's x86-based microprocessors and graphics products. If Microsoft does not continue to support AMD's innovations through its operating systems, independent software vendors may avoid optimizing applications for AMD products, and customers may be less inclined to purchase PCs with AMD components, materially affecting AMD's business.",
      "llm_answer": "Microsoft reports that its product revenue “includes sales from operating systems” (​MSFT 10‑K 2022 p. 62), showing that the OS is a core, revenue‑generating component of its business. AMD’s filing notes that its ability to sell x86‑based microprocessors and graphics products “depends partially on Microsoft designing and developing its operating systems to run on or support” those products (​AMD 10‑K 2022 p. 28). Thus, because the OS is a major part of Microsoft’s product revenue, AMD’s market success is directly tied to Microsoft’s continued support and development of its operating system.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually correct and aligns well with the ground truth. (1) It accurately reflects that Microsoft's product revenue includes operating systems, citing the correct source (MSFT 10-K 2022, p. 62), and correctly states AMD's dependency on Microsoft OS support, citing AMD 10-K 2022, p. 28. These citations confirm the use of accurate, document-based evidence. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—score is 10. (3) The reasoning correctly synthesizes the multi-hop relationship: Microsoft treats OS as a revenue-generating product, and AMD depends on Microsoft’s OS design decisions for market success. The LLM captures the causal link—AMD’s sales depend on Microsoft’s support—but slightly underemphasizes the downstream effects mentioned in the ground truth (e.g., ISV optimization, customer purchasing behavior). This minor omission prevents a perfect 10 on qualitative accuracy. (4) The answer is highly contextually relevant, directly addressing how Microsoft’s revenue model around OS strengthens its strategic role in enabling AMD’s product adoption. Overall, the answer is semantically equivalent to the original, with only slight reduction in depth of consequence explanation.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1292,
        "completion_tokens": 361,
        "total_tokens": 1654
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does Cisco's network infrastructure for AI training and inference workloads compare to Broadcom's support for enterprise-scale AI and machine learning workloads through VMware Cloud Foundation, particularly in terms of enabling multicloud architectures and Kubernetes integration?",
      "original_answer": "Cisco provides high-density routers, switches, and high-performance optics to scale network infrastructure for AI training and inference workloads, aiming to simplify data center operations across multicloud environments. VMware Cloud Foundation (VCF), produced by Broadcom, enables enterprise-scale AI and machine learning workloads by offering native Kubernetes support, allowing both virtual machines and containerized workloads to run on a single platform. VCF also provides license portability, enabling customers to move environments between on-premises and cloud endpoints, aligning with Cisco's vision of policy and operational consistency across multicloud architectures. Broadcom values VCF through developed technology using the multi-period excess earnings method, reflecting its strategic role in supporting AI workloads.",
      "llm_answer": "Cisco’s AI‑training and inference solution is built on high‑density routers, switches and high‑performance optics that extend the data‑center fabric and give customers a multicloud‑ready network with unified policy and management, but it does not embed a container‑orchestration layer (Cisco 10‑K p.4). Broadcom’s VMware Cloud Foundation, by contrast, delivers an integrated software stack that includes native Kubernetes and license‑portable compute, networking and storage, allowing enterprise‑scale AI/ML workloads to run across on‑premises and public clouds in a true multicloud architecture (Broadcom 10‑K p.8‑9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Cisco provides high-density routers, switches, and high-performance optics to support AI workloads and enable multicloud-ready networks with unified policy and management, but lacks an embedded container orchestration layer. Broadcom’s VMware Cloud Foundation (VCF) offers native Kubernetes support, license portability, and integrated infrastructure for running enterprise-scale AI/ML workloads across on-premises and public clouds. These points match the original answer. (2) There are no numeric values, dates, or financial figures in either answer requiring calculation or verification, so quantitative accuracy is not applicable but assumed correct by absence. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Cisco and Broadcom (via VMware) from their respective 10-K filings, contrasting networking infrastructure (Cisco) with software-defined cloud foundation (VCF), and linking both to multicloud and Kubernetes integration. (4) The only minor omission is that the LLM answer does not mention Broadcom’s valuation of VCF using the multi-period excess earnings method, which appears in the original answer and reflects strategic importance. However, this detail is secondary to the core comparison asked in the question. Wording differs but semantic meaning is equivalent. Contextual relevance is perfect—directly addresses the comparison in terms of multicloud and Kubernetes integration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 423,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 124,
      "question": "How does PayPal's use of pricing models for derivatives compare to Morgan Stanley's Level 3 valuation techniques, particularly in terms of reliance on unobservable inputs for fair value measurement?",
      "original_answer": "PayPal primarily uses Level 2 inputs for its derivatives, incorporating observable data such as currency rates, interest rate yield curves, option volatility, and equity prices in its pricing models, and did not have any Level 3 assets or liabilities as of December 31, 2024. In contrast, Morgan Stanley utilizes Level 3 classifications when unobservable inputs are significant, particularly for non-exchange-traded investments and certain secured financings where market liquidity is limited or unavailable. This indicates that Morgan Stanley has a greater reliance on internally derived assumptions for fair value measurement compared to PayPal, which avoids Level 3 classifications entirely.",
      "llm_answer": "PayPal says that most of its derivatives are valued with pricing models that use contract‑specific terms together with observable market data such as currency rates, yield curves, option volatilities and equity prices, and it classifies those instruments at Level 2 with no material reliance on unobservable inputs (PayPal 10‑K p. 93). Morgan Stanley, by contrast, notes that its Level 3 valuations are applied to more complex or ill‑liquid OTC derivatives where significant unobservable inputs are required and judgment is needed to estimate those inputs (Morgan Stanley 10‑K p. 97; also see p. 98).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that PayPal uses Level 2 inputs for its derivatives, relying on observable market data such as currency rates, yield curves, option volatilities, and equity prices, with no material reliance on unobservable inputs—consistent with the original answer's claim that PayPal had no Level 3 assets or liabilities as of December 31, 2024. The LLM cites the correct page (p. 93) of PayPal’s 10-K, supporting its claim. (2) For Morgan Stanley, the LLM accurately notes the use of Level 3 valuations for complex or illiquid OTC derivatives requiring significant unobservable inputs and judgment, citing p. 97 (and referencing p. 98), which matches the ground truth’s emphasis on non-exchange-traded investments and secured financings in illiquid markets. (3) The multi-hop reasoning is sound: the model correctly contrasts PayPal’s avoidance of Level 3 classifications with Morgan Stanley’s reliance on them when observable inputs are insufficient, capturing the core comparative insight. (4) While the LLM does not explicitly state 'PayPal has no Level 3 assets or liabilities as of December 31, 2024,' it conveys the same meaning by stating 'no material reliance on unobservable inputs,' which is semantically equivalent in the context of fair value hierarchy reporting. The only minor omission is the specific date, but the information is contextually implied and factually correct. All entities, metrics, and sources are accurately referenced. Thus, the answer is factually correct, well-reasoned, and fully relevant, warranting a high score with only a slight deduction for the missing explicit date reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 462,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "Given that META's Class B common stockholders have limited voting rights on specific corporate actions, and CMCSA's Class A common stock is the primary voting share class, how might the ownership structure of 343,761,117 outstanding Class B shares at META affect the potential for shareholder-driven governance changes compared to CMCSA's 3,778,302,017 outstanding Class A shares?",
      "original_answer": "META's Class B common stockholders, of which there are 343,761,117 outstanding shares, possess limited voting rights, only applicable in specific corporate actions such as exiting the core payments business or certain mergers. This restricts their ability to influence broader governance decisions, which are largely controlled by Class A shareholders. In contrast, CMCSA's 3,778,302,017 outstanding Class A shares carry full voting rights, enabling more direct shareholder influence over corporate governance. As a result, shareholder activism or governance overhauls would face a higher threshold for success at META due to the constrained voting power of its Class B holders, compared to the more broadly distributed and influential Class A shareholder base at CMCSA.",
      "llm_answer": "META’s 2024 filing shows it has 343,761,117 Class B shares outstanding, but those shares are only entitled to vote on a narrow set of corporate actions (e.g., certain mergers or charter amendments)【page_1】. By contrast, Comcast’s 2024 balance sheet lists 3,778,302,017 Class A shares as the primary voting class【page_67】, giving a far larger pool of fully‑voting shares. Consequently, even though META’s Class B holders represent a sizable block, their limited voting rights constrain their ability to drive broad governance changes, whereas Comcast’s much larger, fully‑voting Class A base makes shareholder‑initiated governance actions far more feasible.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META has 343,761,117 Class B shares with limited voting rights, and CMCSA has 3,778,302,017 Class A shares as the primary voting class. These numbers match the original answer exactly and are correctly attributed. (2) Quantitative accuracy is perfect—both share counts are reported correctly, and no calculations are required beyond comparison, which is handled appropriately. (3) The reasoning is sound: the LLM correctly infers that limited voting rights for META’s Class B shares constrain shareholder-driven governance changes, while CMCSA’s larger base of fully voting shares enables greater shareholder influence. The multi-hop synthesis—comparing ownership structures across two companies to assess governance implications—is logically executed. (4) The only minor shortcoming is a slight lack of specificity regarding *which* corporate actions Class B shares at META can vote on (e.g., exiting core payments business), which is mentioned in the original answer but omitted here. However, the reference to 'certain mergers or charter amendments' is consistent with typical Class B limitations and does not introduce error. Wording differs but semantic meaning is equivalent. Contextual relevance is excellent, directly addressing the comparative governance impact as asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 383,
        "total_tokens": 1798
      },
      "error": null
    },
    {
      "question_id": 125,
      "question": "What percentage of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in territories where CCEP operates, and how does this compare to PM's operational presence in Portugal, one of CCEP's key markets?",
      "original_answer": "KO's non-U.S. unit case volume is 71% attributable to sparkling soft drinks in territories where CCEP operates, including Portugal. Meanwhile, PM has a manufacturing facility in Portugal, which is among its largest facilities producing over 30 billion units (cigarettes and heated tobacco units combined). This highlights KO's significant reliance on CCEP for sparkling beverage distribution in key international markets, while PM maintains a direct production footprint in one of those same strategic locations.",
      "llm_answer": "KO states that 71 % of its non‑U.S. unit‑case volume is attributable to sparkling soft drinks – a share that applies to the territories where its bottler CCEP operates【page_7】. In contrast, PMI’s presence in one of CCEP’s key markets, Portugal, is a physical manufacturing facility, listed among its largest plants outside the United States【page_19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that 71% of KO's non-U.S. unit case volume is attributable to sparkling soft drinks in CCEP-operated territories, matching the ground truth exactly. It also accurately notes PMI's (PM) manufacturing presence in Portugal, one of CCEP's key markets, and correctly characterizes it as one of its largest facilities outside the U.S. (2) Quantitatively, the 71% figure is correct and properly attributed. While the original answer specifies PM's facility produces over 30 billion units (cigarettes and heated tobacco), the LLM omits this specific output number but still correctly conveys the scale by calling it one of the largest plants. This is a minor omission but does not distort the fact. (3) The multi-hop reasoning is sound: the model connects KO’s reliance on CCEP for distribution in international markets with PM’s direct operational footprint in Portugal, highlighting the contrast in business models. (4) The answer is semantically equivalent to the ground truth, with only slight reduction in detail regarding PM’s production volume. All entities (KO, CCEP, PM/PMI, Portugal) are correctly identified and contextualized. The minor lack of specificity on PM’s 30 billion+ unit output prevents a perfect 10, but overall accuracy and relevance are very high.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1234,
        "completion_tokens": 366,
        "total_tokens": 1600
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "Given Cisco's reduced credit loss allowance for loan receivables from $103 million in 2022 to $53 million in 2023, how might this change impact their ability to finance technical support services, which are explicitly included in their loan receivables portfolio?",
      "original_answer": "Cisco's credit loss allowance for loan receivables decreased by 48.5% from $103 million in 2022 to $53 million in 2023. Since Cisco explicitly states that loan receivables include financing arrangements for technical support services, this reduction in credit loss allowance suggests improved credit quality or lower risk in these financing arrangements. A smaller allowance could indicate Cisco is more confident in the creditworthiness of customers receiving technical support financing, potentially enabling Cisco to expand financing options for technical support services with reduced financial risk. This could lead to more competitive financing terms for customers seeking technical support services.",
      "llm_answer": "Cisco’s credit‑loss allowance for loan receivables fell from $103 million in 2022 to $53 million in 2023 (see page 84), and those loan receivables “represent financing arrangements … including technical support and advanced services” (see page 82). The smaller reserve signals lower expected defaults, boosting the net value of the loan‑receivable portfolio and freeing cash flow, which should give Cisco more capacity and flexibility to extend or expand financing for its technical‑support services.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the reduction in credit loss allowance from $103 million in 2022 to $53 million in 2023, matching the ground truth exactly. While the ground truth includes a calculated percentage decrease of 48.5%, the LLM omits this specific figure but still accurately conveys the direction and significance of the change. (2) All numeric values and years are correct, with proper context and formatting. The calculation of the 48.5% decrease is accurate in the original answer, but its absence in the LLM response is a minor omission, not an error. (3) The LLM correctly performs multi-hop reasoning by linking the reduced allowance to improved credit quality and then to Cisco's loan receivables portfolio, which explicitly includes technical support services (citing page 82). It logically infers that lower expected defaults enhance the net value of receivables and improve cash flow, thereby increasing Cisco’s capacity to expand financing—aligning well with the ground truth’s conclusion about expanded financing options. (4) The answer is highly relevant, factually accurate, and synthesizes information correctly across financial data and business context. The only minor shortcoming is the lack of the explicit percentage decline, which slightly reduces completeness but does not impair the overall correctness or reasoning. Hence, a score of 9 is justified for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1330,
        "completion_tokens": 409,
        "total_tokens": 1740
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does AT&T's Series B Preferred Stock structure, which grants limited voting rights only on specific merger-related matters, compare to Netflix's universal voting rights for common stockholders in terms of corporate governance influence?",
      "original_answer": "AT&T's Series B Preferred Stockholders have no voting rights except on specific merger-related matters where they can vote as a single class with each holder casting votes equal to the number of shares held. This contrasts with Netflix, where each share of common stock provides one vote on all matters to be voted upon by stockholders, giving common stockholders broader governance influence. AT&T's structure limits Series B Preferred Stockholders' influence to defined corporate actions, whereas Netflix's model ensures universal voting participation for common stockholders.",
      "llm_answer": "AT&T’s Series B preferred shares are only granted voting rights on a narrow set of merger‑related matters, limiting their holders’ ability to influence corporate governance to those specific events (see AT&T exhibit list for Series B Preferred Stock, p. 103). In contrast, Netflix’s common stockholders receive one vote per share on all shareholder matters, giving them universal voting power and a much broader role in the company’s governance (see Netflix voting‑rights section, p. 61).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: AT&T’s Series B Preferred Stockholders have limited voting rights only on specific merger-related matters, while Netflix common stockholders have one vote per share on all matters. There are no numerical values requiring calculation, but the qualitative descriptions of voting rights are precise. (2) The answer correctly identifies both companies and their respective stock structures without entity errors. (3) The multi-hop reasoning—comparing corporate governance influence across two different companies’ stock classes—is sound and well-synthesized, drawing correct contrasts in governance models. (4) Minor deduction in qualitative accuracy due to the inclusion of hypothetical document references ('see AT&T exhibit list...', 'p. 103', 'p. 61') not present in the original answer; while these may reflect plausible sourcing, they introduce unverified specifics not in the ground truth. Otherwise, the answer is fully contextually relevant, complete, and accurately conveys the comparative governance influence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1290,
        "completion_tokens": 320,
        "total_tokens": 1610
      },
      "error": null
    },
    {
      "question_id": 126,
      "question": "How does PayPal's risk of technological disruption from emerging payment methods like BNPL and cryptocurrency compare with Visa's strategic positioning as both partner and competitor to these alternative payment providers?",
      "original_answer": "PayPal faces significant risk from rapid technological changes, particularly in payment methods like BNPL and cryptocurrency, which could render its current offerings obsolete if not adopted timely. Visa, on the other hand, strategically partners with these alternative payment providers while also competing with them, leveraging its global network and security advantages to maintain relevance. This dual role allows Visa to adapt to the evolving payments landscape, whereas PayPal must invest heavily to keep pace or risk losing market share to these emerging platforms.",
      "llm_answer": "PayPal flags rapid‑technology change – including virtual‑currency, blockchain and other emerging payment tools that could evolve into BNPL‑type services – as a material risk that could erode usage of its platform and depress revenue if it cannot adopt or integrate those innovations quickly (see PayPal 10‑K p. 18). By contrast, Visa treats the same alternative‑payment players as both collaborators and rivals, positioning its “network of networks” (e.g., Visa Direct, token services) to partner with BNPL and crypto platforms while also competing for the same transaction volume (see Visa 10‑K p. 16). This makes PayPal’s exposure a downside‑‑risk, whereas Visa’s approach is a strategic opportunity to capture new flows even as it competes with those providers.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with strong semantic equivalence. (1) All factual elements are correct: PayPal identifies technological disruption (including cryptocurrency, blockchain, and emerging payment tools like BNPL) as a material risk to its platform usage and revenue (citing PayPal 10-K p.18), while Visa strategically engages with these innovations as both partner and competitor (citing Visa 10-K p.16). (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk exposure for PayPal versus strategic positioning for Visa, drawing from two different 10-K filings and contrasting their business responses to the same technological trends. (4) The LLM enhances the original answer slightly by referencing specific Visa capabilities (Visa Direct, token services) and framing Visa’s model as a 'network of networks,' which adds contextual depth without introducing inaccuracies. The only minor gap is that the original emphasizes PayPal’s need to 'invest heavily' to keep pace, which is slightly underemphasized in the LLM version—though the risk of revenue depression due to slow adoption captures the essence. Overall, the answer is factually correct, well-sourced, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1353,
        "completion_tokens": 394,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the voting power per share of Netflix's common stock compare to the voting rights associated with Alphabet's Class A Common Stock, given both companies' disclosed equity structures?",
      "original_answer": "Netflix's common stock grants one vote per share, as stated in its 2023 10-K filing. Similarly, Alphabet's Class A Common Stock also provides one vote per share, as outlined in its 2023 10-K filing. This indicates that both companies offer equivalent voting power per share for their respective common stockholders, despite Alphabet having multiple stock classes with differing voting rights, such as Class B shares with 10 votes per share.",
      "llm_answer": "Netflix’s common stock provides one vote for each share (NFLX 10‑K, p. 61). Alphabet’s Class A common stock is also entitled to one vote per share (GOOGL 10‑K, p. 81). Thus, the voting power per share is the same for Netflix and Alphabet’s Class A shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) It accurately states that Netflix's common stock provides one vote per share, citing the correct source (Netflix 10-K, p. 61), and that Alphabet's Class A Common Stock also provides one vote per share, citing the correct source (Alphabet 10-K, p. 81). (2) There are no numerical values requiring calculation, but the voting rights (1 vote per share for both) are correctly reported with no discrepancies. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies' 10-K filings to compare voting rights, concluding that both classes of stock have equal voting power per share. (4) The answer is contextually relevant, directly addressing the comparison asked in the question. While the LLM omits mention of Alphabet's Class B shares (which have 10 votes per share), this detail is contextual and not essential to the specific comparison of Netflix common stock and Alphabet Class A stock. The core factual claim — equivalent voting power per share — is correct and well-supported.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1184,
        "completion_tokens": 316,
        "total_tokens": 1501
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does the use of the parametric delta-gamma approximation technique by PM under normal market conditions compare with MDLZ's application of the same method, particularly in terms of their respective VAR estimates and risk exposure assumptions?",
      "original_answer": "Both PM and MDLZ utilize the parametric delta-gamma approximation technique in their VAR models under normal market conditions, with a 95% confidence interval and a one-day holding period. PM observed interest rate and forward currency rate movements primarily over the preceding quarter to determine interrelationships and calculate risk for their portfolio. MDLZ similarly observed interest rate, currency exchange, and commodity price movements over the prior quarter for VAR calculations at year-end. However, MDLZ specifically notes that the values of currency and commodity options do not change on a one-to-one basis with the underlying assets and were valued accordingly, while PM focuses on interrelationships between movements in interest rates and currencies. Both companies use VAR to estimate maximum potential one-day losses, but MDLZ provides specific disclosure of their VAR amounts at year-end, while PM focuses on the methodology and assumptions without disclosing a specific VAR figure.",
      "llm_answer": "Both Philip Morris (PM) and Mondelēz International (MDLZ) calculate VAR using a parametric delta‑gamma approximation under normal market conditions with a 95 % confidence level and a one‑day horizon. PM’s VAR reports only interest‑rate and foreign‑currency fair‑value impacts – $297 million (interest) and $77 million (currency) at 12/31/23 (average $332 m and $74 m) – while MDLZ’s VAR includes interest‑rate, currency and commodity exposures and provides both fair‑value and pre‑tax‑earnings impacts – $119 million (interest), $14 million (currency) and $21 million (commodity) at 12/31/23 (average $144 m, $17 m, $40 m), reflecting MDLZ’s broader risk‑exposure assumptions (PM p.81; MDLZ p.64).",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) The Original Answer (ground truth) states that PM does *not* disclose a specific VAR figure, but the LLM claims PM reported VAR values of $297M (interest) and $77M (currency) at 12/31/23 — this data is not present in the ground truth and contradicts it directly. Similarly, the LLM attributes specific VAR amounts to MDLZ ($119M interest, $14M currency, $21M commodity), but the ground truth only confirms that MDLZ *discloses* VAR amounts at year-end without specifying these exact numbers. These fabricated figures severely compromise quantitative accuracy. (2) The LLM introduces average VAR values (e.g., $332M, $74M for PM) and page references (PM p.81; MDLZ p.64) not found in the ground truth, suggesting hallucination. (3) While the LLM correctly identifies that both companies use the parametric delta-gamma method under normal conditions with a 95% confidence level and one-day horizon, and notes MDLZ includes commodity risk while PM does not, this qualitative insight is partially correct but overshadowed by false precision. (4) The reasoning is flawed in multi-hop synthesis: the model incorrectly assumes that because MDLZ discloses VAR amounts, specific numbers must exist and be comparable to non-existent PM figures, leading to erroneous side-by-side comparison. (5) Contextually, the answer addresses the right topic — comparison of VAR methodologies and risk exposures — but fails on factual fidelity. Semantic equivalence is not achieved due to invented metrics. The contextual relevance is moderate because the structure and intent align with the question, but correctness is low due to hallucinated data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 466,
        "total_tokens": 1916
      },
      "error": null
    },
    {
      "question_id": 127,
      "question": "How does Capital One's exposure to the Market Risk Rule, which adjusts capital ratios based on trading book risks, compare with JPMorgan Chase's regulatory capital requirements under Basel III, particularly in relation to their respective trading asset thresholds and VaR methodologies?",
      "original_answer": "Capital One (COF) is subject to the Market Risk Rule due to its trading assets and liabilities exceeding $1 billion or 10% of total assets, requiring adjustments to its risk-based capital ratios. This rule supplements the Basel III Capital Rules, which are also central to JPMorgan Chase's (JPM) regulatory capital framework. JPM calculates Regulatory VaR under Basel III with a 99% confidence level and a ten-business-day holding period, applying it to 'covered' positions. In contrast, COF’s capital adequacy is evaluated under Basel III standardized and proposed Expanded Risk-Based Approaches, with the latter phasing in by 2028. These differences highlight how both firms manage market risk capital requirements, with JPM using a more granular internal VaR model while COF must comply with both current and evolving Basel III standards.",
      "llm_answer": "Capital One is subject to the U.S. “Market Risk Rule,” which forces a capital‑ratio adjustment whenever a firm’s aggregate trading assets and liabilities equal at least 10 % of total assets or $1 billion – a threshold that Capital One met as of 12/31/2024 (see COF 10‑K p. 86). In contrast, JPMorgan Chase’s Basel III capital requirements are driven by a regulatory VaR model that uses a ten‑business‑day holding period and a 99 % confidence level (with a separate one‑day, 95 % confidence Risk‑Management VaR) rather than a specific trading‑asset threshold, and its reported Basel III ratios are higher (CET1 15.7 %, Tier 1 16.8 %, Total 18.5 % as of 12/31/2024; see JPM 10‑K p. 56, 145‑146). Thus, Capital One’s exposure is tied to a trading‑asset size trigger and a capital‑ratio adjustment, while JPMorgan’s exposure is embedded in Basel III’s VaR‑based capital calculations without an explicit asset‑size trigger.",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth, with only minor omissions affecting completeness. (1) Quantitatively, all numbers and thresholds are accurate: the $1 billion or 10% trading asset threshold for Capital One, the 99% confidence level and ten-business-day holding period for JPMorgan's Regulatory VaR, and the CET1 (15.7%), Tier 1 (16.8%), and Total (18.5%) capital ratios for JPM as of 12/31/2024 are correctly cited from the 10-Ks. These match the expected data sources and formatting is acceptable. (2) The answer correctly identifies both entities (COF and JPM) and ties their regulatory frameworks to appropriate standards—Market Risk Rule for COF and Basel III VaR for JPM. (3) The multi-hop reasoning is sound: it contrasts COF’s threshold-based trigger for market risk capital adjustments with JPM’s reliance on internal VaR modeling under Basel III, which does not depend on a trading-asset size trigger. However, the LLM omits key qualitative details present in the original answer—specifically, that COF is subject to both current Basel III standardized approaches and the proposed Expanded Risk-Based Approaches phasing in by 2028, and that JPM applies VaR only to 'covered' positions. These omissions reduce completeness but do not invalidate the core comparison. (4) Despite these gaps, the LLM captures the essential contrast in methodologies and regulatory exposure, making the response contextually relevant and factually strong. The inclusion of specific 10-K page references adds credibility, though not required. Final scores reflect high accuracy with room for improvement in full regulatory scope coverage.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1474,
        "completion_tokens": 452,
        "total_tokens": 1927
      },
      "error": null
    },
    {
      "question_id": 128,
      "question": "How does Cisco's credit loss allowance for loan receivables tied to technical support services compare to Salesforce's reliance on third-party technical support providers, given both companies' exposure to service delivery risks?",
      "original_answer": "Cisco reported a $53 million credit loss allowance for loan receivables as of July 29, 2023, which includes financing arrangements specifically related to technical support services provided to customers. This indicates a financial risk exposure tied directly to service delivery outcomes. Meanwhile, Salesforce acknowledges its reliance on third parties to deliver technical support services to customers, stating that dissatisfaction with third-party service quality could harm its business and revenue recognition. While Cisco directly finances its technical support services and bears credit risk, Salesforce's risk manifests through potential third-party service failures affecting customer satisfaction and retention.",
      "llm_answer": "Cisco reports a $50 million allowance for credit losses on its loan receivables – which include financing tied to the sale of hardware, software and technical‑support services – as of July 27 2024 (see CSCO 10‑K page 82/84). Salesforce, by contrast, flags in its 10‑K that it “works with third parties to increase the breadth of capability and depth of capacity for delivery of these services” and warns that poor quality or timing of third‑party support could hurt customer relationships, but it does not disclose a comparable dollar‑amount allowance for such risks (see CRM 10‑K page 19). Thus, Cisco quantifies its exposure with a $50 M credit‑loss provision, whereas Salesforce’s exposure to service‑delivery risk is described only qualitatively.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer is mostly correct in content and reasoning but contains a critical error in the reported dollar amount and fiscal date. The ground truth states Cisco's credit loss allowance was $53 million as of July 29, 2023; the LLM incorrectly reports $50 million as of July 27, 2024. This discrepancy affects quantitative accuracy significantly—both the amount and the fiscal year are wrong. While $50M and $53M are close, they are not equivalent, and the one-year time difference misaligns the data point from the correct reporting period. (2) The LLM correctly identifies that Salesforce does not disclose a dollar amount for its third-party service delivery risk and accurately quotes the qualitative risk disclosure from its 10-K. However, it fails to mention that Cisco’s financing includes arrangements specifically tied to technical support services, which is a key link in the multi-hop comparison. (3) The reasoning is sound in structure—correctly contrasting Cisco’s quantified credit risk with Salesforce’s unquantified operational risk via third parties—and the synthesis across both companies’ 10-K disclosures is logical and relevant. The model captures the core contrast: Cisco bears direct financial (credit) risk, while Salesforce faces reputational and service-quality risk. (4) Despite the numerical and temporal inaccuracies, the answer remains contextually relevant and qualitatively strong, earning high marks for reasoning and relevance. The correctness score is reduced due to the factual inaccuracy in the key quantitative figure and date, which are central to the question’s financial comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 449,
        "total_tokens": 1838
      },
      "error": null
    },
    {
      "question_id": 130,
      "question": "How does the governance risk associated with META's dual-class structure, particularly its impact on investor confidence in Class A common stock, contrast with CMCSA's equity structure that includes Class B common stock but lacks a conversion mechanism tied to governance restrictions?",
      "original_answer": "CMCSA's equity structure includes 9,444,375 issued and outstanding shares of Class B common stock as of 2023, but unlike META, there is no indication that CMCSA ties governance rights or stock conversion to special investor restrictions. In contrast, META's dual-class structure grants Class B stockholders, including Mr. Zuckerberg, disproportionate control over corporate decisions, such as requiring a majority of Class B stock approval for any change in control until those shares represent less than 35% of combined voting power. META also notes that its status as a 'controlled company' could make its Class A common stock less attractive to some investors due to reduced corporate governance protections. This implies that while both companies have Class B shares, META's structural governance risks tied to its dual-class system are more pronounced and explicitly linked to investor sentiment toward Class A shares, unlike CMCSA where the Class B shares do not appear to carry similar governance-linked conversion or control features.",
      "llm_answer": "Meta’s filing notes that its dual‑class structure gives Mark Zuckerberg voting control that can dominate shareholder votes, which “could make our Class A common stock less attractive to some investors or otherwise harm our stock price” and creates a governance‑risk that can erode confidence in the Class A shares 【page_50】. Comcast’s filing shows it also has a Class B common share class, but the balance‑sheet disclosure simply lists the shares as issued and outstanding with no conversion feature or governance‑linked conversion right, meaning the Class A stock is not subject to the same control‑related governance risk 【page_69】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core contrast between META's and CMCSA's equity structures as described in the ground truth. (1) All factual elements are correct: META’s dual-class structure gives disproportionate voting control to Class B shareholders (specifically Mark Zuckerberg), which the filing states could make Class A stock less attractive to investors due to reduced governance protections. CMCSA has Class B shares but no conversion mechanism or governance-linked restrictions are mentioned. The LLM correctly identifies that CMCSA’s Class B shares are simply listed as issued and outstanding without special governance features. (2) There are no numeric inaccuracies; while the ground truth includes the exact number of CMCSA Class B shares (9,444,375), the LLM does not attempt to reproduce this figure. However, the omission is not a material error because the question focuses on structural governance differences, not specific share counts, and the LLM does not make any false quantitative claims. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from both companies’ filings to contrast governance risks tied to dual-class structures, particularly the lack of investor protections in META versus the absence of such risks in CMCSA. (4) The answer is contextually relevant and semantically equivalent to the ground truth in all key aspects, with only minor omission of the precise share count for CMCSA. This does not affect the correctness of the comparative governance analysis. The LLM cites specific pages (50 and 69), which aligns with expected sourcing behavior. Overall, the answer is factually correct, well-reasoned, and focused on the governance-risk contrast central to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 477,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 131,
      "question": "How does AIG's valuation of RMBS using discounted cash flow models compare to MS's use of discounted cash flow in fair value estimation, particularly in terms of reliance on unobservable inputs?",
      "original_answer": "AIG values its RMBS portfolio using discounted cash flow models that rely heavily on unobservable inputs such as constant prepayment rate (ranging from 4.10% to 9.26%) and loss severity (ranging from 40.81% to 76.72%). Similarly, MS identifies discounted cash flow as a key valuation technique in estimating fair value for financial instruments and goodwill impairment testing, particularly for Level 3 assets which rely on significant unobservable inputs. MS notes that Level 3 assets represented 0.9% of total assets as of December 31, 2024, indicating a smaller but still material reliance on unobservable assumptions in their fair value measurements.",
      "llm_answer": "AIG values its residential‑mortgage‑backed securities with a discounted‑cash‑flow model that relies on several security‑specific unobservable inputs – the yield, a constant pre‑payment rate, loss‑severity and a constant default rate – which are derived from the firm’s assumptions about how market participants would price the loans. Morgan Stanley also uses discounted‑cash‑flow techniques for fair‑value estimates (e.g., goodwill impairment), but its inputs are broader, consisting mainly of projected earnings cash flows and a cost‑of‑equity discount rate, and are treated as Level 3 judgments rather than the granular mortgage‑level parameters AIG employs. Thus, both firms depend on unobservable inputs, but AIG’s DCF is driven by multiple detailed, loan‑specific assumptions, whereas MS’s DCF rests on higher‑level forecasts and discount‑rate estimates.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual information is correct: AIG uses discounted cash flow (DCF) models for RMBS valuation relying on unobservable inputs such as constant prepayment rate and loss severity. Morgan Stanley (MS) also uses DCF models for fair value estimation, particularly for Level 3 assets and goodwill impairment, which involve significant unobservable inputs. (2) Quantitative accuracy is excellent—while the LLM does not repeat the exact numerical ranges (e.g., CPR 4.10%–9.26%, loss severity 40.81%–76.72%, Level 3 assets at 0.9% of total assets), these specific numbers were not required for the comparison asked. The omission is not a factual error but a matter of detail depth; the core quantitative claims (use of unobservable inputs, Level 3 classification) are correct. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both firms use DCF with unobservable inputs, but differ in granularity—AIG uses loan-level assumptions while MS uses higher-level forecasts like earnings and discount rates. (4) The answer captures the essence of the comparison: both rely on unobservable inputs, but AIG’s approach is more granular and security-specific, whereas MS applies broader, firm-level assumptions. The only minor shortcoming is the lack of specific percentages from the original, which slightly reduces completeness but does not affect correctness. Hence, a score of 9 is justified—excellent accuracy with near-perfect qualitative and quantitative fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 424,
        "total_tokens": 1814
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does the change in Cisco's allowance for credit losses on loan receivables tied to hardware financing compare to Microsoft's revenue recognition approach for hardware that is similarly interdependent with software, and what does this reveal about their respective financial exposures to integrated hardware-software offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables tied to hardware financing decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023, indicating a reduction in expected defaults on financing extended for hardware sales. These loan receivables are explicitly tied to the sale of Cisco's hardware and third-party products. Meanwhile, Microsoft recognizes hardware revenue at the point of sale only when it is transferred to resellers or end customers, especially in cases where the hardware is highly interdependent with the operating system and cannot function without it, similar to Cisco's financing structure for integrated offerings. This reveals that while Cisco manages credit risk exposure through allowances on multi-year financing arrangements, Microsoft's financial exposure is more closely tied to point-of-sale recognition, with less direct credit risk but greater dependency on the performance of integrated software-hardware systems post-sale.",
      "llm_answer": "Cisco’s allowance for credit losses on loan receivables – which largely cover financing of its hardware, software and services – fell from $53 million at July 29 2023 to $50 million at July 27 2024, a $3 million reduction (see the allowance‑roll‑forward tables)【page_84】. Microsoft, however, treats hardware that is “highly dependent on, and interrelated with, the underlying operating system” as a single performance obligation and recognises the bundled hardware‑software revenue at the point of transfer to the customer (i.e., upfront)【page_62】. Thus, Cisco retains a modest, ongoing credit‑risk buffer for its financed, integrated hardware‑software sales, while Microsoft front‑loads revenue on such bundles, shifting its exposure from credit‑loss risk to sales‑volume risk.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in numbers and time periods. The ground truth states that Cisco's allowance decreased from $103 million in fiscal year 2022 to $53 million in fiscal year 2023. However, the LLM claims a decrease from $53 million in 2023 to $50 million in 2024, which misrepresents both the magnitude and direction of the change relative to the correct time frame. This is a critical error in quantitative reporting. (2) The calculation of a $3 million reduction is accurate based on the numbers the LLM provides, but those numbers themselves are incorrect per the original data. Additionally, the fiscal years referenced (2022 to 2023) are not acknowledged; instead, the LLM uses later dates (2023 to 2024), which do not align with the ground truth. (3) The qualitative reasoning about Microsoft’s revenue recognition is largely correct: it accurately identifies that Microsoft treats highly interdependent hardware-software bundles as a single performance obligation and recognizes revenue upfront upon transfer. This reflects sound multi-hop understanding of accounting treatment differences. The conclusion that Cisco retains credit risk via allowances while Microsoft shifts exposure to sales-volume risk is conceptually aligned with the ground truth. However, the synthesis is based on incorrect Cisco data, undermining the validity of the comparison. (4) Contextual relevance is high because the LLM addresses both companies, the financial treatments of integrated hardware-software offerings, and draws a meaningful contrast in risk exposure. Despite correct framing and relevant concepts, the answer fails on core factual accuracy, especially in the numerical and temporal dimensions, which are central to the question. Hence, correctness is scored low due to incorrect figures and timeframes, even though the conceptual logic is partially sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1487,
        "completion_tokens": 516,
        "total_tokens": 2003
      },
      "error": null
    },
    {
      "question_id": 132,
      "question": "How does AIG's $75 million loss from embedded derivatives in 2024 compare to MS's credit risk exposure through CDOs that contain similar hybrid instruments with embedded derivatives, given both firms' involvement in structured credit products?",
      "original_answer": "AIG reported a $75 million loss from embedded derivatives in 2024, indicating significant credit-related losses from these structured instruments. MS disclosed involvement in CDOs and CLNs that are classified as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer. If a credit event occurs on the underlying reference entity, the principal balance of the note may not be repaid in full to the Firm. This parallels AIG’s exposure, as both firms face direct credit risk tied to the performance of reference entities in structured products, with MS’s CDOs posing similar potential for principal loss under credit events as seen in AIG’s realized loss.",
      "llm_answer": "AIG reported a $75 million loss from embedded derivatives in 2024 (see AIG 10‑K, “Embedded derivatives” line, $‑75 m)【page_144】.  \nMorgan Stanley’s filing notes that it holds “Other Credit Contracts” – which include CLNs and CDOs, hybrid instruments with embedded derivatives – with a notional amount of about $3 billion (the “Other credit contracts” line in the credit‑protection table, shown in $ billions)【page_108】, and these CDO exposures sit within a much larger $368 billion total credit‑protection portfolio【page_108】.  \n\nThus, MS’s credit‑risk exposure to CDOs is on the order of tens of billions of dollars, roughly 40‑times larger than AIG’s $75 million loss.",
      "correctness_score": 5,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains partially correct information but introduces significant inaccuracies in both quantitative and qualitative dimensions. (1) Quantitatively, while AIG's $75 million loss in 2024 is correctly reported, the claim that Morgan Stanley has 'tens of billions' in CDO exposure—derived from a $3 billion notional in 'Other Credit Contracts' and a $368 billion total credit-protection portfolio—is misleading. The original answer (ground truth) does not provide a specific dollar amount for MS's CDO exposure, nor does it support a quantitative comparison such as '40-times larger.' The $368 billion portfolio includes all credit protection (e.g., CDS, CLNs, etc.), not just CDOs, and the $3 billion notional is not explicitly tied to CDOs alone. Thus, the 40x comparison is an unsupported extrapolation. (2) The entity identification (AIG, MS, CDOs, CLNs, embedded derivatives) and years (2024) are accurate. (3) Qualitatively, the LLM fails to capture the core parallel emphasized in the ground truth: both firms face similar *mechanisms of credit risk*—namely, potential principal loss due to credit events on reference entities in hybrid instruments. Instead, the LLM focuses on a numerical comparison that isn't grounded in the source data, missing the conceptual alignment between AIG’s realized loss and MS’s structural exposure. (4) Contextually, the answer is relevant and cites appropriate sections (e.g., credit-protection tables), but the reasoning misdirects from a risk-mechanism comparison to an unsupported scale comparison. The multi-hop synthesis is flawed: it should link AIG’s loss mechanism to MS’s analogous exposure structure, not attempt a magnitude comparison absent in the evidence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 466,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 133,
      "question": "How does the duration of Disney's foreign exchange cash flow hedges for forecasted transactions compare to Google's hedge maturity periods, given both companies' use of option contracts to manage foreign currency exposure?",
      "original_answer": "Disney hedges its forecasted foreign currency transactions for periods generally not to exceed four years, while Google's foreign currency cash flow hedges have maturities of 24 months or less. Both companies use option contracts as part of their cash flow hedging strategies, with Disney reporting $9.9 billion in net foreign exchange cash flow hedges as of September 28, 2024, and Google holding $731 million in net accumulated gains on foreign currency cash flow hedges as of December 31, 2024.",
      "llm_answer": "Disney’s policy says it hedges forecasted foreign‑currency transactions for periods “generally not to exceed four years” (DIS 10‑K p. 121). Google, by contrast, designates its foreign‑currency forward and option contracts as cash‑flow hedges with “maturities of 24 months or less” (GOOGL 10‑K p. 70). Thus Disney’s hedge horizon can be up to about twice as long as Google’s, which is limited to two‑year maturities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all key facts are correct: Disney's hedge duration is 'generally not to exceed four years' and Google's is '24 months or less'—both durations are accurately reported and correctly attributed to their respective 10-K filings. The comparison stating Disney’s horizon can be up to twice as long is logically sound and semantically equivalent to the original. (2) The dollar amounts ($9.9 billion for Disney and $731 million for Google) are not included in the LLM answer, which represents a minor omission in completeness. However, these figures were not directly required to answer the comparative duration question, so their absence does not undermine the core response. (3) Entity accuracy is strong: correct tickers (DIS, GOOGL), correct metrics (forecasted transactions, cash flow hedges), and correct use of option contracts are all properly identified. (4) The multi-hop reasoning—comparing hedge durations across two companies using their respective hedging instruments and timeframes—is sound and clearly articulated. The conclusion that Disney’s horizon is up to twice as long is a valid inference. (5) The answer is contextually relevant and directly addresses the question’s focus on duration comparison and use of option contracts. Only a perfect score is withheld due to the omission of the financial values mentioned in the original, which add context but do not alter the primary comparison. Overall, the answer is factually correct, well-reasoned, and concise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1247,
        "completion_tokens": 428,
        "total_tokens": 1675
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the expected impact of the Global Minimum Tax on QCOM's fiscal year 2025 tax liabilities compare to INTC's exposure under the Pillar Two Model Rules, given the differing geographic distribution of their operations?",
      "original_answer": "QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025, as it does not operate materially in jurisdictions with tax rates below the 15% Pillar Two minimum. In contrast, INTC, which has a significant portion of its income taxed in non-US jurisdictions, is still evaluating the impacts of Pillar Two, particularly as several jurisdictions like the EU plan to adopt components starting in 2024. Both companies monitor Pillar Two developments closely, but INTC faces more immediate uncertainty due to its broader international tax footprint and ongoing legislative adoptions in key markets.",
      "llm_answer": "Qualcomm says the OECD‑mandated 15 % global minimum tax (Pillar Two) will start to apply to its operations in fiscal 2025, but it “does not currently expect this to materially impact our consolidated financial statements”【page_43】. Intel, while still evaluating the Pillar Two model rules, points out that most of its earnings are already taxed in non‑U.S. jurisdictions and it has no material operations in low‑tax countries, so it likewise does not expect a material increase in its global tax cost【page_44】. The contrast reflects Qualcomm’s tax base being heavily U.S.‑centric (with large FDII benefits) versus Intel’s more geographically diversified income, which dampens Intel’s exposure.",
      "correctness_score": 6,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that QCOM expects minimal impact from the Global Minimum Tax starting in fiscal year 2025 and references its U.S.-centric operations and FDII benefits. It also correctly states that INTC is still evaluating Pillar Two and notes its diversified geographic income. However, the LLM incorrectly asserts that Intel 'does not expect a material increase in its global tax cost,' which contradicts the ground truth stating that INTC faces 'more immediate uncertainty' and is still assessing impacts due to ongoing legislative adoptions in key markets like the EU. This misrepresents INTC's exposure as more certain and less risky than it actually is. (2) Quantitatively, all references to percentages (15%), fiscal years (2025), and jurisdictions are accurate or reasonably interpreted. There are no calculation errors. (3) The multi-hop reasoning is partially sound—linking geographic distribution to tax exposure is valid, and contrasting QCOM’s U.S.-focused model with INTC’s international footprint aligns with the ground truth. However, the synthesis fails in the conclusion: while both companies may currently anticipate limited impact, the LLM understates INTC’s greater exposure and uncertainty, which is a key differentiator in the original answer. (4) The correctness score is 6 due to this significant qualitative error in portraying INTC’s position, despite accurate numbers and mostly relevant context. Quantitative accuracy is high (9) due to correct figures and dates. Qualitative accuracy is moderate (6) because of flawed reasoning in the comparison. Contextual relevance is strong (8) as the response addresses the core question about comparative exposure and geographic distribution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 475,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the difference in voting power ratios between Alphabet's Class B to Class A conversion structure and Comcast's non-dilutable Class B voting rights affect the degree of founder control in corporate governance decisions?",
      "original_answer": "Alphabet maintains a 10:1 voting power ratio between Class B and Class A shares, with Class B shares converting automatically to Class A upon sale or transfer, which allows for dynamic founder control that can diminish with share transfers. In contrast, Comcast's Class B shares hold 33⅓% of voting power that is non-dilutable and convertible share-for-share into Class A, preserving a fixed level of control for Class B holders regardless of share issuance. This means Alphabet's structure allows for more fluid founder influence depending on shareholding behavior, while Comcast's design guarantees a minimum level of voting control that cannot be diluted, offering stronger long-term governance insulation for its Class B shareholders.",
      "llm_answer": "Alphabet’s dual‑class system gives each Class B share ten votes versus one vote for a Class A share, and the Class B shares may be converted share‑for‑share into Class A shares—when that happens the voting power drops from ten to one per share (see GOOGL Note 11, p. 81; diluted EPS assumes conversion, p. 82). Comcast’s structure gives each Class B share fifteen votes, but the aggregate voting power of the Class B stock is fixed at one‑third of the total and cannot be diluted by issuing other shares (see Comcast Note 12, p. 91). As a result, Alphabet’s founders enjoy a larger per‑share voting advantage that can be reduced if they convert their shares, whereas Comcast’s founders retain a stable, non‑dilutable one‑third voting block that provides consistent, though proportionally smaller, control over corporate‑governance decisions.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in its qualitative assessment and captures the core contrast between Alphabet's and Comcast's voting structures. It correctly identifies Alphabet's 10:1 voting ratio (Class B to Class A) and notes that conversion reduces voting power, aligning with the ground truth. It also accurately describes Comcast's non-dilutable one-third (33⅓%) voting power for Class B shares. However, there is a quantitative inaccuracy: the LLM states that each Comcast Class B share has 'fifteen votes', which is not supported by the ground truth and appears incorrect—no such per-share vote count is mentioned in the original answer, and this detail introduces a factual error. The ground truth emphasizes aggregate voting power (33⅓%) without specifying per-share votes, making the LLM's 'fifteen votes' claim unsupported and likely erroneous. Despite this, the reasoning about the stability of Comcast's control versus Alphabet's fluid control is sound and well-articulated. The answer addresses all parts of the question, synthesizes the governance implications correctly, and maintains high contextual relevance. The error is limited to an incorrect numerical detail not present in the source, but the overall conclusion about founder control dynamics remains valid. Hence, a minor deduction in quantitative accuracy, but high scores for qualitative reasoning and completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 385,
        "total_tokens": 1800
      },
      "error": null
    },
    {
      "question_id": 134,
      "question": "How does the indemnification agreement between PM USA and PMI affect Altria's (MO) financial exposure to tobacco-related litigation liabilities compared to PM's retained obligations through RBH deconsolidation?",
      "original_answer": "Under the Distribution Agreement, PMI indemnifies Altria and PM USA for liabilities related to tobacco products manufactured by PMI or contract manufactured by PM USA, while PM USA indemnifies PMI for liabilities related to its own manufactured products, excluding those made for PMI. Altria has not recorded a liability for this indemnification as its fair value is considered insignificant. Meanwhile, PM retains obligations tied to the deconsolidation of RBH, which involved reclassifications from accumulated other comprehensive losses. This structure limits Altria's direct financial exposure to PMI-related litigation, while PM faces ongoing impacts from RBH-related reclassifications.",
      "llm_answer": "The distribution agreement makes PMI indemnify Altria (and its U.S. subsidiary PM USA) for any tobacco‑product claims that arise from products PMI makes or contracts‑manufactures for PM USA, and Altria records no liability for that indemnity because its fair‑value is “insignificant” 【page_108】. In contrast, PMI continues to carry the liabilities associated with the RBH deconsolidation – they are reflected in PMI’s accumulated other‑comprehensive losses and remain on PMI’s balance sheet after RBH was removed from consolidation 【page_112】. Thus, Altria’s exposure to tobacco‑related litigation is largely transferred to PMI, whereas PMI retains the RBH‑related obligations on its own books.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) It accurately states that PMI indemnifies Altria and PM USA for liabilities related to PMI-manufactured or contract-manufactured products, and that Altria has not recorded a liability due to the indemnification's insignificant fair value — all factually correct and supported by the original answer. (2) Quantitatively, there are no numerical values to verify (e.g., dollar amounts, percentages, dates), so no inaccuracies exist; the response correctly avoids introducing any false numbers. (3) Regarding multi-hop reasoning: the answer correctly synthesizes the indemnification structure between PMI and Altria/PM USA and contrasts it with the retention of RBH-related obligations. However, it slightly misattributes the RBH deconsolidation impact to PMI alone, while the original answer notes that PM (Philip Morris USA, part of Altria) retains obligations tied to RBH deconsolidation involving reclassifications from accumulated other comprehensive loss — a subtle but important distinction. The LLM incorrectly implies PMI carries the RBH obligations, when in fact RBH was part of Altria’s U.S. operations and the reclassifications affect PM (USA), not PMI. (4) Despite this entity-level confusion in the second part, the core of the indemnification logic is sound and contextually relevant, hence high scores in qualitative accuracy and contextual relevance. The correctness score is 8 due to this significant but not fundamental error in entity attribution regarding RBH.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1362,
        "completion_tokens": 425,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the decline in Cisco's allowance for credit losses on loan receivables from $103 million in 2022 to $53 million in 2023 impact the financing of technical support services, and how does this compare to Adobe's approach in funding its technical support offerings?",
      "original_answer": "Cisco's allowance for credit losses on loan receivables decreased significantly from $103 million in 2022 to $53 million in 2023, indicating a reduced financial risk in their financing arrangements tied to hardware, software, and services—including technical support. This decline may suggest either improved credit quality of borrowers or a strategic reduction in financing extended for such services. Cisco offers financing, including loans and leases, for the sale of its products and services, which explicitly include technical support and advanced services. In contrast, Adobe funds its technical support through subscription entitlements and annual fee-based maintenance programs, providing customers with technical support, product help, and upgrades over 1- to 3-year terms. Unlike Cisco, Adobe does not rely on loan receivables but integrates support funding directly into its subscription and maintenance models.",
      "llm_answer": "Cisco’s loan‑receivable allowance fell from $103 million in FY 2022 to $53 million in FY 2023 (see the credit‑loss roll‑forward on page 84), and those loan receivables are used to finance the sale of hardware, software and “technical support and advanced services” (page 82). The lower allowance means Cisco is setting aside less reserve for defaults, freeing more net financing capacity for its support programs. Adobe, by contrast, does not rely on financing receivables; it provides technical support as part of subscription entitlements and annual maintenance‑fee contracts that are funded directly from its recurring‑revenue streams (page 17).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the decline in Cisco's allowance from $103 million in 2022 to $53 million in 2023 is accurately reported, with appropriate fiscal year labeling (FY 2022/FY 2023), and no calculation errors. (2) The answer correctly identifies that Cisco uses loan receivables to finance technical support services and that the reduced allowance implies less risk and potentially increased net financing capacity—this reflects sound reasoning about the financial implication. (3) The comparison to Adobe is accurate: Adobe funds technical support through subscription and maintenance fees, not loan receivables, and this is correctly contrasted with Cisco’s financing model. (4) Minor deduction in qualitative accuracy due to the LLM referencing specific document pages (e.g., page 84, 82, 17), which were not part of the original answer and may not be verifiable from the knowledge graph alone—this introduces extraneous detail not in the ground truth, though it doesn’t affect factual correctness. Otherwise, the multi-hop synthesis across Cisco and Adobe, including business models and funding mechanisms, is logically sound and semantically equivalent to the original. Contextual relevance is perfect as all parts of the question are addressed with precise, relevant information.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 383,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 135,
      "question": "How does the involvement of Citibank, N.A. as administrative agent in Caterpillar's 2022 5-Year Credit Facility compare with its role in Boeing's similarly named 2019 Five-Year Credit Agreement, particularly in terms of the amendment timelines and the syndication structure?",
      "original_answer": "Citibank, N.A. served as the administrative agent in both Caterpillar's 2022 5-Year Credit Facility and Boeing's 2019 Five-Year Credit Agreement. In Caterpillar's case, Amendment No. 1 to the 5-Year Facility was dated August 31, 2023, indicating a modification within one year of the original agreement. For Boeing, Amendment No. 1 to its Five-Year Credit Agreement occurred on August 25, 2022, nearly three years after the initial agreement on October 30, 2019. Additionally, Boeing's syndication structure included JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger alongside Citibank, N.A., while Caterpillar's syndication involved Citibank, N.A. and MUFG Bank, Ltd. in agent roles without a comparable dual lead arranger structure.",
      "llm_answer": "Citibank, N.A. serves as the sole agent on Caterpillar’s September 1 2022 five‑year credit facility (the “5‑Year Facility”) and the agreement was first amended a year later in August 2023 (Amendment No. 1) – the filing lists only Citibank as “Agent” with no syndication or lead‑arranger roles disclosed. In Boeing’s October 30 2019 five‑year credit agreement, Citibank, N.A. is also the administrative agent but the deal includes JPMorgan Chase Bank, N.A. as syndication agent and both banks as joint lead arrangers/book‑managers, and its first amendment was executed in August 2022, roughly three years after the original agreement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: Citibank, N.A. is correctly identified as administrative agent in both Caterpillar's 2022 and Boeing's 2019 credit agreements. The amendment dates are accurate—August 2023 for Caterpillar (within one year) and August 2022 for Boeing (nearly three years after October 30, 2019). (2) Quantitative accuracy is perfect: dates (September 1, 2022 vs. October 30, 2019; August 2023 vs. August 2022) match or are consistent with the original answer. The time intervals (one year vs. three years) are correctly implied. (3) Syndication structures are accurately contrasted: Boeing’s inclusion of JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger is correctly noted, while Caterpillar’s facility is correctly described as lacking such dual roles, with only Citibank listed as agent. The mention of MUFG Bank, Ltd. in the original answer is missing in the LLM response, which slightly reduces completeness but does not invalidate the core comparison. (4) The reasoning is sound and synthesizes multi-hop information across two companies, agreements, agent roles, and amendment timelines. Wording differs (e.g., 'sole agent' vs. 'administrative agent'), but the semantic meaning is equivalent. The LLM omits MUFG Bank, Ltd.'s role, which is a minor gap in completeness, preventing a perfect 10. Overall, the answer is factually correct, well-structured, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1379,
        "completion_tokens": 417,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's and Qualcomm's supply chain reliability, given their shared dependency on foundry partners in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt both NVIDIA's and Qualcomm's supply chains, as both companies rely heavily on foundry partners located in Taiwan for critical semiconductor manufacturing. NVIDIA has explicitly stated that challenges in estimating demand could be exacerbated by geopolitical tensions involving Taiwan and China, which are significant to their revenue and supply continuity. Similarly, Qualcomm depends on consistent chipset supply from foundry partners in Taiwan, and a conflict could severely limit or prevent them from receiving these components, directly impacting their ability to manufacture and deliver products. Both companies face the risk of supply constraints, production delays, and potential revenue loss due to the geographic concentration of their manufacturing dependencies in a geopolitically sensitive region.",
      "llm_answer": "A prolonged conflict over Taiwan could cut off the wafer and chipset supply that both companies obtain from Taiwanese foundries, creating severe supply‑chain disruptions, production delays and an inability to meet customer demand. NVIDIA warns that such a conflict would “severely limit or prevent us from receiving chipset supply from Taiwan” (NVDA 10‑K p. 35) and Qualcomm notes that geopolitical tensions in the region could disrupt its suppliers and foundry partners (QCOM 10‑K p. 35), exposing both firms to material adverse financial impacts.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All factual information is correct: both NVIDIA and Qualcomm are correctly identified as reliant on Taiwanese foundries, and the risks of supply-chain disruption, production delays, and financial impact are accurately described. The LLM correctly attributes NVIDIA's warning about limited chipset supply to its 10-K (p. 35), and Qualcomm's exposure to geopolitical risks with its foundry partners is also properly cited from its 10-K (p. 35). (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a traditional sense, but all non-numeric data is correctly represented—thus a score of 10 is justified. (3) The multi-hop reasoning is sound: the model synthesizes information from both companies' 10-K filings, connects their shared dependency on Taiwan-based manufacturing, and infers the common risk from geopolitical conflict. The only minor shortcoming is that the LLM slightly condenses NVIDIA’s broader concern about demand estimation under geopolitical uncertainty mentioned in the original answer, focusing more narrowly on supply interruption. However, the core risk is preserved. (4) The answer is fully contextually relevant, directly addressing the impact on supply chain reliability due to shared foundry dependencies. Wording differs slightly but maintains semantic equivalence. Overall, this is a strong, well-supported response with only negligible omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 418,
        "total_tokens": 1786
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Boeing's indemnification risk exposure from U.S. government contracts compare with 3M's indemnification liabilities transferred to Solventum following the spin-off, particularly in relation to their respective legal proceedings and liability assumptions?",
      "original_answer": "Boeing discloses indemnification risks tied to U.S. government contracts where pension cost allocations under CAS may affect contract profitability. Meanwhile, 3M transferred indemnification obligations related to historical legal proceedings—such as the Bair Hugger and Federal False Claims Act litigation—to Solventum as part of the April 1, 2024 spin-off. Both companies face potential liabilities from legal proceedings, but Boeing's exposure is tied to contract cost allocations and uninsurable risks from defense and aerospace products, whereas 3M's transferred liabilities are now the responsibility of Solventum, which must indemnify and defend claims previously held by 3M.",
      "llm_answer": "Boeing’s 10‑K notes that it “may receive indemnification from the U.S. government” for certain contracts, but its insurance may be insufficient and many product‑related liabilities are not insurable or protected outside the U.S. (see BA page 20). By contrast, 3M’s spin‑off filing states that the health‑care business (Solventum) has assumed specific legal liabilities—such as the Bair Hugger and Federal False Claims Act/Qui Tam matters—and will indemnify and defend 3M for those actions, effectively transferring the exposure to Solventum (see MMM page 84). Thus Boeing retains a broad, uncertain indemnification risk on government contracts, whereas 3M has shifted defined indemnification liabilities to Solventum, reducing its own exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Boeing's indemnification risk from U.S. government contracts is properly framed as uncertain and tied to CAS pension cost allocations and uninsurable liabilities, particularly in defense and aerospace. 3M's transfer of specific legal liabilities (Bair Hugger, False Claims Act) to Solventum in the spin-off is accurately described, with correct attribution to the April 1, 2024 event (implied by context). (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages), so quantitative accuracy is not compromised—no errors in dates or figures. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Boeing’s and 3M’s disclosures, contrasting retained risk (Boeing) versus transferred liability (3M/Solventum). The use of specific document page references (BA p.20, MMM p.84) adds credibility and suggests accurate sourcing. (4) Semantic equivalence is strong: while the LLM uses slightly different phrasing (e.g., 'may receive indemnification' vs. 'discloses indemnification risks'), the meaning is consistent with the original—Boeing faces exposure where indemnification is not guaranteed. The only minor shortcoming is that the LLM slightly downplays Boeing’s risk being tied to CAS pension allocations, focusing more broadly on uninsurable risks; this nuance is present in the ground truth but less emphasized in the LLM response. Still, the core comparison—Boeing retains risk, 3M transferred it—is correctly and clearly conveyed. Hence, a score of 9 is warranted for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 474,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does the voting power structure of CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance risks associated with META's Class A common stock, particularly in light of META's controlled company status and dual-class structure?",
      "original_answer": "CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power, with each share carrying 15 votes. This concentrated voting power allows the holder significant influence over corporate decisions. Similarly, META's governance structure gives its Class B common stockholders, including Mark Zuckerberg, outsized voting control, with the dual-class structure requiring a majority of Class B votes for any change in control until they fall below 35% of voting power. This setup increases governance risks for Class A shareholders, as it limits their influence and could deter investors, mirroring the concerns raised in META's 10-K about its 'controlled company' status making Class A shares less attractive.",
      "llm_answer": "Comcast’s Class B shares are owned solely by Brian L. Roberts and each carry 15 votes, giving the single holder roughly 33 % of the combined voting power of the company (CMCSA 10‑K p. 33). That concentration of voting power mirrors Meta’s situation, where Mark Zuckerberg’s Class B stock gives him control of a “controlled company” and lets him dominate shareholder votes even though he holds far fewer total shares (Meta 10‑K p. 50). Consequently, Meta’s Class A shareholders face heightened governance risk—limited board independence, anti‑takeover provisions and the need for the controlling stockholder’s approval for key actions—just as the concentrated voting power in Comcast illustrates the risks of dual‑class structures.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Brian L. Roberts owns CMCSA's Class B stock with 15 votes per share, representing approximately 33% (specifically 33⅓%) of combined voting power. The LLM correctly cites the 33% figure (a rounded but acceptable form of 33⅓%) and accurately references the 15 votes per share. For META, it correctly identifies Mark Zuckerberg’s control via Class B shares and the controlled company status, consistent with the 10-K. (2) The answer correctly cites page numbers (p. 33 for CMCSA, p. 50 for META), indicating proper sourcing from the 10-Ks. (3) The multi-hop reasoning is sound: it draws a valid parallel between CMCSA’s concentrated voting structure and META’s dual-class system, explaining how both create governance risks for Class A shareholders. It correctly identifies key risks: limited board independence, anti-takeover effects, and dependency on controlling shareholders for major decisions. (4) The only minor shortcoming is that the LLM does not explicitly mention the 35% threshold in META’s structure (i.e., that Class B must fall below 35% of voting power before control changes), which is included in the ground truth and relevant to the governance risk timeline. However, the core concept of outsized control and its implications is clearly conveyed. Wording differs slightly but maintains semantic equivalence. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1403,
        "completion_tokens": 419,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How does Coca-Cola's reliance on Arca Continental for beverage distribution in northern Argentina intersect with Procter & Gamble's foreign exchange risk exposure in the same country?",
      "original_answer": "Coca-Cola relies on Arca Continental for beverage distribution in northern Argentina, which accounts for a portion of its 17% worldwide unit case volume through bottling partners. Arca Continental's operations in northern Argentina expose Coca-Cola indirectly to macroeconomic risks in the country. Meanwhile, Procter & Gamble directly cites Argentina as one of the countries with significant exchange rate fluctuations that have historically impacted its financials, noting foreign exchange volatility in Argentina has significantly affected its net sales, costs, and earnings. This creates a shared exposure point where both companies face risks tied to Argentina’s economic environment, with Coca-Cola exposed through its supply chain dependency and P&G through direct market operations.",
      "llm_answer": "Coca‑Cola’s North‑Argentina sales are handled by its independent bottler Arca Continental, which “has bottling and distribution operations in … northern Argentina” (KO 10‑K p. 7). Procter & Gamble flags Argentina as one of the markets where it has “translation and transaction exposure” to currency swings, noting that “countries … currently experiencing significant exchange‑rate fluctuations include Argentina” (PG 10‑K p. 23). Thus, both companies are exposed to the same Argentine macro‑economic environment—Coca‑Cola through its bottler partner’s operations and P&G through direct foreign‑exchange risk—so a peso depreciation could impact both firms’ results in that country.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: Coca-Cola relies on Arca Continental for distribution in northern Argentina, and Procter & Gamble explicitly identifies Argentina as a country with significant foreign exchange risk. The entities (Coca-Cola, Arca Continental, P&G), relationships, and risk channels (indirect via partner vs. direct operational exposure) are correctly identified. (2) There are no numeric values in the original or LLM answer that require calculation or quantitative verification—both describe qualitative exposures without specific percentages or dollar amounts beyond what’s in the 10-Ks. The LLM correctly avoids inventing numbers. (3) The multi-hop reasoning is sound: it connects Coca-Cola’s indirect exposure through its bottler to P&G’s direct FX risk in the same country, concluding that both face macroeconomic risks from Argentina’s volatile currency environment. This synthesis across two companies and their respective SEC filings is logically and factually valid. (4) The LLM enhances the original answer slightly by citing page numbers from the 10-Ks (p.7 for KO, p.23 for PG), which adds verifiability, though these aren’t required. The only minor shortcoming is that it omits the detail about Arca Continental contributing to Coca-Cola’s 17% global unit case volume through bottlers—this contextual metric from the ground truth is missing, slightly reducing completeness. However, this omission does not undermine the core reasoning or correctness. Overall, the answer is semantically equivalent, contextually precise, and factually sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 448,
        "total_tokens": 1825
      },
      "error": null
    },
    {
      "question_id": 136,
      "question": "How might the expiration of Alimta's patent protection impact Eli Lilly's oncology revenue stream compared to Amgen's exposure to patent-related risks for its biologics, given the differing regulatory frameworks governing small molecule drugs and biologics?",
      "original_answer": "The expiration of Alimta's patent protection is expected to result in a rapid and severe decline in Eli Lilly's revenue from the product due to the entry of generic competitors in the U.S. and other jurisdictions. This is typical for small molecule drugs like Alimta, where loss of exclusivity often leads to immediate and significant revenue erosion. In contrast, Amgen, which relies heavily on patent protection for its biologics, faces a different regulatory landscape where biosimilars may not enter the market as quickly due to manufacturing complexities and regulatory uncertainties, such as the FDA's stance on 'umbrella exclusivity'. However, Amgen still faces increasing biosimilar competition in the U.S., Europe, and elsewhere, which has had and could increasingly have a material adverse effect on its product sales. Thus, while both companies are exposed to patent-related risks, the speed and severity of revenue impact differ due to the nature of their product portfolios and the regulatory frameworks governing them.",
      "llm_answer": "Alimta is a small‑molecule drug, so once its U.S. patents expire Lilly expects generic competitors to enter quickly and “cause a rapid and severe decline in revenue for the product” (LLY p. 25; p. 46), which would sharply dent its oncology sales. Amgen’s biologics, by contrast, are covered by the BPCIA’s 12‑year data‑exclusivity and a more cumbersome biosimilar‑approval pathway, so the company’s patent‑related risk is more gradual and hinges on possible regulatory or legislative changes that could shorten that exclusivity (Amgen 10‑K pp. 44‑48).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Alimta as a small molecule drug and explains that its patent expiration will lead to rapid generic entry and a 'rapid and severe decline in revenue' for Eli Lilly, citing internal document page references (LLY p.25; p.46), which matches the original answer's claim about immediate and significant revenue erosion. (2) There are no explicit numbers (e.g., dollar amounts, specific years) in either answer, so quantitative accuracy is not compromised—no errors in dates, percentages, or financial figures. (3) The reasoning across entities is sound: it contrasts Eli Lilly’s exposure via small-molecule generics with Amgen’s biologics protected under the BPCIA’s 12-year exclusivity and more complex biosimilar approval process. It correctly notes that Amgen’s risk is more gradual and tied to potential regulatory or legislative changes, citing Amgen 10-K pp.44–48. This reflects the multi-hop synthesis required—understanding differences in regulatory frameworks (small molecule vs. biologic) and their business impacts. (4) The only minor shortcoming is that the LLM answer does not explicitly mention 'umbrella exclusivity' or the FDA’s stance on it, a nuance present in the original answer that adds depth to Amgen’s regulatory risk. It also omits the point that biosimilar competition has already had a 'material adverse effect' on Amgen’s sales, which slightly reduces completeness. However, the core factual content, logic, and comparative analysis are correct and well-supported. Wording differs but semantic equivalence is strong. Contextual relevance is excellent—directly addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 467,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the impact of the OECD's Pillar Two Model Rules on Intel's non-US tax benefits compare to Microsoft's exposure under the global minimum tax, given the differences in their international tax strategies?",
      "original_answer": "Intel's tax benefits have increased due to a higher proportion of income taxed in non-US jurisdictions, and the company is actively evaluating the impact of Pillar Two Model Rules, which may begin in 2024 in several jurisdictions where Intel operates. In contrast, Microsoft acknowledges the global minimum tax as part of its broader regulatory exposure but does not expect a material increase in tax costs due to limited operations in jurisdictions below the 15% minimum rate. This suggests that while both companies are subject to Pillar Two, their exposure differs based on geographic tax strategy and operational footprint.",
      "llm_answer": "Intel says the OECD’s Pillar‑Two model rules – which impose a 15 % global minimum tax – could erode the R&D credits and other non‑U.S. tax benefits that have helped lower its effective tax rate, and the company is still evaluating any impact (INTC 10‑K p. 44). Microsoft, on the other hand, merely notes a possible exposure to additional tax expense from the global minimum‑tax regime but does not expect a material effect, reflecting its broader, diversified international tax strategy (MSFT 10‑K p. 30).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: Intel is evaluating the impact of Pillar Two, which may affect its non-US tax benefits such as R&D credits, with potential implementation starting in 2024 (cited from INTC 10-K p.44). Microsoft acknowledges exposure but does not expect a material impact due to its international footprint (cited from MSFT 10-K p.30). (2) There are no numeric values, percentages, or dates in the LLM answer that conflict with the ground truth; the 15% minimum tax rate mentioned is consistent with OECD Pillar Two standards and contextually accurate, even if not explicitly stated in the original answer. (3) The multi-hop reasoning is sound—correctly comparing Intel’s reliance on non-US tax benefits to Microsoft’s diversified strategy and lower sensitivity to the global minimum tax. (4) The LLM captures the core contrast in exposure due to differing international tax strategies, aligning with the original answer’s conclusion. The only minor limitation is that the LLM does not explicitly mention '2024' as a potential start year for Pillar Two in certain jurisdictions (present in the ground truth), but this does not detract significantly from the overall correctness. Wording differs but meaning is preserved. Citations to 10-K pages add precision and credibility.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1299,
        "completion_tokens": 380,
        "total_tokens": 1679
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does KO's 2024 transfer of $523 million in surplus international pension assets to general assets affect its exposure to limited partnerships compared to PEP's continued use of limited partnerships in its pension investment strategy?",
      "original_answer": "KO's transfer of $523 million in surplus international pension assets to general assets in 2024 reduced its exposure to limited partnerships, as these assets were previously part of its pension plan investments, which include vehicles like limited partnerships (as seen in NEE's pension strategy). Meanwhile, PEP continues to maintain exposure to limited partnerships through its pension investments, as explicitly stated in its 2024 10-K, where it holds investments in limited partnerships and private credit funds valued based on net asset value. This indicates a strategic divergence: KO reduced its pension-linked alternative investments, while PEP maintains them as part of its diversified pension fund strategy.",
      "llm_answer": "Coca‑Cola’s 2024 move of $523 million of surplus international pension assets out of its pension trusts and into general corporate assets trims the size of the pension pool that could be allocated to alternative vehicles, thereby reducing any exposure it may have had to limited‑partnership investments 【page_43】. PepsiCo, on the other hand, still holds limited‑partnership and private‑credit fund investments within its pension plan (note h), so it maintains ongoing exposure to limited‑partnership assets 【page_99】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: the $523 million transfer by KO in 2024 is accurately reported, and no calculations are required beyond correct interpretation. (2) Entity accuracy is strong: KO (Coca-Cola) and PEP (PepsiCo) are correctly identified, and the years (2024) and financial instruments (limited partnerships, private credit funds) match the original. (3) Reasoning is sound: the LLM correctly infers that removing surplus pension assets reduces the pool available for alternative investments like limited partnerships, thereby reducing exposure—this aligns with the ground truth's logic. It also correctly contrasts this with PEP’s continued use of limited partnerships, citing its 10-K disclosure. (4) The only minor shortcoming is that the LLM does not explicitly mention that KO’s prior pension investments included limited partnerships (it only implies reduced potential exposure), whereas the ground truth clarifies that these assets were previously part of pension investments that could include such vehicles. However, the semantic meaning and strategic contrast—KO reducing exposure vs. PEP maintaining it—are preserved. The answer is contextually relevant, directly addressing the comparative exposure question with proper sourcing cues (page references). Thus, the answer earns a 9/10 for correctness due to slightly less explicit justification for KO’s prior exposure, but all critical facts and logic are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 420,
        "total_tokens": 1751
      },
      "error": null
    },
    {
      "question_id": 137,
      "question": "How does the $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 relate to the role of patent rights in determining market exclusivity periods, especially when considering LLY's reliance on 12-year U.S. biologic data protection to safeguard revenue post-patent expiration?",
      "original_answer": "The $17.3 billion increase in PFE's income from continuing operations in 2021 compared to 2020 was partly due to factors like lower asset impairment charges and higher net gains on equity securities. However, PFE acknowledges that patent expirations could materially affect revenues, as patent rights are a key determinant of market exclusivity in the pharmaceutical industry. According to evidence, market exclusivity for pharmaceuticals is largely determined by patent rights and regulatory data protection. In the U.S., biologics benefit from a 12-year data protection period under the BPCIA, which LLY explicitly references as a critical mechanism to retain market exclusivity and protect revenues even after compound patents expire. This implies that while PFE's short-term financial performance saw a significant boost, the long-term sustainability of such gains for patented products will depend on both patent strength and complementary regulatory exclusivity mechanisms like those LLY relies on for its biologics.",
      "llm_answer": "Pfizer’s $17.3 billion jump in income from continuing operations in 2021 (driven largely by higher revenues, net benefit credits and lower impairment charges) reflects the financial upside of preserving market‑exclusivity through its patent portfolio and other IP protections 【page_36】—the same IP rights that the company notes are “a key determinant of market exclusivity” for its products 【page_7】.  Eli Lilly’s strategy mirrors this dynamic: it relies on the 12‑year U.S. biologic data‑protection provision of the BPCIA to keep biosimilar competitors at bay after its patents expire, thereby safeguarding its post‑patent revenue 【page_12】.  In both cases, robust patent‑ and data‑exclusivity regimes translate directly into higher earnings.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $17.3 billion increase in PFE's income from continuing operations in 2021 vs. 2020 is correctly stated. No calculations are required beyond this, and the figure matches the original answer. (2) The LLM correctly identifies that PFE’s income increase was influenced by factors like lower impairment charges and higher revenues (aligned with 'lower asset impairment charges and higher net gains on equity securities' in the original), though it adds 'net benefit credits'—a detail not in the ground truth, but not factually incorrect based on typical 10-K disclosures. (3) Entity accuracy is strong: PFE and LLY are correctly identified, the 12-year U.S. biologic data protection under BPCIA is accurately cited, and the connection to market exclusivity is properly drawn. (4) The multi-hop reasoning is sound: the model links PFE’s financial performance to patent-based market exclusivity, then cross-applies the concept to LLY’s reliance on data protection, showing how both companies benefit from IP and regulatory exclusivity. The only minor gap is that the original answer emphasizes that PFE's boost was partly due to non-recurring items (e.g., lower impairments), while the LLM implies a stronger link to IP protections than directly supported by the original—though PFE does acknowledge patent importance. Overall, the semantic meaning, factual content, and synthesis are correct and relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1482,
        "completion_tokens": 410,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 138,
      "question": "How does the revenue-sharing arrangement between ESPN and Hulu, as reflected in Disney's 2024 financials, relate to the $8.6 billion payment Comcast received in late 2023 following the partial exit of its Hulu stake?",
      "original_answer": "Disney's ESPN receives fees from Hulu for the right to air its networks, as noted in the elimination section of Disney's 2024 financials. This relationship is central to Hulu's content costs and revenue model. In late 2023, Comcast exercised a put option, requiring Disney to buy its 33% stake in Hulu for $8.6 billion, which included a $9.2 billion minimum equity value less $557 million for prior capital calls. This payment reflects the financial value derived from Comcast’s stake in Hulu, which is partially driven by revenue streams like those from ESPN content licensing fees. Thus, the revenue-sharing mechanism between ESPN and Hulu underpins part of the valuation that led to the $8.6 billion payment to Comcast.",
      "llm_answer": "Disney’s 2024 filing shows that the “Eliminations” line (‑$1.595 billion in 2024) includes the fees Hulu pays ESPN for the right to air ESPN on Hulu Live – a recurring revenue‑sharing arrangement between two Disney‑owned businesses (see page 38). The $8.6 billion Comcast received in November 2023 was a one‑time purchase price for Comcast’s remaining Hulu equity (see page 85); it gave Disney full ownership of Hulu, which will continue to generate the ESPN‑Hulu fees, but the payment itself is separate from the ongoing ESPN‑Hulu revenue‑share.",
      "correctness_score": 7,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the ESPN-Hulu revenue-sharing arrangement as reflected in Disney's 2024 financials, specifically citing the '$1.595 billion' elimination entry related to intercompany fees (page 38), which aligns with the ground truth's description of ESPN receiving fees from Hulu. It also accurately states that Comcast received $8.6 billion in November 2023 for its Hulu stake (page 85), matching the ground truth. However, the LLM omits key details about *how* the ESPN-Hulu revenue stream contributes to Hulu’s valuation, which is central to the ground truth’s explanation that the $8.6 billion payment was partially driven by such revenue streams. Instead, the LLM calls the payment 'separate from the ongoing ESPN-Hulu revenue-share,' which downplays the causal relationship emphasized in the original answer. (2) Quantitatively, all numbers are correct: $1.595 billion (elimination amount), $8.6 billion (Comcast payout), and November 2023 timing are accurate. The LLM does not mention the $9.2 billion minimum equity value or the $557 million prior capital calls, which are part of the calculation in the ground truth—this is a notable omission affecting completeness. (3) The multi-hop reasoning is partially sound: it connects ESPN-Hulu financials to Disney’s reporting and links Comcast’s exit to Disney’s full ownership. However, it fails to synthesize the full chain: ESPN content fees → Hulu’s content cost/revenue model → Hulu’s equity valuation → Comcast’s put option payout. This weakens the qualitative accuracy. (4) Contextual relevance is high—the answer addresses both parts of the question and uses correct entities (ESPN, Hulu, Disney, Comcast, 2024 financials, late 2023 payment). The main shortcoming is the lack of integration between the revenue-sharing mechanism and the valuation rationale for the $8.6 billion, reducing correctness despite accurate standalone facts.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 521,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How do KO's and MDLZ's respective uses of financial assumptions differ in terms of the instruments they apply them to and the time periods over which the associated costs are recognized?",
      "original_answer": "KO uses the Black-Scholes-Merton option-pricing model to estimate the fair value of stock option awards, which are expensed on a straight-line basis over a typical four-year vesting period. This approach incorporates weighted-average assumptions such as volatility and expected term. In contrast, MDLZ applies weighted-average assumptions to determine net periodic postretirement healthcare costs, which are measured annually and reflect actuarial estimates for long-term obligations. The key differences are that KO applies these assumptions to equity-based compensation instruments with a fixed four-year expense recognition period, while MDLZ applies them to postretirement benefit liabilities that are recalculated annually based on updated actuarial estimates.",
      "llm_answer": "KO uses financial assumptions – a discount rate and a health‑care cost‑trend rate – to measure its post‑retirement health‑care benefit obligations, and the resulting net periodic post‑retirement cost is recognized in the period incurred (e.g., $(5) million in 2023)【page_107】. MDLZ applies Black‑Scholes assumptions (risk‑free rate, expected life, volatility and dividend yield) to value employee stock options, and the unamortized compensation expense from those options is amortized over a weighted‑average period of about 1.7 years【page_108】.",
      "correctness_score": 2,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 2,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer is largely incorrect due to a critical reversal of company-instrument mappings. The ground truth states that KO (Coca-Cola) uses the Black-Scholes-Merton model for stock option awards with a four-year vesting period, while MDLZ (Mondelez) applies weighted-average assumptions to postretirement healthcare costs. However, the LLM answer incorrectly assigns postretirement healthcare obligations to KO and stock option valuation using Black-Scholes to MDLZ—exactly the opposite of the truth. This fundamental error invalidates the core of the response. Quantitatively, the LLM cites a $(5) million cost for KO in 2023 and a 1.7-year amortization period for MDLZ, but these figures are not supported by the ground truth, which specifies a typical four-year vesting period for KO and annual recalculation for MDLZ’s actuarial estimates. The mention of specific assumptions (e.g., risk-free rate, volatility) is plausible in context but misattributed. The reasoning is internally logical but based on incorrect entity-instrument pairings, failing the multi-hop synthesis requirement. While the answer addresses the general structure of applying assumptions and recognizing costs, it does so with reversed entities, leading to severe factual inaccuracies. Contextual relevance is moderate because it discusses financial assumptions and expense recognition, but the misattribution undermines usefulness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 388,
        "total_tokens": 1726
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How might the expiration timeline of specific patent protections for Enbrel impact Pfizer's international revenue from the drug, given AbbVie's broader strategy around patent term restoration and regulatory exclusivity?",
      "original_answer": "The expiration timeline for Enbrel's U.S. patents begins in 2028 (fusion protein composition) and extends to 2037 for formulation methods, which could delay biosimilar competition internationally. However, AbbVie's strategy of seeking patent term restoration and leveraging regulatory exclusivity under the Hatch-Waxman Act—where patent extensions can add up to five years—may further extend protection in key markets. Pfizer, which markets Enbrel outside the U.S. and Canada, could see prolonged exclusivity in certain regions, potentially extending beyond 2028, thereby preserving revenue streams if biosimilar challenges are delayed or unsuccessful.",
      "llm_answer": "Enbrel’s U.S. patents run to 11/22/2028, 4/24/2029 and 10/19/2037 (page 11), and AbbVie’s policy of seeking patent‑term restoration and other regulatory exclusivities can push effective protection even later (page 9). Because Enbrel directly competes with Pfizer’s Xeljanz abroad (page 15), this extended exclusivity will keep Enbrel on the market internationally and limit the upside for Pfizer’s international sales of its competing product—a segment that already accounts for a large share of Pfizer’s revenue (≈ $24 bn in 2024, page 40).",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 5,
      "detailed_feedback": "The LLM answer contains significant factual and reasoning errors that undermine its correctness. (1) Quantitatively, the dates cited (11/22/2028, 4/24/2029, 10/19/2037) are more specific than the ground truth, which only specifies 2028 and 2037 as general years for patent expirations—these exact dates are not corroborated in the original answer and introduce false precision. (2) The core misunderstanding lies in entity accuracy: the question asks how Enbrel’s patent expiration impacts *Pfizer’s revenue from Enbrel*, but Pfizer does not sell Enbrel internationally—AbbVie does. The original answer correctly notes that *Pfizer markets Enbrel outside the U.S. and Canada* is factually incorrect; in reality, Amgen developed Enbrel, AbbVie holds rights in the U.S., and Pfizer holds rights *outside* the U.S. This is a critical entity error. However, the LLM incorrectly claims that Enbrel competes with Pfizer’s Xeljanz abroad, and that extended Enbrel exclusivity would *limit Pfizer’s sales*—this inverts the actual relationship. If Enbrel (a Pfizer product abroad) faces delayed biosimilar competition, that should *benefit* Pfizer’s international revenue, not hurt it. (3) The reasoning is therefore flawed: instead of recognizing that prolonged patent protection on a product Pfizer markets internationally would preserve Pfizer’s revenue, the LLM argues the opposite, suggesting Enbrel competes with Pfizer’s own drug. This reflects a failure in multi-hop synthesis—confusing competitive dynamics and ownership. (4) The $24 billion figure for Pfizer’s revenue in 2024 is not in the original answer and appears fabricated or misattributed; no revenue impact on Pfizer from Enbrel is quantified in the ground truth. While the mention of patent term restoration and regulatory exclusivity aligns thematically, the overall answer misrepresents the financial and strategic implications. Thus, despite some correct elements (patent extension strategies), the answer is largely incorrect in direction and fact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 539,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 139,
      "question": "How does MET's stress testing approach, which factors in early policyholder withdrawal scenarios, influence its reliance on global funding sources like commercial paper compared to COF's liquidity framework that emphasizes diversified funding sources and liquidity reserves?",
      "original_answer": "MET's stress testing includes scenarios of early policyholder withdrawal, which directly impacts its reliance on global funding sources like commercial paper to meet liquidity needs under stress conditions. MET adjusts asset mix and maturities based on rolling 12-month forecasts and relies on alternatives such as commercial paper and credit facilities when anticipated liquidity is exceeded. Similarly, COF's Liquidity Framework emphasizes diversified funding sources and maintains a liquidity reserve of cash, high-quality unencumbered securities, and committed credit lines to withstand systemic and idiosyncratic liquidity events. Both companies use stress testing to inform their funding strategies, but MET's exposure to policyholder behavior introduces a unique risk factor that directly affects its funding source selection, aligning with AIG's defined liquidity stress scenarios that impact funding sources.",
      "llm_answer": "MetLife’s liquidity plan explicitly tests “early contract‑holder and policy‑holder withdrawal” scenarios and, if those stress tests show cash needs beyond its forecast, it turns to “global funding sources including commercial paper and various credit and committed facilities” as a key back‑stop (MET 123). Capital One, by contrast, runs a Liquidity Framework that stresses balance‑sheet metrics but focuses on “a sizable liquidity reserve comprised of cash, cash equivalents, high‑quality un‑encumbered securities and committed credit lines” and maintains diversified access to secured and unsecured debt markets, so it relies less on any single source such as commercial paper.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the original answer. (1) It correctly identifies MET's stress testing approach, specifically including early policyholder withdrawal scenarios, and links this to its reliance on global funding sources like commercial paper and credit facilities when forecasts are exceeded—this aligns with the ground truth. It also accurately describes COF's liquidity framework emphasizing diversified funding and a liquidity reserve of cash, high-quality unencumbered securities, and credit lines. (2) There are no numeric values in the question or answers that require verification; thus, quantitative accuracy is perfect by default. (3) The multi-hop reasoning is sound: the model correctly contrasts MET’s behavior-driven liquidity risk with COF’s structural reserve approach, and infers differing reliance on commercial paper. The only minor omission is that the LLM answer does not explicitly mention AIG’s defined liquidity stress scenarios, which the original answer references as a point of alignment—this contextual nuance is missing but does not detract from the core comparison. (4) All entities (MET, COF, commercial paper, liquidity reserves) are correctly identified and contrasted. Wording differs (e.g., 'contract-holder' vs 'policy-holder') but meaning is preserved. Overall, the answer is factually correct, contextually relevant, and semantically equivalent with only slight loss in completeness regarding the AIG reference.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1431,
        "completion_tokens": 412,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the adoption of ASU 2022-04 impact the comparability of supplier finance obligation disclosures between CAT and GE, particularly regarding the roll-forward requirements that GE began applying in 2024?",
      "original_answer": "GE adopted ASU 2022-04 on January 1, 2023, and began applying the annual roll-forward disclosure requirement prospectively starting January 1, 2024 (GE_10k_2024.pdf:page_47). This aligns with CL's explanation that ASU 2022-04 mandates disclosures including key terms, balance sheet presentation, and a roll-forward of confirmed obligations (CL_10k_2024.pdf:page_57). CAT, in its 2024 10-K (CAT_10k_2024.pdf:page_111), provides a roll-forward of its supplier finance obligations, showing $830 million outstanding at year-end 2024. The adoption of ASU 2022-04 enhances comparability between CAT and GE by standardizing how supplier finance obligations are disclosed, particularly with the new roll-forward requirement that GE implemented in 2024.",
      "llm_answer": "ASU 2022‑04 mandates that companies disclose a roll‑forward of the amounts confirmed under supplier‑finance programs. GE adopted the update on 1 Jan 2023 and, per its 2024 filing, began providing that roll‑forward (beginning balance, additions and payments, ending balance) in Note 19 (see GE page 111) after noting the adoption on page 47, whereas Caterpillar already presents a comparable roll‑forward for 2024 in its Note (see CAT page 112). Thus, for 2024 the two firms now disclose supplier‑finance obligations in the same format, improving comparability, but GE’s roll‑forward was not required in prior years, so comparability with earlier periods or with any prior‑year CAT presentation is limited.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: GE adopted ASU 2022-04 on January 1, 2023, and began applying the roll-forward requirement in 2024; CAT also provides a roll-forward in its 2024 10-K. The dollar amount ($830 million) is not mentioned in the LLM answer, but this is a minor omission since the focus is on the format and comparability rather than the specific value. (2) Quantitative accuracy is perfect: dates (Jan 1, 2023 adoption; 2024 disclosures) match the ground truth. Page numbers cited (GE page 47 for adoption, GE page 111 and CAT page 112 for disclosures) are close to the ground truth (GE_10k_2024.pdf:page_47 and CAT_10k_2024.pdf:page_111), with minor discrepancies possibly due to different document versions or note numbering—this does not affect factual correctness. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across GE and CAT filings, recognizes the impact of ASU 2022-04 on disclosure standardization, and notes the prospective application limiting prior-period comparability. (4) The answer enhances contextual relevance by explicitly stating that 2024 disclosures are now comparable in format, which directly addresses the question. The only minor shortcoming is the lack of explicit mention of CL's explanation about ASU requirements (e.g., key terms, balance sheet presentation), but the focus on roll-forward—which is the central point of comparability—is well-covered. Overall, the answer is factually correct, logically structured, and semantically equivalent to the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1378,
        "completion_tokens": 444,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 140,
      "question": "How does the valuation methodology for MDLZ's Level 1 financial assets, which include exchange-traded commodity futures, differ from PEP's treatment of exchange-traded commodity futures, particularly in terms of fair value determination and daily settlement practices?",
      "original_answer": "MDLZ determines the fair value of its Level 1 financial assets, including exchange-traded commodity futures, based on quoted market prices on commodity exchanges. In contrast, PEP notes that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in their fair value hierarchy tables. While MDLZ relies directly on observable exchange prices for valuation, PEP's daily cash settlement approach for these instruments results in their exclusion from balance sheet reporting, highlighting distinct operational and accounting treatments despite both companies engaging with the same class of financial instruments.",
      "llm_answer": "MDLZ treats exchange‑traded commodity futures as Level 1 assets, measuring them at fair value based on the quoted market price on the commodity exchange【page_96†L13-L15】. PepsiCo, however, does not include its exchange‑traded commodity futures in the fair‑value hierarchy because they are cash‑settled each day, so their value is realized through daily settlement rather than a separate quoted‑price fair‑value determination【page_106†L17-L19】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that MDLZ classifies exchange-traded commodity futures as Level 1 assets valued using quoted market prices, and that PEP excludes these instruments from its fair value hierarchy due to daily cash settlement. These facts match the original answer exactly in substance. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (MDLZ and PEP), contrasting their accounting treatments for the same type of financial instrument. It captures the key distinction: MDLZ reports these assets on the balance sheet using observable prices, while PEP does not report them due to daily settlement. (4) The only minor shortcoming is that the LLM answer could more explicitly state that PEP's exclusion from the fair value hierarchy results in no balance sheet reporting, which slightly weakens the qualitative completeness. However, the phrase 'not included in the fair-value hierarchy' implies this. Wording differs slightly but maintains semantic equivalence. All entities (MDLZ, PEP, Level 1, exchange-traded commodity futures) are correct. The answer is fully relevant and directly addresses both parts of the question: fair value determination and daily settlement practices.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1303,
        "completion_tokens": 411,
        "total_tokens": 1714
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How does the voting rights structure between Class A and Class B common stock at CMCSA compare with META's dual-class share structure?",
      "original_answer": "At CMCSA, Class A common stockholders hold 66 2/3% of the combined voting power, while Class B common stockholders collectively hold 33 1/3%, with each share of Class B having 15 votes. In contrast, META also maintains a dual-class share structure, with Class B common stock possessing superior voting rights, although the exact vote ratio per share is not disclosed in the evidence. META had 343,761,117 shares of Class B common stock outstanding as of January 24, 2025.",
      "llm_answer": "Comcast’s capital structure gives each Class B share 15 votes (about 33 % of total voting power) while Class A shares have one vote each and hold the remaining ≈ 67 % of the votes【page_31】. Meta also uses a dual‑class system, issuing Class A shares with one vote per share and Class B shares with ten votes per share, so a relatively small block of Class B stock held by insiders controls a majority of the voting power【page_1】. Both companies rely on super‑voting shares, but Comcast’s multiplier is 15‑to‑1 and represents a smaller share of total voting power than Meta’s 10‑to‑1 structure.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies, particularly in the quantitative details about META's share structure. (1) For CMCSA, the answer correctly states that Class B shares have 15 votes and hold about 33% of voting power, and Class A holds about 67% with one vote per share — this aligns with the ground truth (66 2/3% and 33 1/3%). However, for META, the LLM incorrectly claims that Class B shares have 'ten votes per share', which is not supported by the evidence; the original answer explicitly states that the exact vote ratio per share is not disclosed. This is a critical error. (2) The LLM also introduces a comparison about the relative size of voting power controlled by insiders, which is not present or verifiable from the ground truth. (3) While the answer correctly identifies that both companies have dual-class structures with super-voting shares, the reasoning is flawed in comparing a 15-to-1 multiplier (Comcast) with a claimed 10-to-1 (Meta), because the latter is unsupported. (4) The ground truth includes a specific number of outstanding Class B shares for META (343,761,117 as of January 24, 2025), which the LLM omits entirely. Thus, despite correct identification of the general structure at CMCSA and contextual relevance, the answer fails on key quantitative and qualitative accuracy metrics due to fabrication of META's vote ratio and omission of disclosed data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1262,
        "completion_tokens": 388,
        "total_tokens": 1651
      },
      "error": null
    },
    {
      "question_id": 141,
      "question": "How do AIG's and MetLife's exposures to CLOs differ in terms of their credit loss evaluation methodologies and unrealized loss recognition, given that both hold these instruments within structured products portfolios?",
      "original_answer": "AIG evaluates credit losses on CLOs by estimating future cash flows based on delinquency rates, default expectations, loss severity timing, and structural features like credit enhancement, with unrealized losses split between credit-related impairments and non-credit fair value changes recorded in OCI. MetLife, while also holding CLOs as part of structured products within AFS fixed maturity securities, limits its involvement to passive investment in trusts without substantial equity and does not appear to disclose the same level of detailed cash flow modeling for credit loss evaluation, instead focusing on maximum exposure to loss being limited to carrying amounts. AIG explicitly accounts for credit impairments under CECL with reversibility features, whereas MetLife emphasizes its passive investor status and lack of active management involvement in CLO structures.",
      "llm_answer": "AIG treats its CLO holdings as structured fixed‑maturity securities and evaluates credit loss under the CECL model, estimating future cash‑flows with inputs such as delinquency, default rates, loss severity, prepayment speeds and bond‑specific structural features (e.g., credit enhancement and payment priority).  When a decline is credit‑related, AIG records an allowance for credit losses against amortized cost; any unrealized loss not tied to credit is reflected in OCI as unrealized appreciation/depreciation (AIG 10‑K pp. 130‑129).  \n\nMetLife, by contrast, carries CLOs as available‑for‑sale securities measured at fair value, using NAIC credit‑quality designations and fair‑value modeling rather than a CECL allowance, and recognizes any unrealized gain or loss directly through changes in fair value in net investment income (MetLife 10‑K p. 84).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is factually accurate in its description of AIG's methodology, correctly identifying the use of CECL, future cash flow estimation with delinquency, default rates, loss severity, and structural features like credit enhancement. It accurately notes that AIG separates credit-related impairments (recorded as allowance for credit losses) from non-credit fair value changes (recorded in OCI), citing the correct section of the 10-K (pp. 130-129, though page order is reversed). These details align with the ground truth.\n\nHowever, the LLM answer contains a significant inaccuracy regarding MetLife. It states that MetLife recognizes unrealized gains and losses on CLOs directly in net investment income, which is incorrect. Available-for-sale (AFS) securities, by definition, recognize unrealized gains and losses in other comprehensive income (OCI), not in net investment income. Net investment income reflects interest and dividends, not fair value changes. The LLM mischaracterizes MetLife’s accounting treatment, likely confusing AFS with fair value through profit or loss (FVTPL) classification. The ground truth emphasizes MetLife’s passive investment stance and lack of detailed cash flow modeling, focusing on limited exposure up to carrying amounts—details that are omitted in the LLM response.\n\nAdditionally, while the LLM mentions NAIC credit-quality designations, this is not highlighted in the original answer and may be extraneous or inferred rather than directly supported in the context provided. The original answer does not mention MetLife using fair-value modeling for credit loss evaluation, nor does it suggest active use of such models—instead, it underscores MetLife’s passive role and lack of active management.\n\nQuantitative accuracy is scored highly because there are no numeric values to verify, and the textual financial concepts (e.g., amortized cost, OCI) are used correctly where applicable. Contextual relevance is high because the response directly addresses the question’s focus on credit loss evaluation and unrealized loss recognition. However, the qualitative accuracy is reduced due to the misrepresentation of MetLife’s accounting model and omission of key differentiators (passive investor status, lack of CECL-like modeling, structural limitations on loss exposure). The multi-hop synthesis is partially sound but flawed in the MetLife leg of the comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1450,
        "completion_tokens": 640,
        "total_tokens": 2090
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does the Inflation Reduction Act's redesign of Medicare Part D affect CVS's ability to forecast medical cost trends and BMY's rebate accruals for the same program?",
      "original_answer": "The Inflation Reduction Act (IRA) redesigns Medicare Part D by reducing federal reinsurance in the catastrophic phase and shifting more costs to manufacturers like BMY starting in 2025, which increases their rebate obligations. This directly impacts BMY’s gross-to-net U.S. rebate accruals for Medicare Part D, as they must account for these new liabilities in their financial reporting. For CVS, the IRA’s changes to Medicare Part D contribute to the uncertainty in forecasting health care and benefit costs, especially as new cost-sharing obligations for manufacturers may alter utilization patterns and overall program dynamics. These shifts make it more challenging for CVS to predict medical cost trends and manage profitability in their Medicare-insured products.",
      "llm_answer": "The IRA’s overhaul of Medicare Part D—capping beneficiary out‑of‑pocket costs, cutting federal reinsurance and adding inflation‑penalty rebates—shifts a larger share of drug‑claim costs onto Part D plans and manufacturers. For CVS, that shift makes the medical‑cost assumptions used to set fixed‑premium rates far more volatile, so its ability to forecast health‑care cost trends and price premiums is less certain (CVS 10‑K pp. 40‑53). For BMS, the redesign creates new mandatory discounts and inflation‑penalty rebates that now accrue as Medicare Part D GTN liabilities, requiring significant judgments in estimating those rebate accruals (BMY 10‑K pp. 83, 125).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies the key provisions of the Inflation Reduction Act (IRA) affecting Medicare Part D: reduced federal reinsurance, new manufacturer obligations including inflation-penalty rebates, and cost shifts to manufacturers and Part D plans. These changes are accurately tied to CVS's forecasting challenges and BMY's (Bristol Myers Squibb, referred to as BMS in the answer—minor ticker inconsistency) rebate accruals. (2) There are no numeric values (e.g., dollar amounts, percentages, years) in either the original or LLM answer that conflict; the mention of 2025 in the original is implied in the LLM’s reference to future liabilities and is consistent with the IRA timeline. The LLM correctly cites page numbers from the 10-Ks (e.g., CVS pp. 40–53, BMY pp. 83, 125), supporting its claims with appropriate source references. (3) The multi-hop reasoning is sound: it connects IRA policy changes → financial impact on manufacturers (BMY) → increased gross-to-net (GTN) liabilities → estimation challenges, and separately links the same policy → increased cost volatility for Part D plans → challenges for CVS in setting premiums and forecasting costs. The only minor issue is the use of 'BMS' instead of 'BMY' (Bristol Myers Squibb’s ticker is BMY, not BMS—though BMS is a common shorthand and likely refers to the same company), which slightly affects entity accuracy but does not mislead. (4) The answer is contextually relevant, directly addressing both parts of the question—CVS’s forecasting ability and BMY’s rebate accruals—and synthesizing the impact of the IRA across both firms. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth, warranting a high correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 491,
        "total_tokens": 1855
      },
      "error": null
    },
    {
      "question_id": 142,
      "question": "How does JPMorgan Chase's exposure to Stress Capital Buffer requirements influence its capital distribution constraints compared to Charles Schwab's obligations under the Capital Conservation Buffer, given the composition of their respective regulatory buffer requirements?",
      "original_answer": "JPMorgan Chase is subject to a Stress Capital Buffer (SCB) as part of its regulatory capital requirements, which could increase based on stress loss estimates from the Federal Reserve’s Comprehensive Capital Analysis and Review. This buffer, along with the GSIB surcharge and countercyclical buffer (CCyB), contributes to JPMorgan’s total capital buffer requirement. On the other hand, Charles Schwab’s banking subsidiary, Charles Schwab Bank (CSB), is required to maintain a Capital Conservation Buffer (CCB) of 2.5%, which imposes restrictions on capital distributions if not met. According to regulatory definitions, the CCB is a fixed component of capital buffer requirements, whereas JPMorgan’s SCB is dynamic and tied to stress testing outcomes. Therefore, JPMorgan faces a more variable and forward-looking capital constraint tied to macroeconomic stress scenarios, while Schwab faces a static buffer requirement that acts as a floor to avoid distribution limitations.",
      "llm_answer": "JPMorgan Chase’s capital‑distribution limits are tied to its Stress Capital Buffer, which is one piece of a larger GSIB buffer package (the SCB plus a 3 % G‑SIB surcharge and a zero‑percent counter‑cyclical buffer that together push the firm’s total buffer requirement to about 8.4 % of risk‑weighted assets). If the SCB falls below the required level, the bank is barred from paying dividends, repurchasing shares or granting discretionary bonuses 【page_22†L1-L7】【page_22†L15-L22】.  \n\nBy contrast, Charles Schwab must only hold a 2.5 % stress capital buffer at the holding‑company level and a 2.5 % capital‑conservation buffer at its banking subsidiary, with minimum capital ratios of 7.0 %/8.5 %/10.5 % (CET1/Tier 1/Total). A breach of either buffer triggers “increasingly strict limits on capital distributions and discretionary bonus payments” but the overall buffer is smaller and less complex than JPMorgan’s 【page_122†L31-L38】【page_122†L39-L44】.  \n\nThus, JPMorgan’s exposure to a larger, multi‑component SCB regime creates tighter, more extensive distribution constraints than Schwab’s comparatively modest capital‑conservation buffer obligations.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly impact correctness, particularly in the quantitative details and entity-specific buffer requirements. (1) The LLM incorrectly states that Charles Schwab must hold a 2.5% 'stress capital buffer' at the holding-company level — this is false; Schwab is not subject to the Stress Capital Buffer (SCB), which applies only to large, internationally active banks like JPMorgan Chase. Instead, Schwab’s banking subsidiary is subject to the Capital Conservation Buffer (CCB) of 2.5%, as correctly stated in the ground truth. This misattribution of SCB to Schwab is a major factual error. (2) The LLM claims JPMorgan’s total buffer is 'about 8.4%' without clear sourcing or breakdown — while JPMorgan does face a higher total buffer due to GSIB surcharge and SCB, the exact figure of 8.4% is not corroborated in the ground truth and introduces unverified precision. (3) The countercyclical buffer (CCyB) is stated as zero percent, which may be contextually true at times but is not confirmed in the original answer and adds unsupported detail. (4) The minimum capital ratios (7.0%/8.5%/10.5%) for Schwab are introduced without grounding in the original answer, making them extraneous and potentially misleading. While the LLM correctly contrasts JPMorgan’s dynamic, multi-component buffer regime with Schwab’s simpler structure, it misrepresents the nature of Schwab’s obligations by conflating SCB and CCB. The reasoning is partially sound in recognizing that JPMorgan faces tighter constraints due to complexity and size, but the flawed premise weakens the conclusion. Semantically, the answer captures the directional idea — JPMorgan has more complex, variable constraints — but fails on key factual distinctions between regulatory buffers. Contextual relevance is high as it directly addresses the comparison and distribution constraints. Overall, the answer is partially correct with significant factual flaws, warranting a mid-range score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1564,
        "completion_tokens": 537,
        "total_tokens": 2101
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do General Dynamics and Raytheon Technologies differ in their financial exposure to state and local income taxes on U.S. government contracts regulated by the FAR, especially considering GD's exclusion of these taxes from its tax provision and RTX's FAR-governed cost allowability and pricing mechanisms?",
      "original_answer": "General Dynamics excludes state and local income taxes allocable to U.S. government contracts from its tax provision, instead recognizing them in operating costs and expenses. This treatment is governed by the Federal Acquisition Regulation (FAR), which dictates how costs are allocated and allowed on government contracts. Raytheon Technologies, also subject to the FAR, structures its pricing under these contracts based on allowable costs, including mechanisms like performance-based payments and progress payments that influence revenue recognition patterns. The difference in financial exposure stems from GD directly expensing these taxes while RTX incorporates them into broader cost considerations under FAR-regulated pricing frameworks.",
      "llm_answer": "General Dynamics does not treat state‑ and local‑income taxes on U.S. government work as a tax‑provision item – they are recorded in operating costs and expenses (see GD 10‑K p. 66), so the taxes hit earnings directly. Raytheon Technologies, however, records state taxes in income‑tax expense but, because the FAR allows those taxes to be treated as allowable contract costs, they are allocated to contracts and generally recovered through pricing to the U.S. government (see RTX 10‑K p. 78‑79), limiting the net financial exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that General Dynamics excludes state and local income taxes on U.S. government contracts from its tax provision and instead records them in operating costs and expenses, directly impacting earnings. It also accurately states that Raytheon Technologies includes these taxes in income tax expense but recovers them as allowable costs under FAR through contract pricing. These characterizations match the original answer’s core distinction in financial exposure. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised; the references to page numbers (p. 66 for GD, pp. 78–79 for RTX) are consistent with typical 10-K disclosures and do not contradict the knowledge graph. (3) The multi-hop reasoning is sound: the model correctly synthesizes tax treatment, FAR cost allowability, and financial statement impact across two companies, linking GD’s expense recognition to direct earnings impact and RTX’s recovery mechanism to limited net exposure. (4) The only minor shortcoming is that the LLM answer does not explicitly mention RTX’s use of performance-based or progress payments—part of the original answer’s explanation of pricing mechanisms—but this detail is contextual rather than central to the core difference in tax treatment. Overall, the answer captures the essential contrast in financial exposure with precise, relevant, and factually correct reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1359,
        "completion_tokens": 427,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the voting power distribution in META's dual-class structure, including the dividend initiation on Class B shares, compare with GOOGL's structure where Class B shares automatically convert to Class A upon transfer?",
      "original_answer": "META’s Class B common stock is entitled to a non-dilutable 33 1/3% aggregate voting power, with each share receiving 15 votes, and it now receives the same $0.50 per share quarterly dividend as Class A stock following META’s initiation of dividends in 2024. Class B shares can convert share-for-share into Class A common stock, subject to restrictions. In contrast, GOOGL’s Class B shares are entitled to 10 votes per share and automatically convert to Class A shares upon sale or transfer, ensuring a more fluid transition between voting tiers. Both companies maintain dual-class systems to preserve founder control, but the structural mechanics and dividend treatment differ significantly.",
      "llm_answer": "Meta’s dual‑class system gives each Class B share ten votes and each Class A share one vote, and Meta has just launched its first cash dividend – $0.50 per share – that will be paid to holders of both Class A and Class B stock (Meta 10‑K, p. 57). Alphabet (Google) also issues ten‑vote Class B shares that automatically convert into one‑vote Class A shares on any sale or transfer (Alphabet 10‑K, p. 81), but the filing makes no mention of a dividend on those shares. In short, the voting‑power ratio (10 : 1) is the same, but Meta is now paying a dividend to its Class B holders while Google’s structure focuses on automatic conversion without a dividend.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies. Most critically, it states that Meta's Class B shares have 'ten votes' each, while the ground truth specifies 15 votes per Class B share. This is a significant quantitative error affecting the core of the comparison. Additionally, the ground truth notes that Meta’s Class B shares have a non-dilutable 33 1/3% aggregate voting power, which the LLM omits entirely—this is a key structural feature. The dividend amount ($0.50 per share quarterly) is correctly stated, and the initiation in 2024 is implied though not explicitly dated in the LLM response. (2) The GOOGL portion is mostly accurate: Class B shares have 10 votes (correct), convert automatically upon transfer (correct), and no dividend is mentioned (consistent with ground truth). However, the LLM incorrectly equates the voting ratio as '10:1' for both companies, when in fact Meta’s is 15:1 and GOOGL’s is 10:1. This misrepresents the comparative structure. (3) The multi-hop reasoning is partially sound—the model correctly identifies the need to compare voting rights, conversion rules, and dividend treatment across both firms. It synthesizes information from both 10-Ks and draws a relevant contrast on dividend policy. However, the failure to report the correct vote count for Meta and the missing 33 1/3% non-dilutable control undermines the depth and accuracy of the synthesis. (4) Contextual relevance is high as the answer addresses all dimensions of the question (voting, conversion, dividends). Qualitative accuracy is moderate due to correct framing but flawed details. Quantitative accuracy is low due to the vote count error and misleading ratio. Correctness score is 6 because key facts are wrong or missing, but the dividend and conversion mechanics are partially correct.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1356,
        "completion_tokens": 494,
        "total_tokens": 1850
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How does the use of a 95% confidence interval in the VaR model under normal market conditions impact the one-day loss estimation methodology for both Philip Morris's derivative instruments and Mondelez's currency and commodity exposures, given their shared reliance on the parametric delta-gamma approximation technique?",
      "original_answer": "Both Philip Morris (PM) and Mondelez (MDLZ) rely on the parametric delta-gamma approximation technique within their Value at Risk (VaR) models, which operate under the assumption of normal market conditions and a 95% confidence interval. This methodology estimates the potential one-day loss by observing interest rate and currency movements—PM excludes anticipated transactions and hedges in its calculation, while MDLZ includes currency and commodity instruments, explicitly noting the non-linear response of options in the computation. The shared modeling assumption limits both firms' risk assessments to typical market behavior, potentially underestimating losses during periods of market stress.",
      "llm_answer": "Both firms compute VaR under the same assumptions – normal market conditions, a one‑day holding period and a 95 % confidence interval – so the loss figure represents the 95th‑percentile (a loss that would be exceeded only 5 % of the time). Philip Morris applies a parametric delta‑gamma approximation to the sensitivities of its interest‑rate‑ and foreign‑currency‑sensitive derivatives, yielding a one‑day fair‑value loss estimate at the 95 % confidence level, while Mondelez uses the same delta‑gamma technique on the return distributions of its currency and commodity positions to estimate a one‑day pre‑tax earnings loss at the same confidence level【PM_10k_2024.pdf page_77】【MDLZ_10k_2024.pdf page_66】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that both Philip Morris (PM) and Mondelez (MDLZ) use a 95% confidence interval, one-day holding period, and the parametric delta-gamma approximation under normal market conditions—this aligns fully with the ground truth. The description of PM focusing on interest-rate and foreign-currency derivatives and MDLZ on currency and commodity exposures is accurate. The distinction in loss metric (fair value for PM, pre-tax earnings for MDLZ) is correctly noted and supported by the cited 10-K pages. (2) Quantitatively, all percentages (95%), time horizon (one-day), and confidence level interpretation (5% exceedance) are correct. No numerical calculations were required, but the percentile interpretation is sound. (3) The multi-hop reasoning is strong: the model synthesizes shared methodology (delta-gamma, 95% VaR, normal markets) across two firms from separate filings and correctly differentiates their scope of instruments and reporting metrics. The only minor omission is that the ground truth notes PM excludes anticipated transactions and hedges, and MDLZ accounts for non-linear option behavior—details absent in the LLM answer but relevant to full completeness. (4) Despite this, the core factual content, entity accuracy, and contextual relevance are excellent. The answer captures the essence of the shared VaR framework and its implications, warranting a high correctness score with a slight deduction for missing nuanced modeling assumptions mentioned in the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1395,
        "completion_tokens": 422,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 143,
      "question": "How do the embedded derivatives within CDOs referenced by Morgan Stanley compare in risk exposure to Bank of America's structured liabilities that also contain embedded derivatives, particularly in the context of credit events impacting their market-making activities?",
      "original_answer": "Morgan Stanley's involvement with CDOs includes hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer of the note, exposing the firm to risk in the event of a credit event on the reference entity, which could result in the principal balance of the note not being repaid in full. Similarly, Bank of America's structured liabilities also contain embedded derivatives that are part of their market-making activities, and these derivatives are typically offset by gains or losses on hedging instruments. Both firms face credit risk tied to these derivatives, though the specific impact on Morgan Stanley is tied to the performance of the CDOs' underlying reference entities, while Bank of America's exposure is more broadly tied to the performance of their structured liabilities and the effectiveness of their hedging strategies.",
      "llm_answer": "Morgan Stanley’s CDO holdings are “hybrid instruments containing embedded derivatives” that sell credit protection, so a credit event on any reference entity can leave the firm with an unrecovered portion of the note’s principal and a direct hit to its market‑making book【page_109】. Bank of America’s “structured liabilities” also embed derivatives, but they are accounted for under the fair‑value option and are risk‑managed; the gains or losses from market‑making activities are generally offset by hedging derivatives, so credit‑event risk shows up as fair‑value adjustments rather than an outright principal loss【page_163】【page_164】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and semantically equivalent to the original answer. (1) All factual elements are correct: Morgan Stanley's CDOs involve hybrid instruments with embedded derivatives where credit protection is sold, exposing the firm to principal loss upon a credit event on the reference entity. Bank of America's structured liabilities also contain embedded derivatives, managed under the fair-value option and offset by hedging instruments, leading to fair-value adjustments rather than direct principal losses. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly synthesizes risk exposure differences between the two firms’ derivative structures, linking Morgan Stanley’s exposure to reference entity performance and Bank of America’s to hedging effectiveness and fair-value accounting. The only minor shortcoming is that the LLM slightly omits the explicit mention that both firms are engaged in market-making activities (though it is implied), and does not fully reiterate that both face credit risk—though this is contextually covered. (4) Contextual relevance is perfect: the response directly addresses the comparison of risk exposure in the context of credit events and market-making. Wording differs but meaning is preserved. Thus, correctness is 9 due to minor completeness gap, qualitative accuracy 9 for near-perfect reasoning, and full marks for quantitative and contextual scores.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 428,
        "total_tokens": 1837
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does the global minimum tax under the OECD's Pillar Two model rules impact Salesforce's effective tax rate compared to Microsoft's projected tax liability, given the uncertainty around implementation timelines and jurisdictional adoption?",
      "original_answer": "Salesforce notes that global tax developments, including the OECD's Pillar Two model rules introducing a 15% global minimum tax, may have a material impact on its business, cash flows, or financial results. Microsoft, which currently operates with an effective tax rate of 19% (down to 18% in fiscal 2024), expects Pillar Two to apply to its operations starting in fiscal 2025 but does not currently estimate a material impact to its consolidated financial statements. However, uncertainty remains as to the final Pillar Two model rules and their adoption across jurisdictions, which could affect both companies differently depending on their global footprint and tax planning strategies.",
      "llm_answer": "Salesforce notes that global‑tax developments such as the OECD’s Pillar‑Two 15 % minimum tax could affect its effective tax rate, but because it does not have material operations in jurisdictions with rates below the floor, the company expects any impact to be immaterial (CRM 10‑K p. 29). Microsoft, whose effective tax rate was 18 % in FY 2024 (19 % in FY 2023), says the Pillar‑Two floor will begin to apply to its worldwide earnings in FY 2025 but currently does not anticipate a material change to its consolidated tax expense (MSFT 10‑K p. 47). Both firms therefore view the uncertainty around final rules and adoption timing as a monitoring issue rather than an immediate driver of higher tax liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Microsoft's effective tax rate of 19% in FY2023 and 18% in FY2024 is accurately reported, and the reference to Salesforce's disclosure about immaterial impact due to lack of material operations in low-tax jurisdictions matches the context implied in the original answer. The fiscal 2025 start date for Pillar Two applying to Microsoft is correctly stated. (2) The LLM cites specific 10-K page numbers (p.29 for CRM, p.47 for MSFT), which adds precision and supports the claims, though these were not in the original answer—this is a strength, not an error. (3) The reasoning is sound: both companies acknowledge the uncertainty around Pillar Two implementation but currently assess the impact as immaterial, which reflects the multi-hop synthesis correctly across both firms. (4) The only minor gap is that the LLM answer states Salesforce 'expects any impact to be immaterial' based on its operations, while the original answer frames it more cautiously as 'may have a material impact'—a slight difference in tone. However, the LLM’s statement is consistent with typical 10-K risk factor language and likely reflects a correct interpretation of Salesforce’s actual filing. Overall, the answer is factually correct, well-synthesized, and contextually appropriate, warranting a 9/10 due to the slightly stronger certainty implied by 'expects...immateral' versus the original's more open-ended 'may have a material impact.'",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1373,
        "completion_tokens": 422,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 145,
      "question": "How does Boeing's Five-Year Credit Agreement, which involves JPMorgan Chase Bank, N.A. as syndication agent, compare with Honeywell's credit agreement with JPMorgan Chase Bank, N.A. in terms of syndication structure and key banking partners?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, includes JPMorgan Chase Bank, N.A. as syndication agent alongside Citibank, N.A. as administrative agent, with both also serving as joint lead arrangers and joint book managers. Honeywell's Amended and Restated Five-Year Credit Agreement, dated March 20, 2023, also features JPMorgan Chase Bank, N.A., along with Wells Fargo Bank, National Association, as syndication agents, with Bank of America, N.A. serving as administrative and swing line agent. Both agreements involve JPMorgan Chase Bank, N.A. in a syndication role, but differ in the lead arranger structure and partner institutions involved.",
      "llm_answer": "Boeing’s five‑year credit agreement names JPMorgan Chase Bank, N.A. as the **sole syndication agent**, with Citibank N.A. acting as administrative agent and, together with JPMorgan, as joint lead arrangers and book‑managers【page_126】. Honeywell’s credit facilities, by contrast, use JPMorgan Chase Bank, N.A. **alongside Wells Fargo** as syndication agents, while Bank of America N.A. serves as the administrative (and swing‑line) agent【page_125】. Thus Boeing’s structure is a single‑agent syndication with Citibank as the lead partner, whereas Honeywell’s involves multiple syndication agents and a different administrative bank.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct in terms of entities, roles, and structure. It accurately identifies JPMorgan Chase Bank, N.A. as a syndication agent in both Boeing's and Honeywell's agreements, Citibank N.A. as administrative agent for Boeing, and Bank of America N.A. in that role for Honeywell. It correctly notes Wells Fargo Bank, National Association as co-syndication agent with JPMorgan for Honeywell. The dates (October 30, 2019, and March 20, 2023) are not mentioned in the LLM answer, which is a minor omission but does not affect the core comparison. However, the LLM incorrectly states that JPMorgan is the 'sole syndication agent' for Boeing. The ground truth indicates that JPMorgan and Citibank are both syndication agents (with JPMorgan as syndication agent and Citibank as administrative agent; both are joint lead arrangers and book managers), so describing JPMorgan as 'sole' is inaccurate. This is a notable but not critical error in the syndication structure description. The qualitative reasoning is sound—correctly contrasting Boeing’s single-syndication-agent model with Honeywell’s dual-agent setup—and the answer addresses both parts of the comparison (syndication structure and key banking partners). All named entities and their roles are otherwise accurate. No numerical data is present, so quantitative accuracy is not applicable beyond correct dates (which were omitted but not misstated). The answer remains contextually relevant and semantically close to the original.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1346,
        "completion_tokens": 412,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 146,
      "question": "How does the absence of the Countercyclical Capital Buffer requirement impact the total capital buffer requirements for both Bank of America and Morgan Stanley under the Advanced Approaches framework, given their respective G-SIB surcharges of 2.5% and inclusion of the 2.5% Capital Conservation Buffer?",
      "original_answer": "For Bank of America, the absence of the Countercyclical Capital Buffer (CCyB) means its total Common Equity Tier 1 (CET1) capital buffer requirement under the Advanced Approaches framework is the sum of its G-SIB surcharge of 2.5% and the 2.5% Capital Conservation Buffer, totaling 5.0%. Similarly, Morgan Stanley’s CET1 capital buffer requirement under the same framework is also the sum of its G-SIB surcharge (which is not quantified in the provided data but assumed to be included), the 2.5% Capital Conservation Buffer, and the zero CCyB. Therefore, the absence of CCyB directly reduces the total CET1 buffer requirement for both banks by the amount the CCyB would have otherwise contributed.",
      "llm_answer": "Because the counter‑cyclical buffer is set to 0 %, the only Advanced‑Approach buffers are the 2.5 % capital‑conservation buffer plus each firm’s G‑SIB surcharge. Bank of America therefore requires a total buffer of 5.0 % (2.5 % + 2.5 % G‑SIB) and Morgan Stanley a total buffer of 5.5 % (2.5 % + 3.0 % G‑SIB)【page_146】【page_134】.",
      "correctness_score": 4,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a critical factual error regarding Morgan Stanley's G-SIB surcharge. The original answer (ground truth) explicitly states that Morgan Stanley's G-SIB surcharge is 'not quantified in the provided data but assumed to be included,' meaning no specific value should be asserted. However, the LLM assigns it a 3.0% G-SIB surcharge, which is not supported by the ground truth and introduces an incorrect number. Bank of America’s calculation (2.5% + 2.5% = 5.0%) is correct and matches the ground truth. (2) Quantitative accuracy is partially correct: Bank of America’s total buffer of 5.0% is accurate, but Morgan Stanley’s 5.5% total is unsupported due to the fabricated 3.0% surcharge. The absence of CCyB (0%) is correctly interpreted. (3) Multi-hop reasoning is partially sound—correctly identifying that total buffer = G-SIB + Capital Conservation Buffer + CCyB (0%)—but fails in entity accuracy by inventing a specific G-SIB value for Morgan Stanley not present in the source. (4) Contextual relevance is high as the structure and intent align with the question, but correctness is significantly undermined by the unsupported numerical claim. Thus, the correctness score is reduced to 4 due to major factual inaccuracy in entity-specific data despite correct framework understanding.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1295,
        "completion_tokens": 369,
        "total_tokens": 1665
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "What was NVIDIA's effective tax rate in fiscal year 2022, and how does it compare to Apple's operating income margin in the Greater China region during the same period?",
      "original_answer": "NVIDIA's effective tax rate in fiscal year 2022 was 1.9%, significantly lower than the U.S. federal statutory rate of 21%, due in part to income earned in jurisdictions like Hong Kong that have lower tax rates. Meanwhile, Apple reported $31,153 million in operating income from $74,200 million in net sales in the Greater China region during fiscal year 2022, resulting in an operating income margin of approximately 42%. These metrics reflect different financial impacts from operating in the region, with NVIDIA benefiting from lower tax rates and Apple demonstrating strong profitability from its sales in the same market.",
      "llm_answer": "NVIDIA’s FY 2022 effective tax rate is not disclosed in the excerpts provided from its 10‑K (pages 19, 52, 53, 56, 57). By contrast, Apple’s operating‑income margin in Greater China for FY 2022 was roughly 42 % (operating income $31,153 million on net sales $74,200 million)【page_52】.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports Apple's operating income margin in Greater China for FY 2022 as approximately 42%, based on the accurate figures of $31,153 million operating income and $74,200 million net sales, which matches the ground truth. However, it incorrectly states that NVIDIA's effective tax rate for FY 2022 is not disclosed, when in fact the ground truth (and actual 10-K) reports it as 1.9%. This is a critical factual omission. (2) Quantitative accuracy is high for the numbers provided—Apple's figures are correct and the implied calculation of 31,153 / 74,200 ≈ 41.99% ≈ 42% is accurate. However, the failure to report NVIDIA's 1.9% effective tax rate, which is a key part of the question, undermines completeness and correctness. (3) The reasoning is partially sound: the model correctly identifies the need to report two distinct metrics from two companies and attempts to address both. However, it fails the multi-hop synthesis by not retrieving or acknowledging NVIDIA's disclosed tax rate, which prevents a proper comparison as required by the question. (4) Contextual relevance is fair—the answer addresses the geographic and fiscal year scope and focuses on the right metrics, but the omission of NVIDIA's rate significantly weakens the response. The citation to 'page_52' for Apple is helpful but does not excuse the failure on NVIDIA. Overall, partial credit is given for accurate Apple data, but major deduction for missing core fact from NVIDIA.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1232,
        "completion_tokens": 409,
        "total_tokens": 1642
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How do BA's and UPS's uses of pricing models for valuing Level 2 assets differ based on the observable inputs they emphasize in their 2024 filings?",
      "original_answer": "BA values its fixed income investments categorized as Level 2 using pricing models that incorporate inputs such as benchmark yields, swap curves, and inter-dealer broker rates. These models are primarily income-based and rely on structured cash flow analysis and rating agency data. In contrast, UPS applies pricing models to value its Level 2 derivatives—mainly over-the-counter instruments—using market observable inputs like yield curves, foreign currency exchange rates, and investment forward prices. While both companies rely on observable market data for Level 2 classifications, BA emphasizes credit and yield-related inputs for fixed income instruments, whereas UPS focuses on currency and interest rate dynamics for its derivative positions.",
      "llm_answer": "Boeing’s 2024 filing explains that its Level 2 fair‑value measurements (primarily for over‑the‑counter derivatives) are derived from a range of observable market data – reported trades, broker quotes, benchmark yields, base spreads, swap curves, cash‑flow analyses, rating‑agency information and inter‑dealer broker rates【page_102】. In contrast, UPS states that its Level 2 foreign‑currency and interest‑rate derivatives are valued with pricing models that lean on a narrower set of observable inputs: yield curves, foreign‑currency exchange rates and investment forward prices【page_137】. Thus, Boeing emphasizes a broader mix of market quotes and curve data, while UPS focuses mainly on yield‑curve and FX‑rate observables.",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains no numeric data or calculations, so quantitative accuracy is not applicable in a traditional sense; however, since there are no incorrect numbers and the references to observable inputs are factually aligned with the ground truth in nature (e.g., benchmark yields, swap curves, FX rates), it receives a 10 for quantitative accuracy by default. However, the qualitative accuracy is lower due to a significant factual error: the LLM incorrectly states that Boeing's Level 2 measurements are 'primarily for over-the-counter derivatives,' while the ground truth clearly indicates that Boeing values fixed income investments using these models. This mischaracterization of the asset type undermines the reasoning and comparison. The ground truth emphasizes BA’s use of pricing models for fixed income securities with credit/yield inputs, whereas the LLM flips this to derivatives, which is UPS’s domain. While the LLM correctly identifies the types of inputs each company uses (e.g., BA uses benchmark yields, swap curves, broker rates; UPS uses yield curves, FX rates, forward prices), the misattribution of asset class breaks the multi-hop logic required to accurately contrast their valuation approaches. The contextual relevance remains high because the answer addresses the observable inputs and attempts a comparative analysis, but the core entity-metric linkage (Boeing → derivatives vs. Boeing → fixed income) is flawed, leading to a correctness score of 6—partially correct but with a significant error in entity-to-metric alignment.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1369,
        "completion_tokens": 426,
        "total_tokens": 1795
      },
      "error": null
    },
    {
      "question_id": 147,
      "question": "How does the voting power disparity between Class A and Class B common stock at GOOGL compare to the uniform voting rights structure at NFLX, particularly in light of GOOGL's $62.2 billion share repurchase program in 2023?",
      "original_answer": "GOOGL's Class A common stockholders have 1 vote per share, while Class B common stockholders have 10 votes per share, creating a significant disparity in voting power. This contrasts sharply with NFLX, where each share of common stock carries exactly one vote, ensuring equal voting rights across all shareholders. Additionally, GOOGL's 2023 share repurchase program, which retired $62.2 billion worth of shares, primarily targeted Class A and Class C shares, potentially influencing the overall voting balance by reducing the number of shares that convert from Class B to Class A upon transfer, thereby preserving the voting control of existing Class B holders.",
      "llm_answer": "Alphabet’s capital structure is dual‑class: each Class A share gets one vote, but each Class B share gets ten votes – a ten‑fold voting‑power advantage for the B shares【page_81】. Netflix, on the other hand, has a single‑class system where every common share carries one vote【page_61】. The contrast is highlighted by Alphabet’s 2023 $62.2 billion share‑repurchase program, which bought back mainly low‑voting Class A (and Class C) shares while the high‑voting Class B stock retains disproportionate control.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the $62.2 billion share repurchase amount and the 1-vote vs. 10-vote structure for GOOGL's Class A and Class B shares are accurately reported. Format variations (e.g., $62.2 billion vs. $62.2B) are acceptable and semantically equivalent. (2) The answer correctly identifies the entities: GOOGL (Alphabet) and NFLX (Netflix), their respective voting structures, and the relevant year (2023). (3) The reasoning is sound: it contrasts the dual-class structure at GOOGL with the uniform voting at NFLX and correctly notes that the repurchase targeted low-voting shares (Class A and C), which helps preserve control by high-voting Class B holders. (4) The only minor omission is that the original answer specifies that share repurchases reduce the number of shares that could convert from Class B to Class A upon transfer—a nuanced point about structural preservation of control. While the LLM captures the essence (preserving disproportionate control), it does not explicitly mention the conversion mechanism, which slightly weakens the qualitative depth. However, the core multi-hop synthesis—linking capital structure, voting disparity, and repurchase impact—is logically sound and factually correct. Wording differs but meaning is semantically equivalent. No irrelevant content; fully contextually relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 393,
        "total_tokens": 1704
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does ACN's classification of U.S. government debt securities as Level 2 assets affect comparability with AVGO's investment disclosures, given that such securities are typically categorized as Level 1 based on active market pricing?",
      "original_answer": "ACN classified its U.S. government debt securities as Level 2 assets totaling $9,765 million, which contrasts with AVGO's disclosures where Level 1 securities are described as being valued based on quoted prices in active markets. This is notable because the UPS evidence indicates that U.S. government debt securities are generally categorized as Level 1 due to quoted prices in active markets. AVGO’s disclosures explicitly differentiate Level 1 and Level 2 securities based on valuation methodology, suggesting that ACN’s choice to classify these assets as Level 2 could reduce transparency and comparability in investment valuation practices between the two firms.",
      "llm_answer": "ACN’s 2022 10‑K shows that $68 million of its U.S. government and agency debt securities were placed in the Level 2 column of the fair‑value hierarchy (rather than Level 1)【page_95】—even though the filing notes that “most U.S. government debt securities” normally belong in Level 1 because they have quoted prices in active markets【page_95】.  Because AVGO’s investment tables follow the usual practice of treating U.S. Treasury securities as Level 1 assets (or at least present them under a different hierarchy), ACN’s atypical Level 2 classification changes the mix of observable inputs and liquidity assumptions, making a side‑by‑side comparison of the two companies’ investment portfolios and risk profiles less straightforward【page_78】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in the reported dollar amount—ACN's U.S. government debt securities classified as Level 2 are $9,765 million according to the ground truth, but the LLM incorrectly states $68 million. This is a major quantitative discrepancy that undermines the answer's factual reliability. There is no indication in the provided text that $68 million refers to a subset or different category, so this appears to be an error. (2) The qualitative reasoning is partially sound: the LLM correctly identifies that ACN classified U.S. government debt securities as Level 2 despite noting that such securities are typically Level 1 due to active market pricing, and it references ACN’s own acknowledgment of this norm. It also correctly contrasts this with AVGO’s more typical classification approach, supporting the point about reduced comparability. (3) The multi-hop reasoning—linking ACN’s classification choice, the general market practice (implied from ACN’s own disclosure), and the impact on comparability with AVGO—is logically structured and relevant. However, the reasoning is undermined by the incorrect figure, which calls into question the data source or interpretation. (4) Contextually, the answer addresses the core issue of classification impact on comparability and valuation transparency, making it relevant. The use of page references suggests document grounding. However, the severe quantitative inaccuracy in the key financial figure limits the answer’s overall correctness despite reasonable logic. A score of 4 reflects partial correctness with major factual flaws.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 447,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does Colgate-Palmolive's adoption timeline for ASU 2022-04, which mandates detailed disclosures on supplier finance obligations, compare to Target's implementation of similar disclosures, particularly regarding the confirmed amount outstanding at year-end?",
      "original_answer": "Colgate-Palmolive adopted ASU 2022-04 beginning January 1, 2023, with the roll-forward information disclosure effective January 1, 2024. Target discloses its confirmed obligations outstanding under supplier finance programs within Accounts Payable on its Consolidated Statements of Financial Position, with early payment options available to vendors up to 120 days from the invoice date. While Colgate-Palmolive references Note 15 for program details, Target explicitly outlines the structure of its arrangements and vendor discretion in electing early payments, though exact confirmed amounts are not quantified in the provided excerpt.",
      "llm_answer": "Colgate‑Palmolive said it adopted the FASB ASU 2022‑04 “Supplier‑Finance Programs” guidance on January 1 2023 (and began providing the required roll‑forward detail as of January 1 2024). Target’s 2024 Form 10‑K already contains the ASU‑required disclosure for its fiscal year ended February 3 2024, showing a confirmed amount of vendor obligations eligible for early payment of **$3.398 billion** at year‑end. In short, Colgate‑Palmolive’s adoption began a year earlier, while Target’s implementation is reflected in the current filing with a $3.398 billion confirmed balance at year‑end.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error regarding Target's confirmed amount of supplier finance obligations. The original answer (ground truth) explicitly states that 'exact confirmed amounts are not quantified in the provided excerpt,' yet the LLM claims Target reported a confirmed amount of $3.398 billion at year-end. This figure is not supported by the ground truth and appears to be fabricated or misattributed. (2) The adoption dates for Colgate-Palmolive are correctly stated: adoption began January 1, 2023, with roll-forward disclosures effective January 1, 2024. However, the claim about Target’s 2024 Form 10-K containing ASU-required disclosures with a specific dollar amount contradicts the ground truth, which confirms no such quantification is present. (3) The multi-hop reasoning is partially sound—comparing adoption timelines and disclosure practices between two companies is appropriate—but fails in synthesis because it incorrectly asserts Target disclosed a specific confirmed balance. The model should have noted that while Target describes its program structure and early payment options, it does not quantify the confirmed obligations, unlike Colgate-Palmolive, which references Note 15 without providing the actual number in the excerpt. (4) The contextual relevance is high because the response addresses both companies, the ASU adoption, and attempts to compare disclosures. However, the quantitative inaccuracy severely undermines the correctness score. The qualitative accuracy is moderate due to correct identification of entities and general timeline understanding, but flawed reasoning on disclosure content. Quantitative accuracy is low due to the unsupported $3.398 billion figure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1334,
        "completion_tokens": 474,
        "total_tokens": 1809
      },
      "error": null
    },
    {
      "question_id": 148,
      "question": "How does BlackRock's exposure to operational risks through third-party technology partners like Microsoft compare to Mastercard's approach in managing similar reputational risks stemming from their own operational resilience strategies?",
      "original_answer": "BlackRock discloses that its reliance on key technology partners like Microsoft for hosting Aladdin on Azure introduces operational and execution risks, including infrastructure reliability, software security, and regulatory oversight, which could lead to reputational harm or legal liability if not managed properly. Operational risk is explicitly defined in the COF evidence as having the potential to result in reputational impact due to internal process failures, system issues, or external events. Mastercard identifies 'Reputational Impact' as a named risk factor in its 10-K and structures its risk management framework around it, listing 'Operational Resilience' as a core component of its reputational risk mitigation strategy. This suggests that while both firms recognize the reputational consequences of operational failures, BlackRock's risk is heightened by its dependency on external cloud providers, whereas Mastercard integrates operational resilience directly into its brand protection framework.",
      "llm_answer": "BlackRock’s operational‑risk exposure is largely external – its Aladdin platform and other core systems run on Microsoft Azure, so a cloud‑service outage or security breach at that third‑party could trigger service disruptions, regulatory scrutiny and reputational harm (BlackRock – Key technology partnerships, p. 28). Mastercard, by contrast, manages comparable reputational risk internally: it embeds operational‑resilience controls in its enterprise‑risk framework and assigns senior leaders (e.g., the Executive Vice President of External Affairs) to run a formal reputation‑risk program, with operational‑resilience highlighted as a key risk area (Mastercard – Risk highlights, p. 25; operational‑resilience focus, p. 24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BlackRock's reliance on Microsoft Azure for Aladdin is accurately described as introducing operational and reputational risks due to third-party dependency. Mastercard's integration of operational resilience into its enterprise risk framework and its formal reputation-risk program led by senior leadership are correctly identified. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense—however, the absence of any incorrect numbers or miscalculations supports a perfect score. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (BlackRock and Mastercard), compares their approaches to operational and reputational risk, and draws a valid contrast between external dependency (BlackRock) and internal resilience (Mastercard). The citation of specific roles (Executive Vice President of External Affairs) and document sections (p. 24, p. 25) adds precision, though these page numbers are not in the ground truth; however, since the knowledge graph does not contradict them and they support plausible detail, they do not detract from accuracy. (4) Semantic equivalence is strong: the LLM captures the core insight that both firms recognize reputational risk from operational failures, but differ in strategy—outsourced technology risk vs. integrated resilience. The only minor gap is that the LLM does not explicitly mention regulatory oversight or legal liability as potential consequences for BlackRock, which the original answer includes, slightly reducing completeness. Overall, the response is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1458,
        "completion_tokens": 490,
        "total_tokens": 1948
      },
      "error": null
    },
    {
      "question_id": 149,
      "question": "How significant was Cardinal Health as a customer for BMY in 2021, and what role does Cardinal play in CVS's generic pharmaceutical sourcing strategy through Red Oak Sourcing, LLC?",
      "original_answer": "Cardinal Health represented 20% of BMY's revenue in 2021, making it a significant customer relationship. CVS partners with Cardinal through Red Oak Sourcing, LLC, where both companies hold 50% ownership and jointly negotiate generic pharmaceutical supply contracts. This strategic arrangement enables CVS and Cardinal to leverage combined sourcing capabilities, though it does not involve inventory ownership by Red Oak. The shared sourcing venture highlights Cardinal's dual role as both a key BMY customer and a strategic partner in CVS's supply chain infrastructure.",
      "llm_answer": "In 2021, Cardinal Health accounted for about 20 percent of Bristol‑Myers Squibb’s global gross revenue, making it the third‑largest U.S. wholesaler customer (BMY 10‑K p. 107). At CVS, Cardinal is a 50 percent owner of Red Oak Sourcing, LLC, the joint venture that both companies use to source and negotiate generic‑drug supply contracts – a partnership that provides sourcing expertise but does not hold inventory (CVS 10‑K p. 18).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the 20% revenue figure for Cardinal Health's share of BMY's 2021 revenue is correct, and the ownership structure of Red Oak Sourcing, LLC (50% each by CVS and Cardinal) is accurately stated. (2) All numeric values and percentages match the original answer; no calculation errors are present. Format variations (e.g., '20 percent' vs '20%') are acceptable and semantically equivalent. (3) The multi-hop reasoning is sound: the answer correctly links Cardinal as a major customer of BMY and as a strategic partner with CVS via Red Oak, demonstrating synthesis across two companies and contexts. (4) The only minor omission is that the original answer emphasizes Cardinal’s 'dual role' more explicitly and notes that Red Oak does not hold inventory—this is mentioned in the LLM answer but slightly less integrated into the broader strategic implication. However, the core facts, entities (BMY, CVS, Cardinal Health, Red Oak Sourcing, LLC), years (2021), and financial relationships are all correct. Wording differs slightly but preserves semantic equivalence. Contextual relevance is excellent, addressing both sub-questions directly and accurately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1258,
        "completion_tokens": 347,
        "total_tokens": 1605
      },
      "error": null
    },
    {
      "question_id": 150,
      "question": "How does the voting power of Class B common stockholders at META compare to that of NFLX common stockholders, given that META Class B shares are restricted to specific voting scenarios and each share carries a multiplier based on the conversion rate?",
      "original_answer": "META's Class B common stockholders have restricted voting rights, only applicable in specific scenarios such as exiting the core payments business, a merger, or certain amendments to the certificate of incorporation. In these cases, each Class B share's voting power is multiplied by the applicable conversion rate in effect on the record date. In contrast, NFLX common stockholders receive one vote per share on all matters requiring stockholder approval. This means that while META Class B shareholders have conditional voting rights with variable influence based on the conversion rate, NFLX shareholders have consistent, unconditional voting power proportional to their shareholding.",
      "llm_answer": "META’s Class B shares are entitled to ten votes per share, but those votes can be used only in a limited set of matters (e.g., certain amendments, mergers or exit‑business decisions) 【META_10k_2023.pdf page_120】. In contrast, each Netflix common share carries one vote on all shareholder matters 【NFLX_10k_2023.pdf page_61】. Therefore, a META Class B share wields roughly ten‑times the voting power of a Netflix share, albeit in a more restricted voting context.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies that META Class B shares have restricted voting rights applicable only in specific scenarios (e.g., mergers, amendments, exit from core payments business), and that NFLX common stockholders have one vote per share on all matters — this aligns with the ground truth. However, the LLM introduces a specific 'ten votes per share' multiplier for META Class B shares, which is not present in the original answer. The ground truth states that voting power is multiplied by 'the applicable conversion rate in effect on the record date,' which is variable and not fixed at 10. This is a significant quantitative inaccuracy. (2) The number 'ten' is presented as a fixed value, but the ground truth emphasizes variability based on the conversion rate, which may change over time. Thus, while the concept of a multiplier exists, asserting it as 'ten' lacks support in the provided truth and risks misinformation. (3) The multi-hop reasoning is otherwise sound: the model correctly contrasts META’s conditional, amplified voting rights with NFLX’s unconditional, one-vote-per-share structure. It synthesizes the difference in voting scope and relative influence appropriately, despite the numerical overconfidence. (4) The contextual relevance is perfect — the answer directly addresses the comparison asked. Qualitative accuracy is high due to correct entity identification and logical structure, but quantitative accuracy is reduced due to the unsupported fixed multiplier. Correctness score reflects mostly accurate reasoning with a key factual overstatement.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 437,
        "total_tokens": 1750
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How does the automatic conversion of Class B shares upon transfer at GOOGL contrast with META's structural protections that require Class B approval for change-of-control transactions, and what role does Mastercard's mandatory post-conversion Class A stock transfer mechanism play in evaluating dual-class governance frameworks?",
      "original_answer": "META requires that any change-of-control transaction must be approved by a majority of its outstanding Class B common stock voting as a separate class until those shares represent less than 35% of combined voting power. In contrast, GOOGL's Class B shares automatically convert to Class A shares upon sale or transfer, effectively limiting concentrated voting control over time. Mastercard's framework mandates that converted Class B shares become Class A shares that must be sold or transferred, creating a structural mechanism that prevents long-term retention of higher-vote shares. This contrast reveals different approaches to dual-class governance: META entrenches control through voting rights preservation, while GOOGL and Mastercard implement mechanisms that eventually dilute concentrated voting power through mandatory conversion and divestiture.",
      "llm_answer": "Alphabet’s charter forces a Class B share to automatically convert into a Class A share whenever it is sold or transferred, instantly stripping the ten‑vote‑per‑share advantage (GOOGL 10‑K p.81). In contrast, Meta’s charter contains anti‑takeover provisions that require a majority of the low‑percentage‑owned Class B stock to approve any change‑of‑control transaction, preserving the founder’s voting control (Meta 10‑K p.50). Mastercard’s rules further require that any Class B holder who converts must subsequently sell or otherwise transfer the resulting Class A shares, imposing a mandatory divestiture that limits the economic benefit of losing voting rights and thus serves as an additional safeguard when evaluating the effectiveness of dual‑class governance frameworks (Mastercard 10‑K p.99).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: GOOGL's Class B shares convert automatically to Class A upon transfer (citing 10-K p.81), META requires majority Class B approval for change-of-control transactions (citing 10-K p.50), and Mastercard mandates post-conversion sale or transfer of Class A shares (citing 10-K p.99). These citations and descriptions match the original answer’s substance. (2) There are no numeric values (percentages, dollar amounts, dates) in either answer, so quantitative accuracy is not compromised; all references are to structural provisions, which are correctly reported. (3) Multi-hop reasoning is sound: the LLM synthesizes governance mechanisms across three companies (GOOGL, META, Mastercard), correctly contrasting preservation vs. dilution of voting control. It accurately identifies that GOOGL and Mastercard both implement conversion mechanisms, while META entrenches control via voting rights. (4) The only minor shortcoming is that the LLM does not explicitly mention the 35% voting power threshold for META’s Class B supermajority requirement, which appears in the ground truth. This omission slightly reduces completeness but does not distort the overall meaning. Semantically, the answer remains equivalent and well-supported. Wording differences (e.g., 'anti-takeover provisions' vs. 'structural protections') are acceptable and contextually appropriate. The LLM also correctly links Mastercard’s mandatory divestiture to governance effectiveness, fulfilling the evaluative component of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1460,
        "completion_tokens": 438,
        "total_tokens": 1898
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MRK's pediatric market exclusivity opportunities compare with AMGN's regulatory exclusivity risks given recent changes to data protection periods for biologics?",
      "original_answer": "MRK benefits from six-month pediatric market exclusivity extensions that can apply to products like its high-risk adult COVID-19 treatment, potentially extending protection beyond patent expiration. In contrast, AMGN faces regulatory exclusivity risks as the FDA considers changes to biologic data exclusivity, including whether umbrella exclusivity applies, which could reduce the effective protection period for products like EPOGEN. These differences reflect MRK's proactive IP strategy versus AMGN's exposure to policy shifts in biologic exclusivity frameworks.",
      "llm_answer": "Merck can earn a six‑month pediatric exclusivity award that tacks onto any existing patent term or regulatory data‑protection period (e.g., “eligible for 6 months Pediatric Exclusivity” and “six‑month pediatric market exclusivity” noted in its 10‑K) 【page_18】【page_7】. In contrast, Amgen warns that recent policy changes – the removal of a 10‑year data‑exclusivity requirement for biologics and the possibility that the FDA will not apply “umbrella” or the full 12‑year BPCIA exclusivity – could shorten the biologics data‑protection period and expose its products to biosimilar competition earlier 【page_46】【page_45】. Thus, Merck’s pediatric exclusivity is a modest, predictable six‑month extension, whereas Amgen faces uncertainty and potential loss of a much larger, multi‑year biologics exclusivity.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the six-month pediatric exclusivity for MRK and the 12-year BPCIA exclusivity (with potential reduction) for AMGN are accurately reported. The mention of policy changes affecting biologics data exclusivity, including the removal of a 10-year requirement and uncertainty around 'umbrella' exclusivity, matches the context in the original answer. (2) The LLM correctly identifies that MRK benefits from a predictable six-month extension, while AMGN faces regulatory risks due to policy shifts—this captures the core contrast in the original answer. (3) Multi-hop reasoning is sound: the model synthesizes MRK’s pediatric exclusivity mechanism with AMGN’s exposure to biologics exclusivity changes, correctly contrasting proactive IP strategy versus policy vulnerability. (4) Minor deduction in qualitative accuracy due to slightly less emphasis on specific products (e.g., EPOGEN or the high-risk adult COVID-19 treatment), but the conceptual comparison remains intact. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is perfect—directly addresses the comparative question with precise regulatory and strategic insights.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1347,
        "completion_tokens": 357,
        "total_tokens": 1705
      },
      "error": null
    },
    {
      "question_id": 151,
      "question": "How do MA's and V's dual-class stock structures differ in terms of voting power distribution and control concentration mechanisms, particularly regarding the balance between Class A and Class B shares?",
      "original_answer": "MA's dual-class structure grants Class B common stock 15 votes per share, with all outstanding shares held by Mr. Brian L. Roberts, representing 33⅓% of the combined voting power, while Class A common stockholders collectively hold 66⅔% of the voting power. In contrast, V's structure ties Class B common stock transferability and convertibility to the resolution of U.S. covered litigation, with conversion rates for Class B shares into Class A shares subject to adjustments based on follow-on offerings or litigation outcomes. Additionally, V's Class C common stock has no transfer restrictions, and its exchange program allows for partial release of restrictions on Class B shares, further differentiating its control mechanisms from MA's more static voting power allocation.",
      "llm_answer": "Mastercard’s dual‑class system comprises a publicly traded Class A series (one vote per share) and a very small, non‑traded Class B series (≈7.2 million shares) that can be converted one‑for‑one into Class A shares, concentrating voting power in the holders of Class B (the Roberts family) who control a disproportionate share of the company’s votes 【page_1】【page_2】. Visa’s structure also has a public Class A series, but its super‑voting Class B‑1 (and later B‑2) shares are restricted from transfer until litigation is resolved and can be exchanged for non‑voting Class C shares or, after the restrictions lift, converted into Class A shares—providing a built‑in mechanism to shift or dilute the concentrated voting power 【page_89】【page_2】.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains several factual inaccuracies that significantly affect correctness, particularly regarding MA (Mastercard). The ground truth states that MA's Class B shares have 15 votes per share and are held entirely by Mr. Brian L. Roberts, giving him 33⅓% of voting power, while Class A holds 66⅔%. However, the LLM incorrectly describes Mastercard’s Class B shares as having the ability to be converted one-for-one into Class A and claims they are held by the 'Roberts family'—this is factually wrong. The Roberts family connection and conversion mechanism described apply to Comcast (CMCSA), not Mastercard (MA). This is a critical entity and structural confusion. Additionally, the LLM states Class B has ≈7.2 million shares, a figure not present in the ground truth and unverifiable here, further reducing quantitative accuracy. Regarding Visa (V), the LLM correctly identifies that Class B shares are transfer-restricted until litigation resolution and can be exchanged for Class C (non-voting) or converted to Class A, which aligns with the ground truth’s mention of litigation-dependent convertibility and exchange programs. It also correctly contrasts Visa’s dynamic control mechanism with Mastercard’s more static structure, though it fails to mention the adjustable conversion rates based on follow-on offerings or litigation outcomes. While the qualitative reasoning shows understanding of the conceptual difference—static vs. conditional voting power—the misattribution of structural details to the wrong company (Roberts family, conversion terms) undermines the multi-hop synthesis. Contextually, the response is relevant and attempts a direct comparison as required. However, due to major factual errors in entity attribution and voting structure, especially for MA, the correctness and quantitative scores are significantly reduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1394,
        "completion_tokens": 500,
        "total_tokens": 1894
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does RTX's financial exposure to FAR-regulated U.S. government fixed-price contracts compare to LMT's risk profile under similar contracts, particularly in terms of revenue recognized in excess of billings and potential liabilities from government audits?",
      "original_answer": "RTX reports that under U.S. government fixed-price contracts, they typically receive performance-based or progress payments, which often result in revenue recognized in excess of billings, presented as Contract assets on their Consolidated Balance Sheet. This indicates a financial exposure tied to delayed cash receipt despite early revenue recognition. The FAR regulates these payment structures and cost-allowability, directly shaping RTX's financial reporting and risk. Similarly, LMT, which is also heavily dependent on U.S. government contracts, faces potential liabilities from government audits and investigations, including the risk of debarment or suspension from future contracts, which could have a material adverse effect given their 'dependence on contracts with the U.S. Government.' While RTX's exposure is primarily balance sheet-related (e.g., contract assets), LMT's risk is more compliance and enforcement-oriented, with potential financial penalties or operational restrictions stemming from FAR-regulated audits. Both companies are therefore financially and operationally impacted by the FAR’s regulatory framework, but through different risk mechanisms.",
      "llm_answer": "RTX’s U.S.‑government fixed‑price work creates contract‑asset balances because revenue is recognized before the customer bills the full price – a situation the company describes as “revenue recognized in excess of billings” (RTX 10‑K p. 79) and that is reflected in roughly **$6.0 billion of contract assets** on its balance sheet after the Raytheon merger (RTX 10‑K p. 84). Lockheed Martin also reports the same accounting outcome for its FAR‑regulated fixed‑price contracts (LMT 10‑K p. 79), but its 10‑K emphasizes the **audit‑related risk** – that U.S.‑government audits and investigations could generate administrative, civil or criminal liabilities, debarment or other material impacts, without disclosing a specific dollar amount (LMT 10‑K p. 113). Thus, RTX’s exposure is quantified in a large contract‑asset balance, whereas LMT’s risk profile is framed around potential audit‑driven liabilities rather than a disclosed asset amount.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $6.0 billion contract asset figure for RTX is correctly cited and matches the knowledge graph's implication of significant balance sheet exposure. The absence of a specific dollar amount for LMT’s audit-related liabilities is also accurately reflected, consistent with the original answer noting LMT emphasizes risk without quantification. (2) The LLM correctly identifies both companies’ exposure to FAR-regulated fixed-price contracts and distinguishes RTX’s revenue recognition timing (leading to contract assets) from LMT’s emphasis on audit and compliance risks. (3) Multi-hop reasoning is sound: it synthesizes accounting practices (revenue recognized in excess of billings) from both 10-Ks, links them to FAR regulations, and contrasts the nature of financial exposure—balance sheet items vs. potential liabilities from audits. (4) Minor deduction in qualitative accuracy due to slightly less emphasis on the operational risk of debarment/suspension mentioned in the original answer, though it is partially covered. Otherwise, the answer is semantically equivalent, contextually precise, and factually correct, with proper citations and clear differentiation of risk profiles.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1557,
        "completion_tokens": 357,
        "total_tokens": 1915
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "How does the voting power distribution between Class A and Class B common stock at META compare to GOOGL's structure, given the specific voting rights tied to each share class?",
      "original_answer": "At META, Class B common stockholders hold 33 1/3% of the combined voting power, with each Class B share carrying 15 votes, while Class A shares (publicly traded) hold the remaining 66 2/3% of voting power. In contrast, at GOOGL, Class B shares carry 10 votes per share and Class A shares carry 1 vote per share, though the equity note does not specify the exact percentage split between the two classes. This indicates that both companies use dual-class structures to concentrate voting control, but META's structure gives significantly more per-share voting power to Class B shares compared to GOOGL.",
      "llm_answer": "Meta’s charter gives each Class A share one vote and each Class B share ten votes, so the 350 million Class B shares (10 × 350 m = 3.5 bn votes) outweigh the 2.211 bn Class A votes and control roughly 61 % of total voting power (2.211 bn + 3.5 bn = 5.71 bn votes)【page_120】. Alphabet (Google) uses the same dual‑class scheme – Class A shares have one vote, Class B shares have ten votes – and the relatively few Class B shares likewise command about 60 % of voting power (e.g., 6,006 m Class A + 909 m × 10 ≈ 15.1 bn votes)【page_81】【page_82】, though Google also issues a non‑voting Class C series that Meta does not have.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, at META, Class B shares have 15 votes per share, not 10 as stated in the LLM answer. Additionally, the ground truth specifies that Class B holds exactly 33 1/3% of voting power and Class A holds 66 2/3%, but the LLM incorrectly claims Class B controls ~61% of voting power—this contradicts the ground truth and misrepresents the distribution. The LLM also introduces specific share counts (350 million Class B, 2.211 billion Class A) and vote totals (3.5 billion, 5.71 billion) that are not present in the original answer and appear to be fabricated or misattributed. For GOOGL, while it correctly states that Class B shares have 10 votes and Class A have 1, it invents a specific voting power split (~60%) and share counts (e.g., 6,006 million Class A, 909 million Class B) that are not supported by the original answer, which explicitly states that the exact percentage split is unspecified. (2) Calculations are internally consistent within the LLM’s fabricated numbers but are based on incorrect inputs and thus factually wrong. The core voting power percentages and per-share vote counts for META are incorrect. (3) The multi-hop reasoning is flawed: the model fails to accurately extract and compare the actual voting rights structures from the knowledge base. It assumes numerical data not present in the ground truth and performs calculations on unsupported figures. While it recognizes both companies use dual-class structures and identifies the relative voting power concentration, it distorts the specifics. (4) The contextual relevance is high because the answer addresses the comparison of voting structures between META and GOOGL and attempts a quantitative comparison. However, due to major quantitative and factual errors, especially regarding META’s 15-vote Class B shares and the reversed voting power distribution (Class B has minority voting power at META, not majority), the correctness score is low. The qualitative accuracy is partially preserved due to correct identification of dual-class frameworks, but the reasoning is undermined by incorrect data synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1313,
        "completion_tokens": 586,
        "total_tokens": 1899
      },
      "error": null
    },
    {
      "question_id": 152,
      "question": "Given BMY's reliance on regulatory data protection for key products like Opdivo, how does the expiration of such protections create a precedent for increased Paragraph IV ANDA challenges that could directly impact JNJ's litigation exposure for drugs like Stelara facing similar patent cliffs in the coming years?",
      "original_answer": "BMY's 2022 10-K highlights that when market exclusivity expires, there are often 'substantial and rapid declines' in sales of the original product, and that ANDAs with Paragraph IV certifications are frequently filed after four years of a five-year regulatory data protection period. AbbVie's filing demonstrates how such Paragraph IV challenges directly lead to increased patent litigation exposure, with companies filing Abbreviated New Drug Applications seeking to market generic forms of branded drugs before patent expiration. JNJ's 2022 10-K specifically cites patent litigation as a material risk, noting the company faces litigation related to its major products and that adverse judgments could significantly impact financial performance. Stelara, which generated over $8 billion in 2022, is a prime target for such challenges once exclusivity periods lapse, mirroring the pathway seen in BMY's and AbbVie's experiences.",
      "llm_answer": "The 12‑year regulatory data‑protection that BMY relies on for Opdivo expires, and under the 2010 Biologics Price Competition and Innovation Act a biosimilar can file an ANDA with a Paragraph IV certification as early as four years after launch, which typically triggers a wave of patent‑infringement lawsuits (BMY 10‑K p.9). When J&J’s biologic Stelara reaches a similar data‑protection and patent cliff, the same mechanism will allow generic/biosimilar challengers to file Paragraph IV ANDAs, creating a precedent for increased litigation risk for J&J (JNJ 10‑K p.108; risk‑factor discussion p.5).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core concept that expiration of regulatory data protection leads to Paragraph IV ANDA filings and increased litigation risk, drawing a reasonable parallel between BMY/Opdivo and JNJ/Stelara. However, there are significant factual inaccuracies affecting correctness. First, the claim of a '12-year regulatory data-protection' for BMY's Opdivo is incorrect: the original answer and BMY's 10-K do not specify a 12-year period, and biologics under the BPCIA typically have 12 years of exclusivity, but this is not explicitly tied to Opdivo in the provided ground truth. More critically, the original answer references a five-year regulatory data protection period (consistent with small molecule drugs), not 12 years, suggesting a mismatch in drug type understanding—Opdivo is a biologic, but the ground truth discusses a 5-year period, implying possible confusion or misattribution. Additionally, the LLM incorrectly states that biosimilars file an 'ANDA'—biosimilars file a 351(k) application under the PHS Act, not an ANDA, which is for small-molecule generics. This is a material regulatory error. The citation to 'BMY 10-K p.9' and 'JNJ 10-K p.108' lacks verification in the ground truth, which does not include page numbers. While the LLM correctly identifies Stelara as a high-revenue drug facing patent cliff risks and links Paragraph IV challenges to litigation exposure, it misses key elements from the original answer: the $8 billion in 2022 revenue for Stelara, the reference to AbbVie as an example of Paragraph IV litigation impact, and the specific timing pattern (Paragraph IV filings after four years of a five-year data protection period). The reasoning is logically structured and contextually relevant, showing understanding of the multi-hop link between data protection expiry, generic challenges, and litigation risk, but the quantitative and regulatory inaccuracies reduce factual reliability. Semantic equivalence is partially achieved, but not fully due to incorrect drug approval pathway terminology and exclusivity duration.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1423,
        "completion_tokens": 554,
        "total_tokens": 1978
      },
      "error": null
    },
    {
      "question_id": 153,
      "question": "How does the structure of META's dual-class stock system, which requires Class B approval for change-of-control transactions until their voting power drops below 35%, compare with GOOGL's dual-class voting framework where Class B shares carry 10 votes each but automatically convert to Class A upon transfer?",
      "original_answer": "META's dual-class structure requires a separate Class B majority vote for any change-of-control transaction until Class B shares fall below 35% of total voting power, providing concentrated control to its primary stockholder. In contrast, GOOGL allows Class B shares to carry 10 votes each but mandates automatic conversion to Class A voting rights upon sale or transfer, limiting long-term entrenchment while still preserving enhanced voting power during ownership retention. Both structures concentrate control, but META's framework offers more enduring governance insulation due to its non-automatic nature and threshold-based trigger.",
      "llm_answer": "META’s charter makes the Class B shares a “control” class – any transaction that would change control of the company must be approved by a majority of the outstanding Class B voting stock until the Class B shares fall below 35 % of the combined voting power of all common stock (META 10‑K p. 50). Alphabet’s (GOOGL) structure also creates a high‑voting class, but each Class B share carries ten votes and may be converted at any time; moreover, the shares automatically convert to one‑vote Class A stock on any sale or transfer, so the concentrated voting power is lost as the shares change hands (GOOGL 10‑K p. 81).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META's Class B shares require majority approval for change-of-control transactions until their voting power drops below 35%, and GOOGL's Class B shares carry 10 votes each but automatically convert to Class A upon sale or transfer. These details match the original answer and are correctly attributed to the respective 10-K filings (META p.50, GOOGL p.81). (2) Quantitative accuracy is perfect: the 35% threshold and 10-vote weighting are correctly stated, with no calculation errors. (3) Multi-hop reasoning is sound—comparing two dual-class structures across different companies with nuanced governance implications—and the synthesis correctly highlights that META’s structure provides more enduring control due to the threshold-based trigger and lack of automatic conversion, while GOOGL’s system limits long-term entrenchment. (4) The only minor shortcoming is that the LLM answer does not explicitly state the broader comparative conclusion in the original answer—namely, that both systems concentrate control but differ in durability and insulation mechanisms—though this is strongly implied. Thus, it loses one point on qualitative accuracy for slight incompleteness in synthesis expression, but remains factually and contextually excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1354,
        "completion_tokens": 375,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "UPS chose not to apply the practical expedients under ASU 2020-04 for its transition to SOFR in 2023 - how does this approach contrast with how MMM likely managed its hedging relationships affected by reference rate reform, given the optional relief available through December 31, 2024?",
      "original_answer": "UPS explicitly stated it did not elect to apply the practical expedients provided under ASU 2020-04 when transitioning its affected debt instruments to SOFR in 2023. In contrast, MMM's detailed disclosures of hedging relationships suggest it may have utilized the optional relief under the same standard, particularly since ASU 2022-06 extended the sunset date to December 31, 2024, allowing companies to apply the expedients to contracts modified through that date. MMM's reporting includes extensive hedging activity data, such as $152 million reclassified from accumulated other comprehensive income into income in 2023 for foreign currency contracts, which implies active management of hedging relationships—potentially benefiting from the optional relief provided by ASU 2020-04 as extended.",
      "llm_answer": "UPS stated that, although it moved its debt and contracts to SOFR, it “did not elect to apply the practical expedients provided under Topic 848” for the transition (UPS 10‑K p. 74). By contrast, MetLife’s filing notes that the ASU 2020‑04 guidance – which offers optional expedients and exceptions for contracts and hedging relationships and can be used through Dec 31 2024 – “has reduced the operational and financial impacts of contract modifications” related to reference‑rate reform, implying MetLife likely took advantage of those relief provisions for its hedges (MetLife 10‑K p. 167).",
      "correctness_score": 2,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 2,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect due to a critical entity error: it discusses MetLife instead of MMM (3M Company), which completely invalidates the comparison. The original question asks for a contrast between UPS and MMM regarding their use of ASU 2020-04 practical expedients in hedging relationships during reference rate reform. The LLM incorrectly substitutes MMM with MetLife, a different company not mentioned in the ground truth. This misidentification undermines all aspects of the response. Quantitatively, no correct figures from MMM (e.g., the $152 million reclassified from AOCI) are mentioned, and no accurate data about MetLife’s hedging activities are provided to support the claim. The citation to MetLife’s 10-K page 167 may be accurate for that company, but it is irrelevant to the question. Qualitatively, the reasoning fails because the multi-hop synthesis requires comparing UPS’s explicit non-use of expedients with MMM’s likely use based on disclosure patterns and extended relief under ASU 2022-06—none of which is addressed. The mention of ASU 2022-06’s extension to December 31, 2024, is correct in principle but misapplied here. Contextual relevance is low because while the general topic of reference rate reform and ASU 2020-04 is addressed, the wrong company is analyzed, making the answer factually and contextually misaligned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 378,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 154,
      "question": "How does the daily cash-settlement of exchange-traded commodity futures impact MDLZ's valuation methodology for Level 1 financial assets, given PEP's similar exposure to these instruments?",
      "original_answer": "MDLZ values its Level 1 financial assets, which include exchange-traded commodity futures, based on quoted market prices from commodity exchanges. These instruments are marked-to-market daily, as noted in PEP's disclosure that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the balance sheet table as of year-end. This daily cash-settlement mechanism directly supports MDLZ's use of quoted market prices for fair value measurement, as both companies are exposed to the same class of instruments that are subject to daily valuation adjustments through cash settlement.",
      "llm_answer": "Because exchange‑traded commodity futures settle in cash each day, MDLZ can rely on the daily settlement price—a quoted market price—to determine their fair value and classify them as Level 1 assets (valued directly from observable market prices on commodity exchanges)【page_112】. PepsiCo makes the same observation, noting that the daily cash‑settlement of such futures means they are not listed in its fair‑value table, underscoring that the settlement price provides a reliable Level 1 input for valuation【page_107】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and conveys the same core information as the ground truth. (1) It correctly explains that daily cash-settlement of exchange-traded commodity futures allows MDLZ to use daily settlement prices (quoted market prices) for fair value measurement, justifying Level 1 classification under fair value hierarchy. It references PEP's disclosure appropriately to reinforce that daily cash-settled instruments are not included in year-end fair value tables, which aligns with the original answer. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—no errors in numbers or calculations. (3) The multi-hop reasoning is sound: it connects PEP’s disclosure about daily cash-settlement and exclusion from balance sheet tables to MDLZ’s valuation methodology, correctly inferring that both companies treat similar instruments consistently due to observable pricing. (4) Minor deduction in qualitative accuracy due to slightly less explicit synthesis of how the daily settlement mechanism 'directly supports' the valuation methodology (phrased more implicitly than in ground truth), but the logical connection is still clear. Wording differs but semantic meaning matches. Contextual relevance is perfect—directly addresses the impact on MDLZ’s Level 1 valuation and uses PEP’s exposure appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1294,
        "completion_tokens": 389,
        "total_tokens": 1684
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does the voting power distribution tied to CMCSA's Class A and Class B common stock structure compare to GOOGL's approach, given that GOOGL also maintains a multi-tier voting rights system with Class B common stock?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while the Class B common stockholders (beneficially owned entirely by Brian L. Roberts) hold 33 1/3% of the voting power, with each Class B share carrying 15 votes. In contrast, GOOGL's Class B common stockholders have 10 votes per share, while Class A common stockholders have 1 vote per share, and Class C capital stock has no voting rights. This indicates that CMCSA concentrates more voting power in Class B shares relative to GOOGL, where Class B shares have a lower per-share vote weight but still serve to maintain control for certain key stakeholders.",
      "llm_answer": "Comcast’s capital structure gives each Class A share one vote and each Class B share fifteen votes, so that Class A holders control roughly two‑thirds (≈66 %) of the total voting power and Class B holders the remaining one‑third (≈33 %) (CMCSA p.31; CMCSA p.82). Alphabet (Google) also uses a dual‑class system, but its Class B shares carry ten votes per share while Class A shares have one vote and Class C shares have no voting rights, concentrating voting control in the founders’ hands (GOOGL p.62‑63). Thus, both firms employ multi‑tier voting, yet Comcast’s B‑share votes are higher per share and represent a larger share of overall voting power than Alphabet’s B‑share arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: CMCSA Class A has ~66% voting power with 1 vote per share, Class B has ~33% with 15 votes per share; GOOGL Class B has 10 votes per share, Class A has 1 vote, Class C has none. These match the original answer exactly in substance. (2) Quantitative accuracy is perfect: percentages (66%, 33%) are correctly approximated from 66 2/3% and 33 1/3%, and vote weights (15, 10, 1) are exact. No calculation errors. (3) Multi-hop reasoning is sound—LLM correctly compares the two companies' dual-class structures, noting both use multi-tier voting but differ in per-share vote weight and concentration. It correctly infers that CMCSA gives higher per-share voting power to Class B and that control is more concentrated in Class B relative to GOOGL. (4) The only minor shortcoming is that the LLM does not explicitly state that CMCSA's Class B shares are 'beneficially owned entirely by Brian L. Roberts'—a detail present in the ground truth that adds context about control concentration. However, this omission does not undermine the overall correctness or comparison. Wording differences (e.g., 'founders’ hands' for GOOGL vs. no named individual) are acceptable under semantic equivalence. The answer is fully relevant and addresses all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 380,
        "total_tokens": 1730
      },
      "error": null
    },
    {
      "question_id": 155,
      "question": "How does BAC's market-making gains related to embedded derivatives compare to MS's involvement in CLNs structured as hybrid instruments with embedded derivatives, given the shared exposure to credit event risks in structured notes?",
      "original_answer": "BAC reports that its net gains (losses) in market-making activities relate to embedded derivatives in structured liabilities and are typically offset by gains (losses) on derivatives and securities used to hedge these liabilities. MS, on the other hand, structures CLNs as hybrid instruments containing embedded derivatives, where the Firm sells credit protection and faces risk of principal loss upon a credit event in the reference entity. Both firms demonstrate exposure to credit-linked derivatives, but BAC actively hedges these exposures while MS retains risk through structured note design.",
      "llm_answer": "Bank of America reported that its market‑making and similar activities generated a net $4.2 billion gain in 2024, which the filing says “relate to the embedded derivatives in structured liabilities” 【page_164】. Morgan Stanley, by contrast, only discloses that it has invested in CLNs (credit‑linked notes) and CDOs—hybrid instruments that contain embedded derivatives and expose the firm to loss of principal if a credit event occurs—but does not quantify any gain or loss from those positions 【page_109】. Thus, BAC’s exposure is reflected in a sizable, positive $4.2 bn gain, whereas MS’s exposure is described qualitatively as a credit‑event risk without a disclosed monetary impact.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "(1) The LLM answer introduces a specific figure—$4.2 billion gain in 2024 for BAC—which is not present in the original answer (ground truth). The ground truth does not provide any quantitative data about BAC's gains, only that gains (losses) are typically offset by hedging activities. This number appears to be fabricated or misattributed, severely undermining factual accuracy. Similarly, the claim that MS does not quantify gains/losses is plausible but not confirmed in the ground truth, which focuses on structural differences rather than disclosure gaps. (2) The quantitative inaccuracy is critical: the $4.2 billion figure and its attribution to 2024 and market-making activities related to embedded derivatives are unsupported by the provided ground truth. There is no way to verify 'page_164' or 'page_109' references as the knowledge graph does not include page numbers or such granular filing excerpts. (3) The multi-hop reasoning is partially sound—both firms are correctly linked to embedded derivatives in structured instruments with credit event risk—but the analysis diverges from the core contrast in the original answer: BAC hedges its exposure while MS retains risk through selling credit protection. The LLM shifts focus to disclosure differences (quantitative vs qualitative) rather than risk management strategy, missing the key conceptual distinction. (4) Contextual relevance is high because the response addresses both firms, embedded derivatives, structured notes, and credit event risks. However, the introduction of unverified financial figures and the mischaracterization of the comparative insight reduce correctness significantly. The answer is partially aligned with the question but contains major factual deviations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 473,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does the implementation of the OECD's Pillar Two Model Rules, which Salesforce (CRM) identifies as a global tax development, potentially affect Intel's (INTC) effective tax rate given Intel's exposure to non-US jurisdictions and ongoing evaluation of Pillar Two impacts?",
      "original_answer": "Salesforce (CRM) identifies the OECD's Pillar Two Model Rules, which introduce a global minimum tax of 15%, as a material global tax development that could impact multinational businesses. Intel (INTC), which reports that a higher proportion of its income is taxed in non-US jurisdictions, is actively evaluating the impact of Pillar Two, particularly as several non-US jurisdictions, including EU Member States, have enacted or plan to enact legislation aligning with the rules starting in 2024. Since Intel's effective tax rate has been influenced by its geographic income distribution and non-US tax regimes, the implementation of Pillar Two could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits.",
      "llm_answer": "Salesforce notes that the OECD’s Pillar Two model rules – a 15 % global minimum tax – are a key “global tax development” (CRM 10‑K p. 29). Intel, which reports a higher proportion of its income taxed outside the United States and is actively evaluating the effect of Pillar Two in those jurisdictions (INTC 10‑K p. 44), could see its effective tax rate rise if the new floor is applied to its non‑U.S. earnings; however, Intel also says it does not have material operations in jurisdictions with rates below the 15 % minimum, so any increase may be modest.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth. (1) Quantitatively, all numbers and percentages are accurate: the 15% global minimum tax rate under OECD Pillar Two is correctly cited, and there are no calculation errors. (2) The LLM correctly identifies Salesforce (CRM) as flagging Pillar Two as a global tax development and Intel (INTC) as evaluating its impact, with proper references to their 10-Ks (p.29 and p.44 respectively), demonstrating solid entity and source accuracy. (3) The multi-hop reasoning is sound: it connects Salesforce’s observation to Intel’s exposure via non-US income and evaluates the potential effect on Intel’s effective tax rate. However, the LLM introduces a nuance—'does not have material operations in jurisdictions with rates below 15%'—that is not present in the original ground truth. While this may be true in Intel’s filing, the ground truth emphasizes that Intel is still assessing the impact due to adoption by EU and other jurisdictions starting in 2024, suggesting potential exposure. The LLM’s conclusion that any increase 'may be modest' downplays the risk compared to the original answer, which states Pillar Two 'could constrain its ability to benefit from lower tax jurisdictions, thereby increasing its effective tax rate or reducing future tax benefits'—a more cautious and comprehensive assessment. (4) Despite this minor omission and slight softening of impact, the core facts, entities, and logic are correct, warranting a high score. The answer is contextually relevant and well-supported, but loses a point for not fully conveying the breadth of potential impact described in the ground truth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1368,
        "completion_tokens": 454,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 156,
      "question": "How does RTX's revenue recognition timing under FAR-regulated U.S. government fixed-price contracts compare to BA's exposure to termination risk in their U.S. government contracts, and what implications does this have for cash flow predictability?",
      "original_answer": "RTX recognizes revenue in excess of billings on U.S. government fixed-price contracts due to retained customer payments until contract completion, typically receiving performance-based payments (PBPs) or progress payments covering 80-90% of costs incurred. This creates contract assets on their balance sheet. In contrast, BA faces risks of contract termination at the convenience of the U.S. government, which could limit payments to work completed and allowable termination costs, or even result in liability for re-procurement costs if terminated for default. The FAR regulations that govern both companies' U.S. government contracts allow for interim payments but expose contractors to different financial risks—RTX to cash flow timing mismatches, and BA to potential revenue reversals or liabilities—making BA's cash flow more unpredictable despite similar regulatory frameworks.",
      "llm_answer": "RTX’s FAR‑regulated fixed‑price contracts are accounted for on a performance‑based or progress‑payment basis, so revenue is recognized as milestones are met or costs are incurred—often ahead of final billing and recorded as contract assets—providing a steady stream of interim cash receipts. By contrast, Boeing notes that U.S. government contracts can be terminated for convenience or for default, leaving the company with payment only for work already accepted (and possibly liable for re‑procurement costs), which makes cash inflows far more uncertain. Thus RTX’s revenue‑recognition timing yields more predictable cash flow, while BA’s termination risk introduces greater cash‑flow volatility.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: RTX recognizes revenue on FAR-regulated fixed-price contracts based on performance or cost incurrence, leading to contract assets (revenue in excess of billings), with interim payments (PBPs or progress payments) covering a significant portion—80–90%—of costs, though the LLM does not explicitly state the 80–90% range. This omission is minor and does not undermine the correctness of the cash flow predictability claim. Boeing’s exposure to termination for convenience or default is accurately described, including limited recovery to work completed and potential liability for re-procurement costs. (2) Quantitative accuracy is strong: no incorrect numbers are presented, and while the 80–90% payment coverage from the original answer is missing, the LLM correctly implies substantial interim payments without fabricating figures. (3) Multi-hop reasoning is sound—LLM correctly synthesizes RTX’s revenue timing (creating contract assets) with Boeing’s termination risk under the same FAR framework, and draws the correct implication about cash flow predictability differences. (4) Semantic equivalence is maintained: the LLM uses slightly different phrasing (e.g., 'steady stream of interim cash receipts' vs. 'cash flow timing mismatches') but accurately contrasts RTX’s more predictable cash flows with Boeing’s volatility due to termination risk. The only reason for not scoring a 10 is the omission of the specific 80–90% payment coverage, which is a minor detail but present in the ground truth. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1420,
        "completion_tokens": 464,
        "total_tokens": 1884
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the $119 million in floating rate notes with put provisions due in 2025 disclosed by MMM compare to GE's $315 million investment in fixed and floating rate notes containing similar 2025 put options, considering both companies' exposure to near-term debt obligations?",
      "original_answer": "MMM discloses $119 million in floating rate notes with put provisions due in 2025, which are classified as current portion of long-term debt. GE holds $315 million in fixed and floating rate notes that also contain put options exercisable in 2025, despite contractual maturities occurring after 2025. Both companies are exposed to near-term liquidity risks tied to these put options, though GE’s exposure is more than 2.5 times larger than MMM’s. This indicates a significant potential cash outflow in 2025 for both companies depending on whether the put options are exercised.",
      "llm_answer": "3M’s 2025 debt exposure consists of $119 million of floating‑rate notes that are classified as the current portion of long‑term borrowings and must be repaid (or put) in 2025. GE, on the other hand, holds $315 million of fixed‑ and floating‑rate notes that carry put options exercisable in 2025 but do not actually mature until later, making its potential near‑term cash‑outflow more than double 3M’s – however, GE’s repayment is contingent on the holders exercising the puts, whereas 3M’s $119 million is a definite 2025 obligation.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and matches the ground truth in key quantitative aspects: both $119 million (MMM) and $315 million (GE) figures are accurately reported, and the years (2025) and instrument types (floating/fixed rate notes with put options) are correctly identified. The comparison that GE’s exposure is more than double MMM’s is accurate (315/119 ≈ 2.65), and the distinction in classification—MMM’s as current portion of long-term debt versus GE’s notes having later contractual maturities but put options in 2025—is correctly captured. However, the LLM introduces a subtle but important mischaracterization: it states that 3M’s $119 million is a 'definite 2025 obligation', implying the put is not optional or that repayment is certain. In reality, like GE, MMM’s obligation is also contingent on the put option being exercised by the holder, as per standard put provision mechanics. The ground truth does not state that MMM’s obligation is definite, only that it is classified as current debt due to the put. This misrepresentation slightly undermines the qualitative accuracy, particularly in reasoning about the nature of the obligations. The multi-hop synthesis across MMM and GE is sound, and the answer is fully contextually relevant. The error is minor but prevents a top score, as it misstates the conditional nature of MMM’s liability.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1309,
        "completion_tokens": 377,
        "total_tokens": 1687
      },
      "error": null
    },
    {
      "question_id": 157,
      "question": "How does the valuation methodology for exchange-traded commodity futures used by PEP compare to MDLZ's treatment of Level 1 financial assets, given both companies' reliance on daily market pricing for fair value determination?",
      "original_answer": "PEP excludes exchange-traded commodity futures from its fair value table because they are cash-settled daily, while MDLZ explicitly includes exchange-traded commodity futures as Level 1 financial assets, valued based on quoted market prices on commodity exchanges. Both companies rely on daily market pricing for fair value determination, but PEP focuses on the daily cash settlement mechanism as the reason for exclusion, whereas MDLZ emphasizes quoted market prices as the basis for Level 1 classification.",
      "llm_answer": "PepsiCo notes that its exchange‑traded commodity futures are cash‑settled on a daily basis and therefore are **not included in the fair‑value hierarchy table**, although their fair value is still measured each day using the market price 【page_107】. Mondelēz classifies exchange‑traded commodity futures as **Level 1 financial assets**, valuing them directly from quoted market prices on the exchanges 【page_95】. Thus, both firms rely on daily market pricing for fair‑value determination, but PepsiCo excludes the futures from its Level 1 presentation, whereas Mondelēz explicitly includes them as Level 1 assets.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the original answer. (1) It correctly states that PEP excludes exchange-traded commodity futures from its fair value hierarchy table due to daily cash settlement, while MDLZ includes them as Level 1 assets based on quoted market prices. These key facts match the ground truth exactly. (2) There are no numerical values requiring calculation (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised; all descriptive financial treatments are correct. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (PEP and MDLZ), their respective valuation methodologies, and the conceptual distinction in presentation despite both using daily market pricing. (4) The answer addresses all parts of the question: both companies’ reliance on daily market pricing is acknowledged, and the contrast in treatment—exclusion vs. inclusion in Level 1—is clearly articulated. Wording differs slightly but meaning is preserved. All entities (PEP, MDLZ, Level 1, exchange-traded commodity futures) are correctly identified and contextualized. No errors in reasoning or omissions affecting correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1300,
        "completion_tokens": 343,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does Apple's revenue from the Greater China region, which includes Taiwan, compare to Intel's revenue specifically from Taiwan operations in 2022?",
      "original_answer": "Apple generated $74,200 million in net sales from the Greater China region in 2022, which includes Taiwan among other markets. In contrast, Intel reported $13,461 million in net revenue specifically from Taiwan operations during the same period. This indicates that Apple's revenue exposure through the Greater China segment, which encompasses Taiwan, is significantly higher than Intel's direct revenue from Taiwan.",
      "llm_answer": "Apple’s Greater China segment (which includes mainland China, Hong Kong and Taiwan) generated **$74.2 billion** in net sales in 2022【page_25】【page_52】. Intel reported **$13.5 billion** of net revenue from Taiwan in its most recent disclosed year (2021)【page_87】—the only Taiwan‑specific figure provided. Thus Apple’s Greater China revenue is roughly **$60 billion higher**, or about **5‑½ times** the size of Intel’s Taiwan revenue.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 6,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Apple's 2022 Greater China revenue as $74.2 billion ($74,200 million), matching the ground truth. However, it incorrectly states that Intel's $13.5 billion revenue from Taiwan is from 2021, while the ground truth specifies 2022. This is a critical error in temporal alignment, undermining the comparison. The LLM also rounds Intel's $13,461 million to $13.5 billion, which is acceptable, but pairs it with the wrong year. (2) The calculation that Apple's revenue is ~$60 billion higher and about 5.5 times larger than Intel's is mathematically sound *if* the numbers were from the same year: $74.2B - $13.5B = $60.7B; $74.2B / $13.5B ≈ 5.5. However, because Intel's figure is misattributed to 2021 instead of 2022, the comparison fails the multi-hop requirement of synchronizing data across entities for the same fiscal year. (3) The reasoning is otherwise logical—comparing regional revenues, identifying scope (Greater China vs. Taiwan only), and drawing a relative size conclusion—but the failure to align both figures to 2022 breaks the chain. The model cites 'page_87' for Intel’s data but incorrectly interprets the year, suggesting a possible misreading of the source. (4) Scores reflect that core numbers are mostly accurate (with rounding) and reasoning structure is sound, but the mismatched year leads to a significant factual flaw in the comparison, reducing correctness and quantitative accuracy. Contextual relevance remains high as the answer addresses the right companies, regions, and intent of comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1213,
        "completion_tokens": 430,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the combined net property, plant, and equipment investment in the Americas by MMM compare to GD's revenue contribution from South America over the same geographic footprint, given that the Americas segment includes South America as part of its geographic definition?",
      "original_answer": "MMM reported $5,864 million in net property, plant, and equipment for the Americas in 2021, which includes South America. GD, in the same year, generated $234 million in revenue specifically from South America. This indicates that while GD's revenue from South America is relatively small, MMM has a significantly larger asset base tied to the broader Americas region, which encompasses South America.",
      "llm_answer": "MMM’s net property, plant & equipment for its Americas segment was $5.864 billion (2021) – $5.752 billion in 2020【page_140】.  By contrast, General Dynamics earned only $234 million from South America in 2021【page_80】.  Thus MMM’s PP&E investment in the Americas is roughly twenty‑five times larger than GD’s revenue from the South‑American portion of that same geographic footprint.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies all key factual elements: MMM's net property, plant, and equipment (PP&E) in the Americas was $5,864 million ($5.864 billion) in 2021, and GD's South America revenue was $234 million in the same year. These values match the ground truth exactly, with acceptable format variation (billion vs million). The comparison stating MMM’s PP&E is roughly twenty-five times larger is accurate: $5,864M / $234M ≈ 25.06. 2) Quantitative accuracy is perfect: numbers, years, and units are correct. The mention of $5.752 billion for 2020 is extra but not incorrect, though not required by the question. 3) Qualitatively, the reasoning is sound—correctly comparing MMM’s asset base in the broader Americas (which includes South America) to GD’s revenue from just South America. The synthesis across companies and metrics is appropriate and logical. The only minor shortcoming is slightly less emphasis on the geographic inclusion (that South America is part of the Americas), though it is implied. 4) The answer is highly relevant, directly addressing the comparative investment vs. revenue question within the defined geography. All components of the multi-hop query (two companies, two metrics, same region, correct year) are properly handled. Thus, the answer is factually excellent with only negligible room for improved clarity on geographic hierarchy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1228,
        "completion_tokens": 381,
        "total_tokens": 1609
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the use of sensitivity analyses by NFLX's auditor in evaluating content amortization assumptions compare to CMCSA's application of sensitivity analyses in managing interest rate risk exposure?",
      "original_answer": "NFLX's auditor performed sensitivity analyses to evaluate how changes in assumptions about viewing patterns could affect content amortization timing, which directly impacts financial reporting accuracy. In contrast, CMCSA uses sensitivity analyses as part of its interest rate risk management strategy to assess the potential impact of interest rate fluctuations on its debt portfolio, with derivative instruments reducing interest expense by $56 million in 2023. While both companies apply sensitivity analyses, NFLX uses it for accounting policy judgment, whereas CMCSA applies it for financial risk management.",
      "llm_answer": "Netflix’s auditor applies sensitivity analyses as an audit procedure to gauge how changes in the viewing‑pattern assumptions underlying content amortization would alter the amortization expense recorded. In contrast, Comcast uses sensitivity analyses as a risk‑management tool to model how shifts in interest rates would affect the fair value of its interest‑rate derivatives and overall interest‑expense exposure. Thus, Netflix’s use is focused on testing accounting estimates, while Comcast’s is aimed at monitoring and managing market‑risk exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All factual elements are correct: NFLX's auditor uses sensitivity analyses to evaluate viewing-pattern assumptions affecting content amortization (audit/testing focus), while CMCSA uses it for interest rate risk management (risk-monitoring focus). The distinction between accounting estimate testing (NFLX) and market-risk exposure management (CMCSA) is correctly captured. (2) There are no numeric inaccuracies; the LLM answer does not include the $56 million derivative impact mentioned in the original answer, but this is a minor omission rather than an error—the LLM focuses on the methodological contrast rather than specific financial impacts. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, two distinct financial processes (amortization assumptions vs. interest rate risk), and two uses of sensitivity analyses (audit procedure vs. risk management tool). (4) Semantic equivalence is strong—wording differs (e.g., 'fair value of derivatives' vs. 'impact on debt portfolio'), but meaning aligns. The only reason for not scoring 10 is the omission of the $56 million figure, which adds specificity to CMCSA's application but does not undermine the correctness of the conceptual comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1305,
        "completion_tokens": 372,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does PEP's use of exchange-traded commodity futures to manage risk compare with COST's disclosure regarding the absence of Level 1 financial liabilities, given that both companies report under the same fair value hierarchy framework?",
      "original_answer": "PEP actively uses exchange-traded commodity futures, which are cash-settled daily and excluded from the balance sheet as of December 25, 2021, to manage market risk, particularly in relation to deferred compensation liabilities. These instruments fall under Level 1 of the fair value hierarchy, which includes instruments valued using quoted market prices. In contrast, COST explicitly states that as of August 28, 2022, it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis, indicating a different risk management approach with no direct use of such derivatives. This contrast highlights differing strategies in managing financial risk exposure under the same fair value reporting framework.",
      "llm_answer": "PepsiCo notes that it uses exchange‑traded commodity futures—Level 1 instruments with quoted market prices—to hedge commodity‑price risk, but because these futures are cash‑settled daily they are not shown as a Level 1 liability in its fair‑value tables (they are excluded from the derivative schedule). Costco, by contrast, explicitly discloses that it holds **no** Level 1 (or Level 3) financial assets or liabilities measured at fair value on a recurring basis. Thus, under the same three‑level fair‑value hierarchy, PepsiCo has exposure to Level 1 contracts used for risk management (though not reported on the balance sheet), whereas Costco reports the absence of any Level 1 financial liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: PEP uses exchange-traded commodity futures (Level 1 instruments) for risk management, which are cash-settled daily and thus excluded from the balance sheet; COST discloses no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis. (2) No specific numbers (e.g., dollar amounts, percentages) are present in either answer, but the dates—December 25, 2021 (PEP) and August 28, 2022 (COST)—are correctly implied by context in the original, and the LLM does not misstate any timeframes. The absence of explicit dates in the LLM answer does not reduce accuracy, as the focus is on the disclosure content rather than timing. (3) Multi-hop reasoning is sound: the model correctly synthesizes that both companies use the same fair value hierarchy framework, yet differ in practice—PEP employs Level 1 derivatives (though not reported due to daily settlement), while COST reports no such exposures. (4) The LLM slightly omits the mention of deferred compensation liabilities as the specific risk being hedged by PEP, which is a minor contextual detail present in the original. However, this does not undermine the overall correctness. Wording differs but semantic meaning is preserved. The conclusion about differing risk management strategies under the same framework is effectively conveyed. Thus, the answer earns a 9 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1384,
        "completion_tokens": 432,
        "total_tokens": 1817
      },
      "error": null
    },
    {
      "question_id": 158,
      "question": "How does the expiration timeline of U.S. patent protections for Enbrel, as detailed in Amgen's 2024 10-K, impact Merck's competitive positioning and Pfizer's international production strategy for the drug, especially considering Merck's stated exposure to biosimilar competition and pricing pressures?",
      "original_answer": "The U.S. patent protections for Enbrel expire in three key phases: fusion protein composition in November 2028, DNA encoding in April 2029, and formulations in October 2037. This staggered expiration timeline creates a gradual risk of biosimilar entry in the U.S., which could indirectly affect global pricing dynamics. Merck, which depends heavily on patent protection to maintain sales and profitability, faces intensified risk of generic competition following these expirations, compounding existing pricing pressures from government programs like the 340B Drug Discount Program. Meanwhile, Pfizer produces Enbrel outside the U.S. and Canada, meaning it will likely face competitive pressure from biosimilars in those international markets sooner than in the U.S., aligning with its broader specialty care portfolio strategy. Thus, the expiration of Enbrel’s U.S. patents affects Merck’s competitive positioning by increasing biosimilar risk and influences Pfizer’s international production strategy by accelerating exposure to generic competition outside the U.S.",
      "llm_answer": "Amgen’s 2024 10‑K lists Enbrel’s U.S. composition‑of‑matter patent expiring 11/22/2028, with additional DNA‑and‑formulation claims extending to 4/24/2029 and 10/19/2037 [Amgen p. 11]. These dates give Merck a short‑term shield against the biosimilar competition and pricing pressure it flags in its 10‑K, but once the 2028‑2029 patents lapse the company will likely face the generic/biosimilar erosion it warns about [Merck p. 33]. Pfizer, which markets Enbrel only outside the U.S. and Canada, can keep producing and selling the drug internationally without being bound by those U.S. patents, allowing it to maintain its overseas supply while monitoring local patent expirations and biosimilar threats [Pfizer p. 14].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) All key facts are correct: the U.S. patent expiration dates for Enbrel are accurately reported as November 22, 2028 (composition-of-matter), April 24, 2029 (DNA encoding), and October 19, 2037 (formulations), which match the ground truth in both timing and sequence. Minor formatting differences (e.g., 11/22/2028 vs 'November 2028') are acceptable and do not affect factual accuracy. (2) Quantitative accuracy is perfect—dates are correct and cited with precision. (3) The multi-hop reasoning is sound: the answer correctly links Amgen’s patent timeline to Merck’s exposure to biosimilar competition and pricing pressures (referencing Merck’s 10-K warning on p.33) and explains Pfizer’s international production strategy in relation to U.S. patent inapplicability abroad. (4) The answer is contextually relevant and addresses all parts of the question: impact on Merck’s competitive positioning, Pfizer’s international strategy, and the role of biosimilar competition and pricing pressures. The only minor shortcoming is that it does not explicitly mention the 340B Drug Discount Program, which the ground truth cites as a source of pricing pressure for Merck. While the general concept of pricing pressure is noted, the absence of this specific detail slightly reduces completeness in qualitative synthesis. However, the core reasoning and factual content remain strong, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 405,
        "total_tokens": 1890
      },
      "error": null
    },
    {
      "question_id": 159,
      "question": "How does the $90 of unfunded commitments in private equity funds disclosed by EMR compare to the $2.7 billion of unfunded commitments to private equity and other limited partnerships reported by UPS, given both companies measure these investments at NAV?",
      "original_answer": "EMR reports $90 of unfunded commitments in private equity funds as of September 30, 2024, while UPS reports a significantly larger amount of $2.7 billion in unfunded commitments to private equity, private debt, and real estate limited partnerships as of December 31, 2024. Both companies disclose these commitments in the context of investments measured at NAV, indicating similar accounting treatment for these alternative assets despite the large difference in scale.",
      "llm_answer": "EMR reports that its private‑equity fund investments have only about **$90 million** of unfunded commitments (measured at NAV)【page_64】. In contrast, UPS’s pension‑plan assets include roughly **$2.7 billion** of unfunded commitments to private‑equity and other limited‑partnership funds (also measured at NAV)【page_93】. Thus EMR’s unfunded exposure is minuscule—on the order of 0.003 % of UPS’s, or roughly 1/30,000 as large.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies EMR's $90 million and UPS's $2.7 billion unfunded commitments, both measured at NAV, which aligns with the ground truth. However, it introduces a quantitative error by stating EMR’s exposure is '0.003 % of UPS’s' or '1/30,000 as large'—this is incorrect. The correct ratio is $90 million / $2.7 billion = 0.0333, or about 3.33%, not 0.003%. This miscalculation significantly undermines the quantitative accuracy. (2) The dollar amounts are correct with acceptable formatting ($90 million vs $90; $2.7 billion is accurate). The dates (September 30, 2024 for EMR and December 31, 2024 for UPS) are not mentioned in the LLM answer, which omits a minor but relevant contextual detail. (3) The multi-hop reasoning is mostly sound—the model correctly synthesizes data from two companies and compares their unfunded commitments under similar accounting treatment (NAV). However, the erroneous percentage comparison reflects a failure in basic arithmetic, weakening the reasoning. (4) Despite the calculation error, the core facts are present and the answer addresses the scale difference appropriately. The qualitative and contextual accuracy remain high because the main point—that UPS has vastly larger unfunded commitments than EMR—is still valid. The correctness score is reduced due to the significant calculation mistake, though not to a failing level because the primary data points are accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1250,
        "completion_tokens": 399,
        "total_tokens": 1649
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "What percentage of PepsiCo's APAC segment revenue in 2024 came from beverages, and how does this compare to Mondelēz's total beverage revenue in 2024?",
      "original_answer": "In 2024, 23% of PepsiCo's APAC segment revenue came from beverages. Given that PepsiCo's APAC revenue was $10 million in 2024, this translates to $2.3 million from beverages. In comparison, Mondelēz reported total beverage revenue of $1,096 million in 2024, which is significantly higher than PepsiCo's beverage revenue in the APAC region.",
      "llm_answer": "PepsiCo’s APAC segment generated 23 % of its revenue from beverages in 2024 (see the disaggregation table for APAC on page 73). Mondelēz International’s total beverage revenue for 2024 was $1.096 billion (the product‑category breakdown on page 121).  In other words, PepsiCo’s APAC beverage sales represent a 23 % share of that region’s revenue, while Mondelēz’s beverage sales amount to roughly $1.1 billion in absolute terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly states that 23% of PepsiCo's APAC segment revenue came from beverages in 2024, matching the ground truth. It also accurately reports Mondelēz's total beverage revenue as $1.096 billion (equivalent to $1,096 million), which is factually correct. The LLM uses acceptable formatting variations ($1.096 billion = $1,096 million) and rounds appropriately to ~$1.1 billion, which is semantically equivalent. (2) All numeric values—percentages, dollar amounts, and years—are accurate. The LLM does not explicitly calculate PepsiCo's APAC beverage revenue ($10M × 23% = $2.3M), but it correctly conveys the percentage and references the disaggregation, implying the source of the data. While the absolute dollar value for PepsiCo’s beverage revenue in APAC is missing, the percentage and comparative context are preserved. (3) The multi-hop reasoning is sound: the model identifies PepsiCo's regional revenue mix and compares it to Mondelēz's global beverage revenue from different documents (page references suggest proper sourcing). The comparison highlights the difference in scale, though it could have more explicitly stated that Mondelēz's beverage revenue is much larger than PepsiCo's APAC beverage segment. (4) The answer is highly accurate, with only a minor omission of the explicit $2.3 million figure. However, since the percentage and total segment revenue context are correct, and the comparison in magnitude is implied, this does not significantly detract from correctness. Hence, a score of 9 is justified—excellent but not fully complete in numerical synthesis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1192,
        "completion_tokens": 440,
        "total_tokens": 1632
      },
      "error": null
    },
    {
      "question_id": 161,
      "question": "How does the volume of Capital One's (COF) delinquent loans as of December 31, 2023, influence the availability of reperforming loans that MetLife (MET) can purchase for its residential mortgage loan portfolio?",
      "original_answer": "Capital One reported total delinquent loans of $623 million as of December 31, 2023, which contributes to the pool of potentially reperforming loans. MetLife purchases reperforming loans that have returned to performing status after being delinquent for at least 12 months. The availability of such loans is directly influenced by the volume and characteristics of initial delinquencies, like those disclosed by Capital One, as these form the source pool for future reperforming loan opportunities.",
      "llm_answer": "Capital One reported $623 million of delinquent loans at December 31 2023 (Table 3.8, COF 10‑K p. 161). MetLife’s residential‑mortgage strategy is to buy “reperforming” loans—loans that were delinquent but have been performing for at least 12 months after a modification (MetLife 10‑K p. 240). Thus, the $623 million delinquent pool at Capital One constitutes a potential source of reperforming loans that can increase the supply of assets MetLife is able to purchase for its residential‑mortgage portfolio.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $623 million figure for Capital One's delinquent loans as of December 31, 2023, is correct and matches the original answer. The date and dollar amount are both accurate, with no calculation errors. (2) The answer correctly identifies that MetLife purchases reperforming loans—defined as loans that were previously delinquent but have been performing for at least 12 months after modification—citing the correct page (p. 240) from MetLife’s 10-K. (3) The multi-hop reasoning is sound: it connects Capital One’s delinquent loans to the future pool of potential reperforming loans that MetLife may purchase, which is the core causal relationship in the question. (4) The only minor shortcoming is that the LLM does not explicitly state that the reperforming loans must have been delinquent for at least 12 months *before* returning to performance (it mentions the 12-month performance period but not the prior delinquency duration), which slightly weakens the completeness of the definition. However, this does not undermine the overall correctness. The answer is contextually relevant, directly addressing how Capital One’s delinquency volume influences MetLife’s investment opportunities. Wording differs slightly from the original but maintains semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1267,
        "completion_tokens": 378,
        "total_tokens": 1645
      },
      "error": null
    },
    {
      "question_id": 162,
      "question": "How does the exposure of UNP's pension plan to limited partnerships investing in real estate compare with UPS's unfunded commitments to similar structures, given both companies' reliance on NAV-based valuations for these illiquid assets?",
      "original_answer": "UNP's pension plan holds interests in limited partnerships that primarily invest in privately-held companies and reports these using NAV-based valuations, while UPS has unfunded commitments totaling approximately $3.3 billion to limited partnerships focused on private equity, private debt, and real estate funds. Both companies rely on NAV as a practical expedient for valuing these illiquid investments, with UPS specifically noting the limited redemption provisions until the end of the partnership terms, typically 10 to 15 years from inception. This indicates that both firms face similar challenges in liquidity and valuation transparency for these alternative investments.",
      "llm_answer": "UNP’s defined‑benefit pension plan holds interests in limited‑partnership real‑estate funds that are valued using a net‑asset‑value (NAV) approach, but the filing excerpts do not disclose the dollar amount of that exposure. In contrast, UPS explicitly reports about $3.3 billion of unfunded commitments to similar limited‑partnership real‑estate, private‑debt and private‑equity funds—also measured at NAV. Thus, while both companies rely on NAV‑based valuations for these illiquid assets, UPS’s exposure is quantified at $3.3 billion, whereas UNP’s specific exposure is not disclosed in the provided pages.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the $3.3 billion unfunded commitment by UPS is correctly reported, matching the original answer. The absence of a disclosed dollar amount for UNP’s exposure is also accurately reflected—no numbers are misstated or miscalculated. (2) The LLM correctly identifies both companies’ use of NAV-based valuations for illiquid assets in limited partnerships, and correctly distinguishes UNP’s holdings (in real estate-focused funds, valued at NAV) from UPS’s $3.3B in unfunded commitments across real estate, private equity, and private debt funds. (3) The multi-hop reasoning is sound: it compares UNP’s pension plan exposure with UPS’s unfunded commitments, acknowledges the common reliance on NAV, and notes the difference in disclosure depth—exactly what the question asks. (4) The only minor shortcoming is that the LLM does not mention UPS’s specific note about limited redemption provisions and partnership terms (10–15 years), which adds a layer of liquidity risk context present in the original answer. However, this omission does not undermine the core factual accuracy or synthesis. Wording differs but semantic meaning is equivalent. All entities (UNP, UPS, NAV, limited partnerships, real estate focus) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 372,
        "total_tokens": 1717
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does AMD's reliance on third-party manufacturers for 7 nm and smaller node production impact its exposure to quality control risks compared to Cisco's approach of maintaining quality control through automated testing and ISO 9001-certified processes?",
      "original_answer": "AMD's reliance on third-party manufacturers like TSMC for 7 nm and smaller node production exposes it to risks related to manufacturing yields, delivery schedules, and quality assurance, as these manufacturers are responsible for implementing leading-edge process technologies and maintaining acceptable yields. In contrast, Cisco maintains quality control internally through automated testing equipment, burn-in procedures, and ISO 9001-certified manufacturing processes, which are designed to ensure product reliability and reduce variability. This difference suggests that AMD has less direct control over quality assurance in its supply chain compared to Cisco, which integrates quality control directly into its manufacturing procedures.",
      "llm_answer": "AMD’s reliance on third‑party wafer foundries—primarily TSMC for 7 nm and smaller nodes—and on external ATMP partners means it has limited direct control over yields, cycle times and quality‑assurance, leaving it vulnerable to supply‑chain and quality‑control problems if those suppliers cannot meet specifications (AMD 10‑K, pp. 23‑25). In contrast, Cisco retains direct oversight of its manufacturing by using automated test equipment, burn‑in, comprehensive inspection, statistical process controls and ISO 9001‑certified processes, which tightly manage product quality and reduce its exposure to such risks (Cisco 10‑K, p. 9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AMD relies on third-party manufacturers like TSMC for 7 nm and smaller nodes, which introduces risks in yield, quality assurance, and supply chain control. Cisco, in contrast, maintains internal quality control via automated testing, burn-in, statistical process controls, and ISO 9001 certification. These points match the original answer semantically. (2) There are no numeric values (e.g., percentages, dollar amounts, dates) in either the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from AMD’s and Cisco’s respective 10-K filings to compare their quality control strategies and supply chain dependencies. It identifies the correct entities (AMD, TSMC, Cisco), processes (automated testing, ISO 9001), and implications (reduced direct control for AMD vs. tighter control for Cisco). (4) The only minor shortcoming is that the LLM answer mentions 'ATMP partners' and 'cycle times', which are not in the original answer, but these are contextually appropriate details from AMD’s risk factors and do not introduce inaccuracies. Overall, the answer is factually correct, complete, and contextually relevant, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 378,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 163,
      "question": "How does Comcast's lack of voting rights in Atairos compare to Alphabet's structure of Class C Capital Stock, which also carries no voting rights, particularly in terms of how each company manages governance influence versus financial exposure?",
      "original_answer": "Comcast does not have voting rights or the power to direct the activities of Atairos, which is classified as a VIE, and therefore does not consolidate it, limiting its governance influence while still being exposed to financial risk up to its investment balance and remaining unfunded capital commitment of $1.4 billion as of December 31, 2024. In contrast, Alphabet issues Class C Capital Stock, which carries no voting rights except as required by law, but the company actively manages these shares through large-scale repurchases—$62.0 billion in 2024—allowing it to maintain governance control through Class A and B shares while offering different voting structures to investors. Both entities separate voting rights from certain stakeholders, but Alphabet retains control through its dual-class share structure, whereas Comcast has no such governance influence over Atairos despite significant financial exposure.",
      "llm_answer": "Comcast’s stake in Atairos is a VIE in which it has **no voting rights**, so it cannot direct the entity’s activities and its governance influence is essentially nil; its risk is limited to the $5.1 billion equity investment and the $1.4 billion unfunded capital commitment it may be called upon to fund (page 85). Alphabet’s Class C capital stock likewise carries **no voting rights** (page 82), but the company retains full governance control through its Class A (1‑vote) and Class B (10‑vote) shares, leaving the financial exposure of the non‑voting shares to the shareholders rather than to Alphabet’s balance sheet.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer correctly captures the core comparison between Comcast's lack of voting rights in Atairos and Alphabet's Class C stock structure, accurately noting that both involve non-voting equity but differ in governance control and financial exposure. It correctly identifies that Comcast has no governance influence over Atairos, a VIE, and highlights the $1.4 billion unfunded capital commitment as of the relevant date. However, the equity investment amount stated ($5.1 billion) does not match the ground truth, which does not specify the exact equity investment figure—only the unfunded commitment of $1.4 billion as of December 31, 2024. This introduces a quantitative inaccuracy. The LLM also omits Alphabet’s $62.0 billion share repurchase in 2024, a key mechanism by which Alphabet manages its capital structure and maintains control, weakening the completeness of the financial strategy comparison. Despite this, the qualitative reasoning is strong: it correctly contrasts Comcast’s passive, non-consolidated VIE position with Alphabet’s active governance via dual-class shares. The entities, financial concepts, and document references (page numbers) are accurate and contextually appropriate. The answer is highly relevant and synthesizes multi-hop information across governance, financial exposure, and corporate structure, but the incorrect investment figure and missing repurchase detail prevent a top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 393,
        "total_tokens": 1802
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does Coca-Cola HBC's distribution footprint in Austria compare with Philip Morris's market presence in the same country, based on their respective operational disclosures?",
      "original_answer": "Coca-Cola HBC, as a key bottler for The Coca-Cola Company, operates in Austria and contributes to 41% of Coca-Cola’s total worldwide unit case volume through its five largest bottlers. Meanwhile, Philip Morris reports a market share of at least 15% in Austria, as part of its presence across approximately 100 markets globally. Both companies maintain a direct or dedicated distribution presence in Austria, with Coca-Cola HBC managing bottling and distribution of beverages, and Philip Morris leveraging its exclusive zonified and direct distribution strategies to maintain its competitive market position.",
      "llm_answer": "Coca‑Cola HBC lists Austria among the countries where its bottling subsidiary “Coca‑Cola Hellenic” operates, meaning it bottles and distributes Coca‑Cola beverages there (page 7). Philip Morris, in its own operational disclosure, says it has “a market share of at least 15 % in … Austria” (page 7), indicating a sizable but not dominant tobacco‑product presence in the same country.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 15% market share for Philip Morris in Austria is correctly reported, matching the original answer. Coca-Cola HBC's operational presence in Austria is accurately stated, though the specific '41%' figure related to the five largest bottlers' contribution to Coca-Cola’s global volume is omitted. However, this detail is contextual and not central to the direct comparison of distribution footprints in Austria. (2) The entities—Coca-Cola HBC and Philip Morris—are correctly identified, and their respective operational disclosures are accurately cited from page 7 of their reports. (3) The reasoning is sound: the LLM correctly infers that Coca-Cola HBC has a direct bottling and distribution presence in Austria, and that Philip Morris has a notable market presence with at least 15% share. The multi-hop synthesis—comparing two companies' operational footprints in the same country—is logically executed. (4) The answer is contextually relevant and directly addresses the question. The only minor omission is the broader context about Coca-Cola HBC being one of the top five bottlers contributing to 41% of global volume, but this does not detract from the core comparison in Austria. Wording differs slightly but maintains semantic equivalence. No calculation errors. Overall, a strong, factually correct response with only slight incompleteness on peripheral context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1254,
        "completion_tokens": 403,
        "total_tokens": 1657
      },
      "error": null
    },
    {
      "question_id": 164,
      "question": "How does the deterioration in BAC's commercial real estate credit quality, particularly in office properties, influence MET's use of the Bornhuetter-Ferguson Method and its annual updates to unpaid claims assumptions for Protection Life and Health products?",
      "original_answer": "BAC experienced a deterioration in commercial credit quality during 2023, especially in the commercial real estate office property type, due to stagnant office space demand and evolving employment models (BAC chunk). MET updates its unpaid claims assumptions annually to reflect emerging trends in claim experience, including macroeconomic conditions (MET chunk). MET uses the Bornhuetter-Ferguson Method to estimate unpaid claims for Protection Life and Health products, relying on historical claims data and expected loss ratios, which are sensitive to economic shifts (Hop2 chunk). Therefore, a worsening macroeconomic environment—such as declining commercial real estate values and increased defaults in office properties—could affect MET’s claims estimation by altering expected loss ratios, particularly for long-duration Protection Health claims or experience-rated contracts where adverse claim experience is passed to sponsors (MET chunk). This creates a multi-hop chain where BAC's credit quality trends serve as an early indicator of macroeconomic deterioration that MET must incorporate into its actuarial models.",
      "llm_answer": "Bank of America reported that commercial‑real‑estate credit quality slipped in 2023, driven almost entirely by office‑property loans – non‑performing office exposure rose sharply and the commercial‑real‑estate net‑charge‑off ratio jumped to 0.34 % (up from 0.10 % in 2022) and reservable‑criticized exposure more than doubled (see BAC 10‑K p.65‑66). MetLife’s IBNR framework for Protection Life and Protection Health relies on the Bornhuetter‑Ferguson method, which blends experience‑derived factors with an expected‑loss component, and the company “updates the assumptions … annually to reflect emerging trends in claim experience” (MET 10‑K p.196). Thus, the worsening office‑property risk at BAC is an emerging macro‑trend that MetLife would factor into its yearly assumption updates—potentially raising the expected‑loss portion or adjusting credibility weights in the Bornhuetter‑Ferguson calculations for its Protection Life and Health unpaid‑claims liabilities.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies BAC's deterioration in commercial real estate credit quality in 2023, specifically in office properties, citing a rise in non-performing loans and an increase in the net-charge-off ratio from 0.10% to 0.34%, and more than doubling of reservable-criticized exposure (supported by BAC 10-K p.65-66). These quantitative details are not in the original answer but are factually consistent with the broader trend described and add precision without contradiction. (2) The LLM accurately states that MET uses the Bornhuetter-Ferguson method for Protection Life and Health products and updates assumptions annually to reflect emerging trends, citing MET 10-K p.196. While the original answer does not include page numbers or exact percentages from BAC, the added detail strengthens the response without introducing error. (3) The multi-hop reasoning is sound: BAC's credit deterioration signals macroeconomic stress, which MET would incorporate into its actuarial models via updated expected loss ratios or credibility weights in the Bornhuetter-Ferguson method. The LLM correctly infers that this affects unpaid claims assumptions, particularly for long-duration or experience-rated contracts, even if not explicitly stated. (4) Minor deduction in quantitative accuracy only because the original answer does not specify the 0.34% or 0.10% figures—while plausible and consistent, they extend beyond the provided ground truth. However, since the LLM cites the 10-K, this is a reasonable enhancement. Overall, the answer is semantically equivalent, contextually precise, and demonstrates strong synthesis across entities and documents.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1551,
        "completion_tokens": 468,
        "total_tokens": 2019
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the voting rights structure of Netflix's common stock compare to Meta's, considering the influence of Class A Common Stock in both companies' governance frameworks?",
      "original_answer": "Netflix's common stockholders are entitled to one vote per share, creating a uniform voting rights structure. In contrast, Meta's Class A Common Stock also provides one vote per share, but Meta has a multi-tiered stock structure that includes Class B Common Stock with 10 votes per share, giving certain shareholders disproportionate voting power. This difference means that while both companies grant one vote per share for Class A Common Stock, Meta's governance framework allows for greater concentration of control through its Class B shares.",
      "llm_answer": "Netflix’s equity is a single‑class structure – each share of its common stock is entitled to one vote on all shareholder matters (NFLX 10‑K, “Voting Rights,” p. 60). Meta, by contrast, uses a dual‑class system: its publicly traded Class A shares also carry one vote per share, but a separate Class B series carries ten votes per share, giving insiders disproportionate control (Meta 10‑K shows 2.19 billion Class A and 344 million Class B shares outstanding, p. 1). Thus, Netflix shareholders have uniform voting power, whereas Meta’s Class A shareholders have relatively limited influence compared with the high‑voting Class B holders.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly states that Netflix has a single-class structure with one vote per share, while Meta has a dual-class system where Class A shares have one vote and Class B shares have ten votes per share—this aligns perfectly with the original answer. (2) The quantitative details cited (2.19 billion Class A and 344 million Class B shares for Meta) are specific and accurate, though not present in the original answer; however, they enhance precision without contradicting the ground truth. These figures support the claim of disproportionate control and are consistent with Meta’s 10-K filing. (3) The multi-hop reasoning is sound: the model correctly compares governance frameworks across two companies, identifies structural differences in voting rights, and synthesizes how these affect shareholder influence. (4) The answer addresses all parts of the question: Netflix’s uniform voting rights, Meta’s Class A one-vote structure, and the broader implication of Meta’s multi-tiered system on governance and control. Wording differs slightly but meaning is preserved. All entities (Netflix, Meta, Class A/B shares) are correctly identified. No factual, numerical, or logical errors are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1302,
        "completion_tokens": 358,
        "total_tokens": 1660
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How does the fair value treatment of exchange-traded commodity futures under Level 1 financial liabilities differ between PEP and MDLZ, given that both companies cash-settle these instruments and include them in their respective liability portfolios?",
      "original_answer": "PEP explicitly states that exchange-traded commodity futures are cash-settled on a daily basis and therefore not included in the fair value hierarchy table as of December 25, 2021. In contrast, MDLZ includes exchange-traded commodity futures in its Level 1 financial liabilities, with fair value determined based on quoted market prices on commodity exchanges. Both companies treat these futures as part of their Level 1 liabilities, but PEP excludes them from reported tables due to daily cash settlement, whereas MDLZ continues to report them based on market pricing as of the balance sheet date.",
      "llm_answer": "PepsiCo notes that its exchange‑traded commodity futures are cash‑settled daily and therefore are **not included in the fair‑value hierarchy table** of Level 1 assets and liabilities (PEP 10‑K p. 107, footnote i). In contrast, Mondelēz explicitly classifies exchange‑traded commodity futures as **Level 1 financial liabilities**, measuring them at the quoted market prices on the commodity exchanges (MDLZ 10‑K p. 112). Thus, while both firms cash‑settle the contracts, PepsiCo excludes them from its Level 1 liability presentation, whereas Mondelēz includes and values them as Level 1 liabilities.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the original answer. (1) It accurately captures that PEP excludes exchange-traded commodity futures from its fair value hierarchy table due to daily cash settlement, while MDLZ includes them in Level 1 financial liabilities based on quoted market prices. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in the question or ground truth that need verification—only qualitative disclosures—and the LLM correctly references the appropriate treatment without introducing incorrect data. (3) The multi-hop reasoning is sound: it synthesizes information from both PEP and MDLZ 10-K filings, correctly contrasting their reporting practices despite similar cash-settlement treatment. (4) The answer is contextually precise, directly addressing the difference in fair value hierarchy presentation between the two companies. Minor wording differences (e.g., 'not included in the fair-value hierarchy table' vs. 'not included in the fair value hierarchy table as of December 25, 2021') do not affect factual accuracy, as the exclusion rationale (daily cash settlement) is correctly stated and the absence of a specific date in the LLM answer does not detract from correctness given that the core disclosure logic is preserved.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1325,
        "completion_tokens": 363,
        "total_tokens": 1688
      },
      "error": null
    },
    {
      "question_id": 165,
      "question": "How do the cost-sharing arrangements between Merck and Gilead for the development of HIV treatments combining islatravir and lenacapavir compare to Pfizer's cost-reduction initiatives, and what implications might this have on each company's financial exposure in long-acting HIV therapies?",
      "original_answer": "Merck and Gilead share global development and commercialization costs for HIV treatments combining islatravir and lenacapavir at a 60/40 split (Gilead/Merck), with equal revenue sharing until certain thresholds are met ($2.0 billion for oral and $3.5 billion for injectable combinations), after which Gilead's revenue share increases. In contrast, Pfizer's 2024 filing highlights enterprise-wide cost realignment and manufacturing optimization programs aimed at reducing costs and improving productivity. These initiatives carry risks such as potential disruption of ongoing business, including impacts on the delivery of their pipeline, which could include HIV-related R&D. While Merck and Gilead are jointly investing in a high-potential, long-acting HIV therapy with shared financial exposure, Pfizer is focusing on internal cost controls that may affect its ability to invest in or compete with such collaborative models. This contrast suggests differing strategic approaches to managing financial exposure in the evolving HIV treatment landscape.",
      "llm_answer": "Gilead’s deal with Merck splits the development and commercialization spend for the islatravir‑lenacapavir long‑acting HIV regimens 60 % to Gilead and 40 % to Merck, with revenue shared 50/50 until each product exceeds a $2 billion (oral) or $3.5 billion (injectable) sales threshold, after which Gilead’s share rises to 65 % (page 74‑75). Pfizer, by contrast, is not sharing HIV‑R&D costs but is pursuing internal cost‑reduction programs – an enterprise‑wide cost‑realignment and manufacturing‑optimization initiative – to lower its overall expense base (page 30). Thus Gilead’s financial exposure to long‑acting HIV therapies is directly limited and tied to the partnership’s cost‑share and sales‑tier structure, whereas Pfizer’s exposure is mitigated more broadly through efficiency gains that free cash for its pipeline rather than through a dedicated cost‑sharing arrangement.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the 60/40 cost split (Gilead/Merck), 50/50 revenue sharing, and the $2.0 billion (oral) and $3.5 billion (injectable) sales thresholds, with Gilead's revenue share increasing post-threshold. These figures match the ground truth exactly, with acceptable formatting variations (e.g., $2 billion vs $2.0 billion). The description of Pfizer's enterprise-wide cost realignment and manufacturing optimization initiatives is also factually accurate and contextually aligned. (2) All numeric values are correct: percentages (60%, 40%, 50/50, $2B, $3.5B) are consistent with the original answer. The LLM adds a specific detail—Gilead’s post-threshold revenue share rising to 65%—which is not contradicted by the ground truth and may reflect additional context from the source (e.g., page 74–75 citation), so it does not count as an error. (3) The multi-hop reasoning is sound: the model correctly contrasts Merck-Gilead’s collaborative, shared-exposure model with Pfizer’s internal cost-control strategy, and infers differing implications for financial exposure in long-acting HIV therapies. It synthesizes across two distinct company strategies and draws a logical comparison. (4) The only minor shortcoming is that the original answer emphasizes the risk to Pfizer’s pipeline delivery due to cost-cutting, while the LLM mentions this less explicitly, instead focusing on cash flow implications. This is a slight omission in completeness but does not undermine the core accuracy. Overall, the answer is factually robust, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1518,
        "completion_tokens": 441,
        "total_tokens": 1960
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does FDX's exposure to LIBOR-related hedging adjustments under ASU 2022-06 compare to UPS's use of hedging relationships, particularly in light of ASU 2022-06's extended sunset date through 2024?",
      "original_answer": "FDX has stated that reference rate reform, including ASU 2022-06, has had no material effect on its financial condition or results of operations as of May 31, 2024, though it continues to monitor contracts for potential application of the standard. ASU 2022-06 extends the sunset date for optional expedients and exceptions related to reference rate reform—including LIBOR transitions—to December 31, 2024. UPS, which designates derivative instruments in hedging relationships, including cash flow and fair value hedges, may benefit from the extended relief under ASU 2022-06 to manage LIBOR-related contracts through 2024 without significant accounting disruptions. Therefore, while FDX has not seen material impacts, UPS could be actively leveraging the extended ASU 2022-06 provisions in its hedging strategies.",
      "llm_answer": "FedEx reports that, even though the ASU 2022‑06 relief can be applied through December 31 2024, it has experienced no material effect from LIBOR‑related hedging adjustments as of May 31 2024 (FedEx 10‑K, p. 93). UPS, by contrast, discusses its use of derivative instruments for cash‑flow, fair‑value and net‑investment hedges but makes no mention of LIBOR‑linked exposure, indicating its hedging program is broader and not directly affected by the ASU 2022‑06 sunset (UPS 10‑K, p. 73).",
      "correctness_score": 6,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer is partially correct but contains a key misinterpretation in reasoning that affects the overall accuracy. (1) Quantitatively, all dates and references are accurate: ASU 2022-06's sunset date of December 31, 2024, and FedEx's disclosure as of May 31, 2024, are correctly cited with proper 10-K page references. There are no numerical errors. (2) Entity accuracy is strong—FDX (FedEx) and UPS are correctly identified, along with relevant hedging types (cash flow, fair value) and the correct ASU. (3) However, the reasoning and synthesis are flawed: the LLM incorrectly infers from UPS's lack of mention of LIBOR that its hedging program is 'not directly affected' by ASU 2022-06. The ground truth states that UPS *may benefit* from the extended relief due to its active use of hedging relationships, implying it could be using the relief even if not explicitly mentioning LIBOR. The LLM wrongly concludes no impact due to absence of mention, which contradicts the ground truth interpretation. (4) While the answer addresses both companies and the extended sunset date, it fails to correctly compare FDX's lack of material impact with UPS's potential active use of the relief—instead suggesting UPS is unaffected, which is not supported. Thus, despite correct facts and numbers, the qualitative reasoning is significantly flawed, leading to a misleading comparison. Correctness score is reduced accordingly.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1338,
        "completion_tokens": 391,
        "total_tokens": 1729
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the dual-class stock structure's impact on investor protections at META compare to the voting power differential in GOOGL's Class B common stock, especially given that Class B shares automatically convert to Class A upon sale or transfer?",
      "original_answer": "META's dual-class structure allows its controlling stockholder to maintain decision-making power even if they own significantly less than a majority of shares, which could make Class A common stock less attractive to investors due to reduced governance protections. In contrast, GOOGL's Class B common stock provides 10 votes per share compared to 1 vote per share for Class A, but these Class B shares automatically convert to Class A upon sale or transfer, potentially limiting long-term control by insiders. This conversion mechanism in GOOGL may offer more eventual governance balance compared to META's structure, where Class B shares can maintain control for extended periods unless their voting power drops below 35% of the combined voting power.",
      "llm_answer": "META’s dual‑class structure gives Mark Zuckerberg’s Class B shares decisive voting power and embeds anti‑takeover provisions that can prevent other shareholders from influencing mergers, board elections or charter amendments, meaning Class A investors enjoy weaker protections (see META 10‑K p. 50). By contrast, Alphabet’s Class B shares carry ten votes each but “automatically convert … upon sale or transfer to Class A common stock,” so the voting premium stays with the original holder and does not extend to new investors, and Delaware‑law safeguards further limit unequal treatment (see GOOGL 10‑K p. 81). Consequently, META’s structure poses a greater risk to investor protections than GOOGL’s voting‑power differential, which is mitigated by the automatic conversion feature.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: META's dual-class structure grants Mark Zuckerberg outsized voting control, weakening governance protections for Class A shareholders, while GOOGL's Class B shares have 10 votes per share but convert to Class A upon sale or transfer. These points match the original answer exactly. (2) There are no numeric values requiring calculation (e.g., percentages, dollar amounts), but the qualitative metrics—such as '10 votes per share' and 'automatic conversion upon sale'—are correctly stated and consistent with the ground truth. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (META and GOOGL), compares their dual-class structures, and draws a valid conclusion about relative investor protection risks. It identifies the critical distinction—the conversion mechanism in GOOGL limiting long-term insider control versus META’s enduring control via Class B shares. (4) The only minor shortcoming is that the LLM does not explicitly mention the 35% combined voting power threshold in META’s structure, which is present in the original answer and adds nuance about when control might dilute. However, this omission does not undermine the core conclusion. Wording differences (e.g., referencing 10-K page numbers, Delaware law) add context without distorting meaning. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 413,
        "total_tokens": 1822
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does KO's use of option contracts to hedge forecasted transactions compare to MDLZ's disclosure of gains and losses on forecasted transactions in terms of financial impact and hedging strategy?",
      "original_answer": "KO utilizes option contracts as part of its broader hedging strategy to mitigate foreign currency exchange rate risk, commodity price risk, and interest rate risk, with the goal of reducing earnings volatility from market fluctuations. These contracts are designated as cash flow hedges, and the unrealized gains or losses are deferred in AOCI until the forecasted transactions occur. In contrast, MDLZ disclosed that in 2024, it recognized $106 million in gains on forecasted transactions through cost of sales, and $17 million through interest and other expense, net, indicating the financial impact of these hedging activities on specific income statement line items. While KO emphasizes a structured hedging approach with clear accounting treatment for deferred gains/losses, MDLZ provides more granular disclosure on the realized financial outcomes of its hedging activities on forecasted transactions.",
      "llm_answer": "KO hedges its forecast‑currency exposures with option (and forward) contracts that are designated as cash‑flow hedges; the mark‑to‑market gains or losses are first recorded in AOCI (about $99 million of deferred gains for contracts maturing in the next 12 months) and are only re‑classified to earnings when the underlying transaction occurs【page_121】. In contrast, MDLZ reports the results of its economic‑hedge program on forecasted transactions directly in net earnings, showing pre‑tax impacts of $106 million in cost of sales, $17 million in interest expense and a $8 million benefit in SG&A for 2024【page_97】. Thus KO’s option‑based hedges defer the financial impact and aim to offset currency moves over the hedge period, while MDLZ’s hedges generate an immediate earnings effect.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies KO's use of option contracts as cash flow hedges with gains/losses deferred in AOCI and reclassified upon occurrence of forecasted transactions, and contrasts this with MDLZ's recognition of hedging gains/losses directly in earnings. This aligns well with the ground truth in terms of strategy and financial impact. However, the LLM introduces a specific figure of '$99 million of deferred gains' for KO, which is not present in the original answer and cannot be verified against the provided ground truth, making it an unsupported addition. Additionally, the LLM states MDLZ had an '$8 million benefit in SG&A', which is not mentioned in the original answer and appears to be extraneous or incorrectly inferred. (2) Quantitatively, the $106 million in cost of sales and $17 million in interest and other expense from MDLZ are accurately reported and match the ground truth. However, the inclusion of the $99 million (KO) and $8 million (MDLZ in SG&A) introduces inaccuracies or unverifiable data, reducing quantitative precision. (3) The multi-hop reasoning is strong: the model correctly synthesizes KO’s deferral-based hedging strategy with MDLZ’s immediate earnings recognition, drawing a valid strategic contrast between structured deferral (KO) versus transparent realized impact (MDLZ). The logic behind the differing financial statement impacts is sound and well-articulated. (4) Contextual relevance is excellent—the response directly addresses the comparison of financial impact and hedging strategy between KO and MDLZ. Despite the extra, unverified numbers, the core qualitative analysis and strategic comparison are accurate and insightful, warranting a high correctness score with a deduction for unsupported quantitative claims.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1436,
        "completion_tokens": 487,
        "total_tokens": 1923
      },
      "error": null
    },
    {
      "question_id": 166,
      "question": "How does the valuation approach for TMO's fixed income funds, which are reported as 'not subject to leveling', contrast with BMY's classification of fixed income funds under Level 2 in the fair value hierarchy, and what does this indicate about their respective reliance on observable market data for pension asset valuation?",
      "original_answer": "TMO reports its fixed income funds as 'not subject to leveling,' indicating that these assets are valued outside the standard fair value hierarchy and likely measured using methods other than quoted market prices or observable inputs. In contrast, BMY classifies its fixed income funds under Level 2, which means their valuation relies on observable market data, such as quoted prices for similar instruments or in nonactive markets. This contrast suggests that BMY's pension assets have a more structured and market-based valuation methodology for fixed income funds, while TMO's approach implies less direct reliance on standardized market inputs for these assets.",
      "llm_answer": "Thermo Fisher’s pension disclosures show that its fixed‑income fund holdings are recorded as “not subject to leveling” – they are measured at net‑asset value using a practical‑expedient and are not placed in the fair‑value hierarchy (Thermo Fisher 10‑K p.57). In contrast, Bristol‑Myers Squibb classifies its fixed‑income funds as Level 2 assets and values them at the funds’ NAV using observable market inputs (BMS 10‑K p.112). Thus BMS explicitly relies on observable market data for pension‑asset valuation, while Thermo Fisher’s approach bypasses the hierarchy and reflects a more indirect, expedient‑based valuation.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: TMO (Thermo Fisher) reports fixed income funds as 'not subject to leveling' using NAV as a practical expedient, placing them outside the fair value hierarchy, while BMY (Bristol-Myers Squibb) classifies its fixed income funds under Level 2, based on observable market inputs. These characterizations match the original answer’s meaning. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not applicable in that sense, but the references to 10-K pages (p.57 and p.112) are consistent with typical disclosure locations and do not contradict the knowledge graph; thus, no factual error is introduced. (3) The multi-hop reasoning is sound: the model correctly contrasts two companies’ pension asset valuation approaches, synthesizing information about their respective use of the fair value hierarchy. It accurately infers that BMY relies more directly on observable market data, while TMO uses an expedient-based method outside the hierarchy. (4) The only minor shortcoming is that the LLM answer does not explicitly state that TMO’s approach implies 'less direct reliance on standardized market inputs'—though this is implied by saying it 'bypasses the hierarchy' and uses an 'expedient-based valuation.' Thus, a small nuance in interpretation is missing, but the core reasoning and facts are intact. Overall, the answer is semantically equivalent and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 429,
        "total_tokens": 1796
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the application of the Federal Acquisition Regulation (FAR) in cost-plus-fixed-fee contracts impact revenue recognition timing differences between LMT and BA for their respective U.S. Government contracts?",
      "original_answer": "LMT applies FAR to its U.S. Government contracts, which results in standalone selling prices being equal to the stated contract price, and revenue being recognized over time as control of work in process transfers continuously to the customer due to clauses allowing unilateral termination and payment for costs incurred plus profit. Similarly, BA notes that U.S. Government contracts can be terminated for convenience, entitling them to payment for completed work and allowable termination costs. This creates a comparable revenue recognition pattern for both companies under FAR-regulated cost-plus-fixed-fee contracts, where revenue is recognized progressively rather than at a point in time, but differences may arise based on contract-specific termination clauses and profit margin negotiations.",
      "llm_answer": "Lockheed Martin applies the FAR to its cost‑plus‑fixed‑fee contracts by treating the work‑in‑process as owned by the government and allowing termination for convenience, so it records revenue continuously as costs are incurred and performance progresses (page 77). Boeing, also subject to the FAR, recognizes revenue from its cost‑plus‑fixed‑fee contracts only when the contract’s performance obligations are satisfied—generally at milestones or contract completion—resulting in a later, more discrete timing of revenue recognition (page 76).",
      "correctness_score": 3,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains a significant factual error in reasoning and entity application. While both Lockheed Martin (LMT) and Boeing (BA) are subject to the Federal Acquisition Regulation (FAR) and have U.S. Government contracts with termination for convenience clauses, the LLM incorrectly states that Boeing recognizes revenue only at milestones or contract completion. This contradicts the ground truth, which indicates that both companies recognize revenue progressively over time due to FAR provisions allowing payment for costs incurred plus profit upon termination. The ground truth emphasizes that both companies have comparable revenue recognition patterns—progressive, not point-in-time—due to continuous transfer of control. The LLM’s claim that Boeing recognizes revenue later and in discrete amounts is unsupported and incorrect. (2) There are no numeric values in the question or answers, so quantitative accuracy is not applicable; no numbers are misstated. (3) The multi-hop reasoning fails because the model does not correctly synthesize the impact of FAR on both companies. It incorrectly differentiates LMT and BA’s revenue recognition timing, when the ground truth states they are comparable due to similar contractual protections and FAR application. The model appears to misinterpret Boeing’s policy, possibly confusing cost-plus contracts with fixed-price milestone-based contracts. (4) Correctness and qualitative accuracy are low due to this major misrepresentation of Boeing’s revenue recognition practice. Contextual relevance is moderate because the answer addresses the right topic (FAR, cost-plus contracts, revenue timing), but draws an incorrect conclusion that undermines the core of the response.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 475,
        "total_tokens": 1827
      },
      "error": null
    },
    {
      "question_id": 168,
      "question": "How does the structure of AbbVie's debt agreements with U.S. Bank National Association compare to Abbott Laboratories' use of Abbott Ireland Financing DAC as an issuer, particularly in terms of trustee roles and note issuance timelines?",
      "original_answer": "AbbVie has multiple Supplemental Indentures with U.S. Bank National Association serving as trustee, transfer agent, and registrar, with key agreements dated September 26, 2019 (Supplemental Indenture No. 6), November 21, 2019 (Supplemental Indenture No. 7), and May 14, 2020 (Supplemental Indenture No. 8 and 9). These agreements involve the issuance of various notes and are supported by Agency Agreements with Elavon Financial Services DAC. Similarly, Abbott Ireland Financing DAC, as issuer, has entered into Indentures with U.S. Bank National Association as trustee, including the September 27, 2018 Indenture and the November 19, 2019 Second Supplemental Indenture, under which specific notes such as the 1.500% Note due 2026 and the 0.100% Note due 2024 were issued. Both companies rely on U.S. Bank National Association in a trustee capacity, but AbbVie’s structure includes more frequent use of Elavon Financial Services DAC as a paying agent, while Abbott Ireland Financing DAC directly issues notes under its own entity name with Abbott Laboratories as guarantor.",
      "llm_answer": "AbbVie’s borrowings are organized under a master indenture and a series of supplemental indentures that name U.S. Bank National Association as the trustee (and, in later supplements, also as transfer agent and registrar), with notes issued under those agreements from the 2012‑2015 period through a 2020 supplement (see AbbVie 10‑K pages 107‑108). In contrast, Abbott Laboratories issues its debt through Abbott Ireland Financing DAC as the issuer, with U.S. Bank National Association serving only as trustee, and the note program was launched with an indenture in September 2018 and supplemental indentures in 2018‑2019 (see Abbott 10‑K page 87).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the general structure of both companies' debt arrangements and correctly identifies U.S. Bank National Association as the common trustee. It also correctly notes that Abbott Ireland Financing DAC is the issuer for Abbott Laboratories' debt, with Abbott as guarantor (implied by context), and that AbbVie uses supplemental indentures under a master agreement. However, there are significant quantitative inaccuracies: the LLM states AbbVie's notes were issued 'from the 2012–2015 period through a 2020 supplement,' but the ground truth specifies exact dates of Supplemental Indentures on September 26, 2019, November 21, 2019, and May 14, 2020—no mention of 2012–2015 activity in the context of these specific agreements. This misrepresents the timeline. Additionally, the LLM omits key details such as the specific note issuances (e.g., 1.500% Note due 2026, 0.100% Note due 2024) and the role of Elavon Financial Services DAC as a paying agent in AbbVie’s structure, which is a key differentiator highlighted in the original answer. The comparison of trustee roles is partially correct but lacks depth—while both use U.S. Bank as trustee, the LLM fails to note that AbbVie’s agreements include expanded roles (transfer agent, registrar) in later supplements, and that Elavon is more frequently used by AbbVie than by Abbott. The Abbott Ireland Financing DAC issuance timeline is understated: the LLM says '2018–2019' but misses the specific September 27, 2018 Indenture and November 19, 2019 Second Supplemental Indenture. While the LLM cites 10-K page references, these are not part of the ground truth and may reflect plausible sourcing but do not compensate for factual omissions. The reasoning is logically structured and addresses the comparison framework, but the lack of precise dates, missing note specifics, and incorrect time range for AbbVie’s agreements reduce factual accuracy. The answer is contextually relevant and attempts multi-hop synthesis, but with incomplete execution.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1452,
        "completion_tokens": 540,
        "total_tokens": 1992
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does NVDA's dependency on foundries for advanced process node manufacturing at 7nm and smaller compare to AMD's reliance on larger wafers for competitive IC production, given both companies' exposure to TSMC's fabrication capabilities?",
      "original_answer": "NVDA depends on foundries like TSMC to manufacture its semiconductor wafers using advanced process node technologies such as 7nm and smaller, which are critical for producing high-performance GPUs and meeting customer demand. NVDA faces risks including supply shortages, yield issues, and delays if TSMC cannot scale production or implement new technologies effectively. Similarly, AMD relies on TSMC to produce wafers with competitive performance attributes, and specifically mentions the importance of transitioning to advanced manufacturing process technologies and increased wafer sizes to maintain cost efficiency and product competitiveness. Both companies are exposed to risks if TSMC fails to deliver sufficient quantities of 7nm or smaller wafers, which could increase per-unit costs, delay product launches, and harm customer relationships. This shared dependency on TSMC for leading-edge wafer production highlights a critical supply chain vulnerability affecting both NVDA and AMD.",
      "llm_answer": "NVIDIA’s fab strategy is tightly bound to the most‑advanced nodes – it depends on TSMC to supply all of its 7 nm‑and‑smaller microprocessor and GPU wafers, and any shortfall at those nodes would materially hurt the business【page_25】. By contrast, AMD’s competitive ICs are largely built on larger‑than‑7 nm process wafers that it sources primarily from GlobalFoundries, with TSMC used only for its smallest‑node products【page_23】. Thus NVIDIA is far more exposed to TSMC’s advanced‑node capacity, while AMD’s core volume can be produced on larger wafers, reducing its reliance on the tightest advanced‑node supply.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains partially correct information but includes a significant factual error that undermines the multi-hop comparison. (1) Correct elements: Both companies' reliance on TSMC and the importance of 7nm and smaller nodes are contextually relevant. The mention of supply risk for NVDA is consistent with the ground truth. (2) Quantitative accuracy is acceptable—no specific numbers (e.g., wafer size, cost figures) are misstated, and the 7nm threshold is correctly used. (3) Major error: The claim that AMD primarily uses GlobalFoundries for larger-than-7nm wafers and that its core volume is not dependent on TSMC contradicts the ground truth, which states AMD relies on TSMC for advanced nodes and specifically emphasizes transitioning to advanced process technologies (including 7nm and smaller) for cost efficiency and competitiveness. The original answer highlights that both companies are exposed to TSMC’s 7nm-and-smaller capacity constraints, but the LLM incorrectly frames AMD as less reliant by using larger wafers from other foundries. (4) This misrepresentation breaks the multi-hop reasoning: the comparison of shared TSMC dependency is lost, and the conclusion that AMD has reduced reliance is unsupported. While the answer is relevant and well-structured, the core factual inaccuracy regarding AMD’s manufacturing strategy significantly reduces correctness. Semantic equivalence is not achieved due to this key discrepancy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1425,
        "completion_tokens": 399,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "Given Philip Morris's ongoing regulatory challenges in Thailand stemming from the WTO panel decision on customs valuation of cigarette imports, and Colgate-Palmolive's manufacturing presence in Thailand, how might the unresolved customs and tax compliance issues in Thailand impact Colgate-Palmolive's operational costs or regulatory risk exposure in the country?",
      "original_answer": "The WTO panel decision found that Thailand lacked grounds to challenge the customs valuation of Philip Morris's cigarette imports and obligated Thailand to revise its customs and tax practices. However, Thailand has not fully complied, and the dispute remains unresolved due to the inoperability of the WTO Appellate Body. This regulatory inertia indicates a persistent risk of non-aligned customs enforcement in Thailand. Colgate-Palmolive operates manufacturing and warehousing facilities in Thailand, a country where customs and tax measures have proven resistant to international rulings. If Thailand continues to apply inconsistent or non-compliant customs valuation practices, Colgate-Palmolive may face increased scrutiny, higher import duties, or regulatory uncertainty affecting its cost structure and compliance burden in the country.",
      "llm_answer": "The WTO panel decision (PM 10‑K p. 68) shows that Thailand has not yet implemented the required reforms to its customs‑valuation and tax rules, leaving the country’s import regime in flux. Because Colgate‑Palmolive operates a major manufacturing facility in Thailand (Colgate 10‑K p. 25), any retroactive re‑valuation of imported raw materials, packaging or components—or tighter enforcement of tax assessments—could raise its cost of goods sold and force the company to devote additional resources to compliance, thereby increasing both operational costs and regulatory‑risk exposure in the market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) It correctly identifies the unresolved WTO panel decision regarding Thailand's customs valuation practices and cites the correct source (Philip Morris 10-K, p. 68), aligning with the core issue in the original answer. It also accurately references Colgate-Palmolive's manufacturing presence in Thailand (Colgate 10-K, p. 25), supporting the relevance of the regulatory environment to its operations. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model connects the WTO ruling against Thailand, Thailand’s non-compliance due to systemic issues (implied by Appellate Body inoperability, though not explicitly stated), and the potential impact on Colgate-Palmolive via increased costs and compliance burden. The LLM correctly infers that inconsistent customs enforcement could affect imported inputs (raw materials, packaging), directly impacting cost of goods sold—a logical and well-supported conclusion. (4) The only minor shortcoming is that the LLM does not explicitly mention the WTO Appellate Body’s inoperability as a cause of the unresolved dispute, which is included in the original answer and adds context for why Thailand has not complied. However, stating that reforms 'have not yet been implemented' and the regime is 'in flux' captures the practical outcome. Overall, the answer is highly accurate, contextually appropriate, and demonstrates strong synthesis across regulatory and operational domains.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1415,
        "completion_tokens": 446,
        "total_tokens": 1861
      },
      "error": null
    },
    {
      "question_id": 169,
      "question": "How does the $265,000 decline in UNH's Medicare Part D enrollment from 2023 to 2024 relate to the IRA's redesign of Medicare Part D and Pfizer's projected $1 billion revenue loss in 2025 under the same program?",
      "original_answer": "The $265,000 decline in UnitedHealth's (UNH) Medicare Part D enrollment from 2023 to 2024 reflects a reduction in the number of beneficiaries in this program, which aligns with broader structural changes introduced by the Inflation Reduction Act (IRA). The IRA's redesign of Medicare Part D, effective in 2025, includes a $2,000 annual out-of-pocket cap for beneficiaries and a new Manufacturer Discount Program requiring 10% and 20% discounts in different coverage phases. These changes increase financial pressure on manufacturers like Pfizer (PFE), which projects a $1 billion revenue loss in 2025 due to IRA-related adjustments. The enrollment decline at UNH may indicate reduced attractiveness of Part D plans to beneficiaries or shifting market dynamics, which, when combined with the IRA's pricing pressures, could contribute to reduced revenue for manufacturers like Pfizer.",
      "llm_answer": "UnitedHealth’s “Medicare Part D stand‑alone” enrollment fell from 3.315 million in 2023 to 3.050 million in 2024 – a drop of about 265 thousand lives (see UNH 10‑K p. 31).  That decline is tied to the Inflation‑Reduction Act’s 2024 redesign of Medicare Part D, which caps beneficiary out‑of‑pocket costs and shifts more cost to Part D plans and drug makers; the same redesign forces manufacturers to provide larger discounts, and Pfizer now expects it will shave roughly $1 billion off its 2025 revenue (see Amgen 10‑K p. 17).  In other words, the enrollment dip reflects the broader market pressure the IRA’s Part D changes are creating, a pressure that Pfizer quantifies as a $1 billion revenue hit.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely aligns with the ground truth. (1) Quantitatively, all numbers are correct: the enrollment decline is accurately stated as 265,000 (from 3.315 million to 3.050 million), and Pfizer's projected $1 billion revenue loss in 2025 is correctly reported. The source references (UNH 10-K p.31, Amgen 10-K p.17) add credibility, though the mention of Amgen's 10-K for Pfizer's data is a minor inconsistency but does not affect factual correctness. (2) The calculation of the enrollment drop (3.315M - 3.050M = 0.265M) is accurate. (3) The multi-hop reasoning is sound: the answer correctly links UNH's enrollment decline to the IRA's Part D redesign, explains the financial impact on drug manufacturers via increased discounts, and ties this to Pfizer's revenue loss. (4) The qualitative explanation captures the causal chain: IRA changes → cost-shifting → lower enrollment attractiveness and higher manufacturer discounts → revenue impact. The only minor shortcoming is slightly less nuance than the original in explaining the specific IRA mechanisms (e.g., 10%/20% discounts in coverage phases), but the core logic and synthesis across UNH, IRA, and Pfizer are correct. Wording differs but meaning is semantically equivalent. Contextual relevance is excellent, directly addressing all parts of the multi-hop question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1411,
        "completion_tokens": 375,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does Lockheed Martin's $4,863 million investment in private equity funds, which are valued using the NAV practical expedient, compare to FedEx's application of the same accounting policy for equity securities without readily determinable fair values?",
      "original_answer": "Lockheed Martin reports $4,863 million in private equity fund investments valued under the NAV practical expedient, which relies on unobservable inputs in valuation models of underlying securities and typically has terms between 8 and 12 years. FedEx also applies the NAV practical expedient to equity securities without readily determinable fair values, though it notes that for these investments, adjustments to cost are made only for observable price changes and impairments. While Lockheed Martin’s NAV-based private equity investments are part of a broader portfolio including real estate and hedge funds, FedEx specifically highlights immaterial annual and cumulative impairment adjustments under the measurement alternative for such equity securities.",
      "llm_answer": "Lockheed Martin reports $4,863 million of private‑equity fund investments that are measured at net‑asset‑value (NAV) under the NAV practical expedient. FedEx applies the same NAV‑practical‑expedient only to a small slice of its equity portfolio – $37 million of equity securities without readily determinable fair values in 2024 (and $26 million in 2023). Thus, Lockheed’s NAV‑valued investment is orders of magnitude larger – roughly a hundred‑plus times the amount FedEx records under the same policy.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. While it correctly states Lockheed Martin's $4,863 million investment in private equity funds valued using the NAV practical expedient, it introduces specific dollar amounts for FedEx—$37 million in 2024 and $26 million in 2023—that are not present in the original answer (ground truth). The ground truth does not provide any numerical value for FedEx’s investments under the NAV practical expedient; instead, it qualitatively notes that FedEx applies the expedient to equity securities without readily determinable fair values and emphasizes that impairment adjustments have been immaterial. The claim that FedEx’s amount is 'a small slice' or 'orders of magnitude smaller'—let alone a quantitative comparison of 'a hundred-plus times'—is unsupported by the original data and represents an unjustified inference. This introduces a major quantitative error. Entity accuracy is otherwise correct (Lockheed Martin, FedEx, NAV practical expedient). The reasoning attempts multi-hop synthesis by comparing scale, but the comparison is based on fabricated numbers, invalidating the logic. Contextually, the answer addresses the question’s intent to compare policy application, but the invented figures severely compromise factual integrity. Thus, while the structure and intent are relevant, the core factual content for FedEx is incorrect, leading to a low correctness and quantitative accuracy score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 407,
        "total_tokens": 1749
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the voting power dilution mechanism in CMCSA's Class B to Class A common stock conversion compare with GOOGL's dual-class structure, particularly in light of GOOGL's $62.0 billion share repurchase in 2024 targeting Class A and Class C shares?",
      "original_answer": "GOOGL's 2024 share repurchase of $62.0 billion focused on Class A and Class C shares, which could indirectly impact ownership concentration by reducing the number of shares outstanding, while maintaining the dual-class voting structure where Class B shares retain 10 votes per share. In contrast, CMCSA's Class B common stock is convertible share-for-share into Class A common stock and holds 33⅓% of the total voting power, which is non-dilutable under their articles of incorporation. This means CMCSA's Class B stock maintains a fixed voting influence regardless of conversions or new issuances, whereas GOOGL's repurchase strategy may influence the economic value of shares without altering the 10:1 voting rights disparity between Class B and Class A shares.",
      "llm_answer": "CMCSA’s Class B shares carry ten votes each and may be converted at any time (or automatically on transfer) into Class A shares that carry only one vote, so a holder who converts loses voting power on a per‑share basis; however, the company’s charter locks the aggregate voting power of Class B at roughly 33 % of total votes and it cannot be diluted by issuing other stock (see page 91 & page 82). Alphabet’s (GOOGL) dual‑class system likewise has a high‑voting Class B (10 votes) and low‑voting Class A (1 vote) and non‑voting Class C shares, and its 2024 $62 billion repurchase of Class A and Class C shares shrank the pool of low‑ or non‑voting stock, thereby concentrating voting power in the remaining high‑voting Class B shares (see page 82).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and matches the ground truth in key aspects, with high quantitative accuracy and strong contextual relevance. (1) Quantitative accuracy: All numbers are correct—GOOGL's $62.0 billion repurchase (rounded to $62 billion is acceptable), and the 33% voting power for CMCSA Class B shares are accurately represented. No calculations were required, and all numeric values align with the original answer. (2) Entity accuracy: Both companies (CMCSA and GOOGL/Alphabet) are correctly identified, share classes (A, B, C) and their voting rights (10:1 for GOOGL, 33⅓% fixed for CMCSA) are properly attributed. (3) Reasoning: The LLM correctly explains that GOOGL’s repurchase of Class A and C shares reduces the number of low- and non-voting shares, thereby concentrating voting power among Class B shares—an accurate interpretation of the indirect effect. It also correctly notes that CMCSA’s Class B voting power is contractually fixed at ~33%, non-dilutable, and conversion does not dilute this aggregate share of voting power. (4) However, there is a minor inaccuracy in stating that CMCSA’s Class B shares 'carry ten votes each'—the ground truth does not specify per-share voting rights but emphasizes the aggregate 33⅓% non-dilutable voting power. This mischaracterization of per-share voting weight (implying a 10:1 ratio like GOOGL) introduces a factual error in qualitative detail, though the core point about non-dilutable voting power remains correct. The original answer does not mention per-share vote counts for CMCSA, only aggregate voting power. This affects qualitative accuracy slightly but does not undermine the overall correctness of the comparison. (5) The answer is semantically close to the original and addresses all parts of the question, including the repurchase impact and structural comparison. Thus, the correctness score is 8 due to the minor but notable error in describing CMCSA's per-share voting mechanism.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 527,
        "total_tokens": 1931
      },
      "error": null
    },
    {
      "question_id": 170,
      "question": "How does the revenue exposure of CVS through its 50% ownership in Red Oak Sourcing, LLC—which negotiates generic pharmaceutical supply contracts with Cardinal Health, Inc., compare to LLY's reliance on Cardinal Health as a top-three distributor accounting for 15–20% of its consolidated revenue?",
      "original_answer": "CVS has a 50% ownership stake in Red Oak Sourcing, LLC, which serves as a joint venture with Cardinal Health, Inc. to negotiate generic pharmaceutical supply contracts for both companies, though Red Oak does not hold inventory. Meanwhile, LLY relies on Cardinal Health, Inc. as one of only three U.S. wholesale distributors each accounting for 15–20% of LLY’s consolidated revenue, alongside McKesson and AmerisourceBergen. This means Cardinal plays a dual role—both as a strategic sourcing partner to CVS via Red Oak and as a critical distribution channel for LLY’s pharmaceutical products in the U.S. market.",
      "llm_answer": "CVS’s exposure to Cardinal Health is indirect – it owns 50 % of Red Oak Sourcing, LLC, a joint‑venture that merely negotiates generic‑drug supply contracts and does not hold inventory, and the filing does not quantify any material revenue impact from that stake. By contrast, Eli Lilly discloses that Cardinal Health is one of its three top U.S. distributors and alone accounts for roughly 15 %–20 % of Lilly’s consolidated revenue, indicating a far larger and more direct reliance on the distributor.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: CVS owns 50% of Red Oak Sourcing, LLC, a joint venture with Cardinal Health that negotiates generic drug supply contracts but does not hold inventory. LLY (Eli Lilly) relies on Cardinal Health as one of three top U.S. distributors, accounting for 15–20% of its consolidated revenue. These numbers and relationships match the original answer exactly. (2) Quantitative accuracy is perfect: the 50% ownership and 15–20% revenue reliance are correctly reported, with acceptable formatting (e.g., '15 %–20 %' vs '15–20%'). No calculations were required, but the comparison in magnitude (indirect vs. direct reliance) is logically sound. (3) Multi-hop reasoning is strong: the model correctly synthesizes information across two companies (CVS and LLY), their respective relationships with Cardinal Health, and the structural differences (sourcing JV vs. distribution channel). It appropriately highlights that CVS’s exposure is indirect and non-revenue-generating from Red Oak, while LLY has direct, material revenue dependence. (4) The only minor shortcoming is that the LLM slightly underemphasizes the dual role of Cardinal Health (as both partner to CVS and distributor for LLY), which is a nuanced but present point in the original. However, the core contrast in exposure type and magnitude is clearly and correctly conveyed. Wording differences do not affect semantic equivalence. Overall, the answer is factually complete, contextually relevant, and logically sound.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1315,
        "completion_tokens": 430,
        "total_tokens": 1745
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "What is the difference in voting rights per share between Class B common stock disclosed by UPS and the common stock voting rights at Honeywell as of 2024?",
      "original_answer": "UPS's Class B common stock has 10 votes per share, while Honeywell's common stock has 1 vote per share, resulting in a 9-vote difference per share in favor of UPS's Class B shares.",
      "llm_answer": "UPS’s Class B common stock is entitled to ten votes per share (UPS 10‑K, Note 12‑Shareholders’ Equity, page 65). Honeywell’s common stock is entitled to one vote per share (Honeywell 10‑K, Note 18‑Capital Stock, page 96). Therefore, UPS Class B shares have nine more votes per share than Honeywell’s common shares.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the voting rights per share are accurately reported: UPS Class B has 10 votes per share and Honeywell common stock has 1 vote per share. The difference of 9 votes per share is correctly calculated. (2) The answer is complete, addressing both companies' voting rights and computing the correct difference. (3) Entities are accurately identified—UPS and Honeywell—with correct references to their respective 10-K filings and specific note numbers and pages, demonstrating proper multi-hop synthesis. (4) The reasoning is sound: it correctly compares two distinct data points from different filings and draws the logical conclusion. The semantic meaning is equivalent to the original answer, with only slight rephrasing (e.g., 'nine more votes' vs '9-vote difference'). All criteria for correctness, accuracy, and relevance are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1125,
        "completion_tokens": 271,
        "total_tokens": 1397
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How does the maturity of AMGN's 3.625% 2024 Notes, which triggered the termination of $1.4 billion in associated interest rate swap contracts, compare with ABBV's use of interest rate swap contracts as cash flow hedges in 2024?",
      "original_answer": "AMGN's 3.625% 2024 Notes matured in 2024, which led to the termination of $1.4 billion in interest rate swap contracts that were hedging this fixed-rate debt. In contrast, ABBV did not have any active interest rate swap contracts designated as cash flow hedges in 2024, as the amount reported for that year was $0, compared to $6 million in 2022. This indicates a difference in hedging strategy between the two companies with respect to interest rate exposure on debt instruments.",
      "llm_answer": "Amgen’s 3.625 % notes were scheduled to mature in 2024, and their repayment that year triggered the termination of $1.4 billion of interest‑rate swap contracts (Amgen 10‑K p. 149). By contrast, AbbVie reported no interest‑rate swap contracts designated as cash‑flow hedges in 2024 – its swaps were used as fair‑value hedges and the cash‑flow‑hedge line shows a zero amount for 2024 (AbbVie 10‑K p. 83 & 86).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: AMGN's 3.625% notes matured in 2024, triggering the termination of $1.4 billion in interest rate swaps; ABBV reported $0 in interest rate swaps designated as cash flow hedges in 2024. These numbers, dates, and dollar amounts match the original answer exactly. (2) Quantitative accuracy is perfect: $1.4 billion and 2024 are correctly cited; ABBV’s $0 in 2024 is accurate (with supporting context from 2022 in the original answer, though not repeated here). (3) The multi-hop reasoning is sound—correctly contrasting AMGN’s terminated swaps due to debt maturity with ABBV’s lack of cash flow hedges in 2024. The LLM adds a detail not in the original (that ABBV’s swaps were used as fair-value hedges), which is consistent with typical hedging classifications and supported by the cited 10-K pages, though not explicitly mentioned in the ground truth. (4) The only minor shortcoming is that the original answer notes ABBV had $6 million in 2022 for context, which the LLM omits—this contextual comparison slightly enriches the original but is not essential to the core question. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1242,
        "completion_tokens": 351,
        "total_tokens": 1593
      },
      "error": null
    },
    {
      "question_id": 171,
      "question": "How did the adoption of ASU 2022-02 impact Capital One's reporting of financial difficulty modifications compared to JPMorgan's prior TDR disclosures, particularly in terms of modification types and their financial effects?",
      "original_answer": "The adoption of ASU 2022-02 eliminated the TDR framework and introduced FDMs, changing how Capital One reports loan modifications. Capital One noted that the types of modifications offered—such as interest rate reductions, term extensions, and principal reductions—remained the same, but they are now categorized and reported differently under FDMs. For JPMorgan, prior to the change, TDRs included similar modifications but were assessed under concession criteria. After the adoption, JPMorgan reported $136 million in FDMs for 2023, primarily involving term extensions and interest rate reductions that extended loan lives by 20 years and reduced the weighted-average rate from 7.21% to 4.44%. This shift reflects a more standardized reporting approach under ASU 2022-02, removing the previous TDR distinctions while maintaining the same types of borrower support.",
      "llm_answer": "Capital One’s adoption of ASU 2022‑02 on January 1 2023 eliminated the TDR concession test and re‑classifies qualifying loan changes as financial‑difficulty modifications (FDMs), but the underlying modification types—principal forgiveness, interest‑rate reductions, other‑than‑insignificant payment delays and term extensions—did not change (COF 10‑K p. 99, 159). In contrast, JPMorgan’s prior TDR disclosures broke out each concession (e.g., 54 % interest‑rate reductions, term extensions extending loan life from 22 to 38 years, interest‑rate cuts from 4.75 % to 3.35 %, charge‑offs, principal deferred/forgiven and re‑default balances) and quantified their financial effects (JPM 10‑K p. 245), whereas Capital One now accumulates FDMs and reports performance on a rolling twelve‑month basis, making the new FDM data not directly comparable to the detailed TDR metrics.",
      "correctness_score": 5,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer captures the conceptual shift from TDRs to FDMs under ASU 2022-02 and correctly identifies that modification types (e.g., interest rate reductions, term extensions) remained similar for Capital One. It also notes the change in reporting approach, with Capital One aggregating FDMs and using rolling performance metrics, which aligns with the intent of the standard. However, the quantitative details are significantly inaccurate and misattributed. The ground truth states that JPMorgan reported $136 million in FDMs in 2023, with term extensions increasing loan lives by 20 years and interest rates dropping from 7.21% to 4.44%. In contrast, the LLM answer cites incorrect figures: 'term extensions from 22 to 38 years' (a 16-year increase, not 20), and interest rate cuts 'from 4.75% to 3.35%', which do not match the ground truth. These numbers appear fabricated or misextracted. Additionally, the LLM attributes these specific percentages and metrics to JPMorgan's 'prior TDR disclosures', but the original answer does not include such granular historical breakdowns (e.g., 54% interest rate reductions), making this detail unsupported. The LLM also fails to mention that JPMorgan’s 2023 FDM total was $136 million, a key quantitative anchor. While the reasoning about non-comparability due to reporting changes is valid, the answer introduces false precision. Entity accuracy is mostly correct (Capital One, JPMorgan, ASU 2022-02, FDMs, TDRs), and the multi-hop synthesis between the two banks’ reporting practices is attempted, but flawed due to incorrect data. Contextually, the response stays on topic and addresses the comparative impact on reporting, modification types, and financial effects, earning moderate scores in qualitative accuracy and relevance despite factual shortcomings.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 488,
        "total_tokens": 1941
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How does the alignment of interest rate swap maturities with debt exposure differ between GD's hedging strategy and UPS's economic hedge approach, and what does this reveal about their respective risk management priorities?",
      "original_answer": "GD's hedging strategy involves interest rate swap contracts with a dollar-weighted two-year average maturity that generally matches the duration of the activities at risk, indicating a focus on closely aligning hedge instruments with underlying exposure timelines. In contrast, UPS uses interest rate swaps as economic hedges for portions of its outstanding debt but does not specify a maturity alignment, instead emphasizing the use of offsetting positions to terminate existing swaps and eliminate market valuation effects. This reveals that GD prioritizes duration-matching to manage interest rate risk over time, while UPS focuses on dynamic risk mitigation through offsetting transactions, reflecting different approaches to managing financial exposure.",
      "llm_answer": "GD’s disclosures note that the “dollar‑weighted two‑year average maturity of these instruments generally matches the duration of the activities that are at risk,” meaning its interest‑rate swaps are deliberately timed to the life of the underlying debt (GD 10‑K p. 82). UPS, however, says its swaps “are intended to provide an economic hedge of portions of our outstanding debt” and are not designated as formal hedges, with no reference to matching swap maturities to the debt schedule (UPS 10‑K p. 159). Thus, GD prioritizes precise, duration‑matched hedging to neutralize interest‑rate risk, while UPS emphasizes a broader, flexible cost‑management approach that uses swaps as an economic offset without strict maturity alignment.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: GD's use of interest rate swaps with a dollar-weighted two-year average maturity that matches the duration of the underlying risk is accurately described, including the source (GD 10-K p. 82). UPS’s use of swaps as economic hedges without formal hedge accounting or maturity alignment is also correctly stated, with proper reference to UPS 10-K p. 159. (2) There are no numerical inaccuracies—while no specific calculations are required, the mention of 'two-year average maturity' matches the ground truth exactly, and no incorrect figures are introduced. (3) The multi-hop reasoning is sound: the model correctly synthesizes information from two different companies’ filings and contrasts their hedging philosophies—duration matching (GD) vs. flexible economic offsetting (UPS)—which reflects the core of the question. (4) The conclusion about differing risk management priorities—precision in timing for GD versus dynamic cost management for UPS—is semantically equivalent to the ground truth’s interpretation, though slightly rephrased. The only minor limitation is that the LLM does not explicitly mention UPS’s use of 'offsetting positions to terminate existing swaps' (a detail in the original), which slightly reduces completeness in qualitative nuance. However, the essence of UPS’s dynamic approach is still captured. Overall, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1392,
        "completion_tokens": 415,
        "total_tokens": 1807
      },
      "error": null
    },
    {
      "question_id": 172,
      "question": "How might Alphabet's share repurchase activity in 2023, which focused on Class A and Class C shares, impact the relative voting power of its undiluted Class B shares, and how does this compare to the non-dilutable 33 1/3% voting power structure of Class B shares at Comcast?",
      "original_answer": "Alphabet's 2023 share repurchase of $62.2 billion in Class A and Class C shares likely increased the relative voting power of its undiluted Class B shares, which are held by insiders and carry 10 votes per share. This mirrors the structure at Comcast, where Class B shares, held entirely by Brian L. Roberts, maintain a non-dilutable 33 1/3% of combined voting power despite having 15 votes per share. Both companies use dual-class structures to protect long-term strategic control, but Alphabet's repurchase activity may have amplified the concentration of voting power further by reducing the number of publicly traded shares.",
      "llm_answer": "Alphabet’s 2023 buy‑back removed 78 million voting Class A shares and 450 million non‑voting Class C shares, while its 10‑vote‑per‑share Class B stock was not repurchased 【page_81】. Because the pool of one‑vote Class A shares shrank and the Class B count stayed the same, the proportion of total voting power held by the undiluted Class B shares rises. By contrast, Comcast’s charter fixes its Class B shares at a non‑dilutable 33 ⅓ % of the combined voting power (each Class B share carries 15 votes) regardless of any share repurchases 【page_33】.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Alphabet's 2023 share repurchase included Class A and Class C shares, with Class B shares (10 votes per share) excluded from repurchases, leading to an increase in their relative voting power—this matches the original answer's core claim. (2) The quantitative details—78 million Class A shares and 450 million Class C shares repurchased—are specific and consistent with the knowledge graph data (though the $62.2 billion dollar amount in the original is not mentioned, this omission does not affect the voting power analysis). The absence of the total dollar value is a minor gap but not critical to the reasoning about voting power concentration. (3) The comparison to Comcast is accurate: the LLM correctly states that Comcast’s Class B shares are contractually entitled to a non-dilutable 33 1/3% of voting power regardless of share count changes, and each carries 15 votes. This reflects proper multi-hop reasoning across Alphabet and Comcast’s governance structures. (4) The reasoning is sound: reducing the number of voting Class A shares while holding Class B constant naturally increases Class B’s proportion of total voting power. The semantic meaning and factual content are equivalent to the ground truth, with only slightly more granular detail on share counts. Wording differences are acceptable and do not detract from accuracy. Minor deduction from 10 due to omission of the $62.2B figure, but this does not impair the correctness of the voting power analysis.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1326,
        "completion_tokens": 432,
        "total_tokens": 1758
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the structure of Robert Iger's Rule 10b5-1 trading plan at DIS, including the number of shares and termination date, compare to Peggy Alford's plan at META, given both are governed by the same regulatory framework?",
      "original_answer": "Robert Iger's trading plan at DIS involves the potential sale of up to 372,412 shares of Disney common stock, with a termination date of December 17, 2024. Peggy Alford's plan at META provides for the sale of up to $1.2 million worth of META Class A common stock, with a termination date of November 15, 2025. Both plans were adopted under Rule 10b5-1(c), which provides an affirmative defense for insider trading activities conducted under a prearranged plan. The comparison shows that while Iger's plan focuses on a fixed number of shares tied to expiring options, Alford’s plan is value-based and has a longer duration.",
      "llm_answer": "Robert Iger’s Disney Rule 10b5‑1 plan authorizes the sale of up to **372,412 shares** of Disney common stock and is slated to **terminate on December 17, 2024** (subject to early termination)【page_61】. Peggy Alford’s Meta Rule 10b5‑1 plan, by contrast, permits the sale of **up to $1.2 million worth of Meta Class A shares** and will **terminate on November 15, 2025** (also subject to early termination)【page_124】. Both plans use the same Rule 10b5‑1 framework but differ in the metric (share count vs. dollar amount) and the termination dates.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitative accuracy: The number of shares (372,412) for Robert Iger at DIS and the dollar amount ($1.2 million) for Peggy Alford at META are correctly reported. Termination dates (December 17, 2024, for Iger; November 15, 2025, for Alford) are accurate. Format variations (e.g., $1.2 million vs $1.2M) are acceptable and semantically equivalent. (2) Completeness: The answer addresses all parts of the multi-hop question—structure, number of shares/dollar value, termination dates, and the shared regulatory framework (Rule 10b5-1). (3) Entity accuracy: Companies (DIS/Disney and META/Meta), individuals (Iger and Alford), stock types (common stock, Class A shares), and regulatory rule (Rule 10b5-1) are correctly identified. (4) Reasoning: The comparison between a fixed share-based plan (Iger) and a value-based plan (Alford) is accurately drawn, and the difference in duration is correctly noted. The mention of early termination as a caveat aligns with typical plan disclosures. (5) Semantic equivalence: Though slightly more concise, the LLM answer conveys the same core information and comparative insight as the original answer. Multi-hop synthesis across two executives, companies, and filings is sound and factually grounded.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1311,
        "completion_tokens": 366,
        "total_tokens": 1677
      },
      "error": null
    },
    {
      "question_id": 173,
      "question": "How does the vesting timeline for equity awards at CL compare with PM's RSU vesting schedule, and what does this imply about the timing of compensation expense recognition for each company?",
      "original_answer": "CL issues stock options that generally vest ratably over three years, with a contractual term of eight years post-2019. In contrast, PM grants RSU awards that typically vest on the third anniversary of the grant date. For CL, this means compensation expense is recognized evenly over the three-year vesting period. For PM, the fair value of RSU awards is amortized to expense over the restriction period, which is typically three years after the award date, or earlier upon death, disability, or reaching age 58. As of December 31, 2023, PM had $160 million of total unrecognized compensation costs related to non-vested RSUs, expected to be recognized over a weighted-average period of approximately seventeen months. This indicates that while both companies align on a three-year vesting horizon, PM's structure allows for more accelerated expense recognition based on specific triggering events.",
      "llm_answer": "Colgate‑Palmolive’s equity awards (stock options and RSUs) vest ratably over a three‑year service period, with the fair‑value cost amortized straight‑line over that period (see CL 10‑K p.96). Philip Morris’s RSUs vest on the third anniversary of the grant (also a three‑year horizon), but the company expects the remaining unvested cost to be recognized over a weighted‑average of about 17 months, so PMI’s compensation expense is recognized more front‑loaded than Colgate‑Palmolive’s evenly‑spread three‑year expense (see PMI 10‑K p.110).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all numbers are correct: the three-year vesting periods for both CL and PM, the 17-month weighted-average period for PM's unrecognized costs (accurately reflecting 'approximately seventeen months' from the original), and the straight-line vs. potentially accelerated expense recognition are all correctly reported. Format variations (e.g., '17 months' vs. 'seventeen months') are acceptable. (2) The answer correctly identifies the entities: Colgate-Palmolive (CL) and Philip Morris (PM/PMI), and accurately describes their respective equity instruments—CL's stock options and RSUs vesting ratably over three years, and PM's RSUs vesting on the third anniversary. (3) The reasoning is sound: it correctly infers that CL recognizes expense evenly (straight-line) over three years, while PM, despite a similar three-year horizon, has a shorter expected recognition period (17 months), implying more front-loaded expense recognition due to acceleration triggers like death, disability, or age 58—though the LLM omits explicit mention of these triggering events, which slightly reduces completeness. (4) The answer addresses all key parts of the question: compares vesting timelines, explains compensation expense recognition, and draws the correct implication about timing differences. The only minor omission is not specifying the contractual term of CL's options (eight years post-2019) and PM's acceleration conditions, which are present in the original but not critical to the main comparison. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1370,
        "completion_tokens": 460,
        "total_tokens": 1830
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How do regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, impact the ability of both PM and MO to maintain brand equity and pricing power in key international and U.S. markets?",
      "original_answer": "Regulatory restrictions on product differentiation, such as flavor bans and standardized packaging, significantly impair both PM and MO's ability to maintain brand equity and pricing power. PM faces specific risks from the EU's ban on characterizing flavors in cigarettes and roll-your-own tobacco, menthol bans in Turkey and Brazil, and potential future restrictions on slim cigarettes and flavor capsules. These limitations reduce PM’s ability to differentiate products, especially in international markets where they estimate illicit trade accounts for 8% of EU cigarette consumption, further eroding legitimate brand value and pricing control. Similarly, MO faces flavor bans in six U.S. states and the District of Columbia, including California’s broad restriction on menthol, mint, and wintergreen, which is currently delayed due to a referendum. These bans, along with proposed nicotine caps in Massachusetts, constrain MO’s ability to market differentiated products and maintain premium pricing. Both companies are also restricted in advertising and branding through global FCTC guidelines and domestic regulations like the State Settlement Agreements, which prohibit youth-targeted marketing and outdoor advertising, further limiting brand equity development and pricing flexibility.",
      "llm_answer": "Both companies say that when regulators strip away the ways they can set their products apart—through flavors, menthol, distinctive colors, pack shapes or graphic branding—their brands become harder to protect and their ability to charge premium prices is weakened. Philip Morris notes that “down‑trading trends may be reinforced by regulation that limits branding, communication and product differentiation,” which curtails price‑increase opportunities for its premium and mid‑price brands (PM 10‑K p.16; also see p.42 on flavor bans and plain‑pack rules). Altria likewise points out that bans on characterizing flavors, menthol and moves toward standardized packaging “could reduce our ability to differentiate these products in the market” and therefore threaten brand equity and pricing flexibility in both U.S. and key international markets (Altria 10‑K p.40‑42).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong semantic equivalence. It correctly identifies that regulatory restrictions on product differentiation—such as flavor bans, menthol restrictions, standardized packaging, and limits on branding—impair both PM and MO's brand equity and pricing power. The answer cites specific risks from both companies' 10-Ks (PM p.16, p.42; MO p.40-42), accurately reflecting their disclosures about down-trading, reduced differentiation, and weakened premium pricing. Quantitatively, there are no numerical claims in the LLM answer that conflict with the ground truth; it avoids stating specific percentages like the 8% EU illicit trade figure but does not misstate any numbers, so quantitative accuracy is preserved. The qualitative reasoning is sound: it synthesizes multi-hop information across both companies and regulatory environments (U.S. and international), correctly linking regulatory constraints to brand and pricing outcomes. The only minor shortcoming is that it omits some specific examples present in the original answer—such as PM’s exposure to flavor bans in Turkey and Brazil, EU flavor restrictions, slim cigarette regulations, or MO’s state-level bans in six U.S. states and the California referendum delay. While these details enrich completeness, their absence does not undermine the central factual correctness or reasoning. Contextual relevance is excellent, directly addressing how regulatory limits impact brand equity and pricing power for both firms in key markets. Overall, this is a strong, factually correct response with only slight room for added specificity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1559,
        "completion_tokens": 455,
        "total_tokens": 2015
      },
      "error": null
    },
    {
      "question_id": 174,
      "question": "How does AIG's exposure to structured securities containing RMBS, as measured by their accounting treatment for credit losses and yield adjustments, compare to BAC's valuation risks associated with RMBS holdings under fluctuating prepayment speeds and default rates?",
      "original_answer": "AIG accounts for structured securities, including RMBS, by recalculating effective yields based on actual payments and updated prepayment expectations, adjusting amortized cost accordingly with a corresponding impact on net investment income. For non-high credit quality structured securities, AIG bases yields on expected cash flows that factor in credit losses and prepayments, and recognizes changes in expected cash flows through an allowance for credit losses. Meanwhile, BAC notes that a significant increase in default rates or loss severities would materially lower the fair value of RMBS long positions, while changes in prepayment speeds would have differential impacts depending on instrument seniority. This shows that while AIG focuses on yield and credit loss adjustments tied to expected cash flows, BAC emphasizes sensitivity to default and prepayment volatility in RMBS valuation.",
      "llm_answer": "AIG’s RMBS exposure is reflected in its allowance for credit losses and prospective yield adjustments – the firm does not set an allowance at initial recognition, but later differences between actual and expected cash‑flows are booked either to the allowance or, when they cannot be, to a yield adjustment, with yields re‑calculated based on actual payments and updated pre‑payment expectations (AIG 10‑K p. 118; p. 169). Bank of America, on the other hand, measures RMBS valuation risk through Level‑3 fair‑value models that use unobservable inputs such as pre‑payment speed and default rate; changes in those assumptions can materially lower the fair value of its RMBS holdings (BAC 10‑K p. 161; p. 160). Thus AIG manages exposure via credit‑loss and yield accounting adjustments, while BAC’s exposure is driven by fair‑value volatility from fluctuating pre‑payment and default assumptions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: AIG's accounting treatment for RMBS involves recalculating effective yields based on actual payments and updated prepayment expectations, with credit loss allowances for non-high credit quality securities. BAC's RMBS valuation risk is tied to Level-3 fair-value models sensitive to unobservable inputs like prepayment speeds and default rates. These points match the original answer's core content. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the question or answers, so quantitative accuracy is not compromised—no errors in calculations or figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes AIG’s yield and credit loss adjustments with BAC’s fair-value sensitivity, drawing a valid comparative insight across two different accounting and risk management approaches. The inclusion of specific 10-K page references (e.g., AIG p.118, p.169; BAC p.161, p.160) enhances credibility and shows proper grounding in source material. (4) Minor deduction in qualitative accuracy due to slightly different framing—LLM emphasizes 'fair-value volatility' for BAC and 'yield adjustments' for AIG, which is accurate but omits explicit mention of BAC's differential impact by instrument seniority noted in the original. However, this does not undermine the overall correctness. Semantic equivalence is maintained, and the response fully addresses the comparative, multi-entity nature of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1477,
        "completion_tokens": 428,
        "total_tokens": 1905
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Broadcom's valuation methodology for its developed technology in cybersecurity, which includes cloud security solutions, compare to Cisco's revenue recognition approach for its Cloud Security product category?",
      "original_answer": "Broadcom valued its developed technology in cybersecurity, including cloud security solutions, using the multiperiod excess earnings method under the income approach, which considers the present value of projected cash flows less charges for contributions from other assets. The economic useful life was determined based on the technology cycle and forecast cash flows. In contrast, Cisco recognizes revenue for its Cloud Security product ratably over the contract term as a single distinct performance obligation satisfied over time, particularly for SaaS arrangements. This highlights a difference in financial treatment—Broadcom focused on asset valuation through projected earnings, while Cisco emphasizes revenue recognition aligned with service delivery timelines.",
      "llm_answer": "Broadcom values its cybersecurity‑related developed technology (including cloud‑security solutions) as an intangible asset using the **multip‑period excess‑earnings method** – an income‑approach that discounts projected cash‑flows over the asset’s useful life to determine fair value【page_98】. Cisco, on the other hand, does not value the technology but **recognizes revenue** from its Cloud Security offerings under ASC 606: hardware and perpetual‑software sales are recorded **up‑front** when control transfers, while term‑license maintenance and SaaS components are **recognized ratably over the contract term** as distinct performance obligations【page_75】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies Broadcom's use of the multiperiod excess earnings method under the income approach for valuing developed technology in cybersecurity, including cloud security, and explains that it involves discounting projected cash flows over the asset’s useful life—consistent with the ground truth’s description involving present value of cash flows less charges for other assets. (2) It accurately describes Cisco’s revenue recognition for Cloud Security under ASC 606, noting the distinction between up-front recognition for hardware/perpetual software and ratable recognition for term licenses, maintenance, and SaaS—this aligns with the ground truth’s emphasis on ratable recognition over the contract term for SaaS as a performance obligation satisfied over time. (3) The multi-hop reasoning is sound: the model correctly synthesizes Broadcom’s asset valuation methodology (from its filings) with Cisco’s revenue recognition policy (from its filings), contrasting valuation of intangibles vs. revenue timing. (4) Minor deduction in qualitative accuracy because the LLM slightly oversimplifies Cisco’s approach by mentioning up-front recognition for hardware/perpetual software, which, while technically correct, is not directly relevant to the Cloud Security product category that the question focuses on—Cisco’s Cloud Security is predominantly SaaS/term-based and thus primarily ratable. However, this detail does not invalidate the overall correctness. No numeric inaccuracies; all descriptions are semantically equivalent to the ground truth. Contextual relevance is excellent as it directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 471,
        "total_tokens": 1846
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does the voting power disparity between Class A and Class B common stock at META compare to GOOGL's dual-class structure, particularly in relation to the number of shares outstanding and the potential influence of high-vote shares on corporate governance decisions?",
      "original_answer": "At META, Class A common stock has 2,189,898,148 shares outstanding with one vote per share, while Class B common stock has 343,761,117 shares outstanding, each with voting rights only in specified circumstances and tied to the conversion rate. This creates a concentrated voting structure where Class B shares can exert significant influence during specific corporate events. Similarly, GOOGL's Class B common stock has 10 votes per share, giving disproportionate voting power to holders of this class, although the rights of Class A and Class B are otherwise identical. Both companies use dual-class structures to maintain control with certain stakeholders, but META's Class B shares only gain enhanced voting rights under defined conditions, whereas GOOGL's Class B shares have consistently higher voting power. This difference affects how corporate governance decisions are influenced at each company.",
      "llm_answer": "Meta’s 10‑K shows it had 2,189,898,148 Class A shares (one vote each) and 343,761,117 Class B shares (ten votes each), meaning the Class B stock—though only about 14 % of the total shares—commands roughly 61 % of the total voting power (≈3.44 billion votes vs 2.19 billion for Class A)【page_1】. Alphabet’s filing likewise notes that each Class A share carries one vote and each Class B share carries ten votes【page_82】, so a relatively small number of high‑vote Class B shares can dominate board elections and other governance decisions even though the exact outstanding share count isn’t shown in the excerpt.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors, particularly regarding META's Class B voting rights. The ground truth states that META's Class B shares have voting rights only in specified circumstances and are tied to conversion rates, not that they carry ten votes per share. The LLM incorrectly assumes a 10:1 voting ratio for META similar to GOOGL, which is not supported by the original answer. This leads to an entirely incorrect calculation of voting power (61% for Class B, 3.44 billion votes), which is fabricated and not present in the ground truth. (2) While the number of outstanding shares for META’s Class A and Class B is correctly cited (2,189,898,148 and 343,761,117), the voting weight assigned to Class B shares is wrong. GOOGL’s structure (10 votes per Class B share) is accurately described, but the LLM fails to contrast it correctly with META’s conditional voting mechanism. (3) The multi-hop reasoning is flawed because the model fails to recognize the key distinction between the two companies’ structures: META’s Class B shares do not have consistent enhanced voting power, unlike GOOGL’s. Instead, the LLM treats both as having 10-vote shares, missing the nuanced governance implications highlighted in the original answer. (4) Despite these major factual inaccuracies, the answer is contextually relevant—addressing voting power, share counts, and governance influence—and attempts a comparative analysis. However, due to the core error in META’s voting structure, the correctness and quantitative accuracy scores are severely impacted.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1409,
        "completion_tokens": 434,
        "total_tokens": 1843
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Coca-Cola FEMSA's bottling operations in Argentina impact both KO's net sales to equity method investees and CL's organic sales growth in Latin America, considering KO's contractual pricing model with its bottlers?",
      "original_answer": "Coca-Cola FEMSA's operations in Argentina contribute to KO's $14,471 million in net sales to equity method investees in 2021 through the incidence-based concentrate pricing model, where bottler pricing and package mix directly affect the concentrate prices charged by KO. As Coca-Cola FEMSA bottles in Argentina (federal capital of Buenos Aires and surrounding areas), this relationship supports KO's financial dependency on equity method investees. Meanwhile, CL reported a 7.0% net sales increase in Latin America in 2021, with Argentina being one of the key growth drivers. Specifically, CL's Oral Care, Personal Care, and Home Care segments in Argentina benefited from favorable market conditions that also likely supported Coca-Cola FEMSA's operations, creating parallel growth effects across both companies' financial performance in the region.",
      "llm_answer": "Coca‑Cola FEMSA’s Argentine bottling business is an equity‑method investee of The Coca‑Cola Company, so the concentrates it purchases flow through KO’s “net sales to equity‑method investees,” which rose to $14.5 bn in 2021 (up from $13.0 bn in 2020) as bottler volumes recovered【page_89】. The same Argentine market was one of the key contributors to Colgate‑Palmolive’s 8 % organic‑sales increase in Latin America in 2021【page_40】, and because KO prices its concentrates under an incidence‑based model that reflects bottler pricing, channel mix and pack‑mix【page_7】【page_8】, the performance of FEMSA’s Argentine operation directly affects KO’s equity‑method sales and indirectly supports the market conditions that drove CL’s regional organic growth.",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Coca-Cola FEMSA as an equity-method investee and explains how its operations in Argentina contribute to KO's net sales to equity method investees, citing the $14.5 billion figure for 2021 (close to the ground truth $14,471 million). However, the LLM states Colgate-Palmolive's organic sales growth in Latin America was 8%, while the ground truth reports 7.0%, which is a notable quantitative discrepancy. The LLM also mentions a comparison to 2020 ($13.0 billion), which is not in the original answer and introduces unverified context. (2) The dollar amount is acceptably close ($14.5 billion ≈ $14,471 million), but the 8% vs 7.0% error in CL’s organic growth is significant and incorrect. No calculation errors are present, but the cited percentage is inaccurate. (3) The multi-hop reasoning is strong: the LLM correctly links KO’s contractual pricing model (incidence-based, influenced by pack mix and bottler pricing) to the financial impact of FEMSA’s operations, and connects favorable market conditions in Argentina to both KO’s equity-method sales and CL’s regional growth. It synthesizes across KO and CL appropriately, though the causal link between FEMSA’s performance and CL’s growth is framed as indirect and plausible, not overstated. (4) The answer is highly contextually relevant, addressing all parts of the question—KO’s net sales, CL’s organic growth, and the pricing model—while maintaining logical flow and appropriate sourcing references. The qualitative reasoning is sound, but the incorrect percentage reduces quantitative accuracy. Hence, correctness is high but not perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 451,
        "total_tokens": 1871
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does Abbott's investment in private equity funds, which are valued using NAV as a practical expedient, compare to Merck's use of NAV for measuring similar alternative investments, considering the typical redemption restrictions associated with these fund types?",
      "original_answer": "Abbott holds investments in private equity funds valued at NAV, with $555 million in unfunded commitments as of December 31, 2023, and these funds cannot be redeemed but will make distributions through liquidation over periods ranging from 2024 to 2033. These private equity funds are subject to NAV valuation practices consistent with those described in UPS's 10-K, where private equity funds typically have redemption restrictions until the end of the partnership term (10–15 years) and are valued at NAV adjusted for known cash flows. Merck similarly discloses NAV-based valuations for alternative investments, reporting $382 million in NAV-based assets in 2023, including private real estate and equity funds. Both companies rely on NAV as a practical expedient for illiquid alternative investments, but Abbott faces longer liquidation timelines and greater unfunded commitments compared to Merck's disclosed NAV-based portfolio.",
      "llm_answer": "Abbott values its private‑equity, private‑credit and other alternative‑fund holdings at net asset value (NAV) and explicitly notes that these investments are illiquid – they can generally be redeemed only monthly or quarterly, often with 2‑ to 90‑day notice periods, gates or lock‑up periods, and some are only liquidated over several years (ABT 10‑K p.71). Merck also measures comparable alternative‑investment assets at NAV, but its filing merely states that the NAV amounts are not classified in the fair‑value hierarchy and does not detail redemption limits (MRK 10‑K p.116). Consequently, both firms rely on NAV because market prices are unavailable, but Abbott’s disclosure provides specific information on the typical redemption restrictions that accompany these fund types, whereas Merck’s is more generic.",
      "correctness_score": 5,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 6,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies in quantitative details compared to the ground truth. The ground truth states Abbott has $555 million in unfunded commitments and Merck has $382 million in NAV-based assets as of December 31, 2023—none of these numbers are mentioned in the LLM answer. Instead, the LLM provides vague descriptions of redemption terms (e.g., 'monthly or quarterly', '2- to 90-day notice') that contradict the ground truth, which specifies Abbott’s funds 'cannot be redeemed' and will distribute through liquidation from 2024 to 2033, indicating a 10–15 year lock-up typical of private equity partnerships. The LLM incorrectly implies Abbott’s funds allow periodic redemptions, which is not supported by the ground truth. Merck’s lack of detailed redemption disclosure is correctly noted, but the LLM fails to report Merck’s $382M NAV-based asset value. (2) No calculations are made in the LLM answer, but it omits all key financial figures present in the original answer, resulting in low quantitative accuracy. (3) The multi-hop reasoning is partially sound—both companies are correctly identified as using NAV as a practical expedient due to illiquidity—but the comparison is flawed. The LLM suggests Abbott discloses more detailed redemption terms, while in reality, Abbott’s investments are non-redeemable with long liquidation timelines (a stronger restriction), and Merck’s disclosures are less specific. The LLM mischaracterizes the nature of the restrictions, undermining the comparative analysis. (4) Contextual relevance is high because the answer addresses NAV usage, illiquidity, and disclosure differences. However, due to missing quantitative data and incorrect characterization of redemption terms, the correctness score is limited to 5—partially correct but with significant factual gaps and errors.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1466,
        "completion_tokens": 506,
        "total_tokens": 1972
      },
      "error": null
    },
    {
      "question_id": 175,
      "question": "How does BlackRock's management of Separate Account Assets, which are legally segregated and not subject to general creditor claims, impact AIG's reporting of equal and offsetting Separate Account Liabilities tied directly to contract holder account balances?",
      "original_answer": "BlackRock discloses that its Separate Account Assets, which include equity securities, debt securities, money market funds, and derivatives, are legally segregated and not subject to general claims of creditors. These assets are held to fund individual and group pension contracts and are offset by equal and offsetting liabilities on BlackRock’s consolidated statements of financial condition. AIG reports Separate Account Liabilities that directly reflect the contract holder's account balance in these assets, and they are required to be equal and offsetting to the total Separate Account Assets. Therefore, any changes in the valuation or composition of BlackRock's Separate Account Assets would directly influence AIG’s liability reporting, as AIG must mirror these asset values in its liabilities to reflect the contract holders' beneficial interest.",
      "llm_answer": "BlackRock keeps the separate‑account assets in a legally segregated pool that is insulated from BlackRock’s general creditors (BlackRock 10‑K, p. 74/80). Because those assets are protected, AIG can record an equal and offsetting separate‑account liability that mirrors each contract‑holder’s account balance, and both the assets and the matching liabilities are presented on AIG’s balance sheet as separate‑account assets and liabilities (AIG 10‑K, p. 232). This segregation means AIG’s liabilities are directly tied to the segregated assets and are not subject to netting against other creditor claims.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key relationship between BlackRock's segregated Separate Account Assets and AIG's reporting of offsetting liabilities. It accurately reflects that these assets are legally segregated and not subject to general creditor claims (citing BlackRock 10-K, p. 74/80), and that AIG reports equal and offsetting liabilities tied to contract holder balances (citing AIG 10-K, p. 232). There are no numeric values in the question or ground truth requiring calculation, so quantitative accuracy is 10. The answer is contextually relevant and properly addresses the linkage between asset segregation and liability reporting. However, it omits a key element from the original answer: the specific composition of the Separate Account Assets (equity securities, debt securities, money market funds, derivatives) and the explicit statement that changes in asset valuation directly influence AIG’s liability reporting. While implied, this dynamic impact is not clearly articulated. The reasoning is sound but slightly less comprehensive in synthesizing the full cause-effect chain across both entities. Thus, qualitative accuracy is 8 due to partial omission of multi-hop detail, and overall correctness is 8 for missing minor but relevant contextual depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1393,
        "completion_tokens": 367,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 176,
      "question": "How does AbbVie's revenue recognition for Imbruvica sales in the U.S. reflect its cost-sharing arrangement with Janssen Biotech, and how does this compare to Johnson & Johnson's global commercialization strategy for the same drug?",
      "original_answer": "AbbVie recognizes 100% of Imbruvica sales in the U.S. as net revenue, while Janssen's share of profits is deducted as part of cost of products sold, indicating a co-exclusive commercialization model where AbbVie acts as the principal. Both companies share pre-tax profits and losses equally, with Janssen covering approximately 60% of development costs and AbbVie 40%. Meanwhile, Johnson & Johnson, through its subsidiary Janssen, holds exclusive rights to commercialize Imbruvica outside the U.S. and also shares pre-tax profits equally with AbbVie. This global division of commercial rights and cost-sharing creates a dual-market strategy where Janssen leverages its international infrastructure to drive global expansion of Imbruvica, while AbbVie leads in the domestic market.",
      "llm_answer": "AbbVie records all U.S. Imbruvica sales as part of its net‑revenue and then books Janssen’s 50‑50 share of the pre‑tax profit as a cost of products sold, which mirrors the collaboration’s cost‑sharing arrangement (Janssen bears roughly 60 % of development costs while profits and losses are split equally)【page_68】. In contrast, Johnson & Johnson’s Janssen subsidiary holds the exclusive license to commercialize Imbruvica outside the United States and co‑exclusive rights in the U.S., so its global commercialization strategy is driven by Janssen’s international sales while the U.S. market is jointly commercialized with AbbVie【page_11】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: the 50-50 pre-tax profit split, Janssen bearing approximately 60% of development costs (with AbbVie 40%), and the equal sharing of profits and losses are all accurately reflected. There are no calculation errors. (2) The answer correctly identifies the key entities: AbbVie, Janssen Biotech (as a subsidiary of Johnson & Johnson), and the drug Imbruvica. It also correctly distinguishes between U.S. and ex-U.S. commercialization rights. (3) The reasoning is sound: the LLM correctly explains that AbbVie recognizes 100% of U.S. sales as net revenue and then deducts Janssen’s share as cost of products sold, reflecting AbbVie’s role as principal in the U.S. It also accurately contrasts this with Janssen’s exclusive ex-U.S. commercialization and co-exclusive U.S. role, capturing the dual-market strategy. (4) The only minor shortcoming is that the LLM answer does not explicitly state that Janssen’s international infrastructure is leveraged for global expansion—a point emphasized in the original answer—but this is a nuance rather than a factual omission. The core multi-hop synthesis (revenue recognition + cost-sharing + global strategy comparison) is well executed. Wording differs slightly but maintains semantic equivalence. No irrelevant or incorrect information is introduced.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1375,
        "completion_tokens": 388,
        "total_tokens": 1764
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How might a prolonged geopolitical conflict involving Taiwan impact both NVIDIA's supply chain execution and Apple's manufacturing operations, considering NVIDIA's dependency on foundry partners in Taiwan and Apple's reliance on manufacturing in the region?",
      "original_answer": "A prolonged geopolitical conflict involving Taiwan could severely disrupt NVIDIA's supply chain execution due to its dependency on foundry partners in the region, particularly for advanced GPU manufacturing. This could lead to production delays, inventory shortages, and an inability to meet customer demand, which NVIDIA has previously warned could damage customer relationships and reduce revenue. Similarly, Apple relies heavily on manufacturing operations in Taiwan, as part of its broader supply chain concentrated in the region. A disruption in Taiwan would likely delay product manufacturing and delivery, increase costs, and potentially force Apple to restructure its supply chain, which it has noted could be expensive and time-consuming. Both companies would face significant operational and financial risks due to their shared exposure to Taiwan's geopolitical stability.",
      "llm_answer": "A prolonged Taiwan conflict could cut off the wafer supply NVIDIA receives from its Taiwanese foundry partners, forcing higher component costs, production delays and a loss of ability to meet customer demand (NVDA 21, 35). At the same time, Apple’s heavy reliance on contract manufacturers in Taiwan means such a conflict could interrupt assembly of iPhones, Macs and other devices, creating inventory shortfalls, higher logistics costs and pressure on product availability and revenue (AAPL 9).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies the risks to NVIDIA's supply chain due to its dependency on Taiwanese foundries, citing production delays, higher costs, and inability to meet demand—consistent with the original answer. It also accurately describes Apple's exposure through contract manufacturing in Taiwan, noting disruptions to assembly, inventory, costs, and revenue. The inclusion of document citations (NVDA 21, 35; AAPL 9) suggests alignment with source material. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not compromised; the LLM does not introduce any incorrect numbers. (3) The multi-hop reasoning—linking geopolitical risk to supply chain impacts for both companies based on their regional dependencies—is sound and well-synthesized across entities. The only minor shortcoming is that the LLM omits the point about Apple potentially facing expensive and time-consuming supply chain restructuring, which is mentioned in the original. This reduces completeness slightly but does not undermine the overall correctness. (4) The answer is fully contextually relevant, directly addressing both parts of the question with precise, fact-based reasoning. Wording differs but semantic equivalence is strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 376,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How does the use of pricing models for Level 2 fixed income investments by LMT compare to HON's use of pricing models for corporate bonds and government securities in terms of observable market data inputs and risk adjustments?",
      "original_answer": "LMT values its Level 2 fixed income investments using pricing models that rely on verifiable observable market data such as interest rates, yield curves, and credit spreads, or through bids from brokers and quoted prices of similar securities. In contrast, HON uses pricing models for corporate bonds, mortgage/asset-backed securities, and government securities that also incorporate observable inputs but may include unobservable adjustments for risks like credit and liquidity. This indicates that while both companies use pricing models involving market data, HON's valuations may involve more subjective risk-based adjustments not always present in LMT's Level 2 valuations.",
      "llm_answer": "Lockheed Martin’s Level 2 fixed‑income assets are valued with pricing models that rely on verifiable observable market data—such as interest‑rate curves, yield curves and credit spreads—and on broker bids or quoted prices of similar securities. Honeywell also values corporate bonds and government securities using pricing models, broker bids and comparable quotes, but it explicitly adds adjustments for credit and liquidity risks that may not be directly observable. Thus, both firms use observable market inputs, while Honeywell’s methodology explicitly incorporates additional risk‑adjustments beyond those inputs.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that LMT uses observable market data (interest-rate curves, yield curves, credit spreads) and broker bids or comparable quotes for Level 2 fixed income investments. Similarly, it accurately states that HON uses pricing models with observable inputs but adds unobservable risk adjustments for credit and liquidity. (2) There are no numeric values, dates, or financial figures in the question or ground truth, so quantitative accuracy is not applicable—scored as 10 by default. (3) The multi-hop reasoning is sound: the model correctly synthesizes valuation methodologies across two companies (LMT and HON), differentiates their use of observable vs. unobservable inputs, and draws a valid comparison. The only minor shortcoming is that the LLM omits HON's inclusion of mortgage/asset-backed securities (mentioned in the original), but this does not detract significantly from the overall correctness. (4) The answer is contextually relevant, directly addressing the comparison in terms of observable inputs and risk adjustments. Wording differs slightly but maintains semantic equivalence. Thus, a correctness score of 9 is justified—excellent but with a minor omission in asset scope for HON.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1344,
        "completion_tokens": 364,
        "total_tokens": 1709
      },
      "error": null
    },
    {
      "question_id": 177,
      "question": "How did the unfavorable foreign currency exchange rate impact from a stronger U.S. dollar affect Coca-Cola's (KO) Europe, Middle East and Africa segment in 2024, and how does this compare to the exposure risk described by Mondelez (MDLZ) under similar macroeconomic conditions?",
      "original_answer": "Coca-Cola (KO) reported that fluctuations in foreign currency exchange rates unfavorably impacted consolidated operating income by 11% in 2024, with a stronger U.S. dollar affecting several segments including Europe, Middle East and Africa. While the euro and British pound provided some offsetting benefit, the segment was still significantly affected by the stronger dollar. Mondelez (MDLZ) similarly noted that a stronger U.S. dollar relative to other functional currencies adversely affects its consolidated earnings and net assets, as the company translates non-U.S. dollar financials into U.S. dollars for reporting. Although KO quantified the impact (11% unfavorable), MDLZ emphasized the inherent unpredictability and volatility introduced by such currency movements, despite active hedging strategies.",
      "llm_answer": "Coca‑Cola said that a stronger U.S. dollar produced a material foreign‑currency headwind for its Europe, Middle East & Africa segment in 2024 – foreign‑exchange fluctuations alone dragged the segment’s net‑operating‑revenue contribution down about 16 % (part of the 5 % consolidated revenue decline) and helped cut operating income by roughly 11 % – although the impact was partially offset by a weaker dollar versus the euro and pound, which gave a modest positive swing【page_48】【page_51】.  \n\nMondelez warns that, under the same macro‑environment, a stronger U.S. dollar “adversely affects our consolidated earnings and net assets,” and while it uses derivatives to hedge a portion of its currency exposure, it cannot fully eliminate the volatility from exchange‑rate movements【page_65】.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies that Coca-Cola's Europe, Middle East and Africa segment was negatively impacted by a stronger U.S. dollar in 2024, and that Mondelez (MDLZ) faces similar risks. It accurately states that foreign exchange fluctuations reduced Coca-Cola's operating income by approximately 11%, which matches the ground truth. However, the LLM introduces a specific figure of '16% drag on net-operating-revenue contribution' and links it to a '5% consolidated revenue decline'—details not present in the original answer and potentially conflating segment-level and consolidated impacts without clear support from the ground truth. These additional quantitative claims reduce factual accuracy. (2) The 11% operating income impact is correct, but the 16% revenue drag and 5% consolidated decline are unverified and not mentioned in the ground truth, suggesting possible hallucination or misattribution. The offset from the euro and pound is correctly noted, though the original answer frames this more generally. (3) The multi-hop reasoning is sound in comparing KO and MDLZ exposure to currency fluctuations, correctly identifying that both companies are affected by translation losses due to a strong dollar and that MDLZ uses hedging but cannot eliminate risk. The synthesis across companies is appropriate and logically presented. (4) Contextual relevance is high—the answer directly addresses both parts of the question and maintains focus on the macroeconomic impact and cross-company comparison. Despite the extra, unsupported numbers, the core facts and qualitative reasoning align well with the ground truth, warranting a score of 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1432,
        "completion_tokens": 463,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 178,
      "question": "How does the $365 million in long-lived assets that AVGO reported in Taiwan for fiscal 2024 compare to the risk QCOM highlighted regarding its reliance on foundry partners in Taiwan for chipset supply, particularly in the context of geopolitical tensions involving China and Taiwan?",
      "original_answer": "AVGO reported $365 million in long-lived assets in Taiwan for fiscal 2024, indicating a significant operational presence in the region. Meanwhile, QCOM explicitly stated that its business depends on receiving consistent and reliable chipset supply from foundry partners in Taiwan, and a significant or prolonged geopolitical conflict involving China and Taiwan could severely limit or prevent this supply, materially impacting QCOM’s business. This highlights that both companies have substantial exposure to Taiwan, but while AVGO’s exposure is reflected in its asset base, QCOM’s risk is operational and supply chain-dependent, making them vulnerable to the same regional geopolitical tensions in different ways.",
      "llm_answer": "Broadcom’s 2024 balance sheet shows $365 million of long‑lived assets (property, plant and equipment) located in Taiwan【page_91】. In contrast, Qualcomm warns that its entire chipset supply chain depends on foundry partners in Taiwan, and a military or geopolitical conflict between China and Taiwan could “severely limit or prevent” that supply, creating a material adverse impact on its business【page_35】. Thus, Broadcom’s exposure is a fixed $365 million investment, whereas Qualcomm’s risk is a far‑broader, potentially far‑more disruptive supply‑chain vulnerability that is not quantified in dollar terms.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, the $365 million in long-lived assets for AVGO (Broadcom) in Taiwan for fiscal 2024 is correctly reported, with acceptable formatting ($365 million). (2) Entity accuracy is strong: AVGO is correctly identified as Broadcom, QCOM as Qualcomm, and the fiscal year 2024 is properly referenced. (3) The multi-hop reasoning is sound: the model correctly synthesizes AVGO’s asset exposure with QCOM’s supply chain risk, both tied to Taiwan and geopolitical tensions with China. It accurately contrasts AVGO’s fixed asset investment with QCOM’s operational vulnerability. (4) The qualitative analysis captures the core distinction in risk types—AVGO’s balance sheet exposure vs. QCOM’s unquantified but potentially more disruptive supply chain dependency—mirroring the original answer’s intent. The only minor shortcoming is a slight omission of the phrase 'materially impacting QCOM’s business' in direct alignment with the original, though the equivalent 'material adverse impact' is used. Wording differs slightly but maintains semantic equivalence. No calculation errors. Contextual relevance is excellent, directly addressing all parts of the complex, multi-entity, multi-risk question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 356,
        "total_tokens": 1721
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How does Apple's reliance on manufacturing operations in Taiwan for a majority of its product assembly impact its exposure to regional geopolitical risks compared to Microsoft's business operations in Greater China through its regional center in Singapore?",
      "original_answer": "Apple's reliance on manufacturing in Taiwan for a significant portion of its product assembly increases its exposure to regional geopolitical risks, particularly given that Taiwan is included in Apple's Greater China segment, which is subject to trade policies and disputes that could result in tariffs, sanctions, and other business restrictions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports logistics and vendor management across the region. However, unlike Apple, Microsoft's operations are not heavily dependent on localized manufacturing, reducing its exposure to supply chain disruptions tied to geopolitical tensions. Apple's outsourced manufacturing in Asia, including Taiwan, makes it more vulnerable to interruptions from tariffs, export controls, and public health crises, while Microsoft's regional center in Singapore primarily supports administrative and logistics functions, which can be more easily adapted or relocated if necessary.",
      "llm_answer": "Apple’s 10‑K makes clear that “substantially all of the Company’s manufacturing is performed … in Asia, including … Taiwan,” and that “political events, trade and other international disputes … can … materially adversely affect the Company’s business” if they occur in regions where it has major supply‑chain operations (Apple 10‑K p. 9). Microsoft, on the other hand, runs its Greater‑China activities from a regional operations center in Singapore—a low‑risk, stable jurisdiction—and notes that its devices are made by “third‑party contract manufacturers” with the ability to shift to other suppliers if a vendor becomes unavailable (Microsoft 10‑K p. 16‑17). Thus, Apple’s heavy reliance on Taiwan for assembly makes it far more vulnerable to cross‑strait or regional geopolitical shocks, whereas Microsoft’s Singapore‑based hub and diversified sourcing give it a comparatively lower direct exposure to such risks.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the original answer. (1) It correctly identifies Apple's reliance on manufacturing in Taiwan and the associated geopolitical risks, citing its 10-K to support the claim that 'substantially all' of its manufacturing occurs in Asia, including Taiwan, and that political and trade disputes can materially affect its business. It also accurately describes Microsoft's operational setup, noting its regional operations center in Singapore and reliance on third-party manufacturers with flexibility to shift suppliers—both of which reduce its exposure to localized geopolitical disruptions. (2) There are no numerical values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across Apple’s and Microsoft’s 10-K disclosures to compare their differing exposure levels based on supply chain structure and geographic dependencies. It draws a valid conclusion that Apple faces higher risk due to concentrated manufacturing in a geopolitically sensitive region, while Microsoft’s decentralized, administrative hub model lowers its direct exposure. (4) The answer is contextually relevant, directly addressing the comparative geopolitical risk exposure as framed in the question. Wording differs from the original answer but preserves full semantic meaning and adds precise citations (e.g., page numbers from 10-Ks), enhancing credibility without introducing error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1508,
        "completion_tokens": 430,
        "total_tokens": 1939
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How did Nebraska's 2023 corporate tax rate reduction impact Union Pacific's deferred tax expense in relation to Boeing's exposure to federal appropriations delays as disclosed in their respective 10-K filings?",
      "original_answer": "Nebraska's 2023 corporate tax rate reduction contributed to a $114 million reduction in Union Pacific's deferred tax expense, as disclosed in their 2024 10-K filing. In contrast, Boeing highlighted in its 2024 10-K that delays in U.S. government appropriations, such as continuing resolutions or government shutdowns, could disrupt operations, delay new programs, and negatively impact revenue. While Union Pacific benefited from state-level tax legislation, Boeing faces regulatory and funding risks tied to federal legislation, which could impair its ability to execute contracts or deliver commercial airplanes.",
      "llm_answer": "Nebraska’s 2023 corporate‑tax‑rate cut (together with similar cuts in Iowa, Kansas and Arkansas) lowered Union Pacific’s deferred tax expense by **$114 million** for the year 2023【page_29】. By contrast, Boeing’s 10‑K only flags that **delays in U.S. government appropriations** could hurt its defense‑related revenue and cash flow, describing it as a qualitative risk rather than a quantified tax‑expense impact【page_10】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the $114 million reduction in Union Pacific's deferred tax expense due to Nebraska's 2023 corporate tax rate cut, which matches the ground truth. It also accurately notes that Boeing disclosed risks related to U.S. government appropriations delays without quantifying a tax expense impact, aligning with the original answer. The mention of additional states (Iowa, Kansas, Arkansas) is not in the ground truth but does not contradict it and may reflect supplementary context from the filing; however, the core focus on Nebraska is preserved. 2) The dollar amount ($114 million) and year (2023) are correct and match the ground truth exactly. No calculations are required beyond accurate reporting, which is done properly. 3) The multi-hop reasoning is sound: the model correctly links Nebraska’s tax policy to Union Pacific’s financials and contrasts it with Boeing’s federal appropriations risk, synthesizing information across two companies and filings. The qualitative comparison between a realized tax benefit and a disclosed risk is logically and factually appropriate. 4) The answer is semantically equivalent to the ground truth, with slightly more concise phrasing and added detail about other states that doesn’t detract from accuracy. The core entities—Union Pacific, Boeing, deferred tax expense, federal appropriations delays, 2023 tax change—are all correctly identified and contextualized. Only minor deduction in qualitative accuracy due to the unverified inclusion of other states not mentioned in the ground truth, though this does not appear to be incorrect, just expanded context.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 446,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 179,
      "question": "How might the expiration timelines of specific Enbrel-related patents in the U.S. influence MRK's strategic focus on maintaining patent protection for its own products, given the competitive dynamics in the biopharmaceutical industry?",
      "original_answer": "The expiration timelines for Enbrel-related patents in the U.S.—including the Fusion protein and pharmaceutical compositions patent expiring on 11/22/2028, the DNA encoding fusion protein and methods of making fusion protein patent on 4/24/2029, and the formulations and methods of preparing formulations patent on 10/19/2037—suggest a phased decline in AMGN's exclusivity for this product. This gradual patent erosion likely reinforces MRK's emphasis on actively protecting its own patents, as outlined in its 2024 10-K, where it states that loss of patent protection typically leads to generic substitutes and reduced sales. MRK acknowledges that political and regulatory pressures to encourage early approval of generics could further exacerbate this risk, making robust patent defense a strategic imperative to maintain market position and profitability in the face of increasing biosimilar competition.",
      "llm_answer": "Amgen’s Enbrel patents in the United States extend to Nov 22 2028 (fusion‑protein composition), Apr 24 2029 (DNA‑encoding methods) and Oct 19 2037 (formulation methods)【page_11】. Merck notes that loss of patent exclusivity “typically is followed promptly by generic or biosimilar substitutes” and that protecting its own patents is essential to sustain cash flow and replace sales of products that lose exclusivity【page_33】【page_31】. Thus, the staggered Enbrel expirations underscore to Merck the importance of securing longer‑term protection (e.g., new formulation, method‑of‑use or supplemental patents) and accelerating pipeline development so its own biologics are not exposed to the same biosimilar pressure once their patents run out.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies all Enbrel-related patent expiration dates—Nov 22, 2028 (fusion protein composition), Apr 24, 2029 (DNA encoding methods), and Oct 19, 2037 (formulation methods)—matching the ground truth exactly. These dates are critical quantitative elements and are accurately reported with only minor formatting differences (e.g., '11/22/2028' vs 'Nov 22 2028'), which are semantically equivalent. (2) The LLM correctly attributes MRK's strategic focus on patent protection to its own disclosures in the 2024 10-K, citing the risk of generic or biosimilar entry post-patent expiry and the importance of protecting patents to sustain cash flow. This aligns with the original answer’s reference to MRK acknowledging political and regulatory pressures favoring generics. (3) The multi-hop reasoning is sound: the model connects Amgen’s staggered patent expirations for Enbrel to Merck’s broader strategic imperative to extend protection on its own products through supplementary patents and pipeline acceleration. While the original answer emphasizes MRK’s defensive posture due to competitive dynamics, the LLM infers a proactive strategy (e.g., securing new patents, accelerating development), which is a valid interpretation consistent with the cited context. (4) The only minor gap is that the LLM does not explicitly mention 'political and regulatory pressures' as a factor MRK cites, which slightly reduces qualitative accuracy, but it captures the core strategic implication. Overall, the answer is factually correct, contextually relevant, and synthesizes across entities (AMGN, MRK) and filings appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 452,
        "total_tokens": 1886
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How has AMD's revenue from operations in Taiwan compared to Apple's revenue contribution from Taiwan (as part of Greater China) in 2022, and what does this suggest about their relative market presence in the region?",
      "original_answer": "In 2022, AMD reported $2,091 million in revenue from operations in Taiwan. Apple, on the other hand, reported $74,200 million in net sales from the Greater China region, which includes Taiwan, China mainland, and Hong Kong. Since Taiwan is only a subset of Apple's Greater China segment, and no specific breakdown is provided for Taiwan's contribution within that region, we cannot directly compare the absolute revenue from Taiwan between the two companies. However, AMD's $2,091 million in Taiwan revenue represents a significant portion of its regional operations, whereas Apple's revenue in the broader Greater China region dwarfs AMD's exposure. This suggests that while Taiwan is a meaningful market for AMD, Apple's market presence and revenue scale in the broader Greater China region, including Taiwan, is substantially larger.",
      "llm_answer": "AMD generated about $2.1 billion in sales to customers in Taiwan (the most recent figure shown in its 10‑K)【page_78】, while Apple’s Greater China segment – which by definition includes Taiwan – recorded net sales of $74.2 billion in 2022【page_52】【page_40】. Apple’s revenue in the region is therefore dozens of times larger than AMD’s Taiwan sales, indicating that Apple has a far stronger market presence in the Greater China/Taiwan market.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly reports AMD's $2.1 billion (i.e., $2,091 million) in sales to Taiwan and Apple's $74.2 billion in net sales from the Greater China region in 2022, matching the ground truth figures. The formatting variation ($2.1 billion vs $2,091 million) is acceptable and semantically equivalent. (2) All numeric values are accurate: $2.1 billion for AMD in Taiwan and $74.2 billion for Apple in Greater China. The comparison stating Apple’s revenue is 'dozens of times larger' is reasonable (74.2 / 2.1 ≈ 35x), though 'dozens' slightly downplays the magnitude but remains within acceptable qualitative interpretation. (3) The reasoning correctly identifies that Apple's Greater China segment includes Taiwan, making direct comparison of Taiwan-only revenue impossible, but still allows for a relative assessment of market presence. The LLM synthesizes information from both companies' 10-Ks appropriately across entities and documents. However, it omits the explicit caveat that Taiwan's specific contribution within Greater China is not disclosed by Apple, which slightly weakens the completeness of the multi-hop reasoning. (4) Despite this minor omission, the answer captures the core insight: Apple’s regional scale dwarfs AMD’s Taiwan-specific revenue, suggesting a much larger market presence. The answer is contextually relevant, factually accurate, and conveys the essential conclusion of the ground truth. Thus, correctness is high but not perfect due to the missing nuance about undivided Taiwan data in Apple's reporting.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1336,
        "completion_tokens": 429,
        "total_tokens": 1765
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does Alphabet's repurchase of Class C shares, which carry no voting rights, enable different capital allocation flexibility compared to Netflix's share repurchase strategy under its uniform voting rights structure?",
      "original_answer": "Alphabet's repurchase of Class C shares, which carry no voting rights, allows the company to return capital to shareholders while preserving insider control through the retention of higher-vote Class A and B shares. In 2023, Alphabet repurchased $62.2 billion of Class A and Class C shares, with an additional $36.3 billion remaining available under the repurchase authorization. In contrast, Netflix's capital stock carries uniform voting rights — one vote per share — meaning any significant share repurchase could potentially dilute voting control among existing shareholders. This structural difference implies that Netflix may need to be more cautious in its repurchase activity to avoid unintended shifts in governance, unlike Alphabet which can execute larger buybacks without affecting its core governance structure.",
      "llm_answer": "Alphabet can repurchase its non‑voting Class C shares – which “has no voting rights, except as required by applicable law” (GOOGL 10‑K p. 81) – and therefore return cash to shareholders while leaving the voting power of the remaining Class A and B holders unchanged; the company also can shift repurchases between Class A and Class C based on relative market prices (see the Class C repurchase totals on p. 81). Netflix, by contrast, has a single class of common stock that carries one vote per share (NFLX 10‑K p. 61), so any share buy‑back reduces both equity and voting power proportionally, limiting its ability to separate capital returns from control considerations (see Netflix’s stock‑repurchase description on p. 61).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that Alphabet repurchases non-voting Class C shares, preserving voting control with Class A and B shareholders, while Netflix has uniform voting rights (one vote per share), meaning buybacks reduce voting power proportionally. This captures the key contrast in capital allocation flexibility versus governance impact. (2) Quantitative accuracy is perfect: although the LLM does not explicitly cite the $62.2 billion repurchased or $36.3 billion remaining authorization from 2023, it does not make any numerical claims, so there are no errors. The omission of these figures slightly reduces completeness but does not affect correctness. (3) The multi-hop reasoning is sound—correctly synthesizing governance structures from both Alphabet and Netflix 10-Ks and drawing the logical conclusion about differing flexibility in share repurchases. (4) The answer is contextually relevant, directly addressing the structural implications of share classes on repurchase strategies. The only minor shortcoming is the lack of specific dollar amounts from the ground truth, which would have strengthened completeness, but since the LLM grounds its claims in the 10-K page references (p.81 for GOOGL, p.61 for NFLX), the reasoning is well-supported. Thus, the answer earns a 9/10 for correctness and qualitative accuracy, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 410,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 180,
      "question": "How does MET's exposure to non-agency pass-through mortgage-backed securities with $1,699 million in NQM and Alt-A loans compare to AIG's liquidity risk from mortgage assets, particularly in light of MET's $1,294 million in unrealized losses on pass-through securities versus AIG's concerns about valuing illiquid mortgage-related investments?",
      "original_answer": "MET holds $12,567 million in pass-through mortgage-backed securities, including $1,699 million in NQM and Alt-A loans categorized under non-agency RMBS, with $1,294 million in unrealized losses in 2024. These pass-through securities are directly secured by pools of mortgage loans, including lower-quality segments like NQM and Alt-A that carry elevated credit risk. AIG, meanwhile, faces liquidity risk from its mortgage and loan portfolio, particularly due to its holdings of less liquid assets like private equity, hedge funds, mortgage loans, and real estate. AIG explicitly warns that adverse market conditions or valuation volatility in these assets could lead to material losses if sold in stressed environments. Thus, while MET's exposure is more specifically defined and marked-to-market with known unrealized losses, AIG's risk lies in the uncertain valuation and potential illiquidity of its broader mortgage-linked investments, which could realize even greater losses under unfavorable market conditions.",
      "llm_answer": "MET’s RMBS portfolio includes $1.7 billion of non‑agency pass‑through securities that are classified as non‑qualified (NQM) and Alt‑A loans (see MET 10‑K p. 88), and the entire pass‑through segment is showing a $1.3 billion unrealized loss (also p. 88). AIG, by contrast, flags a liquidity risk that stems from its mortgage‑related holdings – noting that many of its mortgage‑backed and whole‑loan assets are illiquid and difficult to value or sell in a stressed market (AIG 10‑K p. 20, 19) – but it does not quantify a comparable dollar loss. Thus MET’s exposure is measured in specific $‑amounts of NQM/Alt‑A exposure and unrealized loss, whereas AIG’s risk is described more qualitatively as a potential valuation and liquidity challenge for its mortgage assets.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor formatting differences in numbers. (1) Quantitatively: The LLM correctly reports MET's $1.7 billion (rounded from $1,699 million) in non-agency pass-through securities consisting of NQM and Alt-A loans, and the $1.3 billion unrealized loss (rounded from $1,294 million), both of which align with the original answer. The page references (MET 10-K p.88, AIG 10-K p.19-20) support the sourcing. (2) Completeness: The response addresses all parts of the multi-hop question—MET’s exposure in terms of amount and unrealized losses, AIG’s liquidity risk from mortgage assets, and the qualitative comparison between MET’s quantified losses and AIG’s unquantified but broader illiquidity concerns. (3) Entity accuracy: Both companies (MET and AIG), financial instruments (non-agency RMBS, pass-through securities, NQM/Alt-A), and risk types (unrealized losses vs. liquidity/valuation risk) are correctly identified. (4) Reasoning: The multi-hop synthesis is sound—contrasting MET’s specific, marked-to-market exposures with AIG’s more diffuse, qualitative liquidity warnings is logically presented and faithful to the source data. (5) Semantic equivalence: Despite rounding numbers and omitting the total $12,567 million pass-through portfolio figure (a minor omission), the LLM captures the essential comparison. The lack of a precise total portfolio size doesn’t detract from the core analysis of risk nature (quantified loss vs. potential illiquidity). Thus, the answer is factually correct, well-reasoned, and contextually appropriate, warranting a 9/10 due to slight rounding without explicit qualification.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 464,
        "total_tokens": 1958
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How did the revenue contribution from beverage operations in the Asia Pacific region compare between Coca-Cola (KO) and PepsiCo (PEP) in 2021, based on their regional and product segment reporting?",
      "original_answer": "In 2021, Coca-Cola (KO) generated $4,682 million in third-party beverage revenue from its Asia Pacific (APAC) operations. PepsiCo (PEP) reported that 20% of its total revenue in the APAC region came from beverage operations, though the exact dollar amount is not disclosed. This indicates that while KO's APAC beverage revenue is directly quantifiable for 2021, PEP's APAC beverage revenue would require further calculation based on total regional revenue to determine the precise figure.",
      "llm_answer": "In 2021 Coca‑Cola’s Asia‑Pacific region generated $5,291 million of net operating revenue, which essentially reflects its beverage business (KO 10‑K, p.124). PepsiCo’s APAC division reported $4,615 million of total net revenue, but only about 20 % of that was beverage sales – roughly $923 million (PEP 10‑K, p.73). Thus Coca‑Cola’s Asia‑Pacific beverage contribution was roughly six times larger than PepsiCo’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. According to the ground truth, Coca-Cola's 2021 third-party beverage revenue in APAC was $4,682 million, but the LLM states $5,291 million, which is incorrect. For PepsiCo, the LLM claims total APAC net revenue was $4,615 million and calculates beverage revenue as 20% of that ($923 million), but the ground truth does not provide PepsiCo's total APAC revenue or confirm this figure—only that 20% of APAC revenue came from beverages. Thus, both the total regional revenue and derived beverage revenue for PepsiCo are fabricated. (2) Calculations are internally consistent (20% of $4,615M ≈ $923M), but based on incorrect input data. The comparison that Coca-Cola’s revenue was 'six times larger' relies on these erroneous figures and is therefore invalid. (3) The reasoning attempts multi-hop synthesis by combining regional revenue and segment percentages, but fails because it invents a total revenue number for PepsiCo not present in the source data. The original answer correctly notes that PEP's beverage revenue cannot be precisely determined without additional data. (4) Scores reflect major quantitative errors (2/10), weak qualitative reasoning due to unsupported assumptions (4/10), moderate contextual relevance as it addresses the right companies, region, year, and concept (7/10), and low overall correctness (3/10) due to false precision and incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1237,
        "completion_tokens": 399,
        "total_tokens": 1637
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does Gilead's revenue-sharing structure with Merck for long-acting HIV products compare to Merck's royalty obligations to BMS and Ono for Keytruda sales, and what implications does this have for Merck's profitability from both partnerships?",
      "original_answer": "Gilead and Merck share global product revenues equally for long-acting HIV products until $2.0 billion (oral) or $3.5 billion (injectable) in net sales are surpassed, after which Gilead's share increases to 65%. Meanwhile, Merck pays BMS and Ono royalties of 6.5% through 2023 and 2.5% from 2024–2026 on global Keytruda sales, with BMS receiving 75% of those payments. In 2023, Merck recorded $212 million in alliance revenue from its collaboration with BMS on Reblozyl, which includes a 20–24% sales royalty. These structures indicate that Merck both shares in revenue from joint development (with Gilead) and pays significant royalties (to BMS and Ono), which directly affects its net profitability from these partnerships depending on the scale of product sales.",
      "llm_answer": "Gilead’s deal gives Merck a 50 % share of net product revenues (dropping to 35 % once the oral or injectable combo exceeds $2 bn or $3.5 bn in sales, respectively) while Merck only funds 40 % of the joint development and commercialization costs 【page_76】. By contrast, Merck’s Keytruda licence obligates it to pay a royalty of 6.5 % of global sales (falling to 2.5 % after 2024), which is split 75 % to BMS and 25 % to Ono 【page_90】. Thus, Merck’s profitability from the Gilead HIV partnership is contingent on achieving high sales and managing shared costs, whereas its Keytruda earnings are directly reduced by a fixed royalty that will ease after 2024, making the Gilead deal more variable but cost‑shared and the Keytruda royalty a predictable margin drag.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core elements of both partnership structures with strong quantitative precision. (1) Correctly states that Gilead and Merck share revenues 50% until thresholds of $2.0 billion (oral) or $3.5 billion (injectable) are reached, after which Gilead's share increases to 65%—meaning Merck's share drops to 35%, which is correctly implied. This aligns with the ground truth. (2) Accurately reports Merck’s royalty obligation on Keytruda: 6.5% through 2023, decreasing to 2.5% from 2024–2026, with the royalty split 75% to BMS and 25% to Ono—matching the original answer. (3) Adds a detail not in the ground truth—Merck funds only 40% of joint costs—which may come from the cited page 76 but isn't contradicted by the known facts; however, this cost-sharing nuance wasn't required for the question and doesn't detract from accuracy. (4) Correctly contrasts the variable, sales-dependent profitability in the Gilead deal (with cost-sharing) versus the fixed royalty drag on Keytruda, offering sound reasoning on profitability implications. The only minor shortcoming is the omission of the $212 million Reblozyl alliance revenue detail mentioned in the ground truth, which provides additional context on Merck’s income from BMS but is not central to the comparison asked. All numbers, percentages, and thresholds are correct, and multi-hop synthesis across Gilead, BMS, Ono, and Merck is logically sound. Wording differs but meaning is semantically equivalent. Thus, the answer is excellent with only slight incompleteness on ancillary revenue data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1405,
        "completion_tokens": 434,
        "total_tokens": 1839
      },
      "error": null
    },
    {
      "question_id": 181,
      "question": "How does BAC's investment in CDOs, which contain embedded credit default swaps that transfer risk through tranche structures, compare to AIG's $75 million loss from embedded derivatives in 2024, considering the role of credit events in triggering losses for both institutions?",
      "original_answer": "BAC invests in CDOs, which are hybrid instruments containing embedded derivatives where credit protection has been sold to the issuer. These structures pass credit event losses from junior tranches to more senior ones, exposing investors like BAC to cascading risk. AIG, in turn, reported a $75 million loss from embedded derivatives in 2024, which includes similar instruments like credit default swaps tied to reference entities. A credit event in the underlying reference entity would directly impact both BAC’s CDO value and AIG’s derivative exposure, linking their financial risks through the same type of structured credit mechanism.",
      "llm_answer": "BAC’s balance sheet shows that it holds investments in CLOs (a type of CDO) that embed credit‑default‑swap protection and shift risk down the tranche hierarchy, so a credit event on the underlying reference entity could reduce the principal returned on the tranche and the firm’s loss would be limited to the amount invested (see Note 6, page 128). AIG, by contrast, recorded a $75 million loss in 2024 from embedded derivatives that were triggered by credit‑event outcomes (see page 144). Thus, while both firms’ losses are tied to credit events, AIG’s loss is already realized and quantified, whereas BAC’s exposure remains contingent on the performance of its CDO‑tranche investments.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: AIG's $75 million loss in 2024 is accurately reported, and no incorrect figures are introduced. (2) The LLM correctly identifies BAC's exposure through CDOs (specifically noting CLOs as a subtype) with embedded credit default swaps and tranche-based risk transfer, which matches the original answer’s description of cascading risk through tranches. (3) The reasoning correctly distinguishes between BAC’s contingent exposure (potential future loss tied to credit events) and AIG’s realized $75M loss, adding analytical value by clarifying the difference between realized and unrealized risk—this is a nuanced but valid interpretation supported by the data. (4) The mention of 'Note 6, page 128' and 'page 144' suggests proper sourcing from filings, enhancing credibility. (5) The only minor shortcoming is that the original answer emphasizes the structural similarity in risk mechanism (both tied to credit events in structured credit products), while the LLM focuses more on the difference in loss realization. However, it still acknowledges the common link—credit events triggering losses—so the core multi-hop synthesis across BAC and AIG is sound. Wording differs slightly but maintains semantic equivalence. No factual errors; high contextual relevance and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1364,
        "completion_tokens": 392,
        "total_tokens": 1756
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "What specific roles does Citibank, N.A. hold in both 3M's May 2023 Five-Year Credit Agreement and Caterpillar's September 2022 credit facilities, and how do these roles differ in terms of administrative responsibilities across the two agreements?",
      "original_answer": "In 3M’s May 2023 Five-Year Credit Agreement, Citibank, N.A. serves as an administrative agent and joint lead arranger alongside JPMorgan Chase Bank, N.A., with responsibilities including coordination of the lending group and oversight of borrowing procedures. In Caterpillar’s September 2022 credit facilities, Citibank, N.A. acts as the Agent for both the 3-Year and 5-Year Facilities, and also as the Local Currency Agent through Citibank Europe plc, UK Branch, and Japan Local Currency Agent in coordination with MUFG Bank, Ltd. These roles differ in that Citibank holds multiple layered responsibilities in Caterpillar’s structure, including cross-border coordination, while at 3M it shares leadership with another bank without such international scope.",
      "llm_answer": "Citibank, N.A. is identified as the administrative agent for 3M’s May 2023 Five‑Year Credit Agreement (exhibit 10.29) 【page_114】, while in Caterpillar’s September 2022 credit facilities Citibank, N.A. is named as the Agent (administrative agent) for both the 3‑Year and 5‑Year facilities and also serves as the Local Currency Agent for the related addenda 【page_129】. Thus, Citibank’s role in the 3M agreement is limited to standard loan‑administration duties, whereas in Caterpillar’s facilities it carries broader administrative responsibilities, including coordination of local‑currency arrangements and oversight of multiple facility documents.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Citibank, N.A.'s role as administrative agent in 3M’s May 2023 Five-Year Credit Agreement and as Agent (administrative agent) for both the 3-Year and 5-Year facilities in Caterpillar’s September 2022 credit facilities, as well as Local Currency Agent. These roles match the ground truth. However, the LLM omits the detail that Citibank, N.A. shares the administrative and joint lead arranger role with JPMorgan Chase Bank, N.A. in the 3M agreement, which is a notable omission affecting completeness. Additionally, the LLM does not mention Citibank Europe plc, UK Branch, or the Japan Local Currency Agent coordination with MUFG Bank, Ltd., which are key elements of the multi-layered international responsibilities in Caterpillar’s structure. (2) Quantitative accuracy is perfect: dates (May 2023, September 2022), facility types (3-Year, 5-Year), and roles are factually correct. No numerical calculations were required. (3) The reasoning is sound in comparing the scope of responsibilities across the two agreements, correctly concluding that Citibank has broader duties in Caterpillar’s facilities. However, the multi-hop synthesis is slightly incomplete due to missing the shared agent role at 3M and the international structural details at Caterpillar, which weakens the qualitative accuracy. (4) The answer is contextually relevant and directly addresses the question’s focus on roles and administrative responsibilities. The omission of shared leadership and cross-border coordination details prevents a top score, but core facts are accurate and well-reasoned.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1376,
        "completion_tokens": 442,
        "total_tokens": 1818
      },
      "error": null
    },
    {
      "question_id": 182,
      "question": "How does the use of option contracts by KO to hedge foreign currency exposure compare with PEP's foreign exchange risk management strategy, given the impact of these instruments on their respective foreign currency liabilities?",
      "original_answer": "KO uses option contracts as part of its derivative strategy to hedge foreign currency exchange rate risk, aiming to mitigate the impact of currency fluctuations on its financial performance. These contracts are designated as cash flow hedges and affect KO's foreign currency liabilities by deferring gains and losses in AOCI until the hedged transactions occur. Similarly, PEP actively manages foreign exchange risk through derivatives, including option and forward contracts, which are also used to hedge forecasted transactions and firm commitments. PEP reported that foreign exchange movements unfavorably impacted net revenue by 1.5 percentage points in 2024, highlighting the importance of these hedges. Both companies rely on option contracts to manage foreign currency liabilities, but KO specifically emphasizes the deferral of mark-to-market impacts in AOCI, while PEP focuses on offsetting exposure from its significant international operations (44% of revenue).",
      "llm_answer": "KO explicitly records the fair‑value of its foreign‑currency option (and other) contracts on the balance sheet, showing both asset and liability components that directly offset its foreign‑currency obligations (e.g., $14 million in accounts‑payable‑related liabilities and $39 million in other non‑current liabilities in 2024)【page_81】【page_82】. PEP, on the other hand, hedges foreign‑exchange risk with a mix of forward, option and cross‑currency‑swap contracts that are designated as cash‑flow hedges; the results of those hedges flow through other‑comprehensive‑income (net currency‑translation adjustments and cash‑flow‑hedge gains/losses) rather than being shown as separate liability fair‑value line items【page_42】【page_64】. Thus, KO’s option contracts are reflected as explicit adjustments to foreign‑currency liabilities, whereas PEP’s strategy records the hedge impact mainly in AOCI and translation‑adjustment items.",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer provides a reasonable qualitative comparison between KO and PEP's foreign exchange risk management strategies, correctly identifying that both companies use option contracts and cash flow hedges, and that impacts are recorded in AOCI. However, it introduces specific dollar amounts ($14 million in accounts-payable-related liabilities and $39 million in other non-current liabilities) that are not present in the original answer (ground truth), and there is no verification that these figures are accurate or properly contextualized within the question’s scope. The ground truth does not include any specific liability amounts or balance sheet line items, so these numbers appear to be fabricated or extracted from unverified document excerpts (e.g., 'page_81', 'page_82'), undermining quantitative accuracy. Additionally, while the LLM correctly notes that PEP uses forwards, options, and cross-currency swaps, the mention of cross-currency swaps is not in the original answer and may go beyond the provided truth. The core reasoning—KO reflects hedges as explicit balance sheet adjustments while PEP records hedge impacts in AOCI—is consistent with the ground truth’s emphasis on KO deferring MTM impacts in AOCI and PEP focusing on offsetting exposure from international operations. However, the LLM misattributes the mechanism: the original answer emphasizes deferral in AOCI for both, not balance sheet liability offsets as a distinguishing factor. Thus, while the direction of the comparison is sound, the factual basis and quantitative claims reduce correctness. The answer is contextually relevant and addresses the comparative strategy question, but with significant factual overreach on numbers and some misrepresentation of the hedging mechanics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1494,
        "completion_tokens": 479,
        "total_tokens": 1973
      },
      "error": null
    },
    {
      "question_id": 183,
      "question": "How does the use of discounted cash flow models by GE in assessing goodwill impairment risk compare with LMT's application of DCF in valuing Level 3 fixed income investments, particularly in terms of sensitivity to discount rate assumptions and projected cash flow estimates?",
      "original_answer": "GE uses a discounted cash flow (DCF) approach as part of its annual goodwill impairment testing, relying on cash flow forecasts, terminal value assumptions, and discount rates to estimate fair value. The company performs sensitivity analyses due to the material impact that changes in these assumptions could have on impairment determinations. Similarly, LMT applies DCF models to value certain Level 3 fixed income investments when observable market data is unavailable, using projected annuity payments and discount rates as key inputs. Both companies depend on forward-looking cash flow projections and discount rate assumptions, making their valuations sensitive to shifts in economic conditions or interest rate environments. However, GE’s DCF use is tied to internal strategic and operational planning, while LMT’s is externally focused on asset valuation within its pension fund investments.",
      "llm_answer": "GE says that goodwill fair‑value is estimated with a discounted‑cash‑flow model that uses its strategic and operating cash‑flow forecasts and an “appropriate discount rate,” and that it “performs sensitivity analyses on key estimates and assumptions” – i.e., changes in the discount rate or cash‑flow projections can materially affect the impairment result. LMT values Level 3 fixed‑income assets with a discounted‑cash‑flow approach that also depends on projected annuity payments and the discount rate, making the valuation inherently sensitive to those inputs, but the filing only notes the inputs and does not describe a formal sensitivity‑analysis process. Thus, both firms’ DCF valuations are highly dependent on discount‑rate and cash‑flow assumptions, but GE explicitly tests the sensitivity of those assumptions, whereas LMT’s disclosure does not.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that GE uses DCF for goodwill impairment testing based on internal cash flow forecasts and discount rates, and explicitly performs sensitivity analyses—this matches the original answer's emphasis on GE’s sensitivity testing due to material impacts. (2) It accurately states that LMT applies DCF to value Level 3 fixed income investments using projected annuity payments and discount rates, which is consistent with the ground truth. (3) The key distinction—that GE formally conducts sensitivity analyses while LMT does not disclose such a process—is correctly drawn and supported by the filings. (4) The synthesis across both companies and use cases (GE: internal goodwill testing; LMT: external asset valuation) is logically sound and captures the core comparison in sensitivity practices. The only minor shortcoming is a slight underemphasis on the difference in purpose (GE’s strategic/operational focus vs. LMT’s pension fund asset valuation), though the functional distinction in sensitivity analysis suffices for high accuracy. No numeric inaccuracies exist—both responses are qualitative and correctly represent disclosed practices. Wording differs slightly but maintains semantic equivalence. Multi-hop reasoning is strong, connecting DCF use, sensitivity, and company-specific context appropriately.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1470,
        "completion_tokens": 389,
        "total_tokens": 1860
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the voting power distribution in CMCSA's Class A and Class B common stock compare to GOOGL's structure, given the repurchase activity and voting rights differences?",
      "original_answer": "In CMCSA, holders of Class A common stock collectively hold 66 2/3% of the combined voting power, while Class B common stock (held entirely by Brian L. Roberts) holds 33 1/3%, with each Class B share carrying 15 votes. In contrast, GOOGL's Class A shares carry 1 vote each, while Class B shares have 10 votes per share, giving disproportionate voting power to Class B holders in both companies. Additionally, GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, which could affect ownership concentration and voting dynamics, though CMCSA does not disclose such repurchase volumes for Class A shares directly.",
      "llm_answer": "CMCSA’s voting power is split roughly 66.7 % to its Class A shares (one vote each) and 33.3 % to its single Class B holder (15 votes per share), and its 2023 buy‑back was of about 262 million Class A shares【page_33】. Alphabet’s structure gives Class A one vote, Class B ten votes (concentrated in insiders) and Class C no votes, so voting control rests largely with the high‑voting Class B shares, and its 2023 repurchases targeted Class A (≈78 M) and Class C (≈450 M) shares【page_81】. Thus CMCSA’s voting power is more evenly divided between its two classes, whereas Alphabet’s is heavily weighted toward the high‑voting Class B class.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains several factual inaccuracies, particularly regarding repurchase volumes. The ground truth states that GOOGL repurchased $62.2 billion of Class A and Class C shares in 2023, but the LLM incorrectly reports share counts (78M Class A, 450M Class C) without mentioning the dollar value, which is a key part of the original answer. Additionally, the claim that CMCSA repurchased 'about 262 million Class A shares' in 2023 is not supported by the original answer, which does not disclose any repurchase volume for CMCSA—this is a significant factual addition not present in the ground truth. (2) The voting power percentages (66.7% vs 33.3%) and vote weights (15 votes per Class B share for CMCSA, 10 for GOOGL Class B) are correctly reported, and the distinction between share classes in both companies is qualitatively accurate. However, the LLM introduces Class C shares for GOOGL having 'no votes', which, while likely true, is not mentioned in the original answer and thus adds unverified detail. (3) The multi-hop reasoning is partially sound: the model correctly compares the voting power distribution between CMCSA and GOOGL, noting that CMCSA’s split is more balanced (2:1) while GOOGL’s structure heavily favors Class B. However, the incorrect inclusion of specific repurchase share counts—especially for CMCSA, which the original explicitly states is not disclosed—undermines the quantitative reliability. (4) The contextual relevance is high, as the answer addresses both companies’ voting structures and repurchase activities as asked. However, due to the introduction of unsupported numerical data and omission of the $62.2 billion figure, the quantitative accuracy is low. The qualitative reasoning remains mostly intact, warranting a moderate correctness score of 6.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1322,
        "completion_tokens": 492,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 184,
      "question": "How does the 8.2% increase in Turkey's total cigarette market, driven by increased in-bound tourism, impact PM's business performance in comparison to CL's operational footprint in the same country?",
      "original_answer": "The 8.2% growth in Turkey's total cigarette market, attributed to the easing of pandemic-related measures and increased in-bound tourism (particularly by Turkish expatriates), positively contributed to PM's net revenues and shipment volumes in the region. PM reported favorable volume/mix and pricing variances in Turkey, which were key contributors to its Middle East & Africa regional performance. Meanwhile, CL operates manufacturing and warehousing facilities in Turkey as part of its global Oral, Personal and Home Care product segment, indicating a significant operational presence in the country. Therefore, while PM benefits from increased consumer activity linked to tourism, CL maintains a physical and ongoing business infrastructure in Turkey, suggesting differing but regionally aligned exposure to the country's economic dynamics.",
      "llm_answer": "The 8.2 % rise in Turkey’s total cigarette market – largely from higher inbound tourism – lifted PMI’s shipment volume and regional market‑share (up 1.1 pts) and fed into higher net‑revenue and operating‑income growth (PM 10‑K p.56). In contrast, Colgate‑Palmolive’s exposure in Turkey is limited to a manufacturing/warehousing site listed among its overseas facilities (CL 10‑K p.23), so the market‑growth boost directly benefits PMI’s sales while CL’s impact is confined to its production footprint.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 8.2% cigarette market growth in Turkey and its link to inbound tourism, aligning with the ground truth. It accurately notes PM's (PMI's) benefit in terms of shipment volume, net revenue, and operating income, which is consistent with the original answer’s emphasis on PM's positive performance. However, the LLM introduces a specific 1.1 percentage point market share increase for PMI, which is not present in the original answer and cannot be verified from the provided ground truth, making this an unsupported addition. (2) The quantitative accuracy is partially compromised due to the inclusion of the unverified 1.1 pts market share gain. While the 8.2% market growth is correct, no other specific financial figures (e.g., revenue amounts, shipment volumes) are provided in either answer, so the error lies in the introduction of a precise number not in the ground truth. (3) The multi-hop reasoning is generally sound: the model connects Turkey's market growth to PMI’s performance and contrasts it with CL’s operational footprint. It correctly identifies CL’s manufacturing and warehousing presence in Turkey based on its 10-K, which matches the original answer. However, the original answer emphasizes CL’s broader segment (Oral, Personal and Home Care) and ongoing infrastructure, while the LLM simplifies this to a 'limited' exposure, slightly underrepresenting the significance of CL’s footprint. (4) Despite the unsupported market share figure, the LLM captures the core contrast: PM benefits from consumption growth due to tourism, while CL has a production-side presence. Wording differs but the semantic meaning is largely preserved. The correctness score is 7 due to accurate core facts but a significant unverified quantitative claim; qualitative and contextual scores are high due to sound reasoning and relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1349,
        "completion_tokens": 508,
        "total_tokens": 1857
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How might geopolitical tensions involving Taiwan impact both NVIDIA's ability to secure timely supply from its foundry partners and Qualcomm's operations in the region, given their shared dependency on Taiwanese manufacturing infrastructure?",
      "original_answer": "NVIDIA faces risks related to its dependency on foundry partners, particularly in Taiwan, where it relies on timely production capacity to meet customer demand. If geopolitical tensions involving Taiwan disrupt operations, NVIDIA may not be able to secure sufficient supply to fulfill orders on time, which could damage customer relationships and lead to revenue loss. Similarly, Qualcomm explicitly states that its business depends on receiving consistent chipset supply from foundry partners in Taiwan, and a significant or prolonged conflict involving Taiwan could severely limit or prevent this supply, materially impacting its business. Both companies are exposed to the same regional risk due to their reliance on Taiwanese manufacturing infrastructure, amplifying the cross-company impact of geopolitical instability in the region.",
      "llm_answer": "Both companies depend on Taiwanese fabs and assembly partners, so a flare‑up in Taiwan‑China tensions could choke the supply chain. NVIDIA warns that “geopolitical tensions, such as those involving Taiwan and China… could have a material adverse impact” on its ability to get wafers from its foundry partners and could lead to “lack of guaranteed supply of wafer… limited number and geographic concentration of global suppliers” and shipment delays【NVDA p 17】【NVDA p 18】. Qualcomm similarly notes that its “key suppliers and their manufacturing foundries… are primarily located in Taiwan” and that “acts of war… or tensions such as the current geopolitical tensions involving China and Taiwan could… delay or prevent… our foundry or semiconductor assembly and test providers from manufacturing, assembling or testing our products”【QCOM p 35】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) All key factual elements are correct: both NVIDIA and Qualcomm are shown to rely on Taiwanese foundry partners, and the risks from geopolitical tensions involving Taiwan are accurately described. The LLM correctly cites specific risks such as supply chain disruptions, shipment delays, and concentration of suppliers. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either the original or LLM answer, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the LLM synthesizes risk disclosures from both companies, correctly identifying their shared dependency on Taiwanese manufacturing infrastructure and the potential impact of geopolitical instability. It supports claims with appropriate citations (e.g., NVDA p17, QCOM p35), indicating proper sourcing from 10-K filings. (4) The semantic meaning matches the original answer, though the LLM adds direct quotes and page references not in the ground truth—this enhances accuracy without introducing errors. The only minor shortcoming is that the LLM does not explicitly state that the shared regional risk 'amplifies the cross-company impact,' a synthesis point emphasized in the original. However, this is implied through parallel descriptions. Thus, the answer is factually complete and contextually relevant, warranting a high score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1443,
        "completion_tokens": 401,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How has the application of ASU 2020-04 impacted FDX's exposure to LIBOR-related contract modifications, and how does this compare to MMM's financial treatment of hedging relationships affected by reference rate reform?",
      "original_answer": "FDX has not experienced any material effect from reference rate reform, including ASU 2020-04, as of May 31, 2024, although it continues to monitor contracts that may be affected by LIBOR discontinuation. In contrast, MMM actively manages its hedging relationships, including those affected by reference rate changes, and reported $9 million in losses related to interest rate contracts in 2023, indicating active financial impact and accounting treatment under the ASU 2020-04 framework. This suggests that while FDX has not yet seen significant financial effects, MMM has recognized tangible impacts in its hedging activities tied to reference rate reform.",
      "llm_answer": "FedEx says that, after applying the optional expedients in ASU 2020‑04 (and the later ASU 2022‑06 relief), the LIBOR‑related contract modifications it has made through 2021‑2023 have had **no material effect on its financial condition, results of operations or cash flows** (FedEx 10‑K Note 3, p. 93). By contrast, 3M’s LIBOR‑based interest‑rate swaps were re‑based to SOFR and are accounted for as **fair‑value hedges** – the mark‑to‑market gains or losses are recorded in interest expense and the cumulative hedging adjustments are reflected in the carrying amounts of the hedged liabilities (3M 10‑K, p. 75).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly states that FDX (FedEx) has experienced no material effect from LIBOR-related contract modifications under ASU 2020-04, citing its 10-K Note 3, which matches the original answer's claim about no material impact as of May 31, 2024. (2) For MMM (3M), it accurately describes the re-basing of LIBOR-based swaps to SOFR and their accounting treatment as fair-value hedges, with gains/losses recorded in interest expense—consistent with active financial impact. While the original answer mentions a specific $9 million loss in 2023, the LLM answer does not include this exact figure, which is a minor omission but does not distort the overall conclusion that MMM has recognized tangible impacts. (3) The multi-hop reasoning is sound: the model correctly contrasts FDX’s lack of material impact with MMM’s active hedging adjustments, synthesizing information across two companies and their respective accounting treatments. (4) All entities (FDX, MMM, ASU 2020-04, SOFR, fair-value hedges), years (2021–2023), and financial concepts are correctly identified and contextualized. The only reason for not scoring a 10 is the absence of the $9 million loss figure, which is a relevant quantitative detail in the ground truth. However, the semantic meaning and comparative insight remain intact. Formatting variations are acceptable, and contextual relevance is excellent.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1335,
        "completion_tokens": 400,
        "total_tokens": 1735
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does the voting power distribution tied to CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, influence the governance structure compared to GOOGL's dual-class stock system where Class A and Class B shares have differential voting rights?",
      "original_answer": "CMCSA's Class B common stock, entirely owned by Brian L. Roberts, holds 33⅓% of the combined voting power with each share carrying 15 votes, creating a non-dilutable control mechanism. This contrasts with GOOGL's structure, where Class A shares (1 vote per share) and Class B shares (10 votes per share) allow insiders to maintain control while enabling broader public ownership. Both systems use dual-class structures to preserve founder/leadership control, but differ in the vote ratios and ownership concentration, with CMCSA's setup being more concentrated and structurally rigid due to the non-dilutable nature of Class B shares.",
      "llm_answer": "Comcast’s governance is anchored by the 9.44 million Class B shares that each carry 15 votes and are 100 % owned by Brian L. Roberts, giving him roughly 33 % of the combined voting power and a decisive say in director elections and other corporate actions (CMCSA page 31).  Alphabet’s dual‑class system, by contrast, issues Class A shares with one vote and Class B shares with ten votes, the latter held by founders and insiders, so control is concentrated in that insider group but not in a single shareholder (GOOGL page 82).  Thus Comcast’s voting structure concentrates effective control in one individual, while Alphabet’s concentrates it in a small insider bloc under a similar multi‑class voting scheme.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers are correct: Brian L. Roberts owns 100% of CMCSA's Class B shares, each with 15 votes, giving him approximately 33% (specifically 33⅓%) of combined voting power—this is correctly stated as 'roughly 33%' which is semantically acceptable. GOOGL’s Class A (1 vote) and Class B (10 votes) structure is accurately described. (2) The answer correctly identifies that CMCSA’s structure concentrates control in a single individual (Roberts), while GOOGL’s concentrates control among a group of insiders, not one person—this contrast is central to the question and well-articulated. (3) The multi-hop reasoning—comparing ownership concentration, vote ratios, and governance implications across two companies—is sound and synthesizes information appropriately from both filings. (4) The only minor shortcoming is that the LLM does not explicitly mention the 'non-dilutable' nature of CMCSA’s Class B shares, a key structural rigidity highlighted in the original answer. While implied by 'decisive say', the explicit term strengthens the governance distinction. Otherwise, the answer is complete, factually correct, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 346,
        "total_tokens": 1712
      },
      "error": null
    },
    {
      "question_id": 185,
      "question": "How does Amgen's remaining repatriation tax payment schedule under the 2017 Tax Act compare with Eli Lilly's cash payment obligations for the same tax provision as of December 31, 2023?",
      "original_answer": "Amgen has remaining scheduled repatriation tax payments under the 2017 Tax Act, which it is paying over an eight-year period beginning in 2018. Similarly, Eli Lilly made the election to pay the Toll Tax over the same eight-year period, with its future cash payments extending through 2025. Both companies are managing their obligations under the same regulatory framework introduced by the 2017 Tax Act, though the specific amounts differ based on their foreign earnings and individual tax calculations.",
      "llm_answer": "Amgen still owes $3.301 billion of the 2017 Tax Act repatriation tax – $1.467 billion in 2024 and $1.834 billion in 2025【page_159】. Eli Lilly’s cash‑payment obligation for the same “Toll Tax” is $1.427 billion – $634.2 million in 2024 and $792.8 million in 2025【page_92】. Thus Amgen’s remaining schedule is roughly $2 billion (about twice) larger than Lilly’s cash‑payment liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and directly addresses the comparative question about Amgen's and Eli Lilly's remaining repatriation tax payment schedules under the 2017 Tax Act as of December 31, 2023. (1) All numeric values are correct: Amgen’s remaining obligation of $3.301 billion is broken into $1.467 billion in 2024 and $1.834 billion in 2025, which sum correctly to $3.301 billion. Eli Lilly’s obligation of $1.427 billion is split into $634.2 million (2024) and $792.8 million (2025), which also sum correctly. These figures match the ground truth in magnitude and timing. (2) The comparison stating that Amgen’s remaining schedule is roughly $2 billion larger (about twice) that of Lilly’s is quantitatively sound: $3.301B - $1.427B = ~$1.874B difference, and $3.301B / $1.427B ≈ 2.31x, so 'about twice' is a reasonable approximation. (3) The multi-hop reasoning is strong—LLM correctly synthesizes payment schedules across two companies from separate filings, aligns them temporally (2024–2025), and draws a valid comparative conclusion. (4) While the original answer does not include exact dollar figures, the LLM provides more granular, correct data that enhances the comparison. The only minor limitation is that the LLM does not explicitly mention the eight-year payment period starting in 2018, which is in the ground truth, but this is implied by the 2024–2025 payments. This omission does not detract significantly from correctness, as the focus is on the remaining schedule as of 2023. All entities (Amgen, Eli Lilly, 2017 Tax Act, Toll Tax) are correctly identified. Overall, the answer exceeds the ground truth in specificity while maintaining factual and logical accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1231,
        "completion_tokens": 460,
        "total_tokens": 1692
      },
      "error": null
    },
    {
      "question_id": 186,
      "question": "How does the risk of biosimilar competition following loss of exclusivity for Amgen's biologics compare to Bristol Myers Squibb's exposure, given the differing regulatory pathways and product portfolios in the U.S. and EU?",
      "original_answer": "Amgen's reliance on biologics such as 'Erbitux, Cyramza, Trulicity, Taltz, and Emgality' is at risk due to the potential entry of biosimilars, which could occur after 12 years of regulatory data protection in the U.S. However, litigation and expedited review processes like IPR could weaken patent protection and accelerate biosimilar entry. Similarly, Bristol Myers Squibb faces biosimilar threats to its biologics including 'Opdivo, Yervoy, Orencia, Reblozyl, and Empliciti,' with regulatory data protection lasting 12 years in the U.S., but also faces earlier generic competition in the EU under the '8+2+1' regime, where biosimilars can enter after 8 years of data exclusivity. Both companies are exposed to rapid revenue declines upon loss of exclusivity, but the timing and competitive intensity differ based on regional regulatory frameworks and the complexity of biosimilar development.",
      "llm_answer": "Amgen’s 10‑K excerpts (e.g., page 107‑125) focus on other revenue and investment items and do not contain a discussion of biosimilar competition after loss of exclusivity, whereas Bristol‑Myers Squibb’s filing (pages 8‑9) explicitly warns that loss of exclusivity for its biologics — Opdivo, Yervoy, Orencia, Reblozyl and Empliciti — could invite biosimilar challengers, with the U.S. 12‑year data‑protection window and the EU’s centralized “8+2+1” regime creating uncertainty about when competitors can launch. Thus BMS’s exposure to biosimilar competition is clearly articulated and appears greater than Amgen’s, which is not highlighted in the provided sections.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains partial factual correctness but misrepresents the core premise. The original answer states that both Amgen and Bristol Myers Squibb (BMS) face biosimilar competition risks for their biologics, with specific products listed for each. However, the LLM incorrectly claims that Amgen’s 10-K does not discuss biosimilar competition, concluding that Amgen’s exposure is lower due to lack of disclosure in the 'provided sections.' This is a critical error: the absence of discussion in the excerpts does not imply lower risk; it only reflects limited document scope. The ground truth affirms Amgen’s biologics (e.g., Erbitux, Cyramza, Trulicity, Taltz, Emgality) are at risk, which the LLM fails to acknowledge. (2) Quantitatively, the LLM correctly identifies the U.S. 12-year data protection and EU '8+2+1' regime (8 years data exclusivity + 2 years market exclusivity + 1 year for new indications), aligning with the original answer. These regulatory timelines are accurately represented. (3) The multi-hop reasoning is flawed. The LLM draws an unsupported comparative conclusion (BMS exposure > Amgen) based solely on disclosure presence/absence in filings, rather than analyzing actual product portfolios, regulatory pathways, and biosimilar development complexity as required. The original answer emphasizes differing timing and competitive intensity due to regional frameworks and development complexity—nuances missed by the LLM. (4) Contextual relevance is moderate: the LLM addresses regulatory pathways and names BMS’s products correctly, but fails to identify Amgen’s at-risk biologics or discuss cross-regional comparison of competitive intensity. It substitutes risk assessment with disclosure analysis, undermining factual accuracy. Thus, while some elements are correct, the core comparison is invalid, warranting a low correctness score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1408,
        "completion_tokens": 510,
        "total_tokens": 1919
      },
      "error": null
    },
    {
      "question_id": 187,
      "question": "How does Medtronic's exposure to Medicaid reimbursement policies compare to AbbVie's pricing pressures under the IRA, particularly in relation to their respective product portfolios and revenue risks?",
      "original_answer": "Medtronic faces increased price sensitivity from Medicaid reimbursement limitations, which affects hospitals' purchasing behavior and creates a need for competitively priced medical devices. AbbVie, on the other hand, is directly impacted by the Inflation Reduction Act (IRA), which allows the U.S. Department of Health and Human Services to set government prices for certain drugs like Imbruvica (selected in 2023 for pricing starting in 2026) and Vraylar and Linzess (selected in 2025 for pricing starting in 2027), potentially accelerating revenue erosion before patent expiration. While both companies face healthcare cost-containment pressures, Medtronic’s Medicaid exposure affects device pricing strategies, whereas AbbVie must navigate IRA-driven government pricing that could apply to more high-revenue products in the future.",
      "llm_answer": "Medtronic’s revenue exposure stems from Medicaid (and other government) reimbursement rules that cap payments for the procedures and devices it sells to hospitals and health‑systems, creating broad‑based price‑sensitivity across its diversified medical‑device portfolio (see Medtronic 10‑K p. 13). AbbVie, by contrast, faces direct pricing caps under the Inflation Reduction Act that can force statutory ceiling prices on its high‑revenue single‑source drugs and biologics, concentrating the revenue risk on specific pharmaceutical products rather than a broad device mix (see AbbVie 10‑K p. 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core distinctions between Medtronic's and AbbVie's exposure to healthcare pricing pressures. (1) It correctly identifies Medtronic's broad-based price sensitivity due to Medicaid reimbursement rules affecting its device portfolio and AbbVie's concentrated risk from IRA-imposed pricing caps on specific high-revenue drugs. While the LLM does not name the specific drugs (Imbruvica, Vraylar, Linzess) or the IRA selection and implementation years (2023/2026, 2025/2027) mentioned in the ground truth, it accurately captures the structural difference in risk exposure—device pricing strategies vs. statutory drug pricing—without introducing any factual errors. (2) There are no numeric values, dates, or calculations in the LLM answer, so quantitative accuracy is not compromised; the absence of specific years or drug names does not constitute a numerical inaccuracy but rather a slight reduction in completeness. (3) The multi-hop reasoning is sound: the model correctly synthesizes that both companies face cost-containment pressures but through different mechanisms (reimbursement-driven price sensitivity vs. direct government pricing), which aligns with the ground truth. (4) The answer is contextually excellent—focused, relevant, and directly responsive to the comparative question about product portfolios and revenue risks. The only reason for not scoring a 10 is the omission of specific drug names and IRA timeline details, which are part of the full picture but not essential to the central comparison. Thus, the answer is semantically equivalent in intent and factual structure, warranting a 9 for correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1371,
        "completion_tokens": 460,
        "total_tokens": 1832
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does the $2.7 billion in unfunded commitments to private equity funds held by UPS compare to General Dynamics' use of NAV for valuing its Level 1 plan assets, given both companies rely on NAV as a practical expedient for alternative investments?",
      "original_answer": "UPS reports $2.7 billion in unfunded commitments to private equity and similar funds as of December 31, 2024, with contributions expected over 3 to 6 years. These investments are valued using NAV as a practical expedient due to the lack of readily determinable fair value. Similarly, General Dynamics (GD) uses NAV for its Level 1 plan assets, which include commingled equity and fixed-income funds valued using a unit price or NAV. Both companies rely on NAV for valuation, but UPS's private equity commitments carry longer redemption restrictions (10–15 year terms), whereas GD's NAV-based assets are generally redeemable monthly or quarterly. This suggests UPS has a less liquid exposure to NAV-based investments compared to GD.",
      "llm_answer": "UPS says that, as of December 31 2024, it has roughly **$2.7 billion of unfunded commitments to private‑equity, private‑debt and real‑estate limited‑partnership funds** that will be called over the next three‑to‑six years【page_93】. In contrast, General Dynamics only uses NAV as a **practical expedient to value its existing Level 1 plan assets (commingled equity and fixed‑income funds)** and notes that any unfunded commitments related to those NAV‑valued investments are not material【page_87】【page_93】. Thus, UPS’s $2.7 billion represents a large future cash‑outflow liability, whereas GD’s NAV approach merely values a relatively small portion of its current assets and does not involve comparable unfunded commitments.",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer is quantitatively accurate: it correctly reports UPS's $2.7 billion in unfunded commitments as of December 31, 2024, and accurately references the 3-to-6-year funding horizon. It also correctly states that General Dynamics uses NAV as a practical expedient for valuing its Level 1 plan assets, specifically commingled equity and fixed-income funds. The claim that GD’s unfunded commitments related to NAV-valued investments are not material is supported by the source (page 87, 93). However, the original answer includes a key comparative insight about liquidity differences—UPS’s private equity investments have 10–15 year terms with long redemption restrictions, while GD’s NAV-based assets are generally redeemable monthly or quarterly—highlighting that UPS has less liquid exposure. This qualitative dimension of liquidity and redemption frequency is missing in the LLM answer, which instead focuses solely on the presence or absence of unfunded commitments. While the LLM correctly identifies that UPS has significant future cash outflows and GD does not, it fails to fully synthesize the multi-hop comparison around liquidity and investment structure, which is central to the question’s intent. Thus, while factually correct and contextually relevant, the answer lacks completeness in qualitative reasoning, particularly in comparing the nature of NAV usage beyond just funding commitments.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1389,
        "completion_tokens": 389,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How does CMCSA's issuance of Class B Common Stock in 2024 influence its shareholder voting rights structure, and how does this compare to META's dual-class framework as disclosed in their respective filings?",
      "original_answer": "CMCSA issued 9,444,375 shares of Class B Common Stock in 2024, which, as per the governance structure outlined in V_10k_2024.pdf, carries no voting rights except in limited circumstances such as exiting the core payments business or specific merger scenarios. This creates a tiered voting rights system where Class A shareholders maintain full voting control. Similarly, META's filing reveals a dual-class structure with Class A and Class B common stock, where Class A stockholders have full voting rights while Class B stockholders generally do not, except in defined events like a merger. Both companies thus concentrate voting power among a subset of shareholders, reinforcing control while allowing for differentiated capital structures.",
      "llm_answer": "CMCSA’s 2024 filing shows it issued 9,444,375 shares of a separate Class B common stock (see CMCSA 10‑K p. 65).  Because the filing does not grant any voting rights to that class, the new Class B shares do not affect the voting power of the existing Class A shareholders.  In contrast, Meta’s 10‑K identifies both a publicly‑traded Class A and a non‑public Class B series, with Class A carrying one vote per share and Class B carrying ten votes per share, concentrating control with insiders (see Meta 10‑K p. 1).  Thus, CMCSA’s Class B issuance adds a non‑voting class, whereas Meta’s dual‑class framework creates a super‑voting Class B that outweighs the voting influence of its Class A holders.",
      "correctness_score": 4,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 3,
      "contextual_relevance": 8,
      "detailed_feedback": "The LLM answer correctly identifies the number of Class B shares issued by CMCSA (9,444,375) and accurately references the source (CMCSA 10-K p.65), satisfying quantitative accuracy. It also correctly notes that CMCSA's Class B shares carry no voting rights, preserving Class A voting power. However, the qualitative accuracy is severely compromised due to a critical factual error regarding META's dual-class structure: the LLM claims Meta’s Class B has ten votes per share and that Class A has one vote per share, which contradicts the ground truth. The original answer states that Meta’s Class B shareholders generally have no voting rights except in defined events like a merger—meaning Class B is *non-voting*, not *super-voting*. This misrepresents the core comparison: both CMCSA and META have non-voting Class B shares, but the LLM incorrectly frames META as having a super-voting structure, which fundamentally distorts the analysis. This error indicates a failure in multi-hop reasoning and synthesis, as the model misinterprets Meta’s capital structure despite referencing the correct document. Contextually, the answer is relevant and well-structured, addressing both companies and the voting rights impact, but the key comparative insight is flawed. Thus, while numbers are correct and the response is contextually appropriate, the reasoning and entity-specific facts (especially for META) are significantly inaccurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1374,
        "completion_tokens": 394,
        "total_tokens": 1769
      },
      "error": null
    },
    {
      "question_id": 188,
      "question": "How might the IRA's Medicare price-setting provisions impact revenue erosion timelines for Amgen's products that rely on federal reimbursement, especially in light of AbbVie's experience with Imbruvica and Vraylar being selected for government pricing starting in 2026 and 2027?",
      "original_answer": "The IRA's Medicare price-setting provisions could accelerate revenue erosion for Amgen's products that depend on federal reimbursement by imposing government-determined prices as early as nine or thirteen years post-FDA approval, depending on whether the product is a small molecule or biologic. This mirrors AbbVie's experience where Imbruvica was selected for price setting in 2026 and Vraylar and Linzess in 2027, leading to potential revenue declines before patent expiration. Amgen, which also relies heavily on Medicare reimbursement, faces similar risk as these policies reduce pricing flexibility and increase downward pressure on profitability.",
      "llm_answer": "The IRA gives HHS authority to set Medicare prices for single‑source drugs beginning in 2026 for the first ten products and in 2027 for the next fifteen, so any Amgen medicines that rely on federal reimbursement could be forced to accept lower government‑set prices and see the window of full‑price sales shrink, accelerating revenue erosion before patent expiry (Amgen 10‑K Item 1A risk factors, pages 34‑35). AbbVie’s recent experience—Imbruvica being placed under price‑setting in 2026 and Vraylar in 2027—shows how such selections can hasten revenue declines, suggesting Amgen’s comparable products may face an earlier onset of revenue erosion under the IRA (AbbVie 10‑K, page 19).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all dates (2026 and 2027) and program rollout details (first ten products in 2026, next fifteen in 2027) are correct and consistent with the IRA's implementation timeline. The reference to AbbVie’s Imbruvica and Vraylar being selected in 2026 and 2027 matches the original answer. (2) The LLM correctly identifies the mechanism of the IRA—HHS setting Medicare prices—and links it to reduced pricing flexibility and earlier revenue erosion for Amgen, paralleling AbbVie’s experience. (3) The multi-hop reasoning is sound: it connects IRA provisions → impact on federal reimbursement-dependent drugs → AbbVie’s case as precedent → implications for Amgen. The only minor omission is that the original answer specifies the 9- or 13-year post-approval trigger (based on drug type), which the LLM does not mention, slightly weakening the mechanistic explanation. However, the core logic and factual content remain intact. (4) Wording differs but semantic meaning is equivalent: 'accelerating revenue erosion before patent expiry' matches the original’s 'revenue declines before patent expiration.' Citations to 10-Ks add credibility. Overall, the answer is factually correct, well-reasoned, and contextually precise—just missing a small detail on the approval-to-price-setting timeline.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 380,
        "total_tokens": 1748
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the number of securities remaining available for future issuance under equity compensation plans approved by security holders at Colgate-Palmolive compare to the total remaining available securities disclosed by Procter & Gamble, based on their respective disclosures?",
      "original_answer": "Colgate-Palmolive reported 37,028,000 securities remaining available under equity compensation plans approved by security holders, while Procter & Gamble disclosed a total of 133,185,995 remaining available securities across both Stock Options/SARs and RSUs/PSUs under the same category of approved plans. This indicates PG has a significantly larger pool of available securities for future issuance compared to CL.",
      "llm_answer": "Colgate‑Palmolive reported that, as of December 31 2021, equity‑compensation plans approved by its security holders had **37,028 thousand shares** (≈ 37 million) remaining available for future issuance【page_61】.  \n\nProcter & Gamble disclosed that the only plan that can still grant shares (its 2019 Stock and Incentive Compensation Plan) leaves **about 119 million shares** available for future issuance【page_69】.  \n\nThus, P&G’s remaining‑available pool is roughly three times larger – about **82 million shares more** – than the pool reported by Colgate‑Palmolive.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies Colgate-Palmolive's remaining available securities as 37,028,000 (reported as 37,028 thousand), which matches the ground truth. However, it reports Procter & Gamble's total remaining available securities as approximately 119 million, which is incorrect. The ground truth states 133,185,995 across Stock Options/SARs and RSUs/PSUs under security holder-approved plans. The LLM underreports this by about 14 million shares. (2) The calculation of the difference (82 million more) is based on incorrect input: 119M - 37M = 82M, but the actual difference should be ~96M (133.2M - 37M). This constitutes a significant quantitative error. (3) The multi-hop reasoning is sound in structure—comparing available securities under shareholder-approved plans at two companies—but fails due to inaccurate data extraction for P&G. The LLM appears to have used only the 2019 Plan figure without summing all relevant components, missing part of the required synthesis. (4) Despite the reasoning framework being appropriate and the Colgate number accurate, the incorrect P&G figure undermines the conclusion. The answer is partially correct but contains a major factual inaccuracy in a key numeric value, warranting a moderate score. Contextual relevance is high as the response directly addresses the comparison asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1277,
        "completion_tokens": 375,
        "total_tokens": 1653
      },
      "error": null
    },
    {
      "question_id": 190,
      "question": "How does the joint commercialization of BMY's biologics in Taiwan compare with MRK's strategic spin-off of its biosimilars business, given Taiwan's regulatory requirement for local clinical trial data for biologics registration?",
      "original_answer": "BMY jointly commercializes biologics like Opdivo and Yervoy in Taiwan with Ono, where BMS handles supply and both parties share development costs and profits. This suggests a collaborative, market-access-focused strategy in Taiwan, which requires local clinical trial data for biologics registration. In contrast, MRK spun off its biosimilars business into Organon, signaling a strategic retreat from the biosimilars segment, which faces increasing global competition and regulatory complexity, including in markets like Taiwan that require additional local data for registration. Thus, while BMY maintains a direct and collaborative presence in Taiwan's biologics market, MRK has opted to divest its biosimilars portfolio, potentially avoiding the added burden of meeting such regulatory requirements in markets requiring local trials.",
      "llm_answer": "BMS’s biologics such as Opdivo and Yervoy are being co‑developed and co‑commercialized in Taiwan through a partnership with Ono, with BMS supplying the products and the two companies sharing costs, profits and regulatory responsibilities – a structure that can more readily generate the local clinical‑trial data Taiwan requires for biologic registration (BMS‑Ono alliance, p. 86; Taiwan requirement for local data, p. 22). In contrast, Merck chose to spin off its biosimilars and other established‑brand businesses into the independent company Organon, leaving the new entity to meet Taiwan’s local data demands on its own rather than through a joint‑venture model (Merck spin‑off, p. 3).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: BMS (BMY) collaborates with Ono in Taiwan on Opdivo and Yervoy, sharing costs, profits, and regulatory responsibilities, which supports compliance with Taiwan's requirement for local clinical trial data. This is correctly contrasted with MRK's spin-off of its biosimilars business into Organon, effectively transferring the burden of meeting regulatory requirements like Taiwan's to the new entity. (2) There are no numeric values requiring verification (e.g., dollar amounts, percentages, dates), so quantitative accuracy is not compromised—score is 10. (3) The multi-hop reasoning is sound: the model correctly links Taiwan’s regulatory environment to the strategic implications for two different companies’ business models—collaborative market entry (BMS/Ono) vs. divestiture (MRK/Organon). The only minor shortcoming is that the LLM slightly simplifies the implication for Organon—while it's true that Organon now bears the responsibility, the answer could have clarified that MRK’s spin-off reflects a strategic retreat from biosimilars, which the original answer emphasizes. This nuance is missing but does not invalidate the core reasoning. (4) The response is fully contextually relevant, directly addressing the comparison between BMY’s joint commercialization and MRK’s spin-off in light of Taiwan’s regulatory demands. Wording differs but semantic equivalence is preserved. Overall, this is a strong, factually correct, and logically coherent answer deserving a 9/10 for correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 438,
        "total_tokens": 1840
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How does AAPL's 2022 revenue contribution from Taiwan, as part of its Greater China segment, compare to ADBE's operational presence in the same region?",
      "original_answer": "AAPL reported $74,200 million in net sales for its Greater China segment in 2022, which includes Taiwan among other regions. ADBE maintains a local field office in Taiwan as part of its global operations, indicating a direct market presence. While AAPL's exposure to Taiwan is embedded within its broader Greater China revenue, ADBE's operational footprint in Taiwan suggests a more targeted geographic strategy in the region.",
      "llm_answer": "Apple’s 2022 Form 10‑K shows that the Greater China segment – which aggregates mainland China, Hong Kong and Taiwan – produced **$74.2 billion in net sales** (Apple, 2022 Note 11; page 52). The filing does not break out Taiwan’s share of that amount. Adobe’s filing only notes that it **has a local field office in Taiwan** (Adobe, 2022 Operations; page 15) and gives no separate revenue figure, indicating a modest operational presence compared with Apple’s multi‑billion‑dollar sales exposure in the region.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly reports AAPL's 2022 Greater China net sales as $74.2 billion (equivalent to $74,200 million in the ground truth), with accurate citation to Apple's 2022 10-K, Note 11, page 52. It correctly notes that Taiwan is included in the Greater China segment but not broken out separately, which aligns with the original answer. For ADBE, it accurately states the presence of a local field office in Taiwan based on Adobe’s 2022 filing, page 15, and correctly observes no revenue is disclosed, indicating a modest operational presence. (2) All numeric values are correct and presented in equivalent formats ($74.2 billion = $74,200 million). No calculations were required, but the comparison of scale (multi-billion-dollar sales vs. field office) is appropriately framed. (3) The multi-hop reasoning is sound: the model synthesizes AAPL’s financial data and geographic segmentation with ADBE’s operational footprint, correctly contrasting revenue exposure versus operational presence. It avoids asserting any revenue for ADBE in Taiwan, which is consistent with the source. (4) The answer is factually complete and contextually precise. The only minor limitation is that it frames ADBE’s presence as 'modest'—a slight interpretive leap—though this is reasonable given the lack of revenue data and presence of only a field office. Overall, the answer matches the ground truth in substance, with excellent quantitative accuracy and strong qualitative reasoning.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1235,
        "completion_tokens": 409,
        "total_tokens": 1644
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do CMCSA and META differ in terms of the voting control concentration between Class A and Class B common stockholders, and what implications does this have for shareholder influence in corporate governance decisions?",
      "original_answer": "CMCSA's Class A common stockholders hold 66 2/3% of the combined voting power, while Class B stockholders (led by Brian L. Roberts) hold 33 1/3%, with each Class B share carrying 15 votes. In contrast, META's Class B common stock, though not publicly traded, holds significant voting rights, but the specific voting power percentage is not disclosed. However, META's Class A shares are publicly traded under the ticker META, and as of December 31, 2023, there were only 23 stockholders of record for Class B shares, indicating concentrated control. This means CMCSA maintains a structured balance of voting power, while META's control is more opaque and concentrated among fewer Class B holders.",
      "llm_answer": "Comcast’s dual‑class structure gives Class B shares – each worth 15 votes – about one‑third of the total voting power (≈33 %) and they are all owned by a single insider, Brian L. Roberts, while the remaining ≈66 % of votes belong to the many Class A shareholders (320 k record holders)【page_33】. Meta’s structure gives each Class B share ten votes, and with 350 million Class B shares versus 2,211 million Class A shares the Class B stock controls roughly 60 % of the voting power, concentrated in a relatively small group of insiders【page_120】. Thus, Comcast’s governance is more balanced, allowing broader shareholder influence, whereas Meta’s insiders hold a decisive majority, limiting the impact of ordinary Class A shareholders on board elections and other corporate decisions.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding META's voting structure and percentages. The ground truth states that META's Class B voting power percentage is not disclosed, but the LLM claims Class B holds 'roughly 60%' of voting power based on a calculation using 350 million Class B shares and 2.211 billion Class A shares with a 10:1 vote ratio. This calculation is not supported by the original answer and contradicts the 'not disclosed' nature of META's voting concentration. Additionally, the LLM incorrectly states that each META Class B share carries 10 votes; the original answer does not specify the vote ratio for META. In contrast, the CMCSA portion is mostly accurate: Class A has ~66 2/3%, Class B ~33 1/3%, and each Class B share has 15 votes, all aligning with the ground truth. The claim about 320k record holders for Class A is plausible but not in the original answer, so it cannot be verified. (2) Quantitative accuracy is low because the core numbers for META (10 votes per share, 60% voting control) are fabricated or incorrectly inferred. The calculation (350M * 10) / [(350M * 10) + 2.211B] ≈ 61.3% may be mathematically sound but is based on unverified data not present in the ground truth. The original answer only notes 23 Class B stockholders of record as of Dec 31, 2023, which the LLM omits. (3) Multi-hop reasoning is partially sound: the model attempts to compare dual-class structures and infer governance implications. However, it fails to acknowledge the opacity in META's structure as emphasized in the original answer, instead asserting precise figures that aren't disclosed. This undermines the reasoning. (4) Contextual relevance is high because the answer addresses both companies, their voting structures, and implications for shareholder influence. However, the incorrect data leads to a misleading conclusion that META has 60% insider control, whereas the original emphasizes lack of disclosure and concentrated but unspecified control. The conclusion that CMCSA is 'more balanced' is consistent, but the basis for comparison is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 571,
        "total_tokens": 1959
      },
      "error": null
    },
    {
      "question_id": 191,
      "question": "How do LLY and MRK benefit differently from pediatric exclusivity provisions in the U.S. and EU regulatory frameworks?",
      "original_answer": "LLY benefits from pediatric exclusivity in the U.S. by receiving an additional six months of exclusivity added to data protection, orphan drug exclusivity, or non-expired patents. MRK, on the other hand, benefits in the U.S. through an additional six months of market exclusivity added to Orange Book-listed patents and regulatory data exclusivity, and in the EU through an additional six months added to the Supplementary Protection Certificate (SPC) term. This difference in application highlights how the U.S. framework ties pediatric exclusivity to both patents and data protection, while the EU framework applies it only to the SPC term.",
      "llm_answer": "Lilly’s 10‑K explains that a successful pediatric‑study request gives the company an extra six‑month “pediatric exclusivity” that is tacked onto the **U.S. patent term for all Orange‑Book‑listed (non‑biologic) patents, onto its data‑protection period and any orphan‑drug exclusivity** 【page_10】, and the same six‑month extension is added to the **EU supplementary‑protection certificate (SPC) term** 【page_14】.  \n\nMerck’s 10‑K does not contain a comparable pediatric‑exclusivity clause – it makes no reference to a six‑month extension of patent or orphan‑drug protection in the United States, indicating that Merck does not receive the same additive benefit (its only EU benefit would be the standard SPC‑linked six‑month extension). 【page_19】",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies regarding MRK's benefits from pediatric exclusivity. The original answer states that MRK benefits in the U.S. from a six-month extension on Orange Book-listed patents and regulatory data exclusivity, and in the EU from a six-month extension to the SPC term. However, the LLM incorrectly claims that Merck’s 10-K 'does not contain a comparable pediatric-exclusivity clause' and 'makes no reference' to such benefits, concluding that Merck does not receive the same additive benefit—this contradicts the ground truth. The LLM wrongly infers absence of benefit from absence of explicit mention, which is a critical error in multi-hop reasoning. (2) Quantitatively, the six-month exclusivity duration is correctly stated for both LLY and the EU SPC extension, so numerical accuracy is preserved. (3) The reasoning is flawed: the model fails to correctly synthesize MRK’s actual regulatory benefits as per the knowledge graph, instead relying on document absence to draw a negative conclusion—an invalid inference. It also incorrectly implies LLY receives the benefit in the EU via the same mechanism as the U.S., while the original answer does not specify LLY’s EU mechanism beyond SPC, but the LLM overgeneralizes. (4) Contextual relevance is moderate because the answer addresses the right topic and cites appropriate frameworks (U.S. vs EU, Orange Book, SPC), but misrepresents MRK’s position and misattributes LLY’s EU benefit. The qualitative accuracy is low due to incorrect entity-specific synthesis, despite correct numbers.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1339,
        "completion_tokens": 438,
        "total_tokens": 1778
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the change in EMR's foreign currency liabilities from 2023 to 2024 compare with the scale of LMT's foreign currency hedge exposure, and what might this indicate about their respective foreign exchange risk management strategies?",
      "original_answer": "EMR's foreign currency liabilities decreased from $22 billion in 2023 to $20 billion in 2024, a $2 billion reduction, while LMT maintained $7.5 billion in outstanding foreign currency hedges at the end of 2024. This indicates that LMT is proactively hedging a significant portion of its foreign exchange exposure, whereas EMR appears to be reducing its overall foreign currency liability position rather than necessarily increasing hedging activity. The use of option contracts by LMT suggests a strategy focused on offsetting earnings volatility from exchange rate fluctuations, while EMR's declining liabilities may reflect either reduced international operations or a shift in risk management approach.",
      "llm_answer": "Emerson’s foreign‑currency liabilities slipped from $22 million in 2023 to $20 million in 2024 – a $2 million decline (EMR 10‑K, page 59). Lockheed Martin, by contrast, reported outstanding foreign‑currency hedge contracts with a notional amount of $7.5 billion at year‑end 2024 (up from $6.5 billion in 2023) (LMT 10‑K, page 52). The negligible change in Emerson’s liabilities indicates a relatively modest FX exposure, while Lockheed Martin’s multi‑billion‑dollar hedge position shows it is actively managing a far larger foreign‑exchange risk profile.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "(1) The LLM answer contains a critical factual error: it reports EMR's foreign currency liabilities as $22 million and $20 million in 2023 and 2024, respectively, whereas the ground truth states these values are $22 billion and $20 billion — a 1,000-fold difference. This severely undermines the quantitative and overall correctness. The $2 million reduction is incorrect; it should be a $2 billion reduction. In contrast, the LMT hedge exposure of $7.5 billion is correctly reported, as is the increase from $6.5 billion in 2023 (though this detail is not in the original answer, it is consistent). (2) The calculation of the $2 million difference is mathematically correct based on the wrong inputs, but the scale is entirely inaccurate. The comparison between EMR and LMT is therefore misleading: EMR’s liabilities are on a similar scale to LMT’s hedges (both in tens of billions), but the LLM portrays EMR’s exposure as negligible due to the million-vs-billion error. (3) The multi-hop reasoning is partially sound — the model attempts to compare liability changes with hedge positions and infer risk management strategies — but the flawed data leads to incorrect conclusions. The original answer notes EMR is reducing liabilities as a strategy, possibly indicating structural changes, while LMT actively hedges; the LLM incorrectly frames EMR’s exposure as 'modest' due to the magnitude error, leading to a mischaracterization of EMR’s FX risk profile. (4) Contextual relevance is moderate: the structure and intent align with the question, and LMT data is accurate, but the core EMR data is catastrophically wrong, resulting in a mostly incorrect synthesis. The conclusion about LMT actively managing risk is valid, but the contrast with EMR is not.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 474,
        "total_tokens": 1812
      },
      "error": null
    },
    {
      "question_id": 192,
      "question": "How does the $3.6 billion in dividends paid by AENB to AXP in 2023 relate to the leverage ratio requirements that both AENB and WFC are subject to under federal banking regulations?",
      "original_answer": "The $3.6 billion in dividends paid by AENB to AXP in 2023 is directly tied to AENB's compliance with leverage ratio requirements, as AENB must consider the impact of such distributions on its regulatory capital ratios. AENB, as a subsidiary bank of AXP, is subject to federal banking regulations that restrict dividend payments if they would cause the bank to fall short of required leverage ratios. Similarly, WFC, as a large bank holding company, is also subject to leverage and supplementary leverage ratio requirements under Basel III and FRB rules, which constrain its ability to make capital distributions like dividends. Therefore, both AENB and WFC must ensure that any dividend payments comply with these leverage constraints, making the $3.6 billion distribution by AENB a function of its ability to maintain required capital levels under the same type of regulatory framework that governs WFC.",
      "llm_answer": "The $3.6 billion dividend that American Express National Bank (AENB) paid to its parent in 2023 could be made only if the bank’s Tier 1 leverage ratio stayed above the regulatory floor – the Federal Reserve’s minimum of 4 % – and the bank’s own capital plan deemed the payout safe.  AENB reported a Tier 1 leverage ratio of **9.5 %** at year‑end 2023 (well above the 4 % minimum)【page_66】, and its dividend policy explicitly notes that the payment must not cause the bank to breach its risk‑based capital or leverage‑ratio requirements【page_152】.  Wells Fargo (WFC) is subject to the same Basel III/FRB leverage‑ratio rules, and its regulators can restrict dividend distributions if the bank’s leverage ratio falls below the required level, so both AENB’s $3.6 billion payout and any WFC dividends are constrained by compliance with those leverage‑ratio standards【page_3】【page_4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: the $3.6 billion dividend amount, the 2023 timeframe, AENB's Tier 1 leverage ratio of 9.5% (cited from page 66), and the regulatory minimum of 4% are all accurately reported. The reference to AENB’s dividend policy requiring compliance with capital and leverage ratios (page 152) and WFC being subject to Basel III/FRB rules (pages 3, 4) supports the reasoning. (2) Quantitatively, all numbers are correct and properly contextualized—no calculation errors. The 9.5% ratio being well above the 4% floor is a valid inference supporting the permissibility of the dividend. (3) The multi-hop reasoning is sound: the answer correctly links AENB’s dividend payment to its regulatory leverage ratio requirements, explains that such payments are constrained by capital adequacy, and draws a parallel to WFC under the same regulatory framework (Basel III and FRB rules), which is central to the original answer. (4) The only minor shortcoming is that the LLM does not explicitly mention that AENB is a subsidiary of AXP, which is a small but relevant contextual detail in the ground truth. However, this does not detract significantly from the overall correctness. The answer is semantically equivalent, well-supported with document citations, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1454,
        "completion_tokens": 381,
        "total_tokens": 1836
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does the geographic distribution of Microsoft's pre-tax income ($62.9B U.S. and $44.9B foreign in fiscal 2024) influence its exposure to the OECD's Pillar Two Model Rules, and how does this compare to Qualcomm's expected impact under the same Global Minimum Tax framework given their similar fiscal year 2025 implementation timeline?",
      "original_answer": "Microsoft's geographic distribution of pre-tax income shows significantly higher earnings in the U.S. ($62.9B) compared to foreign jurisdictions ($44.9B), which may reduce its exposure to the Pillar Two Model Rules since these rules target multinational enterprises with operations in low-tax jurisdictions. Microsoft notes it does not expect a material impact from Pillar Two. Similarly, Qualcomm acknowledges the global minimum tax framework will apply to them starting in fiscal 2025 and also states they do not expect a material impact on their financial statements, suggesting both companies anticipate minimal disruption from the same regulatory framework.",
      "llm_answer": "Microsoft’s FY 2024 pre‑tax mix – $62.9 bn from the United States and $44.9 bn from foreign jurisdictions (≈41 % of total) – means a sizable portion of earnings could be subject to the OECD’s 15 % global‑minimum‑tax rules, but the company notes it has no material operations in jurisdictions with rates below that floor and therefore does not expect a material Pillar‑Two impact when the rules apply in FY 2025. Qualcomm makes the same forward‑looking claim – Pillar Two will begin in FY 2025 but it does not anticipate a material effect on its consolidated statements – indicating that, like Microsoft, its exposure to the global minimum tax is considered limited despite any foreign‑income component.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All numeric values are correct: Microsoft's U.S. pre-tax income ($62.9B) and foreign income ($44.9B) are accurately reported, with the foreign share correctly implied as approximately 41% of total pre-tax income (total = $107.8B; $44.9B / $107.8B ≈ 41.6%). The fiscal year 2025 implementation timeline for Pillar Two is correctly noted for both Microsoft and Qualcomm. (2) Entity accuracy is strong: both companies are correctly identified, along with the OECD’s Pillar Two Model Rules and the Global Minimum Tax framework. The fiscal years (2024 for Microsoft’s income data, 2025 for Pillar Two applicability) are correctly used. (3) Reasoning is sound: the LLM correctly infers that Microsoft’s higher U.S. earnings and lack of material operations in low-tax jurisdictions reduce its exposure to Pillar Two, and it appropriately draws a parallel with Qualcomm’s similar expectation of no material impact. (4) Semantic equivalence is achieved—while the LLM adds slight elaboration (e.g., calculating the 41% foreign share), the core message matches the original: both firms expect minimal impact from Pillar Two despite having foreign income. The only minor gap is that the LLM slightly overemphasizes the '41%' calculation, which is not in the original, but this does not introduce error. No factual inaccuracies or calculation errors are present. Thus, the answer earns a 9/10 for correctness due to excellent quantitative and qualitative performance and full contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1388,
        "completion_tokens": 427,
        "total_tokens": 1816
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does WMT's $37.2 billion in unrecorded purchase obligations expose the company to financial risks that aren't captured by the VAR models used by peers like MDLZ?",
      "original_answer": "WMT has $37.2 billion in unrecorded purchase obligations as of January 31, 2025, which includes firm commitments for inventory, utility purchases, and capital expenditures. These obligations are legally binding but are not reflected on the balance sheet. However, according to DIS's 10-K filing, VAR models — like the one used by MDLZ — exclude forecasted transactions and firm commitments when estimating financial risk exposure. MDLZ's VAR model specifically uses a parametric delta-gamma approximation technique based on interest rate, currency, and commodity price movements to estimate potential one-day losses, but does not include firm commitments in its calculations. This means that while WMT has significant off-balance sheet obligations, companies using VAR models like MDLZ do not incorporate these types of commitments into their risk assessments, leaving WMT potentially more exposed to market volatility that isn't captured through standard VAR modeling practices.",
      "llm_answer": "WMT reports $37.2 billion of unrecorded purchase obligations – legally binding contracts for inventory, utilities, capital‑expenditure, software, licenses and services, with $15.9 billion due in the next year (WMT page 45). MDLZ’s VAR model, however, is limited to estimating one‑day market‑risk losses on interest‑rate, currency and commodity derivatives and expressly excludes “anticipated transactions, firm commitments… and accounts receivable/payable” (MDLZ page 66; MDLZ page 65). Therefore, WMT’s sizable contractual cash‑outflow exposure creates liquidity and cost‑inflation risk that the VAR‑based market‑risk metrics used by peers do not capture.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all key numbers are correct: WMT's $37.2 billion in unrecorded purchase obligations is accurately reported, and the LLM adds a specific detail—$15.9 billion due within the next year—which is consistent with the type of information expected in such disclosures (though not in the original answer, it does not contradict it and may reflect additional data from the actual WMT filing). The reference to MDLZ’s VAR model excluding 'firm commitments' is correctly stated. (2) The LLM correctly identifies that MDLZ’s VAR model uses a one-day risk horizon and focuses on interest rate, currency, and commodity derivatives, explicitly excluding firm commitments and anticipated transactions—this matches the original answer’s claim about DIS’s observation and MDLZ’s methodology. (3) Multi-hop reasoning is sound: the model connects WMT’s off-balance sheet obligations to the limitations of MDLZ’s VAR model, concluding that such obligations introduce liquidity and cost-inflation risks not captured by standard VAR practices. This is a valid inference and captures the core of the original answer’s logic. (4) The only minor gap is that the original answer references DIS’s 10-K as the source for the general exclusion of firm commitments in VAR models, while the LLM cites MDLZ’s own filing for that exclusion—this shifts the source slightly but does not affect factual correctness, as MDLZ’s filing does indeed state this limitation. The LLM also adds detail (e.g., software, licenses, services) about the nature of obligations not in the original, but this is plausible elaboration, not error. Overall, the answer is factually correct, well-reasoned, and contextually appropriate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1413,
        "completion_tokens": 479,
        "total_tokens": 1893
      },
      "error": null
    },
    {
      "question_id": 193,
      "question": "How does UNH's use of interest rate swaps to manage exposure to floating-rate liabilities compare with AMGN's use of similar instruments in relation to their respective $1.4 billion repayments of the 3.625% 2024 Notes?",
      "original_answer": "UNH uses interest rate swaps as part of its broader strategy to manage exposure to market interest rate fluctuations on both assets and liabilities, including $27 billion of floating-rate financial liabilities as of December 31, 2024. AMGN, on the other hand, specifically entered into interest rate swap contracts to convert fixed-rate coupons to floating-rate SOFR-based coupons, with $1.4 billion of such swaps maturing in 2024 in connection with the repayment of the 3.625% 2024 Notes. While both companies use interest rate swaps, UNH's application is broader in scope across its balance sheet, whereas AMGN's use is directly tied to specific debt instruments like the 3.625% 2024 Notes that were fully repaid in 2024.",
      "llm_answer": "UnitedHealth Group uses interest‑rate swaps as a broad risk‑management tool – it matches a portion of its $27 billion of floating‑rate liabilities with floating‑rate assets “either directly or through the use of interest‑rate swap contracts” to dampen overall exposure, but the swaps are not tied to a single debt issue 【page_38】. Amgen, by contrast, entered into $1.4 billion of interest‑rate swap contracts that converted the fixed‑rate coupons on its 3.625 % 2024 Notes to floating‑rate (SOFR‑based) coupons, and those swaps matured when the $1.4 billion of notes were repaid 【page_148】【page_149】【page_142】. Thus UNH’s swaps are a general hedge of floating‑rate debt, whereas Amgen’s swaps were a targeted hedge that was unwound at the repayment of the specific $1.4 billion 3.625 % notes.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate and semantically equivalent to the ground truth. (1) All key facts are correct: UNH has $27 billion in floating-rate liabilities and uses swaps broadly across its balance sheet; AMGN used $1.4 billion in swaps tied specifically to the 3.625% 2024 Notes, which matured in 2024. (2) Quantitative accuracy is perfect: dollar amounts ($27 billion, $1.4 billion), interest rate (3.625%), and index (SOFR) match the original. The timing (maturity in 2024) and purpose (conversion from fixed to floating) are correctly stated. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across two companies, their distinct use cases for interest rate swaps, and links AMGN’s swap maturity to the repayment of a specific debt instrument. (4) The comparison is well-articulated—UNH’s general, portfolio-level risk management vs. AMGN’s targeted, debt-specific hedging—and directly addresses the comparative aspect of the question. Citations to page numbers further support the accuracy. No factual errors, omissions, or misinterpretations are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 311,
        "total_tokens": 1708
      },
      "error": null
    },
    {
      "question_id": 194,
      "question": "How does the potential acceleration of AMD's 3.924% Senior Notes Due 2032 in the event of an 'Event of Default' compare with Oracle's exposure to similar default-triggered obligations under their Revolving Credit Agreement, particularly in terms of debt repayment structure and maturity conditions?",
      "original_answer": "AMD's 3.924% Senior Notes Due 2032 could be accelerated upon an Event of Default, which would require AMD to repay $1.0 billion in aggregate principal issued in 2022, plus accrued interest. Oracle, under its Revolving Credit Agreement, also faces potential acceleration if an Event of Default occurs, with the full $6.0 billion facility becoming due unless terminated earlier. Unlike AMD's notes, which are unsecured senior obligations, Oracle's Revolving Facility allows borrowing, prepayment, and reborrowing until March 8, 2027, with interest rates tied to credit ratings. Both companies face significant financial obligations upon default, but Oracle's structure allows more flexibility in managing short-term liquidity.",
      "llm_answer": "AMD’s 3.924 % Senior Notes due 2032 contain an “event of default” clause that would accelerate the notes, making the entire principal amount and accrued interest payable immediately rather than on the scheduled 2032 maturity (AMD 10‑K p. 79). By contrast, Oracle’s $6 billion revolving credit facility matures on March 8 2027, but the agreement provides that, upon an event of default, the lenders may terminate the facility and demand immediate repayment of any outstanding borrowings, effectively accelerating a flexible, revolving loan rather than a fixed‑date note (Oracle 10‑K p. 88).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between AMD's and Oracle's debt obligations upon an Event of Default. (1) All key facts are correct: AMD's 3.924% Senior Notes due 2032 can be accelerated, requiring immediate repayment of principal and accrued interest (ground truth: $1.0 billion issued in 2022); Oracle's $6.0 billion revolving credit facility can be accelerated upon default, with maturity on March 8, 2027. These numbers, dates, and dollar amounts match the ground truth exactly. (2) Quantitative accuracy is perfect: $6 billion for Oracle, 2027 maturity, 2032 maturity for AMD—all correct. While the LLM does not explicitly state the $1.0 billion principal for AMD, this is implied as the 'entire principal amount' of the notes, and the omission is minor given the focus on structural comparison. (3) The reasoning is sound: the LLM correctly identifies that AMD’s obligation is a fixed-term note with acceleration upon default, while Oracle’s is a revolving facility allowing borrowing and repayment flexibility until maturity, with acceleration possible upon default. It correctly contrasts the structural differences in repayment and maturity conditions. (4) The answer is contextually relevant and directly addresses the question’s focus on acceleration, repayment structure, and maturity conditions. The only minor gap is the lack of explicit mention that Oracle’s interest rates are tied to credit ratings and that AMD’s notes are unsecured—details present in the ground truth—but these do not undermine the core accuracy. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the original answer.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1366,
        "completion_tokens": 455,
        "total_tokens": 1821
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How does the $31.0 billion of trust assets under reinsurance agreements at GE, which are subject to strict investment guidelines, compare to General Dynamics' $191 million in marketable securities held in trust as of December 31, 2021, in terms of investment policy and risk exposure?",
      "original_answer": "GE holds $31.0 billion in trust assets associated with reinsurance contracts and is subject to strict investment guidelines that include limitations on asset class concentration, issuer exposure, and duration variances, with a focus on diversification and credit quality while considering risk-based capital requirements. These trust assets are managed to support insurance liabilities and are reviewed periodically for asset allocation changes, including the potential inclusion of non-traditional asset classes. In contrast, General Dynamics held $191 million in marketable securities in trust as of December 31, 2021, governed by an investment policy that restricts purchases to investment-grade fixed-income securities with a maximum maturity of five years, indicating a more conservative and short-duration approach. This highlights a significant difference in scale and investment strategy between the two companies' trust asset management, with GE facing broader credit, interest rate, and reinvestment risks due to the larger and more diverse asset base.",
      "llm_answer": "GE’s run‑off insurance trusts hold about **$31 billion** of assets (page 50) that are managed under **strict investment guidelines** limiting asset‑class concentration, single‑issuer exposure and duration, and that deliberately diversify across credit‑quality, yield, liquidity and even non‑traditional assets such as private‑equity and infrastructure (page 48). This large pool is therefore exposed to **credit, interest‑rate and equity risks**.  \n\nGeneral Dynamics, by contrast, held only **$191 million** of marketable securities in trust at year‑end 2021 (page 52), and its **investment policy** restricts purchases to **investment‑grade fixed‑income securities with maturities of five years or less**, resulting in a much narrower, low‑risk, short‑duration debt exposure.  \n\nThus, GE’s trust assets are over 150‑times larger and subject to a broader, risk‑ier investment framework, while GD’s trust holdings are modest and confined to low‑risk, short‑term debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and closely matches the ground truth in both quantitative and qualitative aspects. (1) All numbers are correct: $31.0 billion for GE and $191 million for General Dynamics as of December 31, 2021, with appropriate context. The comparison stating GE's assets are 'over 150-times larger' is accurate (31,000 / 191 ≈ 162x), and format variations ($31 billion vs $31.0 billion) are acceptable. (2) The investment policies are correctly described: GE’s strict guidelines include diversification across asset classes, credit quality, and inclusion of non-traditional assets like private equity and infrastructure, which aligns with the original answer’s mention of 'potential inclusion of non-traditional asset classes'. General Dynamics’ restriction to investment-grade fixed-income securities with maturities of five years or less is accurately reported. (3) Multi-hop reasoning is sound—information from two different companies and filings is correctly synthesized to compare scale, investment policy, and risk exposure. The conclusion about GE facing broader credit, interest rate, and equity risks due to larger and more diverse holdings is logically derived and consistent with the ground truth. (4) Minor deduction in qualitative accuracy because the LLM answer does not explicitly mention GE’s alignment with risk-based capital requirements or periodic asset allocation reviews, which are part of the original answer and relevant to investment policy depth. However, the core reasoning and risk characterization remain intact. Overall, the answer is factually correct, well-structured, and contextually complete.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1541,
        "completion_tokens": 448,
        "total_tokens": 1989
      },
      "error": null
    },
    {
      "question_id": 195,
      "question": "How do the observable market data inputs used in Lockheed Martin's fixed income pricing models compare to the inputs used in PayPal's derivative valuations, given both institutions rely on Level 2 pricing methodologies?",
      "original_answer": "Lockheed Martin's fixed income investments categorized as Level 2 are valued using pricing models that incorporate verifiable observable market data such as interest rates, yield curves at commonly quoted intervals, and credit spreads. Similarly, PayPal values a majority of its derivative instruments using pricing models that consider observable inputs like currency rates, interest rate yield curves, option volatility, and equity prices. Both institutions rely on Level 2 methodologies, indicating a shared dependence on observable market factors to determine fair value, although applied to different asset classes—fixed income for Lockheed Martin and derivatives for PayPal.",
      "llm_answer": "Lockheed Martin’s Level‑2 fixed‑income pricing models rely on verifiable observable market data such as current interest‑rate and yield‑curve levels, credit spreads and broker/dealer bids (see LMT page 89). PayPal’s Level‑2 derivative valuations also use observable inputs, but they draw on a broader set—including currency exchange rates, interest‑rate yield curves, option‑price volatilities and equity prices—along with comparable‑instrument quotes (see PYPL pages 93‑94).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual information is correct: Lockheed Martin uses observable inputs like interest rates, yield curves, credit spreads, and broker/dealer bids for its Level 2 fixed income valuations; PayPal uses observable inputs such as currency exchange rates, interest rate yield curves, option volatility, and equity prices for its Level 2 derivative valuations. These match the original answer, with only minor additional detail (e.g., broker/dealer bids, comparable-instrument quotes) that are consistent with Level 2 methodology and plausible per SEC filings. (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable in a numerical sense, but all qualitative data points are correctly represented. (3) The multi-hop reasoning is sound—correctly identifying both companies, their respective asset classes (fixed income vs. derivatives), and the nature of observable inputs used, while noting the commonality of Level 2 classification. The LLM appropriately compares the breadth of inputs (suggesting PayPal’s are broader), which is a reasonable inference. (4) The answer is contextually relevant and fully addresses the comparative aspect of the question. The only reason for not scoring a 10 is that the original answer emphasizes the shared reliance on observable data despite different asset classes, which the LLM implies but does not explicitly summarize in the same synthesizing way. However, all key elements are present. Minor enhancement in synthesis phrasing would make it perfect.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1307,
        "completion_tokens": 445,
        "total_tokens": 1752
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to the impact of CSCO's interest rate swap on their fixed-rate debt, given both companies' exposure to market interest rate fluctuations?",
      "original_answer": "AVGO's $56.3 billion in fixed rate senior notes as of November 3, 2024, would see a $1.7 billion change in fair value with a 50 basis point interest rate shift, while CSCO has an interest rate swap with a notional amount of $0.5 billion that converts a portion of its fixed-rate debt to floating, offsetting changes in fair value due to interest rate movements. CSCO’s swap specifically hedges a senior note due in fiscal 2025, whereas AVGO uses treasury rate lock contracts to hedge anticipated future debt issuances, indicating differing hedging strategies despite both managing interest rate risk on fixed-rate debt.",
      "llm_answer": "Broadcom (AVGO) reports that a 50‑basis‑point move in market rates would change the fair value of its $56.3 billion of fixed‑rate senior notes by about $1.7 billion, showing a direct sensitivity to interest‑rate fluctuations. Cisco (CSCO) mitigates a similar exposure by using an interest‑rate swap that converts the fixed‑rate interest on a portion of its senior notes to floating; the swap’s gain or loss “substantially offsets” the fair‑value change of the hedged debt, effectively neutralizing the impact of rate changes on that portion of its fixed‑rate debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core comparison between AVGO's interest rate sensitivity and CSCO's hedging strategy. (1) All key facts are correct: AVGO's $56.3 billion in fixed-rate senior notes and the $1.7 billion fair value change for a 50 basis point rate shift are accurately reported. CSCO's use of a $0.5 billion notional interest rate swap to convert fixed-rate debt to floating is also correct, as is its purpose of offsetting fair value changes. (2) Quantitatively, all numbers match the ground truth exactly—$56.3B, $1.7B, 50 bps—though the LLM omits the specific mention of the $0.5 billion notional amount, instead referring generally to 'a portion' of senior notes. This is a minor omission but does not distort the meaning. (3) The multi-hop reasoning is sound: the LLM correctly contrasts AVGO’s direct exposure with CSCO’s offsetting hedge via swaps, highlighting differing risk management strategies. However, it omits two contextual details from the original: the fiscal 2025 maturity of CSCO’s hedged note and AVGO’s use of treasury rate locks for future debt issuances. These omissions reduce completeness slightly but do not affect the core correctness. (4) The answer remains semantically equivalent in conveying that AVGO has direct sensitivity while CSCO neutralizes part of its exposure via swaps. The response is fully relevant and well-structured for the question asked.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1316,
        "completion_tokens": 391,
        "total_tokens": 1707
      },
      "error": null
    },
    {
      "question_id": 196,
      "question": "How does BMY's joint research and commercialization obligations with Pfizer under the Eliquis alliance compare to Pfizer's financial commitments in its collaboration with Beam for in vivo base editing programs, particularly in terms of upfront payments and potential milestone obligations?",
      "original_answer": "BMY and Pfizer share joint research and commercialization responsibilities under the Eliquis alliance, with Pfizer receiving co-exclusive license rights in exchange for an upfront payment and potential milestone payments, which are being amortized over BMY’s co-promotion obligation period. Separately, Pfizer paid Beam $300 million upfront upon entering their collaboration for in vivo base editing programs and may pay up to an additional $1.05 billion in development, regulatory, and commercial milestone payments across three targets, for a total potential deal value of $1.35 billion. This shows that Pfizer’s financial commitment to Beam could significantly exceed its initial payments under the Eliquis alliance, depending on development progress and milestone achievements.",
      "llm_answer": "BMS’s Eliquis alliance with Pfizer is framed as a co‑promotion and joint‑development partnership in which the two companies share research, development, distribution, sales and marketing responsibilities; the filing notes an upfront payment and contingent milestone proceeds that are recorded as deferred income and amortized, but no dollar amounts are disclosed【page_86】. By contrast, Pfizer’s collaboration with Beam required a $300 million upfront payment and, if all options are exercised, could trigger up to $1.05 billion in development, regulatory and commercial milestones (total potential consideration of $1.35 billion)【page_76】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: the $300 million upfront, $1.05 billion in potential milestones, and total $1.35 billion potential deal value for the Pfizer-Beam collaboration are accurately reported. The absence of disclosed dollar amounts for the Eliquis alliance upfront and milestones is correctly noted. (2) The LLM correctly identifies that BMY (BMS) and Pfizer have joint responsibilities in research and commercialization under the Eliquis alliance, and that Pfizer made an upfront payment with milestone obligations that are amortized—consistent with the original answer. (3) The multi-hop reasoning is sound: the model contrasts the non-disclosed financials of the Eliquis alliance with the fully specified, substantial financial commitments in the Beam deal, effectively highlighting that Pfizer’s potential financial exposure to Beam far exceeds what is publicly known from the Eliquis arrangement. (4) The only minor shortcoming is a slight lack of explicit comparison language (e.g., 'this suggests Pfizer’s commitment to Beam may exceed that to Eliquis'), though the contrast is clearly implied by the presentation. Wording differences do not affect semantic accuracy. All entities (BMS, Pfizer, Beam), financial terms (upfront, milestones, amortization), and contextual details (co-promotion, in vivo base editing) are correct. The answer is fully relevant and responsive to the multi-part, cross-entity question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 415,
        "total_tokens": 1806
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How do Texas Instruments' accounting practices for lease extension and termination options compare with Cisco's treatment of similar provisions in their customer financing arrangements, particularly regarding the impact on long-term liabilities and revenue recognition?",
      "original_answer": "Texas Instruments accounts for lease extension and termination options by recognizing lease assets and liabilities based on the present value of lease payments when it is reasonably certain they will be exercised, using their incremental borrowing rate. This affects long-term liabilities on their balance sheet. Cisco, on the other hand, includes similar extension and termination provisions in its customer financing arrangements, which are primarily collateralized and affect the timing of revenue recognition. Cisco also defers revenue on arrangements involving guarantees until the risk is removed. Both companies incorporate these options into their financial reporting, but with different implications: TXN affects liability valuation, while CSCO affects revenue timing and credit exposure.",
      "llm_answer": "Texas Instruments (see TXN 10‑K p. 35) includes any extension or termination options that are “reasonably certain” to be exercised in the lease term, so the present‑value of those payments is recorded as a lease liability on the balance sheet and lease expense is recognized on a straight‑line basis over the (potentially extended) term. Cisco (see CSCO 10‑K p. 52) treats comparable options in its customer‑financing leases as part of financing receivables and guarantees – it either defers the related revenue or records a liability for the fair‑value of the guarantee and recognizes the revenue only when the guarantee is removed, rather than increasing a long‑term lease liability.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies Texas Instruments' (TXN) accounting for lease extension and termination options when 'reasonably certain' to be exercised, incorporating the present value of lease payments into lease liabilities—this matches the original answer's description of TXN's impact on long-term liabilities. The use of incremental borrowing rate is implied in the reference to present value, though not explicitly mentioned, which is a minor omission. (2) For Cisco (CSCO), the LLM correctly states that similar options in customer financing arrangements are treated as part of financing receivables and guarantees, with revenue deferred or a liability recorded for the fair value of the guarantee. It accurately captures that Cisco’s approach affects revenue recognition timing rather than increasing long-term lease liabilities, consistent with the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies and two distinct accounting treatments—leases (TXN) vs. customer financing/guarantees (CSCO)—and correctly contrasts their impacts on liabilities vs. revenue. (4) The answer cites specific 10-K pages (p. 35 for TXN, p. 52 for CSCO), adding verifiability, though these are not part of the ground truth and cannot be independently validated here; however, they do not detract from accuracy. The only minor shortcoming is the lack of explicit mention of 'collateralized' arrangements for Cisco and the incremental borrowing rate for TXN, which are present in the original answer but not critical to the core comparison. All entities (TXN, CSCO), financial concepts (lease liabilities, revenue deferral, guarantees), and implications are correctly identified. Wording differs but semantic meaning is equivalent. Quantitative accuracy is perfect—no numerical errors. Contextual relevance is excellent, directly addressing all parts of the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1401,
        "completion_tokens": 532,
        "total_tokens": 1933
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does Disney's 73% stake in National Geographic influence the content differentiation strategy on Disney+, and what implications does this have for subscriber acquisition costs relative to YouTube's content licensing model?",
      "original_answer": "Disney's 73% stake in National Geographic allows it to integrate National Geographic-branded programming directly into Disney+ as a top-level tile within the interface, providing exclusive access to content that is not subject to third-party licensing fees (chunk 1 and chunk 2). This vertical integration reduces dependency on external content providers and lowers long-term content acquisition costs. In contrast, YouTube, as a digital video service competitor, relies more heavily on licensed and third-party content, which may involve ongoing licensing expenditures (chunk 3). This structural advantage could give Disney+ a cost edge in subscriber acquisition by leveraging proprietary content like National Geographic to attract and retain users at a lower marginal cost than YouTube.",
      "llm_answer": "Disney’s 73 % ownership of National Geographic gives it control of the National Geographic brand and its documentary library, which is presented as a dedicated “National Geographic” tile on Disney+ and therefore provides a distinctive, in‑house content pillar that sets the service apart from competitors (DIS 10‑K page 78; DIS 10‑K page 12). Because this content is owned rather than licensed, Disney can acquire subscribers at a lower cost than YouTube, which must license third‑party programming and bears higher traffic‑acquisition (TAC) expenses to attract users (GOOG 10‑K page 4 on TAC; GOOG 10‑K page 7 on YouTube non‑advertising).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, the 73% ownership stake is correctly stated, and no other numerical values (e.g., dollar amounts, years) are misreported. Format variations (e.g., '73 %' with space) are minor and do not affect correctness. (2) The answer correctly identifies Disney's ownership of National Geographic and its strategic use as a top-level tile on Disney+, which supports content differentiation—this matches the original answer's claim about exclusive access and interface placement. It also correctly contrasts Disney+'s lower content acquisition costs due to ownership with YouTube's reliance on licensed content and higher traffic acquisition costs (TAC), citing relevant 10-K pages. (3) The multi-hop reasoning is sound: it connects Disney’s ownership stake → control of content → cost-efficient differentiation on Disney+ → competitive advantage in subscriber acquisition costs vs. YouTube’s licensing model. The only minor shortcoming is that the LLM answer references 'traffic-acquisition costs (TAC)' for YouTube, which, while accurate in Google’s filings, refers more broadly to user acquisition via ads and distribution, not strictly content licensing. The original answer focuses on licensing expenditures as a direct cost driver, whereas the LLM shifts slightly to TAC, which is related but not identical. This nuance slightly weakens the qualitative accuracy but does not invalidate the core argument. (4) All entities—Disney (DIS), Google/YouTube (GOOG), National Geographic, Disney+, and correct 10-K page citations—are accurately referenced. The answer is contextually fully relevant, addressing both content differentiation and cost implications. Overall, the answer is factually correct, well-reasoned, and semantically equivalent to the ground truth with only a slight imprecision in framing YouTube's cost structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1377,
        "completion_tokens": 514,
        "total_tokens": 1891
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does the impact of regulatory exclusivity expiration timelines on BMY's biologic products compare to MRK's experience with Januvia family market exclusivity delays, considering the role of regulatory exclusivity in extending market protection beyond patent terms?",
      "original_answer": "BMY's biologic products, such as Opdivo and Yervoy, benefit from 12 years of regulatory exclusivity in the U.S., which prevents the FDA from approving biosimilars until 12 years after initial approval. This regulatory exclusivity can extend beyond patent terms and provide additional market protection. In contrast, MRK's Januvia family of products saw their key U.S. patent expire in January 2023, but due to favorable court rulings and settlement agreements on a later-expiring salt-form patent, MRK expects to maintain market exclusivity until May 2026 for Januvia and Janumet and July 2026 for Janumet XR. This shows that while BMY relies on the standard 12-year biologic exclusivity framework, MRK was able to extend market exclusivity for its chemical products through litigation and secondary patents, highlighting different strategies and outcomes tied to regulatory exclusivity mechanisms.",
      "llm_answer": "BMY’s biologics are shielded by a statutory 12‑year regulatory exclusivity that automatically extends market protection beyond the life of any patents, giving products such as Opdivo (protected until 2028), Yervoy (until 2025) and others a multi‑year, predictable barrier to biosimilar entry (see BMY 10‑K p.7 & p.9). Merck’s Januvia/Janumet family, by contrast, has only delayed U.S. loss of exclusivity to May/July 2026 through a later‑expiring salt‑form patent and settlement agreements—a patent‑driven extension rather than a regulatory exclusivity period (see MRK 10‑K p.58). Thus BMY’s biologics enjoy a longer, regulatory‑based protection horizon, whereas Merck’s delay is a shorter, product‑specific patent postponement of generic competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth, with only minor discrepancies in date specificity. (1) Quantitatively, the LLM correctly identifies the 12-year U.S. regulatory exclusivity for BMY's biologics and the May/July 2026 exclusivity extension for MRK's Januvia family. However, it incorrectly states Yervoy’s protection until 2025 and Opdivo until 2028 without clarifying these are likely patent-based or first-approval-based timelines; the ground truth does not specify exact expiration years, so adding them introduces unsupported precision. (2) The answer correctly contrasts BMY’s reliance on statutory regulatory exclusivity with MRK’s use of secondary patents and settlements—this synthesis across companies and mechanisms is accurate and complete. (3) The reasoning is sound: it distinguishes between regulatory exclusivity (automatic, time-based) and patent-based extensions (litigation/settlement-driven), which directly addresses the question’s focus on differing strategies. (4) Contextually, the response is fully relevant, citing appropriate sections of 10-Ks and focusing on the comparison of exclusivity mechanisms. The only deduction is for introducing specific end dates not present in the ground truth, which could mislead if those dates are inaccurate. Overall, the answer demonstrates strong multi-hop reasoning and semantic equivalence.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 389,
        "total_tokens": 1831
      },
      "error": null
    },
    {
      "question_id": 197,
      "question": "How does MetLife's issuance of 40,000 shares of Series F preferred stock, with redemption terms tied to a 'rating agency event,' intersect with AIG's exposure to financial risks from potential rating downgrades, particularly given AIG's acknowledgment that a downgrade could limit its ability to write new business and impair customer retention?",
      "original_answer": "MetLife has issued 40,000 shares of Series F preferred stock, which includes a redemption clause triggered by a 'rating agency event'—defined as a change in rating criteria that lowers equity credit assigned to such securities. This creates a financial contingency for MetLife should credit agencies revise their treatment of these instruments. Similarly, AIG acknowledges in its 10-K that a downgrade in its Insurer Financial Strength ratings could materially impair its ability to write new business and retain customers. Therefore, both companies face strategic and operational risks tied to rating agency actions, with MetLife facing potential redemption obligations and AIG facing direct business constraints due to a potential loss of creditworthiness.",
      "llm_answer": "MetLife’s 4.75 % non‑cumulative Series F preferred stock – of which 40,000 shares were issued – can be redeemed by the company “within 90 days after the occurrence of a ‘rating agency event’” that lowers the equity credit assigned to the security (MetLife Note 19 and redemption clause)【page_262】【page_264】. AIG explicitly states that a downgrade by rating agencies could “limit their ability to write new business and impair their retention of customers” and would adversely affect its financial condition and liquidity【page_85】. Thus, a rating‑agency downgrade could simultaneously trigger MetLife’s redemption obligation on the Series F shares and exacerbate AIG’s operational and liquidity risks, linking both companies’ exposure to rating‑agency actions.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and terms are correct: 40,000 shares of Series F preferred stock, the 'rating agency event' triggering redemption within 90 days, and the 4.75% non-cumulative dividend rate are all factually consistent with MetLife's disclosures. The citation of specific pages (e.g., page 262, 264 for MetLife; page 85 for AIG) supports accuracy. (2) The answer correctly identifies both companies, the nature of the financial instruments, and the risk exposure to rating agencies. (3) The multi-hop reasoning is sound: it connects MetLife’s contingent redemption obligation to a rating agency event with AIG’s operational risks from downgrades, synthesizing cross-company implications of credit rating actions. (4) The only minor shortcoming is the addition of the 4.75% dividend detail, which, while likely accurate, is not present in the ground truth and slightly extends beyond the provided context. However, this does not detract from correctness. The core logic—that both firms face distinct but parallel risks from rating agency actions—is preserved and well-articulated. Semantic equivalence is maintained, with appropriate flexibility in wording. All parts of the question are addressed with high fidelity.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 363,
        "total_tokens": 1792
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does the use of matrix pricing for U.S. Government Securities differ between LMT's portfolio as of December 31, 2021, and UPS's valuation methodology for similar assets, based on their respective Level 2 classifications?",
      "original_answer": "LMT reported $121 million in U.S. Government Securities as of December 31, 2021, which were classified under Level 2 inputs, indicating they were valued using matrix pricing or similar methods when broker quotes were unavailable. UPS also utilized matrix pricing for Level 2 marketable securities, including U.S. government debt, though the specific amount was not disclosed. Both companies rely on matrix pricing as a fallback when direct market data is not available, aligning with the broader accounting policy described by MO, which lists matrix pricing as a standard valuation technique for government securities when broker quotes are absent.",
      "llm_answer": "Lockheed Martin discloses that its U.S. (and foreign) government‑security holdings are valued using “matrix pricing, yield curves and indices when broker quotes are not available,” which places those securities in the Level 2 fair‑value hierarchy 【page_115】. United Parcel Service, by contrast, reports all of its U.S. government and agency debt securities at Level 1 (quoted market prices) with a $0 Level 2 amount, so matrix pricing is not used for those assets 【page_89】.  Consequently, LMT relies on observable‑input models (matrix pricing) for some government bonds, while UPS values its government securities solely on active‑market quotes.",
      "correctness_score": 3,
      "quantitative_accuracy": 2,
      "qualitative_accuracy": 3,
      "contextual_relevance": 6,
      "detailed_feedback": "The LLM answer contains significant factual inaccuracies that undermine its correctness. (1) Quantitatively, the LLM incorrectly states that UPS reports $0 in Level 2 U.S. government and agency debt securities, directly contradicting the ground truth which confirms UPS uses matrix pricing for Level 2 marketable securities including U.S. government debt. No dollar amount is disclosed for UPS in the ground truth, but the claim of $0 Level 2 classification is unsupported and incorrect based on the provided truth. (2) The ground truth states both LMT and UPS use matrix pricing for Level 2 classification when broker quotes are unavailable, but the LLM claims UPS uses only Level 1 pricing with no Level 2 allocation, which is a fundamental error. (3) The qualitative reasoning is flawed: the LLM draws a sharp contrast between LMT and UPS, asserting UPS relies solely on active-market quotes, while the original answer emphasizes alignment in methodology—both use matrix pricing as a fallback. This misrepresents the comparative analysis required by the multi-hop question. (4) Contextual relevance is moderate because the answer addresses valuation methods and Level 2 classification, but the erroneous characterization of UPS’s methodology invalidates the core comparison. Semantic equivalence fails due to this key factual divergence. Minor positive: LMT’s use of matrix pricing and Level 2 classification is correctly described.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1343,
        "completion_tokens": 394,
        "total_tokens": 1737
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does PM's use of market inputs for derivative valuations compare to MDLZ's approach for its real estate fund investments, given the differing levels of observability in their respective valuation models?",
      "original_answer": "PM values its derivative contracts using standard valuation models based on readily observable market inputs such as foreign exchange spot rates, interest rate differentials, and maturity dates. In contrast, MDLZ values its real estate fund investments using the present value of future cash flows, relying on unobservable inputs like projected operating performance and local market conditions. While PM's approach falls under Level 1 or 2 fair value measurements due to the use of observable data, MDLZ's real estate fund valuations are categorized as Level 3 due to the reliance on unobservable inputs that cannot be corroborated by market data.",
      "llm_answer": "PMI values its derivatives with standard models that rely on readily observable market data—spot FX rates, interest‑rate differentials, volatilities and futures prices—and classifies those contracts as Level 2 fair‑value measurements【page_128】. Mondelēz, by contrast, values its real‑estate fund holdings using Level 2 inputs that come from net‑asset‑value calculations based on manager‑reported unit prices, recent purchase‑sale transaction data and appraisal‑derived cash‑flow projections rather than direct market quotes【page_104】. Thus PMI’s valuations are driven by observable market prices, while MDLZ’s real‑estate valuations depend on derived NAV and appraisal information that is less directly observable.",
      "correctness_score": 4,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 4,
      "contextual_relevance": 7,
      "detailed_feedback": "The LLM answer contains some correct elements but has a critical factual error in the classification of MDLZ's valuation level, which undermines the core comparison. (1) Quantitatively, no specific numbers (e.g., dollar amounts, percentages) are incorrect because none were cited—this avoids inaccuracy but does not compensate for missing key qualitative distinctions. The mention of observable inputs for PMI (FX rates, interest-rate differentials, etc.) aligns with the ground truth and is correctly classified as Level 2, which is consistent (Level 1/2 in original allows for Level 2 designation). (2) However, the LLM incorrectly states that MDLZ’s real estate fund valuations use Level 2 inputs based on NAV calculations and transaction data. The ground truth explicitly states that MDLZ uses unobservable inputs like projected operating performance and local market conditions, categorizing these as Level 3 fair value measurements. This is a major qualitative error: Level 2 implies significant observable inputs, while Level 3 relies on unobservable data, which is the central contrast in the question. (3) The multi-hop reasoning fails because the comparison hinges on the difference in observability—PM uses observable (Level 1/2), MDLZ uses unobservable (Level 3). By misclassifying MDLZ as Level 2, the LLM erases this key distinction and misrepresents the nature of the inputs (appraisal-derived projections are still unobservable if not corroborated). (4) Contextually, the answer addresses the right entities (PM/MDLZ), valuation methods, and general contrast between market-based vs. derived inputs, so relevance is fair. However, due to the incorrect fair value level assignment for MDLZ and the resulting flawed synthesis, the overall correctness is significantly reduced. Minor note: 'PMI' is used instead of 'PM', but this is semantically acceptable.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 503,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 198,
      "question": "How does MetLife's repayment strategy for its junior subordinated debentures compare to AIG's obligations under the AIGLH-issued junior subordinated debentures, particularly in terms of liquidity constraints and deferral provisions?",
      "original_answer": "MetLife has provisions allowing it to defer interest payments on its junior subordinated debentures under certain conditions, which in turn triggers dividend stopper provisions. Additionally, MetLife is subject to replacement capital covenants that require it to raise specified replacement securities before repaying, redeeming, or purchasing the debentures. In contrast, AIG's obligations under the AIGLH-issued junior subordinated debentures include specific maturities such as $54 million of 8.5% debentures due in 2030, $142 million of 8.125% debentures due in 2046, and $31 million of 7.57% debentures due in 2045, all of which are guaranteed by AIG Parent. However, AIG does not guarantee any of the borrowings of AIGLH post-distribution of debentures, indicating a different liquidity risk profile compared to MetLife's structured repayment and deferral constraints.",
      "llm_answer": "MetLife’s junior subordinated debentures include an elective‑interest‑deferral feature – the company may postpone interest payments, but doing so triggers the “dividend stopper” and, under its replacement‑capital covenants, MetLife can only repay or redeem the notes after it first receives cash proceeds from the sale of designated replacement securities (MetLife 10‑K p. 130). AIG’s AIGLH junior subordinated debentures, by contrast, are ordinary guaranteed debt with fixed maturities and interest rates and contain no such deferral right; AIG’s ability to service these obligations is limited mainly by regulatory restrictions that lock up about $43.3 billion of statutory capital and surplus, preventing easy transfer of liquidity to the parent (AIG 10‑K p. 290; p. 303).",
      "correctness_score": 8,
      "quantitative_accuracy": 7,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly captures the core differences in repayment strategy and deferral provisions between MetLife and AIG. It accurately describes MetLife's deferral rights, dividend stopper, and replacement capital covenants, and contrasts them with AIG's fixed-maturity debentures without deferral rights. However, it omits the specific dollar amounts and interest rates of AIGLH's debentures ($54M at 8.5% due 2030, $142M at 8.125% due 2046, $31M at 7.57% due 2045), which are key quantitative details in the ground truth. Instead, it introduces a figure of $43.3 billion in statutory capital and surplus restrictions from AIG’s 10-K, which, while contextually relevant to liquidity constraints, is not directly tied to the AIGLH debentures and was not in the original answer. (2) The omission of the exact debenture amounts and maturities reduces quantitative accuracy. The $43.3 billion figure, though cited from AIG’s 10-K, is not part of the ground truth comparison and may conflate broader liquidity constraints with the specific obligations of AIGLH. (3) The multi-hop reasoning is strong: the model correctly synthesizes information across MetLife and AIG’s 10-Ks, identifies the structural differences in deferral rights and repayment mechanisms, and draws a valid contrast in liquidity risk profiles. The logic and entity identification (MetLife, AIG, AIGLH, junior subordinated debentures) are accurate. (4) The answer is contextually excellent and semantically close to the original, but the absence of specific AIGLH debenture details and introduction of an extraneous $43.3B figure prevent a top score. Correctness is high due to accurate conceptual comparison, but not fully complete on quantitative specifics.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1433,
        "completion_tokens": 475,
        "total_tokens": 1909
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does NVIDIA's competitive positioning against Samsung in the SoC and GPU markets influence Intel's strategic challenges in scaling its IFS Foundry Services, particularly given Intel's historical manufacturing delays and competitive pressures?",
      "original_answer": "NVIDIA competes with Samsung in the SoC and GPU markets, which are critical to automotive, gaming, and accelerated computing applications. Samsung is also a key competitor to Intel's IFS Foundry Services, which Intel established as part of its IDM 2.0 strategy to become a major foundry provider. Intel highlights that IFS must compete with established players like Samsung on multiple fronts including time-to-market, process performance, and ecosystem support. However, Intel's history of manufacturing delays, such as the setbacks with its 10nm and Intel 4 (formerly 7nm) process technologies, creates a disadvantage compared to Samsung's mature foundry capabilities. These delays have already impacted Intel's product competitiveness and gross margins, and could hinder IFS's ability to attract customers in a market where timely access to advanced processes is critical. Therefore, NVIDIA's competitive pressure on Samsung indirectly affects Intel's ability to scale IFS, as Samsung remains a dual threat both in end-product markets and in the underlying manufacturing ecosystem.",
      "llm_answer": "NVIDIA lists Samsung as a key SoC rival and also competes with Samsung’s GPU offerings, showing that the two firms vie for the same high‑performance, integrated‑compute markets (NVDA 10‑K p.15). Intel’s IFS must win business from those same customers, yet Intel’s filing notes that its IDM‑2.0 rollout has been hampered by historic process‑node delays and that its foundry unit now competes directly with Samsung (and TSMC) on capacity, time‑to‑market, performance‑per‑watt and yield (INTC 10‑K p.53‑54). Consequently, NVIDIA’s strong positioning against Samsung raises the performance and timing bar Intel must meet, intensifying the strategic challenge of scaling IFS amid past manufacturing setbacks and fierce foundry competition.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the original (ground truth) answer. (1) All factual elements are correct: NVIDIA competes with Samsung in SoC and GPU markets, Intel's IFS competes with Samsung in foundry services, Intel faces challenges due to historical manufacturing delays (e.g., 10nm, Intel 4), and these delays impact IFS's ability to scale. The mention of 'IDM 2.0' and competition on time-to-market, performance-per-watt, yield, and capacity matches the original. (2) There are no numeric values, dates, or financial figures in either answer, so quantitative accuracy is not applicable—no discrepancies exist. (3) The multi-hop reasoning is sound: the LLM correctly infers that NVIDIA’s competitive pressure on Samsung raises the bar for performance and timing, which indirectly increases the challenge for Intel’s IFS to attract customers. This reflects the indirect competitive dynamic described in the ground truth. (4) The only minor shortcoming is that the LLM does not explicitly state that Samsung is a 'dual threat' (in both end-product and foundry markets), a nuance emphasized in the original answer. However, this concept is implied in the synthesis. The LLM also cites specific 10-K page numbers (p.15 for NVDA, p.53–54 for INTC), which adds credibility and precision, even though the ground truth does not include citations. Overall, the answer is semantically equivalent, contextually relevant, and factually correct with only a slight omission of emphasis on Samsung’s dual role—hence a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1479,
        "completion_tokens": 430,
        "total_tokens": 1910
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "Given that Alphabet repurchased $62.0 billion in Class A and Class C shares in 2024, how does the difference in voting rights between Class A and Class B shares at both Alphabet and Comcast impact their respective share repurchase strategies, particularly in light of Comcast's concentrated ownership of Class B shares by a single individual?",
      "original_answer": "Alphabet's share repurchase strategy in 2024 focused on Class A and Class C shares, with $62.0 billion repurchased, while maintaining the balance between voting classes since Class B shares automatically convert to Class A upon sale. This preserves the concentrated voting power of Class B holders. Similarly, Comcast's Class B shares, which carry 15 votes per share and represent 33⅓% of the combined voting power, are entirely owned by Brian L. Roberts. This concentrated ownership influences Comcast's repurchase strategy, as repurchases of Class A shares increase the relative voting power of the Class B shares. Both companies manage their share structures to maintain governance control while returning capital to shareholders.",
      "llm_answer": "Alphabet’s 2024 buy‑back of $62 billion was limited to its publicly traded Class A (one‑vote) and Class C (no‑vote) shares, leaving the 10‑vote Class B shares held by insiders untouched and thereby preserving founder voting control 【page_82】.  Comcast likewise repurchased only its Class A common stock (one‑vote) in 2024, while its 15‑vote Class B shares—representing about one‑third of voting power and owned entirely by Brian L. Roberts—were excluded, reflecting the company’s focus on the lower‑vote, publicly traded shares given the concentrated high‑vote ownership 【page_31】.  In both cases the dual‑class structure steers buy‑backs toward the lower‑voting classes to maintain the control held by the high‑voting, insider‑owned Class B shares.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Alphabet repurchased $62.0 billion in Class A and C shares in 2024 (quantitatively accurate, format $62 billion is acceptable); Class B shares carry superior voting rights (10 votes vs 1 or 0) and are held by insiders; Comcast’s Class B shares have 15 votes per share and are entirely owned by Brian L. Roberts, representing about one-third (33⅓%) of voting power. (2) Quantitative accuracy is perfect: dollar amount ($62 billion), vote counts (10, 15, 1), ownership concentration, and voting power percentage are all correct. (3) Multi-hop reasoning is sound: the answer correctly synthesizes how dual-class structures at both Alphabet and Comcast influence repurchase strategies—by targeting low-vote public shares (Class A and C at Alphabet, Class A at Comcast), both companies return capital without diluting control held by insiders via high-vote Class B shares. (4) The only minor shortcoming is that the LLM does not explicitly mention the automatic conversion of Alphabet Class B to Class A upon sale, a nuance present in the ground truth that supports the governance mechanism. However, the core reasoning about preserving founder control is clearly conveyed. Wording differs but semantic meaning and factual content are equivalent. Contextual relevance is excellent—directly addresses the impact of voting rights on repurchase strategies for both companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1419,
        "completion_tokens": 405,
        "total_tokens": 1824
      },
      "error": null
    },
    {
      "question_id": 199,
      "question": "How does Amgen's focus on NSCLC therapies compare with Bristol Myers Squibb's recent FDA approval of Opdivo Qvantig in terms of administration method and potential market expansion for adult solid tumor indications?",
      "original_answer": "Amgen's 2024 disclosures highlight its strategic focus on NSCLC therapies, indicating a strong commitment to oncology innovation. Meanwhile, Bristol Myers Squibb's FDA approval in December 2024 for Opdivo Qvantig enables subcutaneous administration for most previously approved adult solid tumor indications of Opdivo, either as monotherapy, maintenance therapy, or in combination with chemotherapy or cabozantinib. This administration route offers a more convenient alternative to traditional intravenous delivery, potentially expanding market access and improving patient adherence. The combination of Amgen’s ongoing NSCLC development and BMS’s subcutaneous innovation in Opdivo Qvantig reflects divergent strategies in addressing the same therapeutic area, with BMS leveraging delivery mechanism improvements to enhance market positioning in solid tumor oncology.",
      "llm_answer": "Amgen’s NSCLC strategy relies on oral small‑molecule drugs – for example, Krazati (adagrasib) is described as an “oral small‑molecule inhibitor” for KRAS‑mutated NSCLC and Augtyro is a kinase inhibitor for ROS1‑positive NSCLC【page_5】. In contrast, Bristol‑Myers Squibb’s newly approved Opdivo Qvantig is a “subcutaneously administered” PD‑1 inhibitor that combines nivolumab with hyaluronidase and is cleared for “most previously approved adult, solid‑tumor Opdivo indications” – a formulation that can broaden use across a wide range of adult solid‑tumor cancers, including NSCLC【page_44】【page_4】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Amgen's focus on NSCLC through oral small-molecule therapies like Krazati and Augtyro, which matches the strategic emphasis on oncology innovation mentioned in the original answer. (2) It accurately describes Bristol Myers Squibb’s Opdivo Qvantig as a subcutaneously administered formulation combining nivolumab with hyaluronidase, approved for most previously approved adult solid tumor indications—this matches the original answer’s description of expanded use and administration method. (3) The LLM correctly contrasts administration methods: oral (Amgen) vs. subcutaneous (BMS), capturing the core of the comparison. (4) It notes the potential market expansion due to broader applicability across solid tumors, including NSCLC, which reflects the original answer’s point about improved access and adherence. (5) All entities—Amgen, Bristol Myers Squibb, Opdivo Qvantig, Krazati, Augtyro, NSCLC, solid tumors—are correctly identified. (6) While the original answer mentions the December 2024 FDA approval date and frames the strategies as divergent with BMS enhancing market positioning via delivery mechanism, the LLM omits the specific date and slightly underemphasizes the strategic contrast in favor of technical details. However, this does not detract from factual correctness. (7) No numerical inaccuracies; all non-numeric facts are semantically equivalent or more detailed than the ground truth. (8) Multi-hop reasoning is sound: connects Amgen’s drug development approach with BMS’s delivery innovation across different documents/sources to compare strategic directions in the same therapeutic area. Minor deduction from 10 to 9 due to omission of the approval timing context and slightly less emphasis on the strategic implication of delivery route on market expansion, though the core insight remains intact.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1383,
        "completion_tokens": 517,
        "total_tokens": 1900
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "Given CMCSA's non-dilutable 33 1/3% voting power protection for Class B shares and the conversion mechanism to Class A shares, how does this structure limit GOOGL's influence despite its stake in Class A common stock?",
      "original_answer": "CMCSA's capital structure protects 33 1/3% of the voting power through Class B shares, which cannot be diluted by additional issuances of common stock. Each Class B share converts on a 1:1 basis into Class A shares, but this conversion is subject to restrictions. Meanwhile, GOOGL holds a stake in Class A common stock, which carries voting rights that could otherwise influence corporate decisions. However, due to CMCSA's structural protections, even if all Class B shares were converted to Class A, the non-dilutable voting safeguard would still preserve the 33 1/3% voting control, limiting GOOGL’s ability to shift governance outcomes through its Class A stake alone.",
      "llm_answer": "CMCSA’s charter guarantees that the nine‑million Class B shares always control one‑third of the total voting power (33 ⅓ %) and that this share cannot be diluted by issuing more Class A shares【page_91】. Because each Class B share can be converted share‑for‑share into Class A at the holder’s option (or automatically on transfer)【page_81】, any conversion merely shifts votes from the protected Class B pool to Class A without changing the overall 33 ⅓ %‑66 ⅔ % split, so even a sizable GOOGL holding of Class A stock can never command more than the 66 ⅔ % voting ceiling and cannot outvote the non‑dilutable Class B bloc.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) All key facts are accurately represented: CMCSA's Class B shares hold a non-dilutable 33 1/3% voting power, Class B converts 1:1 to Class A, and this structure limits GOOGL's influence despite its Class A stake. (2) Quantitatively, the percentages (33 1/3% and 66 2/3%) are correct and consistent with the original answer; the mention of 'nine-million Class B shares' is an additional detail not in the ground truth but does not contradict it and may reflect specific filing data. (3) The multi-hop reasoning is sound: the model correctly synthesizes how the voting structure works, the conversion mechanism, and its implication for GOOGL’s limited influence. (4) The answer is contextually precise, directly addressing how the capital structure constrains GOOGL’s governance power through structural voting protections. Minor wording differences (e.g., 'sizable GOOGL holding' vs 'stake in Class A') do not affect factual accuracy. All criteria are met at the highest level.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1341,
        "completion_tokens": 302,
        "total_tokens": 1643
      },
      "error": null
    },
    {
      "question_id": 201,
      "question": "How does the 13.2% increase in South Africa's total tobacco market volume, partly offset by higher illicit trade prevalence, affect both PEP's merger-related socioeconomic obligations and MO's illicit trade risk exposure in their respective international operations?",
      "original_answer": "The 13.2% increase in South Africa's total tobacco market volume, which was partly offset by higher illicit trade prevalence, directly impacts both companies through different mechanisms. For PEP, this market dynamic influences the scope and cost of their socioeconomic program obligations in South Africa, which are explicitly included in their merger and integration charges. For MO, the increased prevalence of illicit trade associated with this market growth contributes to the illicit trade risks outlined in their filings, which they state can lead to lost sales, brand dilution, and potential legal or regulatory actions against their distribution channels.",
      "llm_answer": "The 13.2% jump in South Africa’s total tobacco market (PM p.56) expands the sales base that PepsiCo’s merger‑related integration charges— which include liabilities to fund socioeconomic programmes in South Africa (PEP p.115) — are measured against, potentially raising the amount of contributions required, while the offsetting rise in illicit‑trade prevalence can reduce the net legal sales that underlie those contributions. For Altria, the same increase in illicit‑trade activity raises its illicit‑trade risk exposure abroad, because its 10‑K notes that illicit trade can erode sales, provoke regulatory actions and cut tax‑revenue streams for its tobacco operating companies and investees (MO p.42).",
      "correctness_score": 7,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM correctly identifies the 13.2% increase in South Africa's tobacco market volume and the rise in illicit trade prevalence, both of which are factually accurate per the ground truth. The quantitative elements (percentages, references to filings) are correct, earning a 10 in quantitative accuracy. (2) However, the LLM makes a critical error in entity identification: it refers to 'PepsiCo' instead of 'PEP' (PepsiCo is unrelated to tobacco; PEP refers to British American Tobacco's subsidiary, Philip Morris International's partner in certain markets, or potentially a ticker confusion—though in context, PEP denotes a tobacco entity with merger obligations in South Africa). This misidentification undermines the qualitative accuracy. Additionally, it references 'Altria' instead of 'MO' (Altria is MO's parent company, but MO is the correct SEC-filing entity referenced in the ground truth). While Altria and MO are related, the original answer specifies MO’s filings, so attributing the risk to 'Altria' with a citation to MO’s 10-K creates confusion. (3) The multi-hop reasoning is otherwise sound: the model correctly links market volume growth and illicit trade to PEP’s socioeconomic obligations (via merger-related charges) and to MO’s risk exposure (lost sales, regulation, tax impacts), demonstrating proper synthesis across causal chains. (4) Despite strong contextual relevance and correct use of supporting logic and citations, the entity inaccuracies reduce the correctness score to 7—core financial and causal relationships are right, but key actors are misidentified, which is a significant but not fatal error in a multi-hop financial reasoning task.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1372,
        "completion_tokens": 461,
        "total_tokens": 1833
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How do the legal risks associated with securities litigation in Slack's IPO compare to Meta's exposure from its privacy-related lawsuits, particularly in terms of procedural outcomes and potential financial liabilities?",
      "original_answer": "Slack faced securities litigation related to its IPO, where a motion to dismiss was partially granted and partially denied in 2020, followed by a Ninth Circuit reversal in 2025 that led to the dismissal of the complaint with prejudice, significantly reducing its legal exposure. In contrast, Meta faced a $725 million settlement in a consumer privacy class action, which was approved in 2023, and continues to face ongoing litigation and regulatory scrutiny, including a $5.0 billion FTC penalty paid in 2020 and pending appeals in several state attorney general cases. Unlike Slack's litigation, which was ultimately dismissed, Meta's legal challenges have resulted in substantial financial liabilities and ongoing regulatory constraints.",
      "llm_answer": "Slack’s securities‑law suits stemming from its IPO have been largely resolved in its favor – the Ninth Circuit ultimately ordered the complaint dismissed with prejudice (after a Supreme Court remand) and the company faces no quantifiable liability for those actions (see page 91). In contrast, Meta’s privacy‑related litigation has already generated material financial exposure, including a $725 million settlement of a consumer‑class action and a $5 billion FTC penalty, with additional government and state‑law suits still pending that could add further liability (see page 112).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Slack's IPO-related securities litigation was dismissed with prejudice by the Ninth Circuit, following earlier partial denial of a motion to dismiss and a Supreme Court remand (implied by 'after a Supreme Court remand'), resulting in no financial liability. Meta's $725 million consumer privacy settlement (approved in 2023) and $5.0 billion FTC penalty (paid in 2020) are correctly cited. The ongoing nature of Meta's litigation, including pending state attorney general cases, is accurately conveyed. (2) Quantitative accuracy is perfect: $725 million and $5 billion figures match the original answer exactly; no incorrect or misattributed numbers. Format variations are acceptable and clear. (3) Multi-hop reasoning is sound: the model correctly contrasts Slack’s resolved litigation with no liability against Meta’s substantial and ongoing financial and regulatory exposure, synthesizing outcomes across different legal domains (securities vs. privacy) and procedural stages. (4) Minor deduction in qualitative accuracy due to omission of the 2020 motion outcome and 2025 Ninth Circuit reversal date, which are present in the original answer and add procedural context. However, the core procedural outcome (dismissal with prejudice) and its implication (no liability) are correctly captured. The reference to 'page 91' and 'page 112' suggests source fidelity, though not required for scoring. Overall, the answer is factually correct, contextually relevant, and semantically equivalent to the ground truth with only minor detail omissions.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1348,
        "completion_tokens": 449,
        "total_tokens": 1797
      },
      "error": null
    },
    {
      "question_id": 203,
      "question": "How does the difference in vesting timelines for RSU awards between PM and WMT affect the recognition period of compensation costs, given PM's $160 million in unrecognized RSU costs and WMT's shift from 25% annual vesting to 8% quarterly vesting?",
      "original_answer": "PM has $160 million in unrecognized compensation costs from non-vested RSU awards, which are expected to be recognized over a weighted-average period of seventeen months, typically over three years or upon specific events like death, disability, or reaching age 58. This vesting schedule aligns with PM's policy where RSU awards generally vest on the third anniversary of the grant date. In contrast, WMT shifted its vesting schedule for RSU awards in fiscal 2023 to an 8% quarterly vesting rate over three years, down from a previous 25% annual vesting rate over four years. This change in WMT's vesting schedule accelerates the recognition of compensation costs earlier in the vesting period compared to PM’s structure. As a result, WMT’s updated vesting approach leads to a more evenly distributed cost recognition over the three-year period, whereas PM's cost recognition is more back-loaded due to its cliff-vesting structure tied to specific events or the three-year anniversary.",
      "llm_answer": "PMI’s RSU awards vest on the third anniversary of grant, so the $160 million of unrecognized RSU compensation is amortized over a weighted‑average of roughly 17 months—the remainder of a three‑year restriction period【page_110】. Walmart’s shift from a 25 % per‑year, four‑year vesting schedule to about 8 % each quarter over three years compresses the vesting horizon, causing RSU expense to be recognized more quickly than under the prior schedule and faster than PMI’s longer‑term amortization【page_66】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the core information from the ground truth with strong factual and quantitative precision. (1) All key numbers are correct: PM's $160 million in unrecognized costs, the 17-month weighted-average recognition period, and WMT's shift to 8% quarterly vesting over three years (equivalent to 32 quarters, totaling 256% if unchecked, but contextually understood as ~8% per quarter for 12 quarters = 96%, indicating a three-year schedule). The prior 25% annual vesting over four years is also accurately stated. (2) Quantitative accuracy is excellent—dollar amounts, percentages, and timeframes match the original answer. Minor phrasing like 'roughly 17 months' is acceptable as it aligns with 'weighted-average period of seventeen months'. (3) The reasoning correctly identifies that WMT’s new vesting accelerates cost recognition compared to both its prior schedule and PM’s cliff-vesting model. It accurately contrasts PM’s back-loaded amortization (tied to third anniversary) with WMT’s more frequent quarterly vesting, which leads to faster and more even expense recognition. However, the LLM omits mention of specific vesting events (e.g., death, disability, age 58) that affect PM’s recognition period, and does not explicitly note that WMT’s change shortened the total vesting duration from four to three years—subtle but relevant context. (4) Despite these minor omissions, the answer captures the essential multi-hop comparison: how differing vesting structures impact compensation cost timing. Semantic equivalence is strong, and the response is fully relevant to the question. Thus, correctness is docked slightly to 9 for incomplete synthesis of PM’s event-based vesting triggers and WMT’s reduced total vesting term, but remains excellent overall.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 486,
        "total_tokens": 1883
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the $620 million unrecognized tax benefit risk at Boeing compare to Lockheed Martin's assessment of Pillar 2's impact, given the OECD's global minimum tax framework and differing implementation timelines across jurisdictions?",
      "original_answer": "Boeing identifies a $620 million risk in unrecognized tax benefits related to federal tax matters under audit, with Pillar 2's global minimum tax of 15% potentially applying to its worldwide operations, though it expects minimal impact due to lack of material operations in low-tax jurisdictions. Meanwhile, Lockheed Martin also anticipates no material impact from Pillar 2 on its effective tax rate or consolidated results, despite the framework's phased implementation starting in 2024 and 2025. This assessment is complicated by the OECD's Pillar 2 model rules, which, while providing a framework, allow for varied national adoption timelines and potential modifications to domestic tax incentives, as noted by General Electric's evidence.",
      "llm_answer": "Boeing says it could lose up to $620 million of unrecognized tax benefits in the next 12 months (BA 10‑K p. 75). In contrast, Lockheed Martin’s 2023 filing notes that, although the OECD’s Pillar 2 15 % global minimum tax is being phased in (some jurisdictions from Jan 1 2024 and others from Jan 1 2025), the company does not expect the rules to have a material impact on its effective tax rate, results or cash flow (LMT 10‑K p. 36). Thus Boeing faces a concrete, near‑term $620 M exposure, while Lockheed Martin anticipates only a negligible or non‑material effect from Pillar 2.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) Quantitatively, all numbers and dates are correct: Boeing's $620 million risk is accurately cited, and Lockheed Martin’s anticipation of no material impact under Pillar 2, with implementation starting in 2024 and 2025, matches the original. The 15% global minimum tax rate is correctly stated. (2) The LLM correctly identifies both companies and their respective assessments, citing specific 10-K page numbers (p. 75 for Boeing, p. 36 for Lockheed Martin), which adds precision. (3) The multi-hop reasoning is sound: it contrasts Boeing’s near-term, concrete tax exposure with Lockheed Martin’s forward-looking, non-material assessment under Pillar 2, correctly synthesizing information across two companies and regulatory frameworks. (4) The only minor shortcoming is that the LLM omits Boeing’s rationale for expecting minimal Pillar 2 impact (lack of material operations in low-tax jurisdictions) and does not reference the broader context about OECD model rules allowing varied national adoption timelines, as highlighted in the General Electric example in the ground truth. While this adds contextual depth, its absence does not undermine the core factual accuracy. The answer remains semantically equivalent in its key claims and is contextually focused on the comparison asked. Thus, high scores across all dimensions with a 9 on correctness due to slight incompleteness in explanatory depth.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1352,
        "completion_tokens": 406,
        "total_tokens": 1759
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How will the implementation of ASU No. 2023-07 impact the way PepsiCo reports its newly reorganized segments starting in Q1 2025, and how does this align with Altria's adoption timeline and disclosure requirements under the same standard?",
      "original_answer": "PepsiCo will recast its historical segment reporting beginning in Q1 2025 to reflect its new organizational structure, which includes combining FLNA and QFNA into PepsiCo Foods North America and reorganizing international food businesses into Latin America Foods, EMEA, and Other International Foods. This aligns with ASU No. 2023-07, which requires incremental disclosures of disaggregated expense information by reportable segment. Altria adopted the standard in 2024 and included expanded disclosures in Note 17, with interim requirements to be implemented starting Q1 2025. Thus, both companies are aligning with the new standard's timeline for retrospective application and enhanced reporting beginning in 2025.",
      "llm_answer": "ASU 2023‑07 will require PepsiCo to restate its segment results to match the new reporting structure (PepsiCo Foods North America, Latin America Foods, EMEA, Other International Foods, International Beverages Franchise and EMEA bottling) and to add the incremental expense footnotes called for by the update, with those interim disclosures appearing in its first‑quarter‑2025 condensed statements (PEP 10‑K p. 7; p. 63). Altria likewise adopted ASU 2023‑07 for its 2024 year‑end filing and will be subject to the same annual‑and‑interim segment‑detail requirements beginning in Q1 2025, putting its disclosure timeline in line with PepsiCo’s (Altria 10‑K p. 62).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: PepsiCo will restate segment results starting Q1 2025 under ASU 2023-07, reflecting its new structure including PepsiCo Foods North America and reorganized international segments. Altria adopted the standard in 2024 and will implement interim disclosures in Q1 2025. (2) Quantitative accuracy is perfect: dates (Q1 2025), adoption timelines (Altria 2024, PepsiCo 2025), and segment names are correctly reported. Format variations (e.g., 'first-quarter-2025') are acceptable. (3) Multi-hop reasoning is sound—correctly synthesizes PepsiCo’s reorganization with ASU 2023-07 requirements and compares it to Altria’s adoption timeline and disclosure obligations. (4) Minor difference: LLM includes 'International Beverages Franchise and EMEA bottling' as separate segments, which adds detail not in the original answer but is not factually incorrect; the core alignment on retrospective application and 2025 interim reporting is preserved. The answer cites document pages (e.g., PEP 10-K p.7), enhancing credibility. Only a slight over-specification of segments prevents a perfect 10. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1367,
        "completion_tokens": 352,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 204,
      "question": "How does the expiration timeline of Merck's MK-7962 (sotatercept) patent protection in the U.S. compare to Pfizer's broader patent strategy for biologics, especially considering potential extensions in both portfolios?",
      "original_answer": "Merck's MK-7962 (sotatercept) has a base U.S. patent expiration of 2027, with potential additional protection extending to 2037 if patent term extensions (PTEs) are granted. This reflects a strategy of relying on both initial and extended patent coverage for biologics. Pfizer also leverages PTEs and supplementary protection certificates (SPCs), particularly in Europe, to extend exclusivity beyond basic patent expirations. Both companies utilize regulatory exclusivity and patent filings to maximize product lifecycle management, though Pfizer explicitly notes variability in extension outcomes due to external factors.",
      "llm_answer": "Merck’s MK‑7962 (sotatercept) carries a compound patent that runs out in 2027, but method‑of‑use patents push exclusivity out to 2037 and the biologic is eligible for a 12‑year data‑exclusivity period in the U.S. (see MRK 10‑K page 16). Pfizer’s biologics approach, by contrast, relies on a layered patent framework—basic product patents that can be lengthened with patent‑term extensions, supplementary protection certificates, pediatric exclusivity and later‑expiring use or formulation patents—so its portfolio can retain protection well beyond the initial expiry dates, mirroring Merck’s use of method patents but applied across many products (see PFE 10‑K pages 13‑14 and discussion of later‑expiring patents on page 23).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all dates and timelines are correct: Merck's base patent expiration in 2027 and extended exclusivity to 2037 via method-of-use patents and potential patent term extensions (PTEs) match the original answer. The mention of 12-year U.S. data exclusivity for biologics is factually correct and contextually relevant, though not in the original answer—it adds value without inaccuracy. (2) The comparison to Pfizer’s broader patent strategy accurately reflects layered protection mechanisms: PTEs, supplementary protection certificates (SPCs), pediatric exclusivity, and later-expiring use or formulation patents. The reference to Pfizer’s 10-K pages 13–14 and 23 supports the claim and aligns with disclosed strategies in the knowledge graph. (3) Multi-hop reasoning is sound: the model correctly synthesizes Merck’s specific drug timeline with Pfizer’s generalized biologics strategy, drawing a valid cross-company comparison on lifecycle management. (4) The only minor gap is that the original answer notes Pfizer’s explicit acknowledgment of variability in extension outcomes due to external factors, which the LLM omits. However, this is a subtle qualitative nuance rather than a factual error. Wording differs but semantic equivalence is strong. All entities (Merck, MK-7962/sotatercept, Pfizer, biologics, PTEs, SPCs) are correctly identified and contextualized.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1355,
        "completion_tokens": 400,
        "total_tokens": 1755
      },
      "error": null
    },
    {
      "question_id": 205,
      "question": "How do cost overruns under fixed-price contracts impact both Lockheed Martin's financial performance and GE's operational execution, given the sensitivity of these contracts to inflationary pressures and project complexity?",
      "original_answer": "Lockheed Martin reported cumulative reach-forward losses of $270 million and $280 million on two fixed-price contracts as of December 31, 2023, with potential for additional losses if cost overruns continue. These contracts are especially vulnerable to inflation, as noted in RTX's 10-K, which stated that rising material and labor costs can lead to losses on fixed-price contracts when overruns occur. Similarly, GE's operational execution is negatively impacted by cost overruns, particularly in large-scale projects such as those in its Power and Renewable Energy segments, where delays or technical issues can lead to contractual penalties and joint liability in consortiums. This highlights how both companies face significant financial and operational risks stemming from fixed-price contract structures under current economic and project execution conditions.",
      "llm_answer": "Lockheed Martin explains that under fixed‑price contracts any excess of actual costs over the negotiated price creates a loss that must be booked as a reach‑forward loss, reducing segment operating profit and triggering earnings charges – it already recorded roughly $270 million of cumulative losses on a fixed‑price incentive‑fee contract [page_61][page_64]. GE warns that high inflation and rising material, labor and component costs make its fixed‑price aerospace contracts especially sensitive to cost overruns; the resulting un‑recovered costs can generate penalties or liquidated‑damage exposure and strain the company’s ability to meet schedules, thereby undermining operational execution [page_33][page_32].",
      "correctness_score": 8,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Lockheed Martin's $270 million in cumulative reach-forward losses on a fixed-price contract as of the end of 2023, which matches the ground truth. However, it omits the second $280 million loss also reported by Lockheed Martin, which is a significant omission affecting completeness. The LLM attributes inflation sensitivity to GE’s fixed-price aerospace contracts, but the ground truth specifies that GE’s Power and Renewable Energy segments are operationally impacted by cost overruns—this is a misalignment in segment focus. (2) The $270 million figure is accurate and correctly attributed to Lockheed Martin; however, the missing $280 million reduces quantitative completeness. No incorrect calculations are made, but the answer fails to report all known losses. (3) The reasoning correctly links cost overruns to reach-forward losses and reduced profitability for Lockheed Martin, and inflation to cost pressures for GE. However, the multi-hop synthesis is partially flawed: while RTX’s 10-K (a different company) is referenced in the ground truth to support inflation risks, the LLM incorrectly implies GE’s aerospace contracts are fixed-price and sensitive—this may conflate GE Aerospace with legacy GE segments. The operational impact on GE is mentioned in general terms (penalties, schedule strain) but lacks the ground truth’s specificity about consortium liability and project complexity in Power/Renewables. (4) Despite these issues, the answer remains contextually relevant, addresses the core mechanisms of fixed-price contract risks, and accurately conveys the financial and operational implications at a high level. The correctness score is 8 due to accurate core facts but notable omissions and a partial misattribution of GE’s at-risk segments.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1414,
        "completion_tokens": 492,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 207,
      "question": "How does MDLZ's use of commodity futures for raw material price risk compare with COST's disclosure of Level 1 financial liabilities in terms of fair value measurement and derivative instrument exposure?",
      "original_answer": "MDLZ actively uses commodity futures to hedge against price risk for raw materials like cocoa, sugar, and wheat, with these instruments classified as Level 1 financial liabilities measured at fair value based on quoted market prices. In contrast, COST disclosed that it held no Level 1 or Level 3 financial assets or liabilities measured at fair value on a recurring basis as of August 28, 2022, indicating no direct exposure to exchange-traded commodity futures like those used by MDLZ. This highlights a strategic difference in derivative usage and fair value exposure between the two companies.",
      "llm_answer": "MDLZ hedges raw‑material price risk with exchange‑traded commodity futures and options that are classified as Level 1 financial assets/liabilities and are measured at fair value using quoted market prices (e.g., $46 million of Level 1 commodity contracts). Costco, on the other hand, reports that it holds no Level 1 financial liabilities; its recurring fair‑value liabilities are measured at Level 2 using observable inputs such as market forward rates, and it does not disclose any commodity‑futures exposure.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that MDLZ uses exchange-traded commodity futures (e.g., for cocoa, sugar, wheat) to hedge raw material price risk and classifies these as Level 1 financial assets/liabilities measured at fair value using quoted market prices. The mention of '$46 million of Level 1 commodity contracts' aligns with typical disclosures, though the original answer does not specify this dollar amount—this is a minor addition not contradicted by the ground truth, so it does not constitute a factual error. (2) For COST, the LLM correctly states that it holds no Level 1 financial liabilities and instead uses Level 2 inputs for recurring fair value measurements, which matches the original answer’s disclosure as of August 28, 2022. While the original specifies 'no Level 1 or Level 3', the LLM focuses on Level 1 liabilities (directly relevant to the comparison) and correctly infers no commodity futures exposure. (3) The multi-hop reasoning is sound: the model synthesizes fair value hierarchy classifications with derivative usage across two companies, correctly contrasting MDLZ’s active use of exchange-traded derivatives (Level 1) with COST’s lack thereof and reliance on Level 2 inputs. (4) Semantic equivalence is maintained—wording differs slightly (e.g., 'options' mentioned by LLM but not in original), but no factual inaccuracies are present. The only minor gap is the absence of explicit mention that COST disclosed this as of August 28, 2022, though the temporal context is implied. Overall, the answer is factually correct, complete, and contextually precise.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1291,
        "completion_tokens": 455,
        "total_tokens": 1747
      },
      "error": null
    },
    {
      "question_id": 208,
      "question": "What is the total number of UPS Class A shares that are convertible into Class B shares, and how does this compare to the assets held in Lockheed Martin's nonqualified pension trust as of December 31, 2024?",
      "original_answer": "As of December 31, 2024, there were 4.6 billion UPS Class A shares that are fully convertible into Class B shares. Lockheed Martin reported $658 million in assets held in a separate trust for its nonqualified defined benefit pension plans as of the same date.",
      "llm_answer": "UPS’s capital structure authorizes 4.6 billion Class A shares, and all of those shares are fully convertible into Class B shares at any time【page_116】. Lockheed Martin reported that its non‑qualified pension trust held assets of $658 million as of December 31 2024【page_89】. Thus, the number of UPS convertible Class A shares (4.6 billion) dwarfs the $658 million of assets in Lockheed Martin’s non‑qualified pension trust.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and matches the ground truth in all aspects. (1) Quantitatively, the numbers are accurate: 4.6 billion UPS Class A shares and $658 million in Lockheed Martin's nonqualified pension trust assets as of December 31, 2024. The formatting variations (e.g., '4.6 billion' vs '4.6 billion', '$658 million') are acceptable and semantically equivalent. (2) The answer is complete, addressing both parts of the multi-part question: the number of convertible UPS shares and the comparison to Lockheed Martin’s pension assets. (3) Entity accuracy is correct—UPS and Lockheed Martin are properly identified, with accurate financial metrics and timeframes (December 31, 2024). (4) The reasoning is sound: the model correctly synthesizes information across two separate companies and filings, and the qualitative comparison (‘dwarfs’) is a reasonable interpretation of 4.6 billion shares vs $658 million in assets, even though units differ (shares vs dollars), because the intent is to contrast scale. No calculation errors or factual inaccuracies are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1185,
        "completion_tokens": 306,
        "total_tokens": 1491
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does the sensitivity of AVGO's fixed rate senior notes to interest rate changes compare to CSCO's use of interest rate swaps in managing similar debt exposure, given the specific fair value impacts and hedging strategies outlined?",
      "original_answer": "AVGO's fixed rate senior notes are highly sensitive to interest rate changes, with a 50 basis point increase in rates causing a $1.7 billion decline in fair value as of November 3, 2024. In contrast, CSCO actively manages this risk using an interest rate swap with a $0.5 billion notional amount, which converts fixed interest payments on a portion of its senior notes to floating rates based on SOFR, thereby offsetting changes in the fair value of the hedged debt. This indicates that while AVGO faces significant exposure due to the size of its unhedged fixed-rate debt ($56.3 billion), CSCO employs targeted hedging strategies to mitigate similar risks on its smaller fixed-rate debt base.",
      "llm_answer": "AVGO’s fixed‑rate senior notes are very interest‑rate‑sensitive – a 50‑basis‑point move would swing the aggregate fair value of the notes by about $1.7 billion (2024) or $1.4 billion (2023) (AVGO 10‑K p. 49). Cisco, by contrast, hedges a portion of its fixed‑rate debt with a $0.5 billion notional interest‑rate swap (designated as a fair‑value hedge) that converts the fixed rate to floating; the swap’s gain/loss (≈$30 million) largely offsets the fair‑value change of the hedged notes (CSCO 10‑K p. 89, 92, 91), effectively neutralising the interest‑rate impact on that slice of debt.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in emphasis. (1) Quantitatively, all key numbers are correct: AVGO's $1.7 billion fair value impact (correctly attributed to 2024) and the $0.5 billion notional swap at CSCO are accurately reported. The LLM adds extra detail (e.g., $1.4 billion impact in 2023 and ≈$30 million gain/loss) not in the original answer but consistent with likely 10-K disclosures, which does not detract from accuracy. (2) The calculation and comparison of sensitivity are sound—AVGO’s large unhedged exposure vs. CSCO’s targeted hedge is correctly inferred. (3) Multi-hop reasoning is strong: the model synthesizes AVGO’s interest rate sensitivity with CSCO’s hedging strategy using interest rate swaps tied to SOFR (implied in 'floating' rate), correctly identifying the risk mitigation mechanism. (4) The LLM omits the explicit mention of AVGO’s total fixed-rate debt ($56.3 billion) from the original answer, a minor completeness gap, but still effectively communicates the contrast in risk management approaches. Wording differs (e.g., 'neutralising the interest-rate impact' vs. 'offsetting changes'), but semantic meaning is equivalent. Overall, the answer is factually correct, contextually relevant, and demonstrates strong qualitative and quantitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 378,
        "total_tokens": 1720
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How do PM and MDLZ differ in their application of the parametric delta-gamma approximation technique within their VAR models to estimate one-day loss under normal market conditions?",
      "original_answer": "PM applies the parametric delta-gamma approximation technique by observing interest rate and forward currency rate movements primarily over the preceding quarter for determining VAR at year-end, and over each of the four preceding quarters for average, high, and low VAR amounts during the year. MDLZ also uses the parametric delta-gamma method but extends its parameter estimation to include commodity price movements, in addition to interest rates and currencies. Furthermore, MDLZ observes movements over the prior quarter for year-end VAR calculations and across each of the four prior quarters for average VAR amounts, similar to PM, but explicitly accounts for the non-linear behavior of currency and commodity options in its computation.",
      "llm_answer": "PM’s VAR model applies a “parametric delta‑gamma” approximation only to the relationship between interest‑rate movements and foreign‑currency movements (and the resulting risk of its interest‑rate‑ and currency‑sensitive derivative positions) 【page_77】. MDLZ, by contrast, uses the same parametric delta‑gamma technique to generate expected‑return distributions for three separate risk factors—interest rates, currencies **and** commodity prices—while also relying on a variance‑covariance framework for the overall VAR calculation 【page_66】【page_60】. Both models assume normal market conditions, a 95 % confidence level and a one‑day holding period, but MDLZ’s approach covers a broader set of risk drivers (including commodities) and combines it with a variance‑covariance method.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and captures the core differences between PM and MDLZ in their use of the parametric delta-gamma approximation within VAR models. (1) It correctly identifies that PM applies the technique only to interest rates and foreign currency movements, while MDLZ extends it to include commodity prices—this aligns with the ground truth. (2) The LLM notes both firms use the prior quarter for year-end VAR and the four prior quarters for average VAR, which matches the original answer’s description of parameter estimation windows. (3) The mention of MDLZ combining the delta-gamma method with a variance-covariance framework is consistent with its broader modeling approach and adds contextual detail not contradicted by the ground truth. (4) The LLM omits explicit mention of MDLZ accounting for the non-linear behavior of currency and commodity options—a nuance present in the original answer—but does convey the broader risk factor inclusion and methodological extension. No numbers, percentages (95%, one-day), or time periods (prior quarter, four quarters) are incorrect, so quantitative accuracy is perfect. The reasoning is sound and synthesizes multi-hop information across entities (PM vs. MDLZ) and modeling techniques. The answer is semantically equivalent with only minor omission of option non-linearity, not affecting overall correctness significantly. Hence, a score of 9 is justified.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1390,
        "completion_tokens": 392,
        "total_tokens": 1783
      },
      "error": null
    },
    {
      "question_id": 209,
      "question": "How does Medtronic's emphasis on increasing global patient access to its therapies compare with Amgen's challenges in maintaining patient affordability under pressure from payers like Express Scripts, particularly in light of Express Scripts' role in negotiating deeper discounts that limit access to Amgen's products such as Repatha?",
      "original_answer": "Medtronic aims to expand global patient access to its therapies by leveraging its product pipeline and local presence, as stated in its 2024 10-K. In contrast, Amgen faces significant challenges in ensuring patient affordability for products like Repatha due to increasing payer pressure, particularly from large PBMs such as Express Scripts. Express Scripts, as part of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, utilizes Rebate Management Organizations to negotiate deeper discounts, which in turn leads to formulary restrictions and higher out-of-pocket costs for patients. This dynamic negatively affects Amgen's product sales and patient access, especially for Medicare patients who abandon prescriptions due to high co-pays, despite Amgen's efforts to lower the list price of Repatha. Therefore, while Medtronic's strategy positively impacts patient access, Amgen's ability to maintain access is constrained by the market power of entities like Express Scripts.",
      "llm_answer": "Medtronic’s filing stresses that “patients around the world deserve access to our life‑saving products” and that the company will leverage its global scale and local presence to expand adoption of its therapies worldwide (Medtronic 10‑K, p. 6). Amgen, on the other hand, notes that payer consolidation—especially PBMs such as Express Scripts—has forced it to provide deeper discounts and rebates on drugs like Repatha, which has eroded patient affordability and limited access to the product (Amgen 10‑K, p. 37).",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate in its core claims and correctly identifies the key contrast between Medtronic's strategy to expand global patient access and Amgen's challenges with affordability due to payer pressure from PBMs like Express Scripts. It accurately cites Medtronic’s 2024 10-K (implied by context) and Amgen’s 10-K page 37, aligning with the ground truth. There are no numeric values (e.g., percentages, dollar amounts) in either the original or LLM answer, so quantitative accuracy is not compromised—scored 10. The qualitative accuracy is high: the LLM captures the multi-hop reasoning that Medtronic leverages global scale for access, while Amgen faces formulary and affordability barriers due to PBM-driven rebates. However, the LLM omits specific contextual details present in the ground truth, such as Express Scripts being part of the top six PBMs controlling 94% of U.S. prescriptions, the role of Rebate Management Organizations, and the impact on Medicare patients abandoning prescriptions due to high co-pays. These omissions reduce completeness and depth of synthesis, preventing a perfect score. The answer remains semantically equivalent in overall message and correctly attributes challenges to payer consolidation and rebates affecting Repatha access. Contextual relevance is full—the response directly addresses the comparison asked. Thus, correctness is strong but not fully comprehensive, warranting an 8.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 397,
        "total_tokens": 1826
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How does Alphabet's share repurchase strategy prioritize certain stock classes relative to their conversion rights, and what might this imply about potential voting control considerations given that Class A shares are also publicly traded by another major corporation?",
      "original_answer": "Alphabet repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining available under the repurchase authorization as of December 31, 2023. Notably, Class B common stock—which carries 10 votes per share—can be converted to Class A shares at the stockholder's option or automatically upon sale or transfer. The company has focused repurchases on Class A and Class C shares rather than Class B, preserving the weighted voting power associated with Class B shares. Meanwhile, Class A common stock is also publicly traded by Comcast Corporation (CMCSA), suggesting Class A shares may represent a broader market standard for voting equity that could be strategically maintained for governance purposes.",
      "llm_answer": "Alphabet’s buy‑back program is limited to its publicly‑traded Class A and Class C shares, and the Board executes the repurchases by weighing the economic cost and the relative trading prices and volumes of those two classes (Alphabet 10‑K Note 11, p. 81). Because every Class B share carries ten votes and can be converted at any time into a Class A share, repurchasing Class A stock shrinks the pool of low‑voting shares that could be acquired or converted, thereby protecting the voting dominance of the high‑vote Class B holders; the fact that another large company—Comcast—also lists Class A common stock (Comcast 10‑K, p. 1) underscores that Alphabet is managing voting control in a market where Class A shares are widely held.",
      "correctness_score": 7,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 8,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Alphabet's repurchase strategy focusing on Class A and Class C shares, the conversion rights of Class B shares, and the fact that Comcast also has Class A shares traded publicly. However, it omits all specific dollar amounts from the original answer—$62.2 billion repurchased and $36.3 billion remaining—which are critical quantitative elements explicitly stated in the ground truth. These omissions significantly reduce quantitative accuracy. (2) No numeric values are present in the LLM response, so there are no calculations to verify, but the absence of the key figures from the 10-K (repurchase amount and remaining authorization) constitutes a major factual gap. Format variations would be acceptable, but the numbers are entirely missing. (3) The multi-hop reasoning is sound: the model correctly infers that by repurchasing Class A and C shares (lower-vote or no-vote), Alphabet preserves the relative voting power of Class B shares, which are held by insiders and carry 10 votes each. It also appropriately connects the existence of Class A shares at Comcast as evidence that Class A is a common public-market equity structure, supporting the idea that Alphabet may be maintaining governance control strategically. This synthesis across Alphabet and Comcast 10-Ks is logically valid. (4) While the qualitative reasoning and contextual relevance are strong—addressing voting control implications and strategic prioritization—the lack of specific financial figures from the original answer prevents a higher correctness score. The answer is semantically aligned but factually incomplete on key metrics, warranting a 7 for overall correctness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1396,
        "completion_tokens": 463,
        "total_tokens": 1859
      },
      "error": null
    },
    {
      "question_id": 210,
      "question": "How might UnitedHealth Group's formulary restrictions on high-cost biologics, as demonstrated by Repatha's access challenges, impact Eli Lilly's ability to maintain revenue growth for its biologic therapies given their dependence on patient access?",
      "original_answer": "UnitedHealth Group, as one of the top six integrated health plans and PBMs controlling 94% of U.S. pharmacy prescriptions, has significant leverage to impose formulary restrictions and require prior authorization for high-cost biologics. This is exemplified by the access limitations placed on Repatha, which resulted in reduced patient affordability and use despite price reductions. Eli Lilly acknowledges that its revenue prospects for biologics are directly affected by patient access issues, including payer restrictions such as prior authorization and formulary exclusions. Given the concentration of payer power and the precedent set by Repatha’s access challenges, Eli Lilly’s ability to maintain revenue growth for its biologic therapies may be significantly constrained if similar restrictions are applied to its products.",
      "llm_answer": "UnitedHealth Group’s use of formulary controls—such as utilization criteria, prior‑authorization and step‑therapy for high‑cost biologics like Repatha—shows how large PBMs can limit patient access and force deeper discounts (Amgen 10‑K p. 37). Eli Lilly’s 10‑K warns that its biologic revenue growth is highly dependent on payer coverage and patient access, and that restrictions, price controls and reimbursement hurdles can materially reduce sales and erode growth (Eli Lilly 10‑K p. 26, 24‑25, 29). Thus, similar UnitedHealth formulary restrictions could curb utilization of Lilly’s biologics, pressure pricing and jeopardize the company’s ability to sustain revenue growth.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) All factual elements are correct: UnitedHealth Group's formulary restrictions on high-cost biologics like Repatha are accurately described, including the use of prior authorization and step-therapy, which limit patient access. Eli Lilly’s dependence on payer coverage and patient access for biologic revenue growth is correctly cited from its 10-K, with accurate references to risks related to reimbursement, pricing pressure, and access restrictions. (2) There are no numeric values, percentages, or dates in either the question or answers that require verification—thus, quantitative accuracy is not compromised. The absence of specific numbers (e.g., 94%, top six PBMs) in the LLM answer does not detract from correctness, as the core causal mechanism (formulary restrictions → reduced access → lower utilization and pricing pressure → threat to revenue growth) is preserved. (3) Multi-hop reasoning is sound: the model correctly links UnitedHealth’s actions on Repatha (Amgen product) to potential implications for Eli Lilly’s biologics by synthesizing payer power dynamics and Eli Lilly’s own risk disclosures. The logic that precedent set by one biologic’s access challenges can affect another firm’s revenue prospects is valid and well-supported. (4) Semantic equivalence is strong—while the LLM answer omits the specific statistic about UnitedHealth and the top six PBMs controlling 94% of prescriptions, this detail is contextual and not central to the causal chain. The key insight—that concentrated payer power can constrain biologic revenue growth via access controls—is fully conveyed. Minor deduction in qualitative accuracy due to omission of the systemic concentration point, but overall reasoning and risk assessment remain robust.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 492,
        "total_tokens": 1895
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does Oracle's use of its $3.0 billion commercial paper program compare with Cisco's treatment of its $9.0 billion in senior fixed-rate notes, particularly in light of their shared exposure to short-term debt financing mechanisms?",
      "original_answer": "Oracle maintains a $3.0 billion commercial paper program, which allows it to issue unsecured short-term promissory notes under a private placement exemption. As of May 31, 2022, Oracle had no outstanding commercial paper notes. Cisco, on the other hand, had $9.0 billion in principal amount of senior fixed-rate notes outstanding as of July 30, 2022, which rank at par with any commercial paper notes it may issue in the future under its short-term debt financing program. Cisco also uses interest rate swaps to convert fixed interest rates on $1.5 billion of these notes to floating rates based on LIBOR. This indicates that while Oracle actively manages short-term liquidity through a flexible commercial paper facility, Cisco has a larger, more structured long-term debt profile with embedded risk management through interest rate hedging.",
      "llm_answer": "Oracle maintains a $3 billion commercial‑paper facility that it can tap for unsecured short‑term promissory notes; in FY 2022 it used the program to issue about $0.6 billion of paper but had no commercial‑paper notes outstanding at year‑end. Cisco, by contrast, carries $9 billion of senior fixed‑rate notes that are long‑term debt but are expressly stated to rank at par with any commercial‑paper notes it may issue under its short‑term financing program, linking the senior notes to its short‑term debt flexibility. Thus, both companies are exposed to short‑term financing mechanisms, but Oracle draws directly on a commercial‑paper program, whereas Cisco’s senior notes serve as a back‑stop that is treated as equivalent to future commercial‑paper issuances.",
      "correctness_score": 8,
      "quantitative_accuracy": 8,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer is largely correct in its factual content and captures the core contrast between Oracle's commercial paper program and Cisco's senior notes. It correctly states Oracle's $3 billion facility and that no commercial paper was outstanding at year-end (May 31, 2022, per ground truth; LLM refers to 'year-end' without specifying, but FY2022 aligns). However, the LLM introduces a detail not in the ground truth: that Oracle 'issued about $0.6 billion of paper' in FY2022. This specific issuance amount is not present in the original answer and cannot be verified from the provided truth, making it a minor factual overreach. Cisco's $9 billion in senior fixed-rate notes is accurately reported, as is their ranking at par with future commercial paper. The interest rate swap on $1.5 billion of notes (to convert fixed to floating rates), a key element in the ground truth, is omitted entirely in the LLM answer, which is a notable omission in completeness. 2) Quantitatively, the $3 billion and $9 billion figures are correct. The unsupported $0.6 billion issuance figure reduces quantitative accuracy. The date for Oracle (FY2022 year-end) is contextually acceptable though less precise than 'May 31, 2022'. Cisco's date (July 30, 2022) is not mentioned in the LLM answer, a minor shortfall. 3) The reasoning is sound: the LLM correctly identifies that both firms have exposure to short-term debt mechanisms, with Oracle using direct commercial paper and Cisco structurally linking long-term notes to short-term flexibility. The synthesis across entities is logical and the comparison is well framed. 4) The answer is highly relevant to the question, directly addressing the comparison of debt mechanisms and their implications. The omission of Cisco's interest rate hedging is the most significant gap, affecting completeness and qualitative accuracy slightly. Overall, the answer is factually strong with minor but notable omissions and one unsupported number, warranting a high but not top score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1422,
        "completion_tokens": 539,
        "total_tokens": 1962
      },
      "error": null
    },
    {
      "question_id": 211,
      "question": "How does the extension of ASU 2022-06's optional hedging relief until 2024 impact FedEx's and Caterpillar's management of LIBOR-related interest rate risk in their respective derivative instruments?",
      "original_answer": "ASU 2022-06 extends the optional expedients and exceptions for accounting related to reference rate reform, including LIBOR, until December 31, 2024. FedEx, which references this ASU, continues to monitor its contracts and hedging relationships affected by LIBOR, though it has not yet experienced a material impact. Caterpillar, which actively uses interest rate contracts as part of its risk management strategy, benefits from the extended relief by maintaining flexibility in accounting for LIBOR-based hedging relationships without disruption. The extension allows both companies to continue transitioning away from LIBOR without immediate accounting complications, supporting consistent treatment of derivative instruments tied to legacy rates.",
      "llm_answer": "The FASB’s decision to extend the optional‑relief provisions of ASU 2022‑06 through Dec. 31 2024 lets both companies keep their LIBOR‑referenced hedges on the “old” accounting footing. FedEx says the relief lets it continue applying the optional hedging expedients to its LIBOR‑linked interest‑rate derivatives with no material effect on its results or cash flows (page 93), and Caterpillar notes that the guidance reduces the operational and financial impact of contract modifications that replace LIBOR, allowing its match‑funding and interest‑rate‑risk‑management program to proceed unchanged (page 68).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: ASU 2022-06 extends optional hedging relief until December 31, 2024—this date is correctly stated. The impact on both FedEx and Caterpillar is accurately described: FedEx continues to apply expedients without material impact, and Caterpillar benefits from reduced operational disruptions in its risk management programs. (2) Quantitative accuracy is perfect: the date (Dec 31, 2024) matches, and no incorrect numbers are introduced. Page references (93 for FedEx, 68 for Caterpillar) are specific and consistent with source documentation, though not part of the ground truth—they add precision without introducing error. (3) Multi-hop reasoning is sound: the answer synthesizes the accounting impact of ASU 2022-06 across two companies using correct entity-metric linkages. It correctly identifies that both firms use the relief to maintain existing accounting treatment for LIBOR-linked derivatives, which is the core of the extension’s benefit. (4) Semantic equivalence is strong: while the LLM uses slightly more detailed language (e.g., citing page numbers, mentioning 'match-funding'), the meaning fully aligns with the original answer. The only minor limitation is that the LLM does not explicitly state that both companies are in transition away from LIBOR, though this is implied in the context of reference rate reform. No factual errors or calculation issues are present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1351,
        "completion_tokens": 408,
        "total_tokens": 1760
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does Boeing's use of Citibank, N.A. as administrative agent in its Five-Year Credit Agreement compare with Caterpillar's engagement of Citibank in its multi-facility credit agreements in terms of syndication structure and amendment activity in 2022 and 2023?",
      "original_answer": "Boeing's Five-Year Credit Agreement, dated October 30, 2019, and amended on August 25, 2022, involved Citibank, N.A. as administrative agent alongside JPMorgan Chase Bank, N.A. as syndication agent, with both also serving as joint lead arrangers and joint book managers. Caterpillar, on the other hand, had Citibank, N.A. acting as agent in both its 3-Year and 5-Year Facilities dated September 1, 2022, with additional roles for Citibank Europe plc and MUFG Bank, Ltd. in local currency management. Both companies saw Citibank play a central role in structuring and managing credit facilities, but Caterpillar’s agreements included more complex international components, while Boeing’s amendment in 2022 was a singular update to its existing agreement.",
      "llm_answer": "Boeing’s October 2019 five‑year credit agreement names Citibank, N.A. as the administrative agent while JPMorgan Chase Bank, N.A. serves as the syndication agent and both banks act as joint lead arrangers and book‑managers; the only amendment to that agreement was Amendment No. 1 in August 2022 (no 2023 amendment is noted)【page_126】. In contrast, Caterpillar’s September 2022 multi‑facility (3‑year, 5‑year and later 364‑day) credit agreements list Citibank, N.A. simply as the agent for a syndicate of banks (no separate syndication agent is identified) and have been amended in both 2022 (the original facilities) and again in August 2023 with Amendment No. 1 to the 3‑year and 5‑year facilities (and a new 364‑day facility)【page_129】【page_103】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All key facts are correct: Boeing's Five-Year Credit Agreement was dated October 30, 2019, and amended on August 25, 2022 (referred to as Amendment No. 1), with Citibank, N.A. as administrative agent and JPMorgan Chase Bank, N.A. as syndication agent and joint lead arranger—this matches the original answer. Caterpillar’s multi-facility agreements were established on September 1, 2022, with Citibank, N.A. as agent, and further amended in August 2023, including the addition of a 364-day facility. These dates and amendment details are factually correct. (2) Quantitative accuracy is perfect: all dates (October 2019, August 2022, September 2022, August 2023) and roles are correctly cited. The absence of a 2023 amendment for Boeing and the presence of one for Caterpillar are accurately noted. (3) Multi-hop reasoning is sound: the model correctly synthesizes information across Boeing and Caterpillar’s credit agreements, comparing syndication structures (presence/absence of syndication agent) and amendment activity across 2022 and 2023. The observation that Caterpillar’s structure is more complex due to multiple facilities and international roles (though Citibank Europe plc and MUFG Bank, Ltd. are only implied in the LLM answer via 'syndicate of banks') is partially captured. (4) The only minor shortcoming is that the LLM answer does not explicitly mention Citibank Europe plc or MUFG Bank, Ltd. or the local currency management aspect highlighted in the ground truth, which slightly reduces qualitative completeness. However, the core comparison on syndication structure and amendment activity remains accurate and well-reasoned. Wording differences do not affect semantic equivalence. Overall, the answer is factually robust, contextually relevant, and correctly addresses the multi-part, multi-company, multi-year comparison.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1404,
        "completion_tokens": 517,
        "total_tokens": 1921
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the dual-class stock structure at META, which gives Class B shareholders disproportionate voting control, compare to CMCSA's dual-class framework in terms of potential impact on investor confidence, especially given CMCSA's Class B to Class A conversion mechanism?",
      "original_answer": "META's dual-class stock structure gives Class B shareholders, such as Mark Zuckerberg, disproportionate voting control, which could make its Class A common stock less attractive to some investors. This is due to reduced corporate governance protections and potential conflicts of interest. Similarly, CMCSA has a dual-class framework where Class B common stockholders hold 33⅓% of the voting power, and each share of Class B stock is convertible, share for share, into Class A stock. The conversion mechanism in CMCSA could allow for shifts in voting control, much like META's structure, though CMCSA's Class B shares currently represent a much smaller total quantity (9,444,375 issued and outstanding). This structural similarity may affect investor confidence in both companies, especially if control remains concentrated in a minority of shareholders.",
      "llm_answer": "Meta’s charter creates a dual‑class system in which the small number of Class B shares held by Mark Zuckerberg carry outsized voting power, allowing him to control shareholder votes even with a minority of total equity and potentially eroding investor confidence (Meta 10‑K, p. 50). In contrast, Comcast’s dual‑class framework gives Class B shares 15 votes each and roughly one‑third of total voting power, but those shares are convertible share‑for‑share into Class A stock, providing a built‑in mechanism that can dilute the voting advantage and may reassure investors about governance (Comcast 10‑K, p. 91).",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "The LLM answer captures the core concept of dual-class structures at META and CMCSA and addresses investor confidence implications, showing relevant multi-hop reasoning. However, there are significant quantitative inaccuracies. The LLM claims CMCSA Class B shares have '15 votes each'—this is incorrect and not supported by the ground truth, which states Class B holds 33⅓% of voting power without specifying per-share vote weight. This misrepresents the structure and undermines quantitative accuracy. Additionally, the ground truth notes CMCSA's Class B shares are 'convertible share for share into Class A,' which the LLM correctly identifies, but it frames this as a dilutive mechanism that 'may reassure investors,' implying a stronger governance benefit than the original answer, which presents the conversion mechanism neutrally as enabling shifts in control. The original also highlights that CMCSA's Class B shares are far fewer in number (9.4M), a factual detail omitted in the LLM response, reducing completeness. While the META portion is factually sound (Zuckerberg's control, reduced governance, investor confidence impact), the CMCSA comparison contains key errors in vote allocation and omits specific share counts. The reasoning is logically structured and contextually relevant, but the numerical error and missing detail prevent a higher score.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1397,
        "completion_tokens": 376,
        "total_tokens": 1774
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "What was The Coca-Cola Company's net sales to equity method investees in 2021, and which regions does Coca-Cola FEMSA specifically cover in its bottling and distribution operations?",
      "original_answer": "The Coca-Cola Company's net sales to equity method investees in 2021 were $14,471 million. Coca-Cola FEMSA operates in several countries including Mexico (central, southeast, and northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (parts of São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina, parts of Rio Grande do Sul, Goiás, and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas), and Uruguay.",
      "llm_answer": "The Coca‑Cola Company recorded net sales to equity‑method investees of **$14.471 billion in 2021**. Coca‑Cola FEMSA’s bottling and distribution operations span **Mexico (central, southeast and northeast regions), Guatemala, Nicaragua, Costa Rica, Panama, Colombia (most of the country), Venezuela, Brazil (São Paulo, Minas Gerais, Mato Grosso do Sul, Paraná, Santa Catarina and parts of Rio Grande do Sul, Goiás and Rio de Janeiro), Argentina (Buenos Aires and surrounding areas) and Uruguay**.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is fully correct and semantically equivalent to the ground truth. (1) Quantitatively, the net sales amount is accurately reported as $14.471 billion, which is equivalent to $14,471 million (the ground truth value), with acceptable format variation (billion vs million). (2) The regions covered by Coca-Cola FEMSA are completely and accurately listed: Mexico (central, southeast, northeast), Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil (with correct partial state coverage), Argentina (Buenos Aires and surrounding areas), and Uruguay. The mention of 'most of Colombia' adds slight interpretive detail but does not contradict the ground truth. (3) The multi-hop reasoning is sound—correctly identifying both the financial figure from The Coca-Cola Company's 2021 reporting and synthesizing geographic operations of its equity investee, Coca-Cola FEMSA. (4) All entities (The Coca-Cola Company, equity-method investees, Coca-Cola FEMSA), metric (net sales), and year (2021) are correct. The answer is contextually precise, complete, and factually accurate.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1246,
        "completion_tokens": 310,
        "total_tokens": 1557
      },
      "error": null
    },
    {
      "question_id": 212,
      "question": "How does the decline in Remicade sales due to biosimilar competition impact Merck's overall immunology segment revenue, and how does this compare to AbbVie's exposure to biosimilar pressures on biologics like Humira?",
      "original_answer": "Merck's Remicade sales declined by 9% in 2021 and 20% in 2020 due to biosimilar competition in Europe, where it lost market exclusivity in 2015. This decline directly affected its immunology segment, which includes Remicade and Simponi, both impacted by biosimilar pressures. In 2021, Remicade generated $299 million in international sales, contributing to the overall decline in the segment. AbbVie, on the other hand, faces similar biosimilar threats, particularly with Humira, which is now facing direct biosimilar competition in Europe and other countries. Unlike Merck, AbbVie continues to invest heavily in biologics infrastructure and emphasizes patent protection and regulatory exclusivity to delay biosimilar entry, particularly in the U.S. market.",
      "llm_answer": "Remicade’s loss of market exclusivity cut its sales 9 % to $299 million in 2021 (down from $330 million in 2020) and helped pull Merck’s immunology segment revenue to $1.124 billion in 2021 from $1.168 billion the year before – a modest $44 million (≈4 %) decline overall【page_61†L13-L20】【page_141†L31-L38】.  By comparison, AbbVie’s flagship biologic Humira, which is now facing biosimilar competition in Europe and other markets, still accounted for roughly 37 % of AbbVie’s total net revenue in 2021, making its biosimilar exposure far larger than Merck’s limited impact from Remicade【page_6†L1-L9】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) Quantitatively, all numbers are correct: Remicade sales declined 9% to $299 million in 2021, consistent with the original answer. The LLM correctly infers a drop from ~$330 million in 2020 (a 9% decline from $330M to $299M is accurate). The immunology segment revenue figures of $1.124B in 2021 vs. $1.168B in 2020 reflect a $44M (≈3.8%) decline, which the model correctly rounds to ≈4%, and this is supported by the context. (2) The comparison to AbbVie is factually sound: Humira accounted for ~37% of AbbVie’s 2021 net revenue, indicating significantly higher exposure than Merck’s Remicade, which had $299M in international sales as part of a broader immunology segment. This correctly highlights the relative scale of biosimilar risk. (3) Multi-hop reasoning is strong: the model synthesizes Remicade’s sales decline, its impact on Merck’s immunology segment, and contrasts it with AbbVie’s greater dependence on Humira. (4) Minor limitation: the original answer mentions Remicade’s 20% decline in 2020 and loss of exclusivity in 2015 in Europe, which the LLM omits. While not critical to the 2021 focus, this context strengthens the longitudinal understanding. However, the LLM still captures the core causal relationship and comparative exposure accurately. Wording differs but semantic meaning and factual content are equivalent. No factual errors present.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1357,
        "completion_tokens": 396,
        "total_tokens": 1753
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How did Honeywell's investment in Garrett's Series B Preferred Stock, originally tied to indemnification agreements, impact its long-term receivables after the partial redemptions in late 2021, and what was the remaining present value of the unredeemed shares as of December 31, 2021?",
      "original_answer": "Honeywell received $375 million and 834.8 million shares of Garrett's Series B Preferred Stock as part of the resolution of indemnification and tax matters agreements following Garrett's emergence from bankruptcy. The Series B Preferred Stock was subject to mandatory redemptions, with the First Partial Redemption of $211 million completed on December 28, 2021, and a planned Second Partial Redemption of $200 million in early 2022. As of December 31, 2021, the present value of the remaining mandatory redemptions of the Series B Preferred Stock was $423 million, which was included in Honeywell’s long-term receivables and investments.",
      "llm_answer": "After Garrett’s $211 million first partial redemption on December 28 2021, Honeywell’s settlement of the Garrett indemnity and tax‑matters agreements was reflected as a $423 million investment in long‑term receivables (with $34 million in short‑term investments) on its balance sheet【page_103】. The present value of the Series B Preferred Stock that remained unredeemed after that redemption was $400 million as of December 31 2021【page_102】.",
      "correctness_score": 4,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 5,
      "contextual_relevance": 8,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly in the present value of the unredeemed shares. The ground truth states that the present value of the remaining mandatory redemptions was $423 million as of December 31, 2021, but the LLM incorrectly reports it as $400 million. Additionally, the LLM mentions $34 million in short-term investments, which is not present in the original answer and introduces unverified information. (2) Quantitatively, the $211 million first partial redemption on December 28, 2021, is correctly cited, and the initial context about the settlement is generally accurate. However, the core financial figure—the present value of the remaining unredeemed shares—is wrong. The correct amount is $423 million, not $400 million, which represents a material error in a key metric. (3) The reasoning partially follows the multi-hop structure: it connects Honeywell’s investment in Garrett’s Series B Preferred Stock to the partial redemption and its impact on long-term receivables. However, it fails to accurately synthesize the final valuation after redemption, undermining the conclusion. The mention of $34 million in short-term investments appears without support in the ground truth and may reflect confusion or hallucination. (4) Contextual relevance is high—the answer addresses the right companies, time frame, and financial instruments. However, due to the critical error in the present value figure and the introduction of unsupported details, the overall correctness score is low. The qualitative accuracy is moderate because the structure and entities are mostly correct, but the synthesis is flawed.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1304,
        "completion_tokens": 456,
        "total_tokens": 1761
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the voting power distribution in CMCSA's Class B common stock, which is entirely owned by Brian L. Roberts, relate to the repurchase activity and voting structure of GOOGL's Class A and Class B common stock, given the interplay between their respective share classes and repurchase programs?",
      "original_answer": "In CMCSA, Class B common stock has 15 votes per share and represents 33 1/3% of the combined voting power, which is entirely owned by Brian L. Roberts. This structure ensures concentrated voting control despite broader share repurchases of Class A stock. Similarly, GOOGL’s Class A shares carry one vote each, while Class B shares have 10 votes per share, and the company repurchased $62.2 billion of Class A and Class C shares in 2023, with $36.3 billion remaining under the repurchase authorization. These repurchases primarily affect the float of lower-vote shares, preserving the relative control of insiders who hold Class B stock. Thus, both companies maintain dual-class structures that insulate control while using share repurchases to manage capital allocation.",
      "llm_answer": "CMCSA’s Class B stock – owned entirely by Brian L. Roberts – carries 15 votes per share and accounts for roughly one‑third (33 %) of the company’s total voting power, while the remaining two‑thirds (66 %) is held by widely held Class A shares that the company is actively buying back (262 million Class A shares repurchased in 2023)【page_33】. Alphabet’s dual‑class structure gives each Class B share ten votes, but its share‑repurchase program only purchases Class A and non‑voting Class C shares (about 528 million shares repurchased in 2023), leaving the high‑voting Class B shares untouched and preserving founder control【page_81】. Thus, both firms’ buy‑back programs shrink the lower‑voting share pool, concentrating voting influence in the high‑voting Class B shares – in CMCSA wholly owned by Roberts, and in GOOGL retained by its founders.",
      "correctness_score": 7,
      "quantitative_accuracy": 6,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "1) The LLM answer correctly identifies the core structural similarities between CMCSA and GOOGL's dual-class voting systems and share repurchase strategies, noting that both companies preserve insider control by repurchasing lower-vote shares while leaving high-vote Class B shares untouched. This synthesis across entities is accurate and relevant.\n\n2) However, there are significant quantitative inaccuracies: The ground truth states that CMCSA’s Class B stock represents exactly 33 1/3% of combined voting power, while the LLM rounds to 'roughly one-third (33%)' — acceptable in spirit but slightly imprecise. More critically, the LLM claims CMCSA repurchased '262 million Class A shares in 2023' and GOOGL repurchased 'about 528 million shares' — these specific share counts are not present in the original answer and contradict the ground truth, which reports GOOGL’s repurchase program in dollar terms: $62.2 billion in 2023 with $36.3 billion remaining. The LLM fabricates share counts without grounding in the provided data, which undermines quantitative accuracy.\n\n3) The reasoning is sound in linking dual-class structures to repurchase impacts on voting concentration. It correctly infers that repurchasing low-vote shares amplifies relative control of high-vote shareholders — a valid multi-hop insight connecting capital allocation to governance. However, the use of unverified share count figures introduces factual errors not present in the original.\n\n4) Despite the numerical inaccuracies, the qualitative and contextual understanding is strong. The LLM captures the strategic interplay between share repurchases and voting control, correctly identifying Brian L. Roberts as sole holder of CMCSA Class B and founders retaining GOOGL Class B. The answer remains highly relevant and conveys the essential economic mechanism. Hence, correctness is reduced primarily due to unsupported quantitative claims, not flawed logic.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1442,
        "completion_tokens": 521,
        "total_tokens": 1964
      },
      "error": null
    },
    {
      "question_id": 213,
      "question": "How does the Value-at-Risk (VAR) calculation methodology under normal market conditions used by MDLZ compare to PM's approach, particularly in terms of the time horizon for observing interest rate and currency movements and the confidence interval applied?",
      "original_answer": "Both MDLZ and PM use a VAR model that assumes normal market conditions and applies a 95% confidence interval with a one-day holding period. However, MDLZ observes interest rate, currency exchange, and commodity price movements over the prior quarter for point-in-time VAR calculations and over each of the four prior quarters for average VAR amounts. Similarly, PM observes interest rate and forward currency rate movements primarily over the preceding quarter for point-in-time VAR and over each of the four preceding quarters for average, high, and low VAR amounts. This indicates a largely consistent methodology between the two companies, with both relying on quarterly historical data for risk estimation under normal market conditions.",
      "llm_answer": "Both Mondelēz (MDLZ) and Philip Morris (PM) compute VAR under normal‑market assumptions with a one‑day holding period and a 95 % confidence interval. Each firm bases the parameters on interest‑rate and currency movements observed over the prior quarter (and uses the four most recent quarters for average‑VAR calculations); MDLZ also includes commodity‑price moves, while PM focuses on interest‑rate and forward‑currency rates.  Thus the time‑horizon and confidence level are essentially identical.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) Quantitatively, all key figures are correct: both companies use a 95% confidence interval and a one-day holding period, and both rely on the prior quarter for point-in-time VAR and the four prior quarters for average VAR calculations—these match the original answer exactly. (2) The LLM correctly identifies that MDLZ includes commodity prices in its observations while PM focuses on interest rates and forward currency rates, which is a nuanced but accurate distinction present in the ground truth. (3) The multi-hop reasoning is sound: the model synthesizes information across both companies’ methodologies, correctly aligning time horizons and confidence levels, and highlighting similarities and minor differences. (4) The only minor shortcoming is that the LLM does not explicitly mention PM’s use of the four preceding quarters for 'high and low' VAR amounts, which is included in the ground truth. While not critical to the main comparison, this detail slightly reduces completeness. However, the omission does not affect the overall correctness of the comparison. Wording differs but maintains semantic equivalence. Thus, the answer is factually correct, well-reasoned, and fully relevant.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1337,
        "completion_tokens": 360,
        "total_tokens": 1697
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Apple's reliance on China Mainland for manufacturing, as a component of its Greater China segment, compare with Microsoft's operational footprint in Greater China, particularly in terms of regional support infrastructure and localized product offerings?",
      "original_answer": "Apple relies heavily on China Mainland for manufacturing, which is a key part of its Greater China segment that also includes Hong Kong and Taiwan. This reliance exposes Apple to risks such as trade tensions, tariffs, and supply chain disruptions. Microsoft operates in Greater China through its regional operations center in Singapore, which supports Japan, India, Greater China, and Asia-Pacific. Microsoft also localizes many of its products to reflect local languages and conventions, modifying user interfaces and translating text to better serve the region. Both companies are significantly engaged in Greater China, but Apple's exposure is more supply-chain intensive while Microsoft's is more focused on localized customer engagement and regional support infrastructure.",
      "llm_answer": "Apple’s Greater China segment is anchored by a heavy reliance on China Mainland manufacturing – the company’s supply chain is largely outsourced to contract makers in China and its long‑lived assets there consist mainly of production facilities, retail stores and related infrastructure (Apple 10‑K p. 9; p. 52). In contrast, Microsoft’s footprint in Greater China is built around a regional operations center in Singapore that provides order‑processing, vendor‑management and logistics support for the market and emphasizes product localization (language, UI, etc.) rather than direct manufacturing in China (Microsoft 10‑K p. 16).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Apple's reliance on China Mainland for manufacturing as part of its Greater China segment, noting outsourced production and long-lived assets such as facilities and retail stores, which matches the original answer’s emphasis on supply-chain intensity. It also accurately contrasts this with Microsoft’s operational model, highlighting the regional operations center in Singapore (not in Greater China), which supports order processing, vendor management, and logistics—consistent with the ground truth. The localization of Microsoft’s products (language, UI) is correctly noted. (2) There are no numeric values, dates, or financial figures in the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the absence of incorrect numbers and correct referencing of 10-K pages (p.9, p.52 for Apple; p.16 for Microsoft) supports factual grounding, earning full marks. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies (Apple and Microsoft), compares their operational models in Greater China, and correctly distinguishes supply-chain reliance (Apple) vs. regional support and localization (Microsoft). The only minor shortcoming is that the LLM answer does not explicitly name Hong Kong and Taiwan as part of Apple’s Greater China segment, slightly reducing completeness. Also, it omits Microsoft’s broader Asia-Pacific support scope (Japan, India, etc.), though the core point about regional infrastructure is preserved. (4) Despite these small omissions, the semantic meaning and factual core are equivalent to the original answer, with strong contextual relevance and accurate entity identification (Apple, Microsoft, Greater China, Singapore, localization, manufacturing). Thus, the correctness score is 9 due to minor completeness gaps, but all other dimensions are strong.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1381,
        "completion_tokens": 526,
        "total_tokens": 1907
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does UPS's use of pricing models for foreign currency derivatives (classified as Level 2) contrast with GE's use of Level 3 valuation techniques in its insurance and pension liabilities, particularly regarding the role of unobservable inputs?",
      "original_answer": "UPS primarily uses pricing models with observable inputs like yield curves and exchange rates for its foreign currency derivatives, which are classified as Level 2 due to reliance on market-observable data. In contrast, GE employs Level 3 valuation techniques—such as discounted cash flow (DCF) methodologies—for certain insurance and pension liabilities, where significant unobservable assumptions are required. This distinction highlights that while UPS’s derivatives are grounded in active market data, GE’s long-duration insurance contracts and postretirement benefit obligations require internal modeling with assumptions not corroborated by market data, resulting in a higher degree of estimation uncertainty.",
      "llm_answer": "UPS values its foreign‑currency swaps, forwards and options with internal pricing models that “maximize the use of market‑observable inputs … such as yield curves, foreign‑currency exchange rates and forward prices,” so the contracts are placed in the Level 2 hierarchy (UPS 10‑K, p. 137‑138). By contrast, GE measures its insurance‑contract reserves and pension obligations using Level 3 techniques that “use significant unobservable inputs…such as assumptions about future cash‑flows, mortality, discount rates and other management‑derived estimates,” which means the liabilities rely heavily on inputs that are not observable in the market (GE 10‑K, p. 46‑47). Thus UPS’s valuations are driven by observable market data, whereas GE’s valuations depend on subjective, unobservable assumptions.",
      "correctness_score": 10,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 10,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is factually accurate, complete, and semantically equivalent to the ground truth. (1) It correctly identifies that UPS uses Level 2 valuation for foreign currency derivatives based on observable inputs like yield curves and exchange rates, while GE uses Level 3 techniques involving unobservable inputs for insurance and pension liabilities. (2) There are no numerical values requiring calculation in this question; the answer appropriately references qualitative inputs (e.g., assumptions about cash flows, mortality, discount rates) without introducing incorrect figures. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies (UPS and GE), two types of financial instruments (derivatives vs. insurance/pension liabilities), and two levels of the fair value hierarchy (Level 2 vs. Level 3), drawing a valid contrast regarding the role of observable vs. unobservable inputs. (4) The answer cites specific examples from each company’s 10-K (page references included), accurately characterizing the nature of the inputs and the resulting valuation hierarchy classification. Wording differs slightly from the original but preserves full meaning and adds contextual detail (e.g., naming specific instruments like swaps, forwards, options), enhancing clarity without introducing error. All evaluation dimensions are fully satisfied.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1402,
        "completion_tokens": 384,
        "total_tokens": 1787
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong compare to Colgate-Palmolive's operational performance in the same market, given both companies' reported activities in the region?",
      "original_answer": "Coca-Cola relies on Swire Beverages for distribution in Hong Kong, where Swire is one of Coca-Cola's top bottling partners, contributing to a significant portion of Coca-Cola’s non-U.S. unit case volume, which totaled 83% of worldwide volume in 2021. In the same region, Colgate-Palmolive reported $2,867 million in Asia Pacific net sales in 2021, with growth led by the Greater China region, particularly in Oral Care categories such as toothpaste and manual toothbrushes. While Coca-Cola’s distribution strategy in Hong Kong is managed through its bottler partner, Colgate-Palmolive directly manages its operations and achieved 3.0% organic sales growth in Asia Pacific, driven by volume increases and cost savings. This comparison highlights differing market strategies—Coca-Cola through a key bottling partner versus Colgate-Palmolive through direct brand growth—within the same geographic region.",
      "llm_answer": "Coca‑Cola does not operate its own bottling plants in Hong Kong; instead it relies on Swire Beverages – an independent bottler that handles bottling and distribution for Hong Kong (as well as mainland China, Taiwan and other territories)【page_7】. By contrast, Colgate‑Palmolive’s own operations in the region (included in its Greater China coverage) helped drive its Asia‑Pacific segment to post a 6 % rise in net sales and a 9 % increase in operating profit in 2021, showing strong performance rather than dependence on a single third‑party distributor【page_42】.",
      "correctness_score": 6,
      "quantitative_accuracy": 5,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies Coca-Cola's reliance on Swire Beverages for distribution in Hong Kong and Colgate-Palmolive's direct operations in the region, which aligns with the ground truth. However, there are significant quantitative inaccuracies. The LLM states that Colgate-Palmolive's Asia-Pacific segment had a '6% rise in net sales' and '9% increase in operating profit' in 2021, but the ground truth reports $2,867 million in Asia Pacific net sales (without specifying year-over-year percentage change) and 3.0% organic sales growth — not 6% net sales growth. The 9% operating profit increase is not mentioned in the original answer and cannot be verified against the provided ground truth. (2) The dollar amount ($2,867 million) is correct in the original but omitted in the LLM response, reducing completeness and quantitative accuracy. The LLM introduces performance metrics not present in the ground truth, which constitutes a factual overreach. (3) The multi-hop reasoning is partially sound: the model correctly contrasts Coca-Cola’s third-party distribution model with Colgate-Palmolive’s direct operations. It captures the strategic difference in market approach, which is central to the question. However, it fabricates specific financial growth figures not supported by the original data, undermining the reasoning chain. (4) Contextual relevance is high because the answer addresses both companies in the Hong Kong/Asia context and draws a meaningful comparison. Qualitative accuracy is moderate due to correct entity and strategic identification but docked for unsupported metrics. Quantitative accuracy is low due to incorrect percentages. Correctness score reflects partially correct information with major numerical errors that affect the reliability of the conclusion.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1382,
        "completion_tokens": 492,
        "total_tokens": 1874
      },
      "error": null
    },
    {
      "question_id": 214,
      "question": "How does BAC's investment in CDOs, which contain embedded derivatives, compare to JPM's valuation methodology for similar structured notes with embedded derivatives, particularly in terms of risk exposure and modeling techniques?",
      "original_answer": "BAC invests in CDOs that are part of its broader involvement with VIEs, and while the Corporation does not consolidate these vehicles, it recognizes maximum loss exposure tied to the value of its investment balances. These CDOs are linked to embedded derivatives, as noted in the context of hybrid instruments where credit protection has been sold to the issuer, exposing the investor to credit events. JPM, on the other hand, explicitly discloses that structured notes with embedded derivatives are valued using discounted cash flow analyses and models such as Black-Scholes or simulation models, depending on the derivative features. JPM also adjusts valuations for its own credit risk (DVA), indicating a more detailed and model-driven approach to managing the risk of these instruments. This comparison highlights differing approaches to both risk exposure and valuation transparency in handling similar financial products.",
      "llm_answer": "BAC’s CDO holdings are part of its VIE and securitisation activities and are measured at fair value using Level 3 inputs that rely on internal credit‑risk models and unobservable assumptions to capture the embedded‑derivative component (see Note 6 on CDOs and the Level 3 fair‑value tables) [page_128][page_155]. JPM, on the other hand, values similar structured notes with embedded derivatives through discounted‑cash‑flow analyses that explicitly model the embedded option with Black‑Scholes, simulation or other option‑pricing techniques and then adjust for its own credit‑ and funding‑risk (CVA/FVA), classifying the instruments at Level 2 or Level 3 depending on input observability [page_186][page_187].",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the original (ground truth) answer. (1) It correctly identifies BAC's involvement with CDOs containing embedded derivatives through VIEs and securitization activities, noting that these are measured at fair value using Level 3 inputs and internal credit-risk models—consistent with the ground truth's emphasis on unobservable assumptions and risk exposure tied to investment balances. (2) For JPM, the LLM accurately states that structured notes with embedded derivatives are valued using discounted cash flow analyses and models like Black-Scholes or simulation techniques, which matches the original answer. It also correctly adds that JPM adjusts for credit- and funding-valued adjustments (CVA/FVA), a detail not in the original but factually correct and enriching—though DVA was mentioned in the original, CVA/FVA are related and contextually appropriate. (3) The multi-hop reasoning is sound: the model synthesizes information across two firms (BAC and JPM), compares their valuation methodologies, and links them to risk modeling and input levels (Level 2/3), demonstrating correct cross-entity analysis. (4) Minor difference: the original emphasizes BAC’s 'maximum loss exposure' and lack of consolidation of VIEs, which the LLM omits, slightly reducing completeness. However, the core comparison on risk exposure and modeling techniques is preserved. No numeric inaccuracies; all financial concepts are correctly used. Wording differs but semantic meaning is equivalent or superior. Hence, high scores across all dimensions with a 9 in correctness due to slight omission of BAC’s non-consolidation and loss exposure framing.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1429,
        "completion_tokens": 459,
        "total_tokens": 1889
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the voting structure of CMCSA's Class B Common Stock compare to NFLX's common stock voting rights, given the specific limitations outlined in CMCSA's disclosure?",
      "original_answer": "CMCSA's Class B Common Stock has limited voting rights, only allowing votes on specific matters such as exiting the core payments business, certain consolidation or merger transactions, or amendments to the certificate of incorporation, and votes are calculated by multiplying shares held by the applicable conversion rate. In contrast, NFLX grants one vote per share on all matters to be voted upon by stockholders, providing more generalized voting power. CMCSA's disclosure also indicates that Class B Common Stock was issued and outstanding as of 2023, reinforcing the structured governance framework in place.",
      "llm_answer": "CMCSA’s Class B common stock does not carry the normal voting power of a typical share – holders can vote only on a narrow set of matters (e.g., a merger, exit of the core‑payments business or certain charter amendments) and, when they do vote, each share’s vote is multiplied by the applicable conversion rate【V_10k_2023 page_90】. By contrast, every share of Netflix’s common stock is entitled to one vote on all shareholder proposals【NFLX_10k_2023 page_61】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) It correctly identifies that CMCSA's Class B Common Stock has limited voting rights, only on specific matters such as mergers, exit from the core payments business, or charter amendments, and that votes are calculated using the conversion rate—this matches the original answer exactly. It also correctly states that NFLX provides one vote per share on all matters, highlighting the broader voting rights. (2) There are no numeric values requiring calculation (e.g., dollar amounts, percentages, or share counts), so quantitative accuracy is not compromised; all referenced disclosures (page numbers and document types) are consistent with factual sourcing. (3) The multi-hop reasoning—comparing governance structures across two companies using their respective 10-Ks—is sound and well-executed. The LLM synthesizes information from both CMCSA and NFLX filings appropriately. (4) The only minor omission is that the LLM does not explicitly mention that CMCSA’s Class B shares were 'issued and outstanding as of 2023,' which reinforces the current applicability of the structure. While implied by citing the 2023 10-K, the explicit confirmation in the ground truth adds a small degree of completeness missing here. Otherwise, semantic equivalence is strong, wording is clear, and all key facts are present. Hence, a score of 9 is warranted for correctness, with full marks for quantitative accuracy and contextual relevance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1274,
        "completion_tokens": 416,
        "total_tokens": 1690
      },
      "error": null
    },
    {
      "question_id": 215,
      "question": "How does the treatment of embedded derivatives within CDOs by Morgan Stanley compare to JPMorgan Chase's valuation methodology for similar instruments, given their respective involvement in structured note products?",
      "original_answer": "Morgan Stanley treats CDOs as hybrid instruments containing embedded derivatives, where credit protection has been sold to the issuer of the note, and if there is a credit event of a reference entity, the principal balance of the note may not be repaid in full. JPMorgan Chase, on the other hand, values structured notes using discounted cash flow analyses that consider the embedded derivative features through models like Black-Scholes or simulation models, with adjustments for the Firm's own credit risk (DVA). Both firms recognize the complexity and risk associated with these instruments, but differ in how they disclose and value the embedded derivatives within their portfolios.",
      "llm_answer": "Morgan Stanley classifies its investments in CLNs and CDOs as “Other Credit Contracts” and measures them at fair value, using the observable fair‑value of the underlying liabilities and the firm’s interest in the VIE rather than a detailed pricing model. JPMorgan Chase, however, values comparable structured notes with embedded derivatives by running discounted‑cash‑flow and option‑pricing (e.g., Black‑Scholes or simulation) models, then adjusting for its own credit risk (DVA), and places those valuations in Level 2 or Level 3 of the fair‑value hierarchy. Thus, Morgan Stanley takes a broader fair‑value approach, while JPMorgan Chase applies a more explicit, model‑driven valuation methodology.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Morgan Stanley's treatment of CDOs/CLNs as hybrid instruments measured at fair value using observable inputs and its interest in VIEs, rather than detailed pricing models—consistent with the original answer’s emphasis on hybrid treatment and credit protection. It also accurately describes JPMorgan Chase’s use of discounted cash flow and option-pricing models (e.g., Black-Scholes or simulation), including DVA adjustments for own credit risk, which matches the original answer. (2) There are no numeric values (e.g., dollar amounts, percentages, dates) in either answer, so quantitative accuracy is not compromised; all financial concepts are correctly represented. (3) The multi-hop reasoning is sound: the model synthesizes information across two firms, compares their valuation methodologies for structured notes with embedded derivatives, and correctly contrasts Morgan Stanley’s broader fair-value approach with JPMorgan’s model-driven method. (4) The LLM adds slightly more detail (e.g., reference to Level 2/3 of fair value hierarchy, classification as 'Other Credit Contracts') not in the original but consistent with plausible SEC filing disclosures, enhancing completeness without introducing error. The only minor gap is that the original emphasizes the risk of non-repayment upon credit events in CDOs, which the LLM implies but does not explicitly state. However, this does not detract significantly from the overall correctness. Semantic equivalence is maintained, and the answer fully addresses the comparative valuation methodology question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1363,
        "completion_tokens": 451,
        "total_tokens": 1815
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Abbott's exposure to intellectual property risks, particularly regarding patent enforcement, intersect with AbbVie's legal actions through its subsidiary Forest Laboratories Holdings Limited to protect the exclusivity of Vraylar, and what implications does this have for both companies' pharmaceutical revenue streams?",
      "original_answer": "Abbott faces significant risks related to the expiration or loss of intellectual property protection, which could reduce future revenues and operating income. In parallel, AbbVie's subsidiary Forest Laboratories Holdings Limited is actively involved in patent enforcement litigation concerning Vraylar (cariprazine), seeking to prevent generic competition from companies like Sun Pharmaceutical and Aurobindo Pharma. This litigation, initiated in the U.S. District Court for the District of Delaware in December 2019, aims to preserve market exclusivity for Vraylar, a key pharmaceutical product. If successful, the enforcement of these patents would protect AbbVie’s revenue from Vraylar. However, if generic versions are allowed to enter the market, both companies could face competitive pressure—Abbott due to its reliance on strong IP protections and AbbVie through reduced exclusivity for Vraylar—highlighting the interplay between IP enforcement and pharmaceutical revenue sustainability.",
      "llm_answer": "Abbott warns that challenges to its patents – such as the DexCom infringement suits it is both defending and bringing (see p.17) and the broader risk that loss or invalidation of IP could cut future revenues (see p.12) – represent a material threat to its pharmaceutical earnings. In contrast, AbbVie, through its wholly‑owned subsidiary Forest Laboratories Holdings Limited, is actively suing generic manufacturers to enforce cariprazine (Vraylar) patents and preserve the drug’s exclusivity (see p.136), a move that safeguards Vraylar’s contribution to AbbVie’s net pharmaceutical revenues (see p.139). Thus, while Abbott’s exposure to IP risk could erode its revenue stream, AbbVie’s aggressive patent enforcement is aimed at protecting and sustaining its own drug‑specific cash flow.",
      "correctness_score": 8,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 8,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is largely correct and aligns well with the ground truth in terms of factual content and reasoning. (1) It accurately identifies Abbott's exposure to intellectual property risks as a material threat to its pharmaceutical revenues, citing the general risk of patent loss and specific litigation like the DexCom suits. While the ground truth does not mention DexCom, this detail does not contradict the original answer and may reflect additional context from the source document (e.g., p.17 reference), so it does not count as an error. (2) Quantitatively, there are no specific numbers, dates, or financial figures in either answer that require verification—both avoid making numerical claims, so quantitative accuracy is not compromised. The LLM correctly references the Vraylar (cariprazine) patent enforcement by AbbVie’s subsidiary Forest Laboratories Holdings Limited, consistent with the original. (3) The multi-hop reasoning is sound: it connects Abbott’s general IP vulnerability with AbbVie’s proactive patent litigation to protect Vraylar’s revenue, highlighting the contrast and intersection in how IP risks affect both companies. The implication for pharmaceutical revenue streams is appropriately framed—Abbott faces potential erosion, while AbbVie is actively defending its revenue. (4) The only minor shortcoming is that the LLM omits mention of the specific generic competitors (Sun Pharmaceutical and Aurobindo Pharma) and the December 2019 Delaware litigation filing, which are part of the original answer. While not critical to the core conclusion, their absence slightly reduces completeness. However, the essence of the interplay between IP enforcement and revenue sustainability is preserved. Hence, the answer is contextually relevant and semantically equivalent, warranting high scores with a slight deduction in qualitative accuracy for partial completeness.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1490,
        "completion_tokens": 510,
        "total_tokens": 2001
      },
      "error": null
    },
    {
      "question_id": 216,
      "question": "How does Citigroup's use of foreign currency forwards and cross-currency swaps in its net investment hedging strategy compare to Morgan Stanley's reliance on VaR models for managing market risk exposure in trading portfolios?",
      "original_answer": "Citigroup utilizes foreign currency forwards, cross-currency swaps, and options to hedge foreign exchange risk on equity investments in non-U.S.-dollar subsidiaries, recording changes in fair value in CTA within AOCI under ASC 815. In contrast, Morgan Stanley employs Value-at-Risk (VaR) models as a key risk management tool to estimate aggregate market risk exposure across trading portfolios, incorporating diversification and hedging effects, while acknowledging VaR's limitations in capturing extreme market events or liquidity constraints. Southern Company Gas, which connects the two entities, also uses weather derivative instruments and other risk management tools to mitigate weather-related revenue volatility in its gas marketing services segment, demonstrating a broader industry application of risk management frameworks.",
      "llm_answer": "Citigroup’s net‑investment‑hedge program is a “hands‑on” hedge that uses foreign‑currency forwards, cross‑currency swaps, options and foreign‑currency‑denominated debt to offset the translation risk of its non‑U.S. subsidiaries, with the fair‑value changes of those instruments recorded in the foreign‑currency translation adjustment (CTA) in AOCI【page_153】. In contrast, Morgan Stanley does not rely on specific currency‑hedge contracts for this purpose; it manages market‑risk exposure across its trading books primarily through a Value‑at‑Risk (VaR) framework that quantifies potential one‑day losses using historical‑simulation and Monte‑Carlo models, supplemented by stress‑testing and scenario analysis【page_60】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns well with the ground truth. (1) It correctly identifies Citigroup's use of foreign currency forwards, cross-currency swaps, and options (adding foreign-currency-denominated debt, which is consistent but not in the original answer) to hedge net investments, with fair value changes recorded in CTA within AOCI under ASC 815—this matches the original answer's core content. It accurately contrasts this with Morgan Stanley's reliance on VaR models for managing market risk in trading portfolios, correctly noting the use of historical-simulation and Monte Carlo methods, stress testing, and scenario analysis. (2) There are no numeric values in the question or answers requiring verification, so quantitative accuracy is not compromised. (3) The multi-hop reasoning is sound: the model correctly synthesizes Citigroup’s hedging instruments and accounting treatment with Morgan Stanley’s VaR-based risk framework. The only minor gap is that the original answer includes a connecting reference to Southern Company Gas and broader industry context, which the LLM omits—this does not detract from the direct comparison asked but slightly reduces completeness. (4) The LLM answer is semantically equivalent in addressing the core comparison, uses correct entities (Citigroup, Morgan Stanley), accurate financial terms (VaR, AOCI, CTA), and appropriate contextual citations (page references). The addition of 'foreign-currency-denominated debt' is plausible and consistent with Citigroup’s strategy but not present in the original; this does not introduce error but adds slight over-specificity. Overall, the response is factually correct, well-reasoned, and fully relevant to the question.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 468,
        "total_tokens": 1876
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does Colgate-Palmolive's use of option contracts to hedge foreign exchange risk compare to Walmart's exposure through firm commitments, given the impact of these financial instruments on their respective cash flow stability?",
      "original_answer": "Colgate-Palmolive utilizes option contracts as part of its foreign exchange risk management strategy, hedging portions of its foreign currency purchases and firm commitments with contracts valued using observable market rates, aiming to minimize earnings volatility from currency fluctuations. These contracts, with a typical duration of no more than 12 months, are aligned with the company's policy of matching derivative terms to underlying exposures. In contrast, Walmart reports $37.2 billion in unrecorded purchase obligations as of January 31, 2025, including $15.9 billion due within one year, which includes firm commitments for inventory, utilities, and capital expenditures. These obligations are legally binding and expose Walmart to cash flow risks if market conditions change. The impact of Colgate's use of option contracts is to stabilize the U.S. dollar equivalent value of foreign currency transactions, while Walmart lacks such financial instrument protections on its firm commitments, leaving it more exposed to market volatility affecting its cash flow stability.",
      "llm_answer": "Colgate‑Palmolive actively uses option (and forward) contracts to hedge the foreign‑currency value of its assets, liabilities, firm commitments and forecasted transactions, maintaining about $9.9 billion of net cash‑flow hedges at September 2024 and deferring the resulting gains or losses in AOCI so that they offset currency‑related swings in earnings and cash flow【page_121】. Walmart’s exposure is reflected in cash‑flow‑hedge results tied to its firm‑commitment obligations – for example a $56 million gain in 2024 and a $‑203 million loss in 2023 reported in other comprehensive income – indicating that its cash‑flow stability depends on the performance of those hedges and is of a smaller, more variable magnitude than Colgate‑Palmolive’s option‑based program【page_54】.",
      "correctness_score": 4,
      "quantitative_accuracy": 3,
      "qualitative_accuracy": 5,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies. It claims Colgate-Palmolive has $9.9 billion in net cash-flow hedges as of September 2024, but this figure is not present in the ground truth and cannot be verified from the provided data. Similarly, it states Walmart reported a $56 million gain in 2024 and a -$203 million loss in 2023 in other comprehensive income related to cash flow hedges on firm commitments—this information is absent from the ground truth and contradicts it, as the original answer states Walmart lacks financial instrument protections like hedges on its firm commitments. Instead, Walmart reports $37.2 billion in unrecorded purchase obligations (including $15.9 billion due within one year), which the LLM fails to mention at all. (2) Quantitative accuracy is low: the only correct number in the LLM answer is the implied fiscal year 2024/2023, but even then, the reported gains/losses are unsupported. The $9.9 billion hedge value is fabricated or misattributed. The ground truth does not provide any hedge values for Colgate, so this number cannot be confirmed. (3) Multi-hop reasoning is partially sound in structure—comparing Colgate’s use of options to Walmart’s exposure—but flawed in execution. The LLM incorrectly assumes Walmart uses cash flow hedges on firm commitments, when the ground truth explicitly states Walmart lacks such protections. This undermines the core comparison about cash flow stability. The reasoning incorrectly equates Walmart’s firm commitments with active hedging, when in fact the absence of hedging is the key differentiator. (4) Contextual relevance is moderate because the answer attempts to address the comparison between Colgate’s hedging strategy and Walmart’s exposure, using appropriate financial terminology and referencing AOCI and cash flow stability. However, due to major factual errors and incorrect attribution of hedging activities to Walmart, the qualitative accuracy is compromised. The answer creates a false equivalence between two fundamentally different risk management approaches.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1485,
        "completion_tokens": 560,
        "total_tokens": 2045
      },
      "error": null
    },
    {
      "question_id": 217,
      "question": "How does the adoption timeline of ASU No. 2023-07 for segment reporting differ between TMO and CVS, and what specific disclosures were required by each company as a result of this new standard?",
      "original_answer": "TMO adopted ASU No. 2023-07 for its 2024 annual report and applied it retrospectively, resulting in increased disclosures in Note 11. CVS adopted the standard on January 1, 2024, for fiscal year reporting and is required to provide additional disclosures related to its reportable segments, including the CODM's title, how the CODM uses segment operating results, and alignment of interim reporting with annual requirements, as detailed in Note 19. Both companies applied the standard retrospectively to prior periods, but TMO implemented it specifically for the 2024 annual report while CVS also aligned it with interim reporting requirements starting after December 15, 2024.",
      "llm_answer": "Thermo Fisher says it adopted ASU 2023‑07 in its 2024 annual report (and all interim periods thereafter) on a retrospective basis, which required it to add expanded segment‑expense tables and new chief‑operating‑decision‑maker (CODM) disclosures in Note 11. CVS, on the other hand, began applying the same ASU on 1 January 2024 for its fiscal‑year filing (with interim periods becoming effective after 15 December 2024) and disclosed the CODM’s title and role, how the CODM uses segment operating results to evaluate performance and allocate resources, and aligned interim segment reporting in Note 19.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth. (1) All key facts are correct: TMO adopted ASU No. 2023-07 for its 2024 annual report with retrospective application, resulting in expanded disclosures in Note 11, including segment-expense tables and CODM disclosures. CVS adopted the standard on January 1, 2024, with interim reporting requirements effective after December 15, 2024, and disclosed the CODM’s title, role, use of segment results, and aligned interim reporting in Note 19. (2) Quantitative accuracy is perfect: dates (January 1, 2024; December 15, 2024), note numbers (11 and 19), and adoption timelines are correctly stated. Format variations (e.g., '1 January 2024' vs 'January 1, 2024') are acceptable. (3) Multi-hop reasoning is sound—LLM correctly synthesizes adoption timelines and disclosure differences between two companies across different reporting periods and notes. The only minor shortcoming is that the LLM does not explicitly state that both applied the standard retrospectively to prior periods, though it implies it by mentioning retrospective adoption for TMO and alignment with interim periods for CVS. (4) Contextual relevance is excellent—the answer directly addresses both parts of the question: adoption timelines and specific disclosures. Wording differs slightly but maintains semantic equivalence. A score of 9 is justified due to near-perfect factual alignment with a minor omission regarding explicit mention of retrospective application for both companies.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1331,
        "completion_tokens": 422,
        "total_tokens": 1754
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "What was the impact of the Philippines' corporate income tax rate reduction on ACN's 2021 effective tax rate, and how does this compare to AMD's disclosure of tax reform effects in the same period?",
      "original_answer": "ACN benefited from the Philippines' corporate income tax rate reduction enacted in Q1 2021, which favorably impacted its 2021 effective tax rate of 21.8%, partially offsetting other unfavorable tax factors like GILTI-related foreign tax credit limitations. In contrast, AMD reported no impact from the Tax Reform Act in 2021, as shown by the $0 value in their tax provision table for that line item, indicating different exposure or geographic applicability of the reform.",
      "llm_answer": "Accenture’s 2022 Form 10‑K does not disclose any effect of the Philippines’ corporate‑income‑tax rate cut on its 2021 effective tax rate – the sections provided (e.g., the legal‑tax discussion on page 30) contain no mention of that reform. In contrast, AMD explicitly notes that the Philippines tax‑rate reduction “partially offset” a 0.1‑percentage‑point rise in its 2021 effective tax rate, mitigating the overall increase 【page 94】.",
      "correctness_score": 1,
      "quantitative_accuracy": 1,
      "qualitative_accuracy": 1,
      "contextual_relevance": 3,
      "detailed_feedback": "The LLM answer is fundamentally incorrect in both direction and entity attribution. (1) It claims Accenture's 10-K does not disclose the Philippines tax rate reduction, but the ground truth states that ACN *did* benefit from it and it *favorably impacted* its 2021 effective tax rate of 21.8%. The LLM incorrectly reverses this, asserting no disclosure by ACN. (2) It incorrectly attributes the impact of the Philippines tax cut to AMD, claiming AMD 'explicitly notes' it 'partially offset' a tax rate increase. However, the ground truth states AMD reported *no impact* from the Tax Reform Act, with a $0 value in their tax provision table. The LLM has swapped the roles of the companies: it falsely claims ACN had no disclosure and AMD had a positive impact, when in reality ACN benefited and AMD had no impact. (3) The multi-hop reasoning fails completely: the comparison between ACN and AMD is inverted, undermining the core of the question. (4) The cited page 94 reference for AMD is inconsistent with the ground truth and cannot support the claim made. While the question involves two companies and a comparison (addressed structurally), the factual content is entirely reversed. Quantitative accuracy is 1 because no correct numbers are used (e.g., ACN’s 21.8% effective tax rate is omitted, and no correct figures are presented). Qualitative accuracy is 1 due to complete misattribution of events and reasoning failure. Contextual relevance is 3 because the answer attempts the right structure and topic but with incorrect data.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1239,
        "completion_tokens": 419,
        "total_tokens": 1659
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Honeywell's use of pricing models for valuing fixed income investments in its pension plans compare to 3M's valuation methodology, particularly in terms of reliance on observable versus unobservable inputs?",
      "original_answer": "Honeywell values its fixed income investments using pricing models, broker bids, or discounted cash flows, incorporating adjustments for credit and liquidity risks when necessary. 3M similarly uses pricing models that rely on observable inputs like interest rates and yield curves for Level 2 fixed income investments, while Level 3 investments depend on unobservable inputs such as projected annuity payments and discount rates. Both companies apply discounted cash flow techniques in certain cases and disclose the use of NAV practical expedients for certain fund types, though 3M explicitly categorizes its fixed income investments by valuation hierarchy levels, whereas Honeywell focuses on the nature of the valuation adjustments made.",
      "llm_answer": "Honeywell values corporate bonds, mortgage‑ and asset‑backed securities in its pension plans by applying pricing models, broker bids, comparable quotes or discounted‑cash‑flow calculations – approaches that use observable market data (interest‑rate curves, yields, credit spreads) but also add adjustments for credit and liquidity risks that are not directly observable【page_110】. 3M’s pension‑plan valuation follows the fair‑value hierarchy: Level 1 assets are priced from active‑market quotes, Level 2 assets are valued with observable inputs such as yields and credit spreads, and only Level 3 assets rely on unobservable inputs, so the company leans heavily on observable data and reserves unobservable assumptions for the least‑observable holdings【page_75】. In short, Honeywell’s models blend observable inputs with explicit unobservable risk adjustments across its fixed‑income holdings, while 3M confines unobservable inputs to Level 3 assets and otherwise depends on observable market information.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Honeywell uses pricing models, broker bids, and discounted cash flows with adjustments for credit and liquidity risks—inputs that blend observable and unobservable factors. 3M uses a fair value hierarchy (Level 1, 2, 3), relying on observable inputs for Level 2 (e.g., yields, credit spreads) and unobservable inputs only for Level 3, such as projected annuity payments and discount rates. The LLM correctly identifies that 3M categorizes by valuation level while Honeywell emphasizes the nature of adjustments. (2) There are no numeric values in the question or answer requiring calculation, so quantitative accuracy is not applicable beyond correct use of terminology—no errors present. (3) Multi-hop reasoning is sound: the model synthesizes information across two companies’ pension valuation methodologies, correctly contrasting Honeywell’s blended approach with 3M’s structured hierarchy. (4) Semantic equivalence is strong; the LLM captures all key points from the original answer, only slightly omitting the explicit mention of NAV practical expedients for certain funds (a minor detail). This omission prevents a perfect 10 but does not undermine the core accuracy. Wording differences are acceptable and do not affect meaning. Contextual relevance is excellent—directly addresses the comparison of observable vs. unobservable input reliance.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1453,
        "completion_tokens": 402,
        "total_tokens": 1856
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does the voting power distribution tied to Class B common stock conversion mechanisms at CMCSA compare with the share repurchase strategy for Class A and Class C shares at GOOGL, given the differing impacts on equity structure and shareholder control?",
      "original_answer": "At CMCSA, Class B common stockholders control 33 1/3% of the voting power, which is non-dilutable and convertible share-for-share into Class A common stock, while the voting power of Class A shares depends on the total number of Class A and Class B shares outstanding. This structure ensures continued influence by Class B holders. In contrast, GOOGL has repurchased $62.2 billion of Class A and Class C shares in 2023, with an additional $36.3 billion remaining under the repurchase authorization. These repurchases reduce the number of outstanding shares, increasing the proportional ownership of remaining shareholders, including those holding Class B shares, which carry 10 votes per share. Since Class B shares automatically convert to Class A upon sale or transfer, these repurchases indirectly influence the balance of voting control by reducing the total pool of shares subject to Class A voting calculations. Thus, while CMCSA’s structure protects Class B voting power through fixed percentages and conversion rules, GOOGL’s equity control dynamics are shaped by aggressive repurchases that affect the relative ownership and voting influence of remaining shareholders.",
      "llm_answer": "Comcast’s Class B shares carry 15 votes each and, by charter, represent about one‑third of the total voting power – a share that is protected from dilution and can be converted share‑for‑share into Class A stock without altering that 33 % voting‑power split (CMCSA 10‑K p. 91). Alphabet’s approach is to repurchase large volumes of its one‑vote Class A and zero‑vote Class C shares, shrinking the overall share pool and thereby increasing the relative weight of the remaining voting shares (and the unchanged Class B holdings), which reshapes the equity structure and concentrates shareholder control (GOOGL 10‑K p. 81).",
      "correctness_score": 6,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 7,
      "contextual_relevance": 9,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual inaccuracies, particularly regarding the voting rights of CMCSA's Class B shares. The original answer states that Class B shareholders control 33 1/3% of the voting power, but does not specify vote-per-share; the LLM incorrectly claims '15 votes each,' which is not supported by the ground truth and appears to be fabricated or misattributed. This is a major quantitative error. Additionally, the LLM cites specific 10-K page numbers (p. 91, p. 81), which may be accurate but are not verifiable from the ground truth and introduce unsupported precision. (2) The GOOGL repurchase figures ($62.2 billion executed, $36.3 billion remaining) are completely omitted in the LLM answer, representing a critical omission of quantitative data. While the general mechanism of share repurchases increasing relative ownership is correctly described, the absence of actual figures from 2023 undermines quantitative accuracy. (3) The reasoning and synthesis are qualitatively sound: the LLM correctly contrasts CMCSA’s structural protection of voting power via fixed percentage and convertibility with GOOGL’s use of repurchases to concentrate control. It accurately notes that Class B shares at GOOGL carry 10 votes (though this detail is missing in the LLM output, it's implied by context), and that repurchases of Class A and C shares increase the relative influence of Class B. The automatic conversion of GOOGL Class B to Class A upon transfer is omitted, weakening completeness. (4) Contextual relevance is high—the response directly addresses the comparison of equity structures and control mechanisms. However, due to the incorrect vote count for CMCSA Class B shares and missing dollar amounts for GOOGL repurchases, the correctness score is limited to 6, reflecting partially correct information with significant factual gaps and one major error.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1476,
        "completion_tokens": 513,
        "total_tokens": 1990
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Altria's exposure to FCTC-driven advertising restrictions, as outlined in its 2022 10-K, compare to Philip Morris International's experience with implemented advertising bans in markets like Australia and Russia, and what implications does this have for their respective international marketing strategies?",
      "original_answer": "Altria acknowledges in its 2022 10-K that while the U.S. is a signatory to the FCTC, it is not a party to the agreement, and therefore FCTC-driven advertising restrictions have limited direct regulatory impact in the U.S. However, the document notes that the FCTC has called for and influenced advertising bans globally. In contrast, Philip Morris International (PMI) reports that in markets like Australia and Russia, governments have already banned the display of tobacco products at the point of sale, which severely restricts visibility and marketing potential. These bans align with FCTC guidelines recommending the prohibition of all forms of communication with adult smokers. Given that Altria's primary market remains the U.S., where such bans are not yet widespread, its international marketing strategy is less constrained compared to PMI, which operates more heavily in FCTC-compliant markets where advertising and product visibility restrictions are already enforced. This divergence suggests that PMI must adapt more aggressively to restrictive advertising environments, while Altria faces more potential future risk if the U.S. adopts similar FCTC-aligned policies.",
      "llm_answer": "Altria’s 2022 10‑K says that the WHO Framework Convention on Tobacco Control – now signed by 181 countries – “recommends … bans on tobacco advertising, marketing, promotions and sponsorships” and that many of those jurisdictions could impose such rules on Altria’s overseas brands (MO 10‑K, p. 13/39). In contrast, Philip Morris International reports that “governments have banned the display of tobacco products at the point of sale … in Australia and Russia” and that “partial or total bans on advertising, marketing, promotions and sponsorships” are already in effect in those markets (PM 10‑K, p. 42). Thus Altria faces a largely prospective exposure to FCTC‑driven advertising limits, while PMI is dealing with concrete bans that force it to rely on reduced‑risk products and alternative, compliance‑friendly marketing channels in those countries.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) It correctly identifies that Altria’s 2022 10-K acknowledges the FCTC's influence but notes limited direct impact in the U.S., while PMI faces implemented advertising and display bans in Australia and Russia. The key factual elements—FCTC’s global reach, Altria’s prospective risk, and PMI’s current operational constraints—are all present and correct. (2) There are no numeric values (e.g., dollar amounts, percentages) in either the question or answers, so quantitative accuracy is not applicable in a traditional sense; however, the citation of page numbers (p. 13/39 for Altria, p. 42 for PMI) is consistent with typical 10-K referencing and does not introduce factual error, thus scoring full marks. (3) The multi-hop reasoning is sound: the model correctly synthesizes information across two companies’ filings, compares prospective vs. implemented regulatory risks, and infers strategic implications—Altria faces future risk while PMI already operates under restrictions. The only minor shortcoming is that the LLM does not explicitly mention that the U.S. is a signatory but not a party to the FCTC, a nuance present in the original answer that clarifies the legal distinction. Additionally, the LLM omits the point about FCTC calling for prohibition of all forms of communication with adult smokers, slightly reducing completeness. (4) Despite these small omissions, the answer captures the core contrast and strategic implication accurately, with excellent contextual relevance and semantic equivalence. The conclusion about PMI adapting to compliance-friendly channels aligns well with the ground truth’s emphasis on adaptation in restrictive markets.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1550,
        "completion_tokens": 472,
        "total_tokens": 2022
      },
      "error": null
    },
    {
      "question_id": 218,
      "question": "How does Goldman Sachs' competitive disadvantage to JPMorgan in cryptocurrency offerings, influenced by Dodd-Frank compliance burdens, compare with Morgan Stanley's exposure to regulatory risks in emerging markets that could impact its cross-border cryptocurrency-related financial activities?",
      "original_answer": "Goldman Sachs faces a competitive disadvantage compared to JPMorgan due to Dodd-Frank compliance burdens that restrict its ability to offer cryptocurrencies and digital assets, as stated in its 2024 10-K filing. JPMorgan, as a competitor, offers these products, giving it a strategic edge in evolving financial markets. Meanwhile, Morgan Stanley's 2024 10-K highlights exposure to regulatory risks in emerging markets, where uncertain and rapidly changing laws could hinder its ability to structure and enforce cryptocurrency-related transactions across borders. Both firms face regulatory constraints, but Goldman Sachs' limitations are self-imposed due to U.S. regulatory frameworks, while Morgan Stanley's risks stem from external geopolitical and legal environments in foreign jurisdictions.",
      "llm_answer": "Goldman Sachs says that the Dodd‑Frank Act’s bans on proprietary trading and its derivative‑transaction rules raise compliance costs and limit the firm’s ability to offer cryptocurrency products, leaving it at a competitive disadvantage to rivals such as JPMorgan that are subject to fewer U.S. restrictions (GS 10‑K p. 13). Morgan Stanley, on the other hand, warns that the uncertain and often stricter regulatory, sanctions‑and‑AML regimes in emerging‑market jurisdictions expose it to regulatory risk that could hinder any cross‑border cryptocurrency‑related financial activities (MS 10‑K p. 24).",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and aligns closely with the ground truth. (1) All factual elements are correct: Goldman Sachs' competitive disadvantage due to Dodd-Frank compliance burdens (specifically proprietary trading bans and derivative rules) limiting cryptocurrency offerings compared to JPMorgan is accurately cited from the GS 2024 10-K (p.13). Morgan Stanley's exposure to regulatory, sanctions, and AML risks in emerging markets affecting cross-border crypto activities is correctly drawn from MS 10-K (p.24). (2) There are no numeric values, dates, or calculations in the question or answers, so quantitative accuracy is not applicable—no errors present. (3) The multi-hop reasoning is sound: the model correctly synthesizes regulatory constraints across two firms, distinguishing between U.S.-based structural limitations (Goldman) versus external geopolitical risks (Morgan Stanley), though it does not explicitly state the contrast in the nature of the regulatory constraints (self-imposed vs. external) as clearly as the original. This minor omission in framing prevents a perfect 10 on qualitative accuracy. (4) The answer is fully contextually relevant, directly addressing the comparative regulatory challenges impacting cryptocurrency-related activities at both firms. Wording differs slightly but maintains semantic equivalence. No factual inaccuracies or hallucinations.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1385,
        "completion_tokens": 385,
        "total_tokens": 1770
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the adoption of ASU 2022-04 impact the disclosure requirements for supplier finance obligations at both 3M and GE, particularly in terms of the roll-forward information introduced in 2024?",
      "original_answer": "The adoption of ASU 2022-04 requires companies like 3M and GE to disclose key terms, balance sheet presentation, and the confirmed amount outstanding under supplier finance programs. For 3M, this includes a $0.3 billion balance in confirmed invoices as of December 31, 2024, with $1.5 billion of invoices confirmed and paid during the year. GE adopted the standard on January 1, 2023, and in line with the ASU's phased requirements, began providing the annual roll-forward information in 2024. This roll-forward requirement, applicable prospectively from January 1, 2024, aligns both companies' disclosures to include changes in confirmed invoice balances over the reporting period, enhancing transparency in their accounts payable disclosures.",
      "llm_answer": "Both companies now must disclose the details of their supplier‑finance programs and provide an annual “roll‑forward” of activity. 3M’s Note 16 reflects this by reporting the year‑end balance of confirmed invoices ($0.3 bn in 2024) and the 2024 roll‑forward of invoices confirmed and paid ($1.5 bn each)【page_77】. GE’s filing states that it adopted ASU 2022‑04 on 1 Jan 2023 and that the standard requires a retrospective disclosure with a prospective roll‑forward beginning 1 Jan 2024, noting that the adoption had no material impact on its consolidated statements【page_46】.",
      "correctness_score": 9,
      "quantitative_accuracy": 10,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer correctly identifies the key impacts of ASU 2022-04 on both 3M and GE, including the requirement for enhanced disclosures and the annual roll-forward information starting January 1, 2024. It accurately reports 3M's $0.3 billion year-end balance of confirmed invoices and $1.5 billion in invoices confirmed and paid during 2024. For GE, it correctly states adoption occurred on January 1, 2023, and that the prospective roll-forward began in 2024. The statement that adoption had no material impact on GE’s consolidated statements aligns with typical disclosures under such standards. (2) All numeric values—$0.3 billion, $1.5 billion, January 1, 2023, and January 1, 2024—are factually correct and match the ground truth. Number formats are consistent and acceptable. (3) The multi-hop reasoning is sound: the model synthesizes information across two companies, correctly applies the phased implementation timeline of ASU 2022-04, and links the 2024 roll-forward requirement to both firms’ disclosures. It correctly interprets that GE adopted early (2023) but complies with the prospective disclosure requirement in 2024. (4) The only minor shortcoming is that the LLM does not explicitly mention 'key terms' and 'balance sheet presentation' as required elements of the new disclosure, which are included in the original answer. However, the focus on roll-forward and balances captures the core of the new requirements. Wording differs slightly but maintains semantic equivalence on all critical points. Thus, the answer is highly accurate with only a small omission in completeness, warranting a 9/10 on correctness and qualitative accuracy.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1342,
        "completion_tokens": 457,
        "total_tokens": 1799
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does MDT's geographic revenue concentration in 'Other Countries' expose it to similar regulatory and reimbursement challenges as those impacting AMGN's drug pricing strategies in international markets?",
      "original_answer": "MDT reports $32.251 billion in net sales from 'Total other countries, excluding Ireland' in fiscal 2024, which represents the majority of its revenue outside the U.S. This significant international exposure subjects MDT to regulatory environments where governments increasingly control healthcare costs through reimbursement and coverage limitations. As outlined in the DHR filing, these limitations include direct price controls, reference pricing, and mandatory licensing, which tie reimbursement to outcomes and constrain revenue potential. Similarly, AMGN notes that many countries outside the U.S. apply price controls, therapeutic-reference pricing, and volume caps, which limit both pricing and market access for its biologics. Both companies face parallel pressures from global payers seeking cost predictability and imposing narrower coverage criteria, despite operating in different healthcare sectors.",
      "llm_answer": "Medtronic’s 2024 net sales were ≈ $32 billion of its $33 billion total coming from “total other countries, excluding Ireland” (≈ 97 % of non‑U.S. sales) 【page_105】. Because those foreign markets are largely governed by government‑run health systems that impose price caps, reference‑pricing, health‑technology‑assessment reviews and other reimbursement limits—exactly the regulatory and pricing pressures Amgen describes for its international drug pricing (e.g., mandatory price controls, price referencing, HTA cost‑effectiveness reviews) 【page_18】—Medtronic’s heavy reliance on “other countries” exposes it to similar pricing and reimbursement challenges.",
      "correctness_score": 9,
      "quantitative_accuracy": 9,
      "qualitative_accuracy": 9,
      "contextual_relevance": 10,
      "detailed_feedback": "The LLM answer is highly accurate and conveys the same core information as the ground truth with only minor differences in precision. (1) Quantitatively, the LLM correctly identifies MDT's net sales from 'total other countries, excluding Ireland' as approximately $32 billion out of $33 billion total revenue, aligning closely with the ground truth figure of $32.251 billion. The ≈97% calculation is reasonable and supports the narrative of heavy international concentration. While '≈$32 billion' slightly rounds down from $32.251B, this is acceptable under format variation. (2) The entities (MDT, AMGN), fiscal year (2024), and metrics (international revenue, regulatory mechanisms) are all correctly identified. (3) The reasoning is sound: the LLM correctly synthesizes that both MDT and AMGN face similar international pricing pressures—such as price controls, reference pricing, and health technology assessments—due to government-run healthcare systems seeking cost containment. It draws a valid cross-company, multi-hop comparison despite different therapeutic areas. (4) The answer is contextually excellent, directly addressing how MDT’s geographic revenue concentration exposes it to regulatory and reimbursement challenges parallel to AMGN’s. The only minor shortcoming is slightly less precise numerical reporting and omission of specific terms like 'mandatory licensing' or 'volume caps' mentioned in the original, but the key mechanisms (price caps, HTA reviews, reference pricing) are covered. Thus, the answer is factually correct, well-reasoned, and semantically equivalent, warranting a 9/10.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1407,
        "completion_tokens": 438,
        "total_tokens": 1845
      },
      "error": null
    },
    {
      "question_id": 219,
      "question": "How does the combined capital buffer requirement above the minimum risk-based capital ratios for SCHW and JPM compare, considering their respective application of countercyclical and capital conservation buffers?",
      "original_answer": "SCHW is subject to a stress capital buffer of 2.5% and a capital conservation buffer of 2.5%, with the countercyclical capital buffer at 0%, resulting in a total buffer requirement of 5.0% above the minimum risk-based capital ratios. JPM, on the other hand, applies a fixed capital conservation buffer of 2.5% and a stress capital buffer (SCB) of 2.9%, with the countercyclical buffer also at 0%, leading to a total buffer requirement of 5.4% above the minimum. Therefore, JPM has a slightly higher combined buffer requirement than SCHW due to its higher SCB. This comparison reflects how both firms are subject to similar regulatory buffer frameworks, but with firm-specific SCB and CCyB determinations.",
      "llm_answer": "Schwab’s consolidated capital‐buffer sits at 5.0 % above the minimum risk‑based ratios – a 2.5 % stress‑capital buffer on the holding company plus a 2.5 % capital‑conservation buffer on its banking subsidiary, with the counter‑cyclical buffer at 0 % (see SCHW page 122). JPMorgan Chase Bank, by contrast, only carries the 2.5 % capital‑conservation buffer (the counter‑cyclical buffer is also 0 %) (see JPM page 291). Thus, Schwab’s total buffer is roughly twice the size of JPM’s.",
      "correctness_score": 3,
      "quantitative_accuracy": 4,
      "qualitative_accuracy": 3,
      "contextual_relevance": 7,
      "detailed_feedback": "Detailed explanation: (1) The LLM answer contains significant factual errors. It correctly identifies SCHW's total buffer as 5.0% (2.5% stress capital buffer + 2.5% capital conservation buffer) and notes the 0% countercyclical buffer, which aligns with the ground truth. However, it incorrectly states that JPM only has a 2.5% capital conservation buffer and omits the 2.9% stress capital buffer (SCB), which is a critical error. The ground truth confirms JPM has both a 2.5% capital conservation buffer and a 2.9% SCB, totaling 5.4%. The LLM's conclusion that Schwab’s buffer is 'roughly twice the size' of JPM’s is factually wrong—JPM actually has a higher total buffer (5.4% vs 5.0%). (2) Quantitative accuracy is partially correct for SCHW but fails for JPM: the 2.9% SCB for JPM is missing, leading to an incorrect total (2.5% vs correct 5.4%). The comparison calculation is therefore invalid. (3) Multi-hop reasoning is flawed: the model fails to synthesize JPM’s full buffer requirements despite referencing the correct document page. It does not recognize that both SCB and capital conservation buffers apply to JPM, undermining the comparative analysis. (4) Contextual relevance is acceptable—the answer addresses the right entities (SCHW, JPM), buffers, and regulatory framework—but the core quantitative and comparative conclusions are incorrect, severely limiting usefulness. The answer misleads rather than informs due to major omissions in JPM’s buffer structure.",
      "hop_count": 3,
      "document_relationship": "inter_document_cross_company",
      "pattern": null,
      "token_usage": {
        "prompt_tokens": 1312,
        "completion_tokens": 405,
        "total_tokens": 1718
      },
      "error": null
    }
  ],
  "evaluation_summary": {
    "total_questions": 600,
    "successful_evaluations": 600,
    "failed_evaluations": 0,
    "average_correctness_score": 7.91,
    "average_quantitative_accuracy": 8.58,
    "average_qualitative_accuracy": 8.09,
    "average_contextual_relevance": 9.5,
    "score_distribution": {
      "excellent": 391,
      "good": 86,
      "fair": 95,
      "poor": 28
    }
  },
  "original_experiment_metadata": {
    "model": "gpt-oss-120b-reasoning",
    "experiment": "e6_semantic_retrieval",
    "pattern": "qualitative_3hop_cross_company_type1",
    "total_questions": 600,
    "successful": 600,
    "failed": 0,
    "elapsed_seconds": 22709.79,
    "timestamp": "2026-02-02T21:58:55.533683"
  }
}